data_2ker_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ker _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 N--CA 1.458 -0.603 0 N-CA-C 113.581 0.57 . . . . 10.0 113.581 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.768 HG13 ' HB3' ' A' ' 67' ' ' LEU . 12.3 m -137.77 -142.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.26 -0.274 . . . . 10.0 110.26 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.605 ' N ' HG21 ' A' ' 6' ' ' VAL . . . -58.65 10.04 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.658 1.183 . . . . 10.0 113.932 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' A' ' 6' ' ' VAL . 35.4 mt-10 72.59 -50.43 0.7 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.4 0.889 . . . . 10.0 113.4 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.2 m -74.78 -8.53 56.71 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.858 0.318 . . . . 10.0 111.858 -172.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.815 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.4 m -95.96 131.97 41.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -132.93 114.46 14.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.529 -0.305 . . . . 10.0 110.616 -171.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.797 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -90.07 155.67 18.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.894 0.855 . . . . 10.0 112.471 175.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -135.05 152.7 51.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.058 -1.46 . . . . 10.0 107.058 170.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.554 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 4.3 pm0 -108.7 105.87 15.66 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.365 0.603 . . . . 10.0 110.863 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 p -108.34 75.93 1.01 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.536 0.684 . . . . 10.0 109.583 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 66.63 -86.21 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.542 -1.208 . . . . 10.0 111.801 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -117.5 24.52 11.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 10.0 110.456 -176.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.35 100.29 4.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.857 -0.794 . . . . 10.0 108.857 -174.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 m -90.58 95.31 10.09 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.797 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.0 p-10 -83.43 107.87 16.21 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.749 -1.114 . . . . 10.0 111.701 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.77 107.95 21.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 122.034 0.921 . . . . 10.0 109.157 174.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.724 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.46 110.34 22.51 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.88 -1.509 . . . . 10.0 110.176 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.815 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 24.6 t30 -82.18 159.4 23.29 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -151.73 23.53 0.93 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.769 -0.729 . . . . 10.0 112.241 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.636 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -75.58 -17.04 60.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.64 0.237 . . . . 10.0 111.64 -177.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 85.06 -4.26 0.92 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.362 1.039 . . . . 10.0 111.171 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.636 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 13.6 p-10 -126.88 156.29 41.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.593 174.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.58 126.07 28.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.451 -0.795 . . . . 10.0 111.139 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.517 ' H ' HG22 ' A' ' 46' ' ' ILE . 24.6 m -132.42 140.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.065 0.459 . . . . 10.0 111.068 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.815 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 5.4 m -88.19 123.91 33.3 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.91 146.14 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-O 121.454 0.645 . . . . 10.0 110.381 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.731 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -124.96 159.43 31.24 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.348 -0.842 . . . . 10.0 109.489 177.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.603 HG23 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.2 138.5 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-O 121.043 0.449 . . . . 10.0 110.544 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -106.97 116.42 31.9 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.694 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 57.1 m-85 -92.71 163.61 13.69 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.727 0.775 . . . . 10.0 112.062 -174.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 47.4 m -52.91 -21.97 4.97 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.238 -1.346 . . . . 10.0 111.693 170.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -135.56 -74.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.871 -0.518 . . . . 10.0 109.84 170.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 40' ' ' TRP . . . 148.76 80.46 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.713 -0.756 . . . . 10.0 112.117 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -74.66 20.0 0.13 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.022 0.379 . . . . 10.0 112.022 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.463 ' H ' ' C ' ' A' ' 38' ' ' GLY . 30.4 t90 59.77 87.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.64 0.733 . . . . 10.0 112.218 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.749 ' N ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.58 29.06 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.115 -0.948 . . . . 10.0 112.831 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.749 ' HD3' ' N ' ' A' ' 41' ' ' ALA . 9.8 Cg_endo -88.86 54.23 1.95 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.802 1.668 . . . . 10.0 112.198 -173.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.1 m 173.3 111.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.086 0.866 . . . . 10.0 111.259 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 131.62 10.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.815 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -82.13 142.7 13.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.112 0.482 . . . . 10.0 110.409 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -101.51 146.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.932 -0.576 . . . . 10.0 109.976 -178.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -87.27 143.38 34.42 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 169.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -41.16 95.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.523 2.816 . . . . 10.0 113.574 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.716 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 95.26 6.86 59.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.838 -1.172 . . . . 10.0 112.137 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.3 -174.46 44.9 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.183 -0.532 . . . . 10.0 113.098 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.724 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 10.0 m0 -120.11 167.39 12.26 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.932 -0.634 . . . . 10.0 111.061 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.14 111.18 5.31 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.768 -1.197 . . . . 10.0 107.768 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 m -77.58 130.53 37.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.433 -0.803 . . . . 10.0 110.061 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.694 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 49.8 m-85 -137.4 134.98 36.52 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.668 -0.864 . . . . 10.0 108.668 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.92 105.1 0.1 Allowed 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 124.23 0.957 . . . . 10.0 110.297 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.86 -157.85 0.65 Allowed Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.891 -1.05 . . . . 10.0 112.564 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.811 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 26.8 p90 . . . . . 0 C--N 1.316 -0.881 0 O-C-N 122.447 -0.443 . . . . 10.0 111.894 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.811 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 15.5 t80 . . . . . 0 CA--C 1.515 -0.404 0 N-CA-C 108.066 -1.087 . . . . 10.0 108.066 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -66.63 130.21 31.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.124 -1.065 . . . . 10.0 108.124 173.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.9 p -113.1 -37.37 4.79 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.064 -0.654 . . . . 10.0 111.322 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -140.05 136.99 8.09 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.826 -1.178 . . . . 10.0 112.496 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.768 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.0 mt -86.61 152.12 22.87 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.769 -0.826 . . . . 10.0 108.769 171.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.691 ' C ' HG12 ' A' ' 6' ' ' VAL . 6.5 m-70 -138.55 146.24 41.65 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.241 -1.022 . . . . 10.0 108.241 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 124.4 31.11 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 118.908 -1.117 . . . . 10.0 110.407 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.731 ' HB2' HG22 ' A' ' 32' ' ' THR . 41.9 t -92.27 158.55 16.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.214 -0.903 . . . . 10.0 109.807 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 C--N 1.327 -0.37 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 174.052 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.532 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 94.8 Cg_endo . . . . . 0 N--CA 1.459 -0.537 0 CA-C-O 120.762 0.234 . . . . 10.0 112.046 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.808 HG11 ' HB3' ' A' ' 67' ' ' LEU . 2.9 m 49.19 -148.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.919 0.887 . . . . 10.0 112.36 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.648 ' N ' HG21 ' A' ' 6' ' ' VAL . . . -58.92 1.32 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.635 1.346 . . . . 10.0 114.635 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 51.8 mt-10 72.22 -33.79 0.28 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.437 0.695 . . . . 10.0 112.322 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.433 ' H ' ' C ' ' A' ' 7' ' ' ALA . 10.2 m -76.86 -13.08 60.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.634 0.254 . . . . 10.0 111.421 -173.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.836 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.9 m -98.35 143.59 12.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.066 -0.716 . . . . 10.0 109.066 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -136.75 111.97 9.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.758 -0.201 . . . . 10.0 110.731 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.789 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -89.19 160.29 17.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.794 0.807 . . . . 10.0 112.546 175.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' THR . 36.9 t80 -142.76 173.95 11.09 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.549 -1.649 . . . . 10.0 106.549 173.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -119.24 103.4 9.47 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.366 -0.534 . . . . 10.0 110.508 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.7 m -104.6 54.29 0.72 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.982 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 60.38 88.99 0.07 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.554 -0.748 . . . . 10.0 111.537 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 49.5 ttt180 63.9 14.49 8.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.581 0.705 . . . . 10.0 111.538 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -130.95 95.72 3.89 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.779 -1.193 . . . . 10.0 107.779 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 61.5 m -86.35 97.67 10.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.31 0.576 . . . . 10.0 109.694 177.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.789 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.7 p-10 -83.19 108.43 16.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.723 -1.126 . . . . 10.0 111.318 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.99 105.84 18.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 122.203 1.001 . . . . 10.0 109.055 175.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.691 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -99.11 109.16 21.9 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 113.707 -1.588 . . . . 10.0 109.993 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.836 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 15.7 t30 -80.08 156.93 26.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -140.11 13.4 3.07 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.704 -0.76 . . . . 10.0 113.041 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.07 156.9 20.88 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 117.21 0.505 . . . . 10.0 109.844 173.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.32 -8.62 56.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.024 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -116.62 152.81 33.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.646 0.736 . . . . 10.0 111.721 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.76 125.36 26.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.695 -1.139 . . . . 10.0 110.256 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.591 ' H ' HG21 ' A' ' 46' ' ' ILE . 35.5 m -124.19 137.31 57.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.109 0.48 . . . . 10.0 111.67 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.768 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 3.8 m -85.69 121.95 29.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.71 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.469 ' HB ' HG12 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -122.78 148.11 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.295 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.662 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.2 OUTLIER -127.44 160.17 32.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.147 -0.933 . . . . 10.0 109.02 176.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.607 HG22 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -132.03 132.04 61.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.598 0.713 . . . . 10.0 111.337 -176.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -103.55 109.74 21.52 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.522 -176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.793 ' HH ' ' HB1' ' A' ' 41' ' ' ALA . 28.4 m-85 -89.59 165.31 14.33 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.584 0.706 . . . . 10.0 111.733 -176.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 52.4 m -52.55 -29.73 26.97 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.231 -1.35 . . . . 10.0 111.397 168.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -126.42 -77.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 10.0 110.206 172.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 40' ' ' TRP . . . 145.01 79.02 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.228 -0.986 . . . . 10.0 111.691 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -76.38 20.01 0.23 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.218 0.451 . . . . 10.0 112.218 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.431 ' H ' ' C ' ' A' ' 38' ' ' GLY . 3.1 t90 66.99 87.41 0.12 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.727 0.811 . . . . 10.0 111.641 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.793 ' HB1' ' HH ' ' A' ' 35' ' ' TYR . . . -170.85 27.77 0.01 OUTLIER Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 113.444 0.905 . . . . 10.0 113.444 174.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.737 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 9.9 Cg_endo -89.16 56.41 2.01 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.726 1.617 . . . . 10.0 112.754 -172.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.2 m 172.27 114.56 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.616 0.766 . . . . 10.0 111.33 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.61 132.0 8.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.1 -0.704 . . . . 10.0 109.1 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.768 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -81.13 138.88 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.199 0.523 . . . . 10.0 110.06 176.227 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.618 HD12 HG23 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -97.05 145.12 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 115.362 -0.835 . . . . 10.0 109.704 -179.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -83.2 141.38 42.96 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 107.966 -1.124 . . . . 10.0 107.966 169.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -47.77 91.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.298 2.666 . . . . 10.0 112.692 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.654 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 104.37 5.91 42.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.161 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.78 -172.4 36.11 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.382 -0.437 . . . . 10.0 112.863 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.691 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 13.4 m0 -120.32 167.28 12.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.514 0.673 . . . . 10.0 111.051 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.401 ' HB1' HD13 ' A' ' 46' ' ' ILE . . . -143.1 113.07 7.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 171.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -81.44 128.31 33.74 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.436 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.607 ' CG ' HG22 ' A' ' 33' ' ' VAL . 42.1 m-85 -138.78 140.52 38.64 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.332 -0.618 . . . . 10.0 109.332 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.72 101.46 0.05 Allowed 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 123.894 0.746 . . . . 10.0 110.192 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.91 -159.27 8.36 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 111.217 -0.753 . . . . 10.0 111.217 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.675 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 28.3 p90 . . . . . 0 N--CA 1.432 -1.368 0 N-CA-C 108.109 -1.071 . . . . 10.0 108.109 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.675 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 28.7 t80 . . . . . 0 CA--C 1.512 -0.51 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.9 m -63.59 131.56 29.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 107.74 -1.207 . . . . 10.0 107.74 173.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.0 t -137.95 11.82 2.87 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.27 -0.572 . . . . 10.0 110.379 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.76 118.93 0.81 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 119.803 -1.189 . . . . 10.0 112.782 173.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.808 ' HB3' HG11 ' A' ' 6' ' ' VAL . 4.4 mt -88.99 127.57 35.67 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.713 ' C ' HG13 ' A' ' 6' ' ' VAL . 17.6 m-70 -118.24 146.45 44.26 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.306 -0.861 . . . . 10.0 108.933 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.15 123.31 28.87 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.032 -1.043 . . . . 10.0 110.513 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.662 ' HB2' HG23 ' A' ' 32' ' ' THR . 42.0 t -92.7 161.01 14.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.799 -0.637 . . . . 10.0 110.205 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 . . . . . 0 C--N 1.33 -0.265 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 172.099 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.479 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 54.2 Cg_endo . . . . . 0 N--CA 1.454 -0.839 0 CA-C-O 120.92 0.3 . . . . 10.0 112.838 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.795 HG12 ' HB3' ' A' ' 67' ' ' LEU . 9.3 m -136.94 -137.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.252 -0.647 . . . . 10.0 109.252 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.66 ' N ' HG22 ' A' ' 6' ' ' VAL . . . -56.48 0.23 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.185 0.994 . . . . 10.0 113.452 174.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 6' ' ' VAL . 10.0 mt-10 74.11 -38.73 0.41 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.518 1.127 . . . . 10.0 113.264 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.1 m -75.77 -13.35 60.29 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.939 0.399 . . . . 10.0 111.318 -175.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.864 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -97.09 137.32 25.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.009 -0.737 . . . . 10.0 109.009 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -143.34 129.94 20.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.043 -0.263 . . . . 10.0 110.477 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.701 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -95.56 165.23 12.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.891 0.853 . . . . 10.0 113.179 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.407 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 87.3 t80 -145.26 154.32 42.24 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 106.72 -1.585 . . . . 10.0 106.72 170.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -105.66 108.26 19.69 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.445 -0.502 . . . . 10.0 111.389 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -99.41 -166.89 1.4 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.124 -1.065 . . . . 10.0 108.124 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.65 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -69.46 100.67 1.43 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.837 0.351 . . . . 10.0 110.541 -178.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 63.92 28.19 14.5 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.118 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.87 101.86 3.59 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 121.207 -0.197 . . . . 10.0 111.15 -169.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.457 HG23 HG11 ' A' ' 64' ' ' VAL . 16.3 m -89.63 96.71 10.81 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 170.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.701 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.1 p-10 -84.34 107.35 16.57 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 114.947 -1.024 . . . . 10.0 112.378 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.29 108.62 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.794 0.807 . . . . 10.0 108.9 174.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.752 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.6 p80 -98.39 113.97 26.14 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.218 -1.356 . . . . 10.0 110.554 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.864 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 22.6 t30 -82.03 163.42 22.11 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.592 -0.522 . . . . 10.0 109.592 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -153.39 25.2 0.77 Allowed Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.288 -0.482 . . . . 10.0 112.203 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -14.0 59.52 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.402 0.281 . . . . 10.0 111.148 -177.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 82.24 -6.03 1.4 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.919 -1.037 . . . . 10.0 110.933 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -126.24 158.58 35.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.02 0.438 . . . . 10.0 110.304 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -70.91 120.3 16.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.039 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.683 ' H ' HG21 ' A' ' 46' ' ' ILE . 29.6 m -126.19 140.75 47.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.221 0.534 . . . . 10.0 111.424 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.718 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.0 m -88.11 120.25 29.28 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.154 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.41 161.15 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 115.729 -0.669 . . . . 10.0 110.409 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.671 HG21 ' HB2' ' A' ' 70' ' ' CYS . 0.4 OUTLIER -143.13 160.88 39.58 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.474 -0.784 . . . . 10.0 109.015 176.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.578 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.58 145.27 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.45 0.643 . . . . 10.0 111.542 -175.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -114.12 110.31 19.81 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.735 -1.121 . . . . 10.0 109.719 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.814 ' HH ' ' HB2' ' A' ' 41' ' ' ALA . 11.9 m-85 -90.57 161.88 15.25 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.369 0.604 . . . . 10.0 111.622 -176.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.1 m -48.79 -38.64 22.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.263 -1.335 . . . . 10.0 112.783 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -101.6 -75.49 0.59 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.518 -0.473 . . . . 10.0 110.064 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.06 46.73 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.553 -0.832 . . . . 10.0 112.048 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.34 136.78 57.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -72.79 100.47 2.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 10.0 111.548 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.84 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.03 19.96 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.256 -0.884 . . . . 10.0 113.233 175.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.84 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 9.2 Cg_endo -87.27 58.62 3.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 CA-C-N 121.112 1.433 . . . . 10.0 112.455 -170.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 176.47 115.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.791 0.682 . . . . 10.0 111.168 170.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 128.67 6.74 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.436 0.694 . . . . 10.0 109.525 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.718 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -83.92 134.38 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.334 0.588 . . . . 10.0 110.534 177.246 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.683 HG21 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -94.67 149.29 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.009 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -86.88 146.73 41.54 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 168.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -43.19 98.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.037 2.491 . . . . 10.0 112.961 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.717 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 89.28 11.48 64.55 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.864 -1.16 . . . . 10.0 111.565 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.12 -176.81 37.78 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 121.283 -0.484 . . . . 10.0 112.418 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.752 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 17.2 m0 -115.93 166.76 11.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.793 0.806 . . . . 10.0 111.815 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB1' HD12 ' A' ' 46' ' ' ILE . . . -143.67 118.3 9.8 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.362 -1.347 . . . . 10.0 107.362 172.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.7 m -85.72 129.7 34.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.178 0.514 . . . . 10.0 110.812 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.578 ' CG ' HG21 ' A' ' 33' ' ' VAL . 56.3 m-85 -136.86 151.34 49.0 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.588 -0.894 . . . . 10.0 108.588 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.97 98.56 0.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.705 0.628 . . . . 10.0 110.562 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.45 178.49 23.11 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 115.049 -0.978 . . . . 10.0 111.107 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.1 p90 . . . . . 0 CA--C 1.534 0.35 0 CA-C-N 118.049 0.925 . . . . 10.0 110.803 -173.159 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.4 t80 . . . . . 0 N--CA 1.442 -0.849 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -59.75 128.91 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.5 p -118.04 -34.3 4.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.046 0.45 . . . . 10.0 111.169 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.84 129.71 4.75 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.062 -1.066 . . . . 10.0 112.468 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.795 ' HB3' HG12 ' A' ' 6' ' ' VAL . 3.8 mt -83.89 148.87 26.71 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.114 -1.069 . . . . 10.0 108.114 171.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.708 ' C ' HG11 ' A' ' 6' ' ' VAL . 15.4 m-70 -134.17 147.44 50.77 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.46 130.04 35.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 118.994 -1.082 . . . . 10.0 110.566 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.671 ' HB2' HG21 ' A' ' 32' ' ' THR . 43.3 t -96.14 159.72 14.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.986 -0.552 . . . . 10.0 109.58 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 CA--C 1.512 -0.489 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 172.843 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 N--CA 1.466 -0.126 0 CA-C-O 119.908 -0.122 . . . . 10.0 111.891 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.59 ' HB ' ' C ' ' A' ' 68' ' ' HIS . 0.3 OUTLIER 38.77 98.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 114.324 1.231 . . . . 10.0 114.324 177.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' A' ' 9' ' ' CYS . . . 75.99 -25.09 0.21 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.558 -0.747 . . . . 10.0 112.559 166.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 6' ' ' VAL . 24.6 mt-10 74.8 -22.19 0.27 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.224 1.009 . . . . 10.0 111.845 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.422 ' H ' ' C ' ' A' ' 7' ' ' ALA . 82.4 m -85.42 -16.5 39.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.907 0.336 . . . . 10.0 111.907 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -94.22 139.78 17.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.619 -0.512 . . . . 10.0 109.619 -177.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -141.55 127.3 19.17 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.625 -0.139 . . . . 10.0 110.625 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.809 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -98.4 164.19 12.38 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.468 1.127 . . . . 10.0 113.787 176.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.402 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 84.6 t80 -145.1 162.6 36.63 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.304 -1.771 . . . . 10.0 106.643 172.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.401 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -117.71 122.7 44.18 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.083 -0.647 . . . . 10.0 110.786 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 25.9 p -121.93 -154.39 0.59 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.78 -0.822 . . . . 10.0 108.78 175.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -67.93 91.11 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.647 0.261 . . . . 10.0 111.412 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 61.4 35.07 17.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.585 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.5 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -147.29 101.19 3.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.4 -0.818 . . . . 10.0 109.345 -173.05 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -90.42 99.37 12.41 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 170.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.809 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -84.37 110.44 18.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.871 -1.059 . . . . 10.0 111.966 -177.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.98 106.69 19.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 122.181 0.991 . . . . 10.0 108.561 171.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.804 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.4 OUTLIER -97.22 111.06 23.47 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.094 -1.412 . . . . 10.0 110.163 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.754 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.4 t30 -80.29 156.66 26.7 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.837 -0.62 . . . . 10.0 109.342 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.47 13.91 3.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.127 -0.558 . . . . 10.0 112.346 174.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.77 156.18 22.66 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.53 -8.41 56.69 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.264 0.468 . . . . 10.0 112.264 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -120.66 157.46 29.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.511 0.672 . . . . 10.0 111.75 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -71.82 117.69 13.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.827 -1.079 . . . . 10.0 110.431 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.616 ' H ' HG23 ' A' ' 46' ' ' ILE . 33.7 m -116.87 139.21 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 121.303 0.573 . . . . 10.0 111.676 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.0 m -88.94 116.88 27.55 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.734 -0.666 . . . . 10.0 109.288 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.517 HG11 HG21 ' A' ' 6' ' ' VAL . 1.1 m -112.8 164.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.452 -0.795 . . . . 10.0 110.517 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.31 153.7 40.04 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.257 -0.883 . . . . 10.0 109.212 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.562 HG22 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -130.23 137.69 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 120.937 0.399 . . . . 10.0 110.915 -174.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -100.6 116.63 32.97 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.782 -0.821 . . . . 10.0 108.782 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.635 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 45.9 m-85 -91.77 160.79 15.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.112 0.482 . . . . 10.0 111.023 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.6 m -48.47 -33.22 9.01 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.664 -1.153 . . . . 10.0 112.604 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -110.26 -69.66 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.929 0.395 . . . . 10.0 109.961 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.45 58.07 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.551 -0.833 . . . . 10.0 112.161 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.2 154.64 30.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.706 0.289 . . . . 10.0 110.681 176.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -76.46 106.45 8.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.837 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -173.62 -40.57 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 113.069 0.766 . . . . 10.0 113.069 -175.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.837 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 5.3 Cg_endo -46.86 67.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 124.884 3.723 . . . . 10.0 116.429 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER 169.96 104.43 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.179 0.992 . . . . 10.0 110.097 168.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -151.85 127.05 9.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.064 -176.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.38 132.85 30.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.277 -0.569 . . . . 10.0 109.856 174.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.616 HG23 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -96.06 147.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-N 115.112 -0.949 . . . . 10.0 109.28 -177.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -84.03 141.42 40.56 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 169.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -47.89 94.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.056 2.504 . . . . 10.0 112.366 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 97.77 14.22 41.01 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.073 -1.061 . . . . 10.0 112.106 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.66 -172.2 26.77 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 121.112 -0.566 . . . . 10.0 112.669 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.804 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 16.5 m0 -119.54 165.54 14.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.423 0.63 . . . . 10.0 111.255 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' A' ' 46' ' ' ILE . . . -139.66 111.15 7.12 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 172.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.6 m -78.74 126.79 31.2 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.394 -0.821 . . . . 10.0 110.439 -176.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.562 ' CG ' HG22 ' A' ' 33' ' ' VAL . 51.5 m-85 -134.53 146.42 49.67 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.509 -0.922 . . . . 10.0 108.509 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.03 102.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.836 0.71 . . . . 10.0 110.459 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.59 179.44 16.65 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.608 -0.997 . . . . 10.0 110.608 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.564 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 14.9 p90 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-N 118.208 1.004 . . . . 10.0 110.64 -174.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.564 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 19.1 t80 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 108.562 -0.903 . . . . 10.0 108.562 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -63.23 130.77 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.2 p -123.83 -19.04 5.84 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.203 -0.599 . . . . 10.0 111.851 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.39 130.69 4.06 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.602 -1.285 . . . . 10.0 113.159 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -94.84 148.0 22.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.399 -0.593 . . . . 10.0 109.399 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.59 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -147.98 164.54 33.47 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.254 -176.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.49 ' N ' ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -83.53 129.1 34.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.22 0.533 . . . . 10.0 111.362 177.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 32.3 t -98.19 168.3 10.33 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.509 -0.923 . . . . 10.0 108.509 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--N 1.317 -0.813 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 174.294 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.577 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 38.4 Cg_endo . . . . . 0 N--CA 1.475 0.385 0 N-CA-C 112.764 0.255 . . . . 10.0 112.764 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.871 HG11 ' HB3' ' A' ' 67' ' ' LEU . 3.9 m 47.35 -141.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.934 0.893 . . . . 10.0 111.689 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.675 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.89 -1.9 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.512 1.125 . . . . 10.0 113.368 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 6' ' ' VAL . 35.9 mt-10 76.27 -26.93 0.18 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.989 0.915 . . . . 10.0 112.655 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.84 -10.88 54.68 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.195 0.443 . . . . 10.0 112.195 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.872 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -96.22 140.56 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 -176.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -132.19 116.04 16.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.206 -0.197 . . . . 10.0 110.958 -173.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.794 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.1 161.68 15.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 122.053 0.93 . . . . 10.0 112.919 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 19' ' ' THR . 90.5 t80 -144.28 158.52 43.69 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.835 -1.53 . . . . 10.0 106.908 172.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HG3' ' OG1' ' A' ' 19' ' ' THR . 2.1 mp0 -117.0 101.78 8.79 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.33 -0.548 . . . . 10.0 111.252 -176.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.1 t -93.89 80.2 4.16 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 61.35 -89.86 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 115.005 -0.998 . . . . 10.0 110.573 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.533 ' H ' ' HD3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -118.17 26.68 9.46 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.153 0.501 . . . . 10.0 111.144 -176.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -132.34 96.0 3.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.3 m -85.28 101.95 12.96 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.245 0.545 . . . . 10.0 110.214 176.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.794 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.6 p-10 -86.19 108.38 18.32 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.845 -1.07 . . . . 10.0 111.454 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.1 107.82 21.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.891 0.853 . . . . 10.0 108.988 173.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.694 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.04 110.67 22.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.229 -1.35 . . . . 10.0 110.297 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.872 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 21.8 t30 -80.14 160.12 25.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 10.0 110.157 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.46 23.53 1.07 Allowed Glycine 0 C--O 1.226 -0.392 0 C-N-CA 121.361 -0.447 . . . . 10.0 112.207 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -75.12 -16.74 60.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.512 0.196 . . . . 10.0 111.316 -178.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 25' ' ' CYS . . . 85.11 -6.33 0.91 Allowed 'General case' 0 N--CA 1.472 0.647 0 O-C-N 124.631 1.207 . . . . 10.0 111.345 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.449 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 5.9 p-10 -126.82 157.02 40.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.959 0.409 . . . . 10.0 110.689 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.79 122.56 18.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.354 -0.839 . . . . 10.0 110.96 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.57 ' H ' HG23 ' A' ' 46' ' ' ILE . 34.6 m -129.1 140.64 48.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.076 0.465 . . . . 10.0 111.442 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.668 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.5 m -87.22 120.34 28.4 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.487 -0.561 . . . . 10.0 109.487 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.623 ' HB ' HG12 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -119.88 146.79 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 115.587 -0.733 . . . . 10.0 110.587 -179.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.587 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -125.74 161.74 26.65 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.28 -0.873 . . . . 10.0 108.834 175.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.633 HG23 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.82 133.63 58.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.35 0.595 . . . . 10.0 110.95 -176.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -106.04 112.65 25.78 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.735 -1.121 . . . . 10.0 108.696 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.464 ' HH ' ' HB1' ' A' ' 41' ' ' ALA . 15.4 m-85 -91.07 164.01 14.1 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.33 0.586 . . . . 10.0 110.959 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.7 m -50.51 -22.53 1.99 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.464 -1.243 . . . . 10.0 112.668 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -123.96 -82.37 0.64 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.987 -0.445 . . . . 10.0 111.159 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.23 51.01 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.645 -1.264 . . . . 10.0 113.084 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.36 136.05 56.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.863 -0.792 . . . . 10.0 108.863 175.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -72.95 118.31 15.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.209 0.528 . . . . 10.0 110.471 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.768 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -177.05 -45.27 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 114.95 -1.023 . . . . 10.0 111.903 -174.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.768 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 3.5 Cg_exo -37.18 68.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.886 1 C-N-CA 125.924 4.416 . . . . 10.0 117.487 -174.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 5.3 t 170.53 111.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.294 1.038 . . . . 10.0 109.759 162.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.31 126.57 9.94 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.668 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -79.98 130.11 36.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.375 0.607 . . . . 10.0 109.369 175.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.612 HD13 HG23 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -93.21 148.91 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 114.83 -1.077 . . . . 10.0 109.804 -176.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.401 ' O ' HG21 ' A' ' 46' ' ' ILE . 21.7 mt-10 -84.77 145.99 45.36 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 108.389 -0.967 . . . . 10.0 108.389 168.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -45.0 94.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.009 2.472 . . . . 10.0 112.564 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.718 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.72 15.12 53.89 Favored Glycine 0 CA--C 1.512 -0.151 0 C-N-CA 120.022 -1.085 . . . . 10.0 111.812 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 22' ' ' HIS . . . -97.26 -176.52 34.56 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 121.706 -0.283 . . . . 10.0 112.48 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.708 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 18.6 m0 -118.15 165.41 13.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.629 0.728 . . . . 10.0 111.784 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.91 115.54 8.17 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.265 -1.334 . . . . 10.0 107.929 172.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.3 m -82.56 131.19 35.22 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.598 -0.728 . . . . 10.0 110.764 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.633 ' CG ' HG23 ' A' ' 33' ' ' VAL . 53.5 m-85 -139.76 145.42 38.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.439 -0.948 . . . . 10.0 108.439 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.1 99.29 0.07 Allowed 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 123.856 0.723 . . . . 10.0 110.69 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.08 -173.59 12.35 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.295 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.437 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 2.9 p90 . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.6 0.714 . . . . 10.0 110.448 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.437 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 26.1 t80 . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.47 129.14 26.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 175.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 t -144.77 10.46 1.38 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.306 -0.557 . . . . 10.0 111.034 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.33 106.6 0.29 Allowed Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.552 -1.308 . . . . 10.0 112.951 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.871 ' HB3' HG11 ' A' ' 6' ' ' VAL . 5.8 mt -81.37 131.92 35.31 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.72 ' C ' HG13 ' A' ' 6' ' ' VAL . 18.7 m-70 -124.65 143.97 50.44 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.443 HG23 ' N ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -79.49 125.12 29.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 119.378 0.99 . . . . 10.0 110.482 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.587 ' HB2' HG23 ' A' ' 32' ' ' THR . 4.4 t -89.61 174.2 7.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.492 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 109.378 -0.601 . . . . 10.0 109.378 175.311 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.48 ' C ' HG12 ' A' ' 6' ' ' VAL . 61.1 Cg_endo . . . . . 0 N--CA 1.451 -1.025 0 N-CA-C 112.697 0.23 . . . . 10.0 112.697 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 31' ' ' VAL . 2.0 m 65.39 -49.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 125.139 1.376 . . . . 10.0 111.951 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.602 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -174.73 114.65 0.17 Allowed 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 106.133 -1.802 . . . . 10.0 106.133 -172.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.84 -14.21 5.64 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.405 -0.816 . . . . 10.0 112.396 -166.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.6 m -86.6 -15.5 39.62 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.807 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.6 m -91.67 131.47 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.019 -0.734 . . . . 10.0 109.019 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -137.39 123.56 20.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.685 -0.234 . . . . 10.0 110.494 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.77 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.45 159.08 15.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.777 0.798 . . . . 10.0 112.629 178.189 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.42 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 78.2 t80 -139.53 165.35 27.46 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.28 -1.378 . . . . 10.0 107.28 172.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.61 107.84 15.21 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.074 -0.65 . . . . 10.0 110.923 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 21.8 m -96.91 -173.73 2.79 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.519 -1.289 . . . . 10.0 107.519 170.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -62.26 98.01 0.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.111 0.481 . . . . 10.0 111.074 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 57.63 40.29 26.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.1 -0.954 . . . . 10.0 111.375 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.516 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 0.9 OUTLIER -148.09 96.06 2.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 -177.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.477 HG21 HG11 ' A' ' 64' ' ' VAL . 25.3 m -86.66 96.56 10.17 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.491 -0.559 . . . . 10.0 109.491 175.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.77 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.4 p-10 -86.04 109.79 19.06 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.458 -0.792 . . . . 10.0 112.071 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.65 107.18 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.951 0.882 . . . . 10.0 109.043 173.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.803 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 3.6 p80 -97.61 115.11 27.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.39 -1.277 . . . . 10.0 110.361 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.807 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 16.9 t-20 -81.76 160.79 23.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.53 -0.759 . . . . 10.0 109.752 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.95 39.41 0.6 Allowed Glycine 0 C--N 1.32 -0.314 0 N-CA-C 111.438 -0.665 . . . . 10.0 111.438 173.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.598 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -91.9 -16.09 27.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.612 -0.294 . . . . 10.0 111.549 -176.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 84.91 -7.66 0.92 Allowed 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.456 1.098 . . . . 10.0 110.923 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.598 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 9.3 p-10 -126.48 151.75 47.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.235 0.54 . . . . 10.0 110.686 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -69.86 126.06 28.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.422 -0.808 . . . . 10.0 111.116 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.519 ' H ' HG23 ' A' ' 46' ' ' ILE . 29.2 m -129.66 140.64 48.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.13 0.491 . . . . 10.0 111.334 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 14.4 m -92.11 117.57 29.98 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -113.04 166.34 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 115.269 -0.878 . . . . 10.0 110.88 -178.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.17 157.96 43.65 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.293 -0.867 . . . . 10.0 108.887 176.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.559 HG23 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.24 141.68 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 120.904 0.383 . . . . 10.0 111.449 -173.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -107.83 119.1 38.48 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.77 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.729 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 25.3 m-85 -92.4 164.3 13.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.21 0.529 . . . . 10.0 111.287 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 49.2 m -50.04 -24.03 2.42 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.764 -1.107 . . . . 10.0 111.875 171.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -117.68 -79.51 0.59 Allowed 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.118 -0.364 . . . . 10.0 110.033 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.57 51.53 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.344 -0.932 . . . . 10.0 112.031 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.4 141.96 57.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.4 t-105 -70.16 116.22 10.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.059 0.457 . . . . 10.0 110.499 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.765 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -175.33 -44.4 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.022 -0.99 . . . . 10.0 112.278 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.765 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 1.6 Cg_endo -40.54 70.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.874 1 C-N-CA 125.437 4.091 . . . . 10.0 116.639 -175.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER 169.6 106.46 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.383 1.073 . . . . 10.0 110.421 166.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.403 ' HB2' ' HZ ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -152.9 125.82 8.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.854 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.738 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -81.26 134.23 27.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.312 -0.555 . . . . 10.0 109.887 173.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.519 HG23 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -95.88 145.08 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-N 115.273 -0.876 . . . . 10.0 109.625 -177.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -85.35 142.78 38.19 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 168.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -41.1 93.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.41 2.74 . . . . 10.0 112.984 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.69 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 95.99 10.9 55.82 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 119.851 -1.166 . . . . 10.0 112.179 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.64 -176.49 35.49 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.525 -0.369 . . . . 10.0 112.717 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.803 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 19.8 m0 -116.04 166.87 11.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.686 0.755 . . . . 10.0 111.672 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.405 ' HB1' HD13 ' A' ' 46' ' ' ILE . . . -141.6 111.85 6.89 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.368 -1.345 . . . . 10.0 107.368 172.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.5 m -79.38 129.82 34.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.699 -0.682 . . . . 10.0 110.663 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.729 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 50.3 m-85 -140.15 142.71 35.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.406 -0.961 . . . . 10.0 108.406 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.22 104.52 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.668 0.605 . . . . 10.0 110.476 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.402 ' HA2' ' HG1' ' A' ' 19' ' ' THR . . . -67.02 -179.05 10.86 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 110.652 -0.979 . . . . 10.0 110.652 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.527 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 12.4 p90 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 122.163 0.982 . . . . 10.0 111.697 -172.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.527 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 16.5 t80 . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 108.999 -0.741 . . . . 10.0 108.999 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 19' ' ' THR . 1.6 m -59.21 129.67 21.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.703 -0.851 . . . . 10.0 108.703 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.1 p -127.0 -10.88 5.97 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.654 -0.418 . . . . 10.0 111.46 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.36 147.07 16.57 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.02 -1.086 . . . . 10.0 112.872 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.458 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.1 mt -116.94 135.62 53.57 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.103 -0.702 . . . . 10.0 109.103 177.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.436 ' N ' HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -131.56 157.81 42.62 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.727 -0.67 . . . . 10.0 109.709 -176.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.469 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -80.19 130.65 35.37 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.386 -0.526 . . . . 10.0 110.382 177.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 30' ' ' SER . 43.0 t -96.7 158.65 15.33 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.237 -0.653 . . . . 10.0 109.237 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.512 -0.505 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 172.709 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.46 -0.457 0 CA-C-O 121.228 0.429 . . . . 10.0 112.136 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.678 HG23 HG22 ' A' ' 10' ' ' VAL . 7.5 m -140.94 -147.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.479 -0.782 . . . . 10.0 110.305 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.483 ' H ' ' HB ' ' A' ' 6' ' ' VAL . . . -65.05 16.03 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.802 1.038 . . . . 10.0 113.802 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.497 ' H ' ' C ' ' A' ' 6' ' ' VAL . 2.3 mt-10 69.59 -52.07 0.61 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.922 0.889 . . . . 10.0 113.387 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.0 m -71.47 -13.4 61.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.688 0.28 . . . . 10.0 111.677 -173.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.77 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -95.59 130.65 44.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 -176.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -137.56 124.2 21.01 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.827 -0.349 . . . . 10.0 110.889 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.747 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.28 164.16 13.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.71 0.766 . . . . 10.0 112.572 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -146.81 137.42 23.8 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.35 -1.296 . . . . 10.0 107.692 169.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.438 ' HG2' ' HE1' ' A' ' 63' ' ' TYR . 23.9 mp0 -91.1 104.4 16.98 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.038 0.447 . . . . 10.0 110.551 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -102.17 82.24 2.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.29 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 69.6 -77.21 0.05 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.163 -0.926 . . . . 10.0 111.264 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -133.39 26.24 4.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.423 0.63 . . . . 10.0 110.015 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -137.88 97.42 3.42 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 -169.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.5 m -86.05 93.99 9.13 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.117 -0.697 . . . . 10.0 109.117 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.747 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 0.9 OUTLIER -84.29 108.37 17.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.868 -1.06 . . . . 10.0 111.564 -177.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -97.9 106.59 18.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.845 0.831 . . . . 10.0 108.788 174.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.806 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 3.0 p80 -97.26 113.14 24.71 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.414 -1.266 . . . . 10.0 109.926 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.77 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 15.4 t30 -81.64 149.04 28.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.953 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -131.9 20.89 4.49 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.775 -0.726 . . . . 10.0 111.886 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.06 155.9 20.63 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.431 -0.951 . . . . 10.0 108.431 175.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.92 -13.09 60.49 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -123.42 159.11 29.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.311 0.577 . . . . 10.0 111.715 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -70.14 125.23 26.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.053 -0.976 . . . . 10.0 111.139 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.478 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.5 m -127.24 138.88 53.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.521 . . . . 10.0 111.489 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.784 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.1 m -87.04 126.25 34.63 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.035 -0.529 . . . . 10.0 109.707 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.09 146.15 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.275 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.786 HG21 ' HB2' ' A' ' 70' ' ' CYS . 0.4 OUTLIER -125.81 157.09 38.4 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.382 -0.826 . . . . 10.0 109.241 178.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.638 ' H ' ' HA ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -131.45 137.94 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.38 0.61 . . . . 10.0 111.555 -177.454 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -99.03 115.03 28.04 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.024 -0.989 . . . . 10.0 109.544 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.613 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 37.6 m-85 -92.61 153.44 19.0 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.377 0.608 . . . . 10.0 110.869 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.446 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 62.5 m -48.7 -28.97 3.93 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.236 -1.347 . . . . 10.0 113.533 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -121.27 -79.09 0.6 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.839 -0.538 . . . . 10.0 111.734 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.13 126.75 0.88 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 119.905 -1.141 . . . . 10.0 112.593 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -163.48 146.25 10.03 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.538 -0.912 . . . . 10.0 108.538 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.448 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 24.0 p90 -77.26 136.14 38.5 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.646 -0.501 . . . . 10.0 109.646 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.711 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 161.51 -41.99 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 115.083 -0.962 . . . . 10.0 111.306 -171.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.711 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 9.3 Cg_endo -51.91 63.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 124.54 3.493 . . . . 10.0 116.13 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.1 m 170.93 99.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.718 1.207 . . . . 10.0 109.695 163.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.69 129.95 16.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.557 -0.534 . . . . 10.0 109.557 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.784 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -79.68 137.79 21.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.438 0.637 . . . . 10.0 110.286 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -101.12 146.3 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.638 -177.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.18 141.9 35.45 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.159 -1.052 . . . . 10.0 108.159 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -46.28 91.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.353 2.702 . . . . 10.0 112.851 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 106.88 2.17 36.61 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.205 -0.997 . . . . 10.0 112.475 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.2 -172.57 40.24 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.859 -0.686 . . . . 10.0 113.157 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.806 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 13.2 m0 -120.03 168.55 11.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.427 0.632 . . . . 10.0 111.289 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.99 109.97 5.1 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.631 -1.248 . . . . 10.0 107.631 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.1 m -79.15 126.61 30.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.527 -0.761 . . . . 10.0 110.964 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.613 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 46.9 m-85 -136.84 136.58 38.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.25 105.84 0.12 Allowed 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 124.01 0.819 . . . . 10.0 110.815 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.54 -170.47 7.52 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 120.38 -0.914 . . . . 10.0 110.955 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.665 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 4.6 p90 . . . . . 0 C--N 1.314 -0.976 0 CA-C-O 121.913 0.863 . . . . 10.0 110.784 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.665 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 12.8 t80 . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 m -66.08 126.93 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.6 p -123.49 -22.41 5.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.583 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.64 124.15 2.32 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.644 -1.265 . . . . 10.0 112.833 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.67 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.8 mt -84.99 151.91 23.84 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 170.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.59 ' C ' HG12 ' A' ' 6' ' ' VAL . 3.6 m-70 -142.57 142.22 32.14 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.439 -0.949 . . . . 10.0 108.439 -177.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.82 125.46 30.11 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.104 -1.038 . . . . 10.0 110.06 177.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.786 ' HB2' HG21 ' A' ' 32' ' ' THR . 51.7 t -95.38 154.48 17.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.532 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 109.307 -0.627 . . . . 10.0 109.307 174.822 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 29.9 Cg_endo . . . . . 0 C--O 1.234 0.296 0 CA-C-O 120.826 0.261 . . . . 10.0 112.487 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.818 HG12 ' HB3' ' A' ' 67' ' ' LEU . 2.4 m 49.3 -144.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 115.207 -0.906 . . . . 10.0 111.795 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.671 ' N ' HG22 ' A' ' 6' ' ' VAL . . . -57.32 -5.4 0.3 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.402 1.081 . . . . 10.0 113.107 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 73.9 -25.28 0.2 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.983 0.913 . . . . 10.0 113.131 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 85.4 m -83.47 -7.14 59.6 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.705 0.261 . . . . 10.0 111.705 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.828 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -97.62 138.81 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.012 -0.736 . . . . 10.0 109.012 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.21 113.88 14.99 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.499 -0.186 . . . . 10.0 110.499 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.825 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -92.87 166.15 12.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.735 0.779 . . . . 10.0 112.762 176.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 19' ' ' THR . 81.7 t80 -149.19 140.8 23.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.187 -1.369 . . . . 10.0 107.886 172.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.505 ' HG3' ' OG1' ' A' ' 19' ' ' THR . 27.5 mp0 -98.71 100.09 11.27 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.538 -0.465 . . . . 10.0 110.1 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 t -96.98 -157.32 0.58 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -64.85 94.36 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.843 0.354 . . . . 10.0 110.804 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 61.23 29.22 18.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.675 -0.693 . . . . 10.0 111.622 176.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.403 ' CE1' HG21 ' A' ' 53' ' ' THR . 0.9 OUTLIER -144.99 102.65 3.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.979 -0.378 . . . . 10.0 109.979 -172.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.9 m -90.46 96.33 10.6 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 168.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.825 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.9 p-10 -85.93 109.04 18.47 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.11 -0.95 . . . . 10.0 111.817 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.89 107.15 19.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 122.016 0.912 . . . . 10.0 108.723 174.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.728 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -99.98 110.08 22.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.105 -1.407 . . . . 10.0 110.356 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.828 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 23.4 t30 -80.51 157.55 26.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.184 -0.462 . . . . 10.0 109.999 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.43 24.12 1.22 Allowed Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.855 -0.688 . . . . 10.0 112.687 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.601 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -75.04 -18.15 60.37 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.088 0.155 . . . . 10.0 111.287 -178.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 85.23 -4.68 0.9 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.359 1.037 . . . . 10.0 111.202 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.601 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 13.1 p-10 -127.22 154.26 45.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.033 0.444 . . . . 10.0 110.953 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 127.54 33.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.393 -0.821 . . . . 10.0 111.295 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.517 ' H ' HG23 ' A' ' 46' ' ' ILE . 31.1 m -134.17 137.71 51.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.277 0.56 . . . . 10.0 111.355 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.767 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 15.0 m -86.35 123.21 31.34 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.048 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.526 ' HB ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -123.23 151.21 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.77 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.484 ' HB ' ' C ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -130.52 159.59 36.66 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.411 -0.813 . . . . 10.0 109.538 176.001 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.623 HG23 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.39 133.6 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 121.322 0.582 . . . . 10.0 111.467 -176.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -98.89 118.15 35.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.169 -0.923 . . . . 10.0 108.946 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.489 ' HH ' ' CB ' ' A' ' 41' ' ' ALA . 20.6 m-85 -92.5 157.09 16.74 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.058 0.456 . . . . 10.0 110.228 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 100.0 m -46.43 -30.09 2.0 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.925 -1.034 . . . . 10.0 112.874 174.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -107.64 -83.72 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.82 -0.55 . . . . 10.0 110.546 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.93 55.21 0.01 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 119.89 -1.147 . . . . 10.0 113.508 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -70.38 154.87 41.42 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.063 0.458 . . . . 10.0 111.166 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -74.53 118.2 17.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.918 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.762 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -176.52 -43.97 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.153 -0.93 . . . . 10.0 111.675 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.762 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 3.3 Cg_endo -44.4 69.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 125.06 3.84 . . . . 10.0 116.661 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.0 t 172.04 110.51 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.304 1.041 . . . . 10.0 109.52 163.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.27 128.54 8.31 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.935 -0.765 . . . . 10.0 108.935 174.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.767 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -81.02 139.06 18.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.333 0.587 . . . . 10.0 109.75 177.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -99.14 147.79 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 115.309 -0.859 . . . . 10.0 109.978 -177.031 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -87.35 144.54 36.03 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 168.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -41.34 96.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.515 2.81 . . . . 10.0 112.966 173.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.707 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 93.53 10.11 59.51 Favored Glycine 0 C--O 1.229 -0.173 0 C-N-CA 119.93 -1.128 . . . . 10.0 112.164 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.06 -177.05 40.77 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.455 -0.402 . . . . 10.0 113.02 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.728 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 15.4 m0 -118.08 165.28 13.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.439 0.638 . . . . 10.0 111.394 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.442 ' HB2' HG13 ' A' ' 21' ' ' VAL . . . -142.14 109.37 5.57 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.454 -1.248 . . . . 10.0 107.699 172.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.403 HG21 ' CE1' ' A' ' 18' ' ' TYR . 25.2 m -79.8 130.37 35.26 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.611 -175.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.623 ' CG ' HG23 ' A' ' 33' ' ' VAL . 52.6 m-85 -139.23 134.17 32.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 -177.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.34 103.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 O-C-N 124.032 0.832 . . . . 10.0 111.531 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.94 176.32 36.94 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 110.386 -1.086 . . . . 10.0 110.386 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 p90 . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 118.346 1.073 . . . . 10.0 110.306 -176.637 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.476 ' CE2' ' HB ' ' A' ' 65' ' ' THR . 41.4 t80 . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 109.544 -0.539 . . . . 10.0 109.544 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.55 127.86 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.771 -0.826 . . . . 10.0 108.771 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.476 ' HB ' ' CE2' ' A' ' 63' ' ' TYR . 9.0 t -141.01 8.8 2.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.96 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.25 128.36 2.07 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 119.629 -1.272 . . . . 10.0 112.622 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.818 ' HB3' HG12 ' A' ' 6' ' ' VAL . 5.2 mt -100.88 132.75 46.13 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 173.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.717 ' C ' HG11 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -126.26 148.59 49.47 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.89 124.58 29.22 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.961 -0.696 . . . . 10.0 110.846 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.48 ' HB2' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -96.93 174.52 6.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.762 -177.058 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 C--N 1.324 -0.508 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 172.069 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' HG21 ' A' ' 6' ' ' VAL . 87.2 Cg_endo . . . . . 0 N--CA 1.453 -0.855 0 N-CA-C 110.749 -0.52 . . . . 10.0 110.749 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.751 HG12 ' HB3' ' A' ' 67' ' ' LEU . 1.7 m 51.35 -147.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.055 0.542 . . . . 10.0 110.402 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.706 ' N ' HG22 ' A' ' 6' ' ' VAL . . . -58.3 4.08 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 175.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 6' ' ' VAL . 41.4 mt-10 74.57 -39.76 0.43 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.313 0.857 . . . . 10.0 113.313 175.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 32.6 m -79.07 -7.0 57.77 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.896 HG12 HD21 ' A' ' 23' ' ' ASN . 2.0 m -99.35 140.55 18.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -142.74 126.35 16.9 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.716 -0.393 . . . . 10.0 111.304 -175.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.754 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.25 164.71 12.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.99 0.9 . . . . 10.0 112.933 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.609 ' O ' ' HA ' ' A' ' 19' ' ' THR . 64.1 t80 -143.88 156.51 44.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.066 -1.424 . . . . 10.0 107.628 172.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.432 ' OE1' ' HE1' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -105.76 107.41 18.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.064 0.459 . . . . 10.0 110.858 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.529 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 33.6 m -103.82 77.6 1.47 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.608 -0.886 . . . . 10.0 108.608 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 65.26 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.514 -173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -127.67 27.56 5.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.414 0.626 . . . . 10.0 109.667 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.529 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 2.1 t80 -135.36 96.29 3.44 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 -172.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.4 m -85.41 96.3 9.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.562 0.696 . . . . 10.0 110.282 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.754 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.6 p-10 -85.21 108.82 17.92 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.404 -1.271 . . . . 10.0 112.353 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -98.39 109.22 23.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.588 -0.893 . . . . 10.0 108.588 174.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.773 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.7 p80 -97.85 114.2 26.2 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.138 -1.392 . . . . 10.0 110.343 176.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.896 HD21 HG12 ' A' ' 10' ' ' VAL . 10.8 t-20 -83.09 155.92 23.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.124 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.88 32.86 1.29 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.128 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.592 ' HB2' HD22 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -82.63 -16.98 46.28 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 122.824 -0.221 . . . . 10.0 111.108 -178.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 83.85 -3.9 1.12 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.512 1.132 . . . . 10.0 111.025 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.499 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 8.7 p-10 -129.25 154.4 46.85 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.073 0.463 . . . . 10.0 110.828 174.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.63 125.54 26.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.041 -0.981 . . . . 10.0 111.183 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.547 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.5 m -133.82 140.38 46.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.511 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.739 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 7.7 m -88.12 120.93 29.95 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.065 -0.516 . . . . 10.0 109.686 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.31 149.07 23.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.549 0.69 . . . . 10.0 110.794 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.803 HG21 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -128.74 161.29 30.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.208 -0.905 . . . . 10.0 108.997 176.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.591 HG22 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -131.82 135.19 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 121.296 0.569 . . . . 10.0 111.316 -175.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -98.81 115.3 28.48 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.096 -0.956 . . . . 10.0 108.958 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.527 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 74.5 m-85 -89.08 161.56 16.46 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.113 0.483 . . . . 10.0 110.97 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.3 m -52.36 -27.01 13.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.918 -1.037 . . . . 10.0 111.171 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -118.28 -74.85 0.59 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.11 60.97 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.295 -0.955 . . . . 10.0 113.072 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -64.82 148.03 52.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.534 0.207 . . . . 10.0 110.449 172.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -71.3 112.11 7.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.843 -0.429 . . . . 10.0 109.843 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.749 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -175.89 -44.51 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 115.824 -0.625 . . . . 10.0 112.548 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.749 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -41.4 76.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 124.88 3.72 . . . . 10.0 115.908 -176.132 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 41' ' ' ALA . 1.2 m 161.91 108.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.081 1.352 . . . . 10.0 110.702 168.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.431 ' NH1' HG11 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -154.07 128.26 9.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.841 -0.8 . . . . 10.0 108.841 179.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.739 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.79 137.18 21.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 118.576 0.625 . . . . 10.0 109.986 174.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.547 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -97.87 148.42 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 115.239 -0.891 . . . . 10.0 109.783 -177.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.07 145.46 38.25 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 107.905 -1.146 . . . . 10.0 107.905 168.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -43.61 95.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.163 2.575 . . . . 10.0 112.521 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.738 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.6 14.57 55.21 Favored Glycine 0 CA--C 1.511 -0.178 0 C-N-CA 119.756 -1.211 . . . . 10.0 111.926 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.66 -176.99 35.47 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.445 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.773 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.2 m0 -117.28 165.31 13.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.411 0.624 . . . . 10.0 111.134 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -141.93 114.27 8.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.572 -1.195 . . . . 10.0 107.89 173.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.5 m -81.49 128.44 33.89 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.99 -0.55 . . . . 10.0 111.088 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.591 ' CG ' HG22 ' A' ' 33' ' ' VAL . 54.0 m-85 -137.98 144.78 41.3 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.106 -1.072 . . . . 10.0 108.106 -178.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.79 104.7 0.38 Allowed 'General case' 0 C--N 1.32 -0.712 0 O-C-N 123.618 0.574 . . . . 10.0 110.587 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.37 177.18 12.35 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.074 -1.21 . . . . 10.0 110.074 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.563 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 15.9 p90 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 118.484 1.142 . . . . 10.0 110.853 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.563 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 29.3 t80 . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 109.069 -0.715 . . . . 10.0 109.069 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -61.11 129.3 23.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.2 p -127.31 -18.57 4.46 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.563 -0.455 . . . . 10.0 112.18 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.97 122.78 1.8 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.783 -1.198 . . . . 10.0 113.136 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.751 ' HB3' HG12 ' A' ' 6' ' ' VAL . 4.4 mt -86.64 131.81 34.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.233 0.539 . . . . 10.0 109.595 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.748 ' C ' HG11 ' A' ' 6' ' ' VAL . 9.0 m170 -123.59 147.45 47.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.293 -0.867 . . . . 10.0 108.934 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.64 128.39 33.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 119.341 0.973 . . . . 10.0 110.835 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.803 ' HB2' HG21 ' A' ' 32' ' ' THR . 41.2 t -95.48 157.71 15.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.287 -177.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 C--N 1.329 -0.287 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 173.411 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.703 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 30.5 Cg_endo . . . . . 0 N--CA 1.446 -1.283 0 N-CA-C 112.87 0.296 . . . . 10.0 112.87 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 69' ' ' THR . 0.5 OUTLIER 47.58 126.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 125.661 1.584 . . . . 10.0 114.41 -177.165 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.669 ' O ' HG11 ' A' ' 10' ' ' VAL . . . 29.04 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.389 1.056 . . . . 10.0 112.513 168.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 2.0 mp0 -58.57 1.21 0.06 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.619 0.97 . . . . 10.0 113.619 -168.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.419 ' H ' ' C ' ' A' ' 7' ' ' ALA . 28.7 m -81.21 -22.02 39.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.528 175.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.827 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.6 m -90.73 137.06 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -139.28 124.39 18.9 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.963 -0.295 . . . . 10.0 110.538 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.792 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -93.63 166.79 12.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.57 0.7 . . . . 10.0 112.316 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 19' ' ' THR . 74.8 t80 -141.39 156.47 45.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.425 -1.324 . . . . 10.0 107.425 172.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.93 109.24 18.92 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.288 0.566 . . . . 10.0 110.684 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.0 t -117.15 -162.84 0.88 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -63.81 92.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 10.0 111.43 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 56.8 ttp180 62.45 31.42 17.14 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.536 0.684 . . . . 10.0 110.22 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.9 107.44 4.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.873 -174.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.5 m -97.75 95.32 7.47 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.303 0.573 . . . . 10.0 109.594 167.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.792 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.8 p-10 -84.78 108.9 17.7 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.905 -1.043 . . . . 10.0 111.94 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.59 106.39 18.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.002 0.906 . . . . 10.0 109.387 175.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.733 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 1.2 p80 -97.14 111.94 23.95 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.145 -1.388 . . . . 10.0 110.581 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.827 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 18.0 t-20 -82.3 157.58 23.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.871 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.49 34.58 1.16 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 121.332 -0.461 . . . . 10.0 112.112 171.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.579 ' HB2' HD22 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -85.17 -17.82 36.03 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 122.566 -0.373 . . . . 10.0 111.615 -176.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 86.88 -12.72 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.367 1.042 . . . . 10.0 111.233 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -123.06 154.44 38.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.983 0.42 . . . . 10.0 110.19 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -67.89 123.75 21.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.504 -0.771 . . . . 10.0 111.335 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.568 ' H ' HG22 ' A' ' 46' ' ' ILE . 27.3 m -125.86 139.17 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 121.176 0.513 . . . . 10.0 111.881 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.741 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 6.4 m -88.78 118.25 28.34 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.618 HG11 HG23 ' A' ' 6' ' ' VAL . 1.1 m -114.76 165.35 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 115.218 -0.901 . . . . 10.0 110.362 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.573 HG21 ' HB2' ' A' ' 70' ' ' CYS . 0.2 OUTLIER -148.49 161.17 42.17 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.669 -0.863 . . . . 10.0 108.669 178.281 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.64 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -136.49 139.94 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 121.41 0.624 . . . . 10.0 111.482 -174.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -107.04 116.37 31.81 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.981 -1.009 . . . . 10.0 109.078 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.511 ' HH ' ' CB ' ' A' ' 41' ' ' ALA . 27.8 m-85 -91.27 162.34 14.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.449 0.642 . . . . 10.0 111.348 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -54.48 -21.35 9.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.692 -1.14 . . . . 10.0 112.116 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -119.72 -85.03 0.66 Allowed 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.001 -0.437 . . . . 10.0 110.561 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.37 52.67 0.01 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 119.567 -1.301 . . . . 10.0 114.147 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -65.65 141.6 58.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.33 0.565 . . . . 10.0 109.77 169.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -72.33 120.72 18.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.071 0.462 . . . . 10.0 110.328 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.849 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -174.32 -40.61 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.246 -0.888 . . . . 10.0 112.338 -173.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.849 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 3.1 Cg_endo -44.08 70.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 124.938 3.759 . . . . 10.0 116.33 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 4.5 t 172.5 112.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.059 0.944 . . . . 10.0 110.215 163.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.507 ' HB2' ' HZ ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -151.11 119.04 6.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.308 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.741 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -78.56 128.46 38.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 173.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.568 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -90.63 144.66 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 115.46 -0.791 . . . . 10.0 109.621 -175.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -85.17 141.64 37.52 Favored Pre-proline 0 C--N 1.293 -1.868 0 N-CA-C 107.726 -1.213 . . . . 10.0 107.726 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -43.21 95.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.301 2.667 . . . . 10.0 112.942 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.717 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.76 13.67 56.36 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.554 -1.307 . . . . 10.0 111.87 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 22' ' ' HIS . . . -97.02 -170.41 33.74 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.106 -0.568 . . . . 10.0 112.846 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.733 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 10.6 m0 -121.46 166.44 14.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.546 0.689 . . . . 10.0 111.425 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HB2' HG13 ' A' ' 21' ' ' VAL . . . -142.68 109.7 5.55 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.56 -1.2 . . . . 10.0 108.103 171.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.2 m -78.88 129.76 34.89 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.712 -0.677 . . . . 10.0 110.606 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.64 ' CG ' HG21 ' A' ' 33' ' ' VAL . 51.3 m-85 -136.58 149.9 48.3 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.93 97.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.775 0.672 . . . . 10.0 111.16 -173.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.14 -178.53 10.73 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.107 -0.797 . . . . 10.0 111.107 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.491 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 9.0 p90 . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 122.556 1.169 . . . . 10.0 110.771 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.491 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 32.1 t80 . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 108.846 -0.798 . . . . 10.0 108.846 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.4 m -59.9 130.14 23.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.949 -0.76 . . . . 10.0 108.949 177.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 p -122.11 -29.04 4.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.653 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -138.5 121.7 2.22 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.417 -1.373 . . . . 10.0 113.63 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.703 ' HB2' ' HB2' ' A' ' 5' ' ' PRO . 5.2 mt -84.35 146.87 27.48 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.974 -0.75 . . . . 10.0 108.974 172.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.514 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 4.2 m-70 -137.92 156.34 47.98 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.846 -0.615 . . . . 10.0 109.944 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.636 HG21 HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -82.61 127.93 33.84 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.984 -0.686 . . . . 10.0 109.59 174.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.573 ' HB2' HG21 ' A' ' 32' ' ' THR . 5.1 t -100.27 171.06 8.02 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.82 -0.352 . . . . 10.0 110.582 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 C--N 1.323 -0.585 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 176.149 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 97.9 Cg_endo . . . . . 0 N--CA 1.453 -0.877 0 CA-C-O 120.771 0.238 . . . . 10.0 112.147 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.839 HG12 ' HB3' ' A' ' 67' ' ' LEU . 2.6 m 47.92 -147.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.33 -0.85 . . . . 10.0 111.818 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.636 ' N ' HG21 ' A' ' 6' ' ' VAL . . . -59.33 0.09 0.13 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.421 1.088 . . . . 10.0 113.933 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 70.49 -31.23 0.22 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.095 0.776 . . . . 10.0 113.095 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.427 ' H ' ' C ' ' A' ' 7' ' ' ALA . 56.9 m -76.44 -11.89 59.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 10.0 111.207 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.821 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -97.97 137.82 24.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.875 -0.787 . . . . 10.0 108.875 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -133.23 115.07 14.54 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.888 -0.325 . . . . 10.0 110.508 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.814 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.74 161.51 14.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.786 0.803 . . . . 10.0 113.078 177.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 19' ' ' THR . 69.0 t80 -141.2 145.69 35.97 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.118 -1.401 . . . . 10.0 107.272 170.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.472 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 27.1 mp0 -107.25 130.59 54.73 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.416 -0.514 . . . . 10.0 110.987 -176.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.3 t -118.81 -160.08 0.79 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.675 -1.231 . . . . 10.0 107.675 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -60.29 -48.33 82.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.847 0.356 . . . . 10.0 111.322 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -140.81 28.77 1.93 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.751 0.31 . . . . 10.0 110.949 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.455 ' CE1' HG23 ' A' ' 53' ' ' THR . 0.4 OUTLIER -142.87 105.51 4.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.7 -0.227 . . . . 10.0 110.613 -173.316 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 15.6 m -95.12 98.51 10.7 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.401 -0.592 . . . . 10.0 109.401 166.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.814 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -86.35 109.27 18.88 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.382 -0.826 . . . . 10.0 112.224 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.83 107.4 20.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.862 0.839 . . . . 10.0 109.065 173.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.756 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 1.9 p80 -98.18 112.53 24.47 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.433 -1.258 . . . . 10.0 110.202 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.821 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 10.7 t-20 -80.72 155.24 26.84 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.563 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -145.32 32.08 1.66 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.082 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.739 ' HB2' HD22 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -79.43 -19.95 48.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 122.831 -0.217 . . . . 10.0 111.316 -176.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 25' ' ' CYS . . . 85.71 -11.73 0.68 Allowed 'General case' 0 N--CA 1.473 0.675 0 O-C-N 124.515 1.134 . . . . 10.0 111.221 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -126.43 155.4 42.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.989 0.423 . . . . 10.0 110.416 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -67.82 121.9 16.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.54 -0.755 . . . . 10.0 111.249 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.597 ' H ' HG21 ' A' ' 46' ' ' ILE . 35.2 m -126.3 141.92 44.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 10.0 111.106 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 6.2 m -92.19 122.89 35.11 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.955 -177.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -124.01 148.02 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.8 -0.637 . . . . 10.0 111.072 -178.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.864 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -126.76 161.84 27.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 177.339 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.591 HG23 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.25 141.7 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.403 0.621 . . . . 10.0 111.787 -176.386 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -104.6 110.94 23.45 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.639 -1.164 . . . . 10.0 109.651 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.825 ' HH ' ' HB2' ' A' ' 41' ' ' ALA . 34.2 m-85 -93.82 159.13 15.33 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.369 0.604 . . . . 10.0 111.642 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.4 m -48.19 -34.45 10.1 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.673 -1.149 . . . . 10.0 112.786 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -112.35 -78.3 0.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.508 -0.477 . . . . 10.0 110.41 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.08 63.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.053 -1.07 . . . . 10.0 112.922 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 144.2 47.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -76.33 102.07 5.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.003 0.43 . . . . 10.0 110.789 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 1.034 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -173.95 10.56 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 114.196 1.184 . . . . 10.0 114.196 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 1.034 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 5.3 Cg_endo -84.96 64.89 6.35 Favored 'Trans proline' 0 C--N 1.358 1.07 0 CA-C-N 122.088 1.781 . . . . 10.0 112.466 -172.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 172.41 109.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.835 0.854 . . . . 10.0 110.63 168.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.78 122.86 6.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.585 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.727 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -77.8 135.34 26.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.544 -0.462 . . . . 10.0 109.796 175.32 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.597 HG21 ' H ' ' A' ' 29' ' ' VAL . 1.1 tp -97.94 147.05 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 115.167 -0.924 . . . . 10.0 109.064 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -85.0 143.49 40.04 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 108.248 -1.019 . . . . 10.0 108.248 168.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -44.07 94.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.41 2.74 . . . . 10.0 112.845 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.754 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 94.77 12.78 55.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 119.813 -1.184 . . . . 10.0 112.289 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.44 -173.95 33.98 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.949 -0.643 . . . . 10.0 112.326 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.756 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 15.7 m0 -117.3 166.07 12.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.535 0.683 . . . . 10.0 111.165 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HB3' HD13 ' A' ' 46' ' ' ILE . . . -140.82 112.03 7.26 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.317 -1.364 . . . . 10.0 107.317 171.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.455 HG23 ' CE1' ' A' ' 18' ' ' TYR . 26.7 m -80.32 126.26 30.93 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.304 -0.862 . . . . 10.0 110.337 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.591 ' CG ' HG23 ' A' ' 33' ' ' VAL . 46.7 m-85 -136.26 140.8 43.72 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.06 104.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.182 0.926 . . . . 10.0 110.698 -173.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.8 -178.21 16.81 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.387 -0.911 . . . . 10.0 110.988 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.529 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 12.2 p90 . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 121.891 0.853 . . . . 10.0 110.698 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.529 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 37.9 t80 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.7 m -65.13 129.8 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.575 -0.898 . . . . 10.0 108.575 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.2 p -117.93 -29.17 5.72 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.721 -0.392 . . . . 10.0 111.34 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.55 136.08 7.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 119.992 -1.099 . . . . 10.0 113.146 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.839 ' HB3' HG12 ' A' ' 6' ' ' VAL . 5.0 mt -95.35 129.87 42.34 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.576 -0.528 . . . . 10.0 109.576 173.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.739 ' C ' HG11 ' A' ' 6' ' ' VAL . 10.5 m170 -117.25 143.27 46.07 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -81.36 125.46 30.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.805 1.184 . . . . 10.0 111.214 -179.162 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.864 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.0 t -96.55 178.07 5.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.256 -0.884 . . . . 10.0 109.346 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.407 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.8 p-10 . . . . . 0 C--N 1.316 -0.848 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.478 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 92.0 Cg_endo . . . . . 0 N--CA 1.461 -0.432 0 CA-C-O 120.825 0.26 . . . . 10.0 112.555 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.822 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.2 m 51.53 -151.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.169 -0.923 . . . . 10.0 112.273 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.651 ' N ' HG21 ' A' ' 6' ' ' VAL . . . -59.67 5.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.652 1.353 . . . . 10.0 114.652 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 42.5 mt-10 75.11 -39.91 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.015 0.746 . . . . 10.0 113.015 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.9 m -74.02 -12.98 60.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.868 0.322 . . . . 10.0 111.868 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.794 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.6 m -99.88 141.07 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.829 -0.434 . . . . 10.0 109.829 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -142.44 128.27 19.38 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 121.05 -0.26 . . . . 10.0 110.822 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.79 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -93.1 165.17 12.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.767 0.794 . . . . 10.0 113.118 176.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' THR . 77.7 t80 -144.01 149.85 37.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.281 -1.377 . . . . 10.0 107.281 171.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.4 121.65 45.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.218 0.532 . . . . 10.0 110.832 -176.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.3 t -138.28 75.54 1.53 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.845 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.7 t90 51.2 90.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.074 -0.966 . . . . 10.0 112.535 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 68.37 1.62 2.98 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.638 -0.71 . . . . 10.0 112.313 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -123.18 97.17 5.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.192 -0.669 . . . . 10.0 109.192 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.494 ' HG1' ' HA2' ' A' ' 56' ' ' GLY . 23.3 m -90.46 100.08 12.98 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 172.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.79 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.0 p-10 -86.09 107.91 18.04 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.914 -0.584 . . . . 10.0 111.974 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -97.78 107.41 20.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.036 0.922 . . . . 10.0 108.564 173.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.806 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.2 p80 -96.86 114.44 26.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.021 -1.445 . . . . 10.0 110.219 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.794 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 14.1 t-20 -83.14 150.33 26.32 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.551 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.5 23.97 3.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.898 -0.668 . . . . 10.0 112.315 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.594 ' HB2' HD22 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -86.76 159.83 19.0 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 175.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.46 -11.55 59.96 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.045 0.387 . . . . 10.0 112.045 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -129.88 159.89 35.23 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.246 0.546 . . . . 10.0 111.462 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.41 130.42 42.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.813 -1.085 . . . . 10.0 111.24 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.459 ' H ' HG23 ' A' ' 46' ' ' ILE . 32.6 m -129.05 141.36 46.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.987 -0.551 . . . . 10.0 111.057 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.793 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 7.3 m -90.38 122.9 33.66 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.183 0.516 . . . . 10.0 109.861 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.87 150.95 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.286 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -131.86 162.67 30.03 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.508 -0.769 . . . . 10.0 108.934 175.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.584 HG22 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -134.1 144.86 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-O 121.026 0.441 . . . . 10.0 110.441 -176.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -114.93 118.87 34.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.319 -0.855 . . . . 10.0 108.964 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.606 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 22.6 m-85 -94.48 159.44 15.1 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.574 0.702 . . . . 10.0 111.953 -175.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.506 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 52.0 m -50.07 -31.04 12.14 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.132 -1.395 . . . . 10.0 113.452 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -114.47 -67.29 1.01 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.738 -0.601 . . . . 10.0 110.426 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.95 62.41 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.951 -1.119 . . . . 10.0 113.125 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.555 ' HA ' ' OE1' ' A' ' 39' ' ' GLN . 7.7 mm-40 -72.47 151.52 42.48 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.922 -0.311 . . . . 10.0 110.319 172.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -80.71 100.18 8.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.333 -0.394 . . . . 10.0 111.513 -177.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.825 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.42 21.82 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 113.733 1.012 . . . . 10.0 113.733 172.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.825 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 8.8 Cg_endo -88.34 63.01 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 CA-C-N 121.165 1.452 . . . . 10.0 112.863 -171.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.2 m 169.89 114.93 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.692 0.797 . . . . 10.0 111.646 169.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.56 132.44 7.73 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 175.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.793 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.2 p -83.81 140.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.345 0.593 . . . . 10.0 110.672 178.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.504 HD13 HG22 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -99.29 146.77 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-N 115.194 -0.912 . . . . 10.0 109.691 -177.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -88.49 139.11 29.86 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 169.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -43.13 95.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.343 2.695 . . . . 10.0 112.38 177.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.02 13.54 42.55 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.101 -1.047 . . . . 10.0 112.663 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.47 -171.65 30.67 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.886 -0.673 . . . . 10.0 113.046 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.806 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.6 m0 -121.79 165.49 15.78 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.505 0.669 . . . . 10.0 111.014 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' A' ' 46' ' ' ILE . . . -142.95 111.97 6.54 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.446 -1.316 . . . . 10.0 107.446 174.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 m -79.63 131.14 35.9 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.479 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.606 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 51.1 m-85 -140.63 145.19 36.31 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.096 -0.705 . . . . 10.0 109.096 -178.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.47 107.61 0.3 Allowed 'General case' 0 C--N 1.322 -0.589 0 O-C-N 124.024 0.827 . . . . 10.0 110.585 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.494 ' HA2' ' HG1' ' A' ' 19' ' ' THR . . . -71.31 -177.03 25.5 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.836 -0.905 . . . . 10.0 110.836 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.872 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 20.1 p90 . . . . . 0 C--N 1.321 -0.651 0 CA-C-N 118.465 1.132 . . . . 10.0 109.98 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.872 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 11.1 t80 . . . . . 0 CA--C 1.509 -0.605 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.33 126.2 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.312 -0.995 . . . . 10.0 108.312 171.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.4 p -118.19 -29.55 5.53 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.448 -0.501 . . . . 10.0 111.051 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -136.99 125.98 3.56 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 119.87 -1.157 . . . . 10.0 112.932 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.822 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -86.17 131.54 34.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.307 -0.627 . . . . 10.0 109.307 171.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.716 ' C ' HG12 ' A' ' 6' ' ' VAL . 12.4 m170 -119.47 147.83 43.96 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.61 -0.885 . . . . 10.0 108.61 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.71 126.12 32.01 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.266 -0.974 . . . . 10.0 110.318 178.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.622 ' HB2' HG23 ' A' ' 32' ' ' THR . 43.2 t -96.22 161.05 14.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.85 -177.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 . . . . . 0 C--N 1.326 -0.431 0 N-CA-C 109.142 -0.688 . . . . 10.0 109.142 169.637 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 26.4 Cg_endo . . . . . 0 C--O 1.234 0.293 0 N-CA-C 112.805 0.271 . . . . 10.0 112.805 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.823 HG12 ' HB3' ' A' ' 67' ' ' LEU . 2.5 m 50.68 -142.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.018 0.927 . . . . 10.0 111.884 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.683 ' N ' HG21 ' A' ' 6' ' ' VAL . . . -55.73 -5.51 0.16 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.307 1.043 . . . . 10.0 113.148 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 6' ' ' VAL . 36.5 mt-10 75.7 -25.93 0.2 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.87 0.868 . . . . 10.0 112.806 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.31 14.66 15.75 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 111.748 0.277 . . . . 10.0 111.748 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.783 HG12 HD21 ' A' ' 23' ' ' ASN . 1.7 m -116.72 142.06 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -135.57 118.0 15.78 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.849 -0.34 . . . . 10.0 111.529 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.756 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.36 161.75 14.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.832 0.825 . . . . 10.0 112.515 174.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -146.3 168.05 22.03 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 106.63 -1.619 . . . . 10.0 106.63 170.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -114.58 107.61 15.73 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.09 -0.644 . . . . 10.0 111.645 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 1.7 p -99.28 50.91 0.94 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.82 -0.808 . . . . 10.0 108.82 175.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 38.7 t-105 74.35 -90.44 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.262 -1.336 . . . . 10.0 111.348 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -100.02 30.99 3.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 10.0 110.93 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.479 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -154.4 107.34 2.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.403 -0.817 . . . . 10.0 109.006 -172.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 m -91.85 97.71 11.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.51 0.671 . . . . 10.0 109.539 170.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.756 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.8 p-10 -83.41 108.17 16.4 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.473 -1.239 . . . . 10.0 111.77 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.23 106.97 20.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 122.26 1.029 . . . . 10.0 108.927 172.518 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.8 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -97.32 111.02 23.45 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.109 -1.405 . . . . 10.0 109.982 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.783 HD21 HG12 ' A' ' 10' ' ' VAL . 13.1 t-20 -80.05 154.19 28.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.16 -0.473 . . . . 10.0 109.746 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.49 21.24 3.26 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.581 -0.608 . . . . 10.0 111.581 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.756 ' HB2' HD22 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -83.08 160.03 22.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.36 -0.608 . . . . 10.0 109.36 174.408 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.02 -10.71 59.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.479 -0.328 . . . . 10.0 111.465 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -128.77 159.31 36.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.406 0.622 . . . . 10.0 111.675 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.7 125.65 27.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.85 -1.068 . . . . 10.0 111.253 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.455 ' H ' HG22 ' A' ' 46' ' ' ILE . 34.1 m -125.44 143.67 38.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.961 0.41 . . . . 10.0 111.231 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.724 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.8 m -90.68 121.36 32.52 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.386 -0.598 . . . . 10.0 109.386 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.544 ' HB ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -121.54 143.53 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.516 0.675 . . . . 10.0 110.994 -178.29 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.751 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -122.21 160.62 24.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.237 -0.892 . . . . 10.0 109.433 176.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.673 ' H ' ' HA ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -133.2 141.04 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.118 0.485 . . . . 10.0 111.61 -177.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -108.34 114.51 28.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.35 -0.841 . . . . 10.0 109.614 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.776 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 56.6 m-85 -90.36 156.56 18.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.277 0.561 . . . . 10.0 112.048 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.4 m -43.21 -46.09 5.94 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.134 -1.394 . . . . 10.0 113.365 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -106.99 -77.21 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.299 -0.56 . . . . 10.0 110.573 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.28 124.83 0.77 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 119.705 -1.236 . . . . 10.0 113.245 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -163.27 151.94 14.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.88 -1.156 . . . . 10.0 107.88 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 26.7 p90 -75.88 146.08 40.05 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.384 -0.526 . . . . 10.0 111.52 -174.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.739 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 159.41 -44.31 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 114.32 -1.309 . . . . 10.0 110.138 -170.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.739 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 1.4 Cg_endo -45.34 65.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 125.283 3.989 . . . . 10.0 116.519 177.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' ALA . 1.1 m 170.72 100.73 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.431 1.093 . . . . 10.0 110.071 164.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.56 130.73 15.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.724 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -82.23 136.77 22.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.131 0.491 . . . . 10.0 110.53 178.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.549 HD13 HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -96.84 145.89 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 115.24 -0.891 . . . . 10.0 109.652 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -85.24 139.44 36.43 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.063 -1.088 . . . . 10.0 108.063 167.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -43.59 98.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.182 2.588 . . . . 10.0 112.309 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.83 2.5 57.24 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.984 -1.103 . . . . 10.0 112.504 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.54 -170.86 37.58 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.975 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.8 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 15.7 m0 -120.26 166.39 13.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.422 0.63 . . . . 10.0 111.22 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.428 ' HB3' HD11 ' A' ' 46' ' ' ILE . . . -142.57 115.75 8.91 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 171.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 m -82.52 128.93 34.76 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.521 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.776 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 50.5 m-85 -135.89 144.41 45.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.705 -0.85 . . . . 10.0 108.705 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.09 101.95 0.07 Allowed 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.826 0.704 . . . . 10.0 110.704 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.01 -166.99 4.78 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.915 -1.038 . . . . 10.0 111.613 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.677 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.8 p90 . . . . . 0 C--N 1.313 -0.987 0 CA-C-O 121.993 0.901 . . . . 10.0 110.782 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.677 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 20.8 t80 . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 108.674 -0.861 . . . . 10.0 108.674 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 m -64.14 131.19 29.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.12 -0.696 . . . . 10.0 109.12 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.9 p -123.33 -24.41 4.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.403 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.94 125.31 2.45 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.162 -1.018 . . . . 10.0 112.549 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.823 ' HB3' HG12 ' A' ' 6' ' ' VAL . 5.0 mt -86.27 137.84 32.3 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 172.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.739 ' C ' HG11 ' A' ' 6' ' ' VAL . 8.4 m-70 -127.61 145.93 50.71 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.505 -0.77 . . . . 10.0 108.924 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -79.26 127.52 32.16 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.219 -0.992 . . . . 10.0 110.26 178.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.751 ' HB2' HG22 ' A' ' 32' ' ' THR . 40.5 t -93.97 155.68 17.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.914 -0.584 . . . . 10.0 109.867 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 C--N 1.327 -0.392 0 N-CA-C 109.041 -0.725 . . . . 10.0 109.041 173.342 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.494 ' O ' HG22 ' A' ' 6' ' ' VAL . 41.3 Cg_endo . . . . . 0 C--O 1.234 0.313 0 CA-C-O 120.669 0.196 . . . . 10.0 111.717 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.7 HG11 ' C ' ' A' ' 68' ' ' HIS . 1.2 m 56.44 -150.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 115.429 -0.805 . . . . 10.0 111.113 177.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.695 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.29 -1.7 0.09 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.4 1.08 . . . . 10.0 113.891 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 6' ' ' VAL . 27.0 mt-10 74.08 -29.18 0.19 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.184 0.994 . . . . 10.0 112.946 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.0 m -80.48 -12.27 59.57 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.027 0.38 . . . . 10.0 112.027 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.9 m -96.42 140.18 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 -175.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -138.79 120.17 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.953 -0.299 . . . . 10.0 110.345 -175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.2 171.19 8.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.733 0.778 . . . . 10.0 112.626 178.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 19' ' ' THR . 34.3 t80 -149.15 179.99 7.47 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.235 -1.394 . . . . 10.0 107.235 172.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -127.34 116.44 20.52 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.501 0.667 . . . . 10.0 111.156 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 t -121.48 84.19 2.2 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 173.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 59.27 -105.28 0.23 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.333 -0.849 . . . . 10.0 111.047 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.472 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 65.8 ttt180 -103.18 24.85 10.25 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.595 0.712 . . . . 10.0 110.13 -177.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.98 95.56 4.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.78 -0.646 . . . . 10.0 109.405 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 2.6 m -86.54 98.82 11.28 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 170.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.73 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -86.65 103.99 15.64 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.195 -0.911 . . . . 10.0 112.123 -176.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -96.24 107.16 19.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.74 -0.837 . . . . 10.0 108.74 174.317 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.791 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 2.5 p80 -97.39 113.46 25.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.621 -1.172 . . . . 10.0 110.439 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 t30 -79.41 150.18 31.41 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.679 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.97 16.02 5.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.775 -0.726 . . . . 10.0 112.39 175.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.43 154.96 23.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 174.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.43 -8.9 57.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.346 0.499 . . . . 10.0 112.346 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -127.25 160.63 30.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.51 0.671 . . . . 10.0 112.145 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -71.06 124.12 23.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.68 -1.145 . . . . 10.0 111.583 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.527 ' H ' HG21 ' A' ' 46' ' ' ILE . 30.7 m -125.61 141.06 46.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.322 0.582 . . . . 10.0 111.523 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 10.6 m -89.78 122.53 32.95 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 m -120.44 153.09 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.444 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.753 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -130.73 157.99 41.31 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.38 -0.827 . . . . 10.0 109.482 176.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.63 HG23 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.48 139.78 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 121.14 0.495 . . . . 10.0 110.523 -178.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.09 117.48 34.11 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.128 -0.942 . . . . 10.0 109.323 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.638 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 44.1 m-85 -90.57 155.75 18.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.083 0.468 . . . . 10.0 111.504 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.8 m -44.61 -41.93 6.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.824 -1.08 . . . . 10.0 112.731 175.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -102.86 -87.54 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.648 -0.421 . . . . 10.0 110.556 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.26 130.89 1.23 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.823 -0.703 . . . . 10.0 111.93 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -172.68 151.74 2.4 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.507 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 23.9 p90 -76.27 144.34 40.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.127 0.489 . . . . 10.0 110.407 -177.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.766 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 158.51 -37.4 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 124.997 1.319 . . . . 10.0 110.855 -169.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.766 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 9.9 Cg_endo -53.39 61.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 124.079 3.186 . . . . 10.0 115.504 176.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 5.1 t 177.69 105.07 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.501 0.72 . . . . 10.0 109.367 163.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -145.15 122.95 11.9 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.315 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.26 128.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 174.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.527 HG21 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -92.67 146.11 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 CA-C-N 114.638 -1.164 . . . . 10.0 109.141 -176.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.34 142.55 43.7 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 107.957 -1.127 . . . . 10.0 107.957 168.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -47.59 96.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.89 2.393 . . . . 10.0 112.034 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 101.05 5.19 53.56 Favored Glycine 0 C--O 1.229 -0.166 0 C-N-CA 120.064 -1.065 . . . . 10.0 112.232 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.44 -176.39 37.29 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 121.069 -0.586 . . . . 10.0 112.979 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.791 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 20.5 m0 -117.04 164.7 14.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.647 0.737 . . . . 10.0 110.966 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB3' HG12 ' A' ' 21' ' ' VAL . . . -138.4 113.76 9.54 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 171.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.7 m -82.25 128.66 34.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.07 -0.514 . . . . 10.0 109.994 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.638 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 50.4 m-85 -137.02 139.22 41.24 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.042 -1.096 . . . . 10.0 108.042 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.29 101.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.375 1.047 . . . . 10.0 111.015 -176.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.17 -178.8 11.21 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.607 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 2.5 p90 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 118.165 0.983 . . . . 10.0 110.799 -172.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 21.7 t80 . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -63.55 130.11 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 174.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 73.4 p -122.3 -30.73 3.94 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.317 -0.553 . . . . 10.0 111.328 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.73 124.16 3.37 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 119.603 -1.284 . . . . 10.0 113.279 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.598 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.4 mt -88.26 141.55 28.46 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.93 -0.767 . . . . 10.0 108.93 172.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.7 ' C ' HG11 ' A' ' 6' ' ' VAL . 3.9 m-70 -132.09 149.61 52.36 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.339 -0.846 . . . . 10.0 108.772 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.573 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -81.98 128.59 34.24 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.219 -0.992 . . . . 10.0 110.025 176.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.753 ' HB2' HG22 ' A' ' 32' ' ' THR . 5.5 t -98.06 168.94 9.96 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--N 1.319 -0.757 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 176.05 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 6' ' ' VAL . 39.7 Cg_endo . . . . . 0 C--O 1.236 0.387 0 CA-C-O 120.819 0.258 . . . . 10.0 111.924 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 67' ' ' LEU . 2.8 m 48.31 -146.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.181 -0.918 . . . . 10.0 111.745 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.663 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.35 -0.57 0.1 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.39 1.076 . . . . 10.0 113.889 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 6' ' ' VAL . 21.4 mt-10 70.36 -24.5 0.16 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.683 0.793 . . . . 10.0 113.043 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.426 ' H ' ' C ' ' A' ' 7' ' ' ALA . 87.0 m -78.27 -15.01 59.18 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.41 0.148 . . . . 10.0 111.346 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.841 HG11 HD21 ' A' ' 23' ' ' ASN . 2.0 m -100.45 143.55 13.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.092 -0.336 . . . . 10.0 110.092 -174.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -141.23 125.38 17.36 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.513 -0.18 . . . . 10.0 110.513 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -96.05 162.43 13.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.814 0.816 . . . . 10.0 112.885 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -143.84 138.1 28.42 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.379 -1.282 . . . . 10.0 107.703 172.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -103.48 127.25 50.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.997 0.427 . . . . 10.0 111.02 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.1 m -131.23 -155.98 0.73 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.294 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -63.36 93.82 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.936 0.398 . . . . 10.0 110.852 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 61.33 30.01 18.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.512 -0.767 . . . . 10.0 111.487 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.89 106.44 3.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.805 -0.443 . . . . 10.0 109.805 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.2 m -94.73 102.08 13.94 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.98 -0.378 . . . . 10.0 109.98 168.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.751 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.3 p-10 -88.05 111.7 21.83 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.903 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.73 107.58 21.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.936 0.874 . . . . 10.0 108.897 172.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.761 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 2.7 p80 -97.23 114.71 26.48 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.399 -1.273 . . . . 10.0 110.025 176.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.841 HD21 HG11 ' A' ' 10' ' ' VAL . 12.3 t-20 -80.79 153.96 27.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.721 177.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.56 25.38 3.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.552 -0.832 . . . . 10.0 112.586 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.552 ' HB2' HD22 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -88.42 164.56 15.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 176.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.58 -15.99 56.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.032 0.382 . . . . 10.0 112.032 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -128.15 156.42 42.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.259 0.552 . . . . 10.0 111.774 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.29 126.52 28.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.894 -1.048 . . . . 10.0 111.648 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.535 ' H ' HG21 ' A' ' 46' ' ' ILE . 34.3 m -124.62 146.0 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-O 121.125 0.488 . . . . 10.0 111.059 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.651 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.3 m -95.21 122.87 38.35 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.635 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.546 ' HB ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -123.07 151.33 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 115.769 -0.65 . . . . 10.0 110.658 -177.218 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.828 HG21 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -130.21 163.08 27.48 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.227 -0.897 . . . . 10.0 109.116 175.371 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.65 HG22 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.4 131.07 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 120.865 0.364 . . . . 10.0 110.089 -176.36 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -103.12 115.29 30.31 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.505 -0.77 . . . . 10.0 109.103 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.775 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 41.4 m-85 -86.26 162.35 18.32 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.729 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.1 m -50.17 -23.42 2.18 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.737 -1.12 . . . . 10.0 112.446 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -131.06 -74.01 0.53 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.919 -0.488 . . . . 10.0 110.402 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.87 133.74 2.29 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.32 -1.112 . . . . 10.0 110.32 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.09 24.76 0.37 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.003 0.43 . . . . 10.0 110.412 -174.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 36.0 t90 58.87 103.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.212 -0.904 . . . . 10.0 112.149 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.703 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -173.83 -45.07 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.355 -0.839 . . . . 10.0 111.587 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.703 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 2.6 Cg_endo -38.27 100.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 123.951 3.101 . . . . 10.0 114.308 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.0 m 129.51 100.38 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.241 1.816 . . . . 10.0 111.244 168.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.37 130.96 11.47 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.9 -1.045 . . . . 10.0 108.293 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -84.56 138.42 19.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.485 0.66 . . . . 10.0 110.731 178.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.535 HG21 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -99.09 148.77 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.457 -1.247 . . . . 10.0 109.692 -177.186 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -87.66 142.62 32.86 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.803 -1.184 . . . . 10.0 107.803 168.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -45.46 93.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.042 2.494 . . . . 10.0 112.843 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.669 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.02 15.11 37.24 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.047 -1.073 . . . . 10.0 112.523 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.78 -174.64 28.11 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.084 -0.579 . . . . 10.0 112.733 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.761 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 16.5 m0 -117.61 167.13 11.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.637 0.732 . . . . 10.0 111.653 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.417 ' HB1' HD11 ' A' ' 46' ' ' ILE . . . -144.64 113.72 6.91 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.56 -1.2 . . . . 10.0 107.982 171.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 m -82.63 131.88 35.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.989 -175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.775 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 46.6 m-85 -140.0 144.51 36.99 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.35 -0.981 . . . . 10.0 108.35 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.22 101.98 0.06 Allowed 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 124.131 0.894 . . . . 10.0 111.151 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.14 175.54 42.23 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.247 -0.977 . . . . 10.0 110.86 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 p90 . . . . . 0 CA--C 1.532 0.26 0 CA-C-N 118.38 1.09 . . . . 10.0 110.041 -177.584 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 44.5 t80 . . . . . 0 N--CA 1.442 -0.838 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -60.19 125.75 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 174.346 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.0 t -138.41 6.56 2.54 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.466 -0.494 . . . . 10.0 110.936 -175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -156.23 107.17 0.31 Allowed Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 119.246 -1.454 . . . . 10.0 113.395 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.803 ' HB3' HG12 ' A' ' 6' ' ' VAL . 4.9 mt -82.28 128.35 34.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.696 -0.853 . . . . 10.0 108.696 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.737 ' C ' HG11 ' A' ' 6' ' ' VAL . 8.5 m-70 -122.36 143.32 49.72 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.254 -0.884 . . . . 10.0 108.685 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.469 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -77.76 129.74 35.86 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.055 -1.028 . . . . 10.0 110.445 179.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.828 ' HB2' HG21 ' A' ' 32' ' ' THR . 44.6 t -99.91 157.76 16.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.394 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--N 1.325 -0.473 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 171.133 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' HG22 ' A' ' 6' ' ' VAL . 71.7 Cg_endo . . . . . 0 C--O 1.235 0.34 0 CA-C-O 120.801 0.25 . . . . 10.0 111.757 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.701 HG12 ' C ' ' A' ' 68' ' ' HIS . 1.4 m 51.35 -151.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.304 -0.862 . . . . 10.0 111.732 174.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.684 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -60.4 9.4 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.342 1.238 . . . . 10.0 114.342 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 47.8 mt-10 75.79 -49.72 0.61 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.454 0.909 . . . . 10.0 113.454 176.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 60.9 m -73.57 -9.67 58.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.68 0.276 . . . . 10.0 111.442 -170.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.776 HG11 HD21 ' A' ' 23' ' ' ASN . 1.5 m -98.73 132.82 43.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.917 -0.772 . . . . 10.0 108.917 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -139.57 126.82 21.29 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.85 -0.34 . . . . 10.0 110.207 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.736 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -90.65 163.24 14.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.767 0.794 . . . . 10.0 111.937 177.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.411 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 55.8 t80 -142.27 155.91 45.25 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.073 -1.455 . . . . 10.0 107.073 171.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.45 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -103.31 94.38 5.47 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.481 0.657 . . . . 10.0 111.208 -177.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.65 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 38.3 m -86.37 60.75 6.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.148 -0.933 . . . . 10.0 108.54 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.8 t90 66.35 -92.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.985 -1.007 . . . . 10.0 110.87 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -110.92 40.85 1.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.668 0.747 . . . . 10.0 109.534 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.65 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 1.7 t80 -151.08 99.57 2.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.013 -0.994 . . . . 10.0 108.496 -175.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.5 m -87.12 98.26 11.2 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.345 0.593 . . . . 10.0 109.783 173.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.736 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.1 p-10 -87.54 104.94 16.96 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.723 -1.126 . . . . 10.0 111.445 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.702 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -96.12 105.22 16.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.497 -0.927 . . . . 10.0 108.497 174.541 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.791 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 3.3 p80 -95.51 112.95 24.57 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.362 -1.29 . . . . 10.0 110.063 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.776 HD21 HG11 ' A' ' 10' ' ' VAL . 14.1 t-20 -81.65 150.1 28.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.737 175.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.14 25.39 3.33 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.078 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.653 ' HB2' HD22 ' A' ' 23' ' ' ASN . 0.5 OUTLIER -89.01 162.59 15.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 176.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.59 -12.96 59.82 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.275 0.472 . . . . 10.0 112.275 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -120.68 152.32 38.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.443 0.64 . . . . 10.0 112.449 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.7 118.54 11.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.894 -1.048 . . . . 10.0 110.735 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.472 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.4 m -121.74 137.81 54.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.332 0.586 . . . . 10.0 112.049 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.4 m -87.46 122.76 31.61 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.786 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.09 151.69 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 115.256 -0.883 . . . . 10.0 110.711 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.765 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -130.1 160.0 35.07 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.964 -0.754 . . . . 10.0 108.964 176.198 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.624 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.36 132.78 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.42 0.629 . . . . 10.0 110.81 -177.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -102.53 114.16 28.13 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.806 -1.088 . . . . 10.0 108.97 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.759 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 53.3 m-85 -89.84 164.73 14.5 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.575 0.702 . . . . 10.0 112.265 -175.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -52.81 -32.91 46.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.191 -1.368 . . . . 10.0 111.597 169.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -106.98 -86.22 0.5 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.813 0.34 . . . . 10.0 110.698 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.81 53.22 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.747 -0.74 . . . . 10.0 111.717 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.11 138.39 55.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -73.11 107.48 5.47 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.91 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -167.13 -42.15 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 118.281 -0.866 . . . . 10.0 112.879 -173.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.91 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 1.6 Cg_endo -41.77 70.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 125.151 3.9 . . . . 10.0 116.877 -173.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 5.7 t 173.77 110.2 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.807 0.843 . . . . 10.0 109.735 164.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.466 ' HB2' ' HZ ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -149.52 121.09 7.99 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.935 177.329 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.702 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -77.98 127.18 38.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.998 -0.741 . . . . 10.0 108.998 173.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.472 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -91.41 146.78 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 114.589 -1.187 . . . . 10.0 109.478 -175.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.03 133.05 41.91 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 107.443 -1.317 . . . . 10.0 107.443 168.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -43.11 96.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.189 2.593 . . . . 10.0 112.369 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 103.19 7.6 43.13 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.343 -0.932 . . . . 10.0 113.084 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.16 -171.79 28.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.098 -0.572 . . . . 10.0 113.589 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.791 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 20.3 m0 -118.43 167.31 11.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.333 0.587 . . . . 10.0 110.896 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -141.58 114.84 8.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.327 -1.36 . . . . 10.0 107.327 171.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.0 m -83.45 130.21 35.02 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.757 -173.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.759 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 56.9 m-85 -138.72 146.63 41.73 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.8 102.59 0.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.601 0.563 . . . . 10.0 110.493 -174.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.97 -169.54 15.15 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.54 -0.838 . . . . 10.0 111.077 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.687 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 6.3 p90 . . . . . 0 C--N 1.319 -0.742 0 CA-C-O 122.014 0.912 . . . . 10.0 110.86 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.687 ' HD1' ' HB3' ' A' ' 57' ' ' TYR . 89.6 t80 . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 120.885 0.374 . . . . 10.0 111.559 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.3 m -60.65 136.89 23.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 172.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.5 t -144.77 12.82 1.48 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.196 -0.602 . . . . 10.0 111.89 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.04 110.62 0.45 Allowed Glycine 0 C--O 1.224 -0.504 0 C-N-CA 119.438 -1.363 . . . . 10.0 113.482 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.54 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.5 mt -84.65 133.78 34.39 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.388 0.613 . . . . 10.0 109.701 173.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.701 ' C ' HG12 ' A' ' 6' ' ' VAL . 27.2 m-70 -127.06 149.58 49.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.033 -0.985 . . . . 10.0 108.706 -176.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.423 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -83.67 129.41 34.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 119.485 1.039 . . . . 10.0 110.381 177.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.765 ' HB2' HG23 ' A' ' 32' ' ' THR . 5.2 t -98.89 172.9 7.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.349 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 108.917 -0.771 . . . . 10.0 108.917 173.584 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 CA--C 1.529 0.261 0 N-CA-C 113.349 0.481 . . . . 10.0 113.349 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.612 HG23 HG22 ' A' ' 69' ' ' THR . 0.2 OUTLIER -157.07 118.72 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.584 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 9' ' ' CYS . . . 68.61 -19.54 0.16 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.505 0.722 . . . . 10.0 112.58 171.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 6' ' ' VAL . 32.6 mt-10 74.49 -28.32 0.19 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.283 1.033 . . . . 10.0 112.041 175.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.425 ' H ' ' C ' ' A' ' 7' ' ' ALA . 31.0 m -87.18 -10.26 53.11 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.919 0.34 . . . . 10.0 111.919 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -95.56 134.85 31.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.871 -0.788 . . . . 10.0 108.871 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -135.82 121.58 19.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.787 -0.188 . . . . 10.0 110.594 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.822 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -98.18 161.33 13.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.146 0.795 . . . . 10.0 113.146 178.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' THR . 82.9 t80 -148.05 155.62 41.69 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 171.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.475 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 0.7 OUTLIER -110.15 124.95 52.47 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.318 -0.553 . . . . 10.0 110.606 178.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.2 t -136.75 77.2 1.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.25 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 55.95 86.79 0.06 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.215 -0.902 . . . . 10.0 112.092 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 67.49 14.14 9.52 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.965 -0.561 . . . . 10.0 112.271 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -139.03 96.52 3.13 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.521 -0.548 . . . . 10.0 109.521 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.5 m -87.46 100.4 12.73 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.656 -0.498 . . . . 10.0 109.656 171.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.822 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.4 p-10 -83.63 111.42 19.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 114.948 -1.024 . . . . 10.0 111.829 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.98 106.65 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 122.015 0.912 . . . . 10.0 108.883 171.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.781 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -97.51 112.07 24.07 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.14 -1.391 . . . . 10.0 110.545 179.02 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.762 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.5 t-20 -80.72 160.03 25.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.89 -0.595 . . . . 10.0 110.255 177.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -154.5 32.0 0.7 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.638 -0.791 . . . . 10.0 111.764 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.507 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -83.05 -18.4 39.85 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 122.132 0.173 . . . . 10.0 111.015 -178.375 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 86.35 -8.34 0.73 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.753 1.283 . . . . 10.0 111.08 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 10.9 p-10 -125.07 155.05 40.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.121 0.486 . . . . 10.0 110.841 175.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.67 123.22 20.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.292 -0.867 . . . . 10.0 111.183 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.542 ' H ' HG23 ' A' ' 46' ' ' ILE . 26.8 m -126.03 139.79 50.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.067 0.46 . . . . 10.0 111.364 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.748 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 9.5 m -88.93 119.67 29.65 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.509 -0.552 . . . . 10.0 109.509 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 43' ' ' CYS . 1.1 m -116.66 165.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 115.401 -0.818 . . . . 10.0 110.51 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.45 HG22 ' CB ' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -148.57 158.16 43.94 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.641 -0.709 . . . . 10.0 109.206 178.221 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.619 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -135.23 138.22 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.338 0.59 . . . . 10.0 111.717 -173.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -101.22 125.99 47.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.947 -1.024 . . . . 10.0 108.908 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.744 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 57.0 m-85 -95.07 165.6 12.34 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.247 -0.581 . . . . 10.0 110.351 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 88.0 m -49.4 -21.07 0.8 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.245 -0.889 . . . . 10.0 112.142 174.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -118.96 -67.05 1.02 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 174.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.04 50.65 0.07 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.735 -0.745 . . . . 10.0 112.352 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -74.43 158.98 32.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.73 0.3 . . . . 10.0 111.362 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -66.92 112.87 4.54 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.388 0.614 . . . . 10.0 112.224 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.712 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -174.82 -47.72 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 CA-C-N 114.844 -1.071 . . . . 10.0 111.101 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.712 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 3.0 Cg_endo -37.06 96.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 124.273 3.316 . . . . 10.0 114.128 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 1.6 m 135.99 108.19 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.0 1.72 . . . . 10.0 111.202 170.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.76 130.58 7.44 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.748 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -83.45 135.74 24.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.392 0.615 . . . . 10.0 110.236 176.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.542 HG23 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.37 146.79 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.829 -1.078 . . . . 10.0 109.994 -176.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -88.27 141.56 30.95 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 168.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -38.9 98.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.71 2.94 . . . . 10.0 113.02 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.716 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 89.37 12.22 63.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 119.603 -1.284 . . . . 10.0 112.23 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.28 -176.63 36.03 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 121.276 -0.488 . . . . 10.0 112.214 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.781 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 23.6 m0 -116.65 165.16 13.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.552 0.692 . . . . 10.0 111.182 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.46 115.87 10.56 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.14 -1.43 . . . . 10.0 107.14 172.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.0 m -85.2 127.88 34.46 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.374 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.744 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 48.5 m-85 -137.42 139.43 40.68 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.462 -0.94 . . . . 10.0 108.462 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.54 100.04 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.172 0.92 . . . . 10.0 111.324 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.29 175.07 43.44 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.233 -1.147 . . . . 10.0 110.233 176.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.444 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 7.7 p90 . . . . . 0 CA--C 1.537 0.475 0 CA-C-N 118.742 1.271 . . . . 10.0 109.96 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 26.9 t80 . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -61.3 129.02 23.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.9 p -128.23 -16.37 4.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.136 -0.484 . . . . 10.0 111.678 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.37 110.65 0.66 Allowed Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 119.226 -1.464 . . . . 10.0 113.709 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.564 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.3 mt -82.36 150.53 27.12 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.069 -0.715 . . . . 10.0 109.069 171.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.526 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -148.22 159.65 43.75 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.264 -178.044 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.612 HG22 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -81.44 126.61 31.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.033 0.444 . . . . 10.0 110.66 174.402 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 30' ' ' SER . 48.9 t -98.92 166.97 11.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.492 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--N 1.321 -0.652 0 N-CA-C 109.164 -0.68 . . . . 10.0 109.164 171.837 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.458 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 36.0 Cg_endo . . . . . 0 N--CA 1.458 -0.586 0 CA-C-O 121.138 0.391 . . . . 10.0 112.62 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.593 HG22 HG21 ' A' ' 69' ' ' THR . 0.2 OUTLIER -151.93 124.42 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 177.141 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 71.06 -27.54 0.17 Allowed 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.752 0.657 . . . . 10.0 111.88 172.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.56 ' H ' ' C ' ' A' ' 6' ' ' VAL . 47.0 mt-10 77.68 -20.17 0.39 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.609 1.163 . . . . 10.0 111.36 175.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.9 m -84.18 -14.46 50.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.414 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.782 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -96.03 134.19 34.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -133.1 119.6 20.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.583 -175.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.805 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -96.71 162.04 13.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.024 0.916 . . . . 10.0 113.296 177.131 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 19' ' ' THR . 33.5 t80 -143.04 178.98 7.32 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.407 -1.701 . . . . 10.0 106.407 169.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -136.96 117.35 13.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.457 0.571 . . . . 10.0 111.349 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 p -120.66 86.65 2.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.664 -0.698 . . . . 10.0 109.85 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 62.72 -84.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.998 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -120.31 16.75 12.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.983 0.42 . . . . 10.0 110.933 -172.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.69 96.45 3.82 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.218 -0.66 . . . . 10.0 109.218 -173.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.474 HG22 HG12 ' A' ' 64' ' ' VAL . 7.0 m -86.17 99.12 11.3 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.624 0.726 . . . . 10.0 109.192 171.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.805 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.0 p-10 -85.27 109.67 18.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.434 -1.257 . . . . 10.0 111.926 -175.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.36 106.48 19.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 172.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.731 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -98.37 110.96 23.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.068 -1.424 . . . . 10.0 110.297 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.782 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 18.6 t-20 -80.98 154.91 26.68 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.957 -0.565 . . . . 10.0 109.939 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.25 36.13 1.03 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.579 -0.82 . . . . 10.0 112.177 173.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -76.59 -66.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.457 -0.306 . . . . 10.0 110.449 -178.032 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 25' ' ' CYS . . . 142.42 -32.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.815 1.322 . . . . 10.0 108.699 -171.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -115.33 157.67 23.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.111 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.35 127.22 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.492 -0.776 . . . . 10.0 111.319 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.531 ' H ' HG21 ' A' ' 46' ' ' ILE . 30.8 m -125.47 139.55 50.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.072 0.463 . . . . 10.0 111.268 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.813 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 14.7 m -88.3 119.7 28.96 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.273 -0.64 . . . . 10.0 109.273 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.497 ' HB ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -119.12 148.45 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 121.775 0.798 . . . . 10.0 111.732 -178.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.531 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -127.16 160.88 29.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.8 -1.091 . . . . 10.0 109.287 176.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.608 ' H ' ' HA ' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -135.73 138.95 47.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.33 0.585 . . . . 10.0 111.867 -178.154 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -100.81 120.36 40.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.72 -1.127 . . . . 10.0 109.241 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.722 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 35.1 m-85 -100.13 158.96 15.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.295 0.569 . . . . 10.0 111.55 -178.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 22.7 m -48.48 -34.9 11.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.608 -1.178 . . . . 10.0 112.601 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -103.29 -83.6 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.931 -0.48 . . . . 10.0 109.876 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.4 49.63 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.246 -0.978 . . . . 10.0 112.898 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -66.3 153.24 43.15 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.088 -0.338 . . . . 10.0 110.088 173.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.468 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 14.5 p90 -75.7 136.68 40.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.866 -0.79 . . . . 10.0 108.866 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.725 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 165.95 -42.52 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 123.57 0.748 . . . . 10.0 111.329 -170.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.725 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 6.3 Cg_endo -48.69 71.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 124.212 3.275 . . . . 10.0 115.29 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER 164.1 97.89 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.794 1.238 . . . . 10.0 110.2 166.166 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.73 126.48 10.31 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.944 -0.761 . . . . 10.0 108.944 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.813 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -80.53 137.39 21.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.287 0.565 . . . . 10.0 110.749 179.613 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.531 HG21 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -96.0 145.64 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.235 -0.893 . . . . 10.0 109.38 -177.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.58 140.45 31.73 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 107.808 -1.182 . . . . 10.0 107.808 169.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -43.53 95.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.267 2.644 . . . . 10.0 113.107 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 99.59 5.44 55.49 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.064 -1.065 . . . . 10.0 112.511 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.24 -171.79 38.33 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 121.29 -0.481 . . . . 10.0 113.117 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.731 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 16.6 m0 -119.74 167.3 12.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.499 0.666 . . . . 10.0 111.005 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.59 114.46 8.13 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.154 -1.424 . . . . 10.0 107.154 171.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.8 m -80.95 129.42 34.53 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.549 -0.751 . . . . 10.0 110.361 -175.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.722 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 50.3 m-85 -137.52 141.0 41.45 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.595 -0.891 . . . . 10.0 108.595 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.01 106.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.958 0.786 . . . . 10.0 110.854 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.5 -170.96 6.31 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.338 -0.846 . . . . 10.0 111.818 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.602 ' HB3' ' HD2' ' A' ' 63' ' ' TYR . 2.3 p90 . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 122.207 1.003 . . . . 10.0 111.556 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.602 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 8.5 t80 . . . . . 0 CA--C 1.513 -0.458 0 N-CA-C 107.471 -1.307 . . . . 10.0 107.471 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.474 HG12 HG22 ' A' ' 19' ' ' THR . 1.6 m -66.53 128.79 30.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.6 p -119.28 -28.84 5.33 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.344 -0.389 . . . . 10.0 111.277 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.51 115.38 1.1 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.569 -1.3 . . . . 10.0 113.209 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.576 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.4 mt -79.34 146.62 32.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 170.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.458 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 5.3 m-70 -140.29 157.93 44.81 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.453 -176.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.593 HG21 HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -79.63 126.44 30.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.011 0.434 . . . . 10.0 110.571 174.249 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.531 ' HB2' HG23 ' A' ' 32' ' ' THR . 35.8 t -94.44 158.77 15.41 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.154 -0.684 . . . . 10.0 109.154 177.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 C--N 1.317 -0.837 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 174.357 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 N--CA 1.456 -0.708 0 N-CA-C 111.941 -0.061 . . . . 10.0 111.941 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.577 HG22 HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER 41.18 106.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.655 1.354 . . . . 10.0 114.655 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 73.6 -19.11 0.35 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.405 -0.816 . . . . 10.0 112.949 164.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 6' ' ' VAL . 40.1 mt-10 77.5 -40.11 0.32 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.864 . . . . 10.0 112.017 174.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.1 m -77.75 -12.73 60.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.818 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.813 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.4 m -90.94 132.43 35.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.869 -0.789 . . . . 10.0 108.869 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.71 113.0 11.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.674 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.774 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -89.34 161.33 16.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.719 0.771 . . . . 10.0 111.996 175.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.434 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 86.4 t80 -142.69 139.87 31.32 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.192 -1.367 . . . . 10.0 107.454 172.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.743 HE21 ' HH ' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -97.03 98.26 9.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.537 0.684 . . . . 10.0 110.123 -178.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 12.9 p -99.15 -156.35 0.54 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.321 -0.854 . . . . 10.0 108.879 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -69.88 93.22 0.74 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.668 0.271 . . . . 10.0 110.713 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 62.35 32.64 16.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.308 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.855 ' HH ' ' HG1' ' A' ' 53' ' ' THR . 0.7 OUTLIER -146.41 103.07 3.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 -173.11 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.418 ' HG1' ' HA2' ' A' ' 56' ' ' GLY . 16.8 m -90.15 91.56 8.59 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.755 -0.831 . . . . 10.0 108.755 170.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.774 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.0 OUTLIER -83.37 109.07 16.99 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.975 -1.012 . . . . 10.0 111.757 -178.411 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.28 107.21 19.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 122.066 0.936 . . . . 10.0 108.928 174.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.748 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -98.54 111.01 23.51 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.13 -1.395 . . . . 10.0 110.042 177.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.813 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.9 t30 -79.39 147.46 32.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.053 -0.521 . . . . 10.0 109.748 178.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -129.43 13.85 5.89 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.718 -0.753 . . . . 10.0 112.502 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.79 154.79 23.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.53 -11.22 60.57 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.443 0.535 . . . . 10.0 112.443 -176.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -124.88 156.75 37.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.365 0.602 . . . . 10.0 112.09 -177.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.31 124.72 24.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.721 -1.127 . . . . 10.0 111.33 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.582 ' H ' HG22 ' A' ' 46' ' ' ILE . 27.8 m -124.14 138.33 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.323 0.582 . . . . 10.0 111.533 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.2 m -87.01 120.15 27.97 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.383 -0.826 . . . . 10.0 109.061 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.577 HG12 HG22 ' A' ' 6' ' ' VAL . 1.2 m -115.42 165.53 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 121.532 0.682 . . . . 10.0 110.653 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.559 ' HB ' ' C ' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -146.96 159.77 43.15 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.968 -1.015 . . . . 10.0 109.037 177.104 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.608 HG22 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.41 144.5 33.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.328 0.585 . . . . 10.0 110.633 -176.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -117.44 114.21 23.18 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.074 -0.967 . . . . 10.0 109.114 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.86 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 20.3 m-85 -93.1 159.73 15.17 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.626 0.727 . . . . 10.0 111.919 -172.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.6 m -50.67 -44.6 57.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.251 -1.34 . . . . 10.0 113.237 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -95.22 -72.68 0.61 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.36 -0.536 . . . . 10.0 110.823 -177.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.71 48.55 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.958 -1.115 . . . . 10.0 113.575 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -68.1 150.35 48.5 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 117.022 0.411 . . . . 10.0 110.391 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -82.91 108.81 16.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.83 -0.623 . . . . 10.0 111.219 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.78 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -171.95 26.67 0.01 OUTLIER Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 113.063 0.764 . . . . 10.0 113.063 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.78 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 14.3 Cg_endo -91.27 56.91 1.02 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.259 1.306 . . . . 10.0 112.7 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 177.01 116.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.632 0.582 . . . . 10.0 111.356 171.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.79 124.42 3.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.7 p -83.15 138.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.359 0.6 . . . . 10.0 110.812 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -100.86 148.3 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 114.941 -1.027 . . . . 10.0 109.494 -177.367 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -90.65 143.26 28.76 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 107.832 -1.173 . . . . 10.0 107.832 168.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -46.08 93.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.106 2.537 . . . . 10.0 112.609 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 102.19 11.52 36.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.86 -1.162 . . . . 10.0 111.884 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.03 -176.79 31.96 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 121.332 -0.461 . . . . 10.0 112.63 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.748 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 12.0 m0 -119.31 166.71 12.67 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.365 0.603 . . . . 10.0 111.126 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.47 110.07 5.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.855 ' HG1' ' HH ' ' A' ' 18' ' ' TYR . 43.9 m -79.41 131.07 35.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.761 -175.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.86 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 49.8 m-85 -140.1 142.83 36.05 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.004 -1.11 . . . . 10.0 108.004 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.91 102.72 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.544 0.527 . . . . 10.0 110.837 -174.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.418 ' HA2' ' HG1' ' A' ' 19' ' ' THR . . . -68.53 -176.26 11.37 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.278 -0.873 . . . . 10.0 111.167 177.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.612 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 13.4 p90 . . . . . 0 N--CA 1.447 -0.599 0 CA-C-N 117.986 0.893 . . . . 10.0 110.903 -174.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.743 ' HH ' HE21 ' A' ' 14' ' ' GLN . 15.8 t80 . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 108.574 -0.898 . . . . 10.0 108.574 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.7 m -63.59 133.0 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.432 -0.951 . . . . 10.0 108.432 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 81.6 p -118.51 -39.29 3.02 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.478 -0.489 . . . . 10.0 111.029 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.45 122.57 3.86 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.719 -1.229 . . . . 10.0 113.21 -174.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.564 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 3.7 mt -86.87 144.37 27.02 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.997 -0.742 . . . . 10.0 108.997 173.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.538 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 8.1 m-70 -138.37 159.6 41.64 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.386 -174.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.556 HG22 HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -84.12 124.88 31.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.129 0.49 . . . . 10.0 111.129 175.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.477 ' HB2' HG21 ' A' ' 32' ' ' THR . 43.3 t -95.37 172.83 7.85 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.809 -0.811 . . . . 10.0 108.809 175.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 6.4 p-10 . . . . . 0 C--N 1.316 -0.871 0 N-CA-C 108.318 -0.994 . . . . 10.0 108.318 172.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.437 ' O ' HG23 ' A' ' 6' ' ' VAL . 90.8 Cg_endo . . . . . 0 N--CA 1.449 -1.118 0 CA-C-O 120.679 0.199 . . . . 10.0 112.264 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.826 HG11 ' HB3' ' A' ' 67' ' ' LEU . 2.2 m 48.55 -147.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.488 0.715 . . . . 10.0 111.458 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.671 ' N ' HG21 ' A' ' 6' ' ' VAL . . . -56.09 -2.5 0.06 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.275 1.03 . . . . 10.0 113.587 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 6' ' ' VAL . 44.8 mt-10 69.21 -24.26 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.036 0.934 . . . . 10.0 113.377 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.442 ' H ' ' C ' ' A' ' 7' ' ' ALA . 33.5 m -80.73 -17.44 51.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.866 0.365 . . . . 10.0 111.189 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.871 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -92.09 141.75 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.26 115.03 12.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.62 -0.264 . . . . 10.0 111.028 -172.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.831 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.81 164.68 12.83 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.687 0.756 . . . . 10.0 112.895 177.493 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 19' ' ' THR . 25.8 t80 -147.5 172.66 13.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.27 -1.381 . . . . 10.0 107.27 172.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HG3' ' HE1' ' A' ' 57' ' ' TYR . 5.7 pm0 -122.55 127.91 50.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 10.0 110.901 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 t -150.75 89.96 1.59 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.123 -0.489 . . . . 10.0 110.733 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.4 t90 55.04 80.02 0.14 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.697 -0.683 . . . . 10.0 112.229 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 58.95 24.74 12.92 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.641 -0.709 . . . . 10.0 111.629 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.36 97.3 3.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.9 m -89.13 99.86 12.76 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.193 0.521 . . . . 10.0 109.796 173.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.831 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -84.6 109.93 18.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.966 -1.016 . . . . 10.0 112.168 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.8 108.62 24.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 122.017 0.913 . . . . 10.0 109.31 174.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.687 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.28 110.55 22.79 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.802 -1.544 . . . . 10.0 110.45 178.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.871 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 20.4 t30 -80.36 155.88 26.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.066 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.03 31.1 1.46 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.181 -0.533 . . . . 10.0 111.874 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -18.92 57.38 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.244 0.218 . . . . 10.0 111.084 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 88.66 -18.1 0.25 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.699 1.249 . . . . 10.0 111.322 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -120.39 158.86 26.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.001 0.429 . . . . 10.0 110.263 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -66.4 123.61 20.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.433 -0.803 . . . . 10.0 111.002 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.613 ' H ' HG21 ' A' ' 46' ' ' ILE . 29.9 m -127.07 138.8 53.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.058 0.456 . . . . 10.0 111.09 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.71 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 9.5 m -87.26 119.48 27.55 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.395 -0.594 . . . . 10.0 109.395 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.38 153.32 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.565 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -134.31 159.62 40.42 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 175.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.622 ' H ' ' HA ' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -134.33 141.78 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 120.85 0.357 . . . . 10.0 110.172 -177.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.71 119.95 39.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.619 -0.882 . . . . 10.0 108.619 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.778 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 43.3 m-85 -94.22 164.62 12.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.971 0.891 . . . . 10.0 112.323 -173.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.6 m -52.12 -28.65 18.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.974 -1.466 . . . . 10.0 112.445 172.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -110.41 -85.94 0.54 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.857 -0.337 . . . . 10.0 111.133 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.23 43.29 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.023 -1.084 . . . . 10.0 113.097 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -71.48 146.18 48.74 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.796 -0.237 . . . . 10.0 110.627 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.494 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 27.7 p90 -75.08 140.54 43.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.222 -0.658 . . . . 10.0 109.222 175.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.761 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 160.71 -43.06 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 124.164 0.986 . . . . 10.0 110.804 -168.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.761 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 4.6 Cg_endo -47.65 66.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 124.894 3.729 . . . . 10.0 116.56 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.404 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER 169.33 102.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.315 1.046 . . . . 10.0 110.276 164.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -148.32 126.51 12.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.474 -0.785 . . . . 10.0 109.837 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.71 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.85 130.94 35.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.319 0.581 . . . . 10.0 109.796 174.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.613 HG21 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -93.41 148.63 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 114.998 -1.001 . . . . 10.0 109.283 -177.689 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -84.86 144.76 42.47 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 108.339 -0.986 . . . . 10.0 108.339 169.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -46.06 95.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.944 2.429 . . . . 10.0 112.711 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.706 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 93.55 13.84 54.56 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 119.948 -1.12 . . . . 10.0 111.824 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.55 -174.32 32.44 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 121.446 -0.407 . . . . 10.0 112.267 -177.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.71 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 19.1 m0 -118.8 166.28 12.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.394 0.616 . . . . 10.0 111.529 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.444 ' HB1' HD11 ' A' ' 46' ' ' ILE . . . -142.92 118.69 10.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.71 -1.218 . . . . 10.0 107.71 171.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.1 m -86.58 130.6 34.43 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.663 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.778 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 52.6 m-85 -138.53 145.82 41.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.56 -0.904 . . . . 10.0 108.56 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.64 97.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.754 0.659 . . . . 10.0 111.157 -174.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.74 171.79 49.66 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 110.002 -1.239 . . . . 10.0 110.002 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.49 ' HE1' ' HG3' ' A' ' 14' ' ' GLN . 7.8 p90 . . . . . 0 CA--C 1.535 0.374 0 CA-C-N 118.816 1.308 . . . . 10.0 111.037 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 30.6 t80 . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 120.528 0.204 . . . . 10.0 110.727 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -64.91 129.39 28.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 170.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.9 p -120.54 -22.9 6.24 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.994 -0.683 . . . . 10.0 111.924 -175.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -145.64 127.39 2.81 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.711 -1.233 . . . . 10.0 113.258 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.826 ' HB3' HG11 ' A' ' 6' ' ' VAL . 4.7 mt -87.71 139.18 30.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.131 0.491 . . . . 10.0 109.704 172.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.749 ' C ' HG13 ' A' ' 6' ' ' VAL . 14.6 m-70 -129.99 147.44 51.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.411 -0.813 . . . . 10.0 108.942 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -80.84 125.49 30.16 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 118.873 -1.131 . . . . 10.0 110.388 178.387 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.623 ' HB2' HG22 ' A' ' 32' ' ' THR . 38.5 t -87.61 158.75 18.79 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.361 -0.836 . . . . 10.0 109.531 -178.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 . . . . . 0 C--N 1.32 -0.679 0 N-CA-C 108.795 -0.817 . . . . 10.0 108.795 177.108 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.531 0.205 . . . . 10.0 111.474 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.7 p -71.42 -66.56 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.787 0.327 . . . . 10.0 111.239 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.56 102.86 2.02 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.849 -0.691 . . . . 10.0 111.555 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -127.61 81.95 69.23 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.954 0.407 . . . . 10.0 110.527 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -93.55 -33.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.095 2.53 . . . . 10.0 113.581 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.768 HG13 ' HB3' ' A' ' 67' ' ' LEU . 12.3 m -137.77 -142.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.26 -0.274 . . . . 10.0 110.26 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.605 ' N ' HG21 ' A' ' 6' ' ' VAL . . . -58.65 10.04 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.658 1.183 . . . . 10.0 113.932 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' A' ' 6' ' ' VAL . 35.4 mt-10 72.59 -50.43 0.7 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.4 0.889 . . . . 10.0 113.4 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.2 m -74.78 -8.53 56.71 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.858 0.318 . . . . 10.0 111.858 -172.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.815 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.4 m -95.96 131.97 41.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -132.93 114.46 14.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.529 -0.305 . . . . 10.0 110.616 -171.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.797 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -90.07 155.67 18.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.894 0.855 . . . . 10.0 112.471 175.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -135.05 152.7 51.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.058 -1.46 . . . . 10.0 107.058 170.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.554 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 4.3 pm0 -108.7 105.87 15.66 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.365 0.603 . . . . 10.0 110.863 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 p -108.34 75.93 1.01 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.536 0.684 . . . . 10.0 109.583 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 66.63 -86.21 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.542 -1.208 . . . . 10.0 111.801 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -117.5 24.52 11.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 10.0 110.456 -176.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.35 100.29 4.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.857 -0.794 . . . . 10.0 108.857 -174.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 m -90.58 95.31 10.09 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.797 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.0 p-10 -83.43 107.87 16.21 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.749 -1.114 . . . . 10.0 111.701 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.77 107.95 21.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 122.034 0.921 . . . . 10.0 109.157 174.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.724 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.46 110.34 22.51 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.88 -1.509 . . . . 10.0 110.176 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.815 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 24.6 t30 -82.18 159.4 23.29 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -151.73 23.53 0.93 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.769 -0.729 . . . . 10.0 112.241 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.636 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -75.58 -17.04 60.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.64 0.237 . . . . 10.0 111.64 -177.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 85.06 -4.26 0.92 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.362 1.039 . . . . 10.0 111.171 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.636 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 13.6 p-10 -126.88 156.29 41.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.593 174.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.58 126.07 28.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.451 -0.795 . . . . 10.0 111.139 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.517 ' H ' HG22 ' A' ' 46' ' ' ILE . 24.6 m -132.42 140.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.065 0.459 . . . . 10.0 111.068 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.815 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 5.4 m -88.19 123.91 33.3 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.91 146.14 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-O 121.454 0.645 . . . . 10.0 110.381 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.731 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -124.96 159.43 31.24 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.348 -0.842 . . . . 10.0 109.489 177.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.603 HG23 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.2 138.5 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-O 121.043 0.449 . . . . 10.0 110.544 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -106.97 116.42 31.9 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.694 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 57.1 m-85 -92.71 163.61 13.69 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.727 0.775 . . . . 10.0 112.062 -174.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 47.4 m -52.91 -21.97 4.97 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.238 -1.346 . . . . 10.0 111.693 170.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -135.56 -74.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.871 -0.518 . . . . 10.0 109.84 170.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 40' ' ' TRP . . . 148.76 80.46 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.713 -0.756 . . . . 10.0 112.117 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.737 HE21 ' HA2' ' A' ' 61' ' ' GLY . 10.4 mm-40 -74.66 20.0 0.13 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.022 0.379 . . . . 10.0 112.022 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.463 ' H ' ' C ' ' A' ' 38' ' ' GLY . 30.4 t90 59.77 87.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.64 0.733 . . . . 10.0 112.218 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.749 ' N ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.58 29.06 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.115 -0.948 . . . . 10.0 112.831 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.749 ' HD3' ' N ' ' A' ' 41' ' ' ALA . 9.8 Cg_endo -88.86 54.23 1.95 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.802 1.668 . . . . 10.0 112.198 -173.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.1 m 173.3 111.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.086 0.866 . . . . 10.0 111.259 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 131.62 10.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.815 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -82.13 142.7 13.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.112 0.482 . . . . 10.0 110.409 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -101.51 146.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.932 -0.576 . . . . 10.0 109.976 -178.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -87.27 143.38 34.42 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 169.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -41.16 95.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.523 2.816 . . . . 10.0 113.574 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.716 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 95.26 6.86 59.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.838 -1.172 . . . . 10.0 112.137 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.3 -174.46 44.9 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.183 -0.532 . . . . 10.0 113.098 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.724 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 10.0 m0 -120.11 167.39 12.26 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.932 -0.634 . . . . 10.0 111.061 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.14 111.18 5.31 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.768 -1.197 . . . . 10.0 107.768 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 m -77.58 130.53 37.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.433 -0.803 . . . . 10.0 110.061 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.694 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 49.8 m-85 -137.4 134.98 36.52 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.668 -0.864 . . . . 10.0 108.668 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.92 105.1 0.1 Allowed 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 124.23 0.957 . . . . 10.0 110.297 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.86 -157.85 0.65 Allowed Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.891 -1.05 . . . . 10.0 112.564 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.811 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 26.8 p90 -83.5 40.87 0.75 Allowed 'General case' 0 C--N 1.316 -0.881 0 O-C-N 122.447 -0.443 . . . . 10.0 111.894 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.99 160.5 53.42 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.7 -0.762 . . . . 10.0 112.001 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.6 p -70.66 -20.82 62.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.233 0.54 . . . . 10.0 110.547 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -94.83 5.09 52.91 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.001 -0.741 . . . . 10.0 109.001 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.737 ' HA2' HE21 ' A' ' 39' ' ' GLN . . . -131.78 -137.65 4.05 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.052 -0.976 . . . . 10.0 111.156 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 9.5 m120 -134.86 -96.7 0.26 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.155 -0.683 . . . . 10.0 109.155 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.811 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 15.5 t80 167.99 112.77 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 114.332 -1.304 . . . . 10.0 108.066 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -66.63 130.21 31.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.124 -1.065 . . . . 10.0 108.124 173.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.9 p -113.1 -37.37 4.79 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.064 -0.654 . . . . 10.0 111.322 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -140.05 136.99 8.09 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.826 -1.178 . . . . 10.0 112.496 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.768 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.0 mt -86.61 152.12 22.87 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.769 -0.826 . . . . 10.0 108.769 171.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.691 ' C ' HG12 ' A' ' 6' ' ' VAL . 6.5 m-70 -138.55 146.24 41.65 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.241 -1.022 . . . . 10.0 108.241 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 124.4 31.11 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 118.908 -1.117 . . . . 10.0 110.407 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.731 ' HB2' HG22 ' A' ' 32' ' ' THR . 41.9 t -92.27 158.55 16.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.214 -0.903 . . . . 10.0 109.807 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -102.72 141.7 23.04 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -23.8 79.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 1 C-N-CA 127.179 5.252 . . . . 10.0 115.577 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -166.78 88.58 0.34 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.16 -0.927 . . . . 10.0 111.145 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.8 t -90.78 139.46 26.19 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.37 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.2 104.78 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.55 2.166 . . . . 10.0 111.869 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.7 m 70.03 91.76 0.09 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.523 -0.762 . . . . 10.0 111.064 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.19 68.76 0.22 Allowed Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.234 -0.894 . . . . 10.0 111.826 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.608 -0.71 . . . . 10.0 110.18 179.642 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.484 0.183 . . . . 10.0 110.705 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.5 p -85.23 -51.66 6.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.882 0.372 . . . . 10.0 111.926 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.75 175.16 32.93 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.804 -0.712 . . . . 10.0 112.066 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.421 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 3.3 p -124.33 107.11 30.08 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 121.302 0.572 . . . . 10.0 111.533 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 94.8 Cg_endo -90.63 147.97 4.11 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.616 2.877 . . . . 10.0 112.046 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.808 HG11 ' HB3' ' A' ' 67' ' ' LEU . 2.9 m 49.19 -148.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.919 0.887 . . . . 10.0 112.36 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.648 ' N ' HG21 ' A' ' 6' ' ' VAL . . . -58.92 1.32 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.635 1.346 . . . . 10.0 114.635 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.421 ' HG2' ' HB2' ' A' ' 4' ' ' SER . 51.8 mt-10 72.22 -33.79 0.28 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.437 0.695 . . . . 10.0 112.322 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.433 ' H ' ' C ' ' A' ' 7' ' ' ALA . 10.2 m -76.86 -13.08 60.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.634 0.254 . . . . 10.0 111.421 -173.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.836 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.9 m -98.35 143.59 12.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.066 -0.716 . . . . 10.0 109.066 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -136.75 111.97 9.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.758 -0.201 . . . . 10.0 110.731 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.789 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -89.19 160.29 17.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.794 0.807 . . . . 10.0 112.546 175.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' THR . 36.9 t80 -142.76 173.95 11.09 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.549 -1.649 . . . . 10.0 106.549 173.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -119.24 103.4 9.47 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.366 -0.534 . . . . 10.0 110.508 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.7 m -104.6 54.29 0.72 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.982 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 60.38 88.99 0.07 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.554 -0.748 . . . . 10.0 111.537 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 49.5 ttt180 63.9 14.49 8.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.581 0.705 . . . . 10.0 111.538 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -130.95 95.72 3.89 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.779 -1.193 . . . . 10.0 107.779 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 61.5 m -86.35 97.67 10.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.31 0.576 . . . . 10.0 109.694 177.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.789 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.7 p-10 -83.19 108.43 16.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.723 -1.126 . . . . 10.0 111.318 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.99 105.84 18.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 122.203 1.001 . . . . 10.0 109.055 175.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.691 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -99.11 109.16 21.9 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 113.707 -1.588 . . . . 10.0 109.993 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.836 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 15.7 t30 -80.08 156.93 26.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -140.11 13.4 3.07 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.704 -0.76 . . . . 10.0 113.041 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.07 156.9 20.88 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 117.21 0.505 . . . . 10.0 109.844 173.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.32 -8.62 56.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.024 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -116.62 152.81 33.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.646 0.736 . . . . 10.0 111.721 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.76 125.36 26.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.695 -1.139 . . . . 10.0 110.256 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.591 ' H ' HG21 ' A' ' 46' ' ' ILE . 35.5 m -124.19 137.31 57.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.109 0.48 . . . . 10.0 111.67 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.768 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 3.8 m -85.69 121.95 29.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.71 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.469 ' HB ' HG12 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -122.78 148.11 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.295 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.662 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.2 OUTLIER -127.44 160.17 32.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.147 -0.933 . . . . 10.0 109.02 176.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.607 HG22 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -132.03 132.04 61.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.598 0.713 . . . . 10.0 111.337 -176.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -103.55 109.74 21.52 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.522 -176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.793 ' HH ' ' HB1' ' A' ' 41' ' ' ALA . 28.4 m-85 -89.59 165.31 14.33 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.584 0.706 . . . . 10.0 111.733 -176.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 52.4 m -52.55 -29.73 26.97 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.231 -1.35 . . . . 10.0 111.397 168.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.443 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 52.6 m-70 -126.42 -77.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 10.0 110.206 172.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 40' ' ' TRP . . . 145.01 79.02 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.228 -0.986 . . . . 10.0 111.691 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.454 ' HG2' ' OD1' ' A' ' 62' ' ' ASN . 12.7 mm100 -76.38 20.01 0.23 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.218 0.451 . . . . 10.0 112.218 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.431 ' H ' ' C ' ' A' ' 38' ' ' GLY . 3.1 t90 66.99 87.41 0.12 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.727 0.811 . . . . 10.0 111.641 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.793 ' HB1' ' HH ' ' A' ' 35' ' ' TYR . . . -170.85 27.77 0.01 OUTLIER Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 113.444 0.905 . . . . 10.0 113.444 174.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.737 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 9.9 Cg_endo -89.16 56.41 2.01 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.726 1.617 . . . . 10.0 112.754 -172.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.2 m 172.27 114.56 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.616 0.766 . . . . 10.0 111.33 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.61 132.0 8.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.1 -0.704 . . . . 10.0 109.1 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.768 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -81.13 138.88 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.199 0.523 . . . . 10.0 110.06 176.227 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.618 HD12 HG23 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -97.05 145.12 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 115.362 -0.835 . . . . 10.0 109.704 -179.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -83.2 141.38 42.96 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 107.966 -1.124 . . . . 10.0 107.966 169.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -47.77 91.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.298 2.666 . . . . 10.0 112.692 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.654 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 104.37 5.91 42.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.161 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.78 -172.4 36.11 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.382 -0.437 . . . . 10.0 112.863 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.691 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 13.4 m0 -120.32 167.28 12.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.514 0.673 . . . . 10.0 111.051 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.401 ' HB1' HD13 ' A' ' 46' ' ' ILE . . . -143.1 113.07 7.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 171.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -81.44 128.31 33.74 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.436 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.607 ' CG ' HG22 ' A' ' 33' ' ' VAL . 42.1 m-85 -138.78 140.52 38.64 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.332 -0.618 . . . . 10.0 109.332 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.72 101.46 0.05 Allowed 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 123.894 0.746 . . . . 10.0 110.192 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.91 -159.27 8.36 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 111.217 -0.753 . . . . 10.0 111.217 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.675 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 28.3 p90 -88.19 127.61 35.44 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.109 -1.071 . . . . 10.0 108.109 173.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.37 -165.23 30.57 Favored Glycine 0 C--N 1.31 -0.895 0 CA-C-N 115.504 -0.771 . . . . 10.0 112.176 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 m -76.57 128.05 33.98 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.127 -0.323 . . . . 10.0 110.127 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 66.51 24.02 10.37 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.889 0.475 . . . . 10.0 111.247 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -125.23 -151.19 7.95 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.094 -0.802 . . . . 10.0 111.094 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.454 ' OD1' ' HG2' ' A' ' 39' ' ' GLN . 4.0 m120 -125.49 -111.72 0.3 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 117.995 0.897 . . . . 10.0 109.097 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.675 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 28.7 t80 175.43 109.08 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 114.465 -1.243 . . . . 10.0 108.646 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.9 m -63.59 131.56 29.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 107.74 -1.207 . . . . 10.0 107.74 173.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.0 t -137.95 11.82 2.87 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.27 -0.572 . . . . 10.0 110.379 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.76 118.93 0.81 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 119.803 -1.189 . . . . 10.0 112.782 173.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.808 ' HB3' HG11 ' A' ' 6' ' ' VAL . 4.4 mt -88.99 127.57 35.67 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.713 ' C ' HG13 ' A' ' 6' ' ' VAL . 17.6 m-70 -118.24 146.45 44.26 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.306 -0.861 . . . . 10.0 108.933 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.15 123.31 28.87 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.032 -1.043 . . . . 10.0 110.513 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.662 ' HB2' HG23 ' A' ' 32' ' ' THR . 42.0 t -92.7 161.01 14.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.799 -0.637 . . . . 10.0 110.205 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.425 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 7.3 p-10 -99.19 146.09 31.13 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 172.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 16.8 Cg_exo -28.35 80.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 1 C-N-CA 126.538 4.825 . . . . 10.0 115.116 175.262 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -169.24 99.06 0.35 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.209 -0.905 . . . . 10.0 111.659 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.1 m -89.33 135.92 30.65 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.635 -0.505 . . . . 10.0 109.635 172.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.14 54.81 0.72 Allowed 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 123.017 2.478 . . . . 10.0 113.008 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.8 p -84.44 88.42 7.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.137 0.494 . . . . 10.0 109.844 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.18 138.91 14.22 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.715 -0.755 . . . . 10.0 112.991 -174.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.392 -0.813 . . . . 10.0 109.265 176.64 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.915 0.388 . . . . 10.0 110.488 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.0 m -161.4 -58.0 0.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.491 ' O ' ' HD3' ' A' ' 5' ' ' PRO . . . -101.4 173.93 24.47 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.71 -0.956 . . . . 10.0 110.71 174.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -113.04 86.57 9.34 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 117.132 0.466 . . . . 10.0 110.096 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 3' ' ' GLY . 54.2 Cg_endo -89.24 -44.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.321 2.014 . . . . 10.0 112.838 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.795 HG12 ' HB3' ' A' ' 67' ' ' LEU . 9.3 m -136.94 -137.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.252 -0.647 . . . . 10.0 109.252 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.66 ' N ' HG22 ' A' ' 6' ' ' VAL . . . -56.48 0.23 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.185 0.994 . . . . 10.0 113.452 174.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 6' ' ' VAL . 10.0 mt-10 74.11 -38.73 0.41 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.518 1.127 . . . . 10.0 113.264 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.1 m -75.77 -13.35 60.29 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.939 0.399 . . . . 10.0 111.318 -175.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.864 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -97.09 137.32 25.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.009 -0.737 . . . . 10.0 109.009 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -143.34 129.94 20.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.043 -0.263 . . . . 10.0 110.477 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.701 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -95.56 165.23 12.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.891 0.853 . . . . 10.0 113.179 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.407 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 87.3 t80 -145.26 154.32 42.24 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 106.72 -1.585 . . . . 10.0 106.72 170.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -105.66 108.26 19.69 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.445 -0.502 . . . . 10.0 111.389 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -99.41 -166.89 1.4 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.124 -1.065 . . . . 10.0 108.124 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.65 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -69.46 100.67 1.43 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.837 0.351 . . . . 10.0 110.541 -178.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 63.92 28.19 14.5 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.118 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.87 101.86 3.59 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 121.207 -0.197 . . . . 10.0 111.15 -169.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.457 HG23 HG11 ' A' ' 64' ' ' VAL . 16.3 m -89.63 96.71 10.81 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 170.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.701 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.1 p-10 -84.34 107.35 16.57 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 114.947 -1.024 . . . . 10.0 112.378 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.29 108.62 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.794 0.807 . . . . 10.0 108.9 174.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.752 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.6 p80 -98.39 113.97 26.14 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.218 -1.356 . . . . 10.0 110.554 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.864 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 22.6 t30 -82.03 163.42 22.11 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.592 -0.522 . . . . 10.0 109.592 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -153.39 25.2 0.77 Allowed Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.288 -0.482 . . . . 10.0 112.203 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -14.0 59.52 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.402 0.281 . . . . 10.0 111.148 -177.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 82.24 -6.03 1.4 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.919 -1.037 . . . . 10.0 110.933 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -126.24 158.58 35.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.02 0.438 . . . . 10.0 110.304 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -70.91 120.3 16.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.039 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.683 ' H ' HG21 ' A' ' 46' ' ' ILE . 29.6 m -126.19 140.75 47.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.221 0.534 . . . . 10.0 111.424 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.718 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.0 m -88.11 120.25 29.28 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.154 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.41 161.15 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 115.729 -0.669 . . . . 10.0 110.409 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.671 HG21 ' HB2' ' A' ' 70' ' ' CYS . 0.4 OUTLIER -143.13 160.88 39.58 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.474 -0.784 . . . . 10.0 109.015 176.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.578 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.58 145.27 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.45 0.643 . . . . 10.0 111.542 -175.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -114.12 110.31 19.81 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.735 -1.121 . . . . 10.0 109.719 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.814 ' HH ' ' HB2' ' A' ' 41' ' ' ALA . 11.9 m-85 -90.57 161.88 15.25 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.369 0.604 . . . . 10.0 111.622 -176.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.1 m -48.79 -38.64 22.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.263 -1.335 . . . . 10.0 112.783 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.599 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 47.0 m-70 -101.6 -75.49 0.59 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.518 -0.473 . . . . 10.0 110.064 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.06 46.73 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.553 -0.832 . . . . 10.0 112.048 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.34 136.78 57.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -72.79 100.47 2.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 10.0 111.548 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.84 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.03 19.96 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.256 -0.884 . . . . 10.0 113.233 175.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.84 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 9.2 Cg_endo -87.27 58.62 3.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 CA-C-N 121.112 1.433 . . . . 10.0 112.455 -170.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 176.47 115.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.791 0.682 . . . . 10.0 111.168 170.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 128.67 6.74 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.436 0.694 . . . . 10.0 109.525 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.718 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -83.92 134.38 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.334 0.588 . . . . 10.0 110.534 177.246 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.683 HG21 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -94.67 149.29 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.009 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -86.88 146.73 41.54 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 168.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -43.19 98.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.037 2.491 . . . . 10.0 112.961 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.717 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 89.28 11.48 64.55 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.864 -1.16 . . . . 10.0 111.565 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.12 -176.81 37.78 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 121.283 -0.484 . . . . 10.0 112.418 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.752 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 17.2 m0 -115.93 166.76 11.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.793 0.806 . . . . 10.0 111.815 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB1' HD12 ' A' ' 46' ' ' ILE . . . -143.67 118.3 9.8 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.362 -1.347 . . . . 10.0 107.362 172.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.7 m -85.72 129.7 34.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.178 0.514 . . . . 10.0 110.812 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.578 ' CG ' HG21 ' A' ' 33' ' ' VAL . 56.3 m-85 -136.86 151.34 49.0 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.588 -0.894 . . . . 10.0 108.588 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.97 98.56 0.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.705 0.628 . . . . 10.0 110.562 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.45 178.49 23.11 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 115.049 -0.978 . . . . 10.0 111.107 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 12.1 p90 -84.78 43.68 1.0 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.049 0.925 . . . . 10.0 110.803 -173.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.85 114.06 4.64 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.386 -0.825 . . . . 10.0 111.796 -173.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m 74.99 27.83 1.12 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.242 0.544 . . . . 10.0 111.138 176.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.6 t70 66.1 81.87 0.19 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.416 0.627 . . . . 10.0 110.917 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.72 -115.59 1.01 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.052 -0.819 . . . . 10.0 111.052 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.599 ' OD1' ' HB2' ' A' ' 37' ' ' HIS . 5.1 m-80 -84.33 139.69 32.11 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.287 -0.634 . . . . 10.0 109.287 173.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -127.29 111.89 14.43 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -59.75 128.91 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.5 p -118.04 -34.3 4.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.046 0.45 . . . . 10.0 111.169 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.84 129.71 4.75 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.062 -1.066 . . . . 10.0 112.468 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.795 ' HB3' HG12 ' A' ' 6' ' ' VAL . 3.8 mt -83.89 148.87 26.71 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.114 -1.069 . . . . 10.0 108.114 171.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.708 ' C ' HG11 ' A' ' 6' ' ' VAL . 15.4 m-70 -134.17 147.44 50.77 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.46 130.04 35.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 118.994 -1.082 . . . . 10.0 110.566 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.671 ' HB2' HG21 ' A' ' 32' ' ' THR . 43.3 t -96.14 159.72 14.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.986 -0.552 . . . . 10.0 109.58 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.95 146.48 37.1 Favored Pre-proline 0 CA--C 1.512 -0.489 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -22.37 78.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.849 1 C-N-CA 126.702 4.935 . . . . 10.0 115.53 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -169.6 81.91 0.12 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.969 -1.014 . . . . 10.0 110.835 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.3 t -84.45 120.35 74.18 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.312 -0.403 . . . . 10.0 110.123 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.42 146.49 93.28 Favored 'Trans proline' 0 CA--C 1.518 -0.277 0 C-N-CA 122.565 2.176 . . . . 10.0 111.726 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.3 t -153.75 100.43 2.38 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.75 -60.62 7.83 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.723 -0.751 . . . . 10.0 111.494 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.049 -0.976 . . . . 10.0 110.013 175.748 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 120.698 0.285 . . . . 10.0 110.96 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 p -75.59 130.31 38.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.886 0.374 . . . . 10.0 111.141 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.78 -134.31 1.88 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.537 -0.625 . . . . 10.0 111.537 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.631 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 14.3 m -95.67 149.89 36.69 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 110.115 -0.328 . . . . 10.0 110.115 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.24 143.05 38.78 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.779 2.319 . . . . 10.0 111.891 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.59 ' HB ' ' C ' ' A' ' 68' ' ' HIS . 0.3 OUTLIER 38.77 98.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 114.324 1.231 . . . . 10.0 114.324 177.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' A' ' 9' ' ' CYS . . . 75.99 -25.09 0.21 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.558 -0.747 . . . . 10.0 112.559 166.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.631 ' HG2' ' HB2' ' A' ' 4' ' ' SER . 24.6 mt-10 74.8 -22.19 0.27 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.224 1.009 . . . . 10.0 111.845 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.422 ' H ' ' C ' ' A' ' 7' ' ' ALA . 82.4 m -85.42 -16.5 39.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.907 0.336 . . . . 10.0 111.907 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -94.22 139.78 17.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.619 -0.512 . . . . 10.0 109.619 -177.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -141.55 127.3 19.17 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.625 -0.139 . . . . 10.0 110.625 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.809 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -98.4 164.19 12.38 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.468 1.127 . . . . 10.0 113.787 176.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.402 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 84.6 t80 -145.1 162.6 36.63 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.304 -1.771 . . . . 10.0 106.643 172.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.401 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -117.71 122.7 44.18 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.083 -0.647 . . . . 10.0 110.786 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 25.9 p -121.93 -154.39 0.59 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.78 -0.822 . . . . 10.0 108.78 175.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -67.93 91.11 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.647 0.261 . . . . 10.0 111.412 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 61.4 35.07 17.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.585 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.5 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -147.29 101.19 3.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.4 -0.818 . . . . 10.0 109.345 -173.05 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -90.42 99.37 12.41 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 170.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.809 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -84.37 110.44 18.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.871 -1.059 . . . . 10.0 111.966 -177.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.98 106.69 19.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 122.181 0.991 . . . . 10.0 108.561 171.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.804 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.4 OUTLIER -97.22 111.06 23.47 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.094 -1.412 . . . . 10.0 110.163 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.754 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.4 t30 -80.29 156.66 26.7 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.837 -0.62 . . . . 10.0 109.342 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.47 13.91 3.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.127 -0.558 . . . . 10.0 112.346 174.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.77 156.18 22.66 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.53 -8.41 56.69 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.264 0.468 . . . . 10.0 112.264 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -120.66 157.46 29.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.511 0.672 . . . . 10.0 111.75 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -71.82 117.69 13.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.827 -1.079 . . . . 10.0 110.431 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.616 ' H ' HG23 ' A' ' 46' ' ' ILE . 33.7 m -116.87 139.21 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 121.303 0.573 . . . . 10.0 111.676 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.0 m -88.94 116.88 27.55 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.734 -0.666 . . . . 10.0 109.288 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.517 HG11 HG21 ' A' ' 6' ' ' VAL . 1.1 m -112.8 164.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.452 -0.795 . . . . 10.0 110.517 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.31 153.7 40.04 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.257 -0.883 . . . . 10.0 109.212 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.562 HG22 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -130.23 137.69 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 120.937 0.399 . . . . 10.0 110.915 -174.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -100.6 116.63 32.97 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.782 -0.821 . . . . 10.0 108.782 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.778 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 45.9 m-85 -91.77 160.79 15.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.112 0.482 . . . . 10.0 111.023 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.6 m -48.47 -33.22 9.01 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.664 -1.153 . . . . 10.0 112.604 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -110.26 -69.66 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.929 0.395 . . . . 10.0 109.961 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.45 58.07 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.551 -0.833 . . . . 10.0 112.161 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.2 154.64 30.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.706 0.289 . . . . 10.0 110.681 176.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -76.46 106.45 8.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.837 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -173.62 -40.57 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 113.069 0.766 . . . . 10.0 113.069 -175.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.837 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 5.3 Cg_endo -46.86 67.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 124.884 3.723 . . . . 10.0 116.429 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER 169.96 104.43 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.179 0.992 . . . . 10.0 110.097 168.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -151.85 127.05 9.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.064 -176.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.38 132.85 30.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.277 -0.569 . . . . 10.0 109.856 174.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.616 HG23 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -96.06 147.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-N 115.112 -0.949 . . . . 10.0 109.28 -177.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -84.03 141.42 40.56 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 169.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -47.89 94.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.056 2.504 . . . . 10.0 112.366 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 97.77 14.22 41.01 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.073 -1.061 . . . . 10.0 112.106 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.66 -172.2 26.77 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 121.112 -0.566 . . . . 10.0 112.669 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.804 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 16.5 m0 -119.54 165.54 14.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.423 0.63 . . . . 10.0 111.255 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' A' ' 46' ' ' ILE . . . -139.66 111.15 7.12 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 172.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.6 m -78.74 126.79 31.2 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.394 -0.821 . . . . 10.0 110.439 -176.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.562 ' CG ' HG22 ' A' ' 33' ' ' VAL . 51.5 m-85 -134.53 146.42 49.67 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.509 -0.922 . . . . 10.0 108.509 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.03 102.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.836 0.71 . . . . 10.0 110.459 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.59 179.44 16.65 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.608 -0.997 . . . . 10.0 110.608 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.642 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 14.9 p90 -79.77 101.38 8.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.208 1.004 . . . . 10.0 110.64 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.15 172.5 47.05 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 115.237 -0.892 . . . . 10.0 111.194 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.9 m -58.6 -27.95 65.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.281 0.562 . . . . 10.0 110.663 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -149.2 106.87 3.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 164.58 -138.91 5.53 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.809 -0.71 . . . . 10.0 112.407 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.778 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -102.62 161.48 13.69 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.329 0.585 . . . . 10.0 110.921 -179.178 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.564 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 19.1 t80 -135.76 119.96 17.78 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.39 -1.277 . . . . 10.0 108.562 170.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -63.23 130.77 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.2 p -123.83 -19.04 5.84 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.203 -0.599 . . . . 10.0 111.851 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.39 130.69 4.06 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.602 -1.285 . . . . 10.0 113.159 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -94.84 148.0 22.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.399 -0.593 . . . . 10.0 109.399 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.59 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -147.98 164.54 33.47 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.254 -176.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.49 ' N ' ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -83.53 129.1 34.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.22 0.533 . . . . 10.0 111.362 177.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 32.3 t -98.19 168.3 10.33 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.509 -0.923 . . . . 10.0 108.509 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -134.56 142.81 44.05 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -16.5 78.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.976 1 C-N-CA 126.969 5.113 . . . . 10.0 115.747 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -163.64 83.96 0.47 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.844 -1.071 . . . . 10.0 109.853 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.0 t -80.13 141.08 53.73 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 115.922 -0.581 . . . . 10.0 111.069 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.19 166.02 30.55 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.821 2.347 . . . . 10.0 112.769 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.2 m -78.54 135.66 37.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.152 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.08 -63.59 1.2 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.315 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.436 -0.793 . . . . 10.0 109.417 177.618 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.279 -0.267 . . . . 10.0 110.279 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.4 m -72.29 101.94 2.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.914 0.388 . . . . 10.0 110.11 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.73 -177.44 51.21 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.589 -0.815 . . . . 10.0 111.37 -175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.1 m -100.29 144.27 28.1 Favored Pre-proline 0 C--N 1.32 -0.71 0 O-C-N 122.523 -0.398 . . . . 10.0 110.583 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.577 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 38.4 Cg_endo -65.51 153.68 77.14 Favored 'Trans proline' 0 N--CA 1.475 0.385 0 C-N-CA 123.476 2.784 . . . . 10.0 112.764 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.871 HG11 ' HB3' ' A' ' 67' ' ' LEU . 3.9 m 47.35 -141.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.934 0.893 . . . . 10.0 111.689 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.675 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.89 -1.9 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.512 1.125 . . . . 10.0 113.368 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 6' ' ' VAL . 35.9 mt-10 76.27 -26.93 0.18 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.989 0.915 . . . . 10.0 112.655 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.84 -10.88 54.68 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.195 0.443 . . . . 10.0 112.195 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.872 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -96.22 140.56 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 -176.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -132.19 116.04 16.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.206 -0.197 . . . . 10.0 110.958 -173.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.794 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.1 161.68 15.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 122.053 0.93 . . . . 10.0 112.919 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 19' ' ' THR . 90.5 t80 -144.28 158.52 43.69 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.835 -1.53 . . . . 10.0 106.908 172.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HG3' ' OG1' ' A' ' 19' ' ' THR . 2.1 mp0 -117.0 101.78 8.79 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.33 -0.548 . . . . 10.0 111.252 -176.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.1 t -93.89 80.2 4.16 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 61.35 -89.86 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 115.005 -0.998 . . . . 10.0 110.573 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.533 ' H ' ' HD3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -118.17 26.68 9.46 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.153 0.501 . . . . 10.0 111.144 -176.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -132.34 96.0 3.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.3 m -85.28 101.95 12.96 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.245 0.545 . . . . 10.0 110.214 176.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.794 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.6 p-10 -86.19 108.38 18.32 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.845 -1.07 . . . . 10.0 111.454 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.1 107.82 21.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.891 0.853 . . . . 10.0 108.988 173.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.694 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.04 110.67 22.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.229 -1.35 . . . . 10.0 110.297 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.872 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 21.8 t30 -80.14 160.12 25.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 10.0 110.157 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.46 23.53 1.07 Allowed Glycine 0 C--O 1.226 -0.392 0 C-N-CA 121.361 -0.447 . . . . 10.0 112.207 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -75.12 -16.74 60.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.512 0.196 . . . . 10.0 111.316 -178.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 25' ' ' CYS . . . 85.11 -6.33 0.91 Allowed 'General case' 0 N--CA 1.472 0.647 0 O-C-N 124.631 1.207 . . . . 10.0 111.345 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.449 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 5.9 p-10 -126.82 157.02 40.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.959 0.409 . . . . 10.0 110.689 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.79 122.56 18.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.354 -0.839 . . . . 10.0 110.96 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.57 ' H ' HG23 ' A' ' 46' ' ' ILE . 34.6 m -129.1 140.64 48.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.076 0.465 . . . . 10.0 111.442 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.668 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.5 m -87.22 120.34 28.4 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.487 -0.561 . . . . 10.0 109.487 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.623 ' HB ' HG12 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -119.88 146.79 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 115.587 -0.733 . . . . 10.0 110.587 -179.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.587 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -125.74 161.74 26.65 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.28 -0.873 . . . . 10.0 108.834 175.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.633 HG23 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.82 133.63 58.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.35 0.595 . . . . 10.0 110.95 -176.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -106.04 112.65 25.78 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.735 -1.121 . . . . 10.0 108.696 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.464 ' HH ' ' HB1' ' A' ' 41' ' ' ALA . 15.4 m-85 -91.07 164.01 14.1 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.33 0.586 . . . . 10.0 110.959 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.7 m -50.51 -22.53 1.99 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.464 -1.243 . . . . 10.0 112.668 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.511 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 85.5 m-70 -123.96 -82.37 0.64 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.987 -0.445 . . . . 10.0 111.159 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.23 51.01 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.645 -1.264 . . . . 10.0 113.084 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.36 136.05 56.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.863 -0.792 . . . . 10.0 108.863 175.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -72.95 118.31 15.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.209 0.528 . . . . 10.0 110.471 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.768 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -177.05 -45.27 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 114.95 -1.023 . . . . 10.0 111.903 -174.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.768 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 3.5 Cg_exo -37.18 68.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.886 1 C-N-CA 125.924 4.416 . . . . 10.0 117.487 -174.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 5.3 t 170.53 111.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.294 1.038 . . . . 10.0 109.759 162.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.31 126.57 9.94 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.668 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -79.98 130.11 36.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.375 0.607 . . . . 10.0 109.369 175.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.612 HD13 HG23 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -93.21 148.91 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 114.83 -1.077 . . . . 10.0 109.804 -176.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.401 ' O ' HG21 ' A' ' 46' ' ' ILE . 21.7 mt-10 -84.77 145.99 45.36 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 108.389 -0.967 . . . . 10.0 108.389 168.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -45.0 94.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.009 2.472 . . . . 10.0 112.564 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.718 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.72 15.12 53.89 Favored Glycine 0 CA--C 1.512 -0.151 0 C-N-CA 120.022 -1.085 . . . . 10.0 111.812 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 22' ' ' HIS . . . -97.26 -176.52 34.56 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 121.706 -0.283 . . . . 10.0 112.48 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.708 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 18.6 m0 -118.15 165.41 13.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.629 0.728 . . . . 10.0 111.784 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.91 115.54 8.17 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.265 -1.334 . . . . 10.0 107.929 172.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.3 m -82.56 131.19 35.22 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.598 -0.728 . . . . 10.0 110.764 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.633 ' CG ' HG23 ' A' ' 33' ' ' VAL . 53.5 m-85 -139.76 145.42 38.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.439 -0.948 . . . . 10.0 108.439 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.1 99.29 0.07 Allowed 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 123.856 0.723 . . . . 10.0 110.69 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.08 -173.59 12.35 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.295 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.437 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 2.9 p90 -91.86 83.99 5.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.6 0.714 . . . . 10.0 110.448 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -50.21 -57.9 9.56 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.746 -0.661 . . . . 10.0 113.369 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 p -144.67 -60.37 0.37 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.178 0.513 . . . . 10.0 110.087 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -141.0 161.49 37.72 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.034 -1.098 . . . . 10.0 108.034 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.82 -131.41 9.3 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.201 -1.0 . . . . 10.0 111.795 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.511 ' OD1' ' HB2' ' A' ' 37' ' ' HIS . 13.0 m-80 -76.24 143.31 41.05 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.257 0.551 . . . . 10.0 111.008 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.437 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 26.1 t80 -140.08 118.09 11.85 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.804 -1.089 . . . . 10.0 109.046 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.47 129.14 26.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 175.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 t -144.77 10.46 1.38 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.306 -0.557 . . . . 10.0 111.034 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.33 106.6 0.29 Allowed Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.552 -1.308 . . . . 10.0 112.951 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.871 ' HB3' HG11 ' A' ' 6' ' ' VAL . 5.8 mt -81.37 131.92 35.31 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.72 ' C ' HG13 ' A' ' 6' ' ' VAL . 18.7 m-70 -124.65 143.97 50.44 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.443 HG23 ' N ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -79.49 125.12 29.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 119.378 0.99 . . . . 10.0 110.482 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.587 ' HB2' HG23 ' A' ' 32' ' ' THR . 4.4 t -89.61 174.2 7.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.492 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 8.0 p-10 -126.44 145.43 52.87 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.378 -0.601 . . . . 10.0 109.378 175.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 27.4 Cg_exo -23.96 80.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 1 C-N-CA 126.89 5.06 . . . . 10.0 115.523 177.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -168.21 91.23 0.31 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.95 -1.023 . . . . 10.0 110.781 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -79.27 128.39 75.83 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.372 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 43' ' ' CYS . 51.3 Cg_endo -71.56 75.81 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.44 2.093 . . . . 10.0 111.879 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.4 p -82.68 -27.3 31.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.577 -0.738 . . . . 10.0 110.738 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.02 144.79 7.07 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.429 -0.668 . . . . 10.0 111.429 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.773 -0.632 . . . . 10.0 110.233 -179.724 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 110.289 -0.264 . . . . 10.0 110.289 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.9 t -74.65 78.89 2.01 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.996 0.903 . . . . 10.0 110.513 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 128.91 -178.67 17.13 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.004 -0.998 . . . . 10.0 110.882 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.5 m 58.34 76.74 0.44 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 121.157 0.504 . . . . 10.0 111.7 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.48 ' C ' HG12 ' A' ' 6' ' ' VAL . 61.1 Cg_endo -90.94 115.38 0.46 Allowed 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.827 2.352 . . . . 10.0 112.697 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 31' ' ' VAL . 2.0 m 65.39 -49.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 125.139 1.376 . . . . 10.0 111.951 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.602 ' O ' HG11 ' A' ' 10' ' ' VAL . . . -174.73 114.65 0.17 Allowed 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 106.133 -1.802 . . . . 10.0 106.133 -172.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.84 -14.21 5.64 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.405 -0.816 . . . . 10.0 112.396 -166.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.6 m -86.6 -15.5 39.62 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.807 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.6 m -91.67 131.47 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.019 -0.734 . . . . 10.0 109.019 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -137.39 123.56 20.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.685 -0.234 . . . . 10.0 110.494 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.77 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.45 159.08 15.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.777 0.798 . . . . 10.0 112.629 178.189 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.42 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 78.2 t80 -139.53 165.35 27.46 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.28 -1.378 . . . . 10.0 107.28 172.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.61 107.84 15.21 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.074 -0.65 . . . . 10.0 110.923 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 21.8 m -96.91 -173.73 2.79 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.519 -1.289 . . . . 10.0 107.519 170.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -62.26 98.01 0.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.111 0.481 . . . . 10.0 111.074 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 57.63 40.29 26.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.1 -0.954 . . . . 10.0 111.375 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.516 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 0.9 OUTLIER -148.09 96.06 2.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 -177.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.477 HG21 HG11 ' A' ' 64' ' ' VAL . 25.3 m -86.66 96.56 10.17 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.491 -0.559 . . . . 10.0 109.491 175.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.77 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.4 p-10 -86.04 109.79 19.06 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.458 -0.792 . . . . 10.0 112.071 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.65 107.18 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.951 0.882 . . . . 10.0 109.043 173.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.803 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 3.6 p80 -97.61 115.11 27.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.39 -1.277 . . . . 10.0 110.361 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.807 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 16.9 t-20 -81.76 160.79 23.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.53 -0.759 . . . . 10.0 109.752 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.95 39.41 0.6 Allowed Glycine 0 C--N 1.32 -0.314 0 N-CA-C 111.438 -0.665 . . . . 10.0 111.438 173.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.598 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -91.9 -16.09 27.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.612 -0.294 . . . . 10.0 111.549 -176.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 84.91 -7.66 0.92 Allowed 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.456 1.098 . . . . 10.0 110.923 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.598 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 9.3 p-10 -126.48 151.75 47.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.235 0.54 . . . . 10.0 110.686 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -69.86 126.06 28.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.422 -0.808 . . . . 10.0 111.116 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.519 ' H ' HG23 ' A' ' 46' ' ' ILE . 29.2 m -129.66 140.64 48.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.13 0.491 . . . . 10.0 111.334 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 14.4 m -92.11 117.57 29.98 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -113.04 166.34 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 115.269 -0.878 . . . . 10.0 110.88 -178.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.17 157.96 43.65 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.293 -0.867 . . . . 10.0 108.887 176.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.559 HG23 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.24 141.68 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 120.904 0.383 . . . . 10.0 111.449 -173.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -107.83 119.1 38.48 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.77 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.729 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 25.3 m-85 -92.4 164.3 13.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.21 0.529 . . . . 10.0 111.287 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 49.2 m -50.04 -24.03 2.42 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.764 -1.107 . . . . 10.0 111.875 171.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.414 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 71.8 m-70 -117.68 -79.51 0.59 Allowed 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.118 -0.364 . . . . 10.0 110.033 172.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.57 51.53 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.344 -0.932 . . . . 10.0 112.031 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.4 141.96 57.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.406 ' CZ2' ' HB3' ' A' ' 75' ' ' PRO . 59.4 t-105 -70.16 116.22 10.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.059 0.457 . . . . 10.0 110.499 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.765 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -175.33 -44.4 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.022 -0.99 . . . . 10.0 112.278 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.765 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 1.6 Cg_endo -40.54 70.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.874 1 C-N-CA 125.437 4.091 . . . . 10.0 116.639 -175.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER 169.6 106.46 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.383 1.073 . . . . 10.0 110.421 166.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.403 ' HB2' ' HZ ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -152.9 125.82 8.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.854 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.738 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -81.26 134.23 27.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.312 -0.555 . . . . 10.0 109.887 173.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.519 HG23 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -95.88 145.08 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-N 115.273 -0.876 . . . . 10.0 109.625 -177.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -85.35 142.78 38.19 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 168.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -41.1 93.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.41 2.74 . . . . 10.0 112.984 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.69 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 95.99 10.9 55.82 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 119.851 -1.166 . . . . 10.0 112.179 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.64 -176.49 35.49 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.525 -0.369 . . . . 10.0 112.717 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.803 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 19.8 m0 -116.04 166.87 11.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.686 0.755 . . . . 10.0 111.672 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' HB1' HD13 ' A' ' 46' ' ' ILE . . . -141.6 111.85 6.89 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.368 -1.345 . . . . 10.0 107.368 172.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.5 m -79.38 129.82 34.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.699 -0.682 . . . . 10.0 110.663 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.729 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 50.3 m-85 -140.15 142.71 35.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.406 -0.961 . . . . 10.0 108.406 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.22 104.52 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.668 0.605 . . . . 10.0 110.476 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' HA2' ' HG1' ' A' ' 19' ' ' THR . . . -67.02 -179.05 10.86 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 110.652 -0.979 . . . . 10.0 110.652 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.546 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 12.4 p90 -76.16 87.36 3.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.163 0.982 . . . . 10.0 111.697 -172.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.96 -54.63 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.668 -1.151 . . . . 10.0 111.662 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.4 m -62.65 110.71 1.81 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.366 0.266 . . . . 10.0 110.582 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 59.48 15.43 4.49 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.16 0.505 . . . . 10.0 111.787 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.5 23.97 77.17 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.698 -0.763 . . . . 10.0 112.758 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.546 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -87.55 131.13 34.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 117.496 0.648 . . . . 10.0 109.362 175.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.527 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 16.5 t80 -125.12 118.35 25.94 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.999 -0.741 . . . . 10.0 108.999 175.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 19' ' ' THR . 1.6 m -59.21 129.67 21.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.703 -0.851 . . . . 10.0 108.703 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.1 p -127.0 -10.88 5.97 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.654 -0.418 . . . . 10.0 111.46 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.36 147.07 16.57 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.02 -1.086 . . . . 10.0 112.872 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.458 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.1 mt -116.94 135.62 53.57 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.103 -0.702 . . . . 10.0 109.103 177.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.436 ' N ' HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -131.56 157.81 42.62 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.727 -0.67 . . . . 10.0 109.709 -176.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.469 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -80.19 130.65 35.37 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.386 -0.526 . . . . 10.0 110.382 177.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 30' ' ' SER . 43.0 t -96.7 158.65 15.33 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.237 -0.653 . . . . 10.0 109.237 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.5 142.67 29.17 Favored Pre-proline 0 CA--C 1.512 -0.505 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 172.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -21.75 77.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 1 C-N-CA 126.776 4.984 . . . . 10.0 115.303 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -168.91 88.86 0.2 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.901 -1.045 . . . . 10.0 110.637 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.2 t -93.82 133.78 27.29 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.284 -0.416 . . . . 10.0 111.247 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.406 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 19.7 Cg_endo -60.75 117.52 4.3 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 123.066 2.511 . . . . 10.0 112.535 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.3 t 66.77 154.81 0.09 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.642 0.734 . . . . 10.0 112.148 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.36 97.61 1.7 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.961 -0.638 . . . . 10.0 111.665 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.492 -0.766 . . . . 10.0 109.014 -179.902 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.488 0.185 . . . . 10.0 110.617 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.0 m 63.61 88.63 0.1 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.399 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 5' ' ' PRO . . . -103.47 166.48 16.07 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.925 -0.655 . . . . 10.0 111.875 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -102.63 99.32 13.02 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.403 -0.221 . . . . 10.0 110.403 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 3' ' ' GLY . 71.9 Cg_endo -86.05 -27.23 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.361 2.041 . . . . 10.0 112.136 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.678 HG23 HG22 ' A' ' 10' ' ' VAL . 7.5 m -140.94 -147.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.479 -0.782 . . . . 10.0 110.305 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.483 ' H ' ' HB ' ' A' ' 6' ' ' VAL . . . -65.05 16.03 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.802 1.038 . . . . 10.0 113.802 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.497 ' H ' ' C ' ' A' ' 6' ' ' VAL . 2.3 mt-10 69.59 -52.07 0.61 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.922 0.889 . . . . 10.0 113.387 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.0 m -71.47 -13.4 61.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.688 0.28 . . . . 10.0 111.677 -173.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.77 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -95.59 130.65 44.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 -176.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -137.56 124.2 21.01 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.827 -0.349 . . . . 10.0 110.889 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.747 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.28 164.16 13.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.71 0.766 . . . . 10.0 112.572 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -146.81 137.42 23.8 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.35 -1.296 . . . . 10.0 107.692 169.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.438 ' HG2' ' HE1' ' A' ' 63' ' ' TYR . 23.9 mp0 -91.1 104.4 16.98 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.038 0.447 . . . . 10.0 110.551 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -102.17 82.24 2.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.29 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 69.6 -77.21 0.05 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.163 -0.926 . . . . 10.0 111.264 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -133.39 26.24 4.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.423 0.63 . . . . 10.0 110.015 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -137.88 97.42 3.42 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 -169.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.5 m -86.05 93.99 9.13 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.117 -0.697 . . . . 10.0 109.117 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.747 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 0.9 OUTLIER -84.29 108.37 17.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.868 -1.06 . . . . 10.0 111.564 -177.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -97.9 106.59 18.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.845 0.831 . . . . 10.0 108.788 174.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.806 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 3.0 p80 -97.26 113.14 24.71 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.414 -1.266 . . . . 10.0 109.926 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.77 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 15.4 t30 -81.64 149.04 28.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.953 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -131.9 20.89 4.49 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.775 -0.726 . . . . 10.0 111.886 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.06 155.9 20.63 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.431 -0.951 . . . . 10.0 108.431 175.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.92 -13.09 60.49 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -123.42 159.11 29.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.311 0.577 . . . . 10.0 111.715 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -70.14 125.23 26.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.053 -0.976 . . . . 10.0 111.139 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.478 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.5 m -127.24 138.88 53.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.521 . . . . 10.0 111.489 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.784 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.1 m -87.04 126.25 34.63 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.035 -0.529 . . . . 10.0 109.707 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.09 146.15 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.275 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.786 HG21 ' HB2' ' A' ' 70' ' ' CYS . 0.4 OUTLIER -125.81 157.09 38.4 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.382 -0.826 . . . . 10.0 109.241 178.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.638 ' H ' ' HA ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -131.45 137.94 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.38 0.61 . . . . 10.0 111.555 -177.454 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -99.03 115.03 28.04 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.024 -0.989 . . . . 10.0 109.544 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.747 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 37.6 m-85 -92.61 153.44 19.0 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.377 0.608 . . . . 10.0 110.869 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.446 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 62.5 m -48.7 -28.97 3.93 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.236 -1.347 . . . . 10.0 113.533 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -121.27 -79.09 0.6 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.839 -0.538 . . . . 10.0 111.734 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.13 126.75 0.88 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 119.905 -1.141 . . . . 10.0 112.593 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -163.48 146.25 10.03 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.538 -0.912 . . . . 10.0 108.538 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.448 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 24.0 p90 -77.26 136.14 38.5 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.646 -0.501 . . . . 10.0 109.646 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.711 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 161.51 -41.99 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 115.083 -0.962 . . . . 10.0 111.306 -171.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.711 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 9.3 Cg_endo -51.91 63.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 124.54 3.493 . . . . 10.0 116.13 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.1 m 170.93 99.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.718 1.207 . . . . 10.0 109.695 163.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.69 129.95 16.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.557 -0.534 . . . . 10.0 109.557 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.784 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -79.68 137.79 21.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.438 0.637 . . . . 10.0 110.286 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -101.12 146.3 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.638 -177.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.18 141.9 35.45 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.159 -1.052 . . . . 10.0 108.159 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -46.28 91.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.353 2.702 . . . . 10.0 112.851 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 106.88 2.17 36.61 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.205 -0.997 . . . . 10.0 112.475 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.2 -172.57 40.24 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.859 -0.686 . . . . 10.0 113.157 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.806 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 13.2 m0 -120.03 168.55 11.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.427 0.632 . . . . 10.0 111.289 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.99 109.97 5.1 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.631 -1.248 . . . . 10.0 107.631 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.1 m -79.15 126.61 30.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.527 -0.761 . . . . 10.0 110.964 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.613 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 46.9 m-85 -136.84 136.58 38.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.25 105.84 0.12 Allowed 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 124.01 0.819 . . . . 10.0 110.815 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.54 -170.47 7.52 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 120.38 -0.914 . . . . 10.0 110.955 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.665 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 4.6 p90 -86.35 78.78 9.21 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.913 0.863 . . . . 10.0 110.784 -176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -125.55 157.22 19.58 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.523 -0.762 . . . . 10.0 111.966 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m 64.17 9.34 4.68 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.894 0.378 . . . . 10.0 110.82 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 65.13 23.33 12.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.601 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.71 -102.05 0.15 Allowed Glycine 0 CA--C 1.502 -0.746 0 C-N-CA 120.829 -0.7 . . . . 10.0 112.026 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.747 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -105.05 -167.41 1.34 Allowed 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 121.629 0.728 . . . . 10.0 109.91 177.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.665 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 12.8 t80 -168.87 117.04 0.67 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 113.904 -1.498 . . . . 10.0 108.666 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 m -66.08 126.93 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.6 p -123.49 -22.41 5.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.583 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.64 124.15 2.32 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.644 -1.265 . . . . 10.0 112.833 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.67 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.8 mt -84.99 151.91 23.84 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 170.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.59 ' C ' HG12 ' A' ' 6' ' ' VAL . 3.6 m-70 -142.57 142.22 32.14 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.439 -0.949 . . . . 10.0 108.439 -177.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.82 125.46 30.11 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.104 -1.038 . . . . 10.0 110.06 177.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.786 ' HB2' HG21 ' A' ' 32' ' ' THR . 51.7 t -95.38 154.48 17.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.532 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -105.87 142.24 24.4 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.307 -0.627 . . . . 10.0 109.307 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -20.77 80.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.72 1 C-N-CA 126.836 5.024 . . . . 10.0 115.154 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -169.91 92.0 0.21 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.845 -1.07 . . . . 10.0 110.772 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -89.87 125.95 59.12 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.381 -0.372 . . . . 10.0 110.439 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -61.15 -46.89 13.79 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.813 2.342 . . . . 10.0 112.294 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.1 m -156.89 -167.25 2.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.2 -0.455 . . . . 10.0 109.906 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.3 5.06 52.96 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.222 -0.989 . . . . 10.0 112.795 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.245 0.843 0 CA-C-O 119.218 -0.42 . . . . 10.0 111.014 179.555 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.338 -0.245 . . . . 10.0 110.338 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.4 m 73.95 -60.21 0.53 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.04 0.536 . . . . 10.0 111.219 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.98 -73.24 0.89 Allowed Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.984 -0.846 . . . . 10.0 110.984 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.443 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 14.2 m -102.35 154.9 37.1 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.696 -0.483 . . . . 10.0 109.696 174.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 29.9 Cg_endo -63.1 150.33 88.92 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.935 2.423 . . . . 10.0 112.487 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.818 HG12 ' HB3' ' A' ' 67' ' ' LEU . 2.4 m 49.3 -144.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 115.207 -0.906 . . . . 10.0 111.795 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.671 ' N ' HG22 ' A' ' 6' ' ' VAL . . . -57.32 -5.4 0.3 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.402 1.081 . . . . 10.0 113.107 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 4' ' ' SER . 38.6 mt-10 73.9 -25.28 0.2 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.983 0.913 . . . . 10.0 113.131 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 85.4 m -83.47 -7.14 59.6 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.705 0.261 . . . . 10.0 111.705 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.828 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -97.62 138.81 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.012 -0.736 . . . . 10.0 109.012 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.21 113.88 14.99 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.499 -0.186 . . . . 10.0 110.499 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.825 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -92.87 166.15 12.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.735 0.779 . . . . 10.0 112.762 176.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 19' ' ' THR . 81.7 t80 -149.19 140.8 23.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.187 -1.369 . . . . 10.0 107.886 172.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.505 ' HG3' ' OG1' ' A' ' 19' ' ' THR . 27.5 mp0 -98.71 100.09 11.27 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.538 -0.465 . . . . 10.0 110.1 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 t -96.98 -157.32 0.58 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -64.85 94.36 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.843 0.354 . . . . 10.0 110.804 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.585 ' HG2' ' HA3' ' A' ' 58' ' ' GLY . 53.8 mtt180 61.23 29.22 18.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.675 -0.693 . . . . 10.0 111.622 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.403 ' CE1' HG21 ' A' ' 53' ' ' THR . 0.9 OUTLIER -144.99 102.65 3.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.979 -0.378 . . . . 10.0 109.979 -172.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.9 m -90.46 96.33 10.6 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 168.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.825 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.9 p-10 -85.93 109.04 18.47 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.11 -0.95 . . . . 10.0 111.817 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.89 107.15 19.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 122.016 0.912 . . . . 10.0 108.723 174.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.728 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -99.98 110.08 22.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.105 -1.407 . . . . 10.0 110.356 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.828 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 23.4 t30 -80.51 157.55 26.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.184 -0.462 . . . . 10.0 109.999 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.43 24.12 1.22 Allowed Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.855 -0.688 . . . . 10.0 112.687 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.601 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -75.04 -18.15 60.37 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.088 0.155 . . . . 10.0 111.287 -178.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 85.23 -4.68 0.9 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.359 1.037 . . . . 10.0 111.202 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.601 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 13.1 p-10 -127.22 154.26 45.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.033 0.444 . . . . 10.0 110.953 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 127.54 33.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.393 -0.821 . . . . 10.0 111.295 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.517 ' H ' HG23 ' A' ' 46' ' ' ILE . 31.1 m -134.17 137.71 51.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.277 0.56 . . . . 10.0 111.355 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.767 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 15.0 m -86.35 123.21 31.34 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.048 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.526 ' HB ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -123.23 151.21 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.77 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.484 ' HB ' ' C ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -130.52 159.59 36.66 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.411 -0.813 . . . . 10.0 109.538 176.001 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.623 HG23 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.39 133.6 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 121.322 0.582 . . . . 10.0 111.467 -176.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -98.89 118.15 35.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.169 -0.923 . . . . 10.0 108.946 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.489 ' HH ' ' CB ' ' A' ' 41' ' ' ALA . 20.6 m-85 -92.5 157.09 16.74 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.058 0.456 . . . . 10.0 110.228 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 100.0 m -46.43 -30.09 2.0 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.925 -1.034 . . . . 10.0 112.874 174.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -107.64 -83.72 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.82 -0.55 . . . . 10.0 110.546 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.93 55.21 0.01 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 119.89 -1.147 . . . . 10.0 113.508 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -70.38 154.87 41.42 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.063 0.458 . . . . 10.0 111.166 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.528 ' CZ2' ' HB3' ' A' ' 75' ' ' PRO . 69.4 t-105 -74.53 118.2 17.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.918 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.762 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -176.52 -43.97 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.153 -0.93 . . . . 10.0 111.675 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.762 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 3.3 Cg_endo -44.4 69.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 125.06 3.84 . . . . 10.0 116.661 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.0 t 172.04 110.51 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.304 1.041 . . . . 10.0 109.52 163.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.27 128.54 8.31 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.935 -0.765 . . . . 10.0 108.935 174.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.767 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -81.02 139.06 18.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.333 0.587 . . . . 10.0 109.75 177.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -99.14 147.79 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 115.309 -0.859 . . . . 10.0 109.978 -177.031 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -87.35 144.54 36.03 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 168.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -41.34 96.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.515 2.81 . . . . 10.0 112.966 173.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.707 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 93.53 10.11 59.51 Favored Glycine 0 C--O 1.229 -0.173 0 C-N-CA 119.93 -1.128 . . . . 10.0 112.164 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.06 -177.05 40.77 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.455 -0.402 . . . . 10.0 113.02 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.728 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 15.4 m0 -118.08 165.28 13.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.439 0.638 . . . . 10.0 111.394 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.442 ' HB2' HG13 ' A' ' 21' ' ' VAL . . . -142.14 109.37 5.57 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.454 -1.248 . . . . 10.0 107.699 172.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.403 HG21 ' CE1' ' A' ' 18' ' ' TYR . 25.2 m -79.8 130.37 35.26 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.611 -175.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.623 ' CG ' HG23 ' A' ' 33' ' ' VAL . 52.6 m-85 -139.23 134.17 32.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 -177.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.34 103.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 O-C-N 124.032 0.832 . . . . 10.0 111.531 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.94 176.32 36.94 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 110.386 -1.086 . . . . 10.0 110.386 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -82.67 80.16 8.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.346 1.073 . . . . 10.0 110.306 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.585 ' HA3' ' HG2' ' A' ' 17' ' ' ARG . . . -97.2 -36.08 5.05 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.202 -0.908 . . . . 10.0 112.17 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.7 p -90.47 10.54 24.87 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.97 0.414 . . . . 10.0 110.016 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 58.59 21.58 8.84 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.224 -0.898 . . . . 10.0 110.061 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.28 -90.12 2.14 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.271 -0.877 . . . . 10.0 112.385 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -75.54 123.53 25.63 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.156 -0.683 . . . . 10.0 109.156 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.476 ' CE2' ' HB ' ' A' ' 65' ' ' THR . 41.4 t80 -130.14 110.88 11.94 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.544 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.55 127.86 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.771 -0.826 . . . . 10.0 108.771 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.476 ' HB ' ' CE2' ' A' ' 63' ' ' TYR . 9.0 t -141.01 8.8 2.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.96 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.25 128.36 2.07 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 119.629 -1.272 . . . . 10.0 112.622 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.818 ' HB3' HG12 ' A' ' 6' ' ' VAL . 5.2 mt -100.88 132.75 46.13 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 173.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.717 ' C ' HG11 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -126.26 148.59 49.47 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.89 124.58 29.22 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.961 -0.696 . . . . 10.0 110.846 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.48 ' HB2' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -96.93 174.52 6.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.762 -177.058 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -109.34 146.48 34.02 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 172.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -29.84 80.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 1 C-N-CA 126.597 4.864 . . . . 10.0 115.039 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -171.05 99.25 0.21 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.928 -1.033 . . . . 10.0 111.011 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.434 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 29.3 m -84.77 122.35 74.6 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.528 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 4.4 Cg_exo -40.73 98.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.076 3.184 . . . . 10.0 113.079 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.9 m -90.87 90.7 8.02 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.45 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.44 -35.09 12.43 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.617 -0.801 . . . . 10.0 111.886 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.246 0.884 0 CA-C-O 119.435 -0.317 . . . . 10.0 110.631 -178.636 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 120.544 0.212 . . . . 10.0 110.776 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.2 m -153.96 -78.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.61 0.243 . . . . 10.0 110.573 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -160.74 77.88 0.17 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.33 -0.938 . . . . 10.0 112.312 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.52 ' HA ' ' HG2' ' A' ' 8' ' ' GLU . 51.0 m 61.31 62.31 2.67 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 175.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' HG21 ' A' ' 6' ' ' VAL . 87.2 Cg_endo -93.81 135.14 0.99 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.3 2.0 . . . . 10.0 110.749 169.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.751 HG12 ' HB3' ' A' ' 67' ' ' LEU . 1.7 m 51.35 -147.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.055 0.542 . . . . 10.0 110.402 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.706 ' N ' HG22 ' A' ' 6' ' ' VAL . . . -58.3 4.08 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 175.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.52 ' HG2' ' HA ' ' A' ' 4' ' ' SER . 41.4 mt-10 74.57 -39.76 0.43 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.313 0.857 . . . . 10.0 113.313 175.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 32.6 m -79.07 -7.0 57.77 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.896 HG12 HD21 ' A' ' 23' ' ' ASN . 2.0 m -99.35 140.55 18.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -142.74 126.35 16.9 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.716 -0.393 . . . . 10.0 111.304 -175.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.754 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.25 164.71 12.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.99 0.9 . . . . 10.0 112.933 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.609 ' O ' ' HA ' ' A' ' 19' ' ' THR . 64.1 t80 -143.88 156.51 44.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.066 -1.424 . . . . 10.0 107.628 172.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.432 ' OE1' ' HE1' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -105.76 107.41 18.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.064 0.459 . . . . 10.0 110.858 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.529 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 33.6 m -103.82 77.6 1.47 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.608 -0.886 . . . . 10.0 108.608 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 65.26 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.514 -173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -127.67 27.56 5.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.414 0.626 . . . . 10.0 109.667 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.529 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 2.1 t80 -135.36 96.29 3.44 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 -172.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.4 m -85.41 96.3 9.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.562 0.696 . . . . 10.0 110.282 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.754 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.6 p-10 -85.21 108.82 17.92 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.404 -1.271 . . . . 10.0 112.353 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -98.39 109.22 23.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.588 -0.893 . . . . 10.0 108.588 174.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.773 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.7 p80 -97.85 114.2 26.2 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.138 -1.392 . . . . 10.0 110.343 176.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.896 HD21 HG12 ' A' ' 10' ' ' VAL . 10.8 t-20 -83.09 155.92 23.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.124 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.88 32.86 1.29 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.128 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.592 ' HB2' HD22 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -82.63 -16.98 46.28 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 122.824 -0.221 . . . . 10.0 111.108 -178.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 83.85 -3.9 1.12 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.512 1.132 . . . . 10.0 111.025 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.499 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 8.7 p-10 -129.25 154.4 46.85 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.073 0.463 . . . . 10.0 110.828 174.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.63 125.54 26.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.041 -0.981 . . . . 10.0 111.183 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.547 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.5 m -133.82 140.38 46.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.511 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.739 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 7.7 m -88.12 120.93 29.95 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.065 -0.516 . . . . 10.0 109.686 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.31 149.07 23.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.549 0.69 . . . . 10.0 110.794 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.803 HG21 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -128.74 161.29 30.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.208 -0.905 . . . . 10.0 108.997 176.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.591 HG22 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -131.82 135.19 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 121.296 0.569 . . . . 10.0 111.316 -175.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -98.81 115.3 28.48 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.096 -0.956 . . . . 10.0 108.958 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.527 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 74.5 m-85 -89.08 161.56 16.46 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.113 0.483 . . . . 10.0 110.97 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.3 m -52.36 -27.01 13.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.918 -1.037 . . . . 10.0 111.171 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -118.28 -74.85 0.59 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.11 60.97 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.295 -0.955 . . . . 10.0 113.072 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.434 ' HG2' ' CG ' ' A' ' 62' ' ' ASN . 9.3 mm100 -64.82 148.03 52.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.534 0.207 . . . . 10.0 110.449 172.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -71.3 112.11 7.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.843 -0.429 . . . . 10.0 109.843 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.749 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -175.89 -44.51 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 115.824 -0.625 . . . . 10.0 112.548 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.749 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -41.4 76.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 124.88 3.72 . . . . 10.0 115.908 -176.132 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 41' ' ' ALA . 1.2 m 161.91 108.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.081 1.352 . . . . 10.0 110.702 168.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.431 ' NH1' HG11 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -154.07 128.26 9.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.841 -0.8 . . . . 10.0 108.841 179.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.739 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.79 137.18 21.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 118.576 0.625 . . . . 10.0 109.986 174.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.547 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -97.87 148.42 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 115.239 -0.891 . . . . 10.0 109.783 -177.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.07 145.46 38.25 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 107.905 -1.146 . . . . 10.0 107.905 168.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -43.61 95.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.163 2.575 . . . . 10.0 112.521 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.738 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.6 14.57 55.21 Favored Glycine 0 CA--C 1.511 -0.178 0 C-N-CA 119.756 -1.211 . . . . 10.0 111.926 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.66 -176.99 35.47 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.445 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.773 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.2 m0 -117.28 165.31 13.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.411 0.624 . . . . 10.0 111.134 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -141.93 114.27 8.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.572 -1.195 . . . . 10.0 107.89 173.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.5 m -81.49 128.44 33.89 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.99 -0.55 . . . . 10.0 111.088 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.591 ' CG ' HG22 ' A' ' 33' ' ' VAL . 54.0 m-85 -137.98 144.78 41.3 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.106 -1.072 . . . . 10.0 108.106 -178.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.79 104.7 0.38 Allowed 'General case' 0 C--N 1.32 -0.712 0 O-C-N 123.618 0.574 . . . . 10.0 110.587 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.37 177.18 12.35 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.074 -1.21 . . . . 10.0 110.074 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.563 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 15.9 p90 -78.66 112.62 15.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 118.484 1.142 . . . . 10.0 110.853 -170.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.8 -178.21 45.03 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.399 -0.819 . . . . 10.0 111.86 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.9 m -70.09 -20.3 63.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.116 0.484 . . . . 10.0 110.585 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -86.38 -30.47 22.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.121 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.28 -147.62 19.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.312 -0.946 . . . . 10.0 113.503 171.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.434 ' CG ' ' HG2' ' A' ' 39' ' ' GLN . 23.2 m-80 51.53 97.29 0.01 OUTLIER 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.64 0.776 . . . . 10.0 112.737 -173.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.563 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 29.3 t80 -115.9 123.23 47.59 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.406 -0.815 . . . . 10.0 109.069 173.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -61.11 129.3 23.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.2 p -127.31 -18.57 4.46 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.563 -0.455 . . . . 10.0 112.18 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.97 122.78 1.8 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.783 -1.198 . . . . 10.0 113.136 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.751 ' HB3' HG12 ' A' ' 6' ' ' VAL . 4.4 mt -86.64 131.81 34.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.233 0.539 . . . . 10.0 109.595 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.748 ' C ' HG11 ' A' ' 6' ' ' VAL . 9.0 m170 -123.59 147.45 47.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.293 -0.867 . . . . 10.0 108.934 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.64 128.39 33.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 119.341 0.973 . . . . 10.0 110.835 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.803 ' HB2' HG21 ' A' ' 32' ' ' THR . 41.2 t -95.48 157.71 15.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.287 -177.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -103.57 148.52 35.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 173.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -26.59 85.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 1 C-N-CA 126.223 4.616 . . . . 10.0 114.896 174.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -168.0 103.77 0.47 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.867 -1.06 . . . . 10.0 111.576 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.9 m -84.82 117.17 68.18 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.892 -0.41 . . . . 10.0 109.892 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.12 111.15 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.221 2.614 . . . . 10.0 112.56 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.3 p -151.31 -4.17 0.29 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.19 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.34 116.89 4.51 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.443 -0.884 . . . . 10.0 111.818 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.9 t . . . . . 0 C--O 1.249 1.042 0 CA-C-O 117.998 -1.001 . . . . 10.0 110.869 -178.617 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 110.269 -0.271 . . . . 10.0 110.269 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 84.5 m -70.83 -44.88 65.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.105 0.478 . . . . 10.0 109.849 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.09 134.65 11.94 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.681 -0.771 . . . . 10.0 112.479 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.429 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 5.0 p -101.06 122.61 48.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.717 -0.475 . . . . 10.0 109.717 174.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.703 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 30.5 Cg_endo -91.05 101.7 0.25 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.717 2.278 . . . . 10.0 112.87 -172.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 69' ' ' THR . 0.5 OUTLIER 47.58 126.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 125.661 1.584 . . . . 10.0 114.41 -177.165 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.669 ' O ' HG11 ' A' ' 10' ' ' VAL . . . 29.04 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.389 1.056 . . . . 10.0 112.513 168.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 2.0 mp0 -58.57 1.21 0.06 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.619 0.97 . . . . 10.0 113.619 -168.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.419 ' H ' ' C ' ' A' ' 7' ' ' ALA . 28.7 m -81.21 -22.02 39.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.528 175.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.827 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.6 m -90.73 137.06 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -139.28 124.39 18.9 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.963 -0.295 . . . . 10.0 110.538 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.792 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -93.63 166.79 12.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.57 0.7 . . . . 10.0 112.316 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 19' ' ' THR . 74.8 t80 -141.39 156.47 45.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.425 -1.324 . . . . 10.0 107.425 172.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.93 109.24 18.92 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.288 0.566 . . . . 10.0 110.684 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.0 t -117.15 -162.84 0.88 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -63.81 92.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 10.0 111.43 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 56.8 ttp180 62.45 31.42 17.14 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.536 0.684 . . . . 10.0 110.22 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.9 107.44 4.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.873 -174.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.5 m -97.75 95.32 7.47 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.303 0.573 . . . . 10.0 109.594 167.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.792 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.8 p-10 -84.78 108.9 17.7 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.905 -1.043 . . . . 10.0 111.94 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.59 106.39 18.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.002 0.906 . . . . 10.0 109.387 175.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.733 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 1.2 p80 -97.14 111.94 23.95 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.145 -1.388 . . . . 10.0 110.581 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.827 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 18.0 t-20 -82.3 157.58 23.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.871 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.49 34.58 1.16 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 121.332 -0.461 . . . . 10.0 112.112 171.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.579 ' HB2' HD22 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -85.17 -17.82 36.03 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 122.566 -0.373 . . . . 10.0 111.615 -176.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 86.88 -12.72 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.367 1.042 . . . . 10.0 111.233 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -123.06 154.44 38.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.983 0.42 . . . . 10.0 110.19 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -67.89 123.75 21.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.504 -0.771 . . . . 10.0 111.335 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.568 ' H ' HG22 ' A' ' 46' ' ' ILE . 27.3 m -125.86 139.17 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 121.176 0.513 . . . . 10.0 111.881 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.741 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 6.4 m -88.78 118.25 28.34 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG11 HG23 ' A' ' 6' ' ' VAL . 1.1 m -114.76 165.35 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 115.218 -0.901 . . . . 10.0 110.362 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.573 HG21 ' HB2' ' A' ' 70' ' ' CYS . 0.2 OUTLIER -148.49 161.17 42.17 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.669 -0.863 . . . . 10.0 108.669 178.281 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.64 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -136.49 139.94 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 121.41 0.624 . . . . 10.0 111.482 -174.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -107.04 116.37 31.81 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.981 -1.009 . . . . 10.0 109.078 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.511 ' HH ' ' CB ' ' A' ' 41' ' ' ALA . 27.8 m-85 -91.27 162.34 14.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.449 0.642 . . . . 10.0 111.348 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -54.48 -21.35 9.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.692 -1.14 . . . . 10.0 112.116 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -119.72 -85.03 0.66 Allowed 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.001 -0.437 . . . . 10.0 110.561 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.37 52.67 0.01 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 119.567 -1.301 . . . . 10.0 114.147 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -65.65 141.6 58.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.33 0.565 . . . . 10.0 109.77 169.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -72.33 120.72 18.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.071 0.462 . . . . 10.0 110.328 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.849 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -174.32 -40.61 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.246 -0.888 . . . . 10.0 112.338 -173.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.849 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 3.1 Cg_endo -44.08 70.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 124.938 3.759 . . . . 10.0 116.33 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 4.5 t 172.5 112.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.059 0.944 . . . . 10.0 110.215 163.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.507 ' HB2' ' HZ ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -151.11 119.04 6.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.308 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.741 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -78.56 128.46 38.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 173.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.568 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -90.63 144.66 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 115.46 -0.791 . . . . 10.0 109.621 -175.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -85.17 141.64 37.52 Favored Pre-proline 0 C--N 1.293 -1.868 0 N-CA-C 107.726 -1.213 . . . . 10.0 107.726 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -43.21 95.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.301 2.667 . . . . 10.0 112.942 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.717 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.76 13.67 56.36 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.554 -1.307 . . . . 10.0 111.87 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 22' ' ' HIS . . . -97.02 -170.41 33.74 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.106 -0.568 . . . . 10.0 112.846 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.733 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 10.6 m0 -121.46 166.44 14.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.546 0.689 . . . . 10.0 111.425 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HB2' HG13 ' A' ' 21' ' ' VAL . . . -142.68 109.7 5.55 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.56 -1.2 . . . . 10.0 108.103 171.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.2 m -78.88 129.76 34.89 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.712 -0.677 . . . . 10.0 110.606 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.64 ' CG ' HG21 ' A' ' 33' ' ' VAL . 51.3 m-85 -136.58 149.9 48.3 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.93 97.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.775 0.672 . . . . 10.0 111.16 -173.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.14 -178.53 10.73 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.107 -0.797 . . . . 10.0 111.107 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 9.0 p90 -79.6 88.98 5.1 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.556 1.169 . . . . 10.0 110.771 -173.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.72 -20.39 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.542 -1.208 . . . . 10.0 112.202 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.3 t -118.62 133.05 56.15 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 122.529 -0.394 . . . . 10.0 110.5 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 62.48 10.63 4.13 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.204 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.45 10.23 59.8 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.923 -0.581 . . . . 10.0 112.946 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.553 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -79.57 137.55 37.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 117.608 0.704 . . . . 10.0 110.468 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.491 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 32.1 t80 -130.96 116.16 17.47 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.028 -0.987 . . . . 10.0 108.846 172.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.4 m -59.9 130.14 23.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.949 -0.76 . . . . 10.0 108.949 177.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 p -122.11 -29.04 4.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.653 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -138.5 121.7 2.22 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.417 -1.373 . . . . 10.0 113.63 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.703 ' HB2' ' HB2' ' A' ' 5' ' ' PRO . 5.2 mt -84.35 146.87 27.48 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.974 -0.75 . . . . 10.0 108.974 172.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.514 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 4.2 m-70 -137.92 156.34 47.98 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.846 -0.615 . . . . 10.0 109.944 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.636 HG21 HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -82.61 127.93 33.84 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.984 -0.686 . . . . 10.0 109.59 174.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.573 ' HB2' HG21 ' A' ' 32' ' ' THR . 5.1 t -100.27 171.06 8.02 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.82 -0.352 . . . . 10.0 110.582 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -134.37 145.63 56.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -18.43 83.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 1 C-N-CA 126.675 4.917 . . . . 10.0 115.616 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -167.08 82.95 0.23 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.287 -1.324 . . . . 10.0 109.941 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.3 p -82.89 142.12 44.68 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.81 -0.632 . . . . 10.0 112.089 -173.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.13 169.25 22.87 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.817 2.345 . . . . 10.0 111.141 171.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.7 t -86.58 103.75 15.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.042 0.449 . . . . 10.0 111.947 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.81 170.45 46.18 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.928 -0.653 . . . . 10.0 113.811 171.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.087 -0.557 . . . . 10.0 109.693 176.128 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 109.869 -0.419 . . . . 10.0 109.869 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.0 t -165.35 158.35 16.07 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.495 -0.557 . . . . 10.0 109.495 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 116.16 -148.41 18.89 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.188 -0.765 . . . . 10.0 111.188 -177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.6 m 60.83 89.81 0.1 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.133 0.492 . . . . 10.0 111.56 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 97.9 Cg_endo -85.32 140.46 7.49 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.27 1.98 . . . . 10.0 112.147 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.839 HG12 ' HB3' ' A' ' 67' ' ' LEU . 2.6 m 47.92 -147.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.33 -0.85 . . . . 10.0 111.818 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.636 ' N ' HG21 ' A' ' 6' ' ' VAL . . . -59.33 0.09 0.13 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.421 1.088 . . . . 10.0 113.933 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 70.49 -31.23 0.22 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.095 0.776 . . . . 10.0 113.095 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.427 ' H ' ' C ' ' A' ' 7' ' ' ALA . 56.9 m -76.44 -11.89 59.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 10.0 111.207 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.821 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -97.97 137.82 24.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.875 -0.787 . . . . 10.0 108.875 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -133.23 115.07 14.54 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.888 -0.325 . . . . 10.0 110.508 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.814 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.74 161.51 14.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.786 0.803 . . . . 10.0 113.078 177.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 19' ' ' THR . 69.0 t80 -141.2 145.69 35.97 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.118 -1.401 . . . . 10.0 107.272 170.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.472 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 27.1 mp0 -107.25 130.59 54.73 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.416 -0.514 . . . . 10.0 110.987 -176.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.3 t -118.81 -160.08 0.79 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.675 -1.231 . . . . 10.0 107.675 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -60.29 -48.33 82.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.847 0.356 . . . . 10.0 111.322 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -140.81 28.77 1.93 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.751 0.31 . . . . 10.0 110.949 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.455 ' CE1' HG23 ' A' ' 53' ' ' THR . 0.4 OUTLIER -142.87 105.51 4.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.7 -0.227 . . . . 10.0 110.613 -173.316 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 15.6 m -95.12 98.51 10.7 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.401 -0.592 . . . . 10.0 109.401 166.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.814 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -86.35 109.27 18.88 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.382 -0.826 . . . . 10.0 112.224 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.83 107.4 20.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.862 0.839 . . . . 10.0 109.065 173.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.756 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 1.9 p80 -98.18 112.53 24.47 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.433 -1.258 . . . . 10.0 110.202 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.821 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 10.7 t-20 -80.72 155.24 26.84 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.563 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -145.32 32.08 1.66 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.082 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.739 ' HB2' HD22 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -79.43 -19.95 48.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 122.831 -0.217 . . . . 10.0 111.316 -176.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 25' ' ' CYS . . . 85.71 -11.73 0.68 Allowed 'General case' 0 N--CA 1.473 0.675 0 O-C-N 124.515 1.134 . . . . 10.0 111.221 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -126.43 155.4 42.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.989 0.423 . . . . 10.0 110.416 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -67.82 121.9 16.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.54 -0.755 . . . . 10.0 111.249 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.597 ' H ' HG21 ' A' ' 46' ' ' ILE . 35.2 m -126.3 141.92 44.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 10.0 111.106 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 6.2 m -92.19 122.89 35.11 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.955 -177.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -124.01 148.02 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.8 -0.637 . . . . 10.0 111.072 -178.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.864 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -126.76 161.84 27.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 177.339 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.591 HG23 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.25 141.7 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.403 0.621 . . . . 10.0 111.787 -176.386 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -104.6 110.94 23.45 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.639 -1.164 . . . . 10.0 109.651 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.825 ' HH ' ' HB2' ' A' ' 41' ' ' ALA . 34.2 m-85 -93.82 159.13 15.33 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.369 0.604 . . . . 10.0 111.642 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.4 m -48.19 -34.45 10.1 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.673 -1.149 . . . . 10.0 112.786 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.452 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 54.3 m-70 -112.35 -78.3 0.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.508 -0.477 . . . . 10.0 110.41 176.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.08 63.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.053 -1.07 . . . . 10.0 112.922 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.533 ' HB2' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -72.69 144.2 47.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 178.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -76.33 102.07 5.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.003 0.43 . . . . 10.0 110.789 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 1.034 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -173.95 10.56 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 114.196 1.184 . . . . 10.0 114.196 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 1.034 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 5.3 Cg_endo -84.96 64.89 6.35 Favored 'Trans proline' 0 C--N 1.358 1.07 0 CA-C-N 122.088 1.781 . . . . 10.0 112.466 -172.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 172.41 109.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.835 0.854 . . . . 10.0 110.63 168.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.78 122.86 6.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.585 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.727 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -77.8 135.34 26.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.544 -0.462 . . . . 10.0 109.796 175.32 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.597 HG21 ' H ' ' A' ' 29' ' ' VAL . 1.1 tp -97.94 147.05 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 115.167 -0.924 . . . . 10.0 109.064 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -85.0 143.49 40.04 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 108.248 -1.019 . . . . 10.0 108.248 168.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -44.07 94.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.41 2.74 . . . . 10.0 112.845 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.754 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 94.77 12.78 55.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 119.813 -1.184 . . . . 10.0 112.289 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.44 -173.95 33.98 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.949 -0.643 . . . . 10.0 112.326 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.756 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 15.7 m0 -117.3 166.07 12.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.535 0.683 . . . . 10.0 111.165 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HB3' HD13 ' A' ' 46' ' ' ILE . . . -140.82 112.03 7.26 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.317 -1.364 . . . . 10.0 107.317 171.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.455 HG23 ' CE1' ' A' ' 18' ' ' TYR . 26.7 m -80.32 126.26 30.93 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.304 -0.862 . . . . 10.0 110.337 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.591 ' CG ' HG23 ' A' ' 33' ' ' VAL . 46.7 m-85 -136.26 140.8 43.72 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.06 104.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.182 0.926 . . . . 10.0 110.698 -173.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.8 -178.21 16.81 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.387 -0.911 . . . . 10.0 110.988 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 12.2 p90 -82.72 91.05 6.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.891 0.853 . . . . 10.0 110.698 -173.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.18 179.19 42.82 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.099 -0.955 . . . . 10.0 112.58 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.3 p -66.27 -28.6 68.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.243 0.545 . . . . 10.0 110.575 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -142.57 85.79 1.92 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.286 -0.87 . . . . 10.0 108.831 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.75 -139.35 3.5 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.288 -0.958 . . . . 10.0 112.955 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.66 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 23.9 m-20 -118.81 166.0 13.34 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.141 0.496 . . . . 10.0 109.777 -173.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.529 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 37.9 t80 -132.56 120.34 21.72 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.097 -0.956 . . . . 10.0 108.965 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.7 m -65.13 129.8 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.575 -0.898 . . . . 10.0 108.575 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.2 p -117.93 -29.17 5.72 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.721 -0.392 . . . . 10.0 111.34 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.55 136.08 7.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 119.992 -1.099 . . . . 10.0 113.146 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.839 ' HB3' HG12 ' A' ' 6' ' ' VAL . 5.0 mt -95.35 129.87 42.34 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.576 -0.528 . . . . 10.0 109.576 173.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.739 ' C ' HG11 ' A' ' 6' ' ' VAL . 10.5 m170 -117.25 143.27 46.07 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -81.36 125.46 30.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.805 1.184 . . . . 10.0 111.214 -179.162 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.864 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.0 t -96.55 178.07 5.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.256 -0.884 . . . . 10.0 109.346 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.407 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.8 p-10 -145.2 149.21 40.86 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 174.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -16.98 87.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.126 1 C-N-CA 126.457 4.771 . . . . 10.0 114.951 177.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -168.52 104.84 0.44 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.354 -1.294 . . . . 10.0 109.843 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.1 p -79.42 125.73 82.43 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.699 0.285 . . . . 10.0 111.523 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.72 -53.16 0.46 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.65 2.233 . . . . 10.0 111.954 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.0 m -154.9 -54.19 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 10.0 109.925 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -170.24 -54.72 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.24 -0.744 . . . . 10.0 111.24 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 C--O 1.242 0.669 0 CA-C-O 118.081 -0.962 . . . . 10.0 108.925 174.88 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 110.088 -0.338 . . . . 10.0 110.088 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.2 m -152.11 99.51 2.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.345 -0.613 . . . . 10.0 109.345 -175.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 113.03 116.89 3.4 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.788 -0.925 . . . . 10.0 110.788 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.5 t 61.95 75.22 0.44 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 121.061 0.458 . . . . 10.0 111.198 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.478 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 92.0 Cg_endo -84.33 140.0 8.35 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.78 2.32 . . . . 10.0 112.555 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.822 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.2 m 51.53 -151.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.169 -0.923 . . . . 10.0 112.273 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.651 ' N ' HG21 ' A' ' 6' ' ' VAL . . . -59.67 5.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.652 1.353 . . . . 10.0 114.652 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 42.5 mt-10 75.11 -39.91 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.015 0.746 . . . . 10.0 113.015 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.9 m -74.02 -12.98 60.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.868 0.322 . . . . 10.0 111.868 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.794 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.6 m -99.88 141.07 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.829 -0.434 . . . . 10.0 109.829 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -142.44 128.27 19.38 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 121.05 -0.26 . . . . 10.0 110.822 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.79 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -93.1 165.17 12.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.767 0.794 . . . . 10.0 113.118 176.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' THR . 77.7 t80 -144.01 149.85 37.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.281 -1.377 . . . . 10.0 107.281 171.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.4 121.65 45.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.218 0.532 . . . . 10.0 110.832 -176.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.3 t -138.28 75.54 1.53 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.845 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.7 t90 51.2 90.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.074 -0.966 . . . . 10.0 112.535 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 68.37 1.62 2.98 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.638 -0.71 . . . . 10.0 112.313 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -123.18 97.17 5.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.192 -0.669 . . . . 10.0 109.192 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.494 ' HG1' ' HA2' ' A' ' 56' ' ' GLY . 23.3 m -90.46 100.08 12.98 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 172.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.79 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.0 p-10 -86.09 107.91 18.04 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.914 -0.584 . . . . 10.0 111.974 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -97.78 107.41 20.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.036 0.922 . . . . 10.0 108.564 173.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.806 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.2 p80 -96.86 114.44 26.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.021 -1.445 . . . . 10.0 110.219 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.794 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 14.1 t-20 -83.14 150.33 26.32 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.551 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.5 23.97 3.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.898 -0.668 . . . . 10.0 112.315 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.594 ' HB2' HD22 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -86.76 159.83 19.0 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 175.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.46 -11.55 59.96 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.045 0.387 . . . . 10.0 112.045 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -129.88 159.89 35.23 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.246 0.546 . . . . 10.0 111.462 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.41 130.42 42.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.813 -1.085 . . . . 10.0 111.24 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.459 ' H ' HG23 ' A' ' 46' ' ' ILE . 32.6 m -129.05 141.36 46.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.987 -0.551 . . . . 10.0 111.057 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.793 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 7.3 m -90.38 122.9 33.66 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.183 0.516 . . . . 10.0 109.861 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.87 150.95 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.286 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -131.86 162.67 30.03 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.508 -0.769 . . . . 10.0 108.934 175.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.584 HG22 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -134.1 144.86 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-O 121.026 0.441 . . . . 10.0 110.441 -176.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -114.93 118.87 34.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.319 -0.855 . . . . 10.0 108.964 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.606 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 22.6 m-85 -94.48 159.44 15.1 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.574 0.702 . . . . 10.0 111.953 -175.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.506 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 52.0 m -50.07 -31.04 12.14 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.132 -1.395 . . . . 10.0 113.452 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.488 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 27.5 m-70 -114.47 -67.29 1.01 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.738 -0.601 . . . . 10.0 110.426 174.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.95 62.41 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.951 -1.119 . . . . 10.0 113.125 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.555 ' HA ' ' OE1' ' A' ' 39' ' ' GLN . 7.7 mm-40 -72.47 151.52 42.48 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.922 -0.311 . . . . 10.0 110.319 172.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -80.71 100.18 8.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.333 -0.394 . . . . 10.0 111.513 -177.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.825 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.42 21.82 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 113.733 1.012 . . . . 10.0 113.733 172.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.825 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 8.8 Cg_endo -88.34 63.01 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 CA-C-N 121.165 1.452 . . . . 10.0 112.863 -171.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 75' ' ' PRO . 1.2 m 169.89 114.93 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.692 0.797 . . . . 10.0 111.646 169.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.56 132.44 7.73 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 175.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.793 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.2 p -83.81 140.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.345 0.593 . . . . 10.0 110.672 178.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.504 HD13 HG22 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -99.29 146.77 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-N 115.194 -0.912 . . . . 10.0 109.691 -177.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -88.49 139.11 29.86 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 169.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -43.13 95.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.343 2.695 . . . . 10.0 112.38 177.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.02 13.54 42.55 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.101 -1.047 . . . . 10.0 112.663 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.47 -171.65 30.67 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.886 -0.673 . . . . 10.0 113.046 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.806 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.6 m0 -121.79 165.49 15.78 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.505 0.669 . . . . 10.0 111.014 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' A' ' 46' ' ' ILE . . . -142.95 111.97 6.54 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.446 -1.316 . . . . 10.0 107.446 174.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 m -79.63 131.14 35.9 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.479 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.606 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 51.1 m-85 -140.63 145.19 36.31 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.096 -0.705 . . . . 10.0 109.096 -178.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.801 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -54.47 107.61 0.3 Allowed 'General case' 0 C--N 1.322 -0.589 0 O-C-N 124.024 0.827 . . . . 10.0 110.585 -176.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.54 ' O ' ' HA3' ' A' ' 61' ' ' GLY . . . -71.31 -177.03 25.5 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.836 -0.905 . . . . 10.0 110.836 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.872 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 20.1 p90 -77.4 120.98 23.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 118.465 1.132 . . . . 10.0 109.98 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 151.06 -153.58 25.06 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.404 -0.817 . . . . 10.0 111.573 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -48.92 112.71 0.65 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.485 0.314 . . . . 10.0 111.527 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 68.5 13.03 8.91 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.31 0.644 . . . . 10.0 112.373 175.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.801 ' HA2' ' HB2' ' A' ' 55' ' ' ALA . . . -114.6 -13.19 9.75 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.503 -1.332 . . . . 10.0 115.272 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.532 ' HB2' ' HB3' ' A' ' 35' ' ' TYR . 7.4 m120 52.71 -101.52 0.11 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.774 0.787 . . . . 10.0 109.647 -168.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.872 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 11.1 t80 175.41 115.54 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 114.887 -1.051 . . . . 10.0 108.838 171.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.33 126.2 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.312 -0.995 . . . . 10.0 108.312 171.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.4 p -118.19 -29.55 5.53 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.448 -0.501 . . . . 10.0 111.051 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -136.99 125.98 3.56 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 119.87 -1.157 . . . . 10.0 112.932 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.822 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -86.17 131.54 34.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.307 -0.627 . . . . 10.0 109.307 171.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.716 ' C ' HG12 ' A' ' 6' ' ' VAL . 12.4 m170 -119.47 147.83 43.96 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.61 -0.885 . . . . 10.0 108.61 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.71 126.12 32.01 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.266 -0.974 . . . . 10.0 110.318 178.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.622 ' HB2' HG23 ' A' ' 32' ' ' THR . 43.2 t -96.22 161.05 14.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.85 -177.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.414 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 12.8 p-10 -104.59 137.45 19.23 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.142 -0.688 . . . . 10.0 109.142 169.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 22.1 Cg_exo -22.44 79.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 1 C-N-CA 127.058 5.172 . . . . 10.0 115.466 179.169 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -171.03 92.74 0.16 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.912 -1.04 . . . . 10.0 111.516 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.9 m -86.62 127.56 60.05 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 43' ' ' CYS . 40.1 Cg_endo -67.05 -2.48 8.02 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.146 2.564 . . . . 10.0 113.643 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.3 m -79.74 85.69 5.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.998 0.428 . . . . 10.0 109.912 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.9 114.64 4.89 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.72 -0.752 . . . . 10.0 112.362 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.089 -0.958 . . . . 10.0 109.705 179.681 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.626 0.25 . . . . 10.0 111.084 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.3 m -151.81 -59.51 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.134 0.492 . . . . 10.0 110.326 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 143.95 -82.71 0.21 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 121.068 -0.587 . . . . 10.0 111.768 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.469 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 8.5 t -119.16 148.77 45.75 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 26.4 Cg_endo -61.56 149.01 91.59 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.086 2.524 . . . . 10.0 112.805 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.823 HG12 ' HB3' ' A' ' 67' ' ' LEU . 2.5 m 50.68 -142.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.018 0.927 . . . . 10.0 111.884 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.683 ' N ' HG21 ' A' ' 6' ' ' VAL . . . -55.73 -5.51 0.16 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.307 1.043 . . . . 10.0 113.148 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 4' ' ' SER . 36.5 mt-10 75.7 -25.93 0.2 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.87 0.868 . . . . 10.0 112.806 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.31 14.66 15.75 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 111.748 0.277 . . . . 10.0 111.748 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.783 HG12 HD21 ' A' ' 23' ' ' ASN . 1.7 m -116.72 142.06 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -135.57 118.0 15.78 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.849 -0.34 . . . . 10.0 111.529 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.756 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.36 161.75 14.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.832 0.825 . . . . 10.0 112.515 174.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -146.3 168.05 22.03 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 106.63 -1.619 . . . . 10.0 106.63 170.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -114.58 107.61 15.73 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.09 -0.644 . . . . 10.0 111.645 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 1.7 p -99.28 50.91 0.94 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.82 -0.808 . . . . 10.0 108.82 175.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 38.7 t-105 74.35 -90.44 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.262 -1.336 . . . . 10.0 111.348 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -100.02 30.99 3.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 10.0 110.93 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.479 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -154.4 107.34 2.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.403 -0.817 . . . . 10.0 109.006 -172.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 m -91.85 97.71 11.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.51 0.671 . . . . 10.0 109.539 170.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.756 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.8 p-10 -83.41 108.17 16.4 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.473 -1.239 . . . . 10.0 111.77 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.23 106.97 20.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 122.26 1.029 . . . . 10.0 108.927 172.518 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.8 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -97.32 111.02 23.45 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.109 -1.405 . . . . 10.0 109.982 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.783 HD21 HG12 ' A' ' 10' ' ' VAL . 13.1 t-20 -80.05 154.19 28.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.16 -0.473 . . . . 10.0 109.746 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.49 21.24 3.26 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.581 -0.608 . . . . 10.0 111.581 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.756 ' HB2' HD22 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -83.08 160.03 22.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.36 -0.608 . . . . 10.0 109.36 174.408 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.02 -10.71 59.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.479 -0.328 . . . . 10.0 111.465 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -128.77 159.31 36.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.406 0.622 . . . . 10.0 111.675 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.7 125.65 27.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.85 -1.068 . . . . 10.0 111.253 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.455 ' H ' HG22 ' A' ' 46' ' ' ILE . 34.1 m -125.44 143.67 38.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.961 0.41 . . . . 10.0 111.231 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.724 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.8 m -90.68 121.36 32.52 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.386 -0.598 . . . . 10.0 109.386 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.544 ' HB ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -121.54 143.53 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.516 0.675 . . . . 10.0 110.994 -178.29 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.751 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -122.21 160.62 24.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.237 -0.892 . . . . 10.0 109.433 176.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.673 ' H ' ' HA ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -133.2 141.04 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.118 0.485 . . . . 10.0 111.61 -177.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -108.34 114.51 28.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.35 -0.841 . . . . 10.0 109.614 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.776 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 56.6 m-85 -90.36 156.56 18.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.277 0.561 . . . . 10.0 112.048 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.4 m -43.21 -46.09 5.94 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.134 -1.394 . . . . 10.0 113.365 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -106.99 -77.21 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.299 -0.56 . . . . 10.0 110.573 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.28 124.83 0.77 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 119.705 -1.236 . . . . 10.0 113.245 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -163.27 151.94 14.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.88 -1.156 . . . . 10.0 107.88 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 26.7 p90 -75.88 146.08 40.05 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.384 -0.526 . . . . 10.0 111.52 -174.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.739 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 159.41 -44.31 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 114.32 -1.309 . . . . 10.0 110.138 -170.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.739 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 1.4 Cg_endo -45.34 65.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 125.283 3.989 . . . . 10.0 116.519 177.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' ALA . 1.1 m 170.72 100.73 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.431 1.093 . . . . 10.0 110.071 164.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.56 130.73 15.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.724 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -82.23 136.77 22.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.131 0.491 . . . . 10.0 110.53 178.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.549 HD13 HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -96.84 145.89 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 115.24 -0.891 . . . . 10.0 109.652 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -85.24 139.44 36.43 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.063 -1.088 . . . . 10.0 108.063 167.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -43.59 98.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.182 2.588 . . . . 10.0 112.309 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.83 2.5 57.24 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.984 -1.103 . . . . 10.0 112.504 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.54 -170.86 37.58 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.975 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.8 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 15.7 m0 -120.26 166.39 13.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.422 0.63 . . . . 10.0 111.22 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.428 ' HB3' HD11 ' A' ' 46' ' ' ILE . . . -142.57 115.75 8.91 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 171.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 m -82.52 128.93 34.76 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.521 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.776 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 50.5 m-85 -135.89 144.41 45.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.705 -0.85 . . . . 10.0 108.705 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.09 101.95 0.07 Allowed 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.826 0.704 . . . . 10.0 110.704 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.01 -166.99 4.78 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.915 -1.038 . . . . 10.0 111.613 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.677 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.8 p90 -86.75 75.46 9.63 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.993 0.901 . . . . 10.0 110.782 -174.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.87 179.82 50.01 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.386 -0.824 . . . . 10.0 112.197 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.8 t -68.46 131.13 44.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 110.418 -0.216 . . . . 10.0 110.418 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 58.43 31.85 21.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.606 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.61 -140.59 6.4 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.559 -0.829 . . . . 10.0 112.046 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.673 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 7.8 m120 -120.42 -155.28 0.62 Allowed 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.828 -0.804 . . . . 10.0 108.828 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.677 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 20.8 t80 -168.76 119.0 0.73 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.128 -0.942 . . . . 10.0 108.674 173.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 m -64.14 131.19 29.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.12 -0.696 . . . . 10.0 109.12 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.9 p -123.33 -24.41 4.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.403 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.94 125.31 2.45 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.162 -1.018 . . . . 10.0 112.549 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.823 ' HB3' HG12 ' A' ' 6' ' ' VAL . 5.0 mt -86.27 137.84 32.3 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 172.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.739 ' C ' HG11 ' A' ' 6' ' ' VAL . 8.4 m-70 -127.61 145.93 50.71 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.505 -0.77 . . . . 10.0 108.924 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -79.26 127.52 32.16 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.219 -0.992 . . . . 10.0 110.26 178.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.751 ' HB2' HG22 ' A' ' 32' ' ' THR . 40.5 t -93.97 155.68 17.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.914 -0.584 . . . . 10.0 109.867 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -109.63 146.61 34.4 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.041 -0.725 . . . . 10.0 109.041 173.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -24.8 84.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 1 C-N-CA 126.212 4.608 . . . . 10.0 114.746 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -171.81 101.83 0.18 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.539 -1.21 . . . . 10.0 110.904 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.6 m -81.98 129.6 63.79 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.733 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.5 118.46 5.55 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.382 2.055 . . . . 10.0 111.442 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.2 t -151.93 7.51 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.793 0.33 . . . . 10.0 110.881 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.93 -8.97 87.52 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.758 -0.734 . . . . 10.0 112.513 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.851 -0.595 . . . . 10.0 110.377 179.454 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.684 0.278 . . . . 10.0 110.254 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.5 m -75.3 125.27 28.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.14 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.19 99.6 2.56 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.202 -0.759 . . . . 10.0 111.202 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.513 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 14.1 m -88.08 162.03 41.92 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.466 0.174 . . . . 10.0 110.603 -174.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 4' ' ' SER . 41.3 Cg_endo -67.52 143.4 62.78 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.244 1.963 . . . . 10.0 111.717 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.7 HG11 ' C ' ' A' ' 68' ' ' HIS . 1.2 m 56.44 -150.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 115.429 -0.805 . . . . 10.0 111.113 177.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.695 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.29 -1.7 0.09 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.4 1.08 . . . . 10.0 113.891 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' A' ' 4' ' ' SER . 27.0 mt-10 74.08 -29.18 0.19 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.184 0.994 . . . . 10.0 112.946 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.0 m -80.48 -12.27 59.57 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.027 0.38 . . . . 10.0 112.027 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.9 m -96.42 140.18 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 -175.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -138.79 120.17 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.953 -0.299 . . . . 10.0 110.345 -175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.2 171.19 8.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.733 0.778 . . . . 10.0 112.626 178.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 19' ' ' THR . 34.3 t80 -149.15 179.99 7.47 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.235 -1.394 . . . . 10.0 107.235 172.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -127.34 116.44 20.52 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.501 0.667 . . . . 10.0 111.156 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 t -121.48 84.19 2.2 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 173.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 59.27 -105.28 0.23 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.333 -0.849 . . . . 10.0 111.047 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.472 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 65.8 ttt180 -103.18 24.85 10.25 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.595 0.712 . . . . 10.0 110.13 -177.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.98 95.56 4.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.78 -0.646 . . . . 10.0 109.405 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 2.6 m -86.54 98.82 11.28 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 170.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.73 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -86.65 103.99 15.64 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.195 -0.911 . . . . 10.0 112.123 -176.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -96.24 107.16 19.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.74 -0.837 . . . . 10.0 108.74 174.317 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.791 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 2.5 p80 -97.39 113.46 25.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.621 -1.172 . . . . 10.0 110.439 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 t30 -79.41 150.18 31.41 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.679 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.97 16.02 5.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.775 -0.726 . . . . 10.0 112.39 175.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.43 154.96 23.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 174.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.43 -8.9 57.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.346 0.499 . . . . 10.0 112.346 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -127.25 160.63 30.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.51 0.671 . . . . 10.0 112.145 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -71.06 124.12 23.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.68 -1.145 . . . . 10.0 111.583 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.527 ' H ' HG21 ' A' ' 46' ' ' ILE . 30.7 m -125.61 141.06 46.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.322 0.582 . . . . 10.0 111.523 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 10.6 m -89.78 122.53 32.95 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 m -120.44 153.09 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.444 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.753 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -130.73 157.99 41.31 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.38 -0.827 . . . . 10.0 109.482 176.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.63 HG23 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.48 139.78 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 121.14 0.495 . . . . 10.0 110.523 -178.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.09 117.48 34.11 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.128 -0.942 . . . . 10.0 109.323 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.638 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 44.1 m-85 -90.57 155.75 18.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.083 0.468 . . . . 10.0 111.504 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.8 m -44.61 -41.93 6.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.824 -1.08 . . . . 10.0 112.731 175.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.827 ' HB2' HD21 ' A' ' 62' ' ' ASN . 78.3 m-70 -102.86 -87.54 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.648 -0.421 . . . . 10.0 110.556 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.26 130.89 1.23 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.823 -0.703 . . . . 10.0 111.93 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -172.68 151.74 2.4 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.507 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 23.9 p90 -76.27 144.34 40.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.127 0.489 . . . . 10.0 110.407 -177.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.766 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 158.51 -37.4 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 124.997 1.319 . . . . 10.0 110.855 -169.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.766 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 9.9 Cg_endo -53.39 61.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 124.079 3.186 . . . . 10.0 115.504 176.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.487 ' HB3' ' HD3' ' A' ' 75' ' ' PRO . 5.1 t 177.69 105.07 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.501 0.72 . . . . 10.0 109.367 163.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -145.15 122.95 11.9 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.315 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.26 128.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 174.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.527 HG21 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -92.67 146.11 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 CA-C-N 114.638 -1.164 . . . . 10.0 109.141 -176.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.34 142.55 43.7 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 107.957 -1.127 . . . . 10.0 107.957 168.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -47.59 96.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.89 2.393 . . . . 10.0 112.034 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 101.05 5.19 53.56 Favored Glycine 0 C--O 1.229 -0.166 0 C-N-CA 120.064 -1.065 . . . . 10.0 112.232 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.44 -176.39 37.29 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 121.069 -0.586 . . . . 10.0 112.979 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.791 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 20.5 m0 -117.04 164.7 14.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.647 0.737 . . . . 10.0 110.966 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB3' HG12 ' A' ' 21' ' ' VAL . . . -138.4 113.76 9.54 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 171.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.7 m -82.25 128.66 34.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.07 -0.514 . . . . 10.0 109.994 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.638 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 50.4 m-85 -137.02 139.22 41.24 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.042 -1.096 . . . . 10.0 108.042 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.29 101.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.375 1.047 . . . . 10.0 111.015 -176.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.17 -178.8 11.21 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.607 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 2.5 p90 -85.25 50.07 1.88 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.165 0.983 . . . . 10.0 110.799 -172.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.93 141.68 16.5 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.235 -1.146 . . . . 10.0 110.235 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.9 m 66.31 14.51 9.71 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.251 0.548 . . . . 10.0 110.301 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 58.35 35.84 25.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.433 -0.803 . . . . 10.0 111.526 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.22 -99.5 0.69 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.848 -0.691 . . . . 10.0 111.743 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.827 HD21 ' HB2' ' A' ' 37' ' ' HIS . 2.6 m120 -106.06 145.33 31.55 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 109.287 -0.635 . . . . 10.0 109.287 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 21.7 t80 -125.04 120.72 32.3 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -63.55 130.11 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 174.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 73.4 p -122.3 -30.73 3.94 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.317 -0.553 . . . . 10.0 111.328 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.73 124.16 3.37 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 119.603 -1.284 . . . . 10.0 113.279 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.598 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.4 mt -88.26 141.55 28.46 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.93 -0.767 . . . . 10.0 108.93 172.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.7 ' C ' HG11 ' A' ' 6' ' ' VAL . 3.9 m-70 -132.09 149.61 52.36 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.339 -0.846 . . . . 10.0 108.772 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.573 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -81.98 128.59 34.24 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.219 -0.992 . . . . 10.0 110.025 176.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.753 ' HB2' HG22 ' A' ' 32' ' ' THR . 5.5 t -98.06 168.94 9.96 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 73' ' ' ALA . 6.0 p-10 -142.79 146.38 37.62 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 34.4 Cg_exo -22.78 74.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 1 C-N-CA 127.341 5.36 . . . . 10.0 115.59 176.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 71' ' ' ASP . . . -172.18 76.42 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.681 -1.145 . . . . 10.0 109.152 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.04 139.16 79.38 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.631 -0.713 . . . . 10.0 112.403 -170.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 43' ' ' CYS . 73.3 Cg_endo -76.84 122.5 6.36 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.211 2.607 . . . . 10.0 113.246 -174.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.7 m -97.8 173.37 7.13 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.448 -0.797 . . . . 10.0 109.599 173.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.34 -55.35 31.2 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.842 -0.694 . . . . 10.0 111.717 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.6 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.267 -0.873 . . . . 10.0 108.988 173.355 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 110.12 -0.326 . . . . 10.0 110.12 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.87 89.03 1.37 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.283 0.563 . . . . 10.0 111.123 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -168.02 113.9 0.55 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.042 -0.823 . . . . 10.0 111.042 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.475 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 1.9 m -94.17 157.19 38.07 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 120.707 0.289 . . . . 10.0 111.115 -174.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 6' ' ' VAL . 39.7 Cg_endo -66.37 153.17 79.04 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.008 2.472 . . . . 10.0 111.924 175.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 67' ' ' LEU . 2.8 m 48.31 -146.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.181 -0.918 . . . . 10.0 111.745 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.663 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.35 -0.57 0.1 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.39 1.076 . . . . 10.0 113.889 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.475 ' HG2' ' HB2' ' A' ' 4' ' ' SER . 21.4 mt-10 70.36 -24.5 0.16 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.683 0.793 . . . . 10.0 113.043 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.426 ' H ' ' C ' ' A' ' 7' ' ' ALA . 87.0 m -78.27 -15.01 59.18 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.41 0.148 . . . . 10.0 111.346 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.841 HG11 HD21 ' A' ' 23' ' ' ASN . 2.0 m -100.45 143.55 13.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.092 -0.336 . . . . 10.0 110.092 -174.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -141.23 125.38 17.36 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.513 -0.18 . . . . 10.0 110.513 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -96.05 162.43 13.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.814 0.816 . . . . 10.0 112.885 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -143.84 138.1 28.42 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.379 -1.282 . . . . 10.0 107.703 172.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -103.48 127.25 50.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.997 0.427 . . . . 10.0 111.02 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.1 m -131.23 -155.98 0.73 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.294 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -63.36 93.82 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.936 0.398 . . . . 10.0 110.852 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.452 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 98.1 mtt180 61.33 30.01 18.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.512 -0.767 . . . . 10.0 111.487 173.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.89 106.44 3.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.805 -0.443 . . . . 10.0 109.805 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.2 m -94.73 102.08 13.94 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.98 -0.378 . . . . 10.0 109.98 168.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.751 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.3 p-10 -88.05 111.7 21.83 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.903 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.73 107.58 21.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.936 0.874 . . . . 10.0 108.897 172.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.761 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 2.7 p80 -97.23 114.71 26.48 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.399 -1.273 . . . . 10.0 110.025 176.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.841 HD21 HG11 ' A' ' 10' ' ' VAL . 12.3 t-20 -80.79 153.96 27.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.721 177.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.56 25.38 3.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.552 -0.832 . . . . 10.0 112.586 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.552 ' HB2' HD22 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -88.42 164.56 15.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 176.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.58 -15.99 56.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.032 0.382 . . . . 10.0 112.032 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -128.15 156.42 42.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.259 0.552 . . . . 10.0 111.774 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.29 126.52 28.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.894 -1.048 . . . . 10.0 111.648 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.535 ' H ' HG21 ' A' ' 46' ' ' ILE . 34.3 m -124.62 146.0 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-O 121.125 0.488 . . . . 10.0 111.059 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.651 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.3 m -95.21 122.87 38.35 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.635 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.546 ' HB ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -123.07 151.33 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 115.769 -0.65 . . . . 10.0 110.658 -177.218 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.828 HG21 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -130.21 163.08 27.48 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.227 -0.897 . . . . 10.0 109.116 175.371 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.65 HG22 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.4 131.07 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 120.865 0.364 . . . . 10.0 110.089 -176.36 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -103.12 115.29 30.31 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.505 -0.77 . . . . 10.0 109.103 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.775 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 41.4 m-85 -86.26 162.35 18.32 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.729 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.1 m -50.17 -23.42 2.18 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.737 -1.12 . . . . 10.0 112.446 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -131.06 -74.01 0.53 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.919 -0.488 . . . . 10.0 110.402 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.87 133.74 2.29 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.32 -1.112 . . . . 10.0 110.32 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.09 24.76 0.37 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.003 0.43 . . . . 10.0 110.412 -174.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 36.0 t90 58.87 103.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.212 -0.904 . . . . 10.0 112.149 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.703 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -173.83 -45.07 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.355 -0.839 . . . . 10.0 111.587 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.703 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 2.6 Cg_endo -38.27 100.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 123.951 3.101 . . . . 10.0 114.308 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.0 m 129.51 100.38 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.241 1.816 . . . . 10.0 111.244 168.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.769 HH21 HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -153.37 130.96 11.47 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.9 -1.045 . . . . 10.0 108.293 -178.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -84.56 138.42 19.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.485 0.66 . . . . 10.0 110.731 178.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.535 HG21 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -99.09 148.77 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.457 -1.247 . . . . 10.0 109.692 -177.186 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -87.66 142.62 32.86 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.803 -1.184 . . . . 10.0 107.803 168.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -45.46 93.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.042 2.494 . . . . 10.0 112.843 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.669 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.02 15.11 37.24 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.047 -1.073 . . . . 10.0 112.523 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.78 -174.64 28.11 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.084 -0.579 . . . . 10.0 112.733 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.761 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 16.5 m0 -117.61 167.13 11.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.637 0.732 . . . . 10.0 111.653 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.417 ' HB1' HD11 ' A' ' 46' ' ' ILE . . . -144.64 113.72 6.91 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.56 -1.2 . . . . 10.0 107.982 171.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 m -82.63 131.88 35.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.989 -175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.775 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 46.6 m-85 -140.0 144.51 36.99 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.35 -0.981 . . . . 10.0 108.35 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.22 101.98 0.06 Allowed 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 124.131 0.894 . . . . 10.0 111.151 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.14 175.54 42.23 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.247 -0.977 . . . . 10.0 110.86 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -84.28 55.66 3.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.38 1.09 . . . . 10.0 110.041 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.452 ' HA3' ' CG ' ' A' ' 17' ' ' ARG . . . -88.6 5.14 84.96 Favored Glycine 0 N--CA 1.454 -0.144 0 CA-C-N 114.914 -1.039 . . . . 10.0 113.371 -171.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 m -152.71 37.7 0.52 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.525 -0.917 . . . . 10.0 108.525 174.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 66.2 -89.09 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 114.875 -1.057 . . . . 10.0 108.605 -170.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 31.83 -111.88 0.05 OUTLIER Glycine 0 N--CA 1.468 0.82 0 O-C-N 124.698 1.249 . . . . 10.0 114.445 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -99.39 140.63 33.28 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.413 0.625 . . . . 10.0 110.815 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -124.43 114.1 19.04 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.97 -1.013 . . . . 10.0 109.007 172.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -60.19 125.75 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 174.346 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.0 t -138.41 6.56 2.54 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.466 -0.494 . . . . 10.0 110.936 -175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -156.23 107.17 0.31 Allowed Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 119.246 -1.454 . . . . 10.0 113.395 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.803 ' HB3' HG12 ' A' ' 6' ' ' VAL . 4.9 mt -82.28 128.35 34.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.696 -0.853 . . . . 10.0 108.696 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.737 ' C ' HG11 ' A' ' 6' ' ' VAL . 8.5 m-70 -122.36 143.32 49.72 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.254 -0.884 . . . . 10.0 108.685 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.469 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -77.76 129.74 35.86 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.055 -1.028 . . . . 10.0 110.445 179.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.828 ' HB2' HG21 ' A' ' 32' ' ' THR . 44.6 t -99.91 157.76 16.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.394 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -106.93 145.3 30.83 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 171.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -19.16 81.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.997 1 C-N-CA 126.788 4.992 . . . . 10.0 115.093 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 43' ' ' CYS . . . -172.33 121.06 0.43 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.777 -1.101 . . . . 10.0 108.738 -175.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.769 HG23 HH21 ' A' ' 44' ' ' ARG . 8.0 t -141.86 138.93 17.54 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 109.116 -0.698 . . . . 10.0 109.116 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.51 ' HD2' ' HG1' ' A' ' 74' ' ' THR . 14.3 Cg_endo -57.66 101.97 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.198 2.598 . . . . 10.0 113.356 -175.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.6 m -81.6 82.57 7.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.905 -0.589 . . . . 10.0 109.715 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.81 -93.19 1.52 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.584 -0.735 . . . . 10.0 112.15 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.873 -0.584 . . . . 10.0 109.997 -177.509 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.559 0.218 . . . . 10.0 110.503 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.2 t -173.38 -47.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.538 -0.301 . . . . 10.0 110.315 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.48 166.67 12.25 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.586 -0.606 . . . . 10.0 111.586 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.623 ' HB3' ' HG2' ' A' ' 8' ' ' GLU . 13.1 m -126.85 101.69 26.11 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 121.026 0.441 . . . . 10.0 111.418 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' HG22 ' A' ' 6' ' ' VAL . 71.7 Cg_endo -78.46 144.5 20.25 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.164 2.576 . . . . 10.0 111.757 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.701 HG12 ' C ' ' A' ' 68' ' ' HIS . 1.4 m 51.35 -151.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.304 -0.862 . . . . 10.0 111.732 174.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.684 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -60.4 9.4 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.342 1.238 . . . . 10.0 114.342 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.623 ' HG2' ' HB3' ' A' ' 4' ' ' SER . 47.8 mt-10 75.79 -49.72 0.61 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.454 0.909 . . . . 10.0 113.454 176.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 60.9 m -73.57 -9.67 58.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.68 0.276 . . . . 10.0 111.442 -170.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.776 HG11 HD21 ' A' ' 23' ' ' ASN . 1.5 m -98.73 132.82 43.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.917 -0.772 . . . . 10.0 108.917 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -139.57 126.82 21.29 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.85 -0.34 . . . . 10.0 110.207 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.736 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -90.65 163.24 14.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.767 0.794 . . . . 10.0 111.937 177.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.411 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 55.8 t80 -142.27 155.91 45.25 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.073 -1.455 . . . . 10.0 107.073 171.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.45 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -103.31 94.38 5.47 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.481 0.657 . . . . 10.0 111.208 -177.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.65 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 38.3 m -86.37 60.75 6.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.148 -0.933 . . . . 10.0 108.54 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.8 t90 66.35 -92.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.985 -1.007 . . . . 10.0 110.87 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -110.92 40.85 1.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.668 0.747 . . . . 10.0 109.534 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.65 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 1.7 t80 -151.08 99.57 2.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.013 -0.994 . . . . 10.0 108.496 -175.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.5 m -87.12 98.26 11.2 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.345 0.593 . . . . 10.0 109.783 173.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.736 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.1 p-10 -87.54 104.94 16.96 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.723 -1.126 . . . . 10.0 111.445 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.702 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -96.12 105.22 16.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.497 -0.927 . . . . 10.0 108.497 174.541 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.791 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 3.3 p80 -95.51 112.95 24.57 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.362 -1.29 . . . . 10.0 110.063 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.776 HD21 HG11 ' A' ' 10' ' ' VAL . 14.1 t-20 -81.65 150.1 28.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.737 175.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.14 25.39 3.33 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.078 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.653 ' HB2' HD22 ' A' ' 23' ' ' ASN . 0.5 OUTLIER -89.01 162.59 15.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 176.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.59 -12.96 59.82 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.275 0.472 . . . . 10.0 112.275 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -120.68 152.32 38.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.443 0.64 . . . . 10.0 112.449 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.7 118.54 11.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.894 -1.048 . . . . 10.0 110.735 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.472 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.4 m -121.74 137.81 54.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.332 0.586 . . . . 10.0 112.049 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.4 m -87.46 122.76 31.61 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.786 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.09 151.69 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 115.256 -0.883 . . . . 10.0 110.711 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.765 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -130.1 160.0 35.07 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.964 -0.754 . . . . 10.0 108.964 176.198 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.624 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.36 132.78 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.42 0.629 . . . . 10.0 110.81 -177.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -102.53 114.16 28.13 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.806 -1.088 . . . . 10.0 108.97 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.759 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 53.3 m-85 -89.84 164.73 14.5 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.575 0.702 . . . . 10.0 112.265 -175.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -52.81 -32.91 46.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.191 -1.368 . . . . 10.0 111.597 169.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -106.98 -86.22 0.5 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.813 0.34 . . . . 10.0 110.698 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.81 53.22 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.747 -0.74 . . . . 10.0 111.717 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.11 138.39 55.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -73.11 107.48 5.47 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.91 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -167.13 -42.15 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 118.281 -0.866 . . . . 10.0 112.879 -173.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.91 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 1.6 Cg_endo -41.77 70.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 125.151 3.9 . . . . 10.0 116.877 -173.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.718 ' HB3' ' HD3' ' A' ' 75' ' ' PRO . 5.7 t 173.77 110.2 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.807 0.843 . . . . 10.0 109.735 164.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.466 ' HB2' ' HZ ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -149.52 121.09 7.99 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.935 177.329 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.702 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -77.98 127.18 38.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.998 -0.741 . . . . 10.0 108.998 173.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.472 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -91.41 146.78 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 114.589 -1.187 . . . . 10.0 109.478 -175.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.03 133.05 41.91 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 107.443 -1.317 . . . . 10.0 107.443 168.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -43.11 96.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.189 2.593 . . . . 10.0 112.369 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 103.19 7.6 43.13 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.343 -0.932 . . . . 10.0 113.084 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.16 -171.79 28.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.098 -0.572 . . . . 10.0 113.589 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.791 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 20.3 m0 -118.43 167.31 11.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.333 0.587 . . . . 10.0 110.896 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB2' HG12 ' A' ' 21' ' ' VAL . . . -141.58 114.84 8.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.327 -1.36 . . . . 10.0 107.327 171.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.0 m -83.45 130.21 35.02 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.757 -173.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.759 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 56.9 m-85 -138.72 146.63 41.73 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.8 102.59 0.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.601 0.563 . . . . 10.0 110.493 -174.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.97 -169.54 15.15 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.54 -0.838 . . . . 10.0 111.077 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.687 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 6.3 p90 -84.96 88.36 7.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 122.014 0.912 . . . . 10.0 110.86 -174.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -134.07 -82.19 0.18 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.49 -0.777 . . . . 10.0 112.405 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m -84.62 113.0 20.95 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.853 -0.204 . . . . 10.0 110.542 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 63.14 22.52 13.44 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.958 0.409 . . . . 10.0 110.944 -176.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 57' ' ' TYR . . . 78.19 -95.33 1.29 Allowed Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.368 -0.92 . . . . 10.0 111.471 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.534 ' O ' ' HD2' ' A' ' 35' ' ' TYR . 17.5 m120 61.33 23.62 13.83 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 122.973 0.509 . . . . 10.0 110.87 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.687 ' HD1' ' HB3' ' A' ' 57' ' ' TYR . 89.6 t80 -58.54 110.36 0.97 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.559 -177.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.3 m -60.65 136.89 23.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 172.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.5 t -144.77 12.82 1.48 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.196 -0.602 . . . . 10.0 111.89 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.04 110.62 0.45 Allowed Glycine 0 C--O 1.224 -0.504 0 C-N-CA 119.438 -1.363 . . . . 10.0 113.482 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.54 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.5 mt -84.65 133.78 34.39 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.388 0.613 . . . . 10.0 109.701 173.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.701 ' C ' HG12 ' A' ' 6' ' ' VAL . 27.2 m-70 -127.06 149.58 49.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.033 -0.985 . . . . 10.0 108.706 -176.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.423 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -83.67 129.41 34.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 119.485 1.039 . . . . 10.0 110.381 177.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.765 ' HB2' HG23 ' A' ' 32' ' ' THR . 5.2 t -98.89 172.9 7.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.349 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -130.35 149.03 72.21 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.917 -0.771 . . . . 10.0 108.917 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -20.91 78.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.11 1 C-N-CA 126.777 4.984 . . . . 10.0 115.272 174.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -167.42 68.97 0.09 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.661 -1.154 . . . . 10.0 109.898 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.404 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 67.1 m -70.55 131.43 88.08 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.777 -175.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.718 ' HD3' ' HB3' ' A' ' 43' ' ' CYS . 4.1 Cg_endo -47.54 116.28 1.77 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.829 3.02 . . . . 10.0 112.91 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.4 t -158.26 -34.6 0.07 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.27 -0.877 . . . . 10.0 109.082 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.11 28.65 27.63 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.618 -0.801 . . . . 10.0 112.598 175.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.246 0.893 0 CA-C-O 119.192 -0.432 . . . . 10.0 110.957 -179.518 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 110.168 -0.308 . . . . 10.0 110.168 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.4 p -72.75 -24.73 61.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.943 -176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.11 -97.87 0.11 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.494 -0.86 . . . . 10.0 112.138 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.783 ' HB3' ' HG2' ' A' ' 8' ' ' GLU . 37.8 m 58.57 79.94 0.3 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 121.154 0.502 . . . . 10.0 111.103 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.0 -42.79 1.41 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.588 2.192 . . . . 10.0 113.349 -174.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.612 HG23 HG22 ' A' ' 69' ' ' THR . 0.2 OUTLIER -157.07 118.72 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.584 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 9' ' ' CYS . . . 68.61 -19.54 0.16 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.505 0.722 . . . . 10.0 112.58 171.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.783 ' HG2' ' HB3' ' A' ' 4' ' ' SER . 32.6 mt-10 74.49 -28.32 0.19 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.283 1.033 . . . . 10.0 112.041 175.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.425 ' H ' ' C ' ' A' ' 7' ' ' ALA . 31.0 m -87.18 -10.26 53.11 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.919 0.34 . . . . 10.0 111.919 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -95.56 134.85 31.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.871 -0.788 . . . . 10.0 108.871 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -135.82 121.58 19.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.787 -0.188 . . . . 10.0 110.594 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.822 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -98.18 161.33 13.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.146 0.795 . . . . 10.0 113.146 178.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' THR . 82.9 t80 -148.05 155.62 41.69 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 171.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.475 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 0.7 OUTLIER -110.15 124.95 52.47 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.318 -0.553 . . . . 10.0 110.606 178.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.2 t -136.75 77.2 1.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.25 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 55.95 86.79 0.06 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.215 -0.902 . . . . 10.0 112.092 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 67.49 14.14 9.52 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.965 -0.561 . . . . 10.0 112.271 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -139.03 96.52 3.13 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.521 -0.548 . . . . 10.0 109.521 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.5 m -87.46 100.4 12.73 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.656 -0.498 . . . . 10.0 109.656 171.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.822 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.4 p-10 -83.63 111.42 19.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 114.948 -1.024 . . . . 10.0 111.829 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.98 106.65 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 122.015 0.912 . . . . 10.0 108.883 171.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.781 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -97.51 112.07 24.07 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.14 -1.391 . . . . 10.0 110.545 179.02 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.762 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.5 t-20 -80.72 160.03 25.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.89 -0.595 . . . . 10.0 110.255 177.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -154.5 32.0 0.7 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.638 -0.791 . . . . 10.0 111.764 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.507 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -83.05 -18.4 39.85 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 122.132 0.173 . . . . 10.0 111.015 -178.375 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 86.35 -8.34 0.73 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.753 1.283 . . . . 10.0 111.08 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 10.9 p-10 -125.07 155.05 40.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.121 0.486 . . . . 10.0 110.841 175.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.67 123.22 20.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.292 -0.867 . . . . 10.0 111.183 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.542 ' H ' HG23 ' A' ' 46' ' ' ILE . 26.8 m -126.03 139.79 50.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.067 0.46 . . . . 10.0 111.364 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.748 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 9.5 m -88.93 119.67 29.65 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.509 -0.552 . . . . 10.0 109.509 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 43' ' ' CYS . 1.1 m -116.66 165.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 115.401 -0.818 . . . . 10.0 110.51 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.45 HG22 ' CB ' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -148.57 158.16 43.94 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.641 -0.709 . . . . 10.0 109.206 178.221 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.619 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -135.23 138.22 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.338 0.59 . . . . 10.0 111.717 -173.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -101.22 125.99 47.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.947 -1.024 . . . . 10.0 108.908 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.744 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 57.0 m-85 -95.07 165.6 12.34 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.247 -0.581 . . . . 10.0 110.351 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 88.0 m -49.4 -21.07 0.8 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.245 -0.889 . . . . 10.0 112.142 174.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -118.96 -67.05 1.02 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 174.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.04 50.65 0.07 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.735 -0.745 . . . . 10.0 112.352 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -74.43 158.98 32.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.73 0.3 . . . . 10.0 111.362 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -66.92 112.87 4.54 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.388 0.614 . . . . 10.0 112.224 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.712 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -174.82 -47.72 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 CA-C-N 114.844 -1.071 . . . . 10.0 111.101 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.712 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 3.0 Cg_endo -37.06 96.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 124.273 3.316 . . . . 10.0 114.128 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 1.6 m 135.99 108.19 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.0 1.72 . . . . 10.0 111.202 170.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.76 130.58 7.44 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.748 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -83.45 135.74 24.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.392 0.615 . . . . 10.0 110.236 176.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.542 HG23 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.37 146.79 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.829 -1.078 . . . . 10.0 109.994 -176.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -88.27 141.56 30.95 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 168.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -38.9 98.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.71 2.94 . . . . 10.0 113.02 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.716 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 89.37 12.22 63.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 119.603 -1.284 . . . . 10.0 112.23 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.28 -176.63 36.03 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 121.276 -0.488 . . . . 10.0 112.214 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.781 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 23.6 m0 -116.65 165.16 13.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.552 0.692 . . . . 10.0 111.182 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.46 115.87 10.56 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.14 -1.43 . . . . 10.0 107.14 172.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.0 m -85.2 127.88 34.46 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.374 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.744 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 48.5 m-85 -137.42 139.43 40.68 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.462 -0.94 . . . . 10.0 108.462 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.54 100.04 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.172 0.92 . . . . 10.0 111.324 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.29 175.07 43.44 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.233 -1.147 . . . . 10.0 110.233 176.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.444 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 7.7 p90 -83.93 91.05 7.5 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.742 1.271 . . . . 10.0 109.96 -174.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.18 -50.45 6.77 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.166 -0.925 . . . . 10.0 112.525 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.1 p -116.17 26.2 10.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.797 0.332 . . . . 10.0 110.578 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 65.45 14.73 9.64 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.734 -0.667 . . . . 10.0 111.375 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.81 -88.33 0.19 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.782 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -92.62 113.72 26.07 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 26.9 t80 -115.63 116.84 28.81 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 172.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -61.3 129.02 23.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.9 p -128.23 -16.37 4.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.136 -0.484 . . . . 10.0 111.678 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.37 110.65 0.66 Allowed Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 119.226 -1.464 . . . . 10.0 113.709 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.564 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.3 mt -82.36 150.53 27.12 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.069 -0.715 . . . . 10.0 109.069 171.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.526 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -148.22 159.65 43.75 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.264 -178.044 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.612 HG22 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -81.44 126.61 31.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.033 0.444 . . . . 10.0 110.66 174.402 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 30' ' ' SER . 48.9 t -98.92 166.97 11.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.492 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -124.04 143.6 42.86 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.164 -0.68 . . . . 10.0 109.164 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -17.37 82.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.803 1 C-N-CA 126.754 4.969 . . . . 10.0 115.115 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -168.96 96.77 0.36 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.538 -1.21 . . . . 10.0 110.229 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.5 m -95.7 114.54 64.22 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 111.885 0.328 . . . . 10.0 111.885 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 43' ' ' CYS . 37.1 Cg_endo -66.92 124.1 11.83 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.894 2.396 . . . . 10.0 112.007 175.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.8 m 60.4 74.78 0.43 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.723 -0.672 . . . . 10.0 111.211 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.2 -150.65 25.02 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.837 -0.697 . . . . 10.0 111.827 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t . . . . . 0 C--O 1.245 0.863 0 CA-C-O 117.847 -1.073 . . . . 10.0 110.321 -176.604 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.463 -0.199 . . . . 10.0 110.463 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 t -162.3 -41.92 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.785 -0.189 . . . . 10.0 111.113 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.96 -17.89 28.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.182 -1.009 . . . . 10.0 112.32 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 t -145.17 95.9 5.03 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 110.034 -0.358 . . . . 10.0 110.034 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.458 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 36.0 Cg_endo -87.83 -67.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.559 2.173 . . . . 10.0 112.62 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.593 HG22 HG21 ' A' ' 69' ' ' THR . 0.2 OUTLIER -151.93 124.42 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 177.141 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 71.06 -27.54 0.17 Allowed 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.752 0.657 . . . . 10.0 111.88 172.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.56 ' H ' ' C ' ' A' ' 6' ' ' VAL . 47.0 mt-10 77.68 -20.17 0.39 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.609 1.163 . . . . 10.0 111.36 175.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.9 m -84.18 -14.46 50.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.414 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.782 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -96.03 134.19 34.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -133.1 119.6 20.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.583 -175.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.805 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -96.71 162.04 13.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.024 0.916 . . . . 10.0 113.296 177.131 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 19' ' ' THR . 33.5 t80 -143.04 178.98 7.32 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.407 -1.701 . . . . 10.0 106.407 169.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -136.96 117.35 13.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.457 0.571 . . . . 10.0 111.349 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 p -120.66 86.65 2.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.664 -0.698 . . . . 10.0 109.85 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 62.72 -84.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.998 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -120.31 16.75 12.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.983 0.42 . . . . 10.0 110.933 -172.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.69 96.45 3.82 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.218 -0.66 . . . . 10.0 109.218 -173.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.474 HG22 HG12 ' A' ' 64' ' ' VAL . 7.0 m -86.17 99.12 11.3 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.624 0.726 . . . . 10.0 109.192 171.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.805 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.0 p-10 -85.27 109.67 18.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.434 -1.257 . . . . 10.0 111.926 -175.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.36 106.48 19.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 172.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.731 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -98.37 110.96 23.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.068 -1.424 . . . . 10.0 110.297 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.782 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 18.6 t-20 -80.98 154.91 26.68 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.957 -0.565 . . . . 10.0 109.939 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.25 36.13 1.03 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.579 -0.82 . . . . 10.0 112.177 173.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -76.59 -66.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.457 -0.306 . . . . 10.0 110.449 -178.032 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 25' ' ' CYS . . . 142.42 -32.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.815 1.322 . . . . 10.0 108.699 -171.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -115.33 157.67 23.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.111 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.35 127.22 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.492 -0.776 . . . . 10.0 111.319 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.531 ' H ' HG21 ' A' ' 46' ' ' ILE . 30.8 m -125.47 139.55 50.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.072 0.463 . . . . 10.0 111.268 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.813 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 14.7 m -88.3 119.7 28.96 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.273 -0.64 . . . . 10.0 109.273 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.497 ' HB ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -119.12 148.45 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 121.775 0.798 . . . . 10.0 111.732 -178.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.531 HG23 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -127.16 160.88 29.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.8 -1.091 . . . . 10.0 109.287 176.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.608 ' H ' ' HA ' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -135.73 138.95 47.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.33 0.585 . . . . 10.0 111.867 -178.154 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -100.81 120.36 40.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.72 -1.127 . . . . 10.0 109.241 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.834 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 35.1 m-85 -100.13 158.96 15.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.295 0.569 . . . . 10.0 111.55 -178.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 22.7 m -48.48 -34.9 11.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.608 -1.178 . . . . 10.0 112.601 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.434 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 53.4 m-70 -103.29 -83.6 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.931 -0.48 . . . . 10.0 109.876 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.4 49.63 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.246 -0.978 . . . . 10.0 112.898 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -66.3 153.24 43.15 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.088 -0.338 . . . . 10.0 110.088 173.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.468 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 14.5 p90 -75.7 136.68 40.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.866 -0.79 . . . . 10.0 108.866 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.725 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 165.95 -42.52 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 123.57 0.748 . . . . 10.0 111.329 -170.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.725 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 6.3 Cg_endo -48.69 71.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 124.212 3.275 . . . . 10.0 115.29 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER 164.1 97.89 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.794 1.238 . . . . 10.0 110.2 166.166 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.73 126.48 10.31 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.944 -0.761 . . . . 10.0 108.944 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.813 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -80.53 137.39 21.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.287 0.565 . . . . 10.0 110.749 179.613 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.531 HG21 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -96.0 145.64 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.235 -0.893 . . . . 10.0 109.38 -177.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.58 140.45 31.73 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 107.808 -1.182 . . . . 10.0 107.808 169.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -43.53 95.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.267 2.644 . . . . 10.0 113.107 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 99.59 5.44 55.49 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.064 -1.065 . . . . 10.0 112.511 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.24 -171.79 38.33 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 121.29 -0.481 . . . . 10.0 113.117 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.731 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 16.6 m0 -119.74 167.3 12.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.499 0.666 . . . . 10.0 111.005 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.59 114.46 8.13 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.154 -1.424 . . . . 10.0 107.154 171.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.8 m -80.95 129.42 34.53 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.549 -0.751 . . . . 10.0 110.361 -175.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.722 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 50.3 m-85 -137.52 141.0 41.45 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.595 -0.891 . . . . 10.0 108.595 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.01 106.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.958 0.786 . . . . 10.0 110.854 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.5 -170.96 6.31 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.338 -0.846 . . . . 10.0 111.818 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.723 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 2.3 p90 -83.79 65.87 8.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.207 1.003 . . . . 10.0 111.556 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.25 163.21 39.16 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.311 -0.859 . . . . 10.0 111.61 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 t -59.49 134.95 57.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.685 0.243 . . . . 10.0 110.558 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 64.59 9.35 5.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.095 0.558 . . . . 10.0 111.418 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.562 ' C ' HD21 ' A' ' 62' ' ' ASN . . . -100.42 -145.63 17.89 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.44 -0.886 . . . . 10.0 112.286 -176.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.834 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -120.57 -153.83 0.56 Allowed 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.218 -1.031 . . . . 10.0 108.218 179.139 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.602 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 8.5 t80 -169.01 109.04 0.47 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.471 -1.307 . . . . 10.0 107.471 176.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.474 HG12 HG22 ' A' ' 19' ' ' THR . 1.6 m -66.53 128.79 30.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.6 p -119.28 -28.84 5.33 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.344 -0.389 . . . . 10.0 111.277 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.51 115.38 1.1 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.569 -1.3 . . . . 10.0 113.209 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.576 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.4 mt -79.34 146.62 32.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 170.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.458 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 5.3 m-70 -140.29 157.93 44.81 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.453 -176.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.593 HG21 HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -79.63 126.44 30.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.011 0.434 . . . . 10.0 110.571 174.249 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.531 ' HB2' HG23 ' A' ' 32' ' ' THR . 35.8 t -94.44 158.77 15.41 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.154 -0.684 . . . . 10.0 109.154 177.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -136.45 145.36 51.3 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -16.96 81.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.717 1 C-N-CA 126.637 4.891 . . . . 10.0 114.751 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -169.61 71.23 0.07 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.519 -1.219 . . . . 10.0 109.387 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 m -79.7 127.6 77.32 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.144 -0.934 . . . . 10.0 111.433 -173.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.52 -71.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.208 1.939 . . . . 10.0 111.592 175.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 p -94.24 104.75 16.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.387 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 149.46 -112.99 0.58 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.914 -0.66 . . . . 10.0 111.75 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.301 -0.857 . . . . 10.0 110.656 178.714 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.704 0.288 . . . . 10.0 110.72 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.0 t -80.99 -22.34 39.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.389 0.614 . . . . 10.0 109.965 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 152.35 137.31 2.55 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.697 -0.961 . . . . 10.0 110.697 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.633 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . 9.3 t -144.11 -53.96 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 117.237 0.518 . . . . 10.0 111.833 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 4' ' ' SER . 14.7 Cg_endo -77.52 124.99 7.33 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.343 1.362 . . . . 10.0 111.941 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.577 HG22 HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER 41.18 106.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.655 1.354 . . . . 10.0 114.655 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 73.6 -19.11 0.35 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.405 -0.816 . . . . 10.0 112.949 164.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 6' ' ' VAL . 40.1 mt-10 77.5 -40.11 0.32 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.864 . . . . 10.0 112.017 174.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.1 m -77.75 -12.73 60.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.818 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.813 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.4 m -90.94 132.43 35.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.869 -0.789 . . . . 10.0 108.869 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.71 113.0 11.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.674 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.774 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -89.34 161.33 16.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.719 0.771 . . . . 10.0 111.996 175.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.434 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 86.4 t80 -142.69 139.87 31.32 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.192 -1.367 . . . . 10.0 107.454 172.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.743 HE21 ' HH ' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -97.03 98.26 9.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.537 0.684 . . . . 10.0 110.123 -178.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 12.9 p -99.15 -156.35 0.54 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.321 -0.854 . . . . 10.0 108.879 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -69.88 93.22 0.74 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.668 0.271 . . . . 10.0 110.713 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 62.35 32.64 16.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.308 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.855 ' HH ' ' HG1' ' A' ' 53' ' ' THR . 0.7 OUTLIER -146.41 103.07 3.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 -173.11 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.418 ' HG1' ' HA2' ' A' ' 56' ' ' GLY . 16.8 m -90.15 91.56 8.59 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.755 -0.831 . . . . 10.0 108.755 170.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.774 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.0 OUTLIER -83.37 109.07 16.99 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.975 -1.012 . . . . 10.0 111.757 -178.411 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.28 107.21 19.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 122.066 0.936 . . . . 10.0 108.928 174.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.748 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -98.54 111.01 23.51 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.13 -1.395 . . . . 10.0 110.042 177.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.813 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.9 t30 -79.39 147.46 32.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.053 -0.521 . . . . 10.0 109.748 178.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -129.43 13.85 5.89 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.718 -0.753 . . . . 10.0 112.502 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.79 154.79 23.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.53 -11.22 60.57 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.443 0.535 . . . . 10.0 112.443 -176.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -124.88 156.75 37.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.365 0.602 . . . . 10.0 112.09 -177.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.31 124.72 24.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.721 -1.127 . . . . 10.0 111.33 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.582 ' H ' HG22 ' A' ' 46' ' ' ILE . 27.8 m -124.14 138.33 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.323 0.582 . . . . 10.0 111.533 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.2 m -87.01 120.15 27.97 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.383 -0.826 . . . . 10.0 109.061 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.577 HG12 HG22 ' A' ' 6' ' ' VAL . 1.2 m -115.42 165.53 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 121.532 0.682 . . . . 10.0 110.653 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.559 ' HB ' ' C ' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -146.96 159.77 43.15 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.968 -1.015 . . . . 10.0 109.037 177.104 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.608 HG22 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.41 144.5 33.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.328 0.585 . . . . 10.0 110.633 -176.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -117.44 114.21 23.18 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.074 -0.967 . . . . 10.0 109.114 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.86 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 20.3 m-85 -93.1 159.73 15.17 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.626 0.727 . . . . 10.0 111.919 -172.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.6 m -50.67 -44.6 57.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.251 -1.34 . . . . 10.0 113.237 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.423 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 30.6 m-70 -95.22 -72.68 0.61 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.36 -0.536 . . . . 10.0 110.823 -177.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.71 48.55 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.958 -1.115 . . . . 10.0 113.575 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.523 ' HG2' ' OD1' ' A' ' 62' ' ' ASN . 16.0 mm100 -68.1 150.35 48.5 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 117.022 0.411 . . . . 10.0 110.391 173.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.537 ' HZ2' ' H ' ' A' ' 76' ' ' SER . 53.5 t-105 -82.91 108.81 16.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.83 -0.623 . . . . 10.0 111.219 178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.78 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -171.95 26.67 0.01 OUTLIER Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 113.063 0.764 . . . . 10.0 113.063 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.78 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 14.3 Cg_endo -91.27 56.91 1.02 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.259 1.306 . . . . 10.0 112.7 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 177.01 116.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.632 0.582 . . . . 10.0 111.356 171.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.79 124.42 3.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.7 p -83.15 138.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.359 0.6 . . . . 10.0 110.812 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -100.86 148.3 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 114.941 -1.027 . . . . 10.0 109.494 -177.367 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -90.65 143.26 28.76 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 107.832 -1.173 . . . . 10.0 107.832 168.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -46.08 93.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.106 2.537 . . . . 10.0 112.609 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 102.19 11.52 36.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.86 -1.162 . . . . 10.0 111.884 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.03 -176.79 31.96 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 121.332 -0.461 . . . . 10.0 112.63 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.748 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 12.0 m0 -119.31 166.71 12.67 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.365 0.603 . . . . 10.0 111.126 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.47 110.07 5.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.855 ' HG1' ' HH ' ' A' ' 18' ' ' TYR . 43.9 m -79.41 131.07 35.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.761 -175.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.86 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 49.8 m-85 -140.1 142.83 36.05 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.004 -1.11 . . . . 10.0 108.004 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.91 102.72 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.544 0.527 . . . . 10.0 110.837 -174.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.418 ' HA2' ' HG1' ' A' ' 19' ' ' THR . . . -68.53 -176.26 11.37 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.278 -0.873 . . . . 10.0 111.167 177.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.656 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 13.4 p90 -86.21 94.52 9.32 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 117.986 0.893 . . . . 10.0 110.903 -174.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.59 170.0 34.78 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.209 -0.905 . . . . 10.0 111.154 174.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.6 m -63.82 114.45 4.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.475 -0.195 . . . . 10.0 110.475 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.3 t70 65.81 63.4 0.6 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.569 0.7 . . . . 10.0 110.106 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.94 -147.23 4.49 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.089 -0.804 . . . . 10.0 111.089 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.657 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -106.71 179.41 4.28 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.969 -0.752 . . . . 10.0 108.969 174.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.743 ' HH ' HE21 ' A' ' 14' ' ' GLN . 15.8 t80 -147.75 118.5 7.56 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.706 -1.134 . . . . 10.0 108.574 171.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.7 m -63.59 133.0 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.432 -0.951 . . . . 10.0 108.432 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 81.6 p -118.51 -39.29 3.02 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.478 -0.489 . . . . 10.0 111.029 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.45 122.57 3.86 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.719 -1.229 . . . . 10.0 113.21 -174.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.564 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 3.7 mt -86.87 144.37 27.02 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.997 -0.742 . . . . 10.0 108.997 173.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.538 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 8.1 m-70 -138.37 159.6 41.64 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.386 -174.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.556 HG22 HG21 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -84.12 124.88 31.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.129 0.49 . . . . 10.0 111.129 175.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.477 ' HB2' HG21 ' A' ' 32' ' ' THR . 43.3 t -95.37 172.83 7.85 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.809 -0.811 . . . . 10.0 108.809 175.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 6.4 p-10 -137.1 147.89 60.47 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 108.318 -0.994 . . . . 10.0 108.318 172.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -15.66 83.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 1 C-N-CA 126.546 4.831 . . . . 10.0 114.916 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -165.62 104.96 0.72 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.629 -1.169 . . . . 10.0 109.619 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.8 p -77.36 134.8 66.22 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.291 -0.413 . . . . 10.0 111.44 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.84 144.83 94.23 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.594 2.196 . . . . 10.0 111.911 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.537 ' H ' ' HZ2' ' A' ' 40' ' ' TRP . 13.6 t -78.15 101.97 7.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.025 0.441 . . . . 10.0 110.335 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.04 147.44 18.43 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.015 -0.834 . . . . 10.0 111.015 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 m . . . . . 0 C--O 1.242 0.71 0 CA-C-O 118.908 -0.568 . . . . 10.0 110.931 -178.141 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 4' ' ' SER . . . . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.599 0.238 . . . . 10.0 111.238 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -45.98 70.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.141 -0.481 . . . . 10.0 112.038 -177.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.27 48.73 0.91 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.451 -0.88 . . . . 10.0 112.737 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 1' ' ' ALA . 19.9 t -139.44 62.45 24.25 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.774 0.321 . . . . 10.0 111.157 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 4' ' ' SER . 90.8 Cg_endo -97.88 139.94 0.49 Allowed 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.961 2.441 . . . . 10.0 112.264 176.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.826 HG11 ' HB3' ' A' ' 67' ' ' LEU . 2.2 m 48.55 -147.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.488 0.715 . . . . 10.0 111.458 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.671 ' N ' HG21 ' A' ' 6' ' ' VAL . . . -56.09 -2.5 0.06 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.275 1.03 . . . . 10.0 113.587 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 6' ' ' VAL . 44.8 mt-10 69.21 -24.26 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.036 0.934 . . . . 10.0 113.377 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.442 ' H ' ' C ' ' A' ' 7' ' ' ALA . 33.5 m -80.73 -17.44 51.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.866 0.365 . . . . 10.0 111.189 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.871 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -92.09 141.75 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.26 115.03 12.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.62 -0.264 . . . . 10.0 111.028 -172.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.831 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.81 164.68 12.83 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.687 0.756 . . . . 10.0 112.895 177.493 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 19' ' ' THR . 25.8 t80 -147.5 172.66 13.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.27 -1.381 . . . . 10.0 107.27 172.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HG3' ' HE1' ' A' ' 57' ' ' TYR . 5.7 pm0 -122.55 127.91 50.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 10.0 110.901 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 t -150.75 89.96 1.59 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.123 -0.489 . . . . 10.0 110.733 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.4 t90 55.04 80.02 0.14 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.697 -0.683 . . . . 10.0 112.229 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 58.95 24.74 12.92 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.641 -0.709 . . . . 10.0 111.629 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.36 97.3 3.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.9 m -89.13 99.86 12.76 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.193 0.521 . . . . 10.0 109.796 173.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.831 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -84.6 109.93 18.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.966 -1.016 . . . . 10.0 112.168 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.8 108.62 24.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 122.017 0.913 . . . . 10.0 109.31 174.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.687 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.28 110.55 22.79 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.802 -1.544 . . . . 10.0 110.45 178.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.871 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 20.4 t30 -80.36 155.88 26.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.066 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.03 31.1 1.46 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.181 -0.533 . . . . 10.0 111.874 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -18.92 57.38 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.244 0.218 . . . . 10.0 111.084 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 88.66 -18.1 0.25 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.699 1.249 . . . . 10.0 111.322 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -120.39 158.86 26.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.001 0.429 . . . . 10.0 110.263 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -66.4 123.61 20.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.433 -0.803 . . . . 10.0 111.002 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.613 ' H ' HG21 ' A' ' 46' ' ' ILE . 29.9 m -127.07 138.8 53.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.058 0.456 . . . . 10.0 111.09 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.71 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 9.5 m -87.26 119.48 27.55 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.395 -0.594 . . . . 10.0 109.395 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.38 153.32 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.565 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -134.31 159.62 40.42 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 175.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.622 ' H ' ' HA ' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -134.33 141.78 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 120.85 0.357 . . . . 10.0 110.172 -177.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.71 119.95 39.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.619 -0.882 . . . . 10.0 108.619 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.778 ' HH ' ' HB3' ' A' ' 54' ' ' PHE . 43.3 m-85 -94.22 164.62 12.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.971 0.891 . . . . 10.0 112.323 -173.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.6 m -52.12 -28.65 18.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.974 -1.466 . . . . 10.0 112.445 172.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -110.41 -85.94 0.54 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.857 -0.337 . . . . 10.0 111.133 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.23 43.29 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.023 -1.084 . . . . 10.0 113.097 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -71.48 146.18 48.74 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.796 -0.237 . . . . 10.0 110.627 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.494 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 27.7 p90 -75.08 140.54 43.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.222 -0.658 . . . . 10.0 109.222 175.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.761 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 160.71 -43.06 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 124.164 0.986 . . . . 10.0 110.804 -168.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.761 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 4.6 Cg_endo -47.65 66.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 124.894 3.729 . . . . 10.0 116.56 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.404 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER 169.33 102.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.315 1.046 . . . . 10.0 110.276 164.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -148.32 126.51 12.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.474 -0.785 . . . . 10.0 109.837 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.71 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.85 130.94 35.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.319 0.581 . . . . 10.0 109.796 174.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.613 HG21 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -93.41 148.63 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 114.998 -1.001 . . . . 10.0 109.283 -177.689 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -84.86 144.76 42.47 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 108.339 -0.986 . . . . 10.0 108.339 169.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -46.06 95.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.944 2.429 . . . . 10.0 112.711 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.706 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 93.55 13.84 54.56 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 119.948 -1.12 . . . . 10.0 111.824 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.55 -174.32 32.44 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 121.446 -0.407 . . . . 10.0 112.267 -177.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.71 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 19.1 m0 -118.8 166.28 12.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.394 0.616 . . . . 10.0 111.529 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.444 ' HB1' HD11 ' A' ' 46' ' ' ILE . . . -142.92 118.69 10.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.71 -1.218 . . . . 10.0 107.71 171.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.1 m -86.58 130.6 34.43 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.663 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.778 ' HB3' ' HH ' ' A' ' 35' ' ' TYR . 52.6 m-85 -138.53 145.82 41.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.56 -0.904 . . . . 10.0 108.56 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.64 97.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.754 0.659 . . . . 10.0 111.157 -174.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.74 171.79 49.66 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 110.002 -1.239 . . . . 10.0 110.002 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.49 ' HE1' ' HG3' ' A' ' 14' ' ' GLN . 7.8 p90 -86.3 89.89 8.0 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.816 1.308 . . . . 10.0 111.037 -172.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.7 -75.17 0.59 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 114.872 -1.058 . . . . 10.0 111.573 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.6 t -105.14 144.47 31.9 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 72.06 -43.02 0.55 Allowed 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.009 0.818 . . . . 10.0 111.773 175.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.27 -112.92 1.21 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.045 -0.822 . . . . 10.0 111.045 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.1 m120 58.32 41.12 23.73 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 123.881 0.401 . . . . 10.0 111.496 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 30.6 t80 -69.11 124.09 22.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.145 -0.479 . . . . 10.0 110.727 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -64.91 129.39 28.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 170.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.9 p -120.54 -22.9 6.24 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.994 -0.683 . . . . 10.0 111.924 -175.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -145.64 127.39 2.81 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.711 -1.233 . . . . 10.0 113.258 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.826 ' HB3' HG11 ' A' ' 6' ' ' VAL . 4.7 mt -87.71 139.18 30.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.131 0.491 . . . . 10.0 109.704 172.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.749 ' C ' HG13 ' A' ' 6' ' ' VAL . 14.6 m-70 -129.99 147.44 51.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.411 -0.813 . . . . 10.0 108.942 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -80.84 125.49 30.16 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 118.873 -1.131 . . . . 10.0 110.388 178.387 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.623 ' HB2' HG22 ' A' ' 32' ' ' THR . 38.5 t -87.61 158.75 18.79 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.361 -0.836 . . . . 10.0 109.531 -178.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -137.52 141.79 34.81 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.795 -0.817 . . . . 10.0 108.795 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -14.28 73.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 1 C-N-CA 127.343 5.362 . . . . 10.0 115.932 -176.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -171.26 71.74 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.84 -1.073 . . . . 10.0 109.501 -176.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.0 p -80.14 150.15 70.87 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.825 -0.625 . . . . 10.0 111.528 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.39 102.38 0.58 Allowed 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.57 2.18 . . . . 10.0 111.98 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.6 m 64.73 -160.92 0.28 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.376 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.41 -41.91 1.97 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.709 -0.956 . . . . 10.0 110.709 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 C--O 1.249 1.03 0 N-CA-C 108.937 -0.764 . . . . 10.0 108.937 174.404 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 N--CA 1.458 -0.603 0 N-CA-C 113.581 0.57 . . . . 10.0 113.581 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.821 HG13 ' HB3' ' A' ' 67' ' ' LEU . 12.3 m -137.77 -142.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.26 -0.274 . . . . 10.0 110.26 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.651 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.65 10.04 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.658 1.183 . . . . 10.0 113.932 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 6' ' ' VAL . 35.4 mt-10 72.59 -50.43 0.7 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.4 0.889 . . . . 10.0 113.4 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.2 m -74.78 -8.53 56.71 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.858 0.318 . . . . 10.0 111.858 -172.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.4 m -95.96 131.97 41.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -132.93 114.46 14.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.529 -0.305 . . . . 10.0 110.616 -171.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.782 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -90.07 155.67 18.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.894 0.855 . . . . 10.0 112.471 175.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.403 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 56.3 t80 -135.05 152.7 51.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.058 -1.46 . . . . 10.0 107.058 170.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.546 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 4.3 pm0 -108.7 105.87 15.66 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.365 0.603 . . . . 10.0 110.863 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 p -108.34 75.93 1.01 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.536 0.684 . . . . 10.0 109.583 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 66.63 -86.21 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.542 -1.208 . . . . 10.0 111.801 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -117.5 24.52 11.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 10.0 110.456 -176.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.35 100.29 4.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.857 -0.794 . . . . 10.0 108.857 -174.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.611 HG21 HG21 ' A' ' 64' ' ' VAL . 5.1 m -90.58 95.31 10.09 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 172.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.782 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.0 p-10 -83.43 107.87 16.21 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.749 -1.114 . . . . 10.0 111.701 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.77 107.95 21.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 122.034 0.921 . . . . 10.0 109.157 174.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.726 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.46 110.34 22.51 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.88 -1.509 . . . . 10.0 110.176 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.806 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 24.6 t30 -82.18 159.4 23.29 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -151.73 23.53 0.93 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.769 -0.729 . . . . 10.0 112.241 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.644 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -75.58 -17.04 60.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.64 0.237 . . . . 10.0 111.64 -177.37 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.06 -4.26 0.92 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.362 1.039 . . . . 10.0 111.171 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.644 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 13.6 p-10 -126.88 156.29 41.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.593 174.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.58 126.07 28.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.451 -0.795 . . . . 10.0 111.139 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.579 ' H ' HG22 ' A' ' 46' ' ' ILE . 24.6 m -132.42 140.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.065 0.459 . . . . 10.0 111.068 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.843 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 5.4 m -88.19 123.91 33.3 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.91 146.14 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-O 121.454 0.645 . . . . 10.0 110.381 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.751 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -124.96 159.43 31.24 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.348 -0.842 . . . . 10.0 109.489 177.578 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.613 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.2 138.5 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-O 121.043 0.449 . . . . 10.0 110.544 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -106.97 116.42 31.9 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.519 ' OH ' ' HB3' ' A' ' 41' ' ' ALA . 57.1 m-85 -92.71 163.61 13.69 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.727 0.775 . . . . 10.0 112.062 -174.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 47.4 m -52.91 -21.97 4.97 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.238 -1.346 . . . . 10.0 111.693 170.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -135.56 -74.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.871 -0.518 . . . . 10.0 109.84 170.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 40' ' ' TRP . . . 148.76 80.46 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.713 -0.756 . . . . 10.0 112.117 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -74.66 20.0 0.13 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.022 0.379 . . . . 10.0 112.022 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.418 ' H ' ' C ' ' A' ' 38' ' ' GLY . 30.4 t90 59.77 87.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.64 0.733 . . . . 10.0 112.218 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.744 ' N ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.58 29.06 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.115 -0.948 . . . . 10.0 112.831 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.744 ' HD3' ' N ' ' A' ' 41' ' ' ALA . 9.8 Cg_endo -88.86 54.23 1.95 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.802 1.668 . . . . 10.0 112.198 -173.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.1 m 173.3 111.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.086 0.866 . . . . 10.0 111.259 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 131.62 10.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.843 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -82.13 142.7 13.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.112 0.482 . . . . 10.0 110.409 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -101.51 146.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.932 -0.576 . . . . 10.0 109.976 -178.413 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -87.27 143.38 34.42 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 169.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -41.16 95.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.523 2.816 . . . . 10.0 113.574 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.717 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 95.26 6.86 59.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.838 -1.172 . . . . 10.0 112.137 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.3 -174.46 44.9 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.183 -0.532 . . . . 10.0 113.098 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.726 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 10.0 m0 -120.11 167.39 12.26 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.932 -0.634 . . . . 10.0 111.061 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -146.14 111.18 5.31 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.768 -1.197 . . . . 10.0 107.768 171.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 m -77.58 130.53 37.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.433 -0.803 . . . . 10.0 110.061 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.613 ' CG ' HG21 ' A' ' 33' ' ' VAL . 49.8 m-85 -137.4 134.98 36.52 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.668 -0.864 . . . . 10.0 108.668 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.92 105.1 0.1 Allowed 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 124.23 0.957 . . . . 10.0 110.297 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.86 -157.85 0.65 Allowed Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.891 -1.05 . . . . 10.0 112.564 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.819 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 26.8 p90 . . . . . 0 C--N 1.316 -0.881 0 O-C-N 122.447 -0.443 . . . . 10.0 111.894 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.819 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 15.5 t80 . . . . . 0 CA--C 1.515 -0.404 0 N-CA-C 108.066 -1.087 . . . . 10.0 108.066 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 19' ' ' THR . 1.8 m -66.63 130.21 31.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.124 -1.065 . . . . 10.0 108.124 173.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.9 p -113.1 -37.37 4.79 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.064 -0.654 . . . . 10.0 111.322 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -140.05 136.99 8.09 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.826 -1.178 . . . . 10.0 112.496 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.821 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.0 mt -86.61 152.12 22.87 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.769 -0.826 . . . . 10.0 108.769 171.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.692 ' C ' HG12 ' A' ' 6' ' ' VAL . 6.5 m-70 -138.55 146.24 41.65 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.241 -1.022 . . . . 10.0 108.241 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.444 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -84.14 124.4 31.11 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 118.908 -1.117 . . . . 10.0 110.407 178.479 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.751 ' HB2' HG22 ' A' ' 32' ' ' THR . 41.9 t -92.27 158.55 16.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.214 -0.903 . . . . 10.0 109.807 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 C--N 1.327 -0.37 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 174.052 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.558 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 94.8 Cg_endo . . . . . 0 N--CA 1.459 -0.537 0 CA-C-O 120.762 0.234 . . . . 10.0 112.046 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.9 m 49.19 -148.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.919 0.887 . . . . 10.0 112.36 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.68 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.92 1.32 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.635 1.346 . . . . 10.0 114.635 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 72.22 -33.79 0.28 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.437 0.695 . . . . 10.0 112.322 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 m -76.86 -13.08 60.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.634 0.254 . . . . 10.0 111.421 -173.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.85 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.9 m -98.35 143.59 12.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.066 -0.716 . . . . 10.0 109.066 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -136.75 111.97 9.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.758 -0.201 . . . . 10.0 110.731 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.772 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -89.19 160.29 17.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.794 0.807 . . . . 10.0 112.546 175.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' THR . 36.9 t80 -142.76 173.95 11.09 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.549 -1.649 . . . . 10.0 106.549 173.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -119.24 103.4 9.47 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.366 -0.534 . . . . 10.0 110.508 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.7 m -104.6 54.29 0.72 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.982 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 60.38 88.99 0.07 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.554 -0.748 . . . . 10.0 111.537 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 49.5 ttt180 63.9 14.49 8.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.581 0.705 . . . . 10.0 111.538 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -130.95 95.72 3.89 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.779 -1.193 . . . . 10.0 107.779 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.488 HG21 HG21 ' A' ' 64' ' ' VAL . 61.5 m -86.35 97.67 10.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.31 0.576 . . . . 10.0 109.694 177.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.772 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.7 p-10 -83.19 108.43 16.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.723 -1.126 . . . . 10.0 111.318 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.99 105.84 18.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 122.203 1.001 . . . . 10.0 109.055 175.197 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.686 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -99.11 109.16 21.9 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 113.707 -1.588 . . . . 10.0 109.993 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.85 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 15.7 t30 -80.08 156.93 26.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -140.11 13.4 3.07 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.704 -0.76 . . . . 10.0 113.041 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.07 156.9 20.88 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 117.21 0.505 . . . . 10.0 109.844 173.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.32 -8.62 56.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.024 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -116.62 152.81 33.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.646 0.736 . . . . 10.0 111.721 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.76 125.36 26.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.695 -1.139 . . . . 10.0 110.256 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.5 m -124.19 137.31 57.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.109 0.48 . . . . 10.0 111.67 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.802 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 3.8 m -85.69 121.95 29.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.71 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.509 ' HB ' HG11 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -122.78 148.11 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.295 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.714 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.2 OUTLIER -127.44 160.17 32.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.147 -0.933 . . . . 10.0 109.02 176.53 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -132.03 132.04 61.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.598 0.713 . . . . 10.0 111.337 -176.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -103.55 109.74 21.52 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.522 -176.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.625 ' OH ' ' HB3' ' A' ' 41' ' ' ALA . 28.4 m-85 -89.59 165.31 14.33 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.584 0.706 . . . . 10.0 111.733 -176.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.403 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 52.4 m -52.55 -29.73 26.97 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.231 -1.35 . . . . 10.0 111.397 168.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -126.42 -77.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 10.0 110.206 172.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.01 79.02 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.228 -0.986 . . . . 10.0 111.691 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -76.38 20.01 0.23 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.218 0.451 . . . . 10.0 112.218 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 3.1 t90 66.99 87.41 0.12 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.727 0.811 . . . . 10.0 111.641 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.727 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -170.85 27.77 0.01 OUTLIER Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 113.444 0.905 . . . . 10.0 113.444 174.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.727 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 9.9 Cg_endo -89.16 56.41 2.01 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.726 1.617 . . . . 10.0 112.754 -172.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.2 m 172.27 114.56 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.616 0.766 . . . . 10.0 111.33 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.61 132.0 8.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.1 -0.704 . . . . 10.0 109.1 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.802 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -81.13 138.88 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.199 0.523 . . . . 10.0 110.06 176.227 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -97.05 145.12 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 115.362 -0.835 . . . . 10.0 109.704 -179.166 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -83.2 141.38 42.96 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 107.966 -1.124 . . . . 10.0 107.966 169.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -47.77 91.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.298 2.666 . . . . 10.0 112.692 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.654 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 104.37 5.91 42.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.161 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.78 -172.4 36.11 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.382 -0.437 . . . . 10.0 112.863 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.686 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.4 m0 -120.32 167.28 12.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.514 0.673 . . . . 10.0 111.051 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -143.1 113.07 7.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 171.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -81.44 128.31 33.74 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.436 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.617 ' CG ' HG21 ' A' ' 33' ' ' VAL . 42.1 m-85 -138.78 140.52 38.64 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.332 -0.618 . . . . 10.0 109.332 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.72 101.46 0.05 Allowed 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 123.894 0.746 . . . . 10.0 110.192 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.91 -159.27 8.36 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 111.217 -0.753 . . . . 10.0 111.217 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.68 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 28.3 p90 . . . . . 0 N--CA 1.432 -1.368 0 N-CA-C 108.109 -1.071 . . . . 10.0 108.109 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.68 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 28.7 t80 . . . . . 0 CA--C 1.512 -0.51 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.9 m -63.59 131.56 29.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 107.74 -1.207 . . . . 10.0 107.74 173.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.0 t -137.95 11.82 2.87 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.27 -0.572 . . . . 10.0 110.379 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.76 118.93 0.81 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 119.803 -1.189 . . . . 10.0 112.782 173.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.84 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -88.99 127.57 35.67 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.724 ' C ' HG12 ' A' ' 6' ' ' VAL . 17.6 m-70 -118.24 146.45 44.26 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.306 -0.861 . . . . 10.0 108.933 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.437 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -82.15 123.31 28.87 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.032 -1.043 . . . . 10.0 110.513 177.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.714 ' HB2' HG22 ' A' ' 32' ' ' THR . 42.0 t -92.7 161.01 14.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.799 -0.637 . . . . 10.0 110.205 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 . . . . . 0 C--N 1.33 -0.265 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 172.099 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 54.2 Cg_endo . . . . . 0 N--CA 1.454 -0.839 0 CA-C-O 120.92 0.3 . . . . 10.0 112.838 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.836 HG13 ' HB3' ' A' ' 67' ' ' LEU . 9.3 m -136.94 -137.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.252 -0.647 . . . . 10.0 109.252 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.704 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -56.48 0.23 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.185 0.994 . . . . 10.0 113.452 174.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 6' ' ' VAL . 10.0 mt-10 74.11 -38.73 0.41 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.518 1.127 . . . . 10.0 113.264 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.1 m -75.77 -13.35 60.29 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.939 0.399 . . . . 10.0 111.318 -175.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.878 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -97.09 137.32 25.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.009 -0.737 . . . . 10.0 109.009 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -143.34 129.94 20.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.043 -0.263 . . . . 10.0 110.477 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.686 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -95.56 165.23 12.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.891 0.853 . . . . 10.0 113.179 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.421 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 87.3 t80 -145.26 154.32 42.24 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 106.72 -1.585 . . . . 10.0 106.72 170.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -105.66 108.26 19.69 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.445 -0.502 . . . . 10.0 111.389 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -99.41 -166.89 1.4 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.124 -1.065 . . . . 10.0 108.124 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.669 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -69.46 100.67 1.43 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.837 0.351 . . . . 10.0 110.541 -178.383 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 63.92 28.19 14.5 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.118 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.87 101.86 3.59 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 121.207 -0.197 . . . . 10.0 111.15 -169.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.475 HG21 HG21 ' A' ' 64' ' ' VAL . 16.3 m -89.63 96.71 10.81 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 170.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.686 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.1 p-10 -84.34 107.35 16.57 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 114.947 -1.024 . . . . 10.0 112.378 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.29 108.62 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.794 0.807 . . . . 10.0 108.9 174.584 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.768 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.6 p80 -98.39 113.97 26.14 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.218 -1.356 . . . . 10.0 110.554 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.878 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 22.6 t30 -82.03 163.42 22.11 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.592 -0.522 . . . . 10.0 109.592 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -153.39 25.2 0.77 Allowed Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.288 -0.482 . . . . 10.0 112.203 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -78.72 -14.0 59.52 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.402 0.281 . . . . 10.0 111.148 -177.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 82.24 -6.03 1.4 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.919 -1.037 . . . . 10.0 110.933 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -126.24 158.58 35.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.02 0.438 . . . . 10.0 110.304 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -70.91 120.3 16.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.039 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.74 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.6 m -126.19 140.75 47.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.221 0.534 . . . . 10.0 111.424 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.748 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.0 m -88.11 120.25 29.28 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.154 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.41 161.15 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 115.729 -0.669 . . . . 10.0 110.409 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.691 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.4 OUTLIER -143.13 160.88 39.58 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.474 -0.784 . . . . 10.0 109.015 176.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.587 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.58 145.27 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.45 0.643 . . . . 10.0 111.542 -175.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -114.12 110.31 19.81 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.735 -1.121 . . . . 10.0 109.719 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 11.9 m-85 -90.57 161.88 15.25 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.369 0.604 . . . . 10.0 111.622 -176.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.1 m -48.79 -38.64 22.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.263 -1.335 . . . . 10.0 112.783 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -101.6 -75.49 0.59 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.518 -0.473 . . . . 10.0 110.064 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.06 46.73 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.553 -0.832 . . . . 10.0 112.048 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.34 136.78 57.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -72.79 100.47 2.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 10.0 111.548 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.851 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.03 19.96 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.256 -0.884 . . . . 10.0 113.233 175.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.851 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 9.2 Cg_endo -87.27 58.62 3.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 CA-C-N 121.112 1.433 . . . . 10.0 112.455 -170.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 176.47 115.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.791 0.682 . . . . 10.0 111.168 170.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 128.67 6.74 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.436 0.694 . . . . 10.0 109.525 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.748 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -83.92 134.38 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.334 0.588 . . . . 10.0 110.534 177.246 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.74 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -94.67 149.29 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.009 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -86.88 146.73 41.54 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 168.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -43.19 98.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.037 2.491 . . . . 10.0 112.961 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.718 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 89.28 11.48 64.55 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.864 -1.16 . . . . 10.0 111.565 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.12 -176.81 37.78 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 121.283 -0.484 . . . . 10.0 112.418 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.768 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 17.2 m0 -115.93 166.76 11.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.793 0.806 . . . . 10.0 111.815 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -143.67 118.3 9.8 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.362 -1.347 . . . . 10.0 107.362 172.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.7 m -85.72 129.7 34.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.178 0.514 . . . . 10.0 110.812 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.587 ' CG ' HG21 ' A' ' 33' ' ' VAL . 56.3 m-85 -136.86 151.34 49.0 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.588 -0.894 . . . . 10.0 108.588 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.97 98.56 0.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.705 0.628 . . . . 10.0 110.562 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.45 178.49 23.11 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 115.049 -0.978 . . . . 10.0 111.107 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.1 p90 . . . . . 0 CA--C 1.534 0.35 0 CA-C-N 118.049 0.925 . . . . 10.0 110.803 -173.159 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.4 t80 . . . . . 0 N--CA 1.442 -0.849 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -59.75 128.91 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.5 p -118.04 -34.3 4.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.046 0.45 . . . . 10.0 111.169 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.84 129.71 4.75 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.062 -1.066 . . . . 10.0 112.468 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.836 ' HB3' HG13 ' A' ' 6' ' ' VAL . 3.8 mt -83.89 148.87 26.71 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.114 -1.069 . . . . 10.0 108.114 171.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.7 ' C ' HG12 ' A' ' 6' ' ' VAL . 15.4 m-70 -134.17 147.44 50.77 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.518 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -82.46 130.04 35.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 118.994 -1.082 . . . . 10.0 110.566 178.146 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.691 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.3 t -96.14 159.72 14.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.986 -0.552 . . . . 10.0 109.58 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 CA--C 1.512 -0.489 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 172.843 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 N--CA 1.466 -0.126 0 CA-C-O 119.908 -0.122 . . . . 10.0 111.891 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.598 ' HB ' ' C ' ' A' ' 68' ' ' HIS . 0.3 OUTLIER 38.77 98.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 114.324 1.231 . . . . 10.0 114.324 177.25 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 75.99 -25.09 0.21 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.558 -0.747 . . . . 10.0 112.559 166.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' A' ' 6' ' ' VAL . 24.6 mt-10 74.8 -22.19 0.27 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.224 1.009 . . . . 10.0 111.845 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 82.4 m -85.42 -16.5 39.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.907 0.336 . . . . 10.0 111.907 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -94.22 139.78 17.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.619 -0.512 . . . . 10.0 109.619 -177.35 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -141.55 127.3 19.17 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.625 -0.139 . . . . 10.0 110.625 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.789 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -98.4 164.19 12.38 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.468 1.127 . . . . 10.0 113.787 176.374 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.418 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 84.6 t80 -145.1 162.6 36.63 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.304 -1.771 . . . . 10.0 106.643 172.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.71 122.7 44.18 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.083 -0.647 . . . . 10.0 110.786 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.509 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 25.9 p -121.93 -154.39 0.59 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.78 -0.822 . . . . 10.0 108.78 175.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -67.93 91.11 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.647 0.261 . . . . 10.0 111.412 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 61.4 35.07 17.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.585 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.509 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -147.29 101.19 3.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.4 -0.818 . . . . 10.0 109.345 -173.05 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.495 HG21 HG21 ' A' ' 64' ' ' VAL . 6.3 m -90.42 99.37 12.41 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 170.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.789 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -84.37 110.44 18.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.871 -1.059 . . . . 10.0 111.966 -177.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.98 106.69 19.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 122.181 0.991 . . . . 10.0 108.561 171.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.811 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -97.22 111.06 23.47 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.094 -1.412 . . . . 10.0 110.163 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.772 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.4 t30 -80.29 156.66 26.7 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.837 -0.62 . . . . 10.0 109.342 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.47 13.91 3.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.127 -0.558 . . . . 10.0 112.346 174.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.77 156.18 22.66 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.53 -8.41 56.69 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.264 0.468 . . . . 10.0 112.264 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -120.66 157.46 29.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.511 0.672 . . . . 10.0 111.75 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -71.82 117.69 13.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.827 -1.079 . . . . 10.0 110.431 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.683 ' H ' HG22 ' A' ' 46' ' ' ILE . 33.7 m -116.87 139.21 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 121.303 0.573 . . . . 10.0 111.676 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.0 m -88.94 116.88 27.55 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.734 -0.666 . . . . 10.0 109.288 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.5 HG12 HG21 ' A' ' 6' ' ' VAL . 1.1 m -112.8 164.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.452 -0.795 . . . . 10.0 110.517 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.31 153.7 40.04 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.257 -0.883 . . . . 10.0 109.212 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.565 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -130.23 137.69 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 120.937 0.399 . . . . 10.0 110.915 -174.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -100.6 116.63 32.97 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.782 -0.821 . . . . 10.0 108.782 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.695 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 45.9 m-85 -91.77 160.79 15.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.112 0.482 . . . . 10.0 111.023 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.6 m -48.47 -33.22 9.01 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.664 -1.153 . . . . 10.0 112.604 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -110.26 -69.66 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.929 0.395 . . . . 10.0 109.961 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.45 58.07 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.551 -0.833 . . . . 10.0 112.161 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.2 154.64 30.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.706 0.289 . . . . 10.0 110.681 176.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -76.46 106.45 8.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.853 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -173.62 -40.57 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 113.069 0.766 . . . . 10.0 113.069 -175.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.853 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 5.3 Cg_endo -46.86 67.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 124.884 3.723 . . . . 10.0 116.429 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.461 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER 169.96 104.43 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.179 0.992 . . . . 10.0 110.097 168.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -151.85 127.05 9.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.064 -176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.38 132.85 30.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.277 -0.569 . . . . 10.0 109.856 174.228 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.683 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -96.06 147.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-N 115.112 -0.949 . . . . 10.0 109.28 -177.26 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -84.03 141.42 40.56 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 169.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -47.89 94.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.056 2.504 . . . . 10.0 112.366 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 97.77 14.22 41.01 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.073 -1.061 . . . . 10.0 112.106 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.66 -172.2 26.77 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 121.112 -0.566 . . . . 10.0 112.669 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.811 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 16.5 m0 -119.54 165.54 14.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.423 0.63 . . . . 10.0 111.255 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -139.66 111.15 7.12 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 172.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.6 m -78.74 126.79 31.2 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.394 -0.821 . . . . 10.0 110.439 -176.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.565 ' CG ' HG21 ' A' ' 33' ' ' VAL . 51.5 m-85 -134.53 146.42 49.67 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.509 -0.922 . . . . 10.0 108.509 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.03 102.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.836 0.71 . . . . 10.0 110.459 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.59 179.44 16.65 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.608 -0.997 . . . . 10.0 110.608 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.567 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 14.9 p90 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-N 118.208 1.004 . . . . 10.0 110.64 -174.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 19.1 t80 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 108.562 -0.903 . . . . 10.0 108.562 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.495 HG21 HG21 ' A' ' 19' ' ' THR . 1.5 m -63.23 130.77 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.2 p -123.83 -19.04 5.84 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.203 -0.599 . . . . 10.0 111.851 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.39 130.69 4.06 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.602 -1.285 . . . . 10.0 113.159 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -94.84 148.0 22.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.399 -0.593 . . . . 10.0 109.399 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.598 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -147.98 164.54 33.47 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.254 -176.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.499 ' N ' ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -83.53 129.1 34.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.22 0.533 . . . . 10.0 111.362 177.254 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 30' ' ' SER . 32.3 t -98.19 168.3 10.33 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.509 -0.923 . . . . 10.0 108.509 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--N 1.317 -0.813 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 174.294 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.617 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 38.4 Cg_endo . . . . . 0 N--CA 1.475 0.385 0 N-CA-C 112.764 0.255 . . . . 10.0 112.764 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.936 HG13 ' HB3' ' A' ' 67' ' ' LEU . 3.9 m 47.35 -141.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.934 0.893 . . . . 10.0 111.689 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.696 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.89 -1.9 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.512 1.125 . . . . 10.0 113.368 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 76.27 -26.93 0.18 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.989 0.915 . . . . 10.0 112.655 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.84 -10.88 54.68 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.195 0.443 . . . . 10.0 112.195 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.87 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -96.22 140.56 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 -176.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -132.19 116.04 16.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.206 -0.197 . . . . 10.0 110.958 -173.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.777 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.1 161.68 15.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 122.053 0.93 . . . . 10.0 112.919 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 19' ' ' THR . 90.5 t80 -144.28 158.52 43.69 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.835 -1.53 . . . . 10.0 106.908 172.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HG3' ' OG1' ' A' ' 19' ' ' THR . 22.7 mp0 -117.0 101.78 8.79 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.33 -0.548 . . . . 10.0 111.252 -176.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.1 t -93.89 80.2 4.16 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 61.35 -89.86 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 115.005 -0.998 . . . . 10.0 110.573 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.593 ' H ' ' HD3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -118.17 26.68 9.46 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.153 0.501 . . . . 10.0 111.144 -176.682 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -132.34 96.0 3.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.3 m -85.28 101.95 12.96 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.245 0.545 . . . . 10.0 110.214 176.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.777 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.6 p-10 -86.19 108.38 18.32 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.845 -1.07 . . . . 10.0 111.454 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.1 107.82 21.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.891 0.853 . . . . 10.0 108.988 173.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.699 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.04 110.67 22.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.229 -1.35 . . . . 10.0 110.297 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.87 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 21.8 t30 -80.14 160.12 25.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 10.0 110.157 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.46 23.53 1.07 Allowed Glycine 0 C--O 1.226 -0.392 0 C-N-CA 121.361 -0.447 . . . . 10.0 112.207 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -75.12 -16.74 60.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.512 0.196 . . . . 10.0 111.316 -178.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.11 -6.33 0.91 Allowed 'General case' 0 N--CA 1.472 0.647 0 O-C-N 124.631 1.207 . . . . 10.0 111.345 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 5.9 p-10 -126.82 157.02 40.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.959 0.409 . . . . 10.0 110.689 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.79 122.56 18.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.354 -0.839 . . . . 10.0 110.96 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.633 ' H ' HG22 ' A' ' 46' ' ' ILE . 34.6 m -129.1 140.64 48.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.076 0.465 . . . . 10.0 111.442 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.69 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.5 m -87.22 120.34 28.4 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.487 -0.561 . . . . 10.0 109.487 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.692 ' HB ' HG11 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -119.88 146.79 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 115.587 -0.733 . . . . 10.0 110.587 -179.192 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -125.74 161.74 26.65 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.28 -0.873 . . . . 10.0 108.834 175.576 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.641 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.82 133.63 58.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.35 0.595 . . . . 10.0 110.95 -176.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -106.04 112.65 25.78 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.735 -1.121 . . . . 10.0 108.696 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.51 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 15.4 m-85 -91.07 164.01 14.1 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.33 0.586 . . . . 10.0 110.959 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.7 m -50.51 -22.53 1.99 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.464 -1.243 . . . . 10.0 112.668 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -123.96 -82.37 0.64 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.987 -0.445 . . . . 10.0 111.159 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.23 51.01 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.645 -1.264 . . . . 10.0 113.084 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.36 136.05 56.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.863 -0.792 . . . . 10.0 108.863 175.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -72.95 118.31 15.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.209 0.528 . . . . 10.0 110.471 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.769 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -177.05 -45.27 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 114.95 -1.023 . . . . 10.0 111.903 -174.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.769 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 3.5 Cg_exo -37.18 68.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.886 1 C-N-CA 125.924 4.416 . . . . 10.0 117.487 -174.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 5.3 t 170.53 111.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.294 1.038 . . . . 10.0 109.759 162.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.31 126.57 9.94 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.69 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -79.98 130.11 36.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.375 0.607 . . . . 10.0 109.369 175.259 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.633 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -93.21 148.91 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 114.83 -1.077 . . . . 10.0 109.804 -176.548 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -84.77 145.99 45.36 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 108.389 -0.967 . . . . 10.0 108.389 168.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -45.0 94.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.009 2.472 . . . . 10.0 112.564 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.718 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.72 15.12 53.89 Favored Glycine 0 CA--C 1.512 -0.151 0 C-N-CA 120.022 -1.085 . . . . 10.0 111.812 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 22' ' ' HIS . . . -97.26 -176.52 34.56 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 121.706 -0.283 . . . . 10.0 112.48 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.714 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 18.6 m0 -118.15 165.41 13.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.629 0.728 . . . . 10.0 111.784 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.425 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -143.91 115.54 8.17 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.265 -1.334 . . . . 10.0 107.929 172.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.3 m -82.56 131.19 35.22 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.598 -0.728 . . . . 10.0 110.764 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.641 ' CG ' HG21 ' A' ' 33' ' ' VAL . 53.5 m-85 -139.76 145.42 38.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.439 -0.948 . . . . 10.0 108.439 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.1 99.29 0.07 Allowed 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 123.856 0.723 . . . . 10.0 110.69 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.08 -173.59 12.35 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.295 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.44 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 2.9 p90 . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.6 0.714 . . . . 10.0 110.448 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.44 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 26.1 t80 . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.503 HG21 HG21 ' A' ' 19' ' ' THR . 0.5 OUTLIER -63.47 129.14 26.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 175.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 t -144.77 10.46 1.38 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.306 -0.557 . . . . 10.0 111.034 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.33 106.6 0.29 Allowed Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.552 -1.308 . . . . 10.0 112.951 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.936 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.8 mt -81.37 131.92 35.31 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.737 ' C ' HG12 ' A' ' 6' ' ' VAL . 18.7 m-70 -124.65 143.97 50.44 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.409 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -79.49 125.12 29.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 119.378 0.99 . . . . 10.0 110.482 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.601 ' HB2' HG22 ' A' ' 32' ' ' THR . 4.4 t -89.61 174.2 7.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.492 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 109.378 -0.601 . . . . 10.0 109.378 175.311 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.454 ' O ' HG13 ' A' ' 6' ' ' VAL . 61.1 Cg_endo . . . . . 0 N--CA 1.451 -1.025 0 N-CA-C 112.697 0.23 . . . . 10.0 112.697 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.803 HG21 HG12 ' A' ' 31' ' ' VAL . 2.0 m 65.39 -49.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 125.139 1.376 . . . . 10.0 111.951 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.621 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -174.73 114.65 0.17 Allowed 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 106.133 -1.802 . . . . 10.0 106.133 -172.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 1.6 mp0 -57.84 -14.21 5.64 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.405 -0.816 . . . . 10.0 112.396 -166.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.6 m -86.6 -15.5 39.62 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.819 HG12 HD22 ' A' ' 23' ' ' ASN . 1.6 m -91.67 131.47 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.019 -0.734 . . . . 10.0 109.019 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -137.39 123.56 20.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.685 -0.234 . . . . 10.0 110.494 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.76 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.45 159.08 15.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.777 0.798 . . . . 10.0 112.629 178.189 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.437 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 78.2 t80 -139.53 165.35 27.46 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.28 -1.378 . . . . 10.0 107.28 172.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.61 107.84 15.21 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.074 -0.65 . . . . 10.0 110.923 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 21.8 m -96.91 -173.73 2.79 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.519 -1.289 . . . . 10.0 107.519 170.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -62.26 98.01 0.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.111 0.481 . . . . 10.0 111.074 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 57.63 40.29 26.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.1 -0.954 . . . . 10.0 111.375 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 0.9 OUTLIER -148.09 96.06 2.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 -177.005 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.548 HG21 HG11 ' A' ' 64' ' ' VAL . 25.3 m -86.66 96.56 10.17 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.491 -0.559 . . . . 10.0 109.491 175.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.76 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.4 p-10 -86.04 109.79 19.06 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.458 -0.792 . . . . 10.0 112.071 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.65 107.18 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.951 0.882 . . . . 10.0 109.043 173.385 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.808 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 6.5 p-80 -97.61 115.11 27.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.39 -1.277 . . . . 10.0 110.361 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.819 HD22 HG12 ' A' ' 10' ' ' VAL . 16.9 t-20 -81.76 160.79 23.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.53 -0.759 . . . . 10.0 109.752 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.95 39.41 0.6 Allowed Glycine 0 C--N 1.32 -0.314 0 N-CA-C 111.438 -0.665 . . . . 10.0 111.438 173.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.607 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -91.9 -16.09 27.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.612 -0.294 . . . . 10.0 111.549 -176.528 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 84.91 -7.66 0.92 Allowed 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.456 1.098 . . . . 10.0 110.923 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.607 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 9.3 p-10 -126.48 151.75 47.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.235 0.54 . . . . 10.0 110.686 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.86 126.06 28.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.422 -0.808 . . . . 10.0 111.116 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.582 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.2 m -129.66 140.64 48.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.13 0.491 . . . . 10.0 111.334 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.772 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 14.4 m -92.11 117.57 29.98 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.803 HG12 HG21 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -113.04 166.34 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 115.269 -0.878 . . . . 10.0 110.88 -178.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -150.17 157.96 43.65 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.293 -0.867 . . . . 10.0 108.887 176.225 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.24 141.68 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 120.904 0.383 . . . . 10.0 111.449 -173.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -107.83 119.1 38.48 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.77 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 25.3 m-85 -92.4 164.3 13.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.21 0.529 . . . . 10.0 111.287 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 49.2 m -50.04 -24.03 2.42 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.764 -1.107 . . . . 10.0 111.875 171.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -117.68 -79.51 0.59 Allowed 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.118 -0.364 . . . . 10.0 110.033 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.57 51.53 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.344 -0.932 . . . . 10.0 112.031 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.4 141.96 57.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.4 t-105 -70.16 116.22 10.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.059 0.457 . . . . 10.0 110.499 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.792 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -175.33 -44.4 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.022 -0.99 . . . . 10.0 112.278 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.792 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 1.6 Cg_endo -40.54 70.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.874 1 C-N-CA 125.437 4.091 . . . . 10.0 116.639 -175.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER 169.6 106.46 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.383 1.073 . . . . 10.0 110.421 166.592 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -152.9 125.82 8.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.854 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -81.26 134.23 27.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.312 -0.555 . . . . 10.0 109.887 173.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -95.88 145.08 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-N 115.273 -0.876 . . . . 10.0 109.625 -177.413 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -85.35 142.78 38.19 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 168.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -41.1 93.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.41 2.74 . . . . 10.0 112.984 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 95.99 10.9 55.82 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 119.851 -1.166 . . . . 10.0 112.179 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.64 -176.49 35.49 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.525 -0.369 . . . . 10.0 112.717 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.808 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 19.8 m0 -116.04 166.87 11.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.686 0.755 . . . . 10.0 111.672 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -141.6 111.85 6.89 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.368 -1.345 . . . . 10.0 107.368 172.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.5 m -79.38 129.82 34.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.699 -0.682 . . . . 10.0 110.663 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.57 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.3 m-85 -140.15 142.71 35.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.406 -0.961 . . . . 10.0 108.406 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.22 104.52 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.668 0.605 . . . . 10.0 110.476 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.02 -179.05 10.86 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 110.652 -0.979 . . . . 10.0 110.652 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.53 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 12.4 p90 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 122.163 0.982 . . . . 10.0 111.697 -172.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 16.5 t80 . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 108.999 -0.741 . . . . 10.0 108.999 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.548 HG11 HG21 ' A' ' 19' ' ' THR . 1.6 m -59.21 129.67 21.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.703 -0.851 . . . . 10.0 108.703 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 63' ' ' TYR . 40.1 p -127.0 -10.88 5.97 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.654 -0.418 . . . . 10.0 111.46 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.36 147.07 16.57 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.02 -1.086 . . . . 10.0 112.872 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.467 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.1 mt -116.94 135.62 53.57 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.103 -0.702 . . . . 10.0 109.103 177.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.411 ' N ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -131.56 157.81 42.62 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.727 -0.67 . . . . 10.0 109.709 -176.527 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.502 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -80.19 130.65 35.37 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.386 -0.526 . . . . 10.0 110.382 177.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 30' ' ' SER . 43.0 t -96.7 158.65 15.33 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.237 -0.653 . . . . 10.0 109.237 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.512 -0.505 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 172.709 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.46 -0.457 0 CA-C-O 121.228 0.429 . . . . 10.0 112.136 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.788 HG13 ' HB3' ' A' ' 67' ' ' LEU . 7.5 m -140.94 -147.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.479 -0.782 . . . . 10.0 110.305 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.416 ' H ' ' HB ' ' A' ' 6' ' ' VAL . . . -65.05 16.03 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.802 1.038 . . . . 10.0 113.802 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 6' ' ' VAL . 2.3 mt-10 69.59 -52.07 0.61 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.922 0.889 . . . . 10.0 113.387 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.0 m -71.47 -13.4 61.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.688 0.28 . . . . 10.0 111.677 -173.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -95.59 130.65 44.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 -176.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -137.56 124.2 21.01 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.827 -0.349 . . . . 10.0 110.889 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.732 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.28 164.16 13.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.71 0.766 . . . . 10.0 112.572 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -146.81 137.42 23.8 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.35 -1.296 . . . . 10.0 107.692 169.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HG2' ' HE1' ' A' ' 63' ' ' TYR . 23.9 mp0 -91.1 104.4 16.98 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.038 0.447 . . . . 10.0 110.551 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -102.17 82.24 2.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.29 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 69.6 -77.21 0.05 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.163 -0.926 . . . . 10.0 111.264 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -133.39 26.24 4.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.423 0.63 . . . . 10.0 110.015 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -137.88 97.42 3.42 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 -169.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.622 HG21 HG21 ' A' ' 64' ' ' VAL . 7.5 m -86.05 93.99 9.13 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.117 -0.697 . . . . 10.0 109.117 175.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.732 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 0.9 OUTLIER -84.29 108.37 17.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.868 -1.06 . . . . 10.0 111.564 -177.772 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -97.9 106.59 18.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.845 0.831 . . . . 10.0 108.788 174.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.81 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 5.4 p-80 -97.26 113.14 24.71 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.414 -1.266 . . . . 10.0 109.926 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.774 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 15.4 t30 -81.64 149.04 28.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.953 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -131.9 20.89 4.49 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.775 -0.726 . . . . 10.0 111.886 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.06 155.9 20.63 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.431 -0.951 . . . . 10.0 108.431 175.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.92 -13.09 60.49 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -123.42 159.11 29.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.311 0.577 . . . . 10.0 111.715 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -70.14 125.23 26.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.053 -0.976 . . . . 10.0 111.139 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.553 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.5 m -127.24 138.88 53.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.521 . . . . 10.0 111.489 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.1 m -87.04 126.25 34.63 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.035 -0.529 . . . . 10.0 109.707 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.09 146.15 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.275 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.811 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.4 OUTLIER -125.81 157.09 38.4 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.382 -0.826 . . . . 10.0 109.241 178.135 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.596 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -131.45 137.94 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.38 0.61 . . . . 10.0 111.555 -177.454 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -99.03 115.03 28.04 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.024 -0.989 . . . . 10.0 109.544 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -92.61 153.44 19.0 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.377 0.608 . . . . 10.0 110.869 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 62.5 m -48.7 -28.97 3.93 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.236 -1.347 . . . . 10.0 113.533 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -121.27 -79.09 0.6 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.839 -0.538 . . . . 10.0 111.734 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.13 126.75 0.88 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 119.905 -1.141 . . . . 10.0 112.593 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -163.48 146.25 10.03 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.538 -0.912 . . . . 10.0 108.538 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.417 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 24.0 p90 -77.26 136.14 38.5 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.646 -0.501 . . . . 10.0 109.646 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.723 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 161.51 -41.99 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 115.083 -0.962 . . . . 10.0 111.306 -171.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.723 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 9.3 Cg_endo -51.91 63.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 124.54 3.493 . . . . 10.0 116.13 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.1 m 170.93 99.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.718 1.207 . . . . 10.0 109.695 163.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.69 129.95 16.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.557 -0.534 . . . . 10.0 109.557 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -79.68 137.79 21.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.438 0.637 . . . . 10.0 110.286 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.553 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -101.12 146.3 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.638 -177.51 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.18 141.9 35.45 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.159 -1.052 . . . . 10.0 108.159 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -46.28 91.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.353 2.702 . . . . 10.0 112.851 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 106.88 2.17 36.61 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.205 -0.997 . . . . 10.0 112.475 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.2 -172.57 40.24 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.859 -0.686 . . . . 10.0 113.157 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.81 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 13.2 m0 -120.03 168.55 11.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.427 0.632 . . . . 10.0 111.289 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.99 109.97 5.1 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.631 -1.248 . . . . 10.0 107.631 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.1 m -79.15 126.61 30.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.527 -0.761 . . . . 10.0 110.964 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.596 ' CG ' HG21 ' A' ' 33' ' ' VAL . 46.9 m-85 -136.84 136.58 38.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.25 105.84 0.12 Allowed 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 124.01 0.819 . . . . 10.0 110.815 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.54 -170.47 7.52 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 120.38 -0.914 . . . . 10.0 110.955 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.666 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 4.6 p90 . . . . . 0 C--N 1.314 -0.976 0 CA-C-O 121.913 0.863 . . . . 10.0 110.784 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.666 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 12.8 t80 . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.622 HG21 HG21 ' A' ' 19' ' ' THR . 1.4 m -66.08 126.93 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.6 p -123.49 -22.41 5.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.583 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.64 124.15 2.32 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.644 -1.265 . . . . 10.0 112.833 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.788 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.8 mt -84.99 151.91 23.84 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 170.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.642 ' C ' HG12 ' A' ' 6' ' ' VAL . 3.6 m-70 -142.57 142.22 32.14 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.439 -0.949 . . . . 10.0 108.439 -177.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.82 125.46 30.11 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.104 -1.038 . . . . 10.0 110.06 177.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.811 ' HB2' HG22 ' A' ' 32' ' ' THR . 51.7 t -95.38 154.48 17.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.532 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 109.307 -0.627 . . . . 10.0 109.307 174.822 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 29.9 Cg_endo . . . . . 0 C--O 1.234 0.296 0 CA-C-O 120.826 0.261 . . . . 10.0 112.487 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.853 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.4 m 49.3 -144.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 115.207 -0.906 . . . . 10.0 111.795 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.714 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.32 -5.4 0.3 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.402 1.081 . . . . 10.0 113.107 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 73.9 -25.28 0.2 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.983 0.913 . . . . 10.0 113.131 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 85.4 m -83.47 -7.14 59.6 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.705 0.261 . . . . 10.0 111.705 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.843 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -97.62 138.81 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.012 -0.736 . . . . 10.0 109.012 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.21 113.88 14.99 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.499 -0.186 . . . . 10.0 110.499 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.813 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -92.87 166.15 12.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.735 0.779 . . . . 10.0 112.762 176.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 19' ' ' THR . 81.7 t80 -149.19 140.8 23.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.187 -1.369 . . . . 10.0 107.886 172.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.512 ' HG3' ' OG1' ' A' ' 19' ' ' THR . 27.5 mp0 -98.71 100.09 11.27 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.538 -0.465 . . . . 10.0 110.1 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 t -96.98 -157.32 0.58 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -64.85 94.36 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.843 0.354 . . . . 10.0 110.804 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 61.23 29.22 18.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.675 -0.693 . . . . 10.0 111.622 176.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.99 102.65 3.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.979 -0.378 . . . . 10.0 109.979 -172.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.9 m -90.46 96.33 10.6 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 168.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.813 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.9 p-10 -85.93 109.04 18.47 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.11 -0.95 . . . . 10.0 111.817 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.89 107.15 19.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 122.016 0.912 . . . . 10.0 108.723 174.567 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.732 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -99.98 110.08 22.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.105 -1.407 . . . . 10.0 110.356 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.843 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 23.4 t30 -80.51 157.55 26.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.184 -0.462 . . . . 10.0 109.999 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.43 24.12 1.22 Allowed Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.855 -0.688 . . . . 10.0 112.687 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.604 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -75.04 -18.15 60.37 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.088 0.155 . . . . 10.0 111.287 -178.469 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.23 -4.68 0.9 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.359 1.037 . . . . 10.0 111.202 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.604 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 13.1 p-10 -127.22 154.26 45.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.033 0.444 . . . . 10.0 110.953 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 127.54 33.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.393 -0.821 . . . . 10.0 111.295 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.587 ' H ' HG22 ' A' ' 46' ' ' ILE . 31.1 m -134.17 137.71 51.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.277 0.56 . . . . 10.0 111.355 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.8 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 15.0 m -86.35 123.21 31.34 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.048 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.58 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -123.23 151.21 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.77 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.491 ' HB ' ' C ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -130.52 159.59 36.66 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.411 -0.813 . . . . 10.0 109.538 176.001 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.631 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.39 133.6 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 121.322 0.582 . . . . 10.0 111.467 -176.358 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -98.89 118.15 35.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.169 -0.923 . . . . 10.0 108.946 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -92.5 157.09 16.74 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.058 0.456 . . . . 10.0 110.228 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 100.0 m -46.43 -30.09 2.0 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.925 -1.034 . . . . 10.0 112.874 174.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -107.64 -83.72 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.82 -0.55 . . . . 10.0 110.546 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.93 55.21 0.01 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 119.89 -1.147 . . . . 10.0 113.508 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -70.38 154.87 41.42 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.063 0.458 . . . . 10.0 111.166 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -74.53 118.2 17.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.918 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.769 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -176.52 -43.97 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.153 -0.93 . . . . 10.0 111.675 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.769 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 3.3 Cg_endo -44.4 69.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 125.06 3.84 . . . . 10.0 116.661 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.0 t 172.04 110.51 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.304 1.041 . . . . 10.0 109.52 163.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.27 128.54 8.31 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.935 -0.765 . . . . 10.0 108.935 174.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.8 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -81.02 139.06 18.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.333 0.587 . . . . 10.0 109.75 177.173 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.587 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -99.14 147.79 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 115.309 -0.859 . . . . 10.0 109.978 -177.031 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -87.35 144.54 36.03 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 168.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -41.34 96.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.515 2.81 . . . . 10.0 112.966 173.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 93.53 10.11 59.51 Favored Glycine 0 C--O 1.229 -0.173 0 C-N-CA 119.93 -1.128 . . . . 10.0 112.164 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.06 -177.05 40.77 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.455 -0.402 . . . . 10.0 113.02 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.732 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 15.4 m0 -118.08 165.28 13.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.439 0.638 . . . . 10.0 111.394 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -142.14 109.37 5.57 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.454 -1.248 . . . . 10.0 107.699 172.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -79.8 130.37 35.26 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.611 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.631 ' CG ' HG21 ' A' ' 33' ' ' VAL . 52.6 m-85 -139.23 134.17 32.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 -177.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.34 103.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 O-C-N 124.032 0.832 . . . . 10.0 111.531 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.94 176.32 36.94 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 110.386 -1.086 . . . . 10.0 110.386 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 p90 . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 118.346 1.073 . . . . 10.0 110.306 -176.637 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.463 ' CE2' ' HB ' ' A' ' 65' ' ' THR . 41.4 t80 . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 109.544 -0.539 . . . . 10.0 109.544 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.545 HG21 HG21 ' A' ' 19' ' ' THR . 0.5 OUTLIER -60.55 127.86 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.771 -0.826 . . . . 10.0 108.771 175.122 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.463 ' HB ' ' CE2' ' A' ' 63' ' ' TYR . 9.0 t -141.01 8.8 2.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.96 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.25 128.36 2.07 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 119.629 -1.272 . . . . 10.0 112.622 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.853 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.2 mt -100.88 132.75 46.13 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 173.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.725 ' C ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -126.26 148.59 49.47 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.4 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -80.89 124.58 29.22 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.961 -0.696 . . . . 10.0 110.846 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.473 ' HB2' HG22 ' A' ' 32' ' ' THR . 0.1 OUTLIER -96.93 174.52 6.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.762 -177.058 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 C--N 1.324 -0.508 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 172.069 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.468 ' O ' HG22 ' A' ' 6' ' ' VAL . 87.2 Cg_endo . . . . . 0 N--CA 1.453 -0.855 0 N-CA-C 110.749 -0.52 . . . . 10.0 110.749 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 67' ' ' LEU . 1.7 m 51.35 -147.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.055 0.542 . . . . 10.0 110.402 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.727 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.3 4.08 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 175.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 74.57 -39.76 0.43 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.313 0.857 . . . . 10.0 113.313 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 32.6 m -79.07 -7.0 57.77 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.86 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 2.0 m -99.35 140.55 18.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -142.74 126.35 16.9 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.716 -0.393 . . . . 10.0 111.304 -175.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.745 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.25 164.71 12.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.99 0.9 . . . . 10.0 112.933 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 19' ' ' THR . 64.1 t80 -143.88 156.51 44.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.066 -1.424 . . . . 10.0 107.628 172.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.425 ' OE1' ' HE1' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -105.76 107.41 18.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.064 0.459 . . . . 10.0 110.858 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 33.6 m -103.82 77.6 1.47 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.608 -0.886 . . . . 10.0 108.608 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 65.26 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.514 -173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -127.67 27.56 5.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.414 0.626 . . . . 10.0 109.667 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.55 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 2.1 t80 -135.36 96.29 3.44 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 -172.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.4 m -85.41 96.3 9.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.562 0.696 . . . . 10.0 110.282 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.745 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.6 p-10 -85.21 108.82 17.92 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.404 -1.271 . . . . 10.0 112.353 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.694 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -98.39 109.22 23.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.588 -0.893 . . . . 10.0 108.588 174.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.786 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.7 p80 -97.85 114.2 26.2 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.138 -1.392 . . . . 10.0 110.343 176.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.86 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 2.5 t30 -83.09 155.92 23.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.124 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.88 32.86 1.29 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.128 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.574 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -82.63 -16.98 46.28 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 122.824 -0.221 . . . . 10.0 111.108 -178.569 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 83.85 -3.9 1.12 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.512 1.132 . . . . 10.0 111.025 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 8.7 p-10 -129.25 154.4 46.85 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.073 0.463 . . . . 10.0 110.828 174.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.63 125.54 26.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.041 -0.981 . . . . 10.0 111.183 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.605 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.5 m -133.82 140.38 46.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.511 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.771 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 7.7 m -88.12 120.93 29.95 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.065 -0.516 . . . . 10.0 109.686 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.41 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -120.31 149.07 23.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.549 0.69 . . . . 10.0 110.794 -179.209 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.833 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -128.74 161.29 30.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.208 -0.905 . . . . 10.0 108.997 176.463 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.599 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -131.82 135.19 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 121.296 0.569 . . . . 10.0 111.316 -175.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -98.81 115.3 28.48 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.096 -0.956 . . . . 10.0 108.958 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.554 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 74.5 m-85 -89.08 161.56 16.46 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.113 0.483 . . . . 10.0 110.97 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.3 m -52.36 -27.01 13.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.918 -1.037 . . . . 10.0 111.171 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -118.28 -74.85 0.59 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.11 60.97 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.295 -0.955 . . . . 10.0 113.072 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -64.82 148.03 52.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.534 0.207 . . . . 10.0 110.449 172.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -71.3 112.11 7.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.843 -0.429 . . . . 10.0 109.843 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.777 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -175.89 -44.51 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 115.824 -0.625 . . . . 10.0 112.548 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.777 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -41.4 76.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 124.88 3.72 . . . . 10.0 115.908 -176.132 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 41' ' ' ALA . 1.2 m 161.91 108.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.081 1.352 . . . . 10.0 110.702 168.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.407 ' NH1' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -154.07 128.26 9.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.841 -0.8 . . . . 10.0 108.841 179.248 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.79 137.18 21.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 118.576 0.625 . . . . 10.0 109.986 174.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -97.87 148.42 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 115.239 -0.891 . . . . 10.0 109.783 -177.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.07 145.46 38.25 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 107.905 -1.146 . . . . 10.0 107.905 168.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -43.61 95.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.163 2.575 . . . . 10.0 112.521 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.741 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.6 14.57 55.21 Favored Glycine 0 CA--C 1.511 -0.178 0 C-N-CA 119.756 -1.211 . . . . 10.0 111.926 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.66 -176.99 35.47 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.445 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.786 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.2 m0 -117.28 165.31 13.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.411 0.624 . . . . 10.0 111.134 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -141.93 114.27 8.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.572 -1.195 . . . . 10.0 107.89 173.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.5 m -81.49 128.44 33.89 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.99 -0.55 . . . . 10.0 111.088 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.599 ' CG ' HG21 ' A' ' 33' ' ' VAL . 54.0 m-85 -137.98 144.78 41.3 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.106 -1.072 . . . . 10.0 108.106 -178.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.79 104.7 0.38 Allowed 'General case' 0 C--N 1.32 -0.712 0 O-C-N 123.618 0.574 . . . . 10.0 110.587 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.37 177.18 12.35 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.074 -1.21 . . . . 10.0 110.074 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.56 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 15.9 p90 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 118.484 1.142 . . . . 10.0 110.853 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.56 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 29.3 t80 . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 109.069 -0.715 . . . . 10.0 109.069 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.588 HG21 HG21 ' A' ' 19' ' ' THR . 1.5 m -61.11 129.3 23.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.2 p -127.31 -18.57 4.46 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.563 -0.455 . . . . 10.0 112.18 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.97 122.78 1.8 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.783 -1.198 . . . . 10.0 113.136 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.766 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -86.64 131.81 34.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.233 0.539 . . . . 10.0 109.595 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.756 ' C ' HG12 ' A' ' 6' ' ' VAL . 9.0 m170 -123.59 147.45 47.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.293 -0.867 . . . . 10.0 108.934 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.4 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -80.64 128.39 33.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 119.341 0.973 . . . . 10.0 110.835 178.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.833 ' HB2' HG22 ' A' ' 32' ' ' THR . 41.2 t -95.48 157.71 15.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.287 -177.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 C--N 1.329 -0.287 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 173.411 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.73 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 30.5 Cg_endo . . . . . 0 N--CA 1.446 -1.283 0 N-CA-C 112.87 0.296 . . . . 10.0 112.87 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.678 HG23 HG23 ' A' ' 69' ' ' THR . 0.5 OUTLIER 47.58 126.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 125.661 1.584 . . . . 10.0 114.41 -177.165 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.715 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 29.04 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.389 1.056 . . . . 10.0 112.513 168.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 2.0 mp0 -58.57 1.21 0.06 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.619 0.97 . . . . 10.0 113.619 -168.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' ALA . 28.7 m -81.21 -22.02 39.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.528 175.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.831 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.6 m -90.73 137.06 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -139.28 124.39 18.9 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.963 -0.295 . . . . 10.0 110.538 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.783 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -93.63 166.79 12.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.57 0.7 . . . . 10.0 112.316 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.657 ' O ' ' HA ' ' A' ' 19' ' ' THR . 74.8 t80 -141.39 156.47 45.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.425 -1.324 . . . . 10.0 107.425 172.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -111.93 109.24 18.92 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.288 0.566 . . . . 10.0 110.684 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.0 t -117.15 -162.84 0.88 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -63.81 92.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 10.0 111.43 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 56.8 ttp180 62.45 31.42 17.14 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.536 0.684 . . . . 10.0 110.22 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.9 107.44 4.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.873 -174.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.5 m -97.75 95.32 7.47 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.303 0.573 . . . . 10.0 109.594 167.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.783 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.8 p-10 -84.78 108.9 17.7 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.905 -1.043 . . . . 10.0 111.94 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.59 106.39 18.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.002 0.906 . . . . 10.0 109.387 175.06 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.722 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 1.3 p-80 -97.14 111.94 23.95 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.145 -1.388 . . . . 10.0 110.581 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.831 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 18.0 t-20 -82.3 157.58 23.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.871 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.49 34.58 1.16 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 121.332 -0.461 . . . . 10.0 112.112 171.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.63 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -85.17 -17.82 36.03 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 122.566 -0.373 . . . . 10.0 111.615 -176.06 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 86.88 -12.72 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.367 1.042 . . . . 10.0 111.233 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -123.06 154.44 38.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.983 0.42 . . . . 10.0 110.19 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -67.89 123.75 21.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.504 -0.771 . . . . 10.0 111.335 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.636 ' H ' HG22 ' A' ' 46' ' ' ILE . 27.3 m -125.86 139.17 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 121.176 0.513 . . . . 10.0 111.881 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.767 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 6.4 m -88.78 118.25 28.34 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.67 HG12 HG21 ' A' ' 6' ' ' VAL . 1.1 m -114.76 165.35 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 115.218 -0.901 . . . . 10.0 110.362 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.567 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.2 OUTLIER -148.49 161.17 42.17 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.669 -0.863 . . . . 10.0 108.669 178.281 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.651 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -136.49 139.94 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 121.41 0.624 . . . . 10.0 111.482 -174.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -107.04 116.37 31.81 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.981 -1.009 . . . . 10.0 109.078 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 27.8 m-85 -91.27 162.34 14.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.449 0.642 . . . . 10.0 111.348 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -54.48 -21.35 9.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.692 -1.14 . . . . 10.0 112.116 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -119.72 -85.03 0.66 Allowed 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.001 -0.437 . . . . 10.0 110.561 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.37 52.67 0.01 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 119.567 -1.301 . . . . 10.0 114.147 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -65.65 141.6 58.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.33 0.565 . . . . 10.0 109.77 169.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -72.33 120.72 18.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.071 0.462 . . . . 10.0 110.328 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.862 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -174.32 -40.61 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.246 -0.888 . . . . 10.0 112.338 -173.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.862 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 3.1 Cg_endo -44.08 70.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 124.938 3.759 . . . . 10.0 116.33 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 4.5 t 172.5 112.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.059 0.944 . . . . 10.0 110.215 163.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.513 ' HB2' ' HZ ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -151.11 119.04 6.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.308 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.767 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -78.56 128.46 38.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 173.218 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -90.63 144.66 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 115.46 -0.791 . . . . 10.0 109.621 -175.25 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -85.17 141.64 37.52 Favored Pre-proline 0 C--N 1.293 -1.868 0 N-CA-C 107.726 -1.213 . . . . 10.0 107.726 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -43.21 95.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.301 2.667 . . . . 10.0 112.942 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.721 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.76 13.67 56.36 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.554 -1.307 . . . . 10.0 111.87 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 22' ' ' HIS . . . -97.02 -170.41 33.74 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.106 -0.568 . . . . 10.0 112.846 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.722 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 10.6 m0 -121.46 166.44 14.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.546 0.689 . . . . 10.0 111.425 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.408 ' HB3' HG13 ' A' ' 21' ' ' VAL . . . -142.68 109.7 5.55 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.56 -1.2 . . . . 10.0 108.103 171.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.2 m -78.88 129.76 34.89 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.712 -0.677 . . . . 10.0 110.606 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.651 ' CG ' HG21 ' A' ' 33' ' ' VAL . 51.3 m-85 -136.58 149.9 48.3 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.93 97.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.775 0.672 . . . . 10.0 111.16 -173.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.14 -178.53 10.73 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.107 -0.797 . . . . 10.0 111.107 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.491 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 9.0 p90 . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 122.556 1.169 . . . . 10.0 110.771 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.491 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 32.1 t80 . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 108.846 -0.798 . . . . 10.0 108.846 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.556 HG21 HG21 ' A' ' 19' ' ' THR . 1.4 m -59.9 130.14 23.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.949 -0.76 . . . . 10.0 108.949 177.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 p -122.11 -29.04 4.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.653 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -138.5 121.7 2.22 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.417 -1.373 . . . . 10.0 113.63 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.73 ' HB2' ' HB2' ' A' ' 5' ' ' PRO . 5.2 mt -84.35 146.87 27.48 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.974 -0.75 . . . . 10.0 108.974 172.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.525 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 4.2 m-70 -137.92 156.34 47.98 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.846 -0.615 . . . . 10.0 109.944 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.678 HG23 HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -82.61 127.93 33.84 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.984 -0.686 . . . . 10.0 109.59 174.596 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.567 ' HB2' HG22 ' A' ' 32' ' ' THR . 5.1 t -100.27 171.06 8.02 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.82 -0.352 . . . . 10.0 110.582 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 C--N 1.323 -0.585 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 176.149 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.645 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 97.9 Cg_endo . . . . . 0 N--CA 1.453 -0.877 0 CA-C-O 120.771 0.238 . . . . 10.0 112.147 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.6 m 47.92 -147.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.33 -0.85 . . . . 10.0 111.818 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.687 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -59.33 0.09 0.13 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.421 1.088 . . . . 10.0 113.933 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 70.49 -31.23 0.22 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.095 0.776 . . . . 10.0 113.095 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.9 m -76.44 -11.89 59.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 10.0 111.207 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.83 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -97.97 137.82 24.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.875 -0.787 . . . . 10.0 108.875 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -133.23 115.07 14.54 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.888 -0.325 . . . . 10.0 110.508 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.803 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.74 161.51 14.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.786 0.803 . . . . 10.0 113.078 177.649 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 19' ' ' THR . 69.0 t80 -141.2 145.69 35.97 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.118 -1.401 . . . . 10.0 107.272 170.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.474 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 27.1 mp0 -107.25 130.59 54.73 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.416 -0.514 . . . . 10.0 110.987 -176.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.3 t -118.81 -160.08 0.79 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.675 -1.231 . . . . 10.0 107.675 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -60.29 -48.33 82.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.847 0.356 . . . . 10.0 111.322 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -140.81 28.77 1.93 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.751 0.31 . . . . 10.0 110.949 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CE1' HG23 ' A' ' 53' ' ' THR . 0.4 OUTLIER -142.87 105.51 4.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.7 -0.227 . . . . 10.0 110.613 -173.316 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.539 HG21 HG21 ' A' ' 64' ' ' VAL . 15.6 m -95.12 98.51 10.7 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.401 -0.592 . . . . 10.0 109.401 166.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.803 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -86.35 109.27 18.88 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.382 -0.826 . . . . 10.0 112.224 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.83 107.4 20.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.862 0.839 . . . . 10.0 109.065 173.668 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.749 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 1.9 p80 -98.18 112.53 24.47 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.433 -1.258 . . . . 10.0 110.202 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.83 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 2.7 t30 -80.72 155.24 26.84 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.563 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -145.32 32.08 1.66 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.082 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.595 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -79.43 -19.95 48.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 122.831 -0.217 . . . . 10.0 111.316 -176.224 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.71 -11.73 0.68 Allowed 'General case' 0 N--CA 1.473 0.675 0 O-C-N 124.515 1.134 . . . . 10.0 111.221 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -126.43 155.4 42.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.989 0.423 . . . . 10.0 110.416 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -67.82 121.9 16.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.54 -0.755 . . . . 10.0 111.249 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.662 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.2 m -126.3 141.92 44.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 10.0 111.106 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.742 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 6.2 m -92.19 122.89 35.11 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.955 -177.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.668 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -124.01 148.02 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.8 -0.637 . . . . 10.0 111.072 -178.709 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.891 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -126.76 161.84 27.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 177.339 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.606 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.25 141.7 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.403 0.621 . . . . 10.0 111.787 -176.386 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -104.6 110.94 23.45 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.639 -1.164 . . . . 10.0 109.651 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 34.2 m-85 -93.82 159.13 15.33 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.369 0.604 . . . . 10.0 111.642 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.4 m -48.19 -34.45 10.1 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.673 -1.149 . . . . 10.0 112.786 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -112.35 -78.3 0.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.508 -0.477 . . . . 10.0 110.41 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.08 63.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.053 -1.07 . . . . 10.0 112.922 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 144.2 47.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -76.33 102.07 5.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.003 0.43 . . . . 10.0 110.789 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 1.075 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -173.95 10.56 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 114.196 1.184 . . . . 10.0 114.196 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.075 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 5.3 Cg_endo -84.96 64.89 6.35 Favored 'Trans proline' 0 C--N 1.358 1.07 0 CA-C-N 122.088 1.781 . . . . 10.0 112.466 -172.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 172.41 109.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.835 0.854 . . . . 10.0 110.63 168.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.78 122.86 6.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.585 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.742 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -77.8 135.34 26.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.544 -0.462 . . . . 10.0 109.796 175.32 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.1 tp -97.94 147.05 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 115.167 -0.924 . . . . 10.0 109.064 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -85.0 143.49 40.04 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 108.248 -1.019 . . . . 10.0 108.248 168.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -44.07 94.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.41 2.74 . . . . 10.0 112.845 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.758 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 94.77 12.78 55.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 119.813 -1.184 . . . . 10.0 112.289 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.44 -173.95 33.98 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.949 -0.643 . . . . 10.0 112.326 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.749 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 15.7 m0 -117.3 166.07 12.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.535 0.683 . . . . 10.0 111.165 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.427 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -140.82 112.03 7.26 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.317 -1.364 . . . . 10.0 107.317 171.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.462 HG23 ' CE1' ' A' ' 18' ' ' TYR . 26.7 m -80.32 126.26 30.93 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.304 -0.862 . . . . 10.0 110.337 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.606 ' CG ' HG21 ' A' ' 33' ' ' VAL . 46.7 m-85 -136.26 140.8 43.72 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.06 104.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.182 0.926 . . . . 10.0 110.698 -173.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.8 -178.21 16.81 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.387 -0.911 . . . . 10.0 110.988 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.531 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 12.2 p90 . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 121.891 0.853 . . . . 10.0 110.698 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 37.9 t80 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.539 HG21 HG21 ' A' ' 19' ' ' THR . 1.7 m -65.13 129.8 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.575 -0.898 . . . . 10.0 108.575 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.2 p -117.93 -29.17 5.72 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.721 -0.392 . . . . 10.0 111.34 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.55 136.08 7.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 119.992 -1.099 . . . . 10.0 113.146 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.895 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.0 mt -95.35 129.87 42.34 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.576 -0.528 . . . . 10.0 109.576 173.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.752 ' C ' HG12 ' A' ' 6' ' ' VAL . 10.5 m170 -117.25 143.27 46.07 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.45 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -81.36 125.46 30.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.805 1.184 . . . . 10.0 111.214 -179.162 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.891 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.0 t -96.55 178.07 5.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.256 -0.884 . . . . 10.0 109.346 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.407 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.8 p-10 . . . . . 0 C--N 1.316 -0.848 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.519 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 92.0 Cg_endo . . . . . 0 N--CA 1.461 -0.432 0 CA-C-O 120.825 0.26 . . . . 10.0 112.555 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.842 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.2 m 51.53 -151.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.169 -0.923 . . . . 10.0 112.273 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.691 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -59.67 5.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.652 1.353 . . . . 10.0 114.652 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 42.5 mt-10 75.11 -39.91 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.015 0.746 . . . . 10.0 113.015 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.9 m -74.02 -12.98 60.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.868 0.322 . . . . 10.0 111.868 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.839 HG12 HD22 ' A' ' 23' ' ' ASN . 1.6 m -99.88 141.07 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.829 -0.434 . . . . 10.0 109.829 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -142.44 128.27 19.38 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 121.05 -0.26 . . . . 10.0 110.822 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.776 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -93.1 165.17 12.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.767 0.794 . . . . 10.0 113.118 176.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' THR . 77.7 t80 -144.01 149.85 37.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.281 -1.377 . . . . 10.0 107.281 171.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.4 121.65 45.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.218 0.532 . . . . 10.0 110.832 -176.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.3 t -138.28 75.54 1.53 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.845 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.7 t90 51.2 90.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.074 -0.966 . . . . 10.0 112.535 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 56' ' ' GLY . 22.8 ttt180 68.37 1.62 2.98 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.638 -0.71 . . . . 10.0 112.313 174.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -123.18 97.17 5.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.192 -0.669 . . . . 10.0 109.192 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.466 HG21 HG11 ' A' ' 64' ' ' VAL . 23.3 m -90.46 100.08 12.98 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 172.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.776 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.0 p-10 -86.09 107.91 18.04 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.914 -0.584 . . . . 10.0 111.974 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -97.78 107.41 20.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.036 0.922 . . . . 10.0 108.564 173.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.819 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.9 p-80 -96.86 114.44 26.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.021 -1.445 . . . . 10.0 110.219 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.839 HD22 HG12 ' A' ' 10' ' ' VAL . 14.1 t-20 -83.14 150.33 26.32 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.551 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.5 23.97 3.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.898 -0.668 . . . . 10.0 112.315 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.635 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -86.76 159.83 19.0 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 175.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.46 -11.55 59.96 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.045 0.387 . . . . 10.0 112.045 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -129.88 159.89 35.23 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.246 0.546 . . . . 10.0 111.462 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.41 130.42 42.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.813 -1.085 . . . . 10.0 111.24 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.523 ' H ' HG22 ' A' ' 46' ' ' ILE . 32.6 m -129.05 141.36 46.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.987 -0.551 . . . . 10.0 111.057 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.813 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 7.3 m -90.38 122.9 33.66 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.183 0.516 . . . . 10.0 109.861 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.87 150.95 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.286 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -131.86 162.67 30.03 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.508 -0.769 . . . . 10.0 108.934 175.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.596 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -134.1 144.86 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-O 121.026 0.441 . . . . 10.0 110.441 -176.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -114.93 118.87 34.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.319 -0.855 . . . . 10.0 108.964 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.547 ' OH ' ' HB3' ' A' ' 41' ' ' ALA . 22.6 m-85 -94.48 159.44 15.1 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.574 0.702 . . . . 10.0 111.953 -175.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.518 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 52.0 m -50.07 -31.04 12.14 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.132 -1.395 . . . . 10.0 113.452 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -114.47 -67.29 1.01 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.738 -0.601 . . . . 10.0 110.426 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.95 62.41 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.951 -1.119 . . . . 10.0 113.125 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.573 ' HA ' ' OE1' ' A' ' 39' ' ' GLN . 7.7 mm-40 -72.47 151.52 42.48 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.922 -0.311 . . . . 10.0 110.319 172.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -80.71 100.18 8.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.333 -0.394 . . . . 10.0 111.513 -177.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.833 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.42 21.82 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 113.733 1.012 . . . . 10.0 113.733 172.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.833 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 8.8 Cg_endo -88.34 63.01 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 CA-C-N 121.165 1.452 . . . . 10.0 112.863 -171.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.2 m 169.89 114.93 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.692 0.797 . . . . 10.0 111.646 169.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.56 132.44 7.73 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 175.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.813 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.2 p -83.81 140.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.345 0.593 . . . . 10.0 110.672 178.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.528 HG21 ' CB ' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -99.29 146.77 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-N 115.194 -0.912 . . . . 10.0 109.691 -177.212 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -88.49 139.11 29.86 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 169.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -43.13 95.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.343 2.695 . . . . 10.0 112.38 177.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.02 13.54 42.55 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.101 -1.047 . . . . 10.0 112.663 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.47 -171.65 30.67 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.886 -0.673 . . . . 10.0 113.046 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.819 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.6 m0 -121.79 165.49 15.78 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.505 0.669 . . . . 10.0 111.014 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -142.95 111.97 6.54 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.446 -1.316 . . . . 10.0 107.446 174.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 m -79.63 131.14 35.9 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.479 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.596 ' CG ' HG21 ' A' ' 33' ' ' VAL . 51.1 m-85 -140.63 145.19 36.31 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.096 -0.705 . . . . 10.0 109.096 -178.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.47 107.61 0.3 Allowed 'General case' 0 C--N 1.322 -0.589 0 O-C-N 124.024 0.827 . . . . 10.0 110.585 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 17' ' ' ARG . . . -71.31 -177.03 25.5 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.836 -0.905 . . . . 10.0 110.836 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.876 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 20.1 p90 . . . . . 0 C--N 1.321 -0.651 0 CA-C-N 118.465 1.132 . . . . 10.0 109.98 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.876 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 11.1 t80 . . . . . 0 CA--C 1.509 -0.605 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 19' ' ' THR . 1.0 OUTLIER -62.33 126.2 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.312 -0.995 . . . . 10.0 108.312 171.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.4 p -118.19 -29.55 5.53 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.448 -0.501 . . . . 10.0 111.051 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -136.99 125.98 3.56 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 119.87 -1.157 . . . . 10.0 112.932 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.842 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -86.17 131.54 34.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.307 -0.627 . . . . 10.0 109.307 171.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.72 ' C ' HG12 ' A' ' 6' ' ' VAL . 12.4 m170 -119.47 147.83 43.96 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.61 -0.885 . . . . 10.0 108.61 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.457 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -82.71 126.12 32.01 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.266 -0.974 . . . . 10.0 110.318 178.165 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.623 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.2 t -96.22 161.05 14.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.85 -177.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 . . . . . 0 C--N 1.326 -0.431 0 N-CA-C 109.142 -0.688 . . . . 10.0 109.142 169.637 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 26.4 Cg_endo . . . . . 0 C--O 1.234 0.293 0 N-CA-C 112.805 0.271 . . . . 10.0 112.805 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.911 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.5 m 50.68 -142.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.018 0.927 . . . . 10.0 111.884 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.729 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -55.73 -5.51 0.16 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.307 1.043 . . . . 10.0 113.148 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 75.7 -25.93 0.2 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.87 0.868 . . . . 10.0 112.806 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.31 14.66 15.75 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 111.748 0.277 . . . . 10.0 111.748 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.852 HG12 HD22 ' A' ' 23' ' ' ASN . 1.7 m -116.72 142.06 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -135.57 118.0 15.78 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.849 -0.34 . . . . 10.0 111.529 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.74 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.36 161.75 14.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.832 0.825 . . . . 10.0 112.515 174.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -146.3 168.05 22.03 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 106.63 -1.619 . . . . 10.0 106.63 170.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.495 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -114.58 107.61 15.73 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.09 -0.644 . . . . 10.0 111.645 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 1.7 p -99.28 50.91 0.94 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.82 -0.808 . . . . 10.0 108.82 175.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 38.7 t-105 74.35 -90.44 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.262 -1.336 . . . . 10.0 111.348 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -100.02 30.99 3.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 10.0 110.93 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.486 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -154.4 107.34 2.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.403 -0.817 . . . . 10.0 109.006 -172.779 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.495 HG21 HG11 ' A' ' 64' ' ' VAL . 5.4 m -91.85 97.71 11.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.51 0.671 . . . . 10.0 109.539 170.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.74 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.8 p-10 -83.41 108.17 16.4 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.473 -1.239 . . . . 10.0 111.77 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.23 106.97 20.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 122.26 1.029 . . . . 10.0 108.927 172.518 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.805 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -97.32 111.02 23.45 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.109 -1.405 . . . . 10.0 109.982 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.852 HD22 HG12 ' A' ' 10' ' ' VAL . 13.1 t-20 -80.05 154.19 28.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.16 -0.473 . . . . 10.0 109.746 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.49 21.24 3.26 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.581 -0.608 . . . . 10.0 111.581 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.828 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -83.08 160.03 22.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.36 -0.608 . . . . 10.0 109.36 174.408 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.02 -10.71 59.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.479 -0.328 . . . . 10.0 111.465 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -128.77 159.31 36.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.406 0.622 . . . . 10.0 111.675 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.7 125.65 27.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.85 -1.068 . . . . 10.0 111.253 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.517 ' H ' HG22 ' A' ' 46' ' ' ILE . 34.1 m -125.44 143.67 38.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.961 0.41 . . . . 10.0 111.231 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.8 m -90.68 121.36 32.52 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.386 -0.598 . . . . 10.0 109.386 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.625 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -121.54 143.53 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.516 0.675 . . . . 10.0 110.994 -178.29 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -122.21 160.62 24.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.237 -0.892 . . . . 10.0 109.433 176.338 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.619 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.2 141.04 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.118 0.485 . . . . 10.0 111.61 -177.087 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -108.34 114.51 28.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.35 -0.841 . . . . 10.0 109.614 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.431 ' HE2' ' HD3' ' A' ' 42' ' ' PRO . 56.6 m-85 -90.36 156.56 18.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.277 0.561 . . . . 10.0 112.048 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.4 m -43.21 -46.09 5.94 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.134 -1.394 . . . . 10.0 113.365 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -106.99 -77.21 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.299 -0.56 . . . . 10.0 110.573 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.28 124.83 0.77 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 119.705 -1.236 . . . . 10.0 113.245 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -163.27 151.94 14.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.88 -1.156 . . . . 10.0 107.88 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -75.88 146.08 40.05 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.384 -0.526 . . . . 10.0 111.52 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.732 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 159.41 -44.31 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 114.32 -1.309 . . . . 10.0 110.138 -170.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.732 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 1.4 Cg_endo -45.34 65.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 125.283 3.989 . . . . 10.0 116.519 177.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' ALA . 1.1 m 170.72 100.73 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.431 1.093 . . . . 10.0 110.071 164.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.56 130.73 15.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.74 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -82.23 136.77 22.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.131 0.491 . . . . 10.0 110.53 178.351 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -96.84 145.89 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 115.24 -0.891 . . . . 10.0 109.652 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -85.24 139.44 36.43 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.063 -1.088 . . . . 10.0 108.063 167.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -43.59 98.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.182 2.588 . . . . 10.0 112.309 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.83 2.5 57.24 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.984 -1.103 . . . . 10.0 112.504 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.54 -170.86 37.58 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.975 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.805 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 15.7 m0 -120.26 166.39 13.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.422 0.63 . . . . 10.0 111.22 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -142.57 115.75 8.91 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 171.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 m -82.52 128.93 34.76 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.521 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.5 m-85 -135.89 144.41 45.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.705 -0.85 . . . . 10.0 108.705 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.09 101.95 0.07 Allowed 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.826 0.704 . . . . 10.0 110.704 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.01 -166.99 4.78 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.915 -1.038 . . . . 10.0 111.613 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.678 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.8 p90 . . . . . 0 C--N 1.313 -0.987 0 CA-C-O 121.993 0.901 . . . . 10.0 110.782 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.678 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 20.8 t80 . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 108.674 -0.861 . . . . 10.0 108.674 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 19' ' ' THR . 1.1 m -64.14 131.19 29.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.12 -0.696 . . . . 10.0 109.12 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.9 p -123.33 -24.41 4.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.403 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.94 125.31 2.45 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.162 -1.018 . . . . 10.0 112.549 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.911 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.0 mt -86.27 137.84 32.3 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 172.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.744 ' C ' HG12 ' A' ' 6' ' ' VAL . 8.4 m-70 -127.61 145.93 50.71 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.505 -0.77 . . . . 10.0 108.924 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.26 127.52 32.16 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.219 -0.992 . . . . 10.0 110.26 178.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.777 ' HB2' HG22 ' A' ' 32' ' ' THR . 40.5 t -93.97 155.68 17.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.914 -0.584 . . . . 10.0 109.867 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 C--N 1.327 -0.392 0 N-CA-C 109.041 -0.725 . . . . 10.0 109.041 173.342 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 6' ' ' VAL . 41.3 Cg_endo . . . . . 0 C--O 1.234 0.313 0 CA-C-O 120.669 0.196 . . . . 10.0 111.717 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.726 HG23 ' N ' ' A' ' 7' ' ' ALA . 1.2 m 56.44 -150.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 115.429 -0.805 . . . . 10.0 111.113 177.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.726 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.29 -1.7 0.09 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.4 1.08 . . . . 10.0 113.891 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 74.08 -29.18 0.19 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.184 0.994 . . . . 10.0 112.946 178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.0 m -80.48 -12.27 59.57 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.027 0.38 . . . . 10.0 112.027 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.811 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.9 m -96.42 140.18 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 -175.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -138.79 120.17 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.953 -0.299 . . . . 10.0 110.345 -175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.722 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.2 171.19 8.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.733 0.778 . . . . 10.0 112.626 178.813 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 19' ' ' THR . 34.3 t80 -149.15 179.99 7.47 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.235 -1.394 . . . . 10.0 107.235 172.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -127.34 116.44 20.52 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.501 0.667 . . . . 10.0 111.156 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 t -121.48 84.19 2.2 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 173.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 59.27 -105.28 0.23 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.333 -0.849 . . . . 10.0 111.047 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 65.8 ttt180 -103.18 24.85 10.25 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.595 0.712 . . . . 10.0 110.13 -177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.98 95.56 4.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.78 -0.646 . . . . 10.0 109.405 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.563 HG21 HG21 ' A' ' 64' ' ' VAL . 2.6 m -86.54 98.82 11.28 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 170.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.722 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -86.65 103.99 15.64 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.195 -0.911 . . . . 10.0 112.123 -176.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -96.24 107.16 19.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.74 -0.837 . . . . 10.0 108.74 174.317 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.797 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 3.6 p-80 -97.39 113.46 25.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.621 -1.172 . . . . 10.0 110.439 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.811 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 t30 -79.41 150.18 31.41 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.679 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.97 16.02 5.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.775 -0.726 . . . . 10.0 112.39 175.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.43 154.96 23.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 174.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.43 -8.9 57.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.346 0.499 . . . . 10.0 112.346 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -127.25 160.63 30.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.51 0.671 . . . . 10.0 112.145 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -71.06 124.12 23.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.68 -1.145 . . . . 10.0 111.583 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.59 ' H ' HG22 ' A' ' 46' ' ' ILE . 30.7 m -125.61 141.06 46.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.322 0.582 . . . . 10.0 111.523 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.672 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 10.6 m -89.78 122.53 32.95 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 m -120.44 153.09 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.444 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.768 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -130.73 157.99 41.31 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.38 -0.827 . . . . 10.0 109.482 176.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.643 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.48 139.78 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 121.14 0.495 . . . . 10.0 110.523 -178.032 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.09 117.48 34.11 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.128 -0.942 . . . . 10.0 109.323 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -90.57 155.75 18.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.083 0.468 . . . . 10.0 111.504 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 51.8 m -44.61 -41.93 6.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.824 -1.08 . . . . 10.0 112.731 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -102.86 -87.54 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.648 -0.421 . . . . 10.0 110.556 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.26 130.89 1.23 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.823 -0.703 . . . . 10.0 111.93 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -172.68 151.74 2.4 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.9 p90 -76.27 144.34 40.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.127 0.489 . . . . 10.0 110.407 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.762 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 158.51 -37.4 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 124.997 1.319 . . . . 10.0 110.855 -169.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.762 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 9.9 Cg_endo -53.39 61.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 124.079 3.186 . . . . 10.0 115.504 176.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 5.1 t 177.69 105.07 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.501 0.72 . . . . 10.0 109.367 163.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -145.15 122.95 11.9 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.315 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.672 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.26 128.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 174.503 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -92.67 146.11 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 CA-C-N 114.638 -1.164 . . . . 10.0 109.141 -176.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.34 142.55 43.7 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 107.957 -1.127 . . . . 10.0 107.957 168.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.406 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 13.0 Cg_exo -47.59 96.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.89 2.393 . . . . 10.0 112.034 174.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 101.05 5.19 53.56 Favored Glycine 0 C--O 1.229 -0.166 0 C-N-CA 120.064 -1.065 . . . . 10.0 112.232 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.44 -176.39 37.29 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 121.069 -0.586 . . . . 10.0 112.979 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.797 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 20.5 m0 -117.04 164.7 14.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.647 0.737 . . . . 10.0 110.966 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.457 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -138.4 113.76 9.54 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 171.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.7 m -82.25 128.66 34.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.07 -0.514 . . . . 10.0 109.994 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.643 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.4 m-85 -137.02 139.22 41.24 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.042 -1.096 . . . . 10.0 108.042 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.29 101.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.375 1.047 . . . . 10.0 111.015 -176.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.17 -178.8 11.21 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.605 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 2.5 p90 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 118.165 0.983 . . . . 10.0 110.799 -172.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 21.7 t80 . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.563 HG21 HG21 ' A' ' 19' ' ' THR . 1.8 m -63.55 130.11 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 174.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 73.4 p -122.3 -30.73 3.94 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.317 -0.553 . . . . 10.0 111.328 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.73 124.16 3.37 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 119.603 -1.284 . . . . 10.0 113.279 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.606 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -88.26 141.55 28.46 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.93 -0.767 . . . . 10.0 108.93 172.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.711 ' C ' HG12 ' A' ' 6' ' ' VAL . 3.9 m-70 -132.09 149.61 52.36 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.339 -0.846 . . . . 10.0 108.772 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -81.98 128.59 34.24 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.219 -0.992 . . . . 10.0 110.025 176.557 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.768 ' HB2' HG22 ' A' ' 32' ' ' THR . 5.5 t -98.06 168.94 9.96 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--N 1.319 -0.757 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 176.05 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.429 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 39.7 Cg_endo . . . . . 0 C--O 1.236 0.387 0 CA-C-O 120.819 0.258 . . . . 10.0 111.924 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.824 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.8 m 48.31 -146.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.181 -0.918 . . . . 10.0 111.745 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.697 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.35 -0.57 0.1 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.39 1.076 . . . . 10.0 113.889 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 70.36 -24.5 0.16 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.683 0.793 . . . . 10.0 113.043 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.0 m -78.27 -15.01 59.18 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.41 0.148 . . . . 10.0 111.346 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.9 HG12 HD22 ' A' ' 23' ' ' ASN . 2.0 m -100.45 143.55 13.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.092 -0.336 . . . . 10.0 110.092 -174.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -141.23 125.38 17.36 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.513 -0.18 . . . . 10.0 110.513 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -96.05 162.43 13.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.814 0.816 . . . . 10.0 112.885 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -143.84 138.1 28.42 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.379 -1.282 . . . . 10.0 107.703 172.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -103.48 127.25 50.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.997 0.427 . . . . 10.0 111.02 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.1 m -131.23 -155.98 0.73 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.294 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -63.36 93.82 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.936 0.398 . . . . 10.0 110.852 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 61.33 30.01 18.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.512 -0.767 . . . . 10.0 111.487 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.89 106.44 3.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.805 -0.443 . . . . 10.0 109.805 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.52 HG21 HG21 ' A' ' 64' ' ' VAL . 16.2 m -94.73 102.08 13.94 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.98 -0.378 . . . . 10.0 109.98 168.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.739 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.3 p-10 -88.05 111.7 21.83 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.903 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.73 107.58 21.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.936 0.874 . . . . 10.0 108.897 172.818 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.763 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 2.7 p80 -97.23 114.71 26.48 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.399 -1.273 . . . . 10.0 110.025 176.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.9 HD22 HG12 ' A' ' 10' ' ' VAL . 12.3 t-20 -80.79 153.96 27.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.721 177.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.56 25.38 3.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.552 -0.832 . . . . 10.0 112.586 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.596 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -88.42 164.56 15.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 176.519 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.58 -15.99 56.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.032 0.382 . . . . 10.0 112.032 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -128.15 156.42 42.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.259 0.552 . . . . 10.0 111.774 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.29 126.52 28.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.894 -1.048 . . . . 10.0 111.648 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.607 ' H ' HG22 ' A' ' 46' ' ' ILE . 34.3 m -124.62 146.0 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-O 121.125 0.488 . . . . 10.0 111.059 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.672 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.3 m -95.21 122.87 38.35 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.635 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.573 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -123.07 151.33 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 115.769 -0.65 . . . . 10.0 110.658 -177.218 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.854 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -130.21 163.08 27.48 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.227 -0.897 . . . . 10.0 109.116 175.371 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.662 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.4 131.07 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 120.865 0.364 . . . . 10.0 110.089 -176.36 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -103.12 115.29 30.31 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.505 -0.77 . . . . 10.0 109.103 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 41.4 m-85 -86.26 162.35 18.32 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.729 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.1 m -50.17 -23.42 2.18 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.737 -1.12 . . . . 10.0 112.446 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -131.06 -74.01 0.53 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.919 -0.488 . . . . 10.0 110.402 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.87 133.74 2.29 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.32 -1.112 . . . . 10.0 110.32 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.09 24.76 0.37 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.003 0.43 . . . . 10.0 110.412 -174.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 36.0 t90 58.87 103.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.212 -0.904 . . . . 10.0 112.149 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.703 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -173.83 -45.07 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.355 -0.839 . . . . 10.0 111.587 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.703 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 2.6 Cg_endo -38.27 100.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 123.951 3.101 . . . . 10.0 114.308 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.0 m 129.51 100.38 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.241 1.816 . . . . 10.0 111.244 168.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.37 130.96 11.47 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.9 -1.045 . . . . 10.0 108.293 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.672 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -84.56 138.42 19.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.485 0.66 . . . . 10.0 110.731 178.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -99.09 148.77 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.457 -1.247 . . . . 10.0 109.692 -177.186 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -87.66 142.62 32.86 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.803 -1.184 . . . . 10.0 107.803 168.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -45.46 93.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.042 2.494 . . . . 10.0 112.843 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.02 15.11 37.24 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.047 -1.073 . . . . 10.0 112.523 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.78 -174.64 28.11 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.084 -0.579 . . . . 10.0 112.733 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.763 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 16.5 m0 -117.61 167.13 11.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.637 0.732 . . . . 10.0 111.653 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -144.64 113.72 6.91 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.56 -1.2 . . . . 10.0 107.982 171.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 m -82.63 131.88 35.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.989 -175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.662 ' CG ' HG21 ' A' ' 33' ' ' VAL . 46.6 m-85 -140.0 144.51 36.99 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.35 -0.981 . . . . 10.0 108.35 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.22 101.98 0.06 Allowed 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 124.131 0.894 . . . . 10.0 111.151 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.14 175.54 42.23 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.247 -0.977 . . . . 10.0 110.86 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.456 ' HD1' ' H ' ' A' ' 57' ' ' TYR . 2.6 p90 . . . . . 0 CA--C 1.532 0.26 0 CA-C-N 118.38 1.09 . . . . 10.0 110.041 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 44.5 t80 . . . . . 0 N--CA 1.442 -0.838 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.52 HG21 HG21 ' A' ' 19' ' ' THR . 0.9 OUTLIER -60.19 125.75 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 174.346 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.0 t -138.41 6.56 2.54 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.466 -0.494 . . . . 10.0 110.936 -175.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -156.23 107.17 0.31 Allowed Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 119.246 -1.454 . . . . 10.0 113.395 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.824 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.9 mt -82.28 128.35 34.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.696 -0.853 . . . . 10.0 108.696 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.742 ' C ' HG12 ' A' ' 6' ' ' VAL . 8.5 m-70 -122.36 143.32 49.72 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.254 -0.884 . . . . 10.0 108.685 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -77.76 129.74 35.86 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.055 -1.028 . . . . 10.0 110.445 179.351 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.854 ' HB2' HG22 ' A' ' 32' ' ' THR . 44.6 t -99.91 157.76 16.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.394 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--N 1.325 -0.473 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 171.133 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--O 1.235 0.34 0 CA-C-O 120.801 0.25 . . . . 10.0 111.757 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.727 HG23 ' N ' ' A' ' 7' ' ' ALA . 1.4 m 51.35 -151.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.304 -0.862 . . . . 10.0 111.732 174.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.727 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -60.4 9.4 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.342 1.238 . . . . 10.0 114.342 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 47.8 mt-10 75.79 -49.72 0.61 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.454 0.909 . . . . 10.0 113.454 176.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 60.9 m -73.57 -9.67 58.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.68 0.276 . . . . 10.0 111.442 -170.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.834 HG12 HD22 ' A' ' 23' ' ' ASN . 1.5 m -98.73 132.82 43.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.917 -0.772 . . . . 10.0 108.917 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -139.57 126.82 21.29 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.85 -0.34 . . . . 10.0 110.207 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -90.65 163.24 14.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.767 0.794 . . . . 10.0 111.937 177.313 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.431 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 55.8 t80 -142.27 155.91 45.25 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.073 -1.455 . . . . 10.0 107.073 171.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.444 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -103.31 94.38 5.47 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.481 0.657 . . . . 10.0 111.208 -177.696 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.673 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 38.3 m -86.37 60.75 6.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.148 -0.933 . . . . 10.0 108.54 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.8 t90 66.35 -92.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.985 -1.007 . . . . 10.0 110.87 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -110.92 40.85 1.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.668 0.747 . . . . 10.0 109.534 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.673 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 1.7 t80 -151.08 99.57 2.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.013 -0.994 . . . . 10.0 108.496 -175.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 12' ' ' TYR . 2.5 m -87.12 98.26 11.2 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.345 0.593 . . . . 10.0 109.783 173.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.73 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.1 p-10 -87.54 104.94 16.96 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.723 -1.126 . . . . 10.0 111.445 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -96.12 105.22 16.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.497 -0.927 . . . . 10.0 108.497 174.541 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.8 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 3.3 p80 -95.51 112.95 24.57 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.362 -1.29 . . . . 10.0 110.063 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.834 HD22 HG12 ' A' ' 10' ' ' VAL . 14.1 t-20 -81.65 150.1 28.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.737 175.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.14 25.39 3.33 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.078 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.713 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.5 OUTLIER -89.01 162.59 15.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 176.168 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.59 -12.96 59.82 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.275 0.472 . . . . 10.0 112.275 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -120.68 152.32 38.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.443 0.64 . . . . 10.0 112.449 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.7 118.54 11.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.894 -1.048 . . . . 10.0 110.735 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.548 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.4 m -121.74 137.81 54.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.332 0.586 . . . . 10.0 112.049 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.709 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.4 m -87.46 122.76 31.61 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.786 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.09 151.69 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 115.256 -0.883 . . . . 10.0 110.711 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.775 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -130.1 160.0 35.07 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.964 -0.754 . . . . 10.0 108.964 176.198 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.637 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.36 132.78 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.42 0.629 . . . . 10.0 110.81 -177.655 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -102.53 114.16 28.13 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.806 -1.088 . . . . 10.0 108.97 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 53.3 m-85 -89.84 164.73 14.5 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.575 0.702 . . . . 10.0 112.265 -175.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -52.81 -32.91 46.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.191 -1.368 . . . . 10.0 111.597 169.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -106.98 -86.22 0.5 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.813 0.34 . . . . 10.0 110.698 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.81 53.22 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.747 -0.74 . . . . 10.0 111.717 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.11 138.39 55.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -73.11 107.48 5.47 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.989 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -167.13 -42.15 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 118.281 -0.866 . . . . 10.0 112.879 -173.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.989 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 1.6 Cg_endo -41.77 70.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 125.151 3.9 . . . . 10.0 116.877 -173.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 5.7 t 173.77 110.2 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.807 0.843 . . . . 10.0 109.735 164.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.472 ' NE ' ' HA ' ' A' ' 44' ' ' ARG . 0.6 OUTLIER -149.52 121.09 7.99 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.935 177.329 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -77.98 127.18 38.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.998 -0.741 . . . . 10.0 108.998 173.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -91.41 146.78 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 114.589 -1.187 . . . . 10.0 109.478 -175.593 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.03 133.05 41.91 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 107.443 -1.317 . . . . 10.0 107.443 168.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -43.11 96.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.189 2.593 . . . . 10.0 112.369 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 103.19 7.6 43.13 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.343 -0.932 . . . . 10.0 113.084 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.16 -171.79 28.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.098 -0.572 . . . . 10.0 113.589 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.8 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 20.3 m0 -118.43 167.31 11.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.333 0.587 . . . . 10.0 110.896 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.58 114.84 8.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.327 -1.36 . . . . 10.0 107.327 171.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.0 m -83.45 130.21 35.02 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.757 -173.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.637 ' CG ' HG21 ' A' ' 33' ' ' VAL . 56.9 m-85 -138.72 146.63 41.73 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.8 102.59 0.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.601 0.563 . . . . 10.0 110.493 -174.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.97 -169.54 15.15 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.54 -0.838 . . . . 10.0 111.077 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.666 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 6.3 p90 . . . . . 0 C--N 1.319 -0.742 0 CA-C-O 122.014 0.912 . . . . 10.0 110.86 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.666 ' HD1' ' HB3' ' A' ' 57' ' ' TYR . 89.6 t80 . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 120.885 0.374 . . . . 10.0 111.559 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.693 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.3 m -60.65 136.89 23.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 172.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.5 t -144.77 12.82 1.48 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.196 -0.602 . . . . 10.0 111.89 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.04 110.62 0.45 Allowed Glycine 0 C--O 1.224 -0.504 0 C-N-CA 119.438 -1.363 . . . . 10.0 113.482 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.611 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.5 mt -84.65 133.78 34.39 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.388 0.613 . . . . 10.0 109.701 173.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.704 ' C ' HG12 ' A' ' 6' ' ' VAL . 27.2 m-70 -127.06 149.58 49.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.033 -0.985 . . . . 10.0 108.706 -176.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.436 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -83.67 129.41 34.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 119.485 1.039 . . . . 10.0 110.381 177.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.775 ' HB2' HG22 ' A' ' 32' ' ' THR . 5.2 t -98.89 172.9 7.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.349 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 108.917 -0.771 . . . . 10.0 108.917 173.584 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 CA--C 1.529 0.261 0 N-CA-C 113.349 0.481 . . . . 10.0 113.349 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.628 HG23 HG23 ' A' ' 69' ' ' THR . 0.2 OUTLIER -157.07 118.72 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.584 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.61 -19.54 0.16 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.505 0.722 . . . . 10.0 112.58 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 6' ' ' VAL . 32.6 mt-10 74.49 -28.32 0.19 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.283 1.033 . . . . 10.0 112.041 175.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.0 m -87.18 -10.26 53.11 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.919 0.34 . . . . 10.0 111.919 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -95.56 134.85 31.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.871 -0.788 . . . . 10.0 108.871 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -135.82 121.58 19.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.787 -0.188 . . . . 10.0 110.594 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.813 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -98.18 161.33 13.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.146 0.795 . . . . 10.0 113.146 178.601 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 19' ' ' THR . 82.9 t80 -148.05 155.62 41.69 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 171.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.15 124.95 52.47 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.318 -0.553 . . . . 10.0 110.606 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.2 t -136.75 77.2 1.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.25 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 55.95 86.79 0.06 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.215 -0.902 . . . . 10.0 112.092 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 67.49 14.14 9.52 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.965 -0.561 . . . . 10.0 112.271 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -139.03 96.52 3.13 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.521 -0.548 . . . . 10.0 109.521 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.5 m -87.46 100.4 12.73 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.656 -0.498 . . . . 10.0 109.656 171.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.813 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.4 p-10 -83.63 111.42 19.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 114.948 -1.024 . . . . 10.0 111.829 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.98 106.65 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 122.015 0.912 . . . . 10.0 108.883 171.554 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.784 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -97.51 112.07 24.07 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.14 -1.391 . . . . 10.0 110.545 179.02 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.762 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.5 t-20 -80.72 160.03 25.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.89 -0.595 . . . . 10.0 110.255 177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -154.5 32.0 0.7 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.638 -0.791 . . . . 10.0 111.764 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -83.05 -18.4 39.85 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 122.132 0.173 . . . . 10.0 111.015 -178.375 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 86.35 -8.34 0.73 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.753 1.283 . . . . 10.0 111.08 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 10.9 p-10 -125.07 155.05 40.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.121 0.486 . . . . 10.0 110.841 175.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.67 123.22 20.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.292 -0.867 . . . . 10.0 111.183 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.609 ' H ' HG22 ' A' ' 46' ' ' ILE . 26.8 m -126.03 139.79 50.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.067 0.46 . . . . 10.0 111.364 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.774 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 9.5 m -88.93 119.67 29.65 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.509 -0.552 . . . . 10.0 109.509 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' CYS . 1.1 m -116.66 165.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 115.401 -0.818 . . . . 10.0 110.51 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.489 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -148.57 158.16 43.94 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.641 -0.709 . . . . 10.0 109.206 178.221 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.627 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -135.23 138.22 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.338 0.59 . . . . 10.0 111.717 -173.307 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -101.22 125.99 47.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.947 -1.024 . . . . 10.0 108.908 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 57.0 m-85 -95.07 165.6 12.34 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.247 -0.581 . . . . 10.0 110.351 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 88.0 m -49.4 -21.07 0.8 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.245 -0.889 . . . . 10.0 112.142 174.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -118.96 -67.05 1.02 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 174.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.04 50.65 0.07 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.735 -0.745 . . . . 10.0 112.352 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -74.43 158.98 32.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.73 0.3 . . . . 10.0 111.362 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -66.92 112.87 4.54 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.388 0.614 . . . . 10.0 112.224 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.693 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -174.82 -47.72 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 CA-C-N 114.844 -1.071 . . . . 10.0 111.101 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.693 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 3.0 Cg_endo -37.06 96.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 124.273 3.316 . . . . 10.0 114.128 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 1.6 m 135.99 108.19 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.0 1.72 . . . . 10.0 111.202 170.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.76 130.58 7.44 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -83.45 135.74 24.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.392 0.615 . . . . 10.0 110.236 176.786 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.37 146.79 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.829 -1.078 . . . . 10.0 109.994 -176.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -88.27 141.56 30.95 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 168.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -38.9 98.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.71 2.94 . . . . 10.0 113.02 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.721 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 89.37 12.22 63.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 119.603 -1.284 . . . . 10.0 112.23 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.28 -176.63 36.03 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 121.276 -0.488 . . . . 10.0 112.214 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.784 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 23.6 m0 -116.65 165.16 13.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.552 0.692 . . . . 10.0 111.182 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -139.46 115.87 10.56 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.14 -1.43 . . . . 10.0 107.14 172.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.0 m -85.2 127.88 34.46 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.374 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.627 ' CG ' HG21 ' A' ' 33' ' ' VAL . 48.5 m-85 -137.42 139.43 40.68 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.462 -0.94 . . . . 10.0 108.462 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.54 100.04 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.172 0.92 . . . . 10.0 111.324 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.29 175.07 43.44 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.233 -1.147 . . . . 10.0 110.233 176.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.44 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 7.7 p90 . . . . . 0 CA--C 1.537 0.475 0 CA-C-N 118.742 1.271 . . . . 10.0 109.96 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.451 ' HB3' ' OG1' ' A' ' 36' ' ' THR . 26.9 t80 . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -61.3 129.02 23.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.9 p -128.23 -16.37 4.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.136 -0.484 . . . . 10.0 111.678 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.37 110.65 0.66 Allowed Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 119.226 -1.464 . . . . 10.0 113.709 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.3 mt -82.36 150.53 27.12 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.069 -0.715 . . . . 10.0 109.069 171.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.515 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -148.22 159.65 43.75 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.264 -178.044 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.628 HG23 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -81.44 126.61 31.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.033 0.444 . . . . 10.0 110.66 174.402 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 30' ' ' SER . 48.9 t -98.92 166.97 11.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.492 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--N 1.321 -0.652 0 N-CA-C 109.164 -0.68 . . . . 10.0 109.164 171.837 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 36.0 Cg_endo . . . . . 0 N--CA 1.458 -0.586 0 CA-C-O 121.138 0.391 . . . . 10.0 112.62 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.584 HG12 ' HB3' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -151.93 124.42 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 177.141 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 71.06 -27.54 0.17 Allowed 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.752 0.657 . . . . 10.0 111.88 172.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 6' ' ' VAL . 47.0 mt-10 77.68 -20.17 0.39 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.609 1.163 . . . . 10.0 111.36 175.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.9 m -84.18 -14.46 50.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.414 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.786 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -96.03 134.19 34.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -133.1 119.6 20.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.583 -175.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.787 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -96.71 162.04 13.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.024 0.916 . . . . 10.0 113.296 177.131 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 19' ' ' THR . 33.5 t80 -143.04 178.98 7.32 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.407 -1.701 . . . . 10.0 106.407 169.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -136.96 117.35 13.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.457 0.571 . . . . 10.0 111.349 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 p -120.66 86.65 2.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.664 -0.698 . . . . 10.0 109.85 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 62.72 -84.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.998 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -120.31 16.75 12.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.983 0.42 . . . . 10.0 110.933 -172.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.69 96.45 3.82 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.218 -0.66 . . . . 10.0 109.218 -173.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.504 HG21 HG11 ' A' ' 64' ' ' VAL . 7.0 m -86.17 99.12 11.3 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.624 0.726 . . . . 10.0 109.192 171.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.787 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.0 p-10 -85.27 109.67 18.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.434 -1.257 . . . . 10.0 111.926 -175.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.36 106.48 19.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 172.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.738 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -98.37 110.96 23.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.068 -1.424 . . . . 10.0 110.297 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.786 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 18.6 t-20 -80.98 154.91 26.68 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.957 -0.565 . . . . 10.0 109.939 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.25 36.13 1.03 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.579 -0.82 . . . . 10.0 112.177 173.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -76.59 -66.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.457 -0.306 . . . . 10.0 110.449 -178.032 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 25' ' ' CYS . . . 142.42 -32.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.815 1.322 . . . . 10.0 108.699 -171.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -115.33 157.67 23.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.111 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.35 127.22 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.492 -0.776 . . . . 10.0 111.319 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.599 ' H ' HG22 ' A' ' 46' ' ' ILE . 30.8 m -125.47 139.55 50.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.072 0.463 . . . . 10.0 111.268 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.826 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 14.7 m -88.3 119.7 28.96 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.273 -0.64 . . . . 10.0 109.273 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.442 HG12 HG21 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -119.12 148.45 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 121.775 0.798 . . . . 10.0 111.732 -178.305 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -127.16 160.88 29.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.8 -1.091 . . . . 10.0 109.287 176.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.73 138.95 47.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.33 0.585 . . . . 10.0 111.867 -178.154 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -100.81 120.36 40.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.72 -1.127 . . . . 10.0 109.241 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.466 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 35.1 m-85 -100.13 158.96 15.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.295 0.569 . . . . 10.0 111.55 -178.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.529 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 22.7 m -48.48 -34.9 11.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.608 -1.178 . . . . 10.0 112.601 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -103.29 -83.6 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.931 -0.48 . . . . 10.0 109.876 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.4 49.63 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.246 -0.978 . . . . 10.0 112.898 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -66.3 153.24 43.15 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.088 -0.338 . . . . 10.0 110.088 173.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 14.5 p90 -75.7 136.68 40.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.866 -0.79 . . . . 10.0 108.866 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.73 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 165.95 -42.52 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 123.57 0.748 . . . . 10.0 111.329 -170.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.73 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 6.3 Cg_endo -48.69 71.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 124.212 3.275 . . . . 10.0 115.29 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER 164.1 97.89 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.794 1.238 . . . . 10.0 110.2 166.166 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.73 126.48 10.31 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.944 -0.761 . . . . 10.0 108.944 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.826 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -80.53 137.39 21.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.287 0.565 . . . . 10.0 110.749 179.613 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -96.0 145.64 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.235 -0.893 . . . . 10.0 109.38 -177.59 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.58 140.45 31.73 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 107.808 -1.182 . . . . 10.0 107.808 169.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -43.53 95.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.267 2.644 . . . . 10.0 113.107 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 99.59 5.44 55.49 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.064 -1.065 . . . . 10.0 112.511 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.24 -171.79 38.33 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 121.29 -0.481 . . . . 10.0 113.117 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.738 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 16.6 m0 -119.74 167.3 12.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.499 0.666 . . . . 10.0 111.005 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -142.59 114.46 8.13 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.154 -1.424 . . . . 10.0 107.154 171.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.8 m -80.95 129.42 34.53 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.549 -0.751 . . . . 10.0 110.361 -175.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.617 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.3 m-85 -137.52 141.0 41.45 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.595 -0.891 . . . . 10.0 108.595 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.01 106.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.958 0.786 . . . . 10.0 110.854 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.5 -170.96 6.31 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.338 -0.846 . . . . 10.0 111.818 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.611 ' HB3' ' HD2' ' A' ' 63' ' ' TYR . 2.3 p90 . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 122.207 1.003 . . . . 10.0 111.556 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.611 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 8.5 t80 . . . . . 0 CA--C 1.513 -0.458 0 N-CA-C 107.471 -1.307 . . . . 10.0 107.471 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 19' ' ' THR . 1.6 m -66.53 128.79 30.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.6 p -119.28 -28.84 5.33 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.344 -0.389 . . . . 10.0 111.277 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.51 115.38 1.1 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.569 -1.3 . . . . 10.0 113.209 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.584 ' HB3' HG12 ' A' ' 6' ' ' VAL . 4.4 mt -79.34 146.62 32.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 170.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.458 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 5.3 m-70 -140.29 157.93 44.81 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.453 -176.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.559 HG23 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -79.63 126.44 30.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.011 0.434 . . . . 10.0 110.571 174.249 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.584 ' HB2' HG22 ' A' ' 32' ' ' THR . 35.8 t -94.44 158.77 15.41 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.154 -0.684 . . . . 10.0 109.154 177.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 C--N 1.317 -0.837 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 174.357 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 N--CA 1.456 -0.708 0 N-CA-C 111.941 -0.061 . . . . 10.0 111.941 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.573 ' CG1' ' HB3' ' A' ' 67' ' ' LEU . 0.2 OUTLIER 41.18 106.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.655 1.354 . . . . 10.0 114.655 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 73.6 -19.11 0.35 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.405 -0.816 . . . . 10.0 112.949 164.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 6' ' ' VAL . 40.1 mt-10 77.5 -40.11 0.32 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.864 . . . . 10.0 112.017 174.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.1 m -77.75 -12.73 60.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.818 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.4 m -90.94 132.43 35.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.869 -0.789 . . . . 10.0 108.869 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.71 113.0 11.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.674 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.765 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -89.34 161.33 16.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.719 0.771 . . . . 10.0 111.996 175.725 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.45 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 86.4 t80 -142.69 139.87 31.32 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.192 -1.367 . . . . 10.0 107.454 172.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.03 98.26 9.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.537 0.684 . . . . 10.0 110.123 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 12.9 p -99.15 -156.35 0.54 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.321 -0.854 . . . . 10.0 108.879 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -69.88 93.22 0.74 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.668 0.271 . . . . 10.0 110.713 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 62.35 32.64 16.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.308 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.446 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.7 OUTLIER -146.41 103.07 3.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 -173.11 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.471 HG21 HG21 ' A' ' 64' ' ' VAL . 16.8 m -90.15 91.56 8.59 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.755 -0.831 . . . . 10.0 108.755 170.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.765 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.0 OUTLIER -83.37 109.07 16.99 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.975 -1.012 . . . . 10.0 111.757 -178.411 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.28 107.21 19.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 122.066 0.936 . . . . 10.0 108.928 174.447 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.759 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -98.54 111.01 23.51 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.13 -1.395 . . . . 10.0 110.042 177.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.834 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.9 t30 -79.39 147.46 32.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.053 -0.521 . . . . 10.0 109.748 178.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -129.43 13.85 5.89 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.718 -0.753 . . . . 10.0 112.502 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.79 154.79 23.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.53 -11.22 60.57 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.443 0.535 . . . . 10.0 112.443 -176.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -124.88 156.75 37.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.365 0.602 . . . . 10.0 112.09 -177.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.31 124.72 24.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.721 -1.127 . . . . 10.0 111.33 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.652 ' H ' HG22 ' A' ' 46' ' ' ILE . 27.8 m -124.14 138.33 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.323 0.582 . . . . 10.0 111.533 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.841 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.2 m -87.01 120.15 27.97 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.383 -0.826 . . . . 10.0 109.061 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.564 HG12 HG21 ' A' ' 6' ' ' VAL . 1.2 m -115.42 165.53 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 121.532 0.682 . . . . 10.0 110.653 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.551 ' HB ' ' C ' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -146.96 159.77 43.15 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.968 -1.015 . . . . 10.0 109.037 177.104 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.621 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.41 144.5 33.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.328 0.585 . . . . 10.0 110.633 -176.404 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -117.44 114.21 23.18 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.074 -0.967 . . . . 10.0 109.114 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 20.3 m-85 -93.1 159.73 15.17 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.626 0.727 . . . . 10.0 111.919 -172.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.6 m -50.67 -44.6 57.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.251 -1.34 . . . . 10.0 113.237 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -95.22 -72.68 0.61 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.36 -0.536 . . . . 10.0 110.823 -177.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.71 48.55 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.958 -1.115 . . . . 10.0 113.575 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -68.1 150.35 48.5 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 117.022 0.411 . . . . 10.0 110.391 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -82.91 108.81 16.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.83 -0.623 . . . . 10.0 111.219 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.776 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -171.95 26.67 0.01 OUTLIER Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 113.063 0.764 . . . . 10.0 113.063 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.776 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 14.3 Cg_endo -91.27 56.91 1.02 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.259 1.306 . . . . 10.0 112.7 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 177.01 116.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.632 0.582 . . . . 10.0 111.356 171.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.79 124.42 3.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.841 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.7 p -83.15 138.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.359 0.6 . . . . 10.0 110.812 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.652 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -100.86 148.3 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 114.941 -1.027 . . . . 10.0 109.494 -177.367 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -90.65 143.26 28.76 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 107.832 -1.173 . . . . 10.0 107.832 168.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -46.08 93.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.106 2.537 . . . . 10.0 112.609 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 102.19 11.52 36.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.86 -1.162 . . . . 10.0 111.884 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.03 -176.79 31.96 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 121.332 -0.461 . . . . 10.0 112.63 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.759 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 12.0 m0 -119.31 166.71 12.67 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.365 0.603 . . . . 10.0 111.126 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -143.47 110.07 5.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 172.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.9 m -79.41 131.07 35.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.761 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.621 ' CG ' HG21 ' A' ' 33' ' ' VAL . 49.8 m-85 -140.1 142.83 36.05 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.004 -1.11 . . . . 10.0 108.004 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.91 102.72 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.544 0.527 . . . . 10.0 110.837 -174.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.53 -176.26 11.37 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.278 -0.873 . . . . 10.0 111.167 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.614 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 13.4 p90 . . . . . 0 N--CA 1.447 -0.599 0 CA-C-N 117.986 0.893 . . . . 10.0 110.903 -174.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 15.8 t80 . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 108.574 -0.898 . . . . 10.0 108.574 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.471 HG21 HG21 ' A' ' 19' ' ' THR . 1.7 m -63.59 133.0 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.432 -0.951 . . . . 10.0 108.432 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 81.6 p -118.51 -39.29 3.02 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.478 -0.489 . . . . 10.0 111.029 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.45 122.57 3.86 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.719 -1.229 . . . . 10.0 113.21 -174.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.573 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 3.7 mt -86.87 144.37 27.02 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.997 -0.742 . . . . 10.0 108.997 173.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.541 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 8.1 m-70 -138.37 159.6 41.64 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.386 -174.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.562 HG23 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -84.12 124.88 31.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.129 0.49 . . . . 10.0 111.129 175.735 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.495 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.3 t -95.37 172.83 7.85 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.809 -0.811 . . . . 10.0 108.809 175.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 6.4 p-10 . . . . . 0 C--N 1.316 -0.871 0 N-CA-C 108.318 -0.994 . . . . 10.0 108.318 172.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 N--CA 1.449 -1.118 0 CA-C-O 120.679 0.199 . . . . 10.0 112.264 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.86 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.2 m 48.55 -147.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.488 0.715 . . . . 10.0 111.458 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.705 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -56.09 -2.5 0.06 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.275 1.03 . . . . 10.0 113.587 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 69.21 -24.26 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.036 0.934 . . . . 10.0 113.377 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.409 ' H ' ' C ' ' A' ' 7' ' ' ALA . 33.5 m -80.73 -17.44 51.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.866 0.365 . . . . 10.0 111.189 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.903 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -92.09 141.75 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.26 115.03 12.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.62 -0.264 . . . . 10.0 111.028 -172.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.822 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.81 164.68 12.83 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.687 0.756 . . . . 10.0 112.895 177.493 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' THR . 25.8 t80 -147.5 172.66 13.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.27 -1.381 . . . . 10.0 107.27 172.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.502 ' HG3' ' HE1' ' A' ' 57' ' ' TYR . 5.7 pm0 -122.55 127.91 50.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 10.0 110.901 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 t -150.75 89.96 1.59 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.123 -0.489 . . . . 10.0 110.733 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.4 t90 55.04 80.02 0.14 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.697 -0.683 . . . . 10.0 112.229 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 58.95 24.74 12.92 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.641 -0.709 . . . . 10.0 111.629 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.36 97.3 3.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.9 m -89.13 99.86 12.76 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.193 0.521 . . . . 10.0 109.796 173.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.822 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -84.6 109.93 18.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.966 -1.016 . . . . 10.0 112.168 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.8 108.62 24.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 122.017 0.913 . . . . 10.0 109.31 174.057 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.683 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.28 110.55 22.79 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.802 -1.544 . . . . 10.0 110.45 178.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.903 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 20.4 t30 -80.36 155.88 26.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.066 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.03 31.1 1.46 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.181 -0.533 . . . . 10.0 111.874 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -77.2 -18.92 57.38 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.244 0.218 . . . . 10.0 111.084 -179.264 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 88.66 -18.1 0.25 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.699 1.249 . . . . 10.0 111.322 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -120.39 158.86 26.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.001 0.429 . . . . 10.0 110.263 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -66.4 123.61 20.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.433 -0.803 . . . . 10.0 111.002 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.667 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.9 m -127.07 138.8 53.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.058 0.456 . . . . 10.0 111.09 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 9.5 m -87.26 119.48 27.55 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.395 -0.594 . . . . 10.0 109.395 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.38 153.32 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.565 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -134.31 159.62 40.42 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 175.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.552 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -134.33 141.78 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 120.85 0.357 . . . . 10.0 110.172 -177.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.71 119.95 39.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.619 -0.882 . . . . 10.0 108.619 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.484 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 43.3 m-85 -94.22 164.62 12.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.971 0.891 . . . . 10.0 112.323 -173.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.6 m -52.12 -28.65 18.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.974 -1.466 . . . . 10.0 112.445 172.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -110.41 -85.94 0.54 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.857 -0.337 . . . . 10.0 111.133 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.23 43.29 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.023 -1.084 . . . . 10.0 113.097 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -71.48 146.18 48.74 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.796 -0.237 . . . . 10.0 110.627 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -75.08 140.54 43.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.222 -0.658 . . . . 10.0 109.222 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.76 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 160.71 -43.06 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 124.164 0.986 . . . . 10.0 110.804 -168.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.76 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 4.6 Cg_endo -47.65 66.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 124.894 3.729 . . . . 10.0 116.56 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.419 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER 169.33 102.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.315 1.046 . . . . 10.0 110.276 164.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -148.32 126.51 12.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.474 -0.785 . . . . 10.0 109.837 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.727 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.85 130.94 35.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.319 0.581 . . . . 10.0 109.796 174.788 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -93.41 148.63 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 114.998 -1.001 . . . . 10.0 109.283 -177.689 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -84.86 144.76 42.47 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 108.339 -0.986 . . . . 10.0 108.339 169.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -46.06 95.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.944 2.429 . . . . 10.0 112.711 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.709 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 93.55 13.84 54.56 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 119.948 -1.12 . . . . 10.0 111.824 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.55 -174.32 32.44 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 121.446 -0.407 . . . . 10.0 112.267 -177.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.713 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 19.1 m0 -118.8 166.28 12.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.394 0.616 . . . . 10.0 111.529 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.427 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -142.92 118.69 10.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.71 -1.218 . . . . 10.0 107.71 171.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.1 m -86.58 130.6 34.43 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.663 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.552 ' CG ' HG21 ' A' ' 33' ' ' VAL . 52.6 m-85 -138.53 145.82 41.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.56 -0.904 . . . . 10.0 108.56 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.64 97.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.754 0.659 . . . . 10.0 111.157 -174.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.74 171.79 49.66 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 110.002 -1.239 . . . . 10.0 110.002 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.502 ' HE1' ' HG3' ' A' ' 14' ' ' GLN . 7.8 p90 . . . . . 0 CA--C 1.535 0.374 0 CA-C-N 118.816 1.308 . . . . 10.0 111.037 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 30.6 t80 . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 120.528 0.204 . . . . 10.0 110.727 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 19' ' ' THR . 1.5 m -64.91 129.39 28.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 170.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.9 p -120.54 -22.9 6.24 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.994 -0.683 . . . . 10.0 111.924 -175.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -145.64 127.39 2.81 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.711 -1.233 . . . . 10.0 113.258 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.86 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.7 mt -87.71 139.18 30.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.131 0.491 . . . . 10.0 109.704 172.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.759 ' C ' HG12 ' A' ' 6' ' ' VAL . 14.6 m-70 -129.99 147.44 51.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.411 -0.813 . . . . 10.0 108.942 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -80.84 125.49 30.16 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 118.873 -1.131 . . . . 10.0 110.388 178.387 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.676 ' HB2' HG22 ' A' ' 32' ' ' THR . 38.5 t -87.61 158.75 18.79 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.361 -0.836 . . . . 10.0 109.531 -178.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 . . . . . 0 C--N 1.32 -0.679 0 N-CA-C 108.795 -0.817 . . . . 10.0 108.795 177.108 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.531 0.205 . . . . 10.0 111.474 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.7 p -71.42 -66.56 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.787 0.327 . . . . 10.0 111.239 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.56 102.86 2.02 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.849 -0.691 . . . . 10.0 111.555 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -127.61 81.95 69.23 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.954 0.407 . . . . 10.0 110.527 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -93.55 -33.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.095 2.53 . . . . 10.0 113.581 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.821 HG13 ' HB3' ' A' ' 67' ' ' LEU . 12.3 m -137.77 -142.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.26 -0.274 . . . . 10.0 110.26 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.651 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.65 10.04 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.658 1.183 . . . . 10.0 113.932 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 6' ' ' VAL . 35.4 mt-10 72.59 -50.43 0.7 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.4 0.889 . . . . 10.0 113.4 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.2 m -74.78 -8.53 56.71 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.858 0.318 . . . . 10.0 111.858 -172.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.4 m -95.96 131.97 41.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -132.93 114.46 14.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.529 -0.305 . . . . 10.0 110.616 -171.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.782 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -90.07 155.67 18.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.894 0.855 . . . . 10.0 112.471 175.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.403 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 56.3 t80 -135.05 152.7 51.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.058 -1.46 . . . . 10.0 107.058 170.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.546 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 4.3 pm0 -108.7 105.87 15.66 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.365 0.603 . . . . 10.0 110.863 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 p -108.34 75.93 1.01 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.536 0.684 . . . . 10.0 109.583 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 66.63 -86.21 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.542 -1.208 . . . . 10.0 111.801 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -117.5 24.52 11.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 10.0 110.456 -176.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.35 100.29 4.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.857 -0.794 . . . . 10.0 108.857 -174.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.611 HG21 HG21 ' A' ' 64' ' ' VAL . 5.1 m -90.58 95.31 10.09 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 172.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.782 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.0 p-10 -83.43 107.87 16.21 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.749 -1.114 . . . . 10.0 111.701 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.77 107.95 21.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 122.034 0.921 . . . . 10.0 109.157 174.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.726 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.46 110.34 22.51 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.88 -1.509 . . . . 10.0 110.176 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.806 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 24.6 t30 -82.18 159.4 23.29 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -151.73 23.53 0.93 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.769 -0.729 . . . . 10.0 112.241 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.644 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -75.58 -17.04 60.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.64 0.237 . . . . 10.0 111.64 -177.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.06 -4.26 0.92 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.362 1.039 . . . . 10.0 111.171 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.644 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 13.6 p-10 -126.88 156.29 41.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.593 174.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.58 126.07 28.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.451 -0.795 . . . . 10.0 111.139 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.579 ' H ' HG22 ' A' ' 46' ' ' ILE . 24.6 m -132.42 140.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.065 0.459 . . . . 10.0 111.068 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.843 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 5.4 m -88.19 123.91 33.3 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.91 146.14 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-O 121.454 0.645 . . . . 10.0 110.381 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.751 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -124.96 159.43 31.24 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.348 -0.842 . . . . 10.0 109.489 177.578 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.613 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.2 138.5 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-O 121.043 0.449 . . . . 10.0 110.544 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -106.97 116.42 31.9 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.519 ' OH ' ' HB3' ' A' ' 41' ' ' ALA . 57.1 m-85 -92.71 163.61 13.69 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.727 0.775 . . . . 10.0 112.062 -174.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 47.4 m -52.91 -21.97 4.97 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.238 -1.346 . . . . 10.0 111.693 170.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -135.56 -74.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.871 -0.518 . . . . 10.0 109.84 170.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 40' ' ' TRP . . . 148.76 80.46 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.713 -0.756 . . . . 10.0 112.117 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.779 HE21 ' HA2' ' A' ' 61' ' ' GLY . 10.4 mm-40 -74.66 20.0 0.13 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.022 0.379 . . . . 10.0 112.022 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.418 ' H ' ' C ' ' A' ' 38' ' ' GLY . 30.4 t90 59.77 87.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.64 0.733 . . . . 10.0 112.218 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.744 ' N ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.58 29.06 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.115 -0.948 . . . . 10.0 112.831 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.744 ' HD3' ' N ' ' A' ' 41' ' ' ALA . 9.8 Cg_endo -88.86 54.23 1.95 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.802 1.668 . . . . 10.0 112.198 -173.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.1 m 173.3 111.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.086 0.866 . . . . 10.0 111.259 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 131.62 10.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.843 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -82.13 142.7 13.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.112 0.482 . . . . 10.0 110.409 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -101.51 146.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.932 -0.576 . . . . 10.0 109.976 -178.413 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -87.27 143.38 34.42 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 169.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -41.16 95.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.523 2.816 . . . . 10.0 113.574 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.717 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 95.26 6.86 59.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.838 -1.172 . . . . 10.0 112.137 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.3 -174.46 44.9 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.183 -0.532 . . . . 10.0 113.098 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.726 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 10.0 m0 -120.11 167.39 12.26 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.932 -0.634 . . . . 10.0 111.061 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -146.14 111.18 5.31 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.768 -1.197 . . . . 10.0 107.768 171.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 m -77.58 130.53 37.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.433 -0.803 . . . . 10.0 110.061 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.613 ' CG ' HG21 ' A' ' 33' ' ' VAL . 49.8 m-85 -137.4 134.98 36.52 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.668 -0.864 . . . . 10.0 108.668 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.92 105.1 0.1 Allowed 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 124.23 0.957 . . . . 10.0 110.297 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.86 -157.85 0.65 Allowed Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.891 -1.05 . . . . 10.0 112.564 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.819 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 26.8 p90 -83.5 40.87 0.75 Allowed 'General case' 0 C--N 1.316 -0.881 0 O-C-N 122.447 -0.443 . . . . 10.0 111.894 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.99 160.5 53.42 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.7 -0.762 . . . . 10.0 112.001 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.6 p -70.66 -20.82 62.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.233 0.54 . . . . 10.0 110.547 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -94.83 5.09 52.91 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.001 -0.741 . . . . 10.0 109.001 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.779 ' HA2' HE21 ' A' ' 39' ' ' GLN . . . -131.78 -137.65 4.05 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.052 -0.976 . . . . 10.0 111.156 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 9.5 m120 -134.86 -96.7 0.26 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.155 -0.683 . . . . 10.0 109.155 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.819 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 15.5 t80 167.99 112.77 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 114.332 -1.304 . . . . 10.0 108.066 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 19' ' ' THR . 1.8 m -66.63 130.21 31.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.124 -1.065 . . . . 10.0 108.124 173.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.9 p -113.1 -37.37 4.79 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.064 -0.654 . . . . 10.0 111.322 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -140.05 136.99 8.09 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.826 -1.178 . . . . 10.0 112.496 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.821 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.0 mt -86.61 152.12 22.87 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.769 -0.826 . . . . 10.0 108.769 171.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.692 ' C ' HG12 ' A' ' 6' ' ' VAL . 6.5 m-70 -138.55 146.24 41.65 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.241 -1.022 . . . . 10.0 108.241 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.444 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -84.14 124.4 31.11 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 118.908 -1.117 . . . . 10.0 110.407 178.479 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.751 ' HB2' HG22 ' A' ' 32' ' ' THR . 41.9 t -92.27 158.55 16.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.214 -0.903 . . . . 10.0 109.807 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -102.72 141.7 23.04 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -23.8 79.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 1 C-N-CA 127.179 5.252 . . . . 10.0 115.577 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -166.78 88.58 0.34 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.16 -0.927 . . . . 10.0 111.145 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.8 t -90.78 139.46 26.19 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.37 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.2 104.78 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.55 2.166 . . . . 10.0 111.869 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.7 m 70.03 91.76 0.09 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.523 -0.762 . . . . 10.0 111.064 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.19 68.76 0.22 Allowed Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.234 -0.894 . . . . 10.0 111.826 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.608 -0.71 . . . . 10.0 110.18 179.642 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.484 0.183 . . . . 10.0 110.705 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.5 p -85.23 -51.66 6.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.882 0.372 . . . . 10.0 111.926 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.75 175.16 32.93 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.804 -0.712 . . . . 10.0 112.066 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.459 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 3.3 p -124.33 107.11 30.08 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 121.302 0.572 . . . . 10.0 111.533 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.558 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 94.8 Cg_endo -90.63 147.97 4.11 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.616 2.877 . . . . 10.0 112.046 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.9 m 49.19 -148.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.919 0.887 . . . . 10.0 112.36 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.68 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.92 1.32 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.635 1.346 . . . . 10.0 114.635 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 4' ' ' SER . 51.8 mt-10 72.22 -33.79 0.28 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.437 0.695 . . . . 10.0 112.322 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 m -76.86 -13.08 60.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.634 0.254 . . . . 10.0 111.421 -173.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.85 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.9 m -98.35 143.59 12.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.066 -0.716 . . . . 10.0 109.066 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -136.75 111.97 9.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.758 -0.201 . . . . 10.0 110.731 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.772 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -89.19 160.29 17.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.794 0.807 . . . . 10.0 112.546 175.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' THR . 36.9 t80 -142.76 173.95 11.09 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.549 -1.649 . . . . 10.0 106.549 173.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -119.24 103.4 9.47 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.366 -0.534 . . . . 10.0 110.508 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.7 m -104.6 54.29 0.72 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.982 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 60.38 88.99 0.07 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.554 -0.748 . . . . 10.0 111.537 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 49.5 ttt180 63.9 14.49 8.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.581 0.705 . . . . 10.0 111.538 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -130.95 95.72 3.89 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.779 -1.193 . . . . 10.0 107.779 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.488 HG21 HG21 ' A' ' 64' ' ' VAL . 61.5 m -86.35 97.67 10.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.31 0.576 . . . . 10.0 109.694 177.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.772 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.7 p-10 -83.19 108.43 16.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.723 -1.126 . . . . 10.0 111.318 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.99 105.84 18.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 122.203 1.001 . . . . 10.0 109.055 175.197 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.686 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -99.11 109.16 21.9 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 113.707 -1.588 . . . . 10.0 109.993 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.85 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 15.7 t30 -80.08 156.93 26.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -140.11 13.4 3.07 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.704 -0.76 . . . . 10.0 113.041 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.07 156.9 20.88 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 117.21 0.505 . . . . 10.0 109.844 173.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.32 -8.62 56.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.024 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -116.62 152.81 33.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.646 0.736 . . . . 10.0 111.721 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.76 125.36 26.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.695 -1.139 . . . . 10.0 110.256 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.5 m -124.19 137.31 57.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.109 0.48 . . . . 10.0 111.67 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.802 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 3.8 m -85.69 121.95 29.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.71 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.509 ' HB ' HG11 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -122.78 148.11 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.295 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.714 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.2 OUTLIER -127.44 160.17 32.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.147 -0.933 . . . . 10.0 109.02 176.53 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -132.03 132.04 61.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.598 0.713 . . . . 10.0 111.337 -176.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -103.55 109.74 21.52 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.522 -176.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.625 ' OH ' ' HB3' ' A' ' 41' ' ' ALA . 28.4 m-85 -89.59 165.31 14.33 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.584 0.706 . . . . 10.0 111.733 -176.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.403 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 52.4 m -52.55 -29.73 26.97 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.231 -1.35 . . . . 10.0 111.397 168.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.453 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 52.6 m-70 -126.42 -77.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 10.0 110.206 172.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.01 79.02 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.228 -0.986 . . . . 10.0 111.691 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.451 ' HG2' ' OD1' ' A' ' 62' ' ' ASN . 12.7 mm100 -76.38 20.01 0.23 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.218 0.451 . . . . 10.0 112.218 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 3.1 t90 66.99 87.41 0.12 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.727 0.811 . . . . 10.0 111.641 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.727 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -170.85 27.77 0.01 OUTLIER Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 113.444 0.905 . . . . 10.0 113.444 174.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.727 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 9.9 Cg_endo -89.16 56.41 2.01 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.726 1.617 . . . . 10.0 112.754 -172.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.2 m 172.27 114.56 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.616 0.766 . . . . 10.0 111.33 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.61 132.0 8.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.1 -0.704 . . . . 10.0 109.1 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.802 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -81.13 138.88 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.199 0.523 . . . . 10.0 110.06 176.227 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -97.05 145.12 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 115.362 -0.835 . . . . 10.0 109.704 -179.166 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -83.2 141.38 42.96 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 107.966 -1.124 . . . . 10.0 107.966 169.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -47.77 91.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.298 2.666 . . . . 10.0 112.692 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.654 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 104.37 5.91 42.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.161 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.78 -172.4 36.11 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.382 -0.437 . . . . 10.0 112.863 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.686 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.4 m0 -120.32 167.28 12.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.514 0.673 . . . . 10.0 111.051 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -143.1 113.07 7.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 171.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -81.44 128.31 33.74 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.436 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.617 ' CG ' HG21 ' A' ' 33' ' ' VAL . 42.1 m-85 -138.78 140.52 38.64 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.332 -0.618 . . . . 10.0 109.332 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.72 101.46 0.05 Allowed 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 123.894 0.746 . . . . 10.0 110.192 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.91 -159.27 8.36 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 111.217 -0.753 . . . . 10.0 111.217 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.68 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 28.3 p90 -88.19 127.61 35.44 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.109 -1.071 . . . . 10.0 108.109 173.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.37 -165.23 30.57 Favored Glycine 0 C--N 1.31 -0.895 0 CA-C-N 115.504 -0.771 . . . . 10.0 112.176 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 m -76.57 128.05 33.98 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.127 -0.323 . . . . 10.0 110.127 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 66.51 24.02 10.37 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.889 0.475 . . . . 10.0 111.247 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -125.23 -151.19 7.95 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.094 -0.802 . . . . 10.0 111.094 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 4.0 m120 -125.49 -111.72 0.3 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 117.995 0.897 . . . . 10.0 109.097 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.68 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 28.7 t80 175.43 109.08 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 114.465 -1.243 . . . . 10.0 108.646 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.9 m -63.59 131.56 29.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 107.74 -1.207 . . . . 10.0 107.74 173.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.0 t -137.95 11.82 2.87 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.27 -0.572 . . . . 10.0 110.379 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.76 118.93 0.81 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 119.803 -1.189 . . . . 10.0 112.782 173.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.84 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -88.99 127.57 35.67 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.724 ' C ' HG12 ' A' ' 6' ' ' VAL . 17.6 m-70 -118.24 146.45 44.26 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.306 -0.861 . . . . 10.0 108.933 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.437 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -82.15 123.31 28.87 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.032 -1.043 . . . . 10.0 110.513 177.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.714 ' HB2' HG22 ' A' ' 32' ' ' THR . 42.0 t -92.7 161.01 14.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.799 -0.637 . . . . 10.0 110.205 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 7.3 p-10 -99.19 146.09 31.13 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 172.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 16.8 Cg_exo -28.35 80.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 1 C-N-CA 126.538 4.825 . . . . 10.0 115.116 175.262 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -169.24 99.06 0.35 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.209 -0.905 . . . . 10.0 111.659 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.1 m -89.33 135.92 30.65 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.635 -0.505 . . . . 10.0 109.635 172.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.14 54.81 0.72 Allowed 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 123.017 2.478 . . . . 10.0 113.008 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.8 p -84.44 88.42 7.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.137 0.494 . . . . 10.0 109.844 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.18 138.91 14.22 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.715 -0.755 . . . . 10.0 112.991 -174.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.392 -0.813 . . . . 10.0 109.265 176.64 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.915 0.388 . . . . 10.0 110.488 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.0 m -161.4 -58.0 0.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.514 ' O ' ' HD3' ' A' ' 5' ' ' PRO . . . -101.4 173.93 24.47 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.71 -0.956 . . . . 10.0 110.71 174.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -113.04 86.57 9.34 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 117.132 0.466 . . . . 10.0 110.096 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 54.2 Cg_endo -89.24 -44.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.321 2.014 . . . . 10.0 112.838 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.836 HG13 ' HB3' ' A' ' 67' ' ' LEU . 9.3 m -136.94 -137.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.252 -0.647 . . . . 10.0 109.252 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.704 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -56.48 0.23 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.185 0.994 . . . . 10.0 113.452 174.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 6' ' ' VAL . 10.0 mt-10 74.11 -38.73 0.41 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.518 1.127 . . . . 10.0 113.264 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.1 m -75.77 -13.35 60.29 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.939 0.399 . . . . 10.0 111.318 -175.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.878 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -97.09 137.32 25.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.009 -0.737 . . . . 10.0 109.009 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -143.34 129.94 20.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.043 -0.263 . . . . 10.0 110.477 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.686 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -95.56 165.23 12.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.891 0.853 . . . . 10.0 113.179 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.421 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 87.3 t80 -145.26 154.32 42.24 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 106.72 -1.585 . . . . 10.0 106.72 170.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -105.66 108.26 19.69 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.445 -0.502 . . . . 10.0 111.389 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -99.41 -166.89 1.4 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.124 -1.065 . . . . 10.0 108.124 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.669 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -69.46 100.67 1.43 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.837 0.351 . . . . 10.0 110.541 -178.383 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 63.92 28.19 14.5 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.118 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.87 101.86 3.59 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 121.207 -0.197 . . . . 10.0 111.15 -169.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.475 HG21 HG21 ' A' ' 64' ' ' VAL . 16.3 m -89.63 96.71 10.81 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 170.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.686 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.1 p-10 -84.34 107.35 16.57 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 114.947 -1.024 . . . . 10.0 112.378 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.29 108.62 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.794 0.807 . . . . 10.0 108.9 174.584 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.768 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.6 p80 -98.39 113.97 26.14 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.218 -1.356 . . . . 10.0 110.554 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.878 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 22.6 t30 -82.03 163.42 22.11 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.592 -0.522 . . . . 10.0 109.592 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -153.39 25.2 0.77 Allowed Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.288 -0.482 . . . . 10.0 112.203 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -78.72 -14.0 59.52 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.402 0.281 . . . . 10.0 111.148 -177.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 82.24 -6.03 1.4 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.919 -1.037 . . . . 10.0 110.933 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -126.24 158.58 35.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.02 0.438 . . . . 10.0 110.304 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -70.91 120.3 16.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.039 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.74 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.6 m -126.19 140.75 47.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.221 0.534 . . . . 10.0 111.424 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.748 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.0 m -88.11 120.25 29.28 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.154 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.41 161.15 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 115.729 -0.669 . . . . 10.0 110.409 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.691 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.4 OUTLIER -143.13 160.88 39.58 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.474 -0.784 . . . . 10.0 109.015 176.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.587 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.58 145.27 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.45 0.643 . . . . 10.0 111.542 -175.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -114.12 110.31 19.81 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.735 -1.121 . . . . 10.0 109.719 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 11.9 m-85 -90.57 161.88 15.25 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.369 0.604 . . . . 10.0 111.622 -176.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.1 m -48.79 -38.64 22.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.263 -1.335 . . . . 10.0 112.783 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.614 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 47.0 m-70 -101.6 -75.49 0.59 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.518 -0.473 . . . . 10.0 110.064 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.06 46.73 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.553 -0.832 . . . . 10.0 112.048 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.34 136.78 57.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -72.79 100.47 2.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 10.0 111.548 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.851 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.03 19.96 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.256 -0.884 . . . . 10.0 113.233 175.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.851 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 9.2 Cg_endo -87.27 58.62 3.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 CA-C-N 121.112 1.433 . . . . 10.0 112.455 -170.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 176.47 115.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.791 0.682 . . . . 10.0 111.168 170.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 128.67 6.74 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.436 0.694 . . . . 10.0 109.525 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.748 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -83.92 134.38 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.334 0.588 . . . . 10.0 110.534 177.246 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.74 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -94.67 149.29 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.009 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -86.88 146.73 41.54 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 168.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -43.19 98.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.037 2.491 . . . . 10.0 112.961 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.718 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 89.28 11.48 64.55 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.864 -1.16 . . . . 10.0 111.565 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.12 -176.81 37.78 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 121.283 -0.484 . . . . 10.0 112.418 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.768 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 17.2 m0 -115.93 166.76 11.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.793 0.806 . . . . 10.0 111.815 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -143.67 118.3 9.8 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.362 -1.347 . . . . 10.0 107.362 172.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.7 m -85.72 129.7 34.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.178 0.514 . . . . 10.0 110.812 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.587 ' CG ' HG21 ' A' ' 33' ' ' VAL . 56.3 m-85 -136.86 151.34 49.0 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.588 -0.894 . . . . 10.0 108.588 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.97 98.56 0.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.705 0.628 . . . . 10.0 110.562 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.45 178.49 23.11 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 115.049 -0.978 . . . . 10.0 111.107 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 12.1 p90 -84.78 43.68 1.0 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.049 0.925 . . . . 10.0 110.803 -173.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.85 114.06 4.64 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.386 -0.825 . . . . 10.0 111.796 -173.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m 74.99 27.83 1.12 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.242 0.544 . . . . 10.0 111.138 176.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.6 t70 66.1 81.87 0.19 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.416 0.627 . . . . 10.0 110.917 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.72 -115.59 1.01 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.052 -0.819 . . . . 10.0 111.052 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 37' ' ' HIS . 5.1 m-80 -84.33 139.69 32.11 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.287 -0.634 . . . . 10.0 109.287 173.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -127.29 111.89 14.43 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -59.75 128.91 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.5 p -118.04 -34.3 4.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.046 0.45 . . . . 10.0 111.169 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.84 129.71 4.75 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.062 -1.066 . . . . 10.0 112.468 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.836 ' HB3' HG13 ' A' ' 6' ' ' VAL . 3.8 mt -83.89 148.87 26.71 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.114 -1.069 . . . . 10.0 108.114 171.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.7 ' C ' HG12 ' A' ' 6' ' ' VAL . 15.4 m-70 -134.17 147.44 50.77 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.518 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -82.46 130.04 35.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 118.994 -1.082 . . . . 10.0 110.566 178.146 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.691 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.3 t -96.14 159.72 14.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.986 -0.552 . . . . 10.0 109.58 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.95 146.48 37.1 Favored Pre-proline 0 CA--C 1.512 -0.489 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -22.37 78.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.849 1 C-N-CA 126.702 4.935 . . . . 10.0 115.53 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -169.6 81.91 0.12 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.969 -1.014 . . . . 10.0 110.835 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.3 t -84.45 120.35 74.18 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.312 -0.403 . . . . 10.0 110.123 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.42 146.49 93.28 Favored 'Trans proline' 0 CA--C 1.518 -0.277 0 C-N-CA 122.565 2.176 . . . . 10.0 111.726 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.3 t -153.75 100.43 2.38 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.75 -60.62 7.83 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.723 -0.751 . . . . 10.0 111.494 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.049 -0.976 . . . . 10.0 110.013 175.748 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 120.698 0.285 . . . . 10.0 110.96 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 p -75.59 130.31 38.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.886 0.374 . . . . 10.0 111.141 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.78 -134.31 1.88 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.537 -0.625 . . . . 10.0 111.537 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.62 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 14.3 m -95.67 149.89 36.69 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 110.115 -0.328 . . . . 10.0 110.115 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.24 143.05 38.78 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.779 2.319 . . . . 10.0 111.891 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.598 ' HB ' ' C ' ' A' ' 68' ' ' HIS . 0.3 OUTLIER 38.77 98.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 114.324 1.231 . . . . 10.0 114.324 177.25 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 75.99 -25.09 0.21 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.558 -0.747 . . . . 10.0 112.559 166.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.62 ' HG2' ' HB2' ' A' ' 4' ' ' SER . 24.6 mt-10 74.8 -22.19 0.27 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.224 1.009 . . . . 10.0 111.845 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 82.4 m -85.42 -16.5 39.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.907 0.336 . . . . 10.0 111.907 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -94.22 139.78 17.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.619 -0.512 . . . . 10.0 109.619 -177.35 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -141.55 127.3 19.17 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.625 -0.139 . . . . 10.0 110.625 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.789 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -98.4 164.19 12.38 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.468 1.127 . . . . 10.0 113.787 176.374 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.418 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 84.6 t80 -145.1 162.6 36.63 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.304 -1.771 . . . . 10.0 106.643 172.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.71 122.7 44.18 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.083 -0.647 . . . . 10.0 110.786 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.509 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 25.9 p -121.93 -154.39 0.59 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.78 -0.822 . . . . 10.0 108.78 175.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -67.93 91.11 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.647 0.261 . . . . 10.0 111.412 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 61.4 35.07 17.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.585 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.509 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -147.29 101.19 3.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.4 -0.818 . . . . 10.0 109.345 -173.05 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.495 HG21 HG21 ' A' ' 64' ' ' VAL . 6.3 m -90.42 99.37 12.41 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 170.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.789 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -84.37 110.44 18.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.871 -1.059 . . . . 10.0 111.966 -177.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.98 106.69 19.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 122.181 0.991 . . . . 10.0 108.561 171.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.811 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -97.22 111.06 23.47 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.094 -1.412 . . . . 10.0 110.163 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.772 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.4 t30 -80.29 156.66 26.7 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.837 -0.62 . . . . 10.0 109.342 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.47 13.91 3.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.127 -0.558 . . . . 10.0 112.346 174.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.77 156.18 22.66 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.53 -8.41 56.69 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.264 0.468 . . . . 10.0 112.264 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -120.66 157.46 29.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.511 0.672 . . . . 10.0 111.75 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -71.82 117.69 13.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.827 -1.079 . . . . 10.0 110.431 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.683 ' H ' HG22 ' A' ' 46' ' ' ILE . 33.7 m -116.87 139.21 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 121.303 0.573 . . . . 10.0 111.676 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.0 m -88.94 116.88 27.55 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.734 -0.666 . . . . 10.0 109.288 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.5 HG12 HG21 ' A' ' 6' ' ' VAL . 1.1 m -112.8 164.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.452 -0.795 . . . . 10.0 110.517 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.31 153.7 40.04 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.257 -0.883 . . . . 10.0 109.212 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.565 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -130.23 137.69 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 120.937 0.399 . . . . 10.0 110.915 -174.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -100.6 116.63 32.97 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.782 -0.821 . . . . 10.0 108.782 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.803 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 45.9 m-85 -91.77 160.79 15.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.112 0.482 . . . . 10.0 111.023 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.6 m -48.47 -33.22 9.01 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.664 -1.153 . . . . 10.0 112.604 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -110.26 -69.66 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.929 0.395 . . . . 10.0 109.961 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.45 58.07 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.551 -0.833 . . . . 10.0 112.161 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.2 154.64 30.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.706 0.289 . . . . 10.0 110.681 176.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -76.46 106.45 8.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.853 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -173.62 -40.57 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 113.069 0.766 . . . . 10.0 113.069 -175.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.853 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 5.3 Cg_endo -46.86 67.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 124.884 3.723 . . . . 10.0 116.429 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.461 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER 169.96 104.43 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.179 0.992 . . . . 10.0 110.097 168.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -151.85 127.05 9.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.064 -176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.38 132.85 30.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.277 -0.569 . . . . 10.0 109.856 174.228 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.683 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -96.06 147.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-N 115.112 -0.949 . . . . 10.0 109.28 -177.26 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -84.03 141.42 40.56 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 169.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -47.89 94.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.056 2.504 . . . . 10.0 112.366 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 97.77 14.22 41.01 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.073 -1.061 . . . . 10.0 112.106 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.66 -172.2 26.77 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 121.112 -0.566 . . . . 10.0 112.669 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.811 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 16.5 m0 -119.54 165.54 14.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.423 0.63 . . . . 10.0 111.255 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -139.66 111.15 7.12 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 172.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.6 m -78.74 126.79 31.2 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.394 -0.821 . . . . 10.0 110.439 -176.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.565 ' CG ' HG21 ' A' ' 33' ' ' VAL . 51.5 m-85 -134.53 146.42 49.67 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.509 -0.922 . . . . 10.0 108.509 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.03 102.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.836 0.71 . . . . 10.0 110.459 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.59 179.44 16.65 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.608 -0.997 . . . . 10.0 110.608 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.655 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 14.9 p90 -79.77 101.38 8.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.208 1.004 . . . . 10.0 110.64 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.15 172.5 47.05 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 115.237 -0.892 . . . . 10.0 111.194 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.9 m -58.6 -27.95 65.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.281 0.562 . . . . 10.0 110.663 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -149.2 106.87 3.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 164.58 -138.91 5.53 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.809 -0.71 . . . . 10.0 112.407 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.803 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -102.62 161.48 13.69 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.329 0.585 . . . . 10.0 110.921 -179.178 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 19.1 t80 -135.76 119.96 17.78 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.39 -1.277 . . . . 10.0 108.562 170.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.495 HG21 HG21 ' A' ' 19' ' ' THR . 1.5 m -63.23 130.77 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.2 p -123.83 -19.04 5.84 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.203 -0.599 . . . . 10.0 111.851 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.39 130.69 4.06 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.602 -1.285 . . . . 10.0 113.159 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -94.84 148.0 22.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.399 -0.593 . . . . 10.0 109.399 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.598 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -147.98 164.54 33.47 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.254 -176.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.499 ' N ' ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -83.53 129.1 34.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.22 0.533 . . . . 10.0 111.362 177.254 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 30' ' ' SER . 32.3 t -98.19 168.3 10.33 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.509 -0.923 . . . . 10.0 108.509 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -134.56 142.81 44.05 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -16.5 78.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.976 1 C-N-CA 126.969 5.113 . . . . 10.0 115.747 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -163.64 83.96 0.47 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.844 -1.071 . . . . 10.0 109.853 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.0 t -80.13 141.08 53.73 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 115.922 -0.581 . . . . 10.0 111.069 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.19 166.02 30.55 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.821 2.347 . . . . 10.0 112.769 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.2 m -78.54 135.66 37.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.152 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.08 -63.59 1.2 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.315 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.436 -0.793 . . . . 10.0 109.417 177.618 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.279 -0.267 . . . . 10.0 110.279 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.4 m -72.29 101.94 2.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.914 0.388 . . . . 10.0 110.11 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.73 -177.44 51.21 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.589 -0.815 . . . . 10.0 111.37 -175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.1 m -100.29 144.27 28.1 Favored Pre-proline 0 C--N 1.32 -0.71 0 O-C-N 122.523 -0.398 . . . . 10.0 110.583 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.617 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 38.4 Cg_endo -65.51 153.68 77.14 Favored 'Trans proline' 0 N--CA 1.475 0.385 0 C-N-CA 123.476 2.784 . . . . 10.0 112.764 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.936 HG13 ' HB3' ' A' ' 67' ' ' LEU . 3.9 m 47.35 -141.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.934 0.893 . . . . 10.0 111.689 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.696 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.89 -1.9 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.512 1.125 . . . . 10.0 113.368 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 76.27 -26.93 0.18 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.989 0.915 . . . . 10.0 112.655 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.84 -10.88 54.68 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.195 0.443 . . . . 10.0 112.195 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.87 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -96.22 140.56 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 -176.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -132.19 116.04 16.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.206 -0.197 . . . . 10.0 110.958 -173.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.777 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.1 161.68 15.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 122.053 0.93 . . . . 10.0 112.919 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 19' ' ' THR . 90.5 t80 -144.28 158.52 43.69 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.835 -1.53 . . . . 10.0 106.908 172.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HG3' ' OG1' ' A' ' 19' ' ' THR . 22.7 mp0 -117.0 101.78 8.79 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.33 -0.548 . . . . 10.0 111.252 -176.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.1 t -93.89 80.2 4.16 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 61.35 -89.86 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 115.005 -0.998 . . . . 10.0 110.573 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.593 ' H ' ' HD3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -118.17 26.68 9.46 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.153 0.501 . . . . 10.0 111.144 -176.682 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -132.34 96.0 3.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.3 m -85.28 101.95 12.96 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.245 0.545 . . . . 10.0 110.214 176.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.777 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.6 p-10 -86.19 108.38 18.32 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.845 -1.07 . . . . 10.0 111.454 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.1 107.82 21.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.891 0.853 . . . . 10.0 108.988 173.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.699 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.04 110.67 22.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.229 -1.35 . . . . 10.0 110.297 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.87 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 21.8 t30 -80.14 160.12 25.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 10.0 110.157 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.46 23.53 1.07 Allowed Glycine 0 C--O 1.226 -0.392 0 C-N-CA 121.361 -0.447 . . . . 10.0 112.207 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -75.12 -16.74 60.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.512 0.196 . . . . 10.0 111.316 -178.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.11 -6.33 0.91 Allowed 'General case' 0 N--CA 1.472 0.647 0 O-C-N 124.631 1.207 . . . . 10.0 111.345 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 5.9 p-10 -126.82 157.02 40.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.959 0.409 . . . . 10.0 110.689 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.79 122.56 18.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.354 -0.839 . . . . 10.0 110.96 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.633 ' H ' HG22 ' A' ' 46' ' ' ILE . 34.6 m -129.1 140.64 48.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.076 0.465 . . . . 10.0 111.442 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.69 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.5 m -87.22 120.34 28.4 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.487 -0.561 . . . . 10.0 109.487 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.692 ' HB ' HG11 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -119.88 146.79 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 115.587 -0.733 . . . . 10.0 110.587 -179.192 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -125.74 161.74 26.65 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.28 -0.873 . . . . 10.0 108.834 175.576 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.641 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.82 133.63 58.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.35 0.595 . . . . 10.0 110.95 -176.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -106.04 112.65 25.78 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.735 -1.121 . . . . 10.0 108.696 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.51 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 15.4 m-85 -91.07 164.01 14.1 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.33 0.586 . . . . 10.0 110.959 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.7 m -50.51 -22.53 1.99 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.464 -1.243 . . . . 10.0 112.668 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.53 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 85.5 m-70 -123.96 -82.37 0.64 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.987 -0.445 . . . . 10.0 111.159 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.23 51.01 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.645 -1.264 . . . . 10.0 113.084 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.36 136.05 56.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.863 -0.792 . . . . 10.0 108.863 175.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -72.95 118.31 15.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.209 0.528 . . . . 10.0 110.471 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.769 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -177.05 -45.27 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 114.95 -1.023 . . . . 10.0 111.903 -174.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.769 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 3.5 Cg_exo -37.18 68.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.886 1 C-N-CA 125.924 4.416 . . . . 10.0 117.487 -174.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 5.3 t 170.53 111.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.294 1.038 . . . . 10.0 109.759 162.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.31 126.57 9.94 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.69 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -79.98 130.11 36.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.375 0.607 . . . . 10.0 109.369 175.259 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.633 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -93.21 148.91 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 114.83 -1.077 . . . . 10.0 109.804 -176.548 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -84.77 145.99 45.36 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 108.389 -0.967 . . . . 10.0 108.389 168.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -45.0 94.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.009 2.472 . . . . 10.0 112.564 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.718 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.72 15.12 53.89 Favored Glycine 0 CA--C 1.512 -0.151 0 C-N-CA 120.022 -1.085 . . . . 10.0 111.812 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 22' ' ' HIS . . . -97.26 -176.52 34.56 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 121.706 -0.283 . . . . 10.0 112.48 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.714 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 18.6 m0 -118.15 165.41 13.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.629 0.728 . . . . 10.0 111.784 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.425 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -143.91 115.54 8.17 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.265 -1.334 . . . . 10.0 107.929 172.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.3 m -82.56 131.19 35.22 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.598 -0.728 . . . . 10.0 110.764 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.641 ' CG ' HG21 ' A' ' 33' ' ' VAL . 53.5 m-85 -139.76 145.42 38.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.439 -0.948 . . . . 10.0 108.439 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.1 99.29 0.07 Allowed 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 123.856 0.723 . . . . 10.0 110.69 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.08 -173.59 12.35 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.295 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.44 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 2.9 p90 -91.86 83.99 5.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.6 0.714 . . . . 10.0 110.448 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -50.21 -57.9 9.56 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.746 -0.661 . . . . 10.0 113.369 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 p -144.67 -60.37 0.37 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.178 0.513 . . . . 10.0 110.087 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -141.0 161.49 37.72 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.034 -1.098 . . . . 10.0 108.034 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.82 -131.41 9.3 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.201 -1.0 . . . . 10.0 111.795 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.53 ' OD1' ' HB2' ' A' ' 37' ' ' HIS . 13.0 m-80 -76.24 143.31 41.05 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.257 0.551 . . . . 10.0 111.008 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.44 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 26.1 t80 -140.08 118.09 11.85 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.804 -1.089 . . . . 10.0 109.046 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.503 HG21 HG21 ' A' ' 19' ' ' THR . 0.5 OUTLIER -63.47 129.14 26.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 175.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 t -144.77 10.46 1.38 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.306 -0.557 . . . . 10.0 111.034 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.33 106.6 0.29 Allowed Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.552 -1.308 . . . . 10.0 112.951 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.936 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.8 mt -81.37 131.92 35.31 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.737 ' C ' HG12 ' A' ' 6' ' ' VAL . 18.7 m-70 -124.65 143.97 50.44 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.409 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -79.49 125.12 29.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 119.378 0.99 . . . . 10.0 110.482 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.601 ' HB2' HG22 ' A' ' 32' ' ' THR . 4.4 t -89.61 174.2 7.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.492 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 8.0 p-10 -126.44 145.43 52.87 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.378 -0.601 . . . . 10.0 109.378 175.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 27.4 Cg_exo -23.96 80.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 1 C-N-CA 126.89 5.06 . . . . 10.0 115.523 177.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -168.21 91.23 0.31 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.95 -1.023 . . . . 10.0 110.781 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -79.27 128.39 75.83 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.372 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 43' ' ' CYS . 51.3 Cg_endo -71.56 75.81 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.44 2.093 . . . . 10.0 111.879 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.4 p -82.68 -27.3 31.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.577 -0.738 . . . . 10.0 110.738 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.02 144.79 7.07 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.429 -0.668 . . . . 10.0 111.429 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.773 -0.632 . . . . 10.0 110.233 -179.724 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 110.289 -0.264 . . . . 10.0 110.289 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.9 t -74.65 78.89 2.01 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.996 0.903 . . . . 10.0 110.513 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 128.91 -178.67 17.13 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.004 -0.998 . . . . 10.0 110.882 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.5 m 58.34 76.74 0.44 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 121.157 0.504 . . . . 10.0 111.7 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.454 ' O ' HG13 ' A' ' 6' ' ' VAL . 61.1 Cg_endo -90.94 115.38 0.46 Allowed 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.827 2.352 . . . . 10.0 112.697 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.803 HG21 HG12 ' A' ' 31' ' ' VAL . 2.0 m 65.39 -49.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 125.139 1.376 . . . . 10.0 111.951 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.621 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -174.73 114.65 0.17 Allowed 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 106.133 -1.802 . . . . 10.0 106.133 -172.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 1.6 mp0 -57.84 -14.21 5.64 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.405 -0.816 . . . . 10.0 112.396 -166.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.6 m -86.6 -15.5 39.62 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.819 HG12 HD22 ' A' ' 23' ' ' ASN . 1.6 m -91.67 131.47 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.019 -0.734 . . . . 10.0 109.019 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -137.39 123.56 20.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.685 -0.234 . . . . 10.0 110.494 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.76 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.45 159.08 15.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.777 0.798 . . . . 10.0 112.629 178.189 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.437 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 78.2 t80 -139.53 165.35 27.46 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.28 -1.378 . . . . 10.0 107.28 172.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.61 107.84 15.21 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.074 -0.65 . . . . 10.0 110.923 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 21.8 m -96.91 -173.73 2.79 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.519 -1.289 . . . . 10.0 107.519 170.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -62.26 98.01 0.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.111 0.481 . . . . 10.0 111.074 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 57.63 40.29 26.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.1 -0.954 . . . . 10.0 111.375 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 0.9 OUTLIER -148.09 96.06 2.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 -177.005 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.548 HG21 HG11 ' A' ' 64' ' ' VAL . 25.3 m -86.66 96.56 10.17 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.491 -0.559 . . . . 10.0 109.491 175.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.76 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.4 p-10 -86.04 109.79 19.06 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.458 -0.792 . . . . 10.0 112.071 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.65 107.18 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.951 0.882 . . . . 10.0 109.043 173.385 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.808 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 6.5 p-80 -97.61 115.11 27.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.39 -1.277 . . . . 10.0 110.361 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.819 HD22 HG12 ' A' ' 10' ' ' VAL . 16.9 t-20 -81.76 160.79 23.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.53 -0.759 . . . . 10.0 109.752 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.95 39.41 0.6 Allowed Glycine 0 C--N 1.32 -0.314 0 N-CA-C 111.438 -0.665 . . . . 10.0 111.438 173.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.607 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -91.9 -16.09 27.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.612 -0.294 . . . . 10.0 111.549 -176.528 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 84.91 -7.66 0.92 Allowed 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.456 1.098 . . . . 10.0 110.923 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.607 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 9.3 p-10 -126.48 151.75 47.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.235 0.54 . . . . 10.0 110.686 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.86 126.06 28.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.422 -0.808 . . . . 10.0 111.116 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.582 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.2 m -129.66 140.64 48.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.13 0.491 . . . . 10.0 111.334 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.772 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 14.4 m -92.11 117.57 29.98 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.803 HG12 HG21 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -113.04 166.34 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 115.269 -0.878 . . . . 10.0 110.88 -178.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -150.17 157.96 43.65 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.293 -0.867 . . . . 10.0 108.887 176.225 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.24 141.68 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 120.904 0.383 . . . . 10.0 111.449 -173.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -107.83 119.1 38.48 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.77 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 25.3 m-85 -92.4 164.3 13.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.21 0.529 . . . . 10.0 111.287 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 49.2 m -50.04 -24.03 2.42 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.764 -1.107 . . . . 10.0 111.875 171.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.432 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 71.8 m-70 -117.68 -79.51 0.59 Allowed 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.118 -0.364 . . . . 10.0 110.033 172.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.57 51.53 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.344 -0.932 . . . . 10.0 112.031 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.4 141.96 57.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 75' ' ' PRO . 59.4 t-105 -70.16 116.22 10.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.059 0.457 . . . . 10.0 110.499 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.792 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -175.33 -44.4 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.022 -0.99 . . . . 10.0 112.278 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.792 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 1.6 Cg_endo -40.54 70.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.874 1 C-N-CA 125.437 4.091 . . . . 10.0 116.639 -175.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER 169.6 106.46 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.383 1.073 . . . . 10.0 110.421 166.592 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -152.9 125.82 8.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.854 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -81.26 134.23 27.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.312 -0.555 . . . . 10.0 109.887 173.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -95.88 145.08 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-N 115.273 -0.876 . . . . 10.0 109.625 -177.413 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -85.35 142.78 38.19 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 168.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -41.1 93.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.41 2.74 . . . . 10.0 112.984 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 95.99 10.9 55.82 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 119.851 -1.166 . . . . 10.0 112.179 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.64 -176.49 35.49 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.525 -0.369 . . . . 10.0 112.717 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.808 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 19.8 m0 -116.04 166.87 11.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.686 0.755 . . . . 10.0 111.672 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -141.6 111.85 6.89 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.368 -1.345 . . . . 10.0 107.368 172.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.5 m -79.38 129.82 34.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.699 -0.682 . . . . 10.0 110.663 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.57 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.3 m-85 -140.15 142.71 35.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.406 -0.961 . . . . 10.0 108.406 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.22 104.52 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.668 0.605 . . . . 10.0 110.476 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.02 -179.05 10.86 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 110.652 -0.979 . . . . 10.0 110.652 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 12.4 p90 -76.16 87.36 3.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.163 0.982 . . . . 10.0 111.697 -172.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.96 -54.63 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.668 -1.151 . . . . 10.0 111.662 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.4 m -62.65 110.71 1.81 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.366 0.266 . . . . 10.0 110.582 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 59.48 15.43 4.49 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.16 0.505 . . . . 10.0 111.787 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.5 23.97 77.17 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.698 -0.763 . . . . 10.0 112.758 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -87.55 131.13 34.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 117.496 0.648 . . . . 10.0 109.362 175.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 16.5 t80 -125.12 118.35 25.94 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.999 -0.741 . . . . 10.0 108.999 175.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.548 HG11 HG21 ' A' ' 19' ' ' THR . 1.6 m -59.21 129.67 21.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.703 -0.851 . . . . 10.0 108.703 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 63' ' ' TYR . 40.1 p -127.0 -10.88 5.97 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.654 -0.418 . . . . 10.0 111.46 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.36 147.07 16.57 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.02 -1.086 . . . . 10.0 112.872 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.467 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.1 mt -116.94 135.62 53.57 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.103 -0.702 . . . . 10.0 109.103 177.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.411 ' N ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -131.56 157.81 42.62 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.727 -0.67 . . . . 10.0 109.709 -176.527 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.502 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -80.19 130.65 35.37 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.386 -0.526 . . . . 10.0 110.382 177.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 30' ' ' SER . 43.0 t -96.7 158.65 15.33 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.237 -0.653 . . . . 10.0 109.237 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.5 142.67 29.17 Favored Pre-proline 0 CA--C 1.512 -0.505 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 172.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -21.75 77.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 1 C-N-CA 126.776 4.984 . . . . 10.0 115.303 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -168.91 88.86 0.2 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.901 -1.045 . . . . 10.0 110.637 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.2 t -93.82 133.78 27.29 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.284 -0.416 . . . . 10.0 111.247 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 19.7 Cg_endo -60.75 117.52 4.3 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 123.066 2.511 . . . . 10.0 112.535 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.3 t 66.77 154.81 0.09 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.642 0.734 . . . . 10.0 112.148 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.36 97.61 1.7 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.961 -0.638 . . . . 10.0 111.665 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.492 -0.766 . . . . 10.0 109.014 -179.902 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.488 0.185 . . . . 10.0 110.617 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.0 m 63.61 88.63 0.1 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.399 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.505 ' O ' ' HD3' ' A' ' 5' ' ' PRO . . . -103.47 166.48 16.07 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.925 -0.655 . . . . 10.0 111.875 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -102.63 99.32 13.02 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.403 -0.221 . . . . 10.0 110.403 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 3' ' ' GLY . 71.9 Cg_endo -86.05 -27.23 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.361 2.041 . . . . 10.0 112.136 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.788 HG13 ' HB3' ' A' ' 67' ' ' LEU . 7.5 m -140.94 -147.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.479 -0.782 . . . . 10.0 110.305 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.416 ' H ' ' HB ' ' A' ' 6' ' ' VAL . . . -65.05 16.03 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.802 1.038 . . . . 10.0 113.802 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 6' ' ' VAL . 2.3 mt-10 69.59 -52.07 0.61 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.922 0.889 . . . . 10.0 113.387 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.0 m -71.47 -13.4 61.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.688 0.28 . . . . 10.0 111.677 -173.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -95.59 130.65 44.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 -176.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -137.56 124.2 21.01 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.827 -0.349 . . . . 10.0 110.889 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.732 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.28 164.16 13.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.71 0.766 . . . . 10.0 112.572 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -146.81 137.42 23.8 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.35 -1.296 . . . . 10.0 107.692 169.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HG2' ' HE1' ' A' ' 63' ' ' TYR . 23.9 mp0 -91.1 104.4 16.98 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.038 0.447 . . . . 10.0 110.551 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -102.17 82.24 2.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.29 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 69.6 -77.21 0.05 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.163 -0.926 . . . . 10.0 111.264 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -133.39 26.24 4.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.423 0.63 . . . . 10.0 110.015 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -137.88 97.42 3.42 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 -169.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.622 HG21 HG21 ' A' ' 64' ' ' VAL . 7.5 m -86.05 93.99 9.13 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.117 -0.697 . . . . 10.0 109.117 175.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.732 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 0.9 OUTLIER -84.29 108.37 17.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.868 -1.06 . . . . 10.0 111.564 -177.772 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -97.9 106.59 18.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.845 0.831 . . . . 10.0 108.788 174.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.81 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 5.4 p-80 -97.26 113.14 24.71 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.414 -1.266 . . . . 10.0 109.926 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.774 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 15.4 t30 -81.64 149.04 28.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.953 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -131.9 20.89 4.49 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.775 -0.726 . . . . 10.0 111.886 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.06 155.9 20.63 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.431 -0.951 . . . . 10.0 108.431 175.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.92 -13.09 60.49 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -123.42 159.11 29.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.311 0.577 . . . . 10.0 111.715 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -70.14 125.23 26.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.053 -0.976 . . . . 10.0 111.139 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.553 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.5 m -127.24 138.88 53.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.521 . . . . 10.0 111.489 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.1 m -87.04 126.25 34.63 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.035 -0.529 . . . . 10.0 109.707 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.09 146.15 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.275 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.811 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.4 OUTLIER -125.81 157.09 38.4 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.382 -0.826 . . . . 10.0 109.241 178.135 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.596 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -131.45 137.94 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.38 0.61 . . . . 10.0 111.555 -177.454 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -99.03 115.03 28.04 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.024 -0.989 . . . . 10.0 109.544 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.801 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 37.6 m-85 -92.61 153.44 19.0 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.377 0.608 . . . . 10.0 110.869 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 62.5 m -48.7 -28.97 3.93 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.236 -1.347 . . . . 10.0 113.533 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -121.27 -79.09 0.6 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.839 -0.538 . . . . 10.0 111.734 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.13 126.75 0.88 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 119.905 -1.141 . . . . 10.0 112.593 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -163.48 146.25 10.03 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.538 -0.912 . . . . 10.0 108.538 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.417 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 24.0 p90 -77.26 136.14 38.5 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.646 -0.501 . . . . 10.0 109.646 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.723 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 161.51 -41.99 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 115.083 -0.962 . . . . 10.0 111.306 -171.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.723 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 9.3 Cg_endo -51.91 63.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 124.54 3.493 . . . . 10.0 116.13 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.1 m 170.93 99.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.718 1.207 . . . . 10.0 109.695 163.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.69 129.95 16.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.557 -0.534 . . . . 10.0 109.557 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -79.68 137.79 21.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.438 0.637 . . . . 10.0 110.286 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.553 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -101.12 146.3 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.638 -177.51 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.18 141.9 35.45 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.159 -1.052 . . . . 10.0 108.159 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -46.28 91.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.353 2.702 . . . . 10.0 112.851 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 106.88 2.17 36.61 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.205 -0.997 . . . . 10.0 112.475 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.2 -172.57 40.24 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.859 -0.686 . . . . 10.0 113.157 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.81 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 13.2 m0 -120.03 168.55 11.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.427 0.632 . . . . 10.0 111.289 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.99 109.97 5.1 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.631 -1.248 . . . . 10.0 107.631 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.1 m -79.15 126.61 30.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.527 -0.761 . . . . 10.0 110.964 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.596 ' CG ' HG21 ' A' ' 33' ' ' VAL . 46.9 m-85 -136.84 136.58 38.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.25 105.84 0.12 Allowed 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 124.01 0.819 . . . . 10.0 110.815 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.54 -170.47 7.52 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 120.38 -0.914 . . . . 10.0 110.955 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.666 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 4.6 p90 -86.35 78.78 9.21 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.913 0.863 . . . . 10.0 110.784 -176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -125.55 157.22 19.58 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.523 -0.762 . . . . 10.0 111.966 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m 64.17 9.34 4.68 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.894 0.378 . . . . 10.0 110.82 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 65.13 23.33 12.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.601 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.71 -102.05 0.15 Allowed Glycine 0 CA--C 1.502 -0.746 0 C-N-CA 120.829 -0.7 . . . . 10.0 112.026 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.801 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -105.05 -167.41 1.34 Allowed 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 121.629 0.728 . . . . 10.0 109.91 177.105 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.666 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 12.8 t80 -168.87 117.04 0.67 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 113.904 -1.498 . . . . 10.0 108.666 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.622 HG21 HG21 ' A' ' 19' ' ' THR . 1.4 m -66.08 126.93 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.6 p -123.49 -22.41 5.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.583 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.64 124.15 2.32 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.644 -1.265 . . . . 10.0 112.833 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.788 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.8 mt -84.99 151.91 23.84 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 170.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.642 ' C ' HG12 ' A' ' 6' ' ' VAL . 3.6 m-70 -142.57 142.22 32.14 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.439 -0.949 . . . . 10.0 108.439 -177.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.82 125.46 30.11 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.104 -1.038 . . . . 10.0 110.06 177.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.811 ' HB2' HG22 ' A' ' 32' ' ' THR . 51.7 t -95.38 154.48 17.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.532 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.41 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 8.7 p-10 -105.87 142.24 24.4 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.307 -0.627 . . . . 10.0 109.307 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 38.1 Cg_exo -20.77 80.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.72 1 C-N-CA 126.836 5.024 . . . . 10.0 115.154 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -169.91 92.0 0.21 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.845 -1.07 . . . . 10.0 110.772 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -89.87 125.95 59.12 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.381 -0.372 . . . . 10.0 110.439 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -61.15 -46.89 13.79 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.813 2.342 . . . . 10.0 112.294 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.1 m -156.89 -167.25 2.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.2 -0.455 . . . . 10.0 109.906 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.3 5.06 52.96 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.222 -0.989 . . . . 10.0 112.795 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.245 0.843 0 CA-C-O 119.218 -0.42 . . . . 10.0 111.014 179.555 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.338 -0.245 . . . . 10.0 110.338 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.4 m 73.95 -60.21 0.53 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.04 0.536 . . . . 10.0 111.219 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.98 -73.24 0.89 Allowed Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.984 -0.846 . . . . 10.0 110.984 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.44 ' HB2' ' CB ' ' A' ' 8' ' ' GLU . 14.2 m -102.35 154.9 37.1 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.696 -0.483 . . . . 10.0 109.696 174.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 29.9 Cg_endo -63.1 150.33 88.92 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.935 2.423 . . . . 10.0 112.487 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.853 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.4 m 49.3 -144.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 115.207 -0.906 . . . . 10.0 111.795 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.714 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.32 -5.4 0.3 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.402 1.081 . . . . 10.0 113.107 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.44 ' CB ' ' HB2' ' A' ' 4' ' ' SER . 38.6 mt-10 73.9 -25.28 0.2 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.983 0.913 . . . . 10.0 113.131 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 85.4 m -83.47 -7.14 59.6 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.705 0.261 . . . . 10.0 111.705 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.843 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -97.62 138.81 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.012 -0.736 . . . . 10.0 109.012 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.21 113.88 14.99 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.499 -0.186 . . . . 10.0 110.499 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.813 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -92.87 166.15 12.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.735 0.779 . . . . 10.0 112.762 176.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 19' ' ' THR . 81.7 t80 -149.19 140.8 23.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.187 -1.369 . . . . 10.0 107.886 172.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.512 ' HG3' ' OG1' ' A' ' 19' ' ' THR . 27.5 mp0 -98.71 100.09 11.27 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.538 -0.465 . . . . 10.0 110.1 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 t -96.98 -157.32 0.58 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -64.85 94.36 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.843 0.354 . . . . 10.0 110.804 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.615 ' HG2' ' HA3' ' A' ' 58' ' ' GLY . 53.8 mtt180 61.23 29.22 18.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.675 -0.693 . . . . 10.0 111.622 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.99 102.65 3.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.979 -0.378 . . . . 10.0 109.979 -172.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.9 m -90.46 96.33 10.6 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 168.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.813 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.9 p-10 -85.93 109.04 18.47 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.11 -0.95 . . . . 10.0 111.817 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.89 107.15 19.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 122.016 0.912 . . . . 10.0 108.723 174.567 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.732 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -99.98 110.08 22.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.105 -1.407 . . . . 10.0 110.356 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.843 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 23.4 t30 -80.51 157.55 26.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.184 -0.462 . . . . 10.0 109.999 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.43 24.12 1.22 Allowed Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.855 -0.688 . . . . 10.0 112.687 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.604 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -75.04 -18.15 60.37 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.088 0.155 . . . . 10.0 111.287 -178.469 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.23 -4.68 0.9 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.359 1.037 . . . . 10.0 111.202 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.604 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 13.1 p-10 -127.22 154.26 45.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.033 0.444 . . . . 10.0 110.953 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 127.54 33.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.393 -0.821 . . . . 10.0 111.295 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.587 ' H ' HG22 ' A' ' 46' ' ' ILE . 31.1 m -134.17 137.71 51.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.277 0.56 . . . . 10.0 111.355 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.8 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 15.0 m -86.35 123.21 31.34 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.048 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.58 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -123.23 151.21 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.77 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.491 ' HB ' ' C ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -130.52 159.59 36.66 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.411 -0.813 . . . . 10.0 109.538 176.001 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.631 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.39 133.6 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 121.322 0.582 . . . . 10.0 111.467 -176.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -98.89 118.15 35.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.169 -0.923 . . . . 10.0 108.946 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -92.5 157.09 16.74 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.058 0.456 . . . . 10.0 110.228 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 100.0 m -46.43 -30.09 2.0 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.925 -1.034 . . . . 10.0 112.874 174.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -107.64 -83.72 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.82 -0.55 . . . . 10.0 110.546 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.93 55.21 0.01 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 119.89 -1.147 . . . . 10.0 113.508 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -70.38 154.87 41.42 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.063 0.458 . . . . 10.0 111.166 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.546 ' CZ2' ' HB3' ' A' ' 75' ' ' PRO . 69.4 t-105 -74.53 118.2 17.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.918 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.769 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -176.52 -43.97 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.153 -0.93 . . . . 10.0 111.675 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.769 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 3.3 Cg_endo -44.4 69.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 125.06 3.84 . . . . 10.0 116.661 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.0 t 172.04 110.51 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.304 1.041 . . . . 10.0 109.52 163.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.27 128.54 8.31 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.935 -0.765 . . . . 10.0 108.935 174.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.8 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -81.02 139.06 18.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.333 0.587 . . . . 10.0 109.75 177.173 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.587 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -99.14 147.79 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 115.309 -0.859 . . . . 10.0 109.978 -177.031 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -87.35 144.54 36.03 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 168.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -41.34 96.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.515 2.81 . . . . 10.0 112.966 173.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 93.53 10.11 59.51 Favored Glycine 0 C--O 1.229 -0.173 0 C-N-CA 119.93 -1.128 . . . . 10.0 112.164 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.06 -177.05 40.77 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.455 -0.402 . . . . 10.0 113.02 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.732 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 15.4 m0 -118.08 165.28 13.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.439 0.638 . . . . 10.0 111.394 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -142.14 109.37 5.57 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.454 -1.248 . . . . 10.0 107.699 172.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -79.8 130.37 35.26 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.611 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.631 ' CG ' HG21 ' A' ' 33' ' ' VAL . 52.6 m-85 -139.23 134.17 32.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 -177.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.34 103.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 O-C-N 124.032 0.832 . . . . 10.0 111.531 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.94 176.32 36.94 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 110.386 -1.086 . . . . 10.0 110.386 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -82.67 80.16 8.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.346 1.073 . . . . 10.0 110.306 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.615 ' HA3' ' HG2' ' A' ' 17' ' ' ARG . . . -97.2 -36.08 5.05 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.202 -0.908 . . . . 10.0 112.17 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.7 p -90.47 10.54 24.87 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.97 0.414 . . . . 10.0 110.016 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 58.59 21.58 8.84 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.224 -0.898 . . . . 10.0 110.061 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.28 -90.12 2.14 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.271 -0.877 . . . . 10.0 112.385 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -75.54 123.53 25.63 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.156 -0.683 . . . . 10.0 109.156 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.463 ' CE2' ' HB ' ' A' ' 65' ' ' THR . 41.4 t80 -130.14 110.88 11.94 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.544 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.545 HG21 HG21 ' A' ' 19' ' ' THR . 0.5 OUTLIER -60.55 127.86 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.771 -0.826 . . . . 10.0 108.771 175.122 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.463 ' HB ' ' CE2' ' A' ' 63' ' ' TYR . 9.0 t -141.01 8.8 2.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.96 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.25 128.36 2.07 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 119.629 -1.272 . . . . 10.0 112.622 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.853 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.2 mt -100.88 132.75 46.13 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 173.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.725 ' C ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -126.26 148.59 49.47 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.4 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -80.89 124.58 29.22 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.961 -0.696 . . . . 10.0 110.846 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.473 ' HB2' HG22 ' A' ' 32' ' ' THR . 0.1 OUTLIER -96.93 174.52 6.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.762 -177.058 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -109.34 146.48 34.02 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 172.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -29.84 80.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 1 C-N-CA 126.597 4.864 . . . . 10.0 115.039 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -171.05 99.25 0.21 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.928 -1.033 . . . . 10.0 111.011 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.447 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 29.3 m -84.77 122.35 74.6 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.546 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 4.4 Cg_exo -40.73 98.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.076 3.184 . . . . 10.0 113.079 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.9 m -90.87 90.7 8.02 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.45 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.44 -35.09 12.43 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.617 -0.801 . . . . 10.0 111.886 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.246 0.884 0 CA-C-O 119.435 -0.317 . . . . 10.0 110.631 -178.636 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 120.544 0.212 . . . . 10.0 110.776 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.2 m -153.96 -78.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.61 0.243 . . . . 10.0 110.573 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -160.74 77.88 0.17 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.33 -0.938 . . . . 10.0 112.312 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.527 ' HA ' ' HG2' ' A' ' 8' ' ' GLU . 51.0 m 61.31 62.31 2.67 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 175.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.468 ' O ' HG22 ' A' ' 6' ' ' VAL . 87.2 Cg_endo -93.81 135.14 0.99 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.3 2.0 . . . . 10.0 110.749 169.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 67' ' ' LEU . 1.7 m 51.35 -147.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.055 0.542 . . . . 10.0 110.402 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.727 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.3 4.08 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 175.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 4' ' ' SER . 41.4 mt-10 74.57 -39.76 0.43 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.313 0.857 . . . . 10.0 113.313 175.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 32.6 m -79.07 -7.0 57.77 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.86 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 2.0 m -99.35 140.55 18.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -142.74 126.35 16.9 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.716 -0.393 . . . . 10.0 111.304 -175.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.745 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.25 164.71 12.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.99 0.9 . . . . 10.0 112.933 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 19' ' ' THR . 64.1 t80 -143.88 156.51 44.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.066 -1.424 . . . . 10.0 107.628 172.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.425 ' OE1' ' HE1' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -105.76 107.41 18.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.064 0.459 . . . . 10.0 110.858 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 33.6 m -103.82 77.6 1.47 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.608 -0.886 . . . . 10.0 108.608 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 65.26 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.514 -173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -127.67 27.56 5.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.414 0.626 . . . . 10.0 109.667 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.55 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 2.1 t80 -135.36 96.29 3.44 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 -172.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.4 m -85.41 96.3 9.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.562 0.696 . . . . 10.0 110.282 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.745 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.6 p-10 -85.21 108.82 17.92 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.404 -1.271 . . . . 10.0 112.353 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.694 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -98.39 109.22 23.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.588 -0.893 . . . . 10.0 108.588 174.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.786 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.7 p80 -97.85 114.2 26.2 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.138 -1.392 . . . . 10.0 110.343 176.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.86 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 2.5 t30 -83.09 155.92 23.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.124 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.88 32.86 1.29 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.128 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.574 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -82.63 -16.98 46.28 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 122.824 -0.221 . . . . 10.0 111.108 -178.569 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 83.85 -3.9 1.12 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.512 1.132 . . . . 10.0 111.025 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 8.7 p-10 -129.25 154.4 46.85 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.073 0.463 . . . . 10.0 110.828 174.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.63 125.54 26.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.041 -0.981 . . . . 10.0 111.183 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.605 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.5 m -133.82 140.38 46.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.511 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.771 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 7.7 m -88.12 120.93 29.95 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.065 -0.516 . . . . 10.0 109.686 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.41 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -120.31 149.07 23.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.549 0.69 . . . . 10.0 110.794 -179.209 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.833 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -128.74 161.29 30.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.208 -0.905 . . . . 10.0 108.997 176.463 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.599 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -131.82 135.19 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 121.296 0.569 . . . . 10.0 111.316 -175.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -98.81 115.3 28.48 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.096 -0.956 . . . . 10.0 108.958 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.554 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 74.5 m-85 -89.08 161.56 16.46 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.113 0.483 . . . . 10.0 110.97 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.3 m -52.36 -27.01 13.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.918 -1.037 . . . . 10.0 111.171 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -118.28 -74.85 0.59 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.11 60.97 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.295 -0.955 . . . . 10.0 113.072 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.451 ' HG2' ' CG ' ' A' ' 62' ' ' ASN . 61.4 mm-40 -64.82 148.03 52.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.534 0.207 . . . . 10.0 110.449 172.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -71.3 112.11 7.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.843 -0.429 . . . . 10.0 109.843 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.777 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -175.89 -44.51 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 115.824 -0.625 . . . . 10.0 112.548 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.777 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -41.4 76.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 124.88 3.72 . . . . 10.0 115.908 -176.132 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 41' ' ' ALA . 1.2 m 161.91 108.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.081 1.352 . . . . 10.0 110.702 168.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.407 ' NH1' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -154.07 128.26 9.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.841 -0.8 . . . . 10.0 108.841 179.248 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.79 137.18 21.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 118.576 0.625 . . . . 10.0 109.986 174.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -97.87 148.42 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 115.239 -0.891 . . . . 10.0 109.783 -177.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.07 145.46 38.25 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 107.905 -1.146 . . . . 10.0 107.905 168.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -43.61 95.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.163 2.575 . . . . 10.0 112.521 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.741 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.6 14.57 55.21 Favored Glycine 0 CA--C 1.511 -0.178 0 C-N-CA 119.756 -1.211 . . . . 10.0 111.926 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.66 -176.99 35.47 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.445 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.786 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.2 m0 -117.28 165.31 13.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.411 0.624 . . . . 10.0 111.134 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -141.93 114.27 8.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.572 -1.195 . . . . 10.0 107.89 173.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.5 m -81.49 128.44 33.89 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.99 -0.55 . . . . 10.0 111.088 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.599 ' CG ' HG21 ' A' ' 33' ' ' VAL . 54.0 m-85 -137.98 144.78 41.3 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.106 -1.072 . . . . 10.0 108.106 -178.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.79 104.7 0.38 Allowed 'General case' 0 C--N 1.32 -0.712 0 O-C-N 123.618 0.574 . . . . 10.0 110.587 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.37 177.18 12.35 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.074 -1.21 . . . . 10.0 110.074 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.56 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 15.9 p90 -78.66 112.62 15.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 118.484 1.142 . . . . 10.0 110.853 -170.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.8 -178.21 45.03 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.399 -0.819 . . . . 10.0 111.86 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.9 m -70.09 -20.3 63.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.116 0.484 . . . . 10.0 110.585 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -86.38 -30.47 22.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.121 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.28 -147.62 19.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.312 -0.946 . . . . 10.0 113.503 171.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' CG ' ' HG2' ' A' ' 39' ' ' GLN . 23.2 m-80 51.53 97.29 0.01 OUTLIER 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.64 0.776 . . . . 10.0 112.737 -173.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.56 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 29.3 t80 -115.9 123.23 47.59 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.406 -0.815 . . . . 10.0 109.069 173.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.588 HG21 HG21 ' A' ' 19' ' ' THR . 1.5 m -61.11 129.3 23.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.2 p -127.31 -18.57 4.46 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.563 -0.455 . . . . 10.0 112.18 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.97 122.78 1.8 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.783 -1.198 . . . . 10.0 113.136 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.766 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -86.64 131.81 34.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.233 0.539 . . . . 10.0 109.595 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.756 ' C ' HG12 ' A' ' 6' ' ' VAL . 9.0 m170 -123.59 147.45 47.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.293 -0.867 . . . . 10.0 108.934 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.4 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -80.64 128.39 33.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 119.341 0.973 . . . . 10.0 110.835 178.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.833 ' HB2' HG22 ' A' ' 32' ' ' THR . 41.2 t -95.48 157.71 15.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.287 -177.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -103.57 148.52 35.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 173.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -26.59 85.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 1 C-N-CA 126.223 4.616 . . . . 10.0 114.896 174.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -168.0 103.77 0.47 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.867 -1.06 . . . . 10.0 111.576 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.4 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 60.9 m -84.82 117.17 68.18 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.892 -0.41 . . . . 10.0 109.892 174.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 74' ' ' THR . 13.5 Cg_endo -56.12 111.15 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.221 2.614 . . . . 10.0 112.56 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.3 p -151.31 -4.17 0.29 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.19 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.34 116.89 4.51 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.443 -0.884 . . . . 10.0 111.818 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.9 t . . . . . 0 C--O 1.249 1.042 0 CA-C-O 117.998 -1.001 . . . . 10.0 110.869 -178.617 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 110.269 -0.271 . . . . 10.0 110.269 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 84.5 m -70.83 -44.88 65.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.105 0.478 . . . . 10.0 109.849 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.09 134.65 11.94 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.681 -0.771 . . . . 10.0 112.479 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 5.0 p -101.06 122.61 48.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.717 -0.475 . . . . 10.0 109.717 174.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.73 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 30.5 Cg_endo -91.05 101.7 0.25 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.717 2.278 . . . . 10.0 112.87 -172.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.678 HG23 HG23 ' A' ' 69' ' ' THR . 0.5 OUTLIER 47.58 126.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 125.661 1.584 . . . . 10.0 114.41 -177.165 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.715 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 29.04 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.389 1.056 . . . . 10.0 112.513 168.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 2.0 mp0 -58.57 1.21 0.06 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.619 0.97 . . . . 10.0 113.619 -168.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' ALA . 28.7 m -81.21 -22.02 39.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.528 175.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.831 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.6 m -90.73 137.06 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -139.28 124.39 18.9 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.963 -0.295 . . . . 10.0 110.538 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.783 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -93.63 166.79 12.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.57 0.7 . . . . 10.0 112.316 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.657 ' O ' ' HA ' ' A' ' 19' ' ' THR . 74.8 t80 -141.39 156.47 45.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.425 -1.324 . . . . 10.0 107.425 172.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -111.93 109.24 18.92 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.288 0.566 . . . . 10.0 110.684 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.0 t -117.15 -162.84 0.88 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -63.81 92.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 10.0 111.43 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 56.8 ttp180 62.45 31.42 17.14 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.536 0.684 . . . . 10.0 110.22 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.9 107.44 4.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.873 -174.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.5 m -97.75 95.32 7.47 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.303 0.573 . . . . 10.0 109.594 167.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.783 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.8 p-10 -84.78 108.9 17.7 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.905 -1.043 . . . . 10.0 111.94 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.59 106.39 18.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.002 0.906 . . . . 10.0 109.387 175.06 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.722 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 1.3 p-80 -97.14 111.94 23.95 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.145 -1.388 . . . . 10.0 110.581 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.831 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 18.0 t-20 -82.3 157.58 23.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.871 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.49 34.58 1.16 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 121.332 -0.461 . . . . 10.0 112.112 171.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.63 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -85.17 -17.82 36.03 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 122.566 -0.373 . . . . 10.0 111.615 -176.06 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 86.88 -12.72 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.367 1.042 . . . . 10.0 111.233 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -123.06 154.44 38.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.983 0.42 . . . . 10.0 110.19 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -67.89 123.75 21.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.504 -0.771 . . . . 10.0 111.335 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.636 ' H ' HG22 ' A' ' 46' ' ' ILE . 27.3 m -125.86 139.17 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 121.176 0.513 . . . . 10.0 111.881 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.767 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 6.4 m -88.78 118.25 28.34 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.67 HG12 HG21 ' A' ' 6' ' ' VAL . 1.1 m -114.76 165.35 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 115.218 -0.901 . . . . 10.0 110.362 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.567 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.2 OUTLIER -148.49 161.17 42.17 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.669 -0.863 . . . . 10.0 108.669 178.281 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.651 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -136.49 139.94 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 121.41 0.624 . . . . 10.0 111.482 -174.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -107.04 116.37 31.81 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.981 -1.009 . . . . 10.0 109.078 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 27.8 m-85 -91.27 162.34 14.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.449 0.642 . . . . 10.0 111.348 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -54.48 -21.35 9.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.692 -1.14 . . . . 10.0 112.116 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -119.72 -85.03 0.66 Allowed 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.001 -0.437 . . . . 10.0 110.561 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.37 52.67 0.01 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 119.567 -1.301 . . . . 10.0 114.147 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -65.65 141.6 58.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.33 0.565 . . . . 10.0 109.77 169.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -72.33 120.72 18.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.071 0.462 . . . . 10.0 110.328 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.862 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -174.32 -40.61 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.246 -0.888 . . . . 10.0 112.338 -173.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.862 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 3.1 Cg_endo -44.08 70.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 124.938 3.759 . . . . 10.0 116.33 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 4.5 t 172.5 112.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.059 0.944 . . . . 10.0 110.215 163.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.513 ' HB2' ' HZ ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -151.11 119.04 6.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.308 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.767 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -78.56 128.46 38.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 173.218 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -90.63 144.66 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 115.46 -0.791 . . . . 10.0 109.621 -175.25 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -85.17 141.64 37.52 Favored Pre-proline 0 C--N 1.293 -1.868 0 N-CA-C 107.726 -1.213 . . . . 10.0 107.726 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -43.21 95.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.301 2.667 . . . . 10.0 112.942 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.721 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.76 13.67 56.36 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.554 -1.307 . . . . 10.0 111.87 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 22' ' ' HIS . . . -97.02 -170.41 33.74 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.106 -0.568 . . . . 10.0 112.846 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.722 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 10.6 m0 -121.46 166.44 14.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.546 0.689 . . . . 10.0 111.425 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.408 ' HB3' HG13 ' A' ' 21' ' ' VAL . . . -142.68 109.7 5.55 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.56 -1.2 . . . . 10.0 108.103 171.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.2 m -78.88 129.76 34.89 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.712 -0.677 . . . . 10.0 110.606 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.651 ' CG ' HG21 ' A' ' 33' ' ' VAL . 51.3 m-85 -136.58 149.9 48.3 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.93 97.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.775 0.672 . . . . 10.0 111.16 -173.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.14 -178.53 10.73 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.107 -0.797 . . . . 10.0 111.107 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 9.0 p90 -79.6 88.98 5.1 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.556 1.169 . . . . 10.0 110.771 -173.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.72 -20.39 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.542 -1.208 . . . . 10.0 112.202 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.3 t -118.62 133.05 56.15 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 122.529 -0.394 . . . . 10.0 110.5 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 62.48 10.63 4.13 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.204 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.45 10.23 59.8 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.923 -0.581 . . . . 10.0 112.946 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.551 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -79.57 137.55 37.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 117.608 0.704 . . . . 10.0 110.468 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.491 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 32.1 t80 -130.96 116.16 17.47 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.028 -0.987 . . . . 10.0 108.846 172.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.556 HG21 HG21 ' A' ' 19' ' ' THR . 1.4 m -59.9 130.14 23.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.949 -0.76 . . . . 10.0 108.949 177.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 p -122.11 -29.04 4.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.653 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -138.5 121.7 2.22 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.417 -1.373 . . . . 10.0 113.63 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.73 ' HB2' ' HB2' ' A' ' 5' ' ' PRO . 5.2 mt -84.35 146.87 27.48 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.974 -0.75 . . . . 10.0 108.974 172.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.525 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 4.2 m-70 -137.92 156.34 47.98 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.846 -0.615 . . . . 10.0 109.944 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.678 HG23 HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -82.61 127.93 33.84 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.984 -0.686 . . . . 10.0 109.59 174.596 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.567 ' HB2' HG22 ' A' ' 32' ' ' THR . 5.1 t -100.27 171.06 8.02 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.82 -0.352 . . . . 10.0 110.582 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -134.37 145.63 56.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -18.43 83.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 1 C-N-CA 126.675 4.917 . . . . 10.0 115.616 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -167.08 82.95 0.23 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.287 -1.324 . . . . 10.0 109.941 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.3 p -82.89 142.12 44.68 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.81 -0.632 . . . . 10.0 112.089 -173.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.13 169.25 22.87 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.817 2.345 . . . . 10.0 111.141 171.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.7 t -86.58 103.75 15.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.042 0.449 . . . . 10.0 111.947 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.81 170.45 46.18 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.928 -0.653 . . . . 10.0 113.811 171.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.087 -0.557 . . . . 10.0 109.693 176.128 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 109.869 -0.419 . . . . 10.0 109.869 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.0 t -165.35 158.35 16.07 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.495 -0.557 . . . . 10.0 109.495 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 116.16 -148.41 18.89 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.188 -0.765 . . . . 10.0 111.188 -177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.6 m 60.83 89.81 0.1 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.133 0.492 . . . . 10.0 111.56 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.645 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 97.9 Cg_endo -85.32 140.46 7.49 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.27 1.98 . . . . 10.0 112.147 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.6 m 47.92 -147.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.33 -0.85 . . . . 10.0 111.818 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.687 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -59.33 0.09 0.13 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.421 1.088 . . . . 10.0 113.933 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 70.49 -31.23 0.22 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.095 0.776 . . . . 10.0 113.095 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.9 m -76.44 -11.89 59.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 10.0 111.207 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.83 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -97.97 137.82 24.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.875 -0.787 . . . . 10.0 108.875 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -133.23 115.07 14.54 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.888 -0.325 . . . . 10.0 110.508 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.803 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.74 161.51 14.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.786 0.803 . . . . 10.0 113.078 177.649 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 19' ' ' THR . 69.0 t80 -141.2 145.69 35.97 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.118 -1.401 . . . . 10.0 107.272 170.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.474 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 27.1 mp0 -107.25 130.59 54.73 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.416 -0.514 . . . . 10.0 110.987 -176.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.3 t -118.81 -160.08 0.79 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.675 -1.231 . . . . 10.0 107.675 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -60.29 -48.33 82.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.847 0.356 . . . . 10.0 111.322 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -140.81 28.77 1.93 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.751 0.31 . . . . 10.0 110.949 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CE1' HG23 ' A' ' 53' ' ' THR . 0.4 OUTLIER -142.87 105.51 4.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.7 -0.227 . . . . 10.0 110.613 -173.316 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.539 HG21 HG21 ' A' ' 64' ' ' VAL . 15.6 m -95.12 98.51 10.7 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.401 -0.592 . . . . 10.0 109.401 166.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.803 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -86.35 109.27 18.88 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.382 -0.826 . . . . 10.0 112.224 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.83 107.4 20.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.862 0.839 . . . . 10.0 109.065 173.668 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.749 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 1.9 p80 -98.18 112.53 24.47 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.433 -1.258 . . . . 10.0 110.202 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.83 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 2.7 t30 -80.72 155.24 26.84 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.563 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -145.32 32.08 1.66 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.082 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.595 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -79.43 -19.95 48.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 122.831 -0.217 . . . . 10.0 111.316 -176.224 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.71 -11.73 0.68 Allowed 'General case' 0 N--CA 1.473 0.675 0 O-C-N 124.515 1.134 . . . . 10.0 111.221 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -126.43 155.4 42.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.989 0.423 . . . . 10.0 110.416 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -67.82 121.9 16.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.54 -0.755 . . . . 10.0 111.249 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.662 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.2 m -126.3 141.92 44.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 10.0 111.106 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.742 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 6.2 m -92.19 122.89 35.11 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.955 -177.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.668 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -124.01 148.02 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.8 -0.637 . . . . 10.0 111.072 -178.709 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.891 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -126.76 161.84 27.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 177.339 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.606 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.25 141.7 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.403 0.621 . . . . 10.0 111.787 -176.386 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -104.6 110.94 23.45 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.639 -1.164 . . . . 10.0 109.651 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.701 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 34.2 m-85 -93.82 159.13 15.33 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.369 0.604 . . . . 10.0 111.642 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.4 m -48.19 -34.45 10.1 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.673 -1.149 . . . . 10.0 112.786 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.445 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 54.3 m-70 -112.35 -78.3 0.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.508 -0.477 . . . . 10.0 110.41 176.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.08 63.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.053 -1.07 . . . . 10.0 112.922 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.605 ' HB2' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -72.69 144.2 47.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 178.293 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -76.33 102.07 5.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.003 0.43 . . . . 10.0 110.789 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 1.075 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -173.95 10.56 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 114.196 1.184 . . . . 10.0 114.196 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.075 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 5.3 Cg_endo -84.96 64.89 6.35 Favored 'Trans proline' 0 C--N 1.358 1.07 0 CA-C-N 122.088 1.781 . . . . 10.0 112.466 -172.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 172.41 109.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.835 0.854 . . . . 10.0 110.63 168.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.78 122.86 6.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.585 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.742 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -77.8 135.34 26.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.544 -0.462 . . . . 10.0 109.796 175.32 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.1 tp -97.94 147.05 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 115.167 -0.924 . . . . 10.0 109.064 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -85.0 143.49 40.04 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 108.248 -1.019 . . . . 10.0 108.248 168.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -44.07 94.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.41 2.74 . . . . 10.0 112.845 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.758 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 94.77 12.78 55.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 119.813 -1.184 . . . . 10.0 112.289 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.44 -173.95 33.98 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.949 -0.643 . . . . 10.0 112.326 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.749 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 15.7 m0 -117.3 166.07 12.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.535 0.683 . . . . 10.0 111.165 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.427 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -140.82 112.03 7.26 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.317 -1.364 . . . . 10.0 107.317 171.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.462 HG23 ' CE1' ' A' ' 18' ' ' TYR . 26.7 m -80.32 126.26 30.93 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.304 -0.862 . . . . 10.0 110.337 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.606 ' CG ' HG21 ' A' ' 33' ' ' VAL . 46.7 m-85 -136.26 140.8 43.72 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.06 104.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.182 0.926 . . . . 10.0 110.698 -173.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.8 -178.21 16.81 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.387 -0.911 . . . . 10.0 110.988 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.651 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 12.2 p90 -82.72 91.05 6.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.891 0.853 . . . . 10.0 110.698 -173.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.18 179.19 42.82 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.099 -0.955 . . . . 10.0 112.58 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.3 p -66.27 -28.6 68.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.243 0.545 . . . . 10.0 110.575 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -142.57 85.79 1.92 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.286 -0.87 . . . . 10.0 108.831 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.75 -139.35 3.5 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.288 -0.958 . . . . 10.0 112.955 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.701 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 23.9 m-20 -118.81 166.0 13.34 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.141 0.496 . . . . 10.0 109.777 -173.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 37.9 t80 -132.56 120.34 21.72 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.097 -0.956 . . . . 10.0 108.965 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.539 HG21 HG21 ' A' ' 19' ' ' THR . 1.7 m -65.13 129.8 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.575 -0.898 . . . . 10.0 108.575 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.2 p -117.93 -29.17 5.72 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.721 -0.392 . . . . 10.0 111.34 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.55 136.08 7.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 119.992 -1.099 . . . . 10.0 113.146 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.895 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.0 mt -95.35 129.87 42.34 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.576 -0.528 . . . . 10.0 109.576 173.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.752 ' C ' HG12 ' A' ' 6' ' ' VAL . 10.5 m170 -117.25 143.27 46.07 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.45 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -81.36 125.46 30.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.805 1.184 . . . . 10.0 111.214 -179.162 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.891 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.0 t -96.55 178.07 5.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.256 -0.884 . . . . 10.0 109.346 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.407 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.8 p-10 -145.2 149.21 40.86 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 174.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -16.98 87.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.126 1 C-N-CA 126.457 4.771 . . . . 10.0 114.951 177.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -168.52 104.84 0.44 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.354 -1.294 . . . . 10.0 109.843 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.1 p -79.42 125.73 82.43 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.699 0.285 . . . . 10.0 111.523 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.72 -53.16 0.46 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.65 2.233 . . . . 10.0 111.954 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.0 m -154.9 -54.19 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 10.0 109.925 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -170.24 -54.72 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.24 -0.744 . . . . 10.0 111.24 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 C--O 1.242 0.669 0 CA-C-O 118.081 -0.962 . . . . 10.0 108.925 174.88 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 110.088 -0.338 . . . . 10.0 110.088 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.2 m -152.11 99.51 2.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.345 -0.613 . . . . 10.0 109.345 -175.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 113.03 116.89 3.4 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.788 -0.925 . . . . 10.0 110.788 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.5 t 61.95 75.22 0.44 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 121.061 0.458 . . . . 10.0 111.198 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.519 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 92.0 Cg_endo -84.33 140.0 8.35 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.78 2.32 . . . . 10.0 112.555 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.842 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.2 m 51.53 -151.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.169 -0.923 . . . . 10.0 112.273 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.691 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -59.67 5.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.652 1.353 . . . . 10.0 114.652 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 42.5 mt-10 75.11 -39.91 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.015 0.746 . . . . 10.0 113.015 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.9 m -74.02 -12.98 60.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.868 0.322 . . . . 10.0 111.868 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.839 HG12 HD22 ' A' ' 23' ' ' ASN . 1.6 m -99.88 141.07 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.829 -0.434 . . . . 10.0 109.829 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -142.44 128.27 19.38 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 121.05 -0.26 . . . . 10.0 110.822 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.776 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -93.1 165.17 12.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.767 0.794 . . . . 10.0 113.118 176.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' THR . 77.7 t80 -144.01 149.85 37.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.281 -1.377 . . . . 10.0 107.281 171.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.4 121.65 45.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.218 0.532 . . . . 10.0 110.832 -176.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.3 t -138.28 75.54 1.53 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.845 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.7 t90 51.2 90.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.074 -0.966 . . . . 10.0 112.535 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 56' ' ' GLY . 22.8 ttt180 68.37 1.62 2.98 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.638 -0.71 . . . . 10.0 112.313 174.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -123.18 97.17 5.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.192 -0.669 . . . . 10.0 109.192 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.466 HG21 HG11 ' A' ' 64' ' ' VAL . 23.3 m -90.46 100.08 12.98 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 172.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.776 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.0 p-10 -86.09 107.91 18.04 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.914 -0.584 . . . . 10.0 111.974 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -97.78 107.41 20.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.036 0.922 . . . . 10.0 108.564 173.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.819 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.9 p-80 -96.86 114.44 26.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.021 -1.445 . . . . 10.0 110.219 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.839 HD22 HG12 ' A' ' 10' ' ' VAL . 14.1 t-20 -83.14 150.33 26.32 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.551 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.5 23.97 3.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.898 -0.668 . . . . 10.0 112.315 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.635 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -86.76 159.83 19.0 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 175.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.46 -11.55 59.96 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.045 0.387 . . . . 10.0 112.045 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -129.88 159.89 35.23 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.246 0.546 . . . . 10.0 111.462 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.41 130.42 42.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.813 -1.085 . . . . 10.0 111.24 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.523 ' H ' HG22 ' A' ' 46' ' ' ILE . 32.6 m -129.05 141.36 46.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.987 -0.551 . . . . 10.0 111.057 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.813 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 7.3 m -90.38 122.9 33.66 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.183 0.516 . . . . 10.0 109.861 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.87 150.95 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.286 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -131.86 162.67 30.03 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.508 -0.769 . . . . 10.0 108.934 175.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.596 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -134.1 144.86 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-O 121.026 0.441 . . . . 10.0 110.441 -176.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -114.93 118.87 34.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.319 -0.855 . . . . 10.0 108.964 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.578 ' HB3' ' HB2' ' A' ' 62' ' ' ASN . 22.6 m-85 -94.48 159.44 15.1 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.574 0.702 . . . . 10.0 111.953 -175.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.518 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 52.0 m -50.07 -31.04 12.14 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.132 -1.395 . . . . 10.0 113.452 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.496 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 27.5 m-70 -114.47 -67.29 1.01 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.738 -0.601 . . . . 10.0 110.426 174.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.95 62.41 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.951 -1.119 . . . . 10.0 113.125 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.573 ' HA ' ' OE1' ' A' ' 39' ' ' GLN . 7.7 mm-40 -72.47 151.52 42.48 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.922 -0.311 . . . . 10.0 110.319 172.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -80.71 100.18 8.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.333 -0.394 . . . . 10.0 111.513 -177.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.833 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.42 21.82 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 113.733 1.012 . . . . 10.0 113.733 172.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.833 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 8.8 Cg_endo -88.34 63.01 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 CA-C-N 121.165 1.452 . . . . 10.0 112.863 -171.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 75' ' ' PRO . 1.2 m 169.89 114.93 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.692 0.797 . . . . 10.0 111.646 169.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.56 132.44 7.73 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 175.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.813 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.2 p -83.81 140.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.345 0.593 . . . . 10.0 110.672 178.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.528 HG21 ' CB ' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -99.29 146.77 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-N 115.194 -0.912 . . . . 10.0 109.691 -177.212 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -88.49 139.11 29.86 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 169.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -43.13 95.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.343 2.695 . . . . 10.0 112.38 177.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.02 13.54 42.55 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.101 -1.047 . . . . 10.0 112.663 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.47 -171.65 30.67 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.886 -0.673 . . . . 10.0 113.046 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.819 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.6 m0 -121.79 165.49 15.78 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.505 0.669 . . . . 10.0 111.014 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -142.95 111.97 6.54 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.446 -1.316 . . . . 10.0 107.446 174.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 m -79.63 131.14 35.9 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.479 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.596 ' CG ' HG21 ' A' ' 33' ' ' VAL . 51.1 m-85 -140.63 145.19 36.31 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.096 -0.705 . . . . 10.0 109.096 -178.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.859 ' HB1' ' HA2' ' A' ' 61' ' ' GLY . . . -54.47 107.61 0.3 Allowed 'General case' 0 C--N 1.322 -0.589 0 O-C-N 124.024 0.827 . . . . 10.0 110.585 -176.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' O ' ' HA3' ' A' ' 61' ' ' GLY . . . -71.31 -177.03 25.5 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.836 -0.905 . . . . 10.0 110.836 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.876 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 20.1 p90 -77.4 120.98 23.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 118.465 1.132 . . . . 10.0 109.98 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 151.06 -153.58 25.06 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.404 -0.817 . . . . 10.0 111.573 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -48.92 112.71 0.65 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.485 0.314 . . . . 10.0 111.527 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 68.5 13.03 8.91 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.31 0.644 . . . . 10.0 112.373 175.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.859 ' HA2' ' HB1' ' A' ' 55' ' ' ALA . . . -114.6 -13.19 9.75 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.503 -1.332 . . . . 10.0 115.272 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 35' ' ' TYR . 7.4 m120 52.71 -101.52 0.11 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.774 0.787 . . . . 10.0 109.647 -168.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.876 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 11.1 t80 175.41 115.54 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 114.887 -1.051 . . . . 10.0 108.838 171.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 19' ' ' THR . 1.0 OUTLIER -62.33 126.2 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.312 -0.995 . . . . 10.0 108.312 171.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.4 p -118.19 -29.55 5.53 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.448 -0.501 . . . . 10.0 111.051 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -136.99 125.98 3.56 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 119.87 -1.157 . . . . 10.0 112.932 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.842 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -86.17 131.54 34.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.307 -0.627 . . . . 10.0 109.307 171.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.72 ' C ' HG12 ' A' ' 6' ' ' VAL . 12.4 m170 -119.47 147.83 43.96 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.61 -0.885 . . . . 10.0 108.61 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.457 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -82.71 126.12 32.01 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.266 -0.974 . . . . 10.0 110.318 178.165 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.623 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.2 t -96.22 161.05 14.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.85 -177.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.468 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 12.8 p-10 -104.59 137.45 19.23 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.142 -0.688 . . . . 10.0 109.142 169.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 22.1 Cg_exo -22.44 79.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 1 C-N-CA 127.058 5.172 . . . . 10.0 115.466 179.169 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -171.03 92.74 0.16 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.912 -1.04 . . . . 10.0 111.516 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 76' ' ' SER . 18.9 m -86.62 127.56 60.05 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 175.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 43' ' ' CYS . 40.1 Cg_endo -67.05 -2.48 8.02 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.146 2.564 . . . . 10.0 113.643 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.437 ' H ' HG22 ' A' ' 74' ' ' THR . 30.3 m -79.74 85.69 5.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.998 0.428 . . . . 10.0 109.912 176.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.9 114.64 4.89 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.72 -0.752 . . . . 10.0 112.362 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.089 -0.958 . . . . 10.0 109.705 179.681 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.626 0.25 . . . . 10.0 111.084 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.3 m -151.81 -59.51 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.134 0.492 . . . . 10.0 110.326 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 143.95 -82.71 0.21 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 121.068 -0.587 . . . . 10.0 111.768 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 8.5 t -119.16 148.77 45.75 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 26.4 Cg_endo -61.56 149.01 91.59 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.086 2.524 . . . . 10.0 112.805 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.911 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.5 m 50.68 -142.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.018 0.927 . . . . 10.0 111.884 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.729 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -55.73 -5.51 0.16 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.307 1.043 . . . . 10.0 113.148 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 4' ' ' SER . 36.5 mt-10 75.7 -25.93 0.2 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.87 0.868 . . . . 10.0 112.806 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.31 14.66 15.75 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 111.748 0.277 . . . . 10.0 111.748 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.852 HG12 HD22 ' A' ' 23' ' ' ASN . 1.7 m -116.72 142.06 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -135.57 118.0 15.78 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.849 -0.34 . . . . 10.0 111.529 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.74 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.36 161.75 14.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.832 0.825 . . . . 10.0 112.515 174.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -146.3 168.05 22.03 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 106.63 -1.619 . . . . 10.0 106.63 170.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.495 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -114.58 107.61 15.73 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.09 -0.644 . . . . 10.0 111.645 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 1.7 p -99.28 50.91 0.94 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.82 -0.808 . . . . 10.0 108.82 175.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 38.7 t-105 74.35 -90.44 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.262 -1.336 . . . . 10.0 111.348 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -100.02 30.99 3.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 10.0 110.93 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.486 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -154.4 107.34 2.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.403 -0.817 . . . . 10.0 109.006 -172.779 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.495 HG21 HG11 ' A' ' 64' ' ' VAL . 5.4 m -91.85 97.71 11.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.51 0.671 . . . . 10.0 109.539 170.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.74 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.8 p-10 -83.41 108.17 16.4 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.473 -1.239 . . . . 10.0 111.77 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.23 106.97 20.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 122.26 1.029 . . . . 10.0 108.927 172.518 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.805 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -97.32 111.02 23.45 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.109 -1.405 . . . . 10.0 109.982 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.852 HD22 HG12 ' A' ' 10' ' ' VAL . 13.1 t-20 -80.05 154.19 28.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.16 -0.473 . . . . 10.0 109.746 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.49 21.24 3.26 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.581 -0.608 . . . . 10.0 111.581 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.828 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -83.08 160.03 22.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.36 -0.608 . . . . 10.0 109.36 174.408 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.02 -10.71 59.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.479 -0.328 . . . . 10.0 111.465 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -128.77 159.31 36.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.406 0.622 . . . . 10.0 111.675 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.7 125.65 27.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.85 -1.068 . . . . 10.0 111.253 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.517 ' H ' HG22 ' A' ' 46' ' ' ILE . 34.1 m -125.44 143.67 38.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.961 0.41 . . . . 10.0 111.231 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.8 m -90.68 121.36 32.52 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.386 -0.598 . . . . 10.0 109.386 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.625 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -121.54 143.53 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.516 0.675 . . . . 10.0 110.994 -178.29 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -122.21 160.62 24.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.237 -0.892 . . . . 10.0 109.433 176.338 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.619 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.2 141.04 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.118 0.485 . . . . 10.0 111.61 -177.087 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -108.34 114.51 28.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.35 -0.841 . . . . 10.0 109.614 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.7 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 56.6 m-85 -90.36 156.56 18.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.277 0.561 . . . . 10.0 112.048 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.4 m -43.21 -46.09 5.94 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.134 -1.394 . . . . 10.0 113.365 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -106.99 -77.21 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.299 -0.56 . . . . 10.0 110.573 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.28 124.83 0.77 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 119.705 -1.236 . . . . 10.0 113.245 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -163.27 151.94 14.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.88 -1.156 . . . . 10.0 107.88 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -75.88 146.08 40.05 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.384 -0.526 . . . . 10.0 111.52 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.732 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 159.41 -44.31 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 114.32 -1.309 . . . . 10.0 110.138 -170.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.732 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 1.4 Cg_endo -45.34 65.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 125.283 3.989 . . . . 10.0 116.519 177.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' ALA . 1.1 m 170.72 100.73 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.431 1.093 . . . . 10.0 110.071 164.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.56 130.73 15.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.74 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -82.23 136.77 22.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.131 0.491 . . . . 10.0 110.53 178.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -96.84 145.89 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 115.24 -0.891 . . . . 10.0 109.652 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -85.24 139.44 36.43 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.063 -1.088 . . . . 10.0 108.063 167.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -43.59 98.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.182 2.588 . . . . 10.0 112.309 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.83 2.5 57.24 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.984 -1.103 . . . . 10.0 112.504 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.54 -170.86 37.58 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.975 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.805 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 15.7 m0 -120.26 166.39 13.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.422 0.63 . . . . 10.0 111.22 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -142.57 115.75 8.91 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 171.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 m -82.52 128.93 34.76 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.521 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.5 m-85 -135.89 144.41 45.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.705 -0.85 . . . . 10.0 108.705 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.09 101.95 0.07 Allowed 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.826 0.704 . . . . 10.0 110.704 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.01 -166.99 4.78 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.915 -1.038 . . . . 10.0 111.613 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.678 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.8 p90 -86.75 75.46 9.63 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.993 0.901 . . . . 10.0 110.782 -174.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.87 179.82 50.01 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.386 -0.824 . . . . 10.0 112.197 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.8 t -68.46 131.13 44.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 110.418 -0.216 . . . . 10.0 110.418 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 58.43 31.85 21.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.606 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.61 -140.59 6.4 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.559 -0.829 . . . . 10.0 112.046 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.7 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 48.4 m-20 -120.42 -155.28 0.62 Allowed 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.828 -0.804 . . . . 10.0 108.828 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.678 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 20.8 t80 -168.76 119.0 0.73 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.128 -0.942 . . . . 10.0 108.674 173.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 19' ' ' THR . 1.1 m -64.14 131.19 29.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.12 -0.696 . . . . 10.0 109.12 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.9 p -123.33 -24.41 4.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.403 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.94 125.31 2.45 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.162 -1.018 . . . . 10.0 112.549 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.911 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.0 mt -86.27 137.84 32.3 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 172.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.744 ' C ' HG12 ' A' ' 6' ' ' VAL . 8.4 m-70 -127.61 145.93 50.71 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.505 -0.77 . . . . 10.0 108.924 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.26 127.52 32.16 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.219 -0.992 . . . . 10.0 110.26 178.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.777 ' HB2' HG22 ' A' ' 32' ' ' THR . 40.5 t -93.97 155.68 17.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.914 -0.584 . . . . 10.0 109.867 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -109.63 146.61 34.4 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.041 -0.725 . . . . 10.0 109.041 173.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -24.8 84.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 1 C-N-CA 126.212 4.608 . . . . 10.0 114.746 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -171.81 101.83 0.18 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.539 -1.21 . . . . 10.0 110.904 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.6 m -81.98 129.6 63.79 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.733 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.5 118.46 5.55 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.382 2.055 . . . . 10.0 111.442 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.2 t -151.93 7.51 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.793 0.33 . . . . 10.0 110.881 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.93 -8.97 87.52 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.758 -0.734 . . . . 10.0 112.513 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.851 -0.595 . . . . 10.0 110.377 179.454 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.684 0.278 . . . . 10.0 110.254 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.5 m -75.3 125.27 28.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.14 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.19 99.6 2.56 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.202 -0.759 . . . . 10.0 111.202 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.513 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 14.1 m -88.08 162.03 41.92 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.466 0.174 . . . . 10.0 110.603 -174.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 4' ' ' SER . 41.3 Cg_endo -67.52 143.4 62.78 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.244 1.963 . . . . 10.0 111.717 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.726 HG23 ' N ' ' A' ' 7' ' ' ALA . 1.2 m 56.44 -150.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 115.429 -0.805 . . . . 10.0 111.113 177.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.726 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.29 -1.7 0.09 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.4 1.08 . . . . 10.0 113.891 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.499 ' HG2' ' HB2' ' A' ' 4' ' ' SER . 27.0 mt-10 74.08 -29.18 0.19 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.184 0.994 . . . . 10.0 112.946 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.0 m -80.48 -12.27 59.57 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.027 0.38 . . . . 10.0 112.027 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.811 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.9 m -96.42 140.18 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 -175.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -138.79 120.17 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.953 -0.299 . . . . 10.0 110.345 -175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.722 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.2 171.19 8.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.733 0.778 . . . . 10.0 112.626 178.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 19' ' ' THR . 34.3 t80 -149.15 179.99 7.47 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.235 -1.394 . . . . 10.0 107.235 172.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -127.34 116.44 20.52 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.501 0.667 . . . . 10.0 111.156 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 t -121.48 84.19 2.2 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 173.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 59.27 -105.28 0.23 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.333 -0.849 . . . . 10.0 111.047 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 65.8 ttt180 -103.18 24.85 10.25 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.595 0.712 . . . . 10.0 110.13 -177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.98 95.56 4.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.78 -0.646 . . . . 10.0 109.405 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.563 HG21 HG21 ' A' ' 64' ' ' VAL . 2.6 m -86.54 98.82 11.28 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 170.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.722 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -86.65 103.99 15.64 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.195 -0.911 . . . . 10.0 112.123 -176.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -96.24 107.16 19.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.74 -0.837 . . . . 10.0 108.74 174.317 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.797 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 3.6 p-80 -97.39 113.46 25.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.621 -1.172 . . . . 10.0 110.439 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.811 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 t30 -79.41 150.18 31.41 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.679 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.97 16.02 5.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.775 -0.726 . . . . 10.0 112.39 175.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.43 154.96 23.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 174.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.43 -8.9 57.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.346 0.499 . . . . 10.0 112.346 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -127.25 160.63 30.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.51 0.671 . . . . 10.0 112.145 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -71.06 124.12 23.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.68 -1.145 . . . . 10.0 111.583 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.59 ' H ' HG22 ' A' ' 46' ' ' ILE . 30.7 m -125.61 141.06 46.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.322 0.582 . . . . 10.0 111.523 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.672 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 10.6 m -89.78 122.53 32.95 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 m -120.44 153.09 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.444 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.768 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -130.73 157.99 41.31 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.38 -0.827 . . . . 10.0 109.482 176.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.643 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.48 139.78 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 121.14 0.495 . . . . 10.0 110.523 -178.032 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.09 117.48 34.11 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.128 -0.942 . . . . 10.0 109.323 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.62 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 44.1 m-85 -90.57 155.75 18.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.083 0.468 . . . . 10.0 111.504 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 51.8 m -44.61 -41.93 6.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.824 -1.08 . . . . 10.0 112.731 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.46 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 78.3 m-70 -102.86 -87.54 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.648 -0.421 . . . . 10.0 110.556 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.26 130.89 1.23 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.823 -0.703 . . . . 10.0 111.93 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -172.68 151.74 2.4 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.9 p90 -76.27 144.34 40.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.127 0.489 . . . . 10.0 110.407 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.762 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 158.51 -37.4 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 124.997 1.319 . . . . 10.0 110.855 -169.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.762 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 9.9 Cg_endo -53.39 61.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 124.079 3.186 . . . . 10.0 115.504 176.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.539 ' HB3' ' HD3' ' A' ' 75' ' ' PRO . 5.1 t 177.69 105.07 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.501 0.72 . . . . 10.0 109.367 163.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -145.15 122.95 11.9 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.315 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.672 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.26 128.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 174.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -92.67 146.11 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 CA-C-N 114.638 -1.164 . . . . 10.0 109.141 -176.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.34 142.55 43.7 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 107.957 -1.127 . . . . 10.0 107.957 168.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.406 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 13.0 Cg_exo -47.59 96.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.89 2.393 . . . . 10.0 112.034 174.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 101.05 5.19 53.56 Favored Glycine 0 C--O 1.229 -0.166 0 C-N-CA 120.064 -1.065 . . . . 10.0 112.232 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.44 -176.39 37.29 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 121.069 -0.586 . . . . 10.0 112.979 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.797 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 20.5 m0 -117.04 164.7 14.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.647 0.737 . . . . 10.0 110.966 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.457 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -138.4 113.76 9.54 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 171.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.7 m -82.25 128.66 34.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.07 -0.514 . . . . 10.0 109.994 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.643 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.4 m-85 -137.02 139.22 41.24 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.042 -1.096 . . . . 10.0 108.042 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.29 101.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.375 1.047 . . . . 10.0 111.015 -176.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.17 -178.8 11.21 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.605 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 2.5 p90 -85.25 50.07 1.88 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.165 0.983 . . . . 10.0 110.799 -172.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.93 141.68 16.5 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.235 -1.146 . . . . 10.0 110.235 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.9 m 66.31 14.51 9.71 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.251 0.548 . . . . 10.0 110.301 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 58.35 35.84 25.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.433 -0.803 . . . . 10.0 111.526 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.22 -99.5 0.69 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.848 -0.691 . . . . 10.0 111.743 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.62 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 2.6 m-80 -106.06 145.33 31.55 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 109.287 -0.635 . . . . 10.0 109.287 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 21.7 t80 -125.04 120.72 32.3 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.563 HG21 HG21 ' A' ' 19' ' ' THR . 1.8 m -63.55 130.11 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 174.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 73.4 p -122.3 -30.73 3.94 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.317 -0.553 . . . . 10.0 111.328 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.73 124.16 3.37 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 119.603 -1.284 . . . . 10.0 113.279 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.606 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -88.26 141.55 28.46 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.93 -0.767 . . . . 10.0 108.93 172.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.711 ' C ' HG12 ' A' ' 6' ' ' VAL . 3.9 m-70 -132.09 149.61 52.36 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.339 -0.846 . . . . 10.0 108.772 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -81.98 128.59 34.24 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.219 -0.992 . . . . 10.0 110.025 176.557 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.768 ' HB2' HG22 ' A' ' 32' ' ' THR . 5.5 t -98.06 168.94 9.96 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 73' ' ' ALA . 6.0 p-10 -142.79 146.38 37.62 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 34.4 Cg_exo -22.78 74.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 1 C-N-CA 127.341 5.36 . . . . 10.0 115.59 176.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 71' ' ' ASP . . . -172.18 76.42 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.681 -1.145 . . . . 10.0 109.152 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.04 139.16 79.38 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.631 -0.713 . . . . 10.0 112.403 -170.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 43' ' ' CYS . 73.3 Cg_endo -76.84 122.5 6.36 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.211 2.607 . . . . 10.0 113.246 -174.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.7 m -97.8 173.37 7.13 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.448 -0.797 . . . . 10.0 109.599 173.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.34 -55.35 31.2 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.842 -0.694 . . . . 10.0 111.717 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.6 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.267 -0.873 . . . . 10.0 108.988 173.355 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 110.12 -0.326 . . . . 10.0 110.12 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.87 89.03 1.37 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.283 0.563 . . . . 10.0 111.123 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -168.02 113.9 0.55 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.042 -0.823 . . . . 10.0 111.042 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.46 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 1.9 m -94.17 157.19 38.07 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 120.707 0.289 . . . . 10.0 111.115 -174.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.429 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 39.7 Cg_endo -66.37 153.17 79.04 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.008 2.472 . . . . 10.0 111.924 175.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.824 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.8 m 48.31 -146.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.181 -0.918 . . . . 10.0 111.745 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.697 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.35 -0.57 0.1 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.39 1.076 . . . . 10.0 113.889 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.46 ' HG2' ' HB2' ' A' ' 4' ' ' SER . 21.4 mt-10 70.36 -24.5 0.16 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.683 0.793 . . . . 10.0 113.043 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.0 m -78.27 -15.01 59.18 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.41 0.148 . . . . 10.0 111.346 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.9 HG12 HD22 ' A' ' 23' ' ' ASN . 2.0 m -100.45 143.55 13.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.092 -0.336 . . . . 10.0 110.092 -174.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -141.23 125.38 17.36 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.513 -0.18 . . . . 10.0 110.513 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -96.05 162.43 13.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.814 0.816 . . . . 10.0 112.885 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -143.84 138.1 28.42 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.379 -1.282 . . . . 10.0 107.703 172.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -103.48 127.25 50.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.997 0.427 . . . . 10.0 111.02 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.1 m -131.23 -155.98 0.73 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.294 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -63.36 93.82 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.936 0.398 . . . . 10.0 110.852 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.456 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 98.1 mtt180 61.33 30.01 18.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.512 -0.767 . . . . 10.0 111.487 173.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.89 106.44 3.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.805 -0.443 . . . . 10.0 109.805 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.52 HG21 HG21 ' A' ' 64' ' ' VAL . 16.2 m -94.73 102.08 13.94 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.98 -0.378 . . . . 10.0 109.98 168.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.739 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.3 p-10 -88.05 111.7 21.83 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.903 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.73 107.58 21.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.936 0.874 . . . . 10.0 108.897 172.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.763 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 2.7 p80 -97.23 114.71 26.48 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.399 -1.273 . . . . 10.0 110.025 176.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.9 HD22 HG12 ' A' ' 10' ' ' VAL . 12.3 t-20 -80.79 153.96 27.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.721 177.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.56 25.38 3.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.552 -0.832 . . . . 10.0 112.586 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.596 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -88.42 164.56 15.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 176.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.58 -15.99 56.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.032 0.382 . . . . 10.0 112.032 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -128.15 156.42 42.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.259 0.552 . . . . 10.0 111.774 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.29 126.52 28.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.894 -1.048 . . . . 10.0 111.648 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.607 ' H ' HG22 ' A' ' 46' ' ' ILE . 34.3 m -124.62 146.0 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-O 121.125 0.488 . . . . 10.0 111.059 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.672 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.3 m -95.21 122.87 38.35 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.635 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.573 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -123.07 151.33 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 115.769 -0.65 . . . . 10.0 110.658 -177.218 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.854 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -130.21 163.08 27.48 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.227 -0.897 . . . . 10.0 109.116 175.371 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.662 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.4 131.07 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 120.865 0.364 . . . . 10.0 110.089 -176.36 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -103.12 115.29 30.31 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.505 -0.77 . . . . 10.0 109.103 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.651 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 41.4 m-85 -86.26 162.35 18.32 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.729 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.1 m -50.17 -23.42 2.18 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.737 -1.12 . . . . 10.0 112.446 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -131.06 -74.01 0.53 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.919 -0.488 . . . . 10.0 110.402 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.87 133.74 2.29 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.32 -1.112 . . . . 10.0 110.32 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.09 24.76 0.37 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.003 0.43 . . . . 10.0 110.412 -174.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 36.0 t90 58.87 103.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.212 -0.904 . . . . 10.0 112.149 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.703 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -173.83 -45.07 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.355 -0.839 . . . . 10.0 111.587 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.703 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 2.6 Cg_endo -38.27 100.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 123.951 3.101 . . . . 10.0 114.308 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.0 m 129.51 100.38 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.241 1.816 . . . . 10.0 111.244 168.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.808 HH21 HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -153.37 130.96 11.47 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.9 -1.045 . . . . 10.0 108.293 -178.601 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.672 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -84.56 138.42 19.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.485 0.66 . . . . 10.0 110.731 178.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -99.09 148.77 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.457 -1.247 . . . . 10.0 109.692 -177.186 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -87.66 142.62 32.86 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.803 -1.184 . . . . 10.0 107.803 168.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -45.46 93.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.042 2.494 . . . . 10.0 112.843 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.02 15.11 37.24 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.047 -1.073 . . . . 10.0 112.523 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.78 -174.64 28.11 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.084 -0.579 . . . . 10.0 112.733 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.763 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 16.5 m0 -117.61 167.13 11.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.637 0.732 . . . . 10.0 111.653 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -144.64 113.72 6.91 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.56 -1.2 . . . . 10.0 107.982 171.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 m -82.63 131.88 35.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.989 -175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.662 ' CG ' HG21 ' A' ' 33' ' ' VAL . 46.6 m-85 -140.0 144.51 36.99 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.35 -0.981 . . . . 10.0 108.35 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.22 101.98 0.06 Allowed 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 124.131 0.894 . . . . 10.0 111.151 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.14 175.54 42.23 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.247 -0.977 . . . . 10.0 110.86 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.456 ' HD1' ' H ' ' A' ' 57' ' ' TYR . 2.6 p90 -84.28 55.66 3.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.38 1.09 . . . . 10.0 110.041 -177.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.456 ' HA3' ' CG ' ' A' ' 17' ' ' ARG . . . -88.6 5.14 84.96 Favored Glycine 0 N--CA 1.454 -0.144 0 CA-C-N 114.914 -1.039 . . . . 10.0 113.371 -171.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 m -152.71 37.7 0.52 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.525 -0.917 . . . . 10.0 108.525 174.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 66.2 -89.09 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 114.875 -1.057 . . . . 10.0 108.605 -170.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 31.83 -111.88 0.05 OUTLIER Glycine 0 N--CA 1.468 0.82 0 O-C-N 124.698 1.249 . . . . 10.0 114.445 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.651 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -99.39 140.63 33.28 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.413 0.625 . . . . 10.0 110.815 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -124.43 114.1 19.04 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.97 -1.013 . . . . 10.0 109.007 172.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.52 HG21 HG21 ' A' ' 19' ' ' THR . 0.9 OUTLIER -60.19 125.75 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 174.346 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.0 t -138.41 6.56 2.54 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.466 -0.494 . . . . 10.0 110.936 -175.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -156.23 107.17 0.31 Allowed Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 119.246 -1.454 . . . . 10.0 113.395 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.824 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.9 mt -82.28 128.35 34.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.696 -0.853 . . . . 10.0 108.696 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.742 ' C ' HG12 ' A' ' 6' ' ' VAL . 8.5 m-70 -122.36 143.32 49.72 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.254 -0.884 . . . . 10.0 108.685 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -77.76 129.74 35.86 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.055 -1.028 . . . . 10.0 110.445 179.351 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.854 ' HB2' HG22 ' A' ' 32' ' ' THR . 44.6 t -99.91 157.76 16.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.394 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -106.93 145.3 30.83 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 171.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -19.16 81.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.997 1 C-N-CA 126.788 4.992 . . . . 10.0 115.093 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 43' ' ' CYS . . . -172.33 121.06 0.43 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.777 -1.101 . . . . 10.0 108.738 -175.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.808 HG21 HH21 ' A' ' 44' ' ' ARG . 8.0 t -141.86 138.93 17.54 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 109.116 -0.698 . . . . 10.0 109.116 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.474 ' HD2' ' O ' ' A' ' 43' ' ' CYS . 14.3 Cg_endo -57.66 101.97 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.198 2.598 . . . . 10.0 113.356 -175.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.6 m -81.6 82.57 7.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.905 -0.589 . . . . 10.0 109.715 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.81 -93.19 1.52 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.584 -0.735 . . . . 10.0 112.15 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.873 -0.584 . . . . 10.0 109.997 -177.509 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.559 0.218 . . . . 10.0 110.503 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.2 t -173.38 -47.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.538 -0.301 . . . . 10.0 110.315 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.48 166.67 12.25 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.586 -0.606 . . . . 10.0 111.586 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.65 ' HB3' ' HG2' ' A' ' 8' ' ' GLU . 13.1 m -126.85 101.69 26.11 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 121.026 0.441 . . . . 10.0 111.418 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.46 144.5 20.25 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.164 2.576 . . . . 10.0 111.757 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.727 HG23 ' N ' ' A' ' 7' ' ' ALA . 1.4 m 51.35 -151.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.304 -0.862 . . . . 10.0 111.732 174.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.727 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -60.4 9.4 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.342 1.238 . . . . 10.0 114.342 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.65 ' HG2' ' HB3' ' A' ' 4' ' ' SER . 47.8 mt-10 75.79 -49.72 0.61 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.454 0.909 . . . . 10.0 113.454 176.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 60.9 m -73.57 -9.67 58.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.68 0.276 . . . . 10.0 111.442 -170.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.834 HG12 HD22 ' A' ' 23' ' ' ASN . 1.5 m -98.73 132.82 43.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.917 -0.772 . . . . 10.0 108.917 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -139.57 126.82 21.29 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.85 -0.34 . . . . 10.0 110.207 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -90.65 163.24 14.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.767 0.794 . . . . 10.0 111.937 177.313 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.431 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 55.8 t80 -142.27 155.91 45.25 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.073 -1.455 . . . . 10.0 107.073 171.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.444 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -103.31 94.38 5.47 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.481 0.657 . . . . 10.0 111.208 -177.696 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.673 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 38.3 m -86.37 60.75 6.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.148 -0.933 . . . . 10.0 108.54 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.8 t90 66.35 -92.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.985 -1.007 . . . . 10.0 110.87 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -110.92 40.85 1.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.668 0.747 . . . . 10.0 109.534 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.673 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 1.7 t80 -151.08 99.57 2.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.013 -0.994 . . . . 10.0 108.496 -175.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 12' ' ' TYR . 2.5 m -87.12 98.26 11.2 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.345 0.593 . . . . 10.0 109.783 173.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.73 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.1 p-10 -87.54 104.94 16.96 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.723 -1.126 . . . . 10.0 111.445 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -96.12 105.22 16.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.497 -0.927 . . . . 10.0 108.497 174.541 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.8 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 3.3 p80 -95.51 112.95 24.57 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.362 -1.29 . . . . 10.0 110.063 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.834 HD22 HG12 ' A' ' 10' ' ' VAL . 14.1 t-20 -81.65 150.1 28.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.737 175.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.14 25.39 3.33 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.078 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.713 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.5 OUTLIER -89.01 162.59 15.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 176.168 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.59 -12.96 59.82 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.275 0.472 . . . . 10.0 112.275 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -120.68 152.32 38.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.443 0.64 . . . . 10.0 112.449 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.7 118.54 11.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.894 -1.048 . . . . 10.0 110.735 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.548 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.4 m -121.74 137.81 54.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.332 0.586 . . . . 10.0 112.049 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.709 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.4 m -87.46 122.76 31.61 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.786 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.09 151.69 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 115.256 -0.883 . . . . 10.0 110.711 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.775 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -130.1 160.0 35.07 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.964 -0.754 . . . . 10.0 108.964 176.198 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.637 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.36 132.78 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.42 0.629 . . . . 10.0 110.81 -177.655 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -102.53 114.16 28.13 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.806 -1.088 . . . . 10.0 108.97 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 53.3 m-85 -89.84 164.73 14.5 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.575 0.702 . . . . 10.0 112.265 -175.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -52.81 -32.91 46.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.191 -1.368 . . . . 10.0 111.597 169.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.411 ' HD2' ' H ' ' A' ' 62' ' ' ASN . 87.8 m-70 -106.98 -86.22 0.5 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.813 0.34 . . . . 10.0 110.698 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.81 53.22 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.747 -0.74 . . . . 10.0 111.717 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.11 138.39 55.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -73.11 107.48 5.47 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.989 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -167.13 -42.15 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 118.281 -0.866 . . . . 10.0 112.879 -173.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.989 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 1.6 Cg_endo -41.77 70.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 125.151 3.9 . . . . 10.0 116.877 -173.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.748 ' HB3' ' HD3' ' A' ' 75' ' ' PRO . 5.7 t 173.77 110.2 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.807 0.843 . . . . 10.0 109.735 164.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.472 ' NE ' ' HA ' ' A' ' 44' ' ' ARG . 0.6 OUTLIER -149.52 121.09 7.99 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.935 177.329 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -77.98 127.18 38.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.998 -0.741 . . . . 10.0 108.998 173.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -91.41 146.78 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 114.589 -1.187 . . . . 10.0 109.478 -175.593 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.03 133.05 41.91 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 107.443 -1.317 . . . . 10.0 107.443 168.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -43.11 96.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.189 2.593 . . . . 10.0 112.369 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 103.19 7.6 43.13 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.343 -0.932 . . . . 10.0 113.084 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.16 -171.79 28.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.098 -0.572 . . . . 10.0 113.589 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.8 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 20.3 m0 -118.43 167.31 11.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.333 0.587 . . . . 10.0 110.896 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.58 114.84 8.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.327 -1.36 . . . . 10.0 107.327 171.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.0 m -83.45 130.21 35.02 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.757 -173.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.637 ' CG ' HG21 ' A' ' 33' ' ' VAL . 56.9 m-85 -138.72 146.63 41.73 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.8 102.59 0.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.601 0.563 . . . . 10.0 110.493 -174.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.97 -169.54 15.15 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.54 -0.838 . . . . 10.0 111.077 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.666 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 6.3 p90 -84.96 88.36 7.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 122.014 0.912 . . . . 10.0 110.86 -174.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -134.07 -82.19 0.18 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.49 -0.777 . . . . 10.0 112.405 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m -84.62 113.0 20.95 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.853 -0.204 . . . . 10.0 110.542 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 63.14 22.52 13.44 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.958 0.409 . . . . 10.0 110.944 -176.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 57' ' ' TYR . . . 78.19 -95.33 1.29 Allowed Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.368 -0.92 . . . . 10.0 111.471 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.522 ' O ' ' HD2' ' A' ' 35' ' ' TYR . 89.1 m-20 61.33 23.62 13.83 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 122.973 0.509 . . . . 10.0 110.87 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.666 ' HD1' ' HB3' ' A' ' 57' ' ' TYR . 89.6 t80 -58.54 110.36 0.97 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.559 -177.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.693 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.3 m -60.65 136.89 23.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 172.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.5 t -144.77 12.82 1.48 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.196 -0.602 . . . . 10.0 111.89 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.04 110.62 0.45 Allowed Glycine 0 C--O 1.224 -0.504 0 C-N-CA 119.438 -1.363 . . . . 10.0 113.482 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.611 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.5 mt -84.65 133.78 34.39 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.388 0.613 . . . . 10.0 109.701 173.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.704 ' C ' HG12 ' A' ' 6' ' ' VAL . 27.2 m-70 -127.06 149.58 49.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.033 -0.985 . . . . 10.0 108.706 -176.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.436 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -83.67 129.41 34.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 119.485 1.039 . . . . 10.0 110.381 177.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.775 ' HB2' HG22 ' A' ' 32' ' ' THR . 5.2 t -98.89 172.9 7.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.349 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -130.35 149.03 72.21 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.917 -0.771 . . . . 10.0 108.917 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -20.91 78.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.11 1 C-N-CA 126.777 4.984 . . . . 10.0 115.272 174.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -167.42 68.97 0.09 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.661 -1.154 . . . . 10.0 109.898 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 67.1 m -70.55 131.43 88.08 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.777 -175.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 43' ' ' CYS . 4.1 Cg_endo -47.54 116.28 1.77 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.829 3.02 . . . . 10.0 112.91 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.4 t -158.26 -34.6 0.07 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.27 -0.877 . . . . 10.0 109.082 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.11 28.65 27.63 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.618 -0.801 . . . . 10.0 112.598 175.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.246 0.893 0 CA-C-O 119.192 -0.432 . . . . 10.0 110.957 -179.518 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 110.168 -0.308 . . . . 10.0 110.168 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.4 p -72.75 -24.73 61.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.943 -176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.11 -97.87 0.11 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.494 -0.86 . . . . 10.0 112.138 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.793 ' HB3' ' HG2' ' A' ' 8' ' ' GLU . 37.8 m 58.57 79.94 0.3 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 121.154 0.502 . . . . 10.0 111.103 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.0 -42.79 1.41 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.588 2.192 . . . . 10.0 113.349 -174.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.628 HG23 HG23 ' A' ' 69' ' ' THR . 0.2 OUTLIER -157.07 118.72 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.584 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.61 -19.54 0.16 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.505 0.722 . . . . 10.0 112.58 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.793 ' HG2' ' HB3' ' A' ' 4' ' ' SER . 32.6 mt-10 74.49 -28.32 0.19 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.283 1.033 . . . . 10.0 112.041 175.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.0 m -87.18 -10.26 53.11 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.919 0.34 . . . . 10.0 111.919 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -95.56 134.85 31.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.871 -0.788 . . . . 10.0 108.871 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -135.82 121.58 19.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.787 -0.188 . . . . 10.0 110.594 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.813 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -98.18 161.33 13.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.146 0.795 . . . . 10.0 113.146 178.601 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 19' ' ' THR . 82.9 t80 -148.05 155.62 41.69 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 171.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.15 124.95 52.47 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.318 -0.553 . . . . 10.0 110.606 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.2 t -136.75 77.2 1.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.25 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 55.95 86.79 0.06 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.215 -0.902 . . . . 10.0 112.092 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 67.49 14.14 9.52 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.965 -0.561 . . . . 10.0 112.271 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -139.03 96.52 3.13 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.521 -0.548 . . . . 10.0 109.521 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.5 m -87.46 100.4 12.73 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.656 -0.498 . . . . 10.0 109.656 171.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.813 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.4 p-10 -83.63 111.42 19.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 114.948 -1.024 . . . . 10.0 111.829 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.98 106.65 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 122.015 0.912 . . . . 10.0 108.883 171.554 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.784 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -97.51 112.07 24.07 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.14 -1.391 . . . . 10.0 110.545 179.02 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.762 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.5 t-20 -80.72 160.03 25.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.89 -0.595 . . . . 10.0 110.255 177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -154.5 32.0 0.7 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.638 -0.791 . . . . 10.0 111.764 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -83.05 -18.4 39.85 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 122.132 0.173 . . . . 10.0 111.015 -178.375 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 86.35 -8.34 0.73 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.753 1.283 . . . . 10.0 111.08 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 10.9 p-10 -125.07 155.05 40.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.121 0.486 . . . . 10.0 110.841 175.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.67 123.22 20.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.292 -0.867 . . . . 10.0 111.183 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.609 ' H ' HG22 ' A' ' 46' ' ' ILE . 26.8 m -126.03 139.79 50.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.067 0.46 . . . . 10.0 111.364 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.774 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 9.5 m -88.93 119.67 29.65 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.509 -0.552 . . . . 10.0 109.509 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' CYS . 1.1 m -116.66 165.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 115.401 -0.818 . . . . 10.0 110.51 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.489 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -148.57 158.16 43.94 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.641 -0.709 . . . . 10.0 109.206 178.221 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.627 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -135.23 138.22 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.338 0.59 . . . . 10.0 111.717 -173.307 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -101.22 125.99 47.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.947 -1.024 . . . . 10.0 108.908 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 57.0 m-85 -95.07 165.6 12.34 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.247 -0.581 . . . . 10.0 110.351 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 88.0 m -49.4 -21.07 0.8 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.245 -0.889 . . . . 10.0 112.142 174.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -118.96 -67.05 1.02 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 174.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.04 50.65 0.07 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.735 -0.745 . . . . 10.0 112.352 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -74.43 158.98 32.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.73 0.3 . . . . 10.0 111.362 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -66.92 112.87 4.54 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.388 0.614 . . . . 10.0 112.224 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.693 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -174.82 -47.72 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 CA-C-N 114.844 -1.071 . . . . 10.0 111.101 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.693 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 3.0 Cg_endo -37.06 96.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 124.273 3.316 . . . . 10.0 114.128 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 1.6 m 135.99 108.19 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.0 1.72 . . . . 10.0 111.202 170.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.76 130.58 7.44 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -83.45 135.74 24.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.392 0.615 . . . . 10.0 110.236 176.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.37 146.79 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.829 -1.078 . . . . 10.0 109.994 -176.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -88.27 141.56 30.95 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 168.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -38.9 98.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.71 2.94 . . . . 10.0 113.02 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.721 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 89.37 12.22 63.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 119.603 -1.284 . . . . 10.0 112.23 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.28 -176.63 36.03 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 121.276 -0.488 . . . . 10.0 112.214 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.784 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 23.6 m0 -116.65 165.16 13.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.552 0.692 . . . . 10.0 111.182 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -139.46 115.87 10.56 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.14 -1.43 . . . . 10.0 107.14 172.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.0 m -85.2 127.88 34.46 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.374 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.627 ' CG ' HG21 ' A' ' 33' ' ' VAL . 48.5 m-85 -137.42 139.43 40.68 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.462 -0.94 . . . . 10.0 108.462 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.54 100.04 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.172 0.92 . . . . 10.0 111.324 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.29 175.07 43.44 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.233 -1.147 . . . . 10.0 110.233 176.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.44 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 7.7 p90 -83.93 91.05 7.5 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.742 1.271 . . . . 10.0 109.96 -174.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.18 -50.45 6.77 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.166 -0.925 . . . . 10.0 112.525 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.1 p -116.17 26.2 10.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.797 0.332 . . . . 10.0 110.578 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 65.45 14.73 9.64 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.734 -0.667 . . . . 10.0 111.375 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.81 -88.33 0.19 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.782 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -92.62 113.72 26.07 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.451 ' HB3' ' OG1' ' A' ' 36' ' ' THR . 26.9 t80 -115.63 116.84 28.81 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 172.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -61.3 129.02 23.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.9 p -128.23 -16.37 4.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.136 -0.484 . . . . 10.0 111.678 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.37 110.65 0.66 Allowed Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 119.226 -1.464 . . . . 10.0 113.709 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.3 mt -82.36 150.53 27.12 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.069 -0.715 . . . . 10.0 109.069 171.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.515 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -148.22 159.65 43.75 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.264 -178.044 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.628 HG23 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -81.44 126.61 31.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.033 0.444 . . . . 10.0 110.66 174.402 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 30' ' ' SER . 48.9 t -98.92 166.97 11.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.492 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -124.04 143.6 42.86 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.164 -0.68 . . . . 10.0 109.164 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -17.37 82.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.803 1 C-N-CA 126.754 4.969 . . . . 10.0 115.115 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -168.96 96.77 0.36 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.538 -1.21 . . . . 10.0 110.229 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.5 m -95.7 114.54 64.22 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 111.885 0.328 . . . . 10.0 111.885 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 43' ' ' CYS . 37.1 Cg_endo -66.92 124.1 11.83 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.894 2.396 . . . . 10.0 112.007 175.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.8 m 60.4 74.78 0.43 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.723 -0.672 . . . . 10.0 111.211 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.2 -150.65 25.02 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.837 -0.697 . . . . 10.0 111.827 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t . . . . . 0 C--O 1.245 0.863 0 CA-C-O 117.847 -1.073 . . . . 10.0 110.321 -176.604 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.463 -0.199 . . . . 10.0 110.463 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 t -162.3 -41.92 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.785 -0.189 . . . . 10.0 111.113 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.96 -17.89 28.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.182 -1.009 . . . . 10.0 112.32 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 t -145.17 95.9 5.03 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 110.034 -0.358 . . . . 10.0 110.034 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 36.0 Cg_endo -87.83 -67.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.559 2.173 . . . . 10.0 112.62 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.584 HG12 ' HB3' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -151.93 124.42 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 177.141 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 71.06 -27.54 0.17 Allowed 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.752 0.657 . . . . 10.0 111.88 172.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 6' ' ' VAL . 47.0 mt-10 77.68 -20.17 0.39 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.609 1.163 . . . . 10.0 111.36 175.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.9 m -84.18 -14.46 50.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.414 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.786 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -96.03 134.19 34.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -133.1 119.6 20.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.583 -175.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.787 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -96.71 162.04 13.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.024 0.916 . . . . 10.0 113.296 177.131 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 19' ' ' THR . 33.5 t80 -143.04 178.98 7.32 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.407 -1.701 . . . . 10.0 106.407 169.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -136.96 117.35 13.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.457 0.571 . . . . 10.0 111.349 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 p -120.66 86.65 2.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.664 -0.698 . . . . 10.0 109.85 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 62.72 -84.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.998 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -120.31 16.75 12.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.983 0.42 . . . . 10.0 110.933 -172.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.69 96.45 3.82 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.218 -0.66 . . . . 10.0 109.218 -173.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.504 HG21 HG11 ' A' ' 64' ' ' VAL . 7.0 m -86.17 99.12 11.3 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.624 0.726 . . . . 10.0 109.192 171.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.787 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.0 p-10 -85.27 109.67 18.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.434 -1.257 . . . . 10.0 111.926 -175.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.36 106.48 19.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 172.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.738 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -98.37 110.96 23.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.068 -1.424 . . . . 10.0 110.297 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.786 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 18.6 t-20 -80.98 154.91 26.68 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.957 -0.565 . . . . 10.0 109.939 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.25 36.13 1.03 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.579 -0.82 . . . . 10.0 112.177 173.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -76.59 -66.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.457 -0.306 . . . . 10.0 110.449 -178.032 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 25' ' ' CYS . . . 142.42 -32.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.815 1.322 . . . . 10.0 108.699 -171.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -115.33 157.67 23.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.111 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.35 127.22 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.492 -0.776 . . . . 10.0 111.319 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.599 ' H ' HG22 ' A' ' 46' ' ' ILE . 30.8 m -125.47 139.55 50.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.072 0.463 . . . . 10.0 111.268 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.826 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 14.7 m -88.3 119.7 28.96 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.273 -0.64 . . . . 10.0 109.273 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.442 HG12 HG21 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -119.12 148.45 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 121.775 0.798 . . . . 10.0 111.732 -178.305 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -127.16 160.88 29.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.8 -1.091 . . . . 10.0 109.287 176.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.73 138.95 47.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.33 0.585 . . . . 10.0 111.867 -178.154 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -100.81 120.36 40.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.72 -1.127 . . . . 10.0 109.241 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.85 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 35.1 m-85 -100.13 158.96 15.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.295 0.569 . . . . 10.0 111.55 -178.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.529 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 22.7 m -48.48 -34.9 11.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.608 -1.178 . . . . 10.0 112.601 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.441 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 53.4 m-70 -103.29 -83.6 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.931 -0.48 . . . . 10.0 109.876 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.4 49.63 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.246 -0.978 . . . . 10.0 112.898 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -66.3 153.24 43.15 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.088 -0.338 . . . . 10.0 110.088 173.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 14.5 p90 -75.7 136.68 40.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.866 -0.79 . . . . 10.0 108.866 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.73 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 165.95 -42.52 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 123.57 0.748 . . . . 10.0 111.329 -170.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.73 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 6.3 Cg_endo -48.69 71.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 124.212 3.275 . . . . 10.0 115.29 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER 164.1 97.89 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.794 1.238 . . . . 10.0 110.2 166.166 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.73 126.48 10.31 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.944 -0.761 . . . . 10.0 108.944 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.826 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -80.53 137.39 21.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.287 0.565 . . . . 10.0 110.749 179.613 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -96.0 145.64 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.235 -0.893 . . . . 10.0 109.38 -177.59 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.58 140.45 31.73 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 107.808 -1.182 . . . . 10.0 107.808 169.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -43.53 95.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.267 2.644 . . . . 10.0 113.107 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 99.59 5.44 55.49 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.064 -1.065 . . . . 10.0 112.511 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.24 -171.79 38.33 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 121.29 -0.481 . . . . 10.0 113.117 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.738 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 16.6 m0 -119.74 167.3 12.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.499 0.666 . . . . 10.0 111.005 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -142.59 114.46 8.13 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.154 -1.424 . . . . 10.0 107.154 171.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.8 m -80.95 129.42 34.53 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.549 -0.751 . . . . 10.0 110.361 -175.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.617 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.3 m-85 -137.52 141.0 41.45 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.595 -0.891 . . . . 10.0 108.595 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.01 106.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.958 0.786 . . . . 10.0 110.854 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.5 -170.96 6.31 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.338 -0.846 . . . . 10.0 111.818 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.729 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 2.3 p90 -83.79 65.87 8.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.207 1.003 . . . . 10.0 111.556 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.25 163.21 39.16 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.311 -0.859 . . . . 10.0 111.61 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 t -59.49 134.95 57.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.685 0.243 . . . . 10.0 110.558 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 64.59 9.35 5.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.095 0.558 . . . . 10.0 111.418 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.581 ' C ' HD22 ' A' ' 62' ' ' ASN . . . -100.42 -145.63 17.89 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.44 -0.886 . . . . 10.0 112.286 -176.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.85 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -120.57 -153.83 0.56 Allowed 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.218 -1.031 . . . . 10.0 108.218 179.139 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.611 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 8.5 t80 -169.01 109.04 0.47 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.471 -1.307 . . . . 10.0 107.471 176.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 19' ' ' THR . 1.6 m -66.53 128.79 30.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.6 p -119.28 -28.84 5.33 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.344 -0.389 . . . . 10.0 111.277 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.51 115.38 1.1 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.569 -1.3 . . . . 10.0 113.209 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.584 ' HB3' HG12 ' A' ' 6' ' ' VAL . 4.4 mt -79.34 146.62 32.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 170.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.458 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 5.3 m-70 -140.29 157.93 44.81 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.453 -176.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.559 HG23 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -79.63 126.44 30.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.011 0.434 . . . . 10.0 110.571 174.249 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.584 ' HB2' HG22 ' A' ' 32' ' ' THR . 35.8 t -94.44 158.77 15.41 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.154 -0.684 . . . . 10.0 109.154 177.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -136.45 145.36 51.3 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -16.96 81.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.717 1 C-N-CA 126.637 4.891 . . . . 10.0 114.751 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -169.61 71.23 0.07 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.519 -1.219 . . . . 10.0 109.387 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 m -79.7 127.6 77.32 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.144 -0.934 . . . . 10.0 111.433 -173.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.52 -71.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.208 1.939 . . . . 10.0 111.592 175.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 p -94.24 104.75 16.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.387 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 149.46 -112.99 0.58 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.914 -0.66 . . . . 10.0 111.75 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.301 -0.857 . . . . 10.0 110.656 178.714 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.704 0.288 . . . . 10.0 110.72 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.0 t -80.99 -22.34 39.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.389 0.614 . . . . 10.0 109.965 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 152.35 137.31 2.55 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.697 -0.961 . . . . 10.0 110.697 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.649 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . 9.3 t -144.11 -53.96 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 117.237 0.518 . . . . 10.0 111.833 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 4' ' ' SER . 14.7 Cg_endo -77.52 124.99 7.33 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.343 1.362 . . . . 10.0 111.941 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.573 ' CG1' ' HB3' ' A' ' 67' ' ' LEU . 0.2 OUTLIER 41.18 106.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.655 1.354 . . . . 10.0 114.655 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 73.6 -19.11 0.35 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.405 -0.816 . . . . 10.0 112.949 164.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 6' ' ' VAL . 40.1 mt-10 77.5 -40.11 0.32 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.864 . . . . 10.0 112.017 174.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.1 m -77.75 -12.73 60.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.818 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.4 m -90.94 132.43 35.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.869 -0.789 . . . . 10.0 108.869 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.71 113.0 11.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.674 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.765 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -89.34 161.33 16.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.719 0.771 . . . . 10.0 111.996 175.725 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.45 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 86.4 t80 -142.69 139.87 31.32 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.192 -1.367 . . . . 10.0 107.454 172.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.03 98.26 9.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.537 0.684 . . . . 10.0 110.123 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 12.9 p -99.15 -156.35 0.54 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.321 -0.854 . . . . 10.0 108.879 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -69.88 93.22 0.74 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.668 0.271 . . . . 10.0 110.713 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 62.35 32.64 16.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.308 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.446 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.7 OUTLIER -146.41 103.07 3.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 -173.11 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.471 HG21 HG21 ' A' ' 64' ' ' VAL . 16.8 m -90.15 91.56 8.59 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.755 -0.831 . . . . 10.0 108.755 170.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.765 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.0 OUTLIER -83.37 109.07 16.99 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.975 -1.012 . . . . 10.0 111.757 -178.411 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.28 107.21 19.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 122.066 0.936 . . . . 10.0 108.928 174.447 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.759 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -98.54 111.01 23.51 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.13 -1.395 . . . . 10.0 110.042 177.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.834 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.9 t30 -79.39 147.46 32.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.053 -0.521 . . . . 10.0 109.748 178.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -129.43 13.85 5.89 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.718 -0.753 . . . . 10.0 112.502 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.79 154.79 23.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.53 -11.22 60.57 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.443 0.535 . . . . 10.0 112.443 -176.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -124.88 156.75 37.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.365 0.602 . . . . 10.0 112.09 -177.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.31 124.72 24.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.721 -1.127 . . . . 10.0 111.33 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.652 ' H ' HG22 ' A' ' 46' ' ' ILE . 27.8 m -124.14 138.33 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.323 0.582 . . . . 10.0 111.533 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.841 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.2 m -87.01 120.15 27.97 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.383 -0.826 . . . . 10.0 109.061 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.564 HG12 HG21 ' A' ' 6' ' ' VAL . 1.2 m -115.42 165.53 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 121.532 0.682 . . . . 10.0 110.653 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.551 ' HB ' ' C ' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -146.96 159.77 43.15 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.968 -1.015 . . . . 10.0 109.037 177.104 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.621 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.41 144.5 33.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.328 0.585 . . . . 10.0 110.633 -176.404 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -117.44 114.21 23.18 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.074 -0.967 . . . . 10.0 109.114 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 20.3 m-85 -93.1 159.73 15.17 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.626 0.727 . . . . 10.0 111.919 -172.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.6 m -50.67 -44.6 57.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.251 -1.34 . . . . 10.0 113.237 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.429 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 30.6 m-70 -95.22 -72.68 0.61 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.36 -0.536 . . . . 10.0 110.823 -177.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.71 48.55 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.958 -1.115 . . . . 10.0 113.575 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.534 ' HG2' ' OD1' ' A' ' 62' ' ' ASN . 16.0 mm100 -68.1 150.35 48.5 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 117.022 0.411 . . . . 10.0 110.391 173.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.558 ' HZ2' ' H ' ' A' ' 76' ' ' SER . 53.5 t-105 -82.91 108.81 16.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.83 -0.623 . . . . 10.0 111.219 178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.776 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -171.95 26.67 0.01 OUTLIER Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 113.063 0.764 . . . . 10.0 113.063 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.776 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 14.3 Cg_endo -91.27 56.91 1.02 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.259 1.306 . . . . 10.0 112.7 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 177.01 116.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.632 0.582 . . . . 10.0 111.356 171.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.79 124.42 3.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.841 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.7 p -83.15 138.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.359 0.6 . . . . 10.0 110.812 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.652 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -100.86 148.3 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 114.941 -1.027 . . . . 10.0 109.494 -177.367 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -90.65 143.26 28.76 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 107.832 -1.173 . . . . 10.0 107.832 168.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -46.08 93.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.106 2.537 . . . . 10.0 112.609 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 102.19 11.52 36.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.86 -1.162 . . . . 10.0 111.884 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.03 -176.79 31.96 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 121.332 -0.461 . . . . 10.0 112.63 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.759 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 12.0 m0 -119.31 166.71 12.67 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.365 0.603 . . . . 10.0 111.126 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -143.47 110.07 5.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 172.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.9 m -79.41 131.07 35.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.761 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.621 ' CG ' HG21 ' A' ' 33' ' ' VAL . 49.8 m-85 -140.1 142.83 36.05 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.004 -1.11 . . . . 10.0 108.004 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.91 102.72 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.544 0.527 . . . . 10.0 110.837 -174.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.53 -176.26 11.37 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.278 -0.873 . . . . 10.0 111.167 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.666 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 13.4 p90 -86.21 94.52 9.32 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 117.986 0.893 . . . . 10.0 110.903 -174.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.59 170.0 34.78 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.209 -0.905 . . . . 10.0 111.154 174.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.6 m -63.82 114.45 4.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.475 -0.195 . . . . 10.0 110.475 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.3 t70 65.81 63.4 0.6 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.569 0.7 . . . . 10.0 110.106 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.94 -147.23 4.49 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.089 -0.804 . . . . 10.0 111.089 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.693 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -106.71 179.41 4.28 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.969 -0.752 . . . . 10.0 108.969 174.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 15.8 t80 -147.75 118.5 7.56 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.706 -1.134 . . . . 10.0 108.574 171.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.471 HG21 HG21 ' A' ' 19' ' ' THR . 1.7 m -63.59 133.0 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.432 -0.951 . . . . 10.0 108.432 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 81.6 p -118.51 -39.29 3.02 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.478 -0.489 . . . . 10.0 111.029 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.45 122.57 3.86 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.719 -1.229 . . . . 10.0 113.21 -174.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.573 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 3.7 mt -86.87 144.37 27.02 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.997 -0.742 . . . . 10.0 108.997 173.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.541 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 8.1 m-70 -138.37 159.6 41.64 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.386 -174.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.562 HG23 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -84.12 124.88 31.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.129 0.49 . . . . 10.0 111.129 175.735 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.495 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.3 t -95.37 172.83 7.85 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.809 -0.811 . . . . 10.0 108.809 175.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 6.4 p-10 -137.1 147.89 60.47 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 108.318 -0.994 . . . . 10.0 108.318 172.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -15.66 83.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 1 C-N-CA 126.546 4.831 . . . . 10.0 114.916 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -165.62 104.96 0.72 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.629 -1.169 . . . . 10.0 109.619 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.8 p -77.36 134.8 66.22 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.291 -0.413 . . . . 10.0 111.44 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.84 144.83 94.23 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.594 2.196 . . . . 10.0 111.911 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.558 ' H ' ' HZ2' ' A' ' 40' ' ' TRP . 13.6 t -78.15 101.97 7.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.025 0.441 . . . . 10.0 110.335 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.04 147.44 18.43 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.015 -0.834 . . . . 10.0 111.015 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 m . . . . . 0 C--O 1.242 0.71 0 CA-C-O 118.908 -0.568 . . . . 10.0 110.931 -178.141 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 4' ' ' SER . . . . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.599 0.238 . . . . 10.0 111.238 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -45.98 70.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.141 -0.481 . . . . 10.0 112.038 -177.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.27 48.73 0.91 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.451 -0.88 . . . . 10.0 112.737 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.533 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 19.9 t -139.44 62.45 24.25 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.774 0.321 . . . . 10.0 111.157 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 4' ' ' SER . 90.8 Cg_endo -97.88 139.94 0.49 Allowed 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.961 2.441 . . . . 10.0 112.264 176.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.86 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.2 m 48.55 -147.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.488 0.715 . . . . 10.0 111.458 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.705 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -56.09 -2.5 0.06 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.275 1.03 . . . . 10.0 113.587 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 69.21 -24.26 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.036 0.934 . . . . 10.0 113.377 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.409 ' H ' ' C ' ' A' ' 7' ' ' ALA . 33.5 m -80.73 -17.44 51.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.866 0.365 . . . . 10.0 111.189 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.903 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -92.09 141.75 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.26 115.03 12.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.62 -0.264 . . . . 10.0 111.028 -172.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.822 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.81 164.68 12.83 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.687 0.756 . . . . 10.0 112.895 177.493 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' THR . 25.8 t80 -147.5 172.66 13.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.27 -1.381 . . . . 10.0 107.27 172.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.502 ' HG3' ' HE1' ' A' ' 57' ' ' TYR . 5.7 pm0 -122.55 127.91 50.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 10.0 110.901 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 t -150.75 89.96 1.59 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.123 -0.489 . . . . 10.0 110.733 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.4 t90 55.04 80.02 0.14 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.697 -0.683 . . . . 10.0 112.229 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 58.95 24.74 12.92 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.641 -0.709 . . . . 10.0 111.629 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.36 97.3 3.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.9 m -89.13 99.86 12.76 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.193 0.521 . . . . 10.0 109.796 173.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.822 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -84.6 109.93 18.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.966 -1.016 . . . . 10.0 112.168 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.8 108.62 24.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 122.017 0.913 . . . . 10.0 109.31 174.057 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.683 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.28 110.55 22.79 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.802 -1.544 . . . . 10.0 110.45 178.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.903 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 20.4 t30 -80.36 155.88 26.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.066 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.03 31.1 1.46 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.181 -0.533 . . . . 10.0 111.874 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -77.2 -18.92 57.38 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.244 0.218 . . . . 10.0 111.084 -179.264 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 88.66 -18.1 0.25 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.699 1.249 . . . . 10.0 111.322 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -120.39 158.86 26.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.001 0.429 . . . . 10.0 110.263 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -66.4 123.61 20.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.433 -0.803 . . . . 10.0 111.002 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.667 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.9 m -127.07 138.8 53.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.058 0.456 . . . . 10.0 111.09 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 9.5 m -87.26 119.48 27.55 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.395 -0.594 . . . . 10.0 109.395 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.38 153.32 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.565 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -134.31 159.62 40.42 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 175.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.552 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -134.33 141.78 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 120.85 0.357 . . . . 10.0 110.172 -177.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.71 119.95 39.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.619 -0.882 . . . . 10.0 108.619 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.484 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 43.3 m-85 -94.22 164.62 12.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.971 0.891 . . . . 10.0 112.323 -173.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.6 m -52.12 -28.65 18.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.974 -1.466 . . . . 10.0 112.445 172.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -110.41 -85.94 0.54 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.857 -0.337 . . . . 10.0 111.133 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.23 43.29 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.023 -1.084 . . . . 10.0 113.097 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -71.48 146.18 48.74 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.796 -0.237 . . . . 10.0 110.627 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -75.08 140.54 43.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.222 -0.658 . . . . 10.0 109.222 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.76 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 160.71 -43.06 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 124.164 0.986 . . . . 10.0 110.804 -168.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.76 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 4.6 Cg_endo -47.65 66.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 124.894 3.729 . . . . 10.0 116.56 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.419 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER 169.33 102.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.315 1.046 . . . . 10.0 110.276 164.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -148.32 126.51 12.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.474 -0.785 . . . . 10.0 109.837 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.727 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.85 130.94 35.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.319 0.581 . . . . 10.0 109.796 174.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -93.41 148.63 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 114.998 -1.001 . . . . 10.0 109.283 -177.689 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -84.86 144.76 42.47 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 108.339 -0.986 . . . . 10.0 108.339 169.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -46.06 95.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.944 2.429 . . . . 10.0 112.711 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.709 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 93.55 13.84 54.56 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 119.948 -1.12 . . . . 10.0 111.824 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.55 -174.32 32.44 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 121.446 -0.407 . . . . 10.0 112.267 -177.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.713 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 19.1 m0 -118.8 166.28 12.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.394 0.616 . . . . 10.0 111.529 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.427 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -142.92 118.69 10.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.71 -1.218 . . . . 10.0 107.71 171.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.1 m -86.58 130.6 34.43 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.663 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.552 ' CG ' HG21 ' A' ' 33' ' ' VAL . 52.6 m-85 -138.53 145.82 41.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.56 -0.904 . . . . 10.0 108.56 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.64 97.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.754 0.659 . . . . 10.0 111.157 -174.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.74 171.79 49.66 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 110.002 -1.239 . . . . 10.0 110.002 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.502 ' HE1' ' HG3' ' A' ' 14' ' ' GLN . 7.8 p90 -86.3 89.89 8.0 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.816 1.308 . . . . 10.0 111.037 -172.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.7 -75.17 0.59 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 114.872 -1.058 . . . . 10.0 111.573 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.6 t -105.14 144.47 31.9 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 72.06 -43.02 0.55 Allowed 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.009 0.818 . . . . 10.0 111.773 175.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.27 -112.92 1.21 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.045 -0.822 . . . . 10.0 111.045 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 58.32 41.12 23.73 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 123.881 0.401 . . . . 10.0 111.496 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 30.6 t80 -69.11 124.09 22.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.145 -0.479 . . . . 10.0 110.727 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 19' ' ' THR . 1.5 m -64.91 129.39 28.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 170.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.9 p -120.54 -22.9 6.24 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.994 -0.683 . . . . 10.0 111.924 -175.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -145.64 127.39 2.81 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.711 -1.233 . . . . 10.0 113.258 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.86 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.7 mt -87.71 139.18 30.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.131 0.491 . . . . 10.0 109.704 172.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.759 ' C ' HG12 ' A' ' 6' ' ' VAL . 14.6 m-70 -129.99 147.44 51.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.411 -0.813 . . . . 10.0 108.942 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -80.84 125.49 30.16 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 118.873 -1.131 . . . . 10.0 110.388 178.387 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.676 ' HB2' HG22 ' A' ' 32' ' ' THR . 38.5 t -87.61 158.75 18.79 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.361 -0.836 . . . . 10.0 109.531 -178.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -137.52 141.79 34.81 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.795 -0.817 . . . . 10.0 108.795 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -14.28 73.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 1 C-N-CA 127.343 5.362 . . . . 10.0 115.932 -176.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -171.26 71.74 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.84 -1.073 . . . . 10.0 109.501 -176.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.0 p -80.14 150.15 70.87 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.825 -0.625 . . . . 10.0 111.528 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.39 102.38 0.58 Allowed 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.57 2.18 . . . . 10.0 111.98 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.6 m 64.73 -160.92 0.28 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.376 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.41 -41.91 1.97 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.709 -0.956 . . . . 10.0 110.709 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 C--O 1.249 1.03 0 N-CA-C 108.937 -0.764 . . . . 10.0 108.937 174.404 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 N--CA 1.458 -0.603 0 N-CA-C 113.581 0.57 . . . . 10.0 113.581 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.821 HG13 ' HB3' ' A' ' 67' ' ' LEU . 12.3 m -137.77 -142.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.26 -0.274 . . . . 10.0 110.26 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.651 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.65 10.04 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.658 1.183 . . . . 10.0 113.932 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 6' ' ' VAL . 35.4 mt-10 72.59 -50.43 0.7 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.4 0.889 . . . . 10.0 113.4 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.2 m -74.78 -8.53 56.71 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.858 0.318 . . . . 10.0 111.858 -172.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.4 m -95.96 131.97 41.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -132.93 114.46 14.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.529 -0.305 . . . . 10.0 110.616 -171.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.782 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -90.07 155.67 18.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.894 0.855 . . . . 10.0 112.471 175.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.403 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 56.3 t80 -135.05 152.7 51.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.058 -1.46 . . . . 10.0 107.058 170.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.546 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 4.3 pm0 -108.7 105.87 15.66 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.365 0.603 . . . . 10.0 110.863 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 p -108.34 75.93 1.01 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.536 0.684 . . . . 10.0 109.583 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 66.63 -86.21 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.542 -1.208 . . . . 10.0 111.801 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -117.5 24.52 11.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 10.0 110.456 -176.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.35 100.29 4.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.857 -0.794 . . . . 10.0 108.857 -174.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.611 HG21 HG21 ' A' ' 64' ' ' VAL . 5.1 m -90.58 95.31 10.09 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 172.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.782 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.0 p-10 -83.43 107.87 16.21 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.749 -1.114 . . . . 10.0 111.701 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.77 107.95 21.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 122.034 0.921 . . . . 10.0 109.157 174.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.726 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.46 110.34 22.51 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.88 -1.509 . . . . 10.0 110.176 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.806 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 24.6 t30 -82.18 159.4 23.29 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -151.73 23.53 0.93 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.769 -0.729 . . . . 10.0 112.241 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.644 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -75.58 -17.04 60.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.64 0.237 . . . . 10.0 111.64 -177.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.06 -4.26 0.92 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.362 1.039 . . . . 10.0 111.171 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.644 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 13.6 p-10 -126.88 156.29 41.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.593 174.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.58 126.07 28.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.451 -0.795 . . . . 10.0 111.139 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.579 ' H ' HG22 ' A' ' 46' ' ' ILE . 24.6 m -132.42 140.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.065 0.459 . . . . 10.0 111.068 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.843 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 5.4 m -88.19 123.91 33.3 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.91 146.14 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-O 121.454 0.645 . . . . 10.0 110.381 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.751 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -124.96 159.43 31.24 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.348 -0.842 . . . . 10.0 109.489 177.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.613 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.2 138.5 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-O 121.043 0.449 . . . . 10.0 110.544 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -106.97 116.42 31.9 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.519 ' OH ' ' HB3' ' A' ' 41' ' ' ALA . 57.1 m-85 -92.71 163.61 13.69 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.727 0.775 . . . . 10.0 112.062 -174.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 47.4 m -52.91 -21.97 4.97 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.238 -1.346 . . . . 10.0 111.693 170.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -135.56 -74.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.871 -0.518 . . . . 10.0 109.84 170.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 40' ' ' TRP . . . 148.76 80.46 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.713 -0.756 . . . . 10.0 112.117 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -74.66 20.0 0.13 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.022 0.379 . . . . 10.0 112.022 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.418 ' H ' ' C ' ' A' ' 38' ' ' GLY . 30.4 t90 59.77 87.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.64 0.733 . . . . 10.0 112.218 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.744 ' N ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.58 29.06 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.115 -0.948 . . . . 10.0 112.831 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.744 ' HD3' ' N ' ' A' ' 41' ' ' ALA . 9.8 Cg_endo -88.86 54.23 1.95 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.802 1.668 . . . . 10.0 112.198 -173.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.1 m 173.3 111.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.086 0.866 . . . . 10.0 111.259 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 131.62 10.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.843 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -82.13 142.7 13.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.112 0.482 . . . . 10.0 110.409 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -101.51 146.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.932 -0.576 . . . . 10.0 109.976 -178.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -87.27 143.38 34.42 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 169.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -41.16 95.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.523 2.816 . . . . 10.0 113.574 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.717 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 95.26 6.86 59.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.838 -1.172 . . . . 10.0 112.137 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.3 -174.46 44.9 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.183 -0.532 . . . . 10.0 113.098 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.726 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 10.0 m0 -120.11 167.39 12.26 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.932 -0.634 . . . . 10.0 111.061 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -146.14 111.18 5.31 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.768 -1.197 . . . . 10.0 107.768 171.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 m -77.58 130.53 37.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.433 -0.803 . . . . 10.0 110.061 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.613 ' CG ' HG21 ' A' ' 33' ' ' VAL . 49.8 m-85 -137.4 134.98 36.52 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.668 -0.864 . . . . 10.0 108.668 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.92 105.1 0.1 Allowed 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 124.23 0.957 . . . . 10.0 110.297 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.86 -157.85 0.65 Allowed Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.891 -1.05 . . . . 10.0 112.564 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.819 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 26.8 p90 . . . . . 0 C--N 1.316 -0.881 0 O-C-N 122.447 -0.443 . . . . 10.0 111.894 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.819 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 15.5 t80 . . . . . 0 CA--C 1.515 -0.404 0 N-CA-C 108.066 -1.087 . . . . 10.0 108.066 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 19' ' ' THR . 1.8 m -66.63 130.21 31.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.124 -1.065 . . . . 10.0 108.124 173.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.9 p -113.1 -37.37 4.79 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.064 -0.654 . . . . 10.0 111.322 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -140.05 136.99 8.09 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.826 -1.178 . . . . 10.0 112.496 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.821 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.0 mt -86.61 152.12 22.87 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.769 -0.826 . . . . 10.0 108.769 171.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.692 ' C ' HG12 ' A' ' 6' ' ' VAL . 6.5 m-70 -138.55 146.24 41.65 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.241 -1.022 . . . . 10.0 108.241 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.444 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -84.14 124.4 31.11 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 118.908 -1.117 . . . . 10.0 110.407 178.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.751 ' HB2' HG22 ' A' ' 32' ' ' THR . 41.9 t -92.27 158.55 16.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.214 -0.903 . . . . 10.0 109.807 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 C--N 1.327 -0.37 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 174.052 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.558 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 94.8 Cg_endo . . . . . 0 N--CA 1.459 -0.537 0 CA-C-O 120.762 0.234 . . . . 10.0 112.046 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.9 m 49.19 -148.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.919 0.887 . . . . 10.0 112.36 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.68 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.92 1.32 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.635 1.346 . . . . 10.0 114.635 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 72.22 -33.79 0.28 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.437 0.695 . . . . 10.0 112.322 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 m -76.86 -13.08 60.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.634 0.254 . . . . 10.0 111.421 -173.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.85 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.9 m -98.35 143.59 12.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.066 -0.716 . . . . 10.0 109.066 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -136.75 111.97 9.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.758 -0.201 . . . . 10.0 110.731 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.772 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -89.19 160.29 17.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.794 0.807 . . . . 10.0 112.546 175.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' THR . 36.9 t80 -142.76 173.95 11.09 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.549 -1.649 . . . . 10.0 106.549 173.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -119.24 103.4 9.47 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.366 -0.534 . . . . 10.0 110.508 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.7 m -104.6 54.29 0.72 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.982 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 60.38 88.99 0.07 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.554 -0.748 . . . . 10.0 111.537 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 49.5 ttt180 63.9 14.49 8.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.581 0.705 . . . . 10.0 111.538 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -130.95 95.72 3.89 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.779 -1.193 . . . . 10.0 107.779 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.488 HG21 HG21 ' A' ' 64' ' ' VAL . 61.5 m -86.35 97.67 10.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.31 0.576 . . . . 10.0 109.694 177.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.772 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.7 p-10 -83.19 108.43 16.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.723 -1.126 . . . . 10.0 111.318 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.99 105.84 18.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 122.203 1.001 . . . . 10.0 109.055 175.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.686 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -99.11 109.16 21.9 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 113.707 -1.588 . . . . 10.0 109.993 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.85 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 15.7 t30 -80.08 156.93 26.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -140.11 13.4 3.07 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.704 -0.76 . . . . 10.0 113.041 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.07 156.9 20.88 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 117.21 0.505 . . . . 10.0 109.844 173.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.32 -8.62 56.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.024 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -116.62 152.81 33.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.646 0.736 . . . . 10.0 111.721 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.76 125.36 26.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.695 -1.139 . . . . 10.0 110.256 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.5 m -124.19 137.31 57.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.109 0.48 . . . . 10.0 111.67 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.802 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 3.8 m -85.69 121.95 29.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.71 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.509 ' HB ' HG11 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -122.78 148.11 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.295 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.714 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.2 OUTLIER -127.44 160.17 32.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.147 -0.933 . . . . 10.0 109.02 176.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -132.03 132.04 61.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.598 0.713 . . . . 10.0 111.337 -176.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -103.55 109.74 21.52 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.522 -176.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.625 ' OH ' ' HB3' ' A' ' 41' ' ' ALA . 28.4 m-85 -89.59 165.31 14.33 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.584 0.706 . . . . 10.0 111.733 -176.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.403 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 52.4 m -52.55 -29.73 26.97 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.231 -1.35 . . . . 10.0 111.397 168.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -126.42 -77.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 10.0 110.206 172.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.01 79.02 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.228 -0.986 . . . . 10.0 111.691 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -76.38 20.01 0.23 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.218 0.451 . . . . 10.0 112.218 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 3.1 t90 66.99 87.41 0.12 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.727 0.811 . . . . 10.0 111.641 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.727 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -170.85 27.77 0.01 OUTLIER Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 113.444 0.905 . . . . 10.0 113.444 174.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.727 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 9.9 Cg_endo -89.16 56.41 2.01 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.726 1.617 . . . . 10.0 112.754 -172.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.2 m 172.27 114.56 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.616 0.766 . . . . 10.0 111.33 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.61 132.0 8.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.1 -0.704 . . . . 10.0 109.1 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.802 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -81.13 138.88 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.199 0.523 . . . . 10.0 110.06 176.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -97.05 145.12 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 115.362 -0.835 . . . . 10.0 109.704 -179.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -83.2 141.38 42.96 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 107.966 -1.124 . . . . 10.0 107.966 169.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -47.77 91.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.298 2.666 . . . . 10.0 112.692 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.654 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 104.37 5.91 42.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.161 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.78 -172.4 36.11 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.382 -0.437 . . . . 10.0 112.863 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.686 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.4 m0 -120.32 167.28 12.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.514 0.673 . . . . 10.0 111.051 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -143.1 113.07 7.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 171.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -81.44 128.31 33.74 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.436 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.617 ' CG ' HG21 ' A' ' 33' ' ' VAL . 42.1 m-85 -138.78 140.52 38.64 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.332 -0.618 . . . . 10.0 109.332 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.72 101.46 0.05 Allowed 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 123.894 0.746 . . . . 10.0 110.192 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.91 -159.27 8.36 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 111.217 -0.753 . . . . 10.0 111.217 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.68 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 28.3 p90 . . . . . 0 N--CA 1.432 -1.368 0 N-CA-C 108.109 -1.071 . . . . 10.0 108.109 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.68 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 28.7 t80 . . . . . 0 CA--C 1.512 -0.51 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.9 m -63.59 131.56 29.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 107.74 -1.207 . . . . 10.0 107.74 173.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.0 t -137.95 11.82 2.87 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.27 -0.572 . . . . 10.0 110.379 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.76 118.93 0.81 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 119.803 -1.189 . . . . 10.0 112.782 173.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.84 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -88.99 127.57 35.67 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.724 ' C ' HG12 ' A' ' 6' ' ' VAL . 17.6 m-70 -118.24 146.45 44.26 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.306 -0.861 . . . . 10.0 108.933 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.437 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -82.15 123.31 28.87 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.032 -1.043 . . . . 10.0 110.513 177.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.714 ' HB2' HG22 ' A' ' 32' ' ' THR . 42.0 t -92.7 161.01 14.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.799 -0.637 . . . . 10.0 110.205 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 . . . . . 0 C--N 1.33 -0.265 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 172.099 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 54.2 Cg_endo . . . . . 0 N--CA 1.454 -0.839 0 CA-C-O 120.92 0.3 . . . . 10.0 112.838 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.836 HG13 ' HB3' ' A' ' 67' ' ' LEU . 9.3 m -136.94 -137.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.252 -0.647 . . . . 10.0 109.252 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.704 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -56.48 0.23 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.185 0.994 . . . . 10.0 113.452 174.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 6' ' ' VAL . 10.0 mt-10 74.11 -38.73 0.41 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.518 1.127 . . . . 10.0 113.264 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.1 m -75.77 -13.35 60.29 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.939 0.399 . . . . 10.0 111.318 -175.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.878 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -97.09 137.32 25.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.009 -0.737 . . . . 10.0 109.009 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -143.34 129.94 20.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.043 -0.263 . . . . 10.0 110.477 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.686 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -95.56 165.23 12.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.891 0.853 . . . . 10.0 113.179 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.421 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 87.3 t80 -145.26 154.32 42.24 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 106.72 -1.585 . . . . 10.0 106.72 170.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -105.66 108.26 19.69 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.445 -0.502 . . . . 10.0 111.389 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -99.41 -166.89 1.4 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.124 -1.065 . . . . 10.0 108.124 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.669 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -69.46 100.67 1.43 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.837 0.351 . . . . 10.0 110.541 -178.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 63.92 28.19 14.5 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.118 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.87 101.86 3.59 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 121.207 -0.197 . . . . 10.0 111.15 -169.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.475 HG21 HG21 ' A' ' 64' ' ' VAL . 16.3 m -89.63 96.71 10.81 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 170.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.686 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.1 p-10 -84.34 107.35 16.57 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 114.947 -1.024 . . . . 10.0 112.378 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.29 108.62 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.794 0.807 . . . . 10.0 108.9 174.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.768 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.6 p80 -98.39 113.97 26.14 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.218 -1.356 . . . . 10.0 110.554 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.878 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 22.6 t30 -82.03 163.42 22.11 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.592 -0.522 . . . . 10.0 109.592 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -153.39 25.2 0.77 Allowed Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.288 -0.482 . . . . 10.0 112.203 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -78.72 -14.0 59.52 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.402 0.281 . . . . 10.0 111.148 -177.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 82.24 -6.03 1.4 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.919 -1.037 . . . . 10.0 110.933 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -126.24 158.58 35.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.02 0.438 . . . . 10.0 110.304 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -70.91 120.3 16.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.039 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.74 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.6 m -126.19 140.75 47.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.221 0.534 . . . . 10.0 111.424 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.748 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.0 m -88.11 120.25 29.28 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.154 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.41 161.15 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 115.729 -0.669 . . . . 10.0 110.409 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.691 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.4 OUTLIER -143.13 160.88 39.58 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.474 -0.784 . . . . 10.0 109.015 176.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.587 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.58 145.27 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.45 0.643 . . . . 10.0 111.542 -175.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -114.12 110.31 19.81 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.735 -1.121 . . . . 10.0 109.719 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 11.9 m-85 -90.57 161.88 15.25 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.369 0.604 . . . . 10.0 111.622 -176.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.1 m -48.79 -38.64 22.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.263 -1.335 . . . . 10.0 112.783 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -101.6 -75.49 0.59 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.518 -0.473 . . . . 10.0 110.064 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.06 46.73 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.553 -0.832 . . . . 10.0 112.048 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.34 136.78 57.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -72.79 100.47 2.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 10.0 111.548 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.851 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.03 19.96 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.256 -0.884 . . . . 10.0 113.233 175.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.851 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 9.2 Cg_endo -87.27 58.62 3.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 CA-C-N 121.112 1.433 . . . . 10.0 112.455 -170.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 176.47 115.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.791 0.682 . . . . 10.0 111.168 170.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 128.67 6.74 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.436 0.694 . . . . 10.0 109.525 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.748 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -83.92 134.38 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.334 0.588 . . . . 10.0 110.534 177.246 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.74 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -94.67 149.29 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.009 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -86.88 146.73 41.54 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 168.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -43.19 98.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.037 2.491 . . . . 10.0 112.961 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.718 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 89.28 11.48 64.55 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.864 -1.16 . . . . 10.0 111.565 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.12 -176.81 37.78 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 121.283 -0.484 . . . . 10.0 112.418 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.768 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 17.2 m0 -115.93 166.76 11.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.793 0.806 . . . . 10.0 111.815 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -143.67 118.3 9.8 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.362 -1.347 . . . . 10.0 107.362 172.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.7 m -85.72 129.7 34.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.178 0.514 . . . . 10.0 110.812 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.587 ' CG ' HG21 ' A' ' 33' ' ' VAL . 56.3 m-85 -136.86 151.34 49.0 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.588 -0.894 . . . . 10.0 108.588 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.97 98.56 0.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.705 0.628 . . . . 10.0 110.562 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.45 178.49 23.11 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 115.049 -0.978 . . . . 10.0 111.107 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.1 p90 . . . . . 0 CA--C 1.534 0.35 0 CA-C-N 118.049 0.925 . . . . 10.0 110.803 -173.159 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.4 t80 . . . . . 0 N--CA 1.442 -0.849 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -59.75 128.91 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.5 p -118.04 -34.3 4.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.046 0.45 . . . . 10.0 111.169 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.84 129.71 4.75 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.062 -1.066 . . . . 10.0 112.468 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.836 ' HB3' HG13 ' A' ' 6' ' ' VAL . 3.8 mt -83.89 148.87 26.71 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.114 -1.069 . . . . 10.0 108.114 171.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.7 ' C ' HG12 ' A' ' 6' ' ' VAL . 15.4 m-70 -134.17 147.44 50.77 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.518 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -82.46 130.04 35.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 118.994 -1.082 . . . . 10.0 110.566 178.146 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.691 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.3 t -96.14 159.72 14.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.986 -0.552 . . . . 10.0 109.58 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 CA--C 1.512 -0.489 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 172.843 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 N--CA 1.466 -0.126 0 CA-C-O 119.908 -0.122 . . . . 10.0 111.891 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.598 ' HB ' ' C ' ' A' ' 68' ' ' HIS . 0.3 OUTLIER 38.77 98.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 114.324 1.231 . . . . 10.0 114.324 177.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 75.99 -25.09 0.21 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.558 -0.747 . . . . 10.0 112.559 166.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' A' ' 6' ' ' VAL . 24.6 mt-10 74.8 -22.19 0.27 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.224 1.009 . . . . 10.0 111.845 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 82.4 m -85.42 -16.5 39.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.907 0.336 . . . . 10.0 111.907 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -94.22 139.78 17.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.619 -0.512 . . . . 10.0 109.619 -177.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -141.55 127.3 19.17 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.625 -0.139 . . . . 10.0 110.625 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.789 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -98.4 164.19 12.38 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.468 1.127 . . . . 10.0 113.787 176.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.418 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 84.6 t80 -145.1 162.6 36.63 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.304 -1.771 . . . . 10.0 106.643 172.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.489 ' NE2' ' H ' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -117.71 122.7 44.18 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.083 -0.647 . . . . 10.0 110.786 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.509 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 25.9 p -121.93 -154.39 0.59 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.78 -0.822 . . . . 10.0 108.78 175.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -67.93 91.11 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.647 0.261 . . . . 10.0 111.412 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 61.4 35.07 17.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.585 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.509 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -147.29 101.19 3.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.4 -0.818 . . . . 10.0 109.345 -173.05 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.495 HG21 HG21 ' A' ' 64' ' ' VAL . 6.3 m -90.42 99.37 12.41 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 170.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.789 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -84.37 110.44 18.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.871 -1.059 . . . . 10.0 111.966 -177.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.98 106.69 19.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 122.181 0.991 . . . . 10.0 108.561 171.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.811 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.4 OUTLIER -97.22 111.06 23.47 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.094 -1.412 . . . . 10.0 110.163 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.772 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.4 t30 -80.29 156.66 26.7 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.837 -0.62 . . . . 10.0 109.342 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.47 13.91 3.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.127 -0.558 . . . . 10.0 112.346 174.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.77 156.18 22.66 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.53 -8.41 56.69 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.264 0.468 . . . . 10.0 112.264 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -120.66 157.46 29.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.511 0.672 . . . . 10.0 111.75 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -71.82 117.69 13.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.827 -1.079 . . . . 10.0 110.431 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.683 ' H ' HG22 ' A' ' 46' ' ' ILE . 33.7 m -116.87 139.21 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 121.303 0.573 . . . . 10.0 111.676 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.0 m -88.94 116.88 27.55 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.734 -0.666 . . . . 10.0 109.288 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.5 HG12 HG21 ' A' ' 6' ' ' VAL . 1.1 m -112.8 164.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.452 -0.795 . . . . 10.0 110.517 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.31 153.7 40.04 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.257 -0.883 . . . . 10.0 109.212 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.565 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -130.23 137.69 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 120.937 0.399 . . . . 10.0 110.915 -174.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -100.6 116.63 32.97 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.782 -0.821 . . . . 10.0 108.782 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.695 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 45.9 m-85 -91.77 160.79 15.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.112 0.482 . . . . 10.0 111.023 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.6 m -48.47 -33.22 9.01 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.664 -1.153 . . . . 10.0 112.604 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -110.26 -69.66 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.929 0.395 . . . . 10.0 109.961 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.45 58.07 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.551 -0.833 . . . . 10.0 112.161 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.2 154.64 30.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.706 0.289 . . . . 10.0 110.681 176.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -76.46 106.45 8.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.853 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -173.62 -40.57 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 113.069 0.766 . . . . 10.0 113.069 -175.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.853 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 5.3 Cg_endo -46.86 67.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 124.884 3.723 . . . . 10.0 116.429 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.461 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER 169.96 104.43 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.179 0.992 . . . . 10.0 110.097 168.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -151.85 127.05 9.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.064 -176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.38 132.85 30.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.277 -0.569 . . . . 10.0 109.856 174.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.683 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -96.06 147.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-N 115.112 -0.949 . . . . 10.0 109.28 -177.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -84.03 141.42 40.56 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 169.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -47.89 94.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.056 2.504 . . . . 10.0 112.366 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 97.77 14.22 41.01 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.073 -1.061 . . . . 10.0 112.106 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.66 -172.2 26.77 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 121.112 -0.566 . . . . 10.0 112.669 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.811 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 16.5 m0 -119.54 165.54 14.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.423 0.63 . . . . 10.0 111.255 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -139.66 111.15 7.12 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 172.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.6 m -78.74 126.79 31.2 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.394 -0.821 . . . . 10.0 110.439 -176.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.565 ' CG ' HG21 ' A' ' 33' ' ' VAL . 51.5 m-85 -134.53 146.42 49.67 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.509 -0.922 . . . . 10.0 108.509 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.03 102.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.836 0.71 . . . . 10.0 110.459 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.59 179.44 16.65 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.608 -0.997 . . . . 10.0 110.608 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.567 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 14.9 p90 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-N 118.208 1.004 . . . . 10.0 110.64 -174.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 19.1 t80 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 108.562 -0.903 . . . . 10.0 108.562 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.495 HG21 HG21 ' A' ' 19' ' ' THR . 1.5 m -63.23 130.77 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.2 p -123.83 -19.04 5.84 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.203 -0.599 . . . . 10.0 111.851 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.39 130.69 4.06 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.602 -1.285 . . . . 10.0 113.159 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -94.84 148.0 22.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.399 -0.593 . . . . 10.0 109.399 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.598 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -147.98 164.54 33.47 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.254 -176.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.499 ' N ' ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -83.53 129.1 34.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.22 0.533 . . . . 10.0 111.362 177.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 30' ' ' SER . 32.3 t -98.19 168.3 10.33 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.509 -0.923 . . . . 10.0 108.509 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--N 1.317 -0.813 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 174.294 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.617 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 38.4 Cg_endo . . . . . 0 N--CA 1.475 0.385 0 N-CA-C 112.764 0.255 . . . . 10.0 112.764 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.936 HG13 ' HB3' ' A' ' 67' ' ' LEU . 3.9 m 47.35 -141.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.934 0.893 . . . . 10.0 111.689 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.696 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.89 -1.9 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.512 1.125 . . . . 10.0 113.368 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 76.27 -26.93 0.18 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.989 0.915 . . . . 10.0 112.655 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.84 -10.88 54.68 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.195 0.443 . . . . 10.0 112.195 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.87 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -96.22 140.56 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 -176.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -132.19 116.04 16.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.206 -0.197 . . . . 10.0 110.958 -173.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.777 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.1 161.68 15.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 122.053 0.93 . . . . 10.0 112.919 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 19' ' ' THR . 90.5 t80 -144.28 158.52 43.69 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.835 -1.53 . . . . 10.0 106.908 172.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HG3' ' OG1' ' A' ' 19' ' ' THR . 2.1 mp0 -117.0 101.78 8.79 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.33 -0.548 . . . . 10.0 111.252 -176.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.1 t -93.89 80.2 4.16 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 61.35 -89.86 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 115.005 -0.998 . . . . 10.0 110.573 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.593 ' HD3' ' H ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -118.17 26.68 9.46 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.153 0.501 . . . . 10.0 111.144 -176.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -132.34 96.0 3.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.3 m -85.28 101.95 12.96 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.245 0.545 . . . . 10.0 110.214 176.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.777 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.6 p-10 -86.19 108.38 18.32 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.845 -1.07 . . . . 10.0 111.454 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.1 107.82 21.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.891 0.853 . . . . 10.0 108.988 173.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.699 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.04 110.67 22.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.229 -1.35 . . . . 10.0 110.297 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.87 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 21.8 t30 -80.14 160.12 25.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 10.0 110.157 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.46 23.53 1.07 Allowed Glycine 0 C--O 1.226 -0.392 0 C-N-CA 121.361 -0.447 . . . . 10.0 112.207 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -75.12 -16.74 60.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.512 0.196 . . . . 10.0 111.316 -178.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.11 -6.33 0.91 Allowed 'General case' 0 N--CA 1.472 0.647 0 O-C-N 124.631 1.207 . . . . 10.0 111.345 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 5.9 p-10 -126.82 157.02 40.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.959 0.409 . . . . 10.0 110.689 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.79 122.56 18.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.354 -0.839 . . . . 10.0 110.96 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.633 ' H ' HG22 ' A' ' 46' ' ' ILE . 34.6 m -129.1 140.64 48.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.076 0.465 . . . . 10.0 111.442 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.69 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.5 m -87.22 120.34 28.4 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.487 -0.561 . . . . 10.0 109.487 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.692 ' HB ' HG11 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -119.88 146.79 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 115.587 -0.733 . . . . 10.0 110.587 -179.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -125.74 161.74 26.65 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.28 -0.873 . . . . 10.0 108.834 175.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.641 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.82 133.63 58.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.35 0.595 . . . . 10.0 110.95 -176.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -106.04 112.65 25.78 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.735 -1.121 . . . . 10.0 108.696 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.51 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 15.4 m-85 -91.07 164.01 14.1 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.33 0.586 . . . . 10.0 110.959 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.7 m -50.51 -22.53 1.99 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.464 -1.243 . . . . 10.0 112.668 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -123.96 -82.37 0.64 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.987 -0.445 . . . . 10.0 111.159 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.23 51.01 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.645 -1.264 . . . . 10.0 113.084 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.36 136.05 56.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.863 -0.792 . . . . 10.0 108.863 175.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -72.95 118.31 15.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.209 0.528 . . . . 10.0 110.471 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.769 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -177.05 -45.27 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 114.95 -1.023 . . . . 10.0 111.903 -174.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.769 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 3.5 Cg_exo -37.18 68.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.886 1 C-N-CA 125.924 4.416 . . . . 10.0 117.487 -174.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 5.3 t 170.53 111.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.294 1.038 . . . . 10.0 109.759 162.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.31 126.57 9.94 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.69 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -79.98 130.11 36.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.375 0.607 . . . . 10.0 109.369 175.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.633 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -93.21 148.91 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 114.83 -1.077 . . . . 10.0 109.804 -176.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -84.77 145.99 45.36 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 108.389 -0.967 . . . . 10.0 108.389 168.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -45.0 94.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.009 2.472 . . . . 10.0 112.564 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.718 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.72 15.12 53.89 Favored Glycine 0 CA--C 1.512 -0.151 0 C-N-CA 120.022 -1.085 . . . . 10.0 111.812 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 22' ' ' HIS . . . -97.26 -176.52 34.56 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 121.706 -0.283 . . . . 10.0 112.48 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.714 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 18.6 m0 -118.15 165.41 13.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.629 0.728 . . . . 10.0 111.784 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.425 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -143.91 115.54 8.17 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.265 -1.334 . . . . 10.0 107.929 172.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.3 m -82.56 131.19 35.22 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.598 -0.728 . . . . 10.0 110.764 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.641 ' CG ' HG21 ' A' ' 33' ' ' VAL . 53.5 m-85 -139.76 145.42 38.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.439 -0.948 . . . . 10.0 108.439 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.1 99.29 0.07 Allowed 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 123.856 0.723 . . . . 10.0 110.69 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.08 -173.59 12.35 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.295 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.44 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 2.9 p90 . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.6 0.714 . . . . 10.0 110.448 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.44 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 26.1 t80 . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.503 HG21 HG21 ' A' ' 19' ' ' THR . 0.5 OUTLIER -63.47 129.14 26.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 175.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 t -144.77 10.46 1.38 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.306 -0.557 . . . . 10.0 111.034 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.33 106.6 0.29 Allowed Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.552 -1.308 . . . . 10.0 112.951 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.936 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.8 mt -81.37 131.92 35.31 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.737 ' C ' HG12 ' A' ' 6' ' ' VAL . 18.7 m-70 -124.65 143.97 50.44 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.409 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -79.49 125.12 29.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 119.378 0.99 . . . . 10.0 110.482 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.601 ' HB2' HG22 ' A' ' 32' ' ' THR . 4.4 t -89.61 174.2 7.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.492 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 109.378 -0.601 . . . . 10.0 109.378 175.311 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.454 ' O ' HG13 ' A' ' 6' ' ' VAL . 61.1 Cg_endo . . . . . 0 N--CA 1.451 -1.025 0 N-CA-C 112.697 0.23 . . . . 10.0 112.697 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.803 HG21 HG12 ' A' ' 31' ' ' VAL . 2.0 m 65.39 -49.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 125.139 1.376 . . . . 10.0 111.951 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.621 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -174.73 114.65 0.17 Allowed 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 106.133 -1.802 . . . . 10.0 106.133 -172.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 1.6 mp0 -57.84 -14.21 5.64 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.405 -0.816 . . . . 10.0 112.396 -166.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.6 m -86.6 -15.5 39.62 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.819 HG12 HD22 ' A' ' 23' ' ' ASN . 1.6 m -91.67 131.47 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.019 -0.734 . . . . 10.0 109.019 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -137.39 123.56 20.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.685 -0.234 . . . . 10.0 110.494 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.76 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.45 159.08 15.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.777 0.798 . . . . 10.0 112.629 178.189 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.437 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 78.2 t80 -139.53 165.35 27.46 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.28 -1.378 . . . . 10.0 107.28 172.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.61 107.84 15.21 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.074 -0.65 . . . . 10.0 110.923 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 21.8 m -96.91 -173.73 2.79 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.519 -1.289 . . . . 10.0 107.519 170.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -62.26 98.01 0.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.111 0.481 . . . . 10.0 111.074 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 57.63 40.29 26.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.1 -0.954 . . . . 10.0 111.375 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 0.9 OUTLIER -148.09 96.06 2.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 -177.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.548 HG21 HG11 ' A' ' 64' ' ' VAL . 25.3 m -86.66 96.56 10.17 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.491 -0.559 . . . . 10.0 109.491 175.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.76 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.4 p-10 -86.04 109.79 19.06 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.458 -0.792 . . . . 10.0 112.071 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.65 107.18 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.951 0.882 . . . . 10.0 109.043 173.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.808 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 3.6 p80 -97.61 115.11 27.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.39 -1.277 . . . . 10.0 110.361 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.819 HD22 HG12 ' A' ' 10' ' ' VAL . 16.9 t-20 -81.76 160.79 23.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.53 -0.759 . . . . 10.0 109.752 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.95 39.41 0.6 Allowed Glycine 0 C--N 1.32 -0.314 0 N-CA-C 111.438 -0.665 . . . . 10.0 111.438 173.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.607 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -91.9 -16.09 27.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.612 -0.294 . . . . 10.0 111.549 -176.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 84.91 -7.66 0.92 Allowed 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.456 1.098 . . . . 10.0 110.923 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.607 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 9.3 p-10 -126.48 151.75 47.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.235 0.54 . . . . 10.0 110.686 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.86 126.06 28.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.422 -0.808 . . . . 10.0 111.116 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.582 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.2 m -129.66 140.64 48.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.13 0.491 . . . . 10.0 111.334 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.772 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 14.4 m -92.11 117.57 29.98 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.803 HG12 HG21 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -113.04 166.34 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 115.269 -0.878 . . . . 10.0 110.88 -178.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -150.17 157.96 43.65 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.293 -0.867 . . . . 10.0 108.887 176.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.24 141.68 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 120.904 0.383 . . . . 10.0 111.449 -173.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -107.83 119.1 38.48 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.77 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 25.3 m-85 -92.4 164.3 13.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.21 0.529 . . . . 10.0 111.287 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 49.2 m -50.04 -24.03 2.42 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.764 -1.107 . . . . 10.0 111.875 171.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -117.68 -79.51 0.59 Allowed 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.118 -0.364 . . . . 10.0 110.033 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.57 51.53 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.344 -0.932 . . . . 10.0 112.031 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.4 141.96 57.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.4 t-105 -70.16 116.22 10.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.059 0.457 . . . . 10.0 110.499 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.792 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -175.33 -44.4 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.022 -0.99 . . . . 10.0 112.278 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.792 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 1.6 Cg_endo -40.54 70.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.874 1 C-N-CA 125.437 4.091 . . . . 10.0 116.639 -175.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER 169.6 106.46 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.383 1.073 . . . . 10.0 110.421 166.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -152.9 125.82 8.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.854 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -81.26 134.23 27.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.312 -0.555 . . . . 10.0 109.887 173.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -95.88 145.08 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-N 115.273 -0.876 . . . . 10.0 109.625 -177.413 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -85.35 142.78 38.19 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 168.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -41.1 93.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.41 2.74 . . . . 10.0 112.984 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 95.99 10.9 55.82 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 119.851 -1.166 . . . . 10.0 112.179 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.64 -176.49 35.49 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.525 -0.369 . . . . 10.0 112.717 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.808 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 19.8 m0 -116.04 166.87 11.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.686 0.755 . . . . 10.0 111.672 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -141.6 111.85 6.89 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.368 -1.345 . . . . 10.0 107.368 172.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.5 m -79.38 129.82 34.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.699 -0.682 . . . . 10.0 110.663 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.57 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.3 m-85 -140.15 142.71 35.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.406 -0.961 . . . . 10.0 108.406 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.22 104.52 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.668 0.605 . . . . 10.0 110.476 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.02 -179.05 10.86 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 110.652 -0.979 . . . . 10.0 110.652 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.53 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 12.4 p90 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 122.163 0.982 . . . . 10.0 111.697 -172.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 16.5 t80 . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 108.999 -0.741 . . . . 10.0 108.999 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.548 HG11 HG21 ' A' ' 19' ' ' THR . 1.6 m -59.21 129.67 21.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.703 -0.851 . . . . 10.0 108.703 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 63' ' ' TYR . 40.1 p -127.0 -10.88 5.97 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.654 -0.418 . . . . 10.0 111.46 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.36 147.07 16.57 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.02 -1.086 . . . . 10.0 112.872 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.467 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.1 mt -116.94 135.62 53.57 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.103 -0.702 . . . . 10.0 109.103 177.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.411 ' N ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -131.56 157.81 42.62 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.727 -0.67 . . . . 10.0 109.709 -176.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.502 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -80.19 130.65 35.37 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.386 -0.526 . . . . 10.0 110.382 177.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 30' ' ' SER . 43.0 t -96.7 158.65 15.33 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.237 -0.653 . . . . 10.0 109.237 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.512 -0.505 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 172.709 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.46 -0.457 0 CA-C-O 121.228 0.429 . . . . 10.0 112.136 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.788 HG13 ' HB3' ' A' ' 67' ' ' LEU . 7.5 m -140.94 -147.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.479 -0.782 . . . . 10.0 110.305 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.416 ' H ' ' HB ' ' A' ' 6' ' ' VAL . . . -65.05 16.03 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.802 1.038 . . . . 10.0 113.802 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 6' ' ' VAL . 2.3 mt-10 69.59 -52.07 0.61 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.922 0.889 . . . . 10.0 113.387 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.0 m -71.47 -13.4 61.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.688 0.28 . . . . 10.0 111.677 -173.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -95.59 130.65 44.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 -176.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -137.56 124.2 21.01 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.827 -0.349 . . . . 10.0 110.889 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.732 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.28 164.16 13.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.71 0.766 . . . . 10.0 112.572 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -146.81 137.42 23.8 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.35 -1.296 . . . . 10.0 107.692 169.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HG2' ' HE1' ' A' ' 63' ' ' TYR . 23.9 mp0 -91.1 104.4 16.98 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.038 0.447 . . . . 10.0 110.551 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -102.17 82.24 2.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.29 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 69.6 -77.21 0.05 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.163 -0.926 . . . . 10.0 111.264 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -133.39 26.24 4.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.423 0.63 . . . . 10.0 110.015 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -137.88 97.42 3.42 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 -169.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.622 HG21 HG21 ' A' ' 64' ' ' VAL . 7.5 m -86.05 93.99 9.13 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.117 -0.697 . . . . 10.0 109.117 175.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.732 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 0.9 OUTLIER -84.29 108.37 17.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.868 -1.06 . . . . 10.0 111.564 -177.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -97.9 106.59 18.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.845 0.831 . . . . 10.0 108.788 174.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.81 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 3.0 p80 -97.26 113.14 24.71 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.414 -1.266 . . . . 10.0 109.926 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.774 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 15.4 t30 -81.64 149.04 28.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.953 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -131.9 20.89 4.49 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.775 -0.726 . . . . 10.0 111.886 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.06 155.9 20.63 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.431 -0.951 . . . . 10.0 108.431 175.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.92 -13.09 60.49 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -123.42 159.11 29.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.311 0.577 . . . . 10.0 111.715 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -70.14 125.23 26.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.053 -0.976 . . . . 10.0 111.139 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.553 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.5 m -127.24 138.88 53.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.521 . . . . 10.0 111.489 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.1 m -87.04 126.25 34.63 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.035 -0.529 . . . . 10.0 109.707 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.09 146.15 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.275 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.811 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.4 OUTLIER -125.81 157.09 38.4 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.382 -0.826 . . . . 10.0 109.241 178.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.596 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -131.45 137.94 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.38 0.61 . . . . 10.0 111.555 -177.454 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -99.03 115.03 28.04 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.024 -0.989 . . . . 10.0 109.544 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -92.61 153.44 19.0 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.377 0.608 . . . . 10.0 110.869 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 62.5 m -48.7 -28.97 3.93 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.236 -1.347 . . . . 10.0 113.533 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -121.27 -79.09 0.6 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.839 -0.538 . . . . 10.0 111.734 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.13 126.75 0.88 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 119.905 -1.141 . . . . 10.0 112.593 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -163.48 146.25 10.03 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.538 -0.912 . . . . 10.0 108.538 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.417 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 24.0 p90 -77.26 136.14 38.5 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.646 -0.501 . . . . 10.0 109.646 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.723 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 161.51 -41.99 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 115.083 -0.962 . . . . 10.0 111.306 -171.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.723 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 9.3 Cg_endo -51.91 63.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 124.54 3.493 . . . . 10.0 116.13 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.1 m 170.93 99.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.718 1.207 . . . . 10.0 109.695 163.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.69 129.95 16.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.557 -0.534 . . . . 10.0 109.557 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -79.68 137.79 21.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.438 0.637 . . . . 10.0 110.286 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.553 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -101.12 146.3 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.638 -177.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.18 141.9 35.45 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.159 -1.052 . . . . 10.0 108.159 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -46.28 91.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.353 2.702 . . . . 10.0 112.851 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 106.88 2.17 36.61 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.205 -0.997 . . . . 10.0 112.475 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.2 -172.57 40.24 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.859 -0.686 . . . . 10.0 113.157 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.81 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 13.2 m0 -120.03 168.55 11.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.427 0.632 . . . . 10.0 111.289 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.99 109.97 5.1 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.631 -1.248 . . . . 10.0 107.631 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.1 m -79.15 126.61 30.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.527 -0.761 . . . . 10.0 110.964 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.596 ' CG ' HG21 ' A' ' 33' ' ' VAL . 46.9 m-85 -136.84 136.58 38.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.25 105.84 0.12 Allowed 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 124.01 0.819 . . . . 10.0 110.815 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.54 -170.47 7.52 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 120.38 -0.914 . . . . 10.0 110.955 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.666 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 4.6 p90 . . . . . 0 C--N 1.314 -0.976 0 CA-C-O 121.913 0.863 . . . . 10.0 110.784 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.666 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 12.8 t80 . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.622 HG21 HG21 ' A' ' 19' ' ' THR . 1.4 m -66.08 126.93 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.6 p -123.49 -22.41 5.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.583 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.64 124.15 2.32 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.644 -1.265 . . . . 10.0 112.833 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.788 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.8 mt -84.99 151.91 23.84 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 170.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.642 ' C ' HG12 ' A' ' 6' ' ' VAL . 3.6 m-70 -142.57 142.22 32.14 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.439 -0.949 . . . . 10.0 108.439 -177.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.82 125.46 30.11 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.104 -1.038 . . . . 10.0 110.06 177.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.811 ' HB2' HG22 ' A' ' 32' ' ' THR . 51.7 t -95.38 154.48 17.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.532 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 109.307 -0.627 . . . . 10.0 109.307 174.822 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 29.9 Cg_endo . . . . . 0 C--O 1.234 0.296 0 CA-C-O 120.826 0.261 . . . . 10.0 112.487 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.853 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.4 m 49.3 -144.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 115.207 -0.906 . . . . 10.0 111.795 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.714 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.32 -5.4 0.3 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.402 1.081 . . . . 10.0 113.107 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 73.9 -25.28 0.2 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.983 0.913 . . . . 10.0 113.131 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 85.4 m -83.47 -7.14 59.6 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.705 0.261 . . . . 10.0 111.705 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.843 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -97.62 138.81 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.012 -0.736 . . . . 10.0 109.012 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.21 113.88 14.99 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.499 -0.186 . . . . 10.0 110.499 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.813 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -92.87 166.15 12.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.735 0.779 . . . . 10.0 112.762 176.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 19' ' ' THR . 81.7 t80 -149.19 140.8 23.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.187 -1.369 . . . . 10.0 107.886 172.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.512 ' HG3' ' OG1' ' A' ' 19' ' ' THR . 27.5 mp0 -98.71 100.09 11.27 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.538 -0.465 . . . . 10.0 110.1 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 t -96.98 -157.32 0.58 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -64.85 94.36 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.843 0.354 . . . . 10.0 110.804 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 61.23 29.22 18.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.675 -0.693 . . . . 10.0 111.622 176.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.99 102.65 3.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.979 -0.378 . . . . 10.0 109.979 -172.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.9 m -90.46 96.33 10.6 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 168.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.813 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.9 p-10 -85.93 109.04 18.47 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.11 -0.95 . . . . 10.0 111.817 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.89 107.15 19.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 122.016 0.912 . . . . 10.0 108.723 174.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.732 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -99.98 110.08 22.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.105 -1.407 . . . . 10.0 110.356 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.843 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 23.4 t30 -80.51 157.55 26.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.184 -0.462 . . . . 10.0 109.999 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.43 24.12 1.22 Allowed Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.855 -0.688 . . . . 10.0 112.687 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.604 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -75.04 -18.15 60.37 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.088 0.155 . . . . 10.0 111.287 -178.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.23 -4.68 0.9 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.359 1.037 . . . . 10.0 111.202 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.604 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 13.1 p-10 -127.22 154.26 45.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.033 0.444 . . . . 10.0 110.953 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 127.54 33.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.393 -0.821 . . . . 10.0 111.295 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.587 ' H ' HG22 ' A' ' 46' ' ' ILE . 31.1 m -134.17 137.71 51.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.277 0.56 . . . . 10.0 111.355 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.8 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 15.0 m -86.35 123.21 31.34 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.048 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.58 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -123.23 151.21 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.77 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.491 ' HB ' ' C ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -130.52 159.59 36.66 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.411 -0.813 . . . . 10.0 109.538 176.001 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.631 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.39 133.6 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 121.322 0.582 . . . . 10.0 111.467 -176.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -98.89 118.15 35.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.169 -0.923 . . . . 10.0 108.946 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -92.5 157.09 16.74 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.058 0.456 . . . . 10.0 110.228 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 100.0 m -46.43 -30.09 2.0 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.925 -1.034 . . . . 10.0 112.874 174.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -107.64 -83.72 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.82 -0.55 . . . . 10.0 110.546 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.93 55.21 0.01 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 119.89 -1.147 . . . . 10.0 113.508 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -70.38 154.87 41.42 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.063 0.458 . . . . 10.0 111.166 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -74.53 118.2 17.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.918 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.769 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -176.52 -43.97 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.153 -0.93 . . . . 10.0 111.675 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.769 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 3.3 Cg_endo -44.4 69.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 125.06 3.84 . . . . 10.0 116.661 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.0 t 172.04 110.51 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.304 1.041 . . . . 10.0 109.52 163.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.27 128.54 8.31 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.935 -0.765 . . . . 10.0 108.935 174.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.8 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -81.02 139.06 18.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.333 0.587 . . . . 10.0 109.75 177.173 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.587 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -99.14 147.79 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 115.309 -0.859 . . . . 10.0 109.978 -177.031 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -87.35 144.54 36.03 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 168.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -41.34 96.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.515 2.81 . . . . 10.0 112.966 173.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 93.53 10.11 59.51 Favored Glycine 0 C--O 1.229 -0.173 0 C-N-CA 119.93 -1.128 . . . . 10.0 112.164 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.06 -177.05 40.77 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.455 -0.402 . . . . 10.0 113.02 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.732 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 15.4 m0 -118.08 165.28 13.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.439 0.638 . . . . 10.0 111.394 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -142.14 109.37 5.57 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.454 -1.248 . . . . 10.0 107.699 172.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -79.8 130.37 35.26 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.611 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.631 ' CG ' HG21 ' A' ' 33' ' ' VAL . 52.6 m-85 -139.23 134.17 32.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 -177.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.34 103.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 O-C-N 124.032 0.832 . . . . 10.0 111.531 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.94 176.32 36.94 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 110.386 -1.086 . . . . 10.0 110.386 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 p90 . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 118.346 1.073 . . . . 10.0 110.306 -176.637 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.463 ' CE2' ' HB ' ' A' ' 65' ' ' THR . 41.4 t80 . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 109.544 -0.539 . . . . 10.0 109.544 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.545 HG21 HG21 ' A' ' 19' ' ' THR . 0.5 OUTLIER -60.55 127.86 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.771 -0.826 . . . . 10.0 108.771 175.122 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.463 ' HB ' ' CE2' ' A' ' 63' ' ' TYR . 9.0 t -141.01 8.8 2.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.96 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.25 128.36 2.07 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 119.629 -1.272 . . . . 10.0 112.622 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.853 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.2 mt -100.88 132.75 46.13 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 173.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.725 ' C ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -126.26 148.59 49.47 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.4 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -80.89 124.58 29.22 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.961 -0.696 . . . . 10.0 110.846 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.473 ' HB2' HG22 ' A' ' 32' ' ' THR . 0.1 OUTLIER -96.93 174.52 6.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.762 -177.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 C--N 1.324 -0.508 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 172.069 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.468 ' O ' HG22 ' A' ' 6' ' ' VAL . 87.2 Cg_endo . . . . . 0 N--CA 1.453 -0.855 0 N-CA-C 110.749 -0.52 . . . . 10.0 110.749 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 67' ' ' LEU . 1.7 m 51.35 -147.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.055 0.542 . . . . 10.0 110.402 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.727 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.3 4.08 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 175.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 74.57 -39.76 0.43 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.313 0.857 . . . . 10.0 113.313 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 32.6 m -79.07 -7.0 57.77 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.973 HG12 HD22 ' A' ' 23' ' ' ASN . 2.0 m -99.35 140.55 18.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -142.74 126.35 16.9 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.716 -0.393 . . . . 10.0 111.304 -175.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.745 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.25 164.71 12.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.99 0.9 . . . . 10.0 112.933 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 19' ' ' THR . 64.1 t80 -143.88 156.51 44.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.066 -1.424 . . . . 10.0 107.628 172.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.425 ' OE1' ' HE1' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -105.76 107.41 18.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.064 0.459 . . . . 10.0 110.858 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 33.6 m -103.82 77.6 1.47 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.608 -0.886 . . . . 10.0 108.608 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 65.26 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.514 -173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -127.67 27.56 5.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.414 0.626 . . . . 10.0 109.667 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.55 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 2.1 t80 -135.36 96.29 3.44 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 -172.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.4 m -85.41 96.3 9.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.562 0.696 . . . . 10.0 110.282 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.745 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.6 p-10 -85.21 108.82 17.92 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.404 -1.271 . . . . 10.0 112.353 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.694 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -98.39 109.22 23.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.588 -0.893 . . . . 10.0 108.588 174.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.786 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.7 p80 -97.85 114.2 26.2 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.138 -1.392 . . . . 10.0 110.343 176.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.973 HD22 HG12 ' A' ' 10' ' ' VAL . 10.8 t-20 -83.09 155.92 23.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.124 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.88 32.86 1.29 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.128 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.641 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -82.63 -16.98 46.28 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 122.824 -0.221 . . . . 10.0 111.108 -178.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 83.85 -3.9 1.12 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.512 1.132 . . . . 10.0 111.025 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 8.7 p-10 -129.25 154.4 46.85 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.073 0.463 . . . . 10.0 110.828 174.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.63 125.54 26.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.041 -0.981 . . . . 10.0 111.183 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.605 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.5 m -133.82 140.38 46.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.511 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.771 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 7.7 m -88.12 120.93 29.95 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.065 -0.516 . . . . 10.0 109.686 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.41 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -120.31 149.07 23.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.549 0.69 . . . . 10.0 110.794 -179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.833 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -128.74 161.29 30.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.208 -0.905 . . . . 10.0 108.997 176.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.599 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -131.82 135.19 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 121.296 0.569 . . . . 10.0 111.316 -175.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -98.81 115.3 28.48 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.096 -0.956 . . . . 10.0 108.958 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.554 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 74.5 m-85 -89.08 161.56 16.46 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.113 0.483 . . . . 10.0 110.97 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.3 m -52.36 -27.01 13.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.918 -1.037 . . . . 10.0 111.171 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -118.28 -74.85 0.59 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.11 60.97 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.295 -0.955 . . . . 10.0 113.072 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -64.82 148.03 52.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.534 0.207 . . . . 10.0 110.449 172.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -71.3 112.11 7.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.843 -0.429 . . . . 10.0 109.843 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.777 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -175.89 -44.51 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 115.824 -0.625 . . . . 10.0 112.548 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.777 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -41.4 76.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 124.88 3.72 . . . . 10.0 115.908 -176.132 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 41' ' ' ALA . 1.2 m 161.91 108.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.081 1.352 . . . . 10.0 110.702 168.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.407 ' NH1' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -154.07 128.26 9.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.841 -0.8 . . . . 10.0 108.841 179.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.79 137.18 21.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 118.576 0.625 . . . . 10.0 109.986 174.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -97.87 148.42 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 115.239 -0.891 . . . . 10.0 109.783 -177.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.07 145.46 38.25 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 107.905 -1.146 . . . . 10.0 107.905 168.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -43.61 95.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.163 2.575 . . . . 10.0 112.521 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.741 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.6 14.57 55.21 Favored Glycine 0 CA--C 1.511 -0.178 0 C-N-CA 119.756 -1.211 . . . . 10.0 111.926 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.66 -176.99 35.47 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.445 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.786 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.2 m0 -117.28 165.31 13.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.411 0.624 . . . . 10.0 111.134 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -141.93 114.27 8.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.572 -1.195 . . . . 10.0 107.89 173.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.5 m -81.49 128.44 33.89 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.99 -0.55 . . . . 10.0 111.088 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.599 ' CG ' HG21 ' A' ' 33' ' ' VAL . 54.0 m-85 -137.98 144.78 41.3 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.106 -1.072 . . . . 10.0 108.106 -178.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.79 104.7 0.38 Allowed 'General case' 0 C--N 1.32 -0.712 0 O-C-N 123.618 0.574 . . . . 10.0 110.587 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.37 177.18 12.35 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.074 -1.21 . . . . 10.0 110.074 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.56 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 15.9 p90 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 118.484 1.142 . . . . 10.0 110.853 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.56 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 29.3 t80 . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 109.069 -0.715 . . . . 10.0 109.069 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.588 HG21 HG21 ' A' ' 19' ' ' THR . 1.5 m -61.11 129.3 23.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.2 p -127.31 -18.57 4.46 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.563 -0.455 . . . . 10.0 112.18 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.97 122.78 1.8 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.783 -1.198 . . . . 10.0 113.136 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.766 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -86.64 131.81 34.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.233 0.539 . . . . 10.0 109.595 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.756 ' C ' HG12 ' A' ' 6' ' ' VAL . 9.0 m170 -123.59 147.45 47.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.293 -0.867 . . . . 10.0 108.934 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.4 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -80.64 128.39 33.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 119.341 0.973 . . . . 10.0 110.835 178.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.833 ' HB2' HG22 ' A' ' 32' ' ' THR . 41.2 t -95.48 157.71 15.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.287 -177.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 C--N 1.329 -0.287 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 173.411 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.73 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 30.5 Cg_endo . . . . . 0 N--CA 1.446 -1.283 0 N-CA-C 112.87 0.296 . . . . 10.0 112.87 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.678 HG23 HG23 ' A' ' 69' ' ' THR . 0.5 OUTLIER 47.58 126.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 125.661 1.584 . . . . 10.0 114.41 -177.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.715 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 29.04 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.389 1.056 . . . . 10.0 112.513 168.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.495 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 2.0 mp0 -58.57 1.21 0.06 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.619 0.97 . . . . 10.0 113.619 -168.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' ALA . 28.7 m -81.21 -22.02 39.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.528 175.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.831 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.6 m -90.73 137.06 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -139.28 124.39 18.9 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.963 -0.295 . . . . 10.0 110.538 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.783 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -93.63 166.79 12.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.57 0.7 . . . . 10.0 112.316 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.657 ' O ' ' HA ' ' A' ' 19' ' ' THR . 74.8 t80 -141.39 156.47 45.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.425 -1.324 . . . . 10.0 107.425 172.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.93 109.24 18.92 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.288 0.566 . . . . 10.0 110.684 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.0 t -117.15 -162.84 0.88 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -63.81 92.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 10.0 111.43 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 56.8 ttp180 62.45 31.42 17.14 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.536 0.684 . . . . 10.0 110.22 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.9 107.44 4.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.873 -174.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.5 m -97.75 95.32 7.47 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.303 0.573 . . . . 10.0 109.594 167.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.783 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.8 p-10 -84.78 108.9 17.7 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.905 -1.043 . . . . 10.0 111.94 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.59 106.39 18.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.002 0.906 . . . . 10.0 109.387 175.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.722 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 1.2 p80 -97.14 111.94 23.95 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.145 -1.388 . . . . 10.0 110.581 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.831 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 18.0 t-20 -82.3 157.58 23.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.871 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.49 34.58 1.16 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 121.332 -0.461 . . . . 10.0 112.112 171.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.63 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -85.17 -17.82 36.03 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 122.566 -0.373 . . . . 10.0 111.615 -176.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 86.88 -12.72 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.367 1.042 . . . . 10.0 111.233 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -123.06 154.44 38.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.983 0.42 . . . . 10.0 110.19 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -67.89 123.75 21.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.504 -0.771 . . . . 10.0 111.335 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.636 ' H ' HG22 ' A' ' 46' ' ' ILE . 27.3 m -125.86 139.17 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 121.176 0.513 . . . . 10.0 111.881 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.767 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 6.4 m -88.78 118.25 28.34 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.67 HG12 HG21 ' A' ' 6' ' ' VAL . 1.1 m -114.76 165.35 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 115.218 -0.901 . . . . 10.0 110.362 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.567 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.2 OUTLIER -148.49 161.17 42.17 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.669 -0.863 . . . . 10.0 108.669 178.281 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.651 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -136.49 139.94 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 121.41 0.624 . . . . 10.0 111.482 -174.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -107.04 116.37 31.81 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.981 -1.009 . . . . 10.0 109.078 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 27.8 m-85 -91.27 162.34 14.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.449 0.642 . . . . 10.0 111.348 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -54.48 -21.35 9.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.692 -1.14 . . . . 10.0 112.116 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -119.72 -85.03 0.66 Allowed 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.001 -0.437 . . . . 10.0 110.561 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.37 52.67 0.01 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 119.567 -1.301 . . . . 10.0 114.147 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -65.65 141.6 58.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.33 0.565 . . . . 10.0 109.77 169.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -72.33 120.72 18.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.071 0.462 . . . . 10.0 110.328 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.862 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -174.32 -40.61 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.246 -0.888 . . . . 10.0 112.338 -173.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.862 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 3.1 Cg_endo -44.08 70.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 124.938 3.759 . . . . 10.0 116.33 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 4.5 t 172.5 112.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.059 0.944 . . . . 10.0 110.215 163.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.513 ' HB2' ' HZ ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -151.11 119.04 6.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.308 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.767 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -78.56 128.46 38.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 173.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -90.63 144.66 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 115.46 -0.791 . . . . 10.0 109.621 -175.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -85.17 141.64 37.52 Favored Pre-proline 0 C--N 1.293 -1.868 0 N-CA-C 107.726 -1.213 . . . . 10.0 107.726 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -43.21 95.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.301 2.667 . . . . 10.0 112.942 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.721 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.76 13.67 56.36 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.554 -1.307 . . . . 10.0 111.87 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 22' ' ' HIS . . . -97.02 -170.41 33.74 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.106 -0.568 . . . . 10.0 112.846 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.722 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 10.6 m0 -121.46 166.44 14.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.546 0.689 . . . . 10.0 111.425 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.408 ' HB3' HG13 ' A' ' 21' ' ' VAL . . . -142.68 109.7 5.55 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.56 -1.2 . . . . 10.0 108.103 171.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.2 m -78.88 129.76 34.89 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.712 -0.677 . . . . 10.0 110.606 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.651 ' CG ' HG21 ' A' ' 33' ' ' VAL . 51.3 m-85 -136.58 149.9 48.3 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.93 97.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.775 0.672 . . . . 10.0 111.16 -173.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.14 -178.53 10.73 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.107 -0.797 . . . . 10.0 111.107 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.491 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 9.0 p90 . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 122.556 1.169 . . . . 10.0 110.771 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.491 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 32.1 t80 . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 108.846 -0.798 . . . . 10.0 108.846 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.556 HG21 HG21 ' A' ' 19' ' ' THR . 1.4 m -59.9 130.14 23.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.949 -0.76 . . . . 10.0 108.949 177.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 p -122.11 -29.04 4.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.653 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -138.5 121.7 2.22 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.417 -1.373 . . . . 10.0 113.63 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.73 ' HB2' ' HB2' ' A' ' 5' ' ' PRO . 5.2 mt -84.35 146.87 27.48 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.974 -0.75 . . . . 10.0 108.974 172.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.525 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 4.2 m-70 -137.92 156.34 47.98 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.846 -0.615 . . . . 10.0 109.944 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.678 HG23 HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -82.61 127.93 33.84 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.984 -0.686 . . . . 10.0 109.59 174.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.567 ' HB2' HG22 ' A' ' 32' ' ' THR . 5.1 t -100.27 171.06 8.02 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.82 -0.352 . . . . 10.0 110.582 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 C--N 1.323 -0.585 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 176.149 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.645 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 97.9 Cg_endo . . . . . 0 N--CA 1.453 -0.877 0 CA-C-O 120.771 0.238 . . . . 10.0 112.147 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.6 m 47.92 -147.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.33 -0.85 . . . . 10.0 111.818 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.687 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -59.33 0.09 0.13 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.421 1.088 . . . . 10.0 113.933 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 70.49 -31.23 0.22 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.095 0.776 . . . . 10.0 113.095 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.9 m -76.44 -11.89 59.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 10.0 111.207 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.83 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -97.97 137.82 24.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.875 -0.787 . . . . 10.0 108.875 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -133.23 115.07 14.54 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.888 -0.325 . . . . 10.0 110.508 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.803 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.74 161.51 14.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.786 0.803 . . . . 10.0 113.078 177.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 19' ' ' THR . 69.0 t80 -141.2 145.69 35.97 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.118 -1.401 . . . . 10.0 107.272 170.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.474 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 27.1 mp0 -107.25 130.59 54.73 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.416 -0.514 . . . . 10.0 110.987 -176.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.3 t -118.81 -160.08 0.79 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.675 -1.231 . . . . 10.0 107.675 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -60.29 -48.33 82.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.847 0.356 . . . . 10.0 111.322 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -140.81 28.77 1.93 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.751 0.31 . . . . 10.0 110.949 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CE1' HG23 ' A' ' 53' ' ' THR . 0.4 OUTLIER -142.87 105.51 4.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.7 -0.227 . . . . 10.0 110.613 -173.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.539 HG21 HG21 ' A' ' 64' ' ' VAL . 15.6 m -95.12 98.51 10.7 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.401 -0.592 . . . . 10.0 109.401 166.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.803 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -86.35 109.27 18.88 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.382 -0.826 . . . . 10.0 112.224 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.83 107.4 20.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.862 0.839 . . . . 10.0 109.065 173.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.749 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 1.9 p80 -98.18 112.53 24.47 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.433 -1.258 . . . . 10.0 110.202 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.83 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 10.7 t-20 -80.72 155.24 26.84 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.563 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -145.32 32.08 1.66 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.082 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.78 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -79.43 -19.95 48.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 122.831 -0.217 . . . . 10.0 111.316 -176.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.71 -11.73 0.68 Allowed 'General case' 0 N--CA 1.473 0.675 0 O-C-N 124.515 1.134 . . . . 10.0 111.221 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -126.43 155.4 42.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.989 0.423 . . . . 10.0 110.416 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -67.82 121.9 16.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.54 -0.755 . . . . 10.0 111.249 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.662 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.2 m -126.3 141.92 44.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 10.0 111.106 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.742 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 6.2 m -92.19 122.89 35.11 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.955 -177.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.668 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -124.01 148.02 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.8 -0.637 . . . . 10.0 111.072 -178.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.891 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -126.76 161.84 27.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 177.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.606 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.25 141.7 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.403 0.621 . . . . 10.0 111.787 -176.386 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -104.6 110.94 23.45 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.639 -1.164 . . . . 10.0 109.651 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 34.2 m-85 -93.82 159.13 15.33 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.369 0.604 . . . . 10.0 111.642 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.4 m -48.19 -34.45 10.1 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.673 -1.149 . . . . 10.0 112.786 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -112.35 -78.3 0.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.508 -0.477 . . . . 10.0 110.41 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.08 63.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.053 -1.07 . . . . 10.0 112.922 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 144.2 47.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -76.33 102.07 5.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.003 0.43 . . . . 10.0 110.789 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 1.075 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -173.95 10.56 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 114.196 1.184 . . . . 10.0 114.196 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.075 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 5.3 Cg_endo -84.96 64.89 6.35 Favored 'Trans proline' 0 C--N 1.358 1.07 0 CA-C-N 122.088 1.781 . . . . 10.0 112.466 -172.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 172.41 109.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.835 0.854 . . . . 10.0 110.63 168.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.78 122.86 6.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.585 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.742 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -77.8 135.34 26.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.544 -0.462 . . . . 10.0 109.796 175.32 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.1 tp -97.94 147.05 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 115.167 -0.924 . . . . 10.0 109.064 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -85.0 143.49 40.04 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 108.248 -1.019 . . . . 10.0 108.248 168.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -44.07 94.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.41 2.74 . . . . 10.0 112.845 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.758 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 94.77 12.78 55.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 119.813 -1.184 . . . . 10.0 112.289 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.44 -173.95 33.98 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.949 -0.643 . . . . 10.0 112.326 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.749 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 15.7 m0 -117.3 166.07 12.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.535 0.683 . . . . 10.0 111.165 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.427 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -140.82 112.03 7.26 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.317 -1.364 . . . . 10.0 107.317 171.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.462 HG23 ' CE1' ' A' ' 18' ' ' TYR . 26.7 m -80.32 126.26 30.93 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.304 -0.862 . . . . 10.0 110.337 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.606 ' CG ' HG21 ' A' ' 33' ' ' VAL . 46.7 m-85 -136.26 140.8 43.72 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.06 104.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.182 0.926 . . . . 10.0 110.698 -173.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.8 -178.21 16.81 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.387 -0.911 . . . . 10.0 110.988 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.531 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 12.2 p90 . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 121.891 0.853 . . . . 10.0 110.698 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 37.9 t80 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.539 HG21 HG21 ' A' ' 19' ' ' THR . 1.7 m -65.13 129.8 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.575 -0.898 . . . . 10.0 108.575 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.2 p -117.93 -29.17 5.72 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.721 -0.392 . . . . 10.0 111.34 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.55 136.08 7.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 119.992 -1.099 . . . . 10.0 113.146 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.895 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.0 mt -95.35 129.87 42.34 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.576 -0.528 . . . . 10.0 109.576 173.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.752 ' C ' HG12 ' A' ' 6' ' ' VAL . 10.5 m170 -117.25 143.27 46.07 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.45 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -81.36 125.46 30.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.805 1.184 . . . . 10.0 111.214 -179.162 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.891 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.0 t -96.55 178.07 5.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.256 -0.884 . . . . 10.0 109.346 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.407 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.8 p-10 . . . . . 0 C--N 1.316 -0.848 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.519 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 92.0 Cg_endo . . . . . 0 N--CA 1.461 -0.432 0 CA-C-O 120.825 0.26 . . . . 10.0 112.555 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.842 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.2 m 51.53 -151.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.169 -0.923 . . . . 10.0 112.273 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.691 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -59.67 5.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.652 1.353 . . . . 10.0 114.652 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 42.5 mt-10 75.11 -39.91 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.015 0.746 . . . . 10.0 113.015 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.9 m -74.02 -12.98 60.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.868 0.322 . . . . 10.0 111.868 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.839 HG12 HD22 ' A' ' 23' ' ' ASN . 1.6 m -99.88 141.07 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.829 -0.434 . . . . 10.0 109.829 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -142.44 128.27 19.38 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 121.05 -0.26 . . . . 10.0 110.822 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.776 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -93.1 165.17 12.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.767 0.794 . . . . 10.0 113.118 176.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' THR . 77.7 t80 -144.01 149.85 37.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.281 -1.377 . . . . 10.0 107.281 171.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.4 121.65 45.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.218 0.532 . . . . 10.0 110.832 -176.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.3 t -138.28 75.54 1.53 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.845 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.7 t90 51.2 90.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.074 -0.966 . . . . 10.0 112.535 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 56' ' ' GLY . 22.8 ttt180 68.37 1.62 2.98 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.638 -0.71 . . . . 10.0 112.313 174.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -123.18 97.17 5.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.192 -0.669 . . . . 10.0 109.192 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.466 HG21 HG11 ' A' ' 64' ' ' VAL . 23.3 m -90.46 100.08 12.98 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 172.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.776 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.0 p-10 -86.09 107.91 18.04 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.914 -0.584 . . . . 10.0 111.974 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -97.78 107.41 20.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.036 0.922 . . . . 10.0 108.564 173.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.819 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.2 p80 -96.86 114.44 26.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.021 -1.445 . . . . 10.0 110.219 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.839 HD22 HG12 ' A' ' 10' ' ' VAL . 14.1 t-20 -83.14 150.33 26.32 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.551 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.5 23.97 3.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.898 -0.668 . . . . 10.0 112.315 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.635 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -86.76 159.83 19.0 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 175.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.46 -11.55 59.96 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.045 0.387 . . . . 10.0 112.045 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -129.88 159.89 35.23 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.246 0.546 . . . . 10.0 111.462 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.41 130.42 42.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.813 -1.085 . . . . 10.0 111.24 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.523 ' H ' HG22 ' A' ' 46' ' ' ILE . 32.6 m -129.05 141.36 46.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.987 -0.551 . . . . 10.0 111.057 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.813 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 7.3 m -90.38 122.9 33.66 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.183 0.516 . . . . 10.0 109.861 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.87 150.95 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.286 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -131.86 162.67 30.03 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.508 -0.769 . . . . 10.0 108.934 175.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.596 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -134.1 144.86 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-O 121.026 0.441 . . . . 10.0 110.441 -176.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -114.93 118.87 34.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.319 -0.855 . . . . 10.0 108.964 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.547 ' OH ' ' HB3' ' A' ' 41' ' ' ALA . 22.6 m-85 -94.48 159.44 15.1 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.574 0.702 . . . . 10.0 111.953 -175.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.518 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 52.0 m -50.07 -31.04 12.14 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.132 -1.395 . . . . 10.0 113.452 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -114.47 -67.29 1.01 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.738 -0.601 . . . . 10.0 110.426 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.95 62.41 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.951 -1.119 . . . . 10.0 113.125 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.573 ' HA ' ' OE1' ' A' ' 39' ' ' GLN . 7.7 mm-40 -72.47 151.52 42.48 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.922 -0.311 . . . . 10.0 110.319 172.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -80.71 100.18 8.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.333 -0.394 . . . . 10.0 111.513 -177.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.833 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.42 21.82 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 113.733 1.012 . . . . 10.0 113.733 172.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.833 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 8.8 Cg_endo -88.34 63.01 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 CA-C-N 121.165 1.452 . . . . 10.0 112.863 -171.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.2 m 169.89 114.93 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.692 0.797 . . . . 10.0 111.646 169.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.56 132.44 7.73 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 175.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.813 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.2 p -83.81 140.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.345 0.593 . . . . 10.0 110.672 178.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.528 HG21 ' CB ' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -99.29 146.77 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-N 115.194 -0.912 . . . . 10.0 109.691 -177.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -88.49 139.11 29.86 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 169.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -43.13 95.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.343 2.695 . . . . 10.0 112.38 177.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.02 13.54 42.55 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.101 -1.047 . . . . 10.0 112.663 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.47 -171.65 30.67 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.886 -0.673 . . . . 10.0 113.046 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.819 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.6 m0 -121.79 165.49 15.78 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.505 0.669 . . . . 10.0 111.014 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -142.95 111.97 6.54 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.446 -1.316 . . . . 10.0 107.446 174.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 m -79.63 131.14 35.9 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.479 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.596 ' CG ' HG21 ' A' ' 33' ' ' VAL . 51.1 m-85 -140.63 145.19 36.31 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.096 -0.705 . . . . 10.0 109.096 -178.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.47 107.61 0.3 Allowed 'General case' 0 C--N 1.322 -0.589 0 O-C-N 124.024 0.827 . . . . 10.0 110.585 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 17' ' ' ARG . . . -71.31 -177.03 25.5 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.836 -0.905 . . . . 10.0 110.836 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.876 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 20.1 p90 . . . . . 0 C--N 1.321 -0.651 0 CA-C-N 118.465 1.132 . . . . 10.0 109.98 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.876 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 11.1 t80 . . . . . 0 CA--C 1.509 -0.605 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 19' ' ' THR . 1.0 OUTLIER -62.33 126.2 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.312 -0.995 . . . . 10.0 108.312 171.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.4 p -118.19 -29.55 5.53 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.448 -0.501 . . . . 10.0 111.051 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -136.99 125.98 3.56 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 119.87 -1.157 . . . . 10.0 112.932 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.842 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -86.17 131.54 34.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.307 -0.627 . . . . 10.0 109.307 171.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.72 ' C ' HG12 ' A' ' 6' ' ' VAL . 12.4 m170 -119.47 147.83 43.96 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.61 -0.885 . . . . 10.0 108.61 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.457 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -82.71 126.12 32.01 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.266 -0.974 . . . . 10.0 110.318 178.165 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.623 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.2 t -96.22 161.05 14.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.85 -177.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 . . . . . 0 C--N 1.326 -0.431 0 N-CA-C 109.142 -0.688 . . . . 10.0 109.142 169.637 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 26.4 Cg_endo . . . . . 0 C--O 1.234 0.293 0 N-CA-C 112.805 0.271 . . . . 10.0 112.805 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.911 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.5 m 50.68 -142.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.018 0.927 . . . . 10.0 111.884 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.729 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -55.73 -5.51 0.16 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.307 1.043 . . . . 10.0 113.148 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 75.7 -25.93 0.2 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.87 0.868 . . . . 10.0 112.806 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.31 14.66 15.75 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 111.748 0.277 . . . . 10.0 111.748 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.852 HG12 HD22 ' A' ' 23' ' ' ASN . 1.7 m -116.72 142.06 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -135.57 118.0 15.78 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.849 -0.34 . . . . 10.0 111.529 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.74 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.36 161.75 14.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.832 0.825 . . . . 10.0 112.515 174.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -146.3 168.05 22.03 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 106.63 -1.619 . . . . 10.0 106.63 170.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.495 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -114.58 107.61 15.73 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.09 -0.644 . . . . 10.0 111.645 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 1.7 p -99.28 50.91 0.94 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.82 -0.808 . . . . 10.0 108.82 175.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 38.7 t-105 74.35 -90.44 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.262 -1.336 . . . . 10.0 111.348 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -100.02 30.99 3.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 10.0 110.93 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.486 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -154.4 107.34 2.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.403 -0.817 . . . . 10.0 109.006 -172.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.495 HG21 HG11 ' A' ' 64' ' ' VAL . 5.4 m -91.85 97.71 11.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.51 0.671 . . . . 10.0 109.539 170.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.74 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.8 p-10 -83.41 108.17 16.4 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.473 -1.239 . . . . 10.0 111.77 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.23 106.97 20.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 122.26 1.029 . . . . 10.0 108.927 172.518 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.805 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -97.32 111.02 23.45 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.109 -1.405 . . . . 10.0 109.982 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.852 HD22 HG12 ' A' ' 10' ' ' VAL . 13.1 t-20 -80.05 154.19 28.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.16 -0.473 . . . . 10.0 109.746 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.49 21.24 3.26 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.581 -0.608 . . . . 10.0 111.581 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.828 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -83.08 160.03 22.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.36 -0.608 . . . . 10.0 109.36 174.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.02 -10.71 59.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.479 -0.328 . . . . 10.0 111.465 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -128.77 159.31 36.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.406 0.622 . . . . 10.0 111.675 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.7 125.65 27.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.85 -1.068 . . . . 10.0 111.253 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.517 ' H ' HG22 ' A' ' 46' ' ' ILE . 34.1 m -125.44 143.67 38.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.961 0.41 . . . . 10.0 111.231 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.8 m -90.68 121.36 32.52 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.386 -0.598 . . . . 10.0 109.386 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.625 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -121.54 143.53 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.516 0.675 . . . . 10.0 110.994 -178.29 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -122.21 160.62 24.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.237 -0.892 . . . . 10.0 109.433 176.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.619 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.2 141.04 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.118 0.485 . . . . 10.0 111.61 -177.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -108.34 114.51 28.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.35 -0.841 . . . . 10.0 109.614 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.431 ' HE2' ' HD3' ' A' ' 42' ' ' PRO . 56.6 m-85 -90.36 156.56 18.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.277 0.561 . . . . 10.0 112.048 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.4 m -43.21 -46.09 5.94 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.134 -1.394 . . . . 10.0 113.365 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -106.99 -77.21 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.299 -0.56 . . . . 10.0 110.573 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.28 124.83 0.77 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 119.705 -1.236 . . . . 10.0 113.245 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -163.27 151.94 14.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.88 -1.156 . . . . 10.0 107.88 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -75.88 146.08 40.05 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.384 -0.526 . . . . 10.0 111.52 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.732 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 159.41 -44.31 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 114.32 -1.309 . . . . 10.0 110.138 -170.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.732 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 1.4 Cg_endo -45.34 65.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 125.283 3.989 . . . . 10.0 116.519 177.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' ALA . 1.1 m 170.72 100.73 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.431 1.093 . . . . 10.0 110.071 164.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.56 130.73 15.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.74 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -82.23 136.77 22.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.131 0.491 . . . . 10.0 110.53 178.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -96.84 145.89 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 115.24 -0.891 . . . . 10.0 109.652 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -85.24 139.44 36.43 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.063 -1.088 . . . . 10.0 108.063 167.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -43.59 98.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.182 2.588 . . . . 10.0 112.309 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.83 2.5 57.24 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.984 -1.103 . . . . 10.0 112.504 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.54 -170.86 37.58 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.975 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.805 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 15.7 m0 -120.26 166.39 13.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.422 0.63 . . . . 10.0 111.22 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -142.57 115.75 8.91 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 171.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 m -82.52 128.93 34.76 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.521 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.5 m-85 -135.89 144.41 45.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.705 -0.85 . . . . 10.0 108.705 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.09 101.95 0.07 Allowed 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.826 0.704 . . . . 10.0 110.704 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.01 -166.99 4.78 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.915 -1.038 . . . . 10.0 111.613 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.678 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.8 p90 . . . . . 0 C--N 1.313 -0.987 0 CA-C-O 121.993 0.901 . . . . 10.0 110.782 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.678 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 20.8 t80 . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 108.674 -0.861 . . . . 10.0 108.674 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 19' ' ' THR . 1.1 m -64.14 131.19 29.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.12 -0.696 . . . . 10.0 109.12 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.9 p -123.33 -24.41 4.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.403 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.94 125.31 2.45 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.162 -1.018 . . . . 10.0 112.549 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.911 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.0 mt -86.27 137.84 32.3 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 172.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.744 ' C ' HG12 ' A' ' 6' ' ' VAL . 8.4 m-70 -127.61 145.93 50.71 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.505 -0.77 . . . . 10.0 108.924 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.26 127.52 32.16 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.219 -0.992 . . . . 10.0 110.26 178.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.777 ' HB2' HG22 ' A' ' 32' ' ' THR . 40.5 t -93.97 155.68 17.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.914 -0.584 . . . . 10.0 109.867 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 C--N 1.327 -0.392 0 N-CA-C 109.041 -0.725 . . . . 10.0 109.041 173.342 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 6' ' ' VAL . 41.3 Cg_endo . . . . . 0 C--O 1.234 0.313 0 CA-C-O 120.669 0.196 . . . . 10.0 111.717 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.726 HG23 ' N ' ' A' ' 7' ' ' ALA . 1.2 m 56.44 -150.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 115.429 -0.805 . . . . 10.0 111.113 177.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.726 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.29 -1.7 0.09 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.4 1.08 . . . . 10.0 113.891 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 74.08 -29.18 0.19 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.184 0.994 . . . . 10.0 112.946 178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.0 m -80.48 -12.27 59.57 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.027 0.38 . . . . 10.0 112.027 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.811 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.9 m -96.42 140.18 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 -175.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -138.79 120.17 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.953 -0.299 . . . . 10.0 110.345 -175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.722 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.2 171.19 8.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.733 0.778 . . . . 10.0 112.626 178.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 19' ' ' THR . 34.3 t80 -149.15 179.99 7.47 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.235 -1.394 . . . . 10.0 107.235 172.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -127.34 116.44 20.52 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.501 0.667 . . . . 10.0 111.156 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 t -121.48 84.19 2.2 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 173.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 59.27 -105.28 0.23 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.333 -0.849 . . . . 10.0 111.047 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 65.8 ttt180 -103.18 24.85 10.25 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.595 0.712 . . . . 10.0 110.13 -177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.98 95.56 4.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.78 -0.646 . . . . 10.0 109.405 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.563 HG21 HG21 ' A' ' 64' ' ' VAL . 2.6 m -86.54 98.82 11.28 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 170.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.722 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -86.65 103.99 15.64 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.195 -0.911 . . . . 10.0 112.123 -176.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -96.24 107.16 19.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.74 -0.837 . . . . 10.0 108.74 174.317 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.797 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.5 p80 -97.39 113.46 25.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.621 -1.172 . . . . 10.0 110.439 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.811 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 t30 -79.41 150.18 31.41 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.679 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.97 16.02 5.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.775 -0.726 . . . . 10.0 112.39 175.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.43 154.96 23.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 174.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.43 -8.9 57.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.346 0.499 . . . . 10.0 112.346 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -127.25 160.63 30.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.51 0.671 . . . . 10.0 112.145 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -71.06 124.12 23.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.68 -1.145 . . . . 10.0 111.583 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.59 ' H ' HG22 ' A' ' 46' ' ' ILE . 30.7 m -125.61 141.06 46.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.322 0.582 . . . . 10.0 111.523 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.672 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 10.6 m -89.78 122.53 32.95 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 m -120.44 153.09 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.444 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.768 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -130.73 157.99 41.31 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.38 -0.827 . . . . 10.0 109.482 176.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.643 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.48 139.78 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 121.14 0.495 . . . . 10.0 110.523 -178.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.09 117.48 34.11 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.128 -0.942 . . . . 10.0 109.323 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -90.57 155.75 18.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.083 0.468 . . . . 10.0 111.504 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 51.8 m -44.61 -41.93 6.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.824 -1.08 . . . . 10.0 112.731 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -102.86 -87.54 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.648 -0.421 . . . . 10.0 110.556 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.26 130.89 1.23 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.823 -0.703 . . . . 10.0 111.93 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -172.68 151.74 2.4 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.9 p90 -76.27 144.34 40.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.127 0.489 . . . . 10.0 110.407 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.762 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 158.51 -37.4 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 124.997 1.319 . . . . 10.0 110.855 -169.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.762 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 9.9 Cg_endo -53.39 61.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 124.079 3.186 . . . . 10.0 115.504 176.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 5.1 t 177.69 105.07 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.501 0.72 . . . . 10.0 109.367 163.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -145.15 122.95 11.9 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.315 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.672 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.26 128.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 174.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -92.67 146.11 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 CA-C-N 114.638 -1.164 . . . . 10.0 109.141 -176.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.34 142.55 43.7 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 107.957 -1.127 . . . . 10.0 107.957 168.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.406 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 13.0 Cg_exo -47.59 96.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.89 2.393 . . . . 10.0 112.034 174.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 101.05 5.19 53.56 Favored Glycine 0 C--O 1.229 -0.166 0 C-N-CA 120.064 -1.065 . . . . 10.0 112.232 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.44 -176.39 37.29 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 121.069 -0.586 . . . . 10.0 112.979 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.797 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 20.5 m0 -117.04 164.7 14.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.647 0.737 . . . . 10.0 110.966 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.457 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -138.4 113.76 9.54 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 171.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.7 m -82.25 128.66 34.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.07 -0.514 . . . . 10.0 109.994 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.643 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.4 m-85 -137.02 139.22 41.24 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.042 -1.096 . . . . 10.0 108.042 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.29 101.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.375 1.047 . . . . 10.0 111.015 -176.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.17 -178.8 11.21 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.605 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 2.5 p90 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 118.165 0.983 . . . . 10.0 110.799 -172.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 21.7 t80 . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.563 HG21 HG21 ' A' ' 19' ' ' THR . 1.8 m -63.55 130.11 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 174.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 73.4 p -122.3 -30.73 3.94 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.317 -0.553 . . . . 10.0 111.328 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.73 124.16 3.37 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 119.603 -1.284 . . . . 10.0 113.279 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.606 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -88.26 141.55 28.46 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.93 -0.767 . . . . 10.0 108.93 172.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.711 ' C ' HG12 ' A' ' 6' ' ' VAL . 3.9 m-70 -132.09 149.61 52.36 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.339 -0.846 . . . . 10.0 108.772 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -81.98 128.59 34.24 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.219 -0.992 . . . . 10.0 110.025 176.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.768 ' HB2' HG22 ' A' ' 32' ' ' THR . 5.5 t -98.06 168.94 9.96 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--N 1.319 -0.757 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 176.05 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.429 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 39.7 Cg_endo . . . . . 0 C--O 1.236 0.387 0 CA-C-O 120.819 0.258 . . . . 10.0 111.924 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.824 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.8 m 48.31 -146.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.181 -0.918 . . . . 10.0 111.745 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.697 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.35 -0.57 0.1 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.39 1.076 . . . . 10.0 113.889 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 70.36 -24.5 0.16 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.683 0.793 . . . . 10.0 113.043 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.0 m -78.27 -15.01 59.18 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.41 0.148 . . . . 10.0 111.346 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.9 HG12 HD22 ' A' ' 23' ' ' ASN . 2.0 m -100.45 143.55 13.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.092 -0.336 . . . . 10.0 110.092 -174.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -141.23 125.38 17.36 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.513 -0.18 . . . . 10.0 110.513 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -96.05 162.43 13.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.814 0.816 . . . . 10.0 112.885 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -143.84 138.1 28.42 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.379 -1.282 . . . . 10.0 107.703 172.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -103.48 127.25 50.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.997 0.427 . . . . 10.0 111.02 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.1 m -131.23 -155.98 0.73 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.294 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -63.36 93.82 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.936 0.398 . . . . 10.0 110.852 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 61.33 30.01 18.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.512 -0.767 . . . . 10.0 111.487 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.89 106.44 3.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.805 -0.443 . . . . 10.0 109.805 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.52 HG21 HG21 ' A' ' 64' ' ' VAL . 16.2 m -94.73 102.08 13.94 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.98 -0.378 . . . . 10.0 109.98 168.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.739 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.3 p-10 -88.05 111.7 21.83 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.903 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.73 107.58 21.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.936 0.874 . . . . 10.0 108.897 172.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.763 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 2.7 p80 -97.23 114.71 26.48 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.399 -1.273 . . . . 10.0 110.025 176.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.9 HD22 HG12 ' A' ' 10' ' ' VAL . 12.3 t-20 -80.79 153.96 27.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.721 177.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.56 25.38 3.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.552 -0.832 . . . . 10.0 112.586 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.596 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -88.42 164.56 15.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 176.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.58 -15.99 56.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.032 0.382 . . . . 10.0 112.032 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -128.15 156.42 42.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.259 0.552 . . . . 10.0 111.774 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.29 126.52 28.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.894 -1.048 . . . . 10.0 111.648 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.607 ' H ' HG22 ' A' ' 46' ' ' ILE . 34.3 m -124.62 146.0 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-O 121.125 0.488 . . . . 10.0 111.059 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.672 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.3 m -95.21 122.87 38.35 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.635 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.573 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -123.07 151.33 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 115.769 -0.65 . . . . 10.0 110.658 -177.218 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.854 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -130.21 163.08 27.48 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.227 -0.897 . . . . 10.0 109.116 175.371 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.662 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.4 131.07 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 120.865 0.364 . . . . 10.0 110.089 -176.36 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -103.12 115.29 30.31 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.505 -0.77 . . . . 10.0 109.103 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 41.4 m-85 -86.26 162.35 18.32 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.729 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.1 m -50.17 -23.42 2.18 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.737 -1.12 . . . . 10.0 112.446 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -131.06 -74.01 0.53 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.919 -0.488 . . . . 10.0 110.402 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.87 133.74 2.29 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.32 -1.112 . . . . 10.0 110.32 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.09 24.76 0.37 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.003 0.43 . . . . 10.0 110.412 -174.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 36.0 t90 58.87 103.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.212 -0.904 . . . . 10.0 112.149 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.703 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -173.83 -45.07 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.355 -0.839 . . . . 10.0 111.587 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.703 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 2.6 Cg_endo -38.27 100.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 123.951 3.101 . . . . 10.0 114.308 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.0 m 129.51 100.38 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.241 1.816 . . . . 10.0 111.244 168.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.37 130.96 11.47 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.9 -1.045 . . . . 10.0 108.293 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.672 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -84.56 138.42 19.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.485 0.66 . . . . 10.0 110.731 178.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -99.09 148.77 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.457 -1.247 . . . . 10.0 109.692 -177.186 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -87.66 142.62 32.86 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.803 -1.184 . . . . 10.0 107.803 168.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -45.46 93.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.042 2.494 . . . . 10.0 112.843 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.02 15.11 37.24 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.047 -1.073 . . . . 10.0 112.523 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.78 -174.64 28.11 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.084 -0.579 . . . . 10.0 112.733 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.763 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 16.5 m0 -117.61 167.13 11.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.637 0.732 . . . . 10.0 111.653 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -144.64 113.72 6.91 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.56 -1.2 . . . . 10.0 107.982 171.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 m -82.63 131.88 35.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.989 -175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.662 ' CG ' HG21 ' A' ' 33' ' ' VAL . 46.6 m-85 -140.0 144.51 36.99 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.35 -0.981 . . . . 10.0 108.35 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.22 101.98 0.06 Allowed 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 124.131 0.894 . . . . 10.0 111.151 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.14 175.54 42.23 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.247 -0.977 . . . . 10.0 110.86 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.456 ' H ' ' HD1' ' A' ' 57' ' ' TYR . 2.6 p90 . . . . . 0 CA--C 1.532 0.26 0 CA-C-N 118.38 1.09 . . . . 10.0 110.041 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 44.5 t80 . . . . . 0 N--CA 1.442 -0.838 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.52 HG21 HG21 ' A' ' 19' ' ' THR . 0.9 OUTLIER -60.19 125.75 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 174.346 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.0 t -138.41 6.56 2.54 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.466 -0.494 . . . . 10.0 110.936 -175.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -156.23 107.17 0.31 Allowed Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 119.246 -1.454 . . . . 10.0 113.395 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.824 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.9 mt -82.28 128.35 34.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.696 -0.853 . . . . 10.0 108.696 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.742 ' C ' HG12 ' A' ' 6' ' ' VAL . 8.5 m-70 -122.36 143.32 49.72 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.254 -0.884 . . . . 10.0 108.685 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -77.76 129.74 35.86 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.055 -1.028 . . . . 10.0 110.445 179.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.854 ' HB2' HG22 ' A' ' 32' ' ' THR . 44.6 t -99.91 157.76 16.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.394 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--N 1.325 -0.473 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 171.133 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--O 1.235 0.34 0 CA-C-O 120.801 0.25 . . . . 10.0 111.757 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.727 HG23 ' N ' ' A' ' 7' ' ' ALA . 1.4 m 51.35 -151.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.304 -0.862 . . . . 10.0 111.732 174.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.727 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -60.4 9.4 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.342 1.238 . . . . 10.0 114.342 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 47.8 mt-10 75.79 -49.72 0.61 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.454 0.909 . . . . 10.0 113.454 176.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 60.9 m -73.57 -9.67 58.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.68 0.276 . . . . 10.0 111.442 -170.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.834 HG12 HD22 ' A' ' 23' ' ' ASN . 1.5 m -98.73 132.82 43.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.917 -0.772 . . . . 10.0 108.917 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -139.57 126.82 21.29 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.85 -0.34 . . . . 10.0 110.207 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -90.65 163.24 14.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.767 0.794 . . . . 10.0 111.937 177.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.431 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 55.8 t80 -142.27 155.91 45.25 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.073 -1.455 . . . . 10.0 107.073 171.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.444 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -103.31 94.38 5.47 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.481 0.657 . . . . 10.0 111.208 -177.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.673 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 38.3 m -86.37 60.75 6.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.148 -0.933 . . . . 10.0 108.54 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.8 t90 66.35 -92.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.985 -1.007 . . . . 10.0 110.87 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -110.92 40.85 1.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.668 0.747 . . . . 10.0 109.534 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.673 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 1.7 t80 -151.08 99.57 2.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.013 -0.994 . . . . 10.0 108.496 -175.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 12' ' ' TYR . 2.5 m -87.12 98.26 11.2 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.345 0.593 . . . . 10.0 109.783 173.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.73 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.1 p-10 -87.54 104.94 16.96 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.723 -1.126 . . . . 10.0 111.445 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -96.12 105.22 16.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.497 -0.927 . . . . 10.0 108.497 174.541 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.8 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 3.3 p80 -95.51 112.95 24.57 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.362 -1.29 . . . . 10.0 110.063 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.834 HD22 HG12 ' A' ' 10' ' ' VAL . 14.1 t-20 -81.65 150.1 28.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.737 175.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.14 25.39 3.33 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.078 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.713 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.5 OUTLIER -89.01 162.59 15.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 176.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.59 -12.96 59.82 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.275 0.472 . . . . 10.0 112.275 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -120.68 152.32 38.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.443 0.64 . . . . 10.0 112.449 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.7 118.54 11.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.894 -1.048 . . . . 10.0 110.735 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.548 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.4 m -121.74 137.81 54.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.332 0.586 . . . . 10.0 112.049 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.709 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.4 m -87.46 122.76 31.61 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.786 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.09 151.69 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 115.256 -0.883 . . . . 10.0 110.711 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.775 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -130.1 160.0 35.07 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.964 -0.754 . . . . 10.0 108.964 176.198 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.637 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.36 132.78 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.42 0.629 . . . . 10.0 110.81 -177.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -102.53 114.16 28.13 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.806 -1.088 . . . . 10.0 108.97 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 53.3 m-85 -89.84 164.73 14.5 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.575 0.702 . . . . 10.0 112.265 -175.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -52.81 -32.91 46.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.191 -1.368 . . . . 10.0 111.597 169.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -106.98 -86.22 0.5 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.813 0.34 . . . . 10.0 110.698 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.81 53.22 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.747 -0.74 . . . . 10.0 111.717 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.11 138.39 55.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -73.11 107.48 5.47 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.989 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -167.13 -42.15 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 118.281 -0.866 . . . . 10.0 112.879 -173.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.989 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 1.6 Cg_endo -41.77 70.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 125.151 3.9 . . . . 10.0 116.877 -173.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 5.7 t 173.77 110.2 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.807 0.843 . . . . 10.0 109.735 164.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HA ' ' NE ' ' A' ' 44' ' ' ARG . 0.6 OUTLIER -149.52 121.09 7.99 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.935 177.329 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -77.98 127.18 38.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.998 -0.741 . . . . 10.0 108.998 173.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -91.41 146.78 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 114.589 -1.187 . . . . 10.0 109.478 -175.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.03 133.05 41.91 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 107.443 -1.317 . . . . 10.0 107.443 168.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -43.11 96.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.189 2.593 . . . . 10.0 112.369 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 103.19 7.6 43.13 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.343 -0.932 . . . . 10.0 113.084 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.16 -171.79 28.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.098 -0.572 . . . . 10.0 113.589 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.8 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 20.3 m0 -118.43 167.31 11.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.333 0.587 . . . . 10.0 110.896 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.58 114.84 8.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.327 -1.36 . . . . 10.0 107.327 171.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.0 m -83.45 130.21 35.02 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.757 -173.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.637 ' CG ' HG21 ' A' ' 33' ' ' VAL . 56.9 m-85 -138.72 146.63 41.73 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.8 102.59 0.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.601 0.563 . . . . 10.0 110.493 -174.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.97 -169.54 15.15 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.54 -0.838 . . . . 10.0 111.077 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.666 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 6.3 p90 . . . . . 0 C--N 1.319 -0.742 0 CA-C-O 122.014 0.912 . . . . 10.0 110.86 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.666 ' HD1' ' HB3' ' A' ' 57' ' ' TYR . 89.6 t80 . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 120.885 0.374 . . . . 10.0 111.559 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.693 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.3 m -60.65 136.89 23.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 172.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.5 t -144.77 12.82 1.48 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.196 -0.602 . . . . 10.0 111.89 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.04 110.62 0.45 Allowed Glycine 0 C--O 1.224 -0.504 0 C-N-CA 119.438 -1.363 . . . . 10.0 113.482 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.611 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.5 mt -84.65 133.78 34.39 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.388 0.613 . . . . 10.0 109.701 173.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.704 ' C ' HG12 ' A' ' 6' ' ' VAL . 27.2 m-70 -127.06 149.58 49.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.033 -0.985 . . . . 10.0 108.706 -176.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.436 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -83.67 129.41 34.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 119.485 1.039 . . . . 10.0 110.381 177.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.775 ' HB2' HG22 ' A' ' 32' ' ' THR . 5.2 t -98.89 172.9 7.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.349 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 108.917 -0.771 . . . . 10.0 108.917 173.584 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 CA--C 1.529 0.261 0 N-CA-C 113.349 0.481 . . . . 10.0 113.349 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.628 HG23 HG23 ' A' ' 69' ' ' THR . 0.2 OUTLIER -157.07 118.72 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.584 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.61 -19.54 0.16 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.505 0.722 . . . . 10.0 112.58 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 6' ' ' VAL . 32.6 mt-10 74.49 -28.32 0.19 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.283 1.033 . . . . 10.0 112.041 175.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.0 m -87.18 -10.26 53.11 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.919 0.34 . . . . 10.0 111.919 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -95.56 134.85 31.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.871 -0.788 . . . . 10.0 108.871 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -135.82 121.58 19.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.787 -0.188 . . . . 10.0 110.594 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.813 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -98.18 161.33 13.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.146 0.795 . . . . 10.0 113.146 178.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 19' ' ' THR . 82.9 t80 -148.05 155.62 41.69 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 171.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.553 ' NE2' ' H ' ' A' ' 14' ' ' GLN . 0.7 OUTLIER -110.15 124.95 52.47 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.318 -0.553 . . . . 10.0 110.606 178.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.2 t -136.75 77.2 1.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.25 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 55.95 86.79 0.06 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.215 -0.902 . . . . 10.0 112.092 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 67.49 14.14 9.52 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.965 -0.561 . . . . 10.0 112.271 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -139.03 96.52 3.13 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.521 -0.548 . . . . 10.0 109.521 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.5 m -87.46 100.4 12.73 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.656 -0.498 . . . . 10.0 109.656 171.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.813 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.4 p-10 -83.63 111.42 19.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 114.948 -1.024 . . . . 10.0 111.829 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.98 106.65 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 122.015 0.912 . . . . 10.0 108.883 171.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.784 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -97.51 112.07 24.07 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.14 -1.391 . . . . 10.0 110.545 179.02 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.762 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.5 t-20 -80.72 160.03 25.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.89 -0.595 . . . . 10.0 110.255 177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -154.5 32.0 0.7 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.638 -0.791 . . . . 10.0 111.764 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -83.05 -18.4 39.85 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 122.132 0.173 . . . . 10.0 111.015 -178.375 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 86.35 -8.34 0.73 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.753 1.283 . . . . 10.0 111.08 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 10.9 p-10 -125.07 155.05 40.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.121 0.486 . . . . 10.0 110.841 175.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.67 123.22 20.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.292 -0.867 . . . . 10.0 111.183 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.609 ' H ' HG22 ' A' ' 46' ' ' ILE . 26.8 m -126.03 139.79 50.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.067 0.46 . . . . 10.0 111.364 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.774 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 9.5 m -88.93 119.67 29.65 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.509 -0.552 . . . . 10.0 109.509 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' CYS . 1.1 m -116.66 165.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 115.401 -0.818 . . . . 10.0 110.51 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.489 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -148.57 158.16 43.94 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.641 -0.709 . . . . 10.0 109.206 178.221 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.627 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -135.23 138.22 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.338 0.59 . . . . 10.0 111.717 -173.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -101.22 125.99 47.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.947 -1.024 . . . . 10.0 108.908 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 57.0 m-85 -95.07 165.6 12.34 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.247 -0.581 . . . . 10.0 110.351 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 88.0 m -49.4 -21.07 0.8 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.245 -0.889 . . . . 10.0 112.142 174.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -118.96 -67.05 1.02 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 174.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.04 50.65 0.07 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.735 -0.745 . . . . 10.0 112.352 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -74.43 158.98 32.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.73 0.3 . . . . 10.0 111.362 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -66.92 112.87 4.54 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.388 0.614 . . . . 10.0 112.224 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.693 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -174.82 -47.72 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 CA-C-N 114.844 -1.071 . . . . 10.0 111.101 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.693 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 3.0 Cg_endo -37.06 96.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 124.273 3.316 . . . . 10.0 114.128 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 1.6 m 135.99 108.19 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.0 1.72 . . . . 10.0 111.202 170.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.76 130.58 7.44 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -83.45 135.74 24.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.392 0.615 . . . . 10.0 110.236 176.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.37 146.79 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.829 -1.078 . . . . 10.0 109.994 -176.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -88.27 141.56 30.95 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 168.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -38.9 98.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.71 2.94 . . . . 10.0 113.02 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.721 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 89.37 12.22 63.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 119.603 -1.284 . . . . 10.0 112.23 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.28 -176.63 36.03 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 121.276 -0.488 . . . . 10.0 112.214 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.784 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 23.6 m0 -116.65 165.16 13.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.552 0.692 . . . . 10.0 111.182 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -139.46 115.87 10.56 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.14 -1.43 . . . . 10.0 107.14 172.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.0 m -85.2 127.88 34.46 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.374 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.627 ' CG ' HG21 ' A' ' 33' ' ' VAL . 48.5 m-85 -137.42 139.43 40.68 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.462 -0.94 . . . . 10.0 108.462 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.54 100.04 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.172 0.92 . . . . 10.0 111.324 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.29 175.07 43.44 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.233 -1.147 . . . . 10.0 110.233 176.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.44 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 7.7 p90 . . . . . 0 CA--C 1.537 0.475 0 CA-C-N 118.742 1.271 . . . . 10.0 109.96 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.451 ' HB3' ' OG1' ' A' ' 36' ' ' THR . 26.9 t80 . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -61.3 129.02 23.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.9 p -128.23 -16.37 4.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.136 -0.484 . . . . 10.0 111.678 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.37 110.65 0.66 Allowed Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 119.226 -1.464 . . . . 10.0 113.709 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.3 mt -82.36 150.53 27.12 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.069 -0.715 . . . . 10.0 109.069 171.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.515 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -148.22 159.65 43.75 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.264 -178.044 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.628 HG23 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -81.44 126.61 31.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.033 0.444 . . . . 10.0 110.66 174.402 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 30' ' ' SER . 48.9 t -98.92 166.97 11.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.492 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--N 1.321 -0.652 0 N-CA-C 109.164 -0.68 . . . . 10.0 109.164 171.837 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 36.0 Cg_endo . . . . . 0 N--CA 1.458 -0.586 0 CA-C-O 121.138 0.391 . . . . 10.0 112.62 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.584 HG12 ' HB3' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -151.93 124.42 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 177.141 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 71.06 -27.54 0.17 Allowed 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.752 0.657 . . . . 10.0 111.88 172.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 6' ' ' VAL . 47.0 mt-10 77.68 -20.17 0.39 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.609 1.163 . . . . 10.0 111.36 175.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.9 m -84.18 -14.46 50.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.414 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.786 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -96.03 134.19 34.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -133.1 119.6 20.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.583 -175.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.787 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -96.71 162.04 13.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.024 0.916 . . . . 10.0 113.296 177.131 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 19' ' ' THR . 33.5 t80 -143.04 178.98 7.32 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.407 -1.701 . . . . 10.0 106.407 169.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -136.96 117.35 13.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.457 0.571 . . . . 10.0 111.349 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 p -120.66 86.65 2.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.664 -0.698 . . . . 10.0 109.85 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 62.72 -84.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.998 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -120.31 16.75 12.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.983 0.42 . . . . 10.0 110.933 -172.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.69 96.45 3.82 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.218 -0.66 . . . . 10.0 109.218 -173.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.504 HG21 HG11 ' A' ' 64' ' ' VAL . 7.0 m -86.17 99.12 11.3 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.624 0.726 . . . . 10.0 109.192 171.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.787 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.0 p-10 -85.27 109.67 18.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.434 -1.257 . . . . 10.0 111.926 -175.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.36 106.48 19.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 172.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.738 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -98.37 110.96 23.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.068 -1.424 . . . . 10.0 110.297 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.786 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 18.6 t-20 -80.98 154.91 26.68 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.957 -0.565 . . . . 10.0 109.939 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.25 36.13 1.03 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.579 -0.82 . . . . 10.0 112.177 173.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -76.59 -66.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.457 -0.306 . . . . 10.0 110.449 -178.032 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 25' ' ' CYS . . . 142.42 -32.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.815 1.322 . . . . 10.0 108.699 -171.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -115.33 157.67 23.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.111 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.35 127.22 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.492 -0.776 . . . . 10.0 111.319 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.599 ' H ' HG22 ' A' ' 46' ' ' ILE . 30.8 m -125.47 139.55 50.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.072 0.463 . . . . 10.0 111.268 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.826 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 14.7 m -88.3 119.7 28.96 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.273 -0.64 . . . . 10.0 109.273 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.442 HG12 HG21 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -119.12 148.45 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 121.775 0.798 . . . . 10.0 111.732 -178.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -127.16 160.88 29.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.8 -1.091 . . . . 10.0 109.287 176.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.73 138.95 47.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.33 0.585 . . . . 10.0 111.867 -178.154 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -100.81 120.36 40.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.72 -1.127 . . . . 10.0 109.241 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.466 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 35.1 m-85 -100.13 158.96 15.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.295 0.569 . . . . 10.0 111.55 -178.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.529 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 22.7 m -48.48 -34.9 11.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.608 -1.178 . . . . 10.0 112.601 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -103.29 -83.6 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.931 -0.48 . . . . 10.0 109.876 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.4 49.63 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.246 -0.978 . . . . 10.0 112.898 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -66.3 153.24 43.15 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.088 -0.338 . . . . 10.0 110.088 173.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 14.5 p90 -75.7 136.68 40.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.866 -0.79 . . . . 10.0 108.866 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.73 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 165.95 -42.52 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 123.57 0.748 . . . . 10.0 111.329 -170.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.73 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 6.3 Cg_endo -48.69 71.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 124.212 3.275 . . . . 10.0 115.29 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER 164.1 97.89 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.794 1.238 . . . . 10.0 110.2 166.166 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.73 126.48 10.31 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.944 -0.761 . . . . 10.0 108.944 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.826 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -80.53 137.39 21.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.287 0.565 . . . . 10.0 110.749 179.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -96.0 145.64 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.235 -0.893 . . . . 10.0 109.38 -177.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.58 140.45 31.73 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 107.808 -1.182 . . . . 10.0 107.808 169.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -43.53 95.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.267 2.644 . . . . 10.0 113.107 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 99.59 5.44 55.49 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.064 -1.065 . . . . 10.0 112.511 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.24 -171.79 38.33 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 121.29 -0.481 . . . . 10.0 113.117 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.738 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 16.6 m0 -119.74 167.3 12.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.499 0.666 . . . . 10.0 111.005 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -142.59 114.46 8.13 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.154 -1.424 . . . . 10.0 107.154 171.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.8 m -80.95 129.42 34.53 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.549 -0.751 . . . . 10.0 110.361 -175.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.617 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.3 m-85 -137.52 141.0 41.45 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.595 -0.891 . . . . 10.0 108.595 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.01 106.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.958 0.786 . . . . 10.0 110.854 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.5 -170.96 6.31 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.338 -0.846 . . . . 10.0 111.818 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.611 ' HB3' ' HD2' ' A' ' 63' ' ' TYR . 2.3 p90 . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 122.207 1.003 . . . . 10.0 111.556 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.611 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 8.5 t80 . . . . . 0 CA--C 1.513 -0.458 0 N-CA-C 107.471 -1.307 . . . . 10.0 107.471 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 19' ' ' THR . 1.6 m -66.53 128.79 30.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.6 p -119.28 -28.84 5.33 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.344 -0.389 . . . . 10.0 111.277 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.51 115.38 1.1 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.569 -1.3 . . . . 10.0 113.209 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.584 ' HB3' HG12 ' A' ' 6' ' ' VAL . 4.4 mt -79.34 146.62 32.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 170.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.458 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 5.3 m-70 -140.29 157.93 44.81 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.453 -176.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.559 HG23 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -79.63 126.44 30.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.011 0.434 . . . . 10.0 110.571 174.249 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.584 ' HB2' HG22 ' A' ' 32' ' ' THR . 35.8 t -94.44 158.77 15.41 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.154 -0.684 . . . . 10.0 109.154 177.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 C--N 1.317 -0.837 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 174.357 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 N--CA 1.456 -0.708 0 N-CA-C 111.941 -0.061 . . . . 10.0 111.941 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.573 ' CG1' ' HB3' ' A' ' 67' ' ' LEU . 0.2 OUTLIER 41.18 106.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.655 1.354 . . . . 10.0 114.655 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 73.6 -19.11 0.35 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.405 -0.816 . . . . 10.0 112.949 164.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 6' ' ' VAL . 40.1 mt-10 77.5 -40.11 0.32 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.864 . . . . 10.0 112.017 174.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.1 m -77.75 -12.73 60.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.818 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.4 m -90.94 132.43 35.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.869 -0.789 . . . . 10.0 108.869 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.71 113.0 11.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.674 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.765 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -89.34 161.33 16.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.719 0.771 . . . . 10.0 111.996 175.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.45 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 86.4 t80 -142.69 139.87 31.32 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.192 -1.367 . . . . 10.0 107.454 172.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.03 98.26 9.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.537 0.684 . . . . 10.0 110.123 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 12.9 p -99.15 -156.35 0.54 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.321 -0.854 . . . . 10.0 108.879 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -69.88 93.22 0.74 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.668 0.271 . . . . 10.0 110.713 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 62.35 32.64 16.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.308 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.446 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.7 OUTLIER -146.41 103.07 3.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 -173.11 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.471 HG21 HG21 ' A' ' 64' ' ' VAL . 16.8 m -90.15 91.56 8.59 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.755 -0.831 . . . . 10.0 108.755 170.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.765 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.0 OUTLIER -83.37 109.07 16.99 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.975 -1.012 . . . . 10.0 111.757 -178.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.28 107.21 19.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 122.066 0.936 . . . . 10.0 108.928 174.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.759 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -98.54 111.01 23.51 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.13 -1.395 . . . . 10.0 110.042 177.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.834 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.9 t30 -79.39 147.46 32.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.053 -0.521 . . . . 10.0 109.748 178.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -129.43 13.85 5.89 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.718 -0.753 . . . . 10.0 112.502 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.79 154.79 23.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.53 -11.22 60.57 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.443 0.535 . . . . 10.0 112.443 -176.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -124.88 156.75 37.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.365 0.602 . . . . 10.0 112.09 -177.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.31 124.72 24.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.721 -1.127 . . . . 10.0 111.33 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.652 ' H ' HG22 ' A' ' 46' ' ' ILE . 27.8 m -124.14 138.33 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.323 0.582 . . . . 10.0 111.533 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.841 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.2 m -87.01 120.15 27.97 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.383 -0.826 . . . . 10.0 109.061 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.564 HG12 HG21 ' A' ' 6' ' ' VAL . 1.2 m -115.42 165.53 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 121.532 0.682 . . . . 10.0 110.653 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.551 ' HB ' ' C ' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -146.96 159.77 43.15 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.968 -1.015 . . . . 10.0 109.037 177.104 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.621 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.41 144.5 33.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.328 0.585 . . . . 10.0 110.633 -176.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -117.44 114.21 23.18 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.074 -0.967 . . . . 10.0 109.114 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 20.3 m-85 -93.1 159.73 15.17 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.626 0.727 . . . . 10.0 111.919 -172.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.6 m -50.67 -44.6 57.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.251 -1.34 . . . . 10.0 113.237 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -95.22 -72.68 0.61 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.36 -0.536 . . . . 10.0 110.823 -177.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.71 48.55 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.958 -1.115 . . . . 10.0 113.575 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -68.1 150.35 48.5 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 117.022 0.411 . . . . 10.0 110.391 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -82.91 108.81 16.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.83 -0.623 . . . . 10.0 111.219 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.776 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -171.95 26.67 0.01 OUTLIER Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 113.063 0.764 . . . . 10.0 113.063 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.776 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 14.3 Cg_endo -91.27 56.91 1.02 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.259 1.306 . . . . 10.0 112.7 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 177.01 116.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.632 0.582 . . . . 10.0 111.356 171.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.79 124.42 3.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.841 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.7 p -83.15 138.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.359 0.6 . . . . 10.0 110.812 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.652 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -100.86 148.3 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 114.941 -1.027 . . . . 10.0 109.494 -177.367 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -90.65 143.26 28.76 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 107.832 -1.173 . . . . 10.0 107.832 168.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -46.08 93.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.106 2.537 . . . . 10.0 112.609 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 102.19 11.52 36.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.86 -1.162 . . . . 10.0 111.884 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.03 -176.79 31.96 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 121.332 -0.461 . . . . 10.0 112.63 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.759 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 12.0 m0 -119.31 166.71 12.67 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.365 0.603 . . . . 10.0 111.126 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -143.47 110.07 5.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 172.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.9 m -79.41 131.07 35.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.761 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.621 ' CG ' HG21 ' A' ' 33' ' ' VAL . 49.8 m-85 -140.1 142.83 36.05 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.004 -1.11 . . . . 10.0 108.004 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.91 102.72 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.544 0.527 . . . . 10.0 110.837 -174.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.53 -176.26 11.37 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.278 -0.873 . . . . 10.0 111.167 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.614 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 13.4 p90 . . . . . 0 N--CA 1.447 -0.599 0 CA-C-N 117.986 0.893 . . . . 10.0 110.903 -174.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 15.8 t80 . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 108.574 -0.898 . . . . 10.0 108.574 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.471 HG21 HG21 ' A' ' 19' ' ' THR . 1.7 m -63.59 133.0 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.432 -0.951 . . . . 10.0 108.432 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 81.6 p -118.51 -39.29 3.02 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.478 -0.489 . . . . 10.0 111.029 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.45 122.57 3.86 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.719 -1.229 . . . . 10.0 113.21 -174.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.573 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 3.7 mt -86.87 144.37 27.02 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.997 -0.742 . . . . 10.0 108.997 173.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.541 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 8.1 m-70 -138.37 159.6 41.64 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.386 -174.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.562 HG23 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -84.12 124.88 31.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.129 0.49 . . . . 10.0 111.129 175.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.495 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.3 t -95.37 172.83 7.85 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.809 -0.811 . . . . 10.0 108.809 175.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 6.4 p-10 . . . . . 0 C--N 1.316 -0.871 0 N-CA-C 108.318 -0.994 . . . . 10.0 108.318 172.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 N--CA 1.449 -1.118 0 CA-C-O 120.679 0.199 . . . . 10.0 112.264 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.86 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.2 m 48.55 -147.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.488 0.715 . . . . 10.0 111.458 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.705 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -56.09 -2.5 0.06 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.275 1.03 . . . . 10.0 113.587 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 69.21 -24.26 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.036 0.934 . . . . 10.0 113.377 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.409 ' H ' ' C ' ' A' ' 7' ' ' ALA . 33.5 m -80.73 -17.44 51.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.866 0.365 . . . . 10.0 111.189 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.903 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -92.09 141.75 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.26 115.03 12.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.62 -0.264 . . . . 10.0 111.028 -172.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.822 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.81 164.68 12.83 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.687 0.756 . . . . 10.0 112.895 177.493 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' THR . 25.8 t80 -147.5 172.66 13.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.27 -1.381 . . . . 10.0 107.27 172.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.502 ' HG3' ' HE1' ' A' ' 57' ' ' TYR . 5.7 pm0 -122.55 127.91 50.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 10.0 110.901 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 t -150.75 89.96 1.59 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.123 -0.489 . . . . 10.0 110.733 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.4 t90 55.04 80.02 0.14 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.697 -0.683 . . . . 10.0 112.229 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 58.95 24.74 12.92 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.641 -0.709 . . . . 10.0 111.629 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.36 97.3 3.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.9 m -89.13 99.86 12.76 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.193 0.521 . . . . 10.0 109.796 173.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.822 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -84.6 109.93 18.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.966 -1.016 . . . . 10.0 112.168 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.8 108.62 24.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 122.017 0.913 . . . . 10.0 109.31 174.057 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.683 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.28 110.55 22.79 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.802 -1.544 . . . . 10.0 110.45 178.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.903 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 20.4 t30 -80.36 155.88 26.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.066 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.03 31.1 1.46 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.181 -0.533 . . . . 10.0 111.874 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -77.2 -18.92 57.38 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.244 0.218 . . . . 10.0 111.084 -179.264 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 88.66 -18.1 0.25 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.699 1.249 . . . . 10.0 111.322 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -120.39 158.86 26.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.001 0.429 . . . . 10.0 110.263 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -66.4 123.61 20.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.433 -0.803 . . . . 10.0 111.002 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.667 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.9 m -127.07 138.8 53.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.058 0.456 . . . . 10.0 111.09 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 9.5 m -87.26 119.48 27.55 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.395 -0.594 . . . . 10.0 109.395 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.38 153.32 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.565 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -134.31 159.62 40.42 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 175.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.552 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -134.33 141.78 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 120.85 0.357 . . . . 10.0 110.172 -177.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.71 119.95 39.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.619 -0.882 . . . . 10.0 108.619 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.484 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 43.3 m-85 -94.22 164.62 12.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.971 0.891 . . . . 10.0 112.323 -173.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.6 m -52.12 -28.65 18.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.974 -1.466 . . . . 10.0 112.445 172.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -110.41 -85.94 0.54 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.857 -0.337 . . . . 10.0 111.133 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.23 43.29 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.023 -1.084 . . . . 10.0 113.097 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -71.48 146.18 48.74 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.796 -0.237 . . . . 10.0 110.627 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -75.08 140.54 43.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.222 -0.658 . . . . 10.0 109.222 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.76 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 160.71 -43.06 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 124.164 0.986 . . . . 10.0 110.804 -168.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.76 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 4.6 Cg_endo -47.65 66.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 124.894 3.729 . . . . 10.0 116.56 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.419 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER 169.33 102.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.315 1.046 . . . . 10.0 110.276 164.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -148.32 126.51 12.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.474 -0.785 . . . . 10.0 109.837 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.727 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.85 130.94 35.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.319 0.581 . . . . 10.0 109.796 174.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -93.41 148.63 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 114.998 -1.001 . . . . 10.0 109.283 -177.689 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -84.86 144.76 42.47 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 108.339 -0.986 . . . . 10.0 108.339 169.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -46.06 95.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.944 2.429 . . . . 10.0 112.711 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.709 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 93.55 13.84 54.56 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 119.948 -1.12 . . . . 10.0 111.824 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.55 -174.32 32.44 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 121.446 -0.407 . . . . 10.0 112.267 -177.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.713 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 19.1 m0 -118.8 166.28 12.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.394 0.616 . . . . 10.0 111.529 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.427 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -142.92 118.69 10.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.71 -1.218 . . . . 10.0 107.71 171.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.1 m -86.58 130.6 34.43 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.663 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.552 ' CG ' HG21 ' A' ' 33' ' ' VAL . 52.6 m-85 -138.53 145.82 41.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.56 -0.904 . . . . 10.0 108.56 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.64 97.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.754 0.659 . . . . 10.0 111.157 -174.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.74 171.79 49.66 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 110.002 -1.239 . . . . 10.0 110.002 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.502 ' HE1' ' HG3' ' A' ' 14' ' ' GLN . 7.8 p90 . . . . . 0 CA--C 1.535 0.374 0 CA-C-N 118.816 1.308 . . . . 10.0 111.037 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 30.6 t80 . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 120.528 0.204 . . . . 10.0 110.727 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 19' ' ' THR . 1.5 m -64.91 129.39 28.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 170.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.9 p -120.54 -22.9 6.24 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.994 -0.683 . . . . 10.0 111.924 -175.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -145.64 127.39 2.81 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.711 -1.233 . . . . 10.0 113.258 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.86 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.7 mt -87.71 139.18 30.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.131 0.491 . . . . 10.0 109.704 172.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.759 ' C ' HG12 ' A' ' 6' ' ' VAL . 14.6 m-70 -129.99 147.44 51.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.411 -0.813 . . . . 10.0 108.942 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -80.84 125.49 30.16 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 118.873 -1.131 . . . . 10.0 110.388 178.387 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.676 ' HB2' HG22 ' A' ' 32' ' ' THR . 38.5 t -87.61 158.75 18.79 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.361 -0.836 . . . . 10.0 109.531 -178.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 . . . . . 0 C--N 1.32 -0.679 0 N-CA-C 108.795 -0.817 . . . . 10.0 108.795 177.108 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.531 0.205 . . . . 10.0 111.474 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.7 p -71.42 -66.56 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.787 0.327 . . . . 10.0 111.239 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.56 102.86 2.02 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.849 -0.691 . . . . 10.0 111.555 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -127.61 81.95 69.23 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.954 0.407 . . . . 10.0 110.527 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -93.55 -33.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.095 2.53 . . . . 10.0 113.581 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.821 HG13 ' HB3' ' A' ' 67' ' ' LEU . 12.3 m -137.77 -142.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.26 -0.274 . . . . 10.0 110.26 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.651 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.65 10.04 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.658 1.183 . . . . 10.0 113.932 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 6' ' ' VAL . 35.4 mt-10 72.59 -50.43 0.7 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.4 0.889 . . . . 10.0 113.4 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.2 m -74.78 -8.53 56.71 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.858 0.318 . . . . 10.0 111.858 -172.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.4 m -95.96 131.97 41.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -132.93 114.46 14.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.529 -0.305 . . . . 10.0 110.616 -171.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.782 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -90.07 155.67 18.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.894 0.855 . . . . 10.0 112.471 175.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.403 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 56.3 t80 -135.05 152.7 51.93 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.058 -1.46 . . . . 10.0 107.058 170.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.546 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 4.3 pm0 -108.7 105.87 15.66 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.365 0.603 . . . . 10.0 110.863 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 p -108.34 75.93 1.01 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.536 0.684 . . . . 10.0 109.583 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 66.63 -86.21 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.542 -1.208 . . . . 10.0 111.801 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -117.5 24.52 11.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 10.0 110.456 -176.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.35 100.29 4.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.857 -0.794 . . . . 10.0 108.857 -174.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.611 HG21 HG21 ' A' ' 64' ' ' VAL . 5.1 m -90.58 95.31 10.09 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 172.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.782 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.0 p-10 -83.43 107.87 16.21 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.749 -1.114 . . . . 10.0 111.701 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.77 107.95 21.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 122.034 0.921 . . . . 10.0 109.157 174.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.726 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.46 110.34 22.51 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.88 -1.509 . . . . 10.0 110.176 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.806 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 24.6 t30 -82.18 159.4 23.29 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -151.73 23.53 0.93 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.769 -0.729 . . . . 10.0 112.241 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.644 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -75.58 -17.04 60.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.64 0.237 . . . . 10.0 111.64 -177.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.06 -4.26 0.92 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.362 1.039 . . . . 10.0 111.171 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.644 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 13.6 p-10 -126.88 156.29 41.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.593 174.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.58 126.07 28.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.451 -0.795 . . . . 10.0 111.139 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.579 ' H ' HG22 ' A' ' 46' ' ' ILE . 24.6 m -132.42 140.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.065 0.459 . . . . 10.0 111.068 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.843 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 5.4 m -88.19 123.91 33.3 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.91 146.14 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-O 121.454 0.645 . . . . 10.0 110.381 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.751 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -124.96 159.43 31.24 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.348 -0.842 . . . . 10.0 109.489 177.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.613 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.2 138.5 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-O 121.043 0.449 . . . . 10.0 110.544 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -106.97 116.42 31.9 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.519 ' OH ' ' HB3' ' A' ' 41' ' ' ALA . 57.1 m-85 -92.71 163.61 13.69 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.727 0.775 . . . . 10.0 112.062 -174.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 47.4 m -52.91 -21.97 4.97 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.238 -1.346 . . . . 10.0 111.693 170.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -135.56 -74.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.871 -0.518 . . . . 10.0 109.84 170.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 40' ' ' TRP . . . 148.76 80.46 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.713 -0.756 . . . . 10.0 112.117 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.779 HE21 ' HA2' ' A' ' 61' ' ' GLY . 10.4 mm-40 -74.66 20.0 0.13 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.022 0.379 . . . . 10.0 112.022 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.418 ' H ' ' C ' ' A' ' 38' ' ' GLY . 30.4 t90 59.77 87.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.64 0.733 . . . . 10.0 112.218 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.744 ' N ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.58 29.06 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.115 -0.948 . . . . 10.0 112.831 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.744 ' HD3' ' N ' ' A' ' 41' ' ' ALA . 9.8 Cg_endo -88.86 54.23 1.95 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.802 1.668 . . . . 10.0 112.198 -173.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.1 m 173.3 111.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.086 0.866 . . . . 10.0 111.259 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 131.62 10.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.843 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -82.13 142.7 13.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.112 0.482 . . . . 10.0 110.409 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -101.51 146.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.932 -0.576 . . . . 10.0 109.976 -178.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -87.27 143.38 34.42 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 169.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -41.16 95.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.523 2.816 . . . . 10.0 113.574 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.717 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 95.26 6.86 59.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.838 -1.172 . . . . 10.0 112.137 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.3 -174.46 44.9 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.183 -0.532 . . . . 10.0 113.098 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.726 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 10.0 m0 -120.11 167.39 12.26 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.932 -0.634 . . . . 10.0 111.061 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -146.14 111.18 5.31 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.768 -1.197 . . . . 10.0 107.768 171.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 m -77.58 130.53 37.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.433 -0.803 . . . . 10.0 110.061 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.613 ' CG ' HG21 ' A' ' 33' ' ' VAL . 49.8 m-85 -137.4 134.98 36.52 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.668 -0.864 . . . . 10.0 108.668 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.92 105.1 0.1 Allowed 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 124.23 0.957 . . . . 10.0 110.297 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.86 -157.85 0.65 Allowed Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.891 -1.05 . . . . 10.0 112.564 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.819 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 26.8 p90 -83.5 40.87 0.75 Allowed 'General case' 0 C--N 1.316 -0.881 0 O-C-N 122.447 -0.443 . . . . 10.0 111.894 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.99 160.5 53.42 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.7 -0.762 . . . . 10.0 112.001 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.6 p -70.66 -20.82 62.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.233 0.54 . . . . 10.0 110.547 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -94.83 5.09 52.91 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.001 -0.741 . . . . 10.0 109.001 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.779 ' HA2' HE21 ' A' ' 39' ' ' GLN . . . -131.78 -137.65 4.05 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.052 -0.976 . . . . 10.0 111.156 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 9.5 m120 -134.86 -96.7 0.26 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.155 -0.683 . . . . 10.0 109.155 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.819 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 15.5 t80 167.99 112.77 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 114.332 -1.304 . . . . 10.0 108.066 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 19' ' ' THR . 1.8 m -66.63 130.21 31.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.124 -1.065 . . . . 10.0 108.124 173.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.9 p -113.1 -37.37 4.79 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.064 -0.654 . . . . 10.0 111.322 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -140.05 136.99 8.09 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.826 -1.178 . . . . 10.0 112.496 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.821 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.0 mt -86.61 152.12 22.87 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.769 -0.826 . . . . 10.0 108.769 171.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.692 ' C ' HG12 ' A' ' 6' ' ' VAL . 6.5 m-70 -138.55 146.24 41.65 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.241 -1.022 . . . . 10.0 108.241 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.444 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -84.14 124.4 31.11 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 118.908 -1.117 . . . . 10.0 110.407 178.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.751 ' HB2' HG22 ' A' ' 32' ' ' THR . 41.9 t -92.27 158.55 16.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.214 -0.903 . . . . 10.0 109.807 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -102.72 141.7 23.04 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -23.8 79.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 1 C-N-CA 127.179 5.252 . . . . 10.0 115.577 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -166.78 88.58 0.34 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.16 -0.927 . . . . 10.0 111.145 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.8 t -90.78 139.46 26.19 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.37 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.2 104.78 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.55 2.166 . . . . 10.0 111.869 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.7 m 70.03 91.76 0.09 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.523 -0.762 . . . . 10.0 111.064 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.19 68.76 0.22 Allowed Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.234 -0.894 . . . . 10.0 111.826 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.608 -0.71 . . . . 10.0 110.18 179.642 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.484 0.183 . . . . 10.0 110.705 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.5 p -85.23 -51.66 6.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.882 0.372 . . . . 10.0 111.926 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.75 175.16 32.93 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.804 -0.712 . . . . 10.0 112.066 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.459 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 3.3 p -124.33 107.11 30.08 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 121.302 0.572 . . . . 10.0 111.533 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.558 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 94.8 Cg_endo -90.63 147.97 4.11 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.616 2.877 . . . . 10.0 112.046 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.9 m 49.19 -148.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.919 0.887 . . . . 10.0 112.36 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.68 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.92 1.32 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.635 1.346 . . . . 10.0 114.635 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 4' ' ' SER . 51.8 mt-10 72.22 -33.79 0.28 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.437 0.695 . . . . 10.0 112.322 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 m -76.86 -13.08 60.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.634 0.254 . . . . 10.0 111.421 -173.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.85 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.9 m -98.35 143.59 12.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.066 -0.716 . . . . 10.0 109.066 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -136.75 111.97 9.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.758 -0.201 . . . . 10.0 110.731 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.772 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -89.19 160.29 17.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.794 0.807 . . . . 10.0 112.546 175.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' THR . 36.9 t80 -142.76 173.95 11.09 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.549 -1.649 . . . . 10.0 106.549 173.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -119.24 103.4 9.47 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.366 -0.534 . . . . 10.0 110.508 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.7 m -104.6 54.29 0.72 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.982 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 60.38 88.99 0.07 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.554 -0.748 . . . . 10.0 111.537 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 49.5 ttt180 63.9 14.49 8.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.581 0.705 . . . . 10.0 111.538 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -130.95 95.72 3.89 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.779 -1.193 . . . . 10.0 107.779 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.488 HG21 HG21 ' A' ' 64' ' ' VAL . 61.5 m -86.35 97.67 10.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.31 0.576 . . . . 10.0 109.694 177.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.772 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.7 p-10 -83.19 108.43 16.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.723 -1.126 . . . . 10.0 111.318 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.99 105.84 18.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 122.203 1.001 . . . . 10.0 109.055 175.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.686 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -99.11 109.16 21.9 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 113.707 -1.588 . . . . 10.0 109.993 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.85 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 15.7 t30 -80.08 156.93 26.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -140.11 13.4 3.07 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.704 -0.76 . . . . 10.0 113.041 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.07 156.9 20.88 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 117.21 0.505 . . . . 10.0 109.844 173.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.32 -8.62 56.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.024 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -116.62 152.81 33.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.646 0.736 . . . . 10.0 111.721 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.76 125.36 26.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.695 -1.139 . . . . 10.0 110.256 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.5 m -124.19 137.31 57.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.109 0.48 . . . . 10.0 111.67 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.802 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 3.8 m -85.69 121.95 29.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.71 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.509 ' HB ' HG11 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -122.78 148.11 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.295 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.714 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.2 OUTLIER -127.44 160.17 32.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.147 -0.933 . . . . 10.0 109.02 176.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -132.03 132.04 61.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.598 0.713 . . . . 10.0 111.337 -176.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -103.55 109.74 21.52 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.522 -176.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.625 ' OH ' ' HB3' ' A' ' 41' ' ' ALA . 28.4 m-85 -89.59 165.31 14.33 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.584 0.706 . . . . 10.0 111.733 -176.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.403 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 52.4 m -52.55 -29.73 26.97 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.231 -1.35 . . . . 10.0 111.397 168.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.453 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 52.6 m-70 -126.42 -77.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 10.0 110.206 172.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.01 79.02 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.228 -0.986 . . . . 10.0 111.691 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.451 ' HG2' ' OD1' ' A' ' 62' ' ' ASN . 12.7 mm100 -76.38 20.01 0.23 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.218 0.451 . . . . 10.0 112.218 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 3.1 t90 66.99 87.41 0.12 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.727 0.811 . . . . 10.0 111.641 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.727 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -170.85 27.77 0.01 OUTLIER Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 113.444 0.905 . . . . 10.0 113.444 174.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.727 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 9.9 Cg_endo -89.16 56.41 2.01 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.726 1.617 . . . . 10.0 112.754 -172.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.2 m 172.27 114.56 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.616 0.766 . . . . 10.0 111.33 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.61 132.0 8.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.1 -0.704 . . . . 10.0 109.1 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.802 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -81.13 138.88 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.199 0.523 . . . . 10.0 110.06 176.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -97.05 145.12 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 115.362 -0.835 . . . . 10.0 109.704 -179.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -83.2 141.38 42.96 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 107.966 -1.124 . . . . 10.0 107.966 169.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -47.77 91.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.298 2.666 . . . . 10.0 112.692 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.654 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 104.37 5.91 42.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.161 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.78 -172.4 36.11 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.382 -0.437 . . . . 10.0 112.863 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.686 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.4 m0 -120.32 167.28 12.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.514 0.673 . . . . 10.0 111.051 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -143.1 113.07 7.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 171.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -81.44 128.31 33.74 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.436 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.617 ' CG ' HG21 ' A' ' 33' ' ' VAL . 42.1 m-85 -138.78 140.52 38.64 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.332 -0.618 . . . . 10.0 109.332 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.72 101.46 0.05 Allowed 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 123.894 0.746 . . . . 10.0 110.192 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.91 -159.27 8.36 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 111.217 -0.753 . . . . 10.0 111.217 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.68 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 28.3 p90 -88.19 127.61 35.44 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.109 -1.071 . . . . 10.0 108.109 173.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.37 -165.23 30.57 Favored Glycine 0 C--N 1.31 -0.895 0 CA-C-N 115.504 -0.771 . . . . 10.0 112.176 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 m -76.57 128.05 33.98 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.127 -0.323 . . . . 10.0 110.127 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 66.51 24.02 10.37 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.889 0.475 . . . . 10.0 111.247 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -125.23 -151.19 7.95 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.094 -0.802 . . . . 10.0 111.094 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 4.0 m120 -125.49 -111.72 0.3 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 117.995 0.897 . . . . 10.0 109.097 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.68 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 28.7 t80 175.43 109.08 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 114.465 -1.243 . . . . 10.0 108.646 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.9 m -63.59 131.56 29.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 107.74 -1.207 . . . . 10.0 107.74 173.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.0 t -137.95 11.82 2.87 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.27 -0.572 . . . . 10.0 110.379 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.76 118.93 0.81 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 119.803 -1.189 . . . . 10.0 112.782 173.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.84 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -88.99 127.57 35.67 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.724 ' C ' HG12 ' A' ' 6' ' ' VAL . 17.6 m-70 -118.24 146.45 44.26 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.306 -0.861 . . . . 10.0 108.933 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.437 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -82.15 123.31 28.87 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.032 -1.043 . . . . 10.0 110.513 177.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.714 ' HB2' HG22 ' A' ' 32' ' ' THR . 42.0 t -92.7 161.01 14.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.799 -0.637 . . . . 10.0 110.205 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 7.3 p-10 -99.19 146.09 31.13 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 172.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 16.8 Cg_exo -28.35 80.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 1 C-N-CA 126.538 4.825 . . . . 10.0 115.116 175.262 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -169.24 99.06 0.35 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.209 -0.905 . . . . 10.0 111.659 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.1 m -89.33 135.92 30.65 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.635 -0.505 . . . . 10.0 109.635 172.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.14 54.81 0.72 Allowed 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 123.017 2.478 . . . . 10.0 113.008 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.8 p -84.44 88.42 7.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.137 0.494 . . . . 10.0 109.844 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.18 138.91 14.22 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.715 -0.755 . . . . 10.0 112.991 -174.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.392 -0.813 . . . . 10.0 109.265 176.64 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.915 0.388 . . . . 10.0 110.488 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.0 m -161.4 -58.0 0.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.514 ' O ' ' HD3' ' A' ' 5' ' ' PRO . . . -101.4 173.93 24.47 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.71 -0.956 . . . . 10.0 110.71 174.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -113.04 86.57 9.34 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 117.132 0.466 . . . . 10.0 110.096 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 54.2 Cg_endo -89.24 -44.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.321 2.014 . . . . 10.0 112.838 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.836 HG13 ' HB3' ' A' ' 67' ' ' LEU . 9.3 m -136.94 -137.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.252 -0.647 . . . . 10.0 109.252 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.704 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -56.48 0.23 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.185 0.994 . . . . 10.0 113.452 174.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 6' ' ' VAL . 10.0 mt-10 74.11 -38.73 0.41 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.518 1.127 . . . . 10.0 113.264 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.1 m -75.77 -13.35 60.29 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.939 0.399 . . . . 10.0 111.318 -175.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.878 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -97.09 137.32 25.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.009 -0.737 . . . . 10.0 109.009 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -143.34 129.94 20.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.043 -0.263 . . . . 10.0 110.477 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.686 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -95.56 165.23 12.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.891 0.853 . . . . 10.0 113.179 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.421 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 87.3 t80 -145.26 154.32 42.24 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 106.72 -1.585 . . . . 10.0 106.72 170.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -105.66 108.26 19.69 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.445 -0.502 . . . . 10.0 111.389 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -99.41 -166.89 1.4 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.124 -1.065 . . . . 10.0 108.124 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.669 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -69.46 100.67 1.43 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.837 0.351 . . . . 10.0 110.541 -178.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 63.92 28.19 14.5 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.118 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.87 101.86 3.59 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 121.207 -0.197 . . . . 10.0 111.15 -169.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.475 HG21 HG21 ' A' ' 64' ' ' VAL . 16.3 m -89.63 96.71 10.81 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 170.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.686 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.1 p-10 -84.34 107.35 16.57 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 114.947 -1.024 . . . . 10.0 112.378 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.29 108.62 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.794 0.807 . . . . 10.0 108.9 174.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.768 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.6 p80 -98.39 113.97 26.14 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.218 -1.356 . . . . 10.0 110.554 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.878 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 22.6 t30 -82.03 163.42 22.11 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.592 -0.522 . . . . 10.0 109.592 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -153.39 25.2 0.77 Allowed Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.288 -0.482 . . . . 10.0 112.203 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -78.72 -14.0 59.52 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.402 0.281 . . . . 10.0 111.148 -177.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 82.24 -6.03 1.4 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.919 -1.037 . . . . 10.0 110.933 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -126.24 158.58 35.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.02 0.438 . . . . 10.0 110.304 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -70.91 120.3 16.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.039 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.74 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.6 m -126.19 140.75 47.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.221 0.534 . . . . 10.0 111.424 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.748 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.0 m -88.11 120.25 29.28 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.154 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.41 161.15 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 115.729 -0.669 . . . . 10.0 110.409 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.691 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.4 OUTLIER -143.13 160.88 39.58 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.474 -0.784 . . . . 10.0 109.015 176.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.587 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.58 145.27 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.45 0.643 . . . . 10.0 111.542 -175.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -114.12 110.31 19.81 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.735 -1.121 . . . . 10.0 109.719 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 11.9 m-85 -90.57 161.88 15.25 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.369 0.604 . . . . 10.0 111.622 -176.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.1 m -48.79 -38.64 22.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.263 -1.335 . . . . 10.0 112.783 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.614 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 47.0 m-70 -101.6 -75.49 0.59 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.518 -0.473 . . . . 10.0 110.064 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.06 46.73 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.553 -0.832 . . . . 10.0 112.048 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.34 136.78 57.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -72.79 100.47 2.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 10.0 111.548 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.851 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.03 19.96 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.256 -0.884 . . . . 10.0 113.233 175.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.851 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 9.2 Cg_endo -87.27 58.62 3.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 CA-C-N 121.112 1.433 . . . . 10.0 112.455 -170.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 176.47 115.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.791 0.682 . . . . 10.0 111.168 170.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 128.67 6.74 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.436 0.694 . . . . 10.0 109.525 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.748 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -83.92 134.38 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.334 0.588 . . . . 10.0 110.534 177.246 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.74 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -94.67 149.29 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.009 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -86.88 146.73 41.54 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 168.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -43.19 98.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.037 2.491 . . . . 10.0 112.961 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.718 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 89.28 11.48 64.55 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.864 -1.16 . . . . 10.0 111.565 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.12 -176.81 37.78 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 121.283 -0.484 . . . . 10.0 112.418 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.768 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 17.2 m0 -115.93 166.76 11.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.793 0.806 . . . . 10.0 111.815 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -143.67 118.3 9.8 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.362 -1.347 . . . . 10.0 107.362 172.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.7 m -85.72 129.7 34.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.178 0.514 . . . . 10.0 110.812 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.587 ' CG ' HG21 ' A' ' 33' ' ' VAL . 56.3 m-85 -136.86 151.34 49.0 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.588 -0.894 . . . . 10.0 108.588 -177.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.97 98.56 0.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.705 0.628 . . . . 10.0 110.562 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.45 178.49 23.11 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 115.049 -0.978 . . . . 10.0 111.107 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 12.1 p90 -84.78 43.68 1.0 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.049 0.925 . . . . 10.0 110.803 -173.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.85 114.06 4.64 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.386 -0.825 . . . . 10.0 111.796 -173.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m 74.99 27.83 1.12 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.242 0.544 . . . . 10.0 111.138 176.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.6 t70 66.1 81.87 0.19 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.416 0.627 . . . . 10.0 110.917 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.72 -115.59 1.01 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.052 -0.819 . . . . 10.0 111.052 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 37' ' ' HIS . 5.1 m-80 -84.33 139.69 32.11 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.287 -0.634 . . . . 10.0 109.287 173.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -127.29 111.89 14.43 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -59.75 128.91 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.5 p -118.04 -34.3 4.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.046 0.45 . . . . 10.0 111.169 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.84 129.71 4.75 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.062 -1.066 . . . . 10.0 112.468 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.836 ' HB3' HG13 ' A' ' 6' ' ' VAL . 3.8 mt -83.89 148.87 26.71 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.114 -1.069 . . . . 10.0 108.114 171.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.7 ' C ' HG12 ' A' ' 6' ' ' VAL . 15.4 m-70 -134.17 147.44 50.77 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.552 -1.277 . . . . 10.0 107.552 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.518 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -82.46 130.04 35.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 118.994 -1.082 . . . . 10.0 110.566 178.146 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.691 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.3 t -96.14 159.72 14.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.986 -0.552 . . . . 10.0 109.58 -178.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.95 146.48 37.1 Favored Pre-proline 0 CA--C 1.512 -0.489 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -22.37 78.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.849 1 C-N-CA 126.702 4.935 . . . . 10.0 115.53 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -169.6 81.91 0.12 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.969 -1.014 . . . . 10.0 110.835 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.3 t -84.45 120.35 74.18 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.312 -0.403 . . . . 10.0 110.123 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.42 146.49 93.28 Favored 'Trans proline' 0 CA--C 1.518 -0.277 0 C-N-CA 122.565 2.176 . . . . 10.0 111.726 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.3 t -153.75 100.43 2.38 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.75 -60.62 7.83 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.723 -0.751 . . . . 10.0 111.494 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.049 -0.976 . . . . 10.0 110.013 175.748 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 120.698 0.285 . . . . 10.0 110.96 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 p -75.59 130.31 38.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.886 0.374 . . . . 10.0 111.141 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.78 -134.31 1.88 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.537 -0.625 . . . . 10.0 111.537 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.62 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 14.3 m -95.67 149.89 36.69 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 110.115 -0.328 . . . . 10.0 110.115 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.24 143.05 38.78 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.779 2.319 . . . . 10.0 111.891 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.598 ' HB ' ' C ' ' A' ' 68' ' ' HIS . 0.3 OUTLIER 38.77 98.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 114.324 1.231 . . . . 10.0 114.324 177.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 75.99 -25.09 0.21 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.558 -0.747 . . . . 10.0 112.559 166.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.62 ' HG2' ' HB2' ' A' ' 4' ' ' SER . 24.6 mt-10 74.8 -22.19 0.27 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.224 1.009 . . . . 10.0 111.845 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 82.4 m -85.42 -16.5 39.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.907 0.336 . . . . 10.0 111.907 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -94.22 139.78 17.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.619 -0.512 . . . . 10.0 109.619 -177.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -141.55 127.3 19.17 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.625 -0.139 . . . . 10.0 110.625 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.789 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -98.4 164.19 12.38 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.468 1.127 . . . . 10.0 113.787 176.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.418 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 84.6 t80 -145.1 162.6 36.63 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.304 -1.771 . . . . 10.0 106.643 172.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.489 ' NE2' ' H ' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -117.71 122.7 44.18 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.083 -0.647 . . . . 10.0 110.786 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.509 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 25.9 p -121.93 -154.39 0.59 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.78 -0.822 . . . . 10.0 108.78 175.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -67.93 91.11 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.647 0.261 . . . . 10.0 111.412 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 61.4 35.07 17.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.585 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.509 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -147.29 101.19 3.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.4 -0.818 . . . . 10.0 109.345 -173.05 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.495 HG21 HG21 ' A' ' 64' ' ' VAL . 6.3 m -90.42 99.37 12.41 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 170.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.789 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -84.37 110.44 18.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.871 -1.059 . . . . 10.0 111.966 -177.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.98 106.69 19.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 122.181 0.991 . . . . 10.0 108.561 171.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.811 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.4 OUTLIER -97.22 111.06 23.47 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.094 -1.412 . . . . 10.0 110.163 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.772 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.4 t30 -80.29 156.66 26.7 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.837 -0.62 . . . . 10.0 109.342 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.47 13.91 3.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.127 -0.558 . . . . 10.0 112.346 174.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.77 156.18 22.66 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.53 -8.41 56.69 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.264 0.468 . . . . 10.0 112.264 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -120.66 157.46 29.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.511 0.672 . . . . 10.0 111.75 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -71.82 117.69 13.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.827 -1.079 . . . . 10.0 110.431 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.683 ' H ' HG22 ' A' ' 46' ' ' ILE . 33.7 m -116.87 139.21 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 121.303 0.573 . . . . 10.0 111.676 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.0 m -88.94 116.88 27.55 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.734 -0.666 . . . . 10.0 109.288 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.5 HG12 HG21 ' A' ' 6' ' ' VAL . 1.1 m -112.8 164.21 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.452 -0.795 . . . . 10.0 110.517 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.31 153.7 40.04 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.257 -0.883 . . . . 10.0 109.212 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.565 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -130.23 137.69 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 120.937 0.399 . . . . 10.0 110.915 -174.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -100.6 116.63 32.97 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.782 -0.821 . . . . 10.0 108.782 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.803 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 45.9 m-85 -91.77 160.79 15.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.112 0.482 . . . . 10.0 111.023 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.6 m -48.47 -33.22 9.01 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.664 -1.153 . . . . 10.0 112.604 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -110.26 -69.66 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.929 0.395 . . . . 10.0 109.961 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.45 58.07 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.551 -0.833 . . . . 10.0 112.161 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.2 154.64 30.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.706 0.289 . . . . 10.0 110.681 176.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -76.46 106.45 8.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.201 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.853 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -173.62 -40.57 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 113.069 0.766 . . . . 10.0 113.069 -175.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.853 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 5.3 Cg_endo -46.86 67.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 124.884 3.723 . . . . 10.0 116.429 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.461 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER 169.96 104.43 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.179 0.992 . . . . 10.0 110.097 168.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -151.85 127.05 9.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.064 -176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.38 132.85 30.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.277 -0.569 . . . . 10.0 109.856 174.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.683 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -96.06 147.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-N 115.112 -0.949 . . . . 10.0 109.28 -177.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -84.03 141.42 40.56 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 169.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -47.89 94.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.056 2.504 . . . . 10.0 112.366 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 97.77 14.22 41.01 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.073 -1.061 . . . . 10.0 112.106 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.66 -172.2 26.77 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 121.112 -0.566 . . . . 10.0 112.669 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.811 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 16.5 m0 -119.54 165.54 14.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.423 0.63 . . . . 10.0 111.255 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -139.66 111.15 7.12 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 172.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.6 m -78.74 126.79 31.2 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.394 -0.821 . . . . 10.0 110.439 -176.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.565 ' CG ' HG21 ' A' ' 33' ' ' VAL . 51.5 m-85 -134.53 146.42 49.67 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.509 -0.922 . . . . 10.0 108.509 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.03 102.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.836 0.71 . . . . 10.0 110.459 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.59 179.44 16.65 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.608 -0.997 . . . . 10.0 110.608 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.655 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 14.9 p90 -79.77 101.38 8.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 118.208 1.004 . . . . 10.0 110.64 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.15 172.5 47.05 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 115.237 -0.892 . . . . 10.0 111.194 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.9 m -58.6 -27.95 65.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.281 0.562 . . . . 10.0 110.663 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -149.2 106.87 3.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 164.58 -138.91 5.53 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.809 -0.71 . . . . 10.0 112.407 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.803 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -102.62 161.48 13.69 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.329 0.585 . . . . 10.0 110.921 -179.178 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 19.1 t80 -135.76 119.96 17.78 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.39 -1.277 . . . . 10.0 108.562 170.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.495 HG21 HG21 ' A' ' 19' ' ' THR . 1.5 m -63.23 130.77 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.2 p -123.83 -19.04 5.84 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.203 -0.599 . . . . 10.0 111.851 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.39 130.69 4.06 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.602 -1.285 . . . . 10.0 113.159 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -94.84 148.0 22.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.399 -0.593 . . . . 10.0 109.399 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.598 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -147.98 164.54 33.47 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.254 -176.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.499 ' N ' ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -83.53 129.1 34.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.22 0.533 . . . . 10.0 111.362 177.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 30' ' ' SER . 32.3 t -98.19 168.3 10.33 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.509 -0.923 . . . . 10.0 108.509 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -134.56 142.81 44.05 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -16.5 78.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.976 1 C-N-CA 126.969 5.113 . . . . 10.0 115.747 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -163.64 83.96 0.47 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.844 -1.071 . . . . 10.0 109.853 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.0 t -80.13 141.08 53.73 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 115.922 -0.581 . . . . 10.0 111.069 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.19 166.02 30.55 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.821 2.347 . . . . 10.0 112.769 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.2 m -78.54 135.66 37.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.152 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.08 -63.59 1.2 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.315 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.436 -0.793 . . . . 10.0 109.417 177.618 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.279 -0.267 . . . . 10.0 110.279 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.4 m -72.29 101.94 2.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.914 0.388 . . . . 10.0 110.11 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.73 -177.44 51.21 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.589 -0.815 . . . . 10.0 111.37 -175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.1 m -100.29 144.27 28.1 Favored Pre-proline 0 C--N 1.32 -0.71 0 O-C-N 122.523 -0.398 . . . . 10.0 110.583 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.617 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 38.4 Cg_endo -65.51 153.68 77.14 Favored 'Trans proline' 0 N--CA 1.475 0.385 0 C-N-CA 123.476 2.784 . . . . 10.0 112.764 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.936 HG13 ' HB3' ' A' ' 67' ' ' LEU . 3.9 m 47.35 -141.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.934 0.893 . . . . 10.0 111.689 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.696 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.89 -1.9 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.512 1.125 . . . . 10.0 113.368 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 76.27 -26.93 0.18 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.989 0.915 . . . . 10.0 112.655 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.84 -10.88 54.68 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.195 0.443 . . . . 10.0 112.195 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.87 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -96.22 140.56 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 -176.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -132.19 116.04 16.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.206 -0.197 . . . . 10.0 110.958 -173.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.777 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.1 161.68 15.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 122.053 0.93 . . . . 10.0 112.919 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 19' ' ' THR . 90.5 t80 -144.28 158.52 43.69 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.835 -1.53 . . . . 10.0 106.908 172.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HG3' ' OG1' ' A' ' 19' ' ' THR . 2.1 mp0 -117.0 101.78 8.79 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.33 -0.548 . . . . 10.0 111.252 -176.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.1 t -93.89 80.2 4.16 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 61.35 -89.86 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 115.005 -0.998 . . . . 10.0 110.573 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.593 ' HD3' ' H ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -118.17 26.68 9.46 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.153 0.501 . . . . 10.0 111.144 -176.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -132.34 96.0 3.77 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.3 m -85.28 101.95 12.96 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.245 0.545 . . . . 10.0 110.214 176.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.777 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.6 p-10 -86.19 108.38 18.32 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.845 -1.07 . . . . 10.0 111.454 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.1 107.82 21.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.891 0.853 . . . . 10.0 108.988 173.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.699 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.04 110.67 22.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.229 -1.35 . . . . 10.0 110.297 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.87 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 21.8 t30 -80.14 160.12 25.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.919 -0.582 . . . . 10.0 110.157 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.46 23.53 1.07 Allowed Glycine 0 C--O 1.226 -0.392 0 C-N-CA 121.361 -0.447 . . . . 10.0 112.207 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -75.12 -16.74 60.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.512 0.196 . . . . 10.0 111.316 -178.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.11 -6.33 0.91 Allowed 'General case' 0 N--CA 1.472 0.647 0 O-C-N 124.631 1.207 . . . . 10.0 111.345 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 5.9 p-10 -126.82 157.02 40.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.959 0.409 . . . . 10.0 110.689 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.79 122.56 18.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.354 -0.839 . . . . 10.0 110.96 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.633 ' H ' HG22 ' A' ' 46' ' ' ILE . 34.6 m -129.1 140.64 48.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.076 0.465 . . . . 10.0 111.442 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.69 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.5 m -87.22 120.34 28.4 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.487 -0.561 . . . . 10.0 109.487 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.692 ' HB ' HG11 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -119.88 146.79 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 115.587 -0.733 . . . . 10.0 110.587 -179.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -125.74 161.74 26.65 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.28 -0.873 . . . . 10.0 108.834 175.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.641 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.82 133.63 58.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.35 0.595 . . . . 10.0 110.95 -176.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -106.04 112.65 25.78 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.735 -1.121 . . . . 10.0 108.696 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.51 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 15.4 m-85 -91.07 164.01 14.1 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.33 0.586 . . . . 10.0 110.959 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.7 m -50.51 -22.53 1.99 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.464 -1.243 . . . . 10.0 112.668 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.53 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 85.5 m-70 -123.96 -82.37 0.64 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.987 -0.445 . . . . 10.0 111.159 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.23 51.01 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.645 -1.264 . . . . 10.0 113.084 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.36 136.05 56.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.863 -0.792 . . . . 10.0 108.863 175.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -72.95 118.31 15.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.209 0.528 . . . . 10.0 110.471 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.769 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -177.05 -45.27 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 114.95 -1.023 . . . . 10.0 111.903 -174.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.769 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 3.5 Cg_exo -37.18 68.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.886 1 C-N-CA 125.924 4.416 . . . . 10.0 117.487 -174.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 5.3 t 170.53 111.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.294 1.038 . . . . 10.0 109.759 162.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.31 126.57 9.94 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.69 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -79.98 130.11 36.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.375 0.607 . . . . 10.0 109.369 175.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.633 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -93.21 148.91 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 114.83 -1.077 . . . . 10.0 109.804 -176.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -84.77 145.99 45.36 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 108.389 -0.967 . . . . 10.0 108.389 168.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -45.0 94.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.009 2.472 . . . . 10.0 112.564 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.718 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.72 15.12 53.89 Favored Glycine 0 CA--C 1.512 -0.151 0 C-N-CA 120.022 -1.085 . . . . 10.0 111.812 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 22' ' ' HIS . . . -97.26 -176.52 34.56 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 121.706 -0.283 . . . . 10.0 112.48 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.714 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 18.6 m0 -118.15 165.41 13.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.629 0.728 . . . . 10.0 111.784 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.425 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -143.91 115.54 8.17 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.265 -1.334 . . . . 10.0 107.929 172.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.3 m -82.56 131.19 35.22 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.598 -0.728 . . . . 10.0 110.764 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.641 ' CG ' HG21 ' A' ' 33' ' ' VAL . 53.5 m-85 -139.76 145.42 38.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.439 -0.948 . . . . 10.0 108.439 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.1 99.29 0.07 Allowed 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 123.856 0.723 . . . . 10.0 110.69 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.08 -173.59 12.35 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.295 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.44 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 2.9 p90 -91.86 83.99 5.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.6 0.714 . . . . 10.0 110.448 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -50.21 -57.9 9.56 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.746 -0.661 . . . . 10.0 113.369 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 p -144.67 -60.37 0.37 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.178 0.513 . . . . 10.0 110.087 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -141.0 161.49 37.72 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.034 -1.098 . . . . 10.0 108.034 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.82 -131.41 9.3 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.201 -1.0 . . . . 10.0 111.795 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.53 ' OD1' ' HB2' ' A' ' 37' ' ' HIS . 13.0 m-80 -76.24 143.31 41.05 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.257 0.551 . . . . 10.0 111.008 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.44 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 26.1 t80 -140.08 118.09 11.85 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.804 -1.089 . . . . 10.0 109.046 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.503 HG21 HG21 ' A' ' 19' ' ' THR . 0.5 OUTLIER -63.47 129.14 26.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 175.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 t -144.77 10.46 1.38 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.306 -0.557 . . . . 10.0 111.034 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.33 106.6 0.29 Allowed Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.552 -1.308 . . . . 10.0 112.951 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.936 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.8 mt -81.37 131.92 35.31 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.737 ' C ' HG12 ' A' ' 6' ' ' VAL . 18.7 m-70 -124.65 143.97 50.44 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.409 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -79.49 125.12 29.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 119.378 0.99 . . . . 10.0 110.482 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.601 ' HB2' HG22 ' A' ' 32' ' ' THR . 4.4 t -89.61 174.2 7.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.492 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 8.0 p-10 -126.44 145.43 52.87 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.378 -0.601 . . . . 10.0 109.378 175.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 27.4 Cg_exo -23.96 80.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 1 C-N-CA 126.89 5.06 . . . . 10.0 115.523 177.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -168.21 91.23 0.31 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.95 -1.023 . . . . 10.0 110.781 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -79.27 128.39 75.83 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.372 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 43' ' ' CYS . 51.3 Cg_endo -71.56 75.81 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.44 2.093 . . . . 10.0 111.879 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.4 p -82.68 -27.3 31.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.577 -0.738 . . . . 10.0 110.738 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.02 144.79 7.07 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.429 -0.668 . . . . 10.0 111.429 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.773 -0.632 . . . . 10.0 110.233 -179.724 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 110.289 -0.264 . . . . 10.0 110.289 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.9 t -74.65 78.89 2.01 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.996 0.903 . . . . 10.0 110.513 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 128.91 -178.67 17.13 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.004 -0.998 . . . . 10.0 110.882 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.5 m 58.34 76.74 0.44 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 121.157 0.504 . . . . 10.0 111.7 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.454 ' O ' HG13 ' A' ' 6' ' ' VAL . 61.1 Cg_endo -90.94 115.38 0.46 Allowed 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.827 2.352 . . . . 10.0 112.697 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.803 HG21 HG12 ' A' ' 31' ' ' VAL . 2.0 m 65.39 -49.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 125.139 1.376 . . . . 10.0 111.951 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.621 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -174.73 114.65 0.17 Allowed 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 106.133 -1.802 . . . . 10.0 106.133 -172.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 1.6 mp0 -57.84 -14.21 5.64 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.405 -0.816 . . . . 10.0 112.396 -166.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.6 m -86.6 -15.5 39.62 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.819 HG12 HD22 ' A' ' 23' ' ' ASN . 1.6 m -91.67 131.47 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.019 -0.734 . . . . 10.0 109.019 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -137.39 123.56 20.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.685 -0.234 . . . . 10.0 110.494 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.76 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.45 159.08 15.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.777 0.798 . . . . 10.0 112.629 178.189 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.437 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 78.2 t80 -139.53 165.35 27.46 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.28 -1.378 . . . . 10.0 107.28 172.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.61 107.84 15.21 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.074 -0.65 . . . . 10.0 110.923 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 21.8 m -96.91 -173.73 2.79 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.519 -1.289 . . . . 10.0 107.519 170.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -62.26 98.01 0.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.111 0.481 . . . . 10.0 111.074 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 57.63 40.29 26.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.1 -0.954 . . . . 10.0 111.375 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 0.9 OUTLIER -148.09 96.06 2.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 -177.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.548 HG21 HG11 ' A' ' 64' ' ' VAL . 25.3 m -86.66 96.56 10.17 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.491 -0.559 . . . . 10.0 109.491 175.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.76 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.4 p-10 -86.04 109.79 19.06 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.458 -0.792 . . . . 10.0 112.071 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.65 107.18 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.951 0.882 . . . . 10.0 109.043 173.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.808 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 3.6 p80 -97.61 115.11 27.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.39 -1.277 . . . . 10.0 110.361 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.819 HD22 HG12 ' A' ' 10' ' ' VAL . 16.9 t-20 -81.76 160.79 23.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.53 -0.759 . . . . 10.0 109.752 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.95 39.41 0.6 Allowed Glycine 0 C--N 1.32 -0.314 0 N-CA-C 111.438 -0.665 . . . . 10.0 111.438 173.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.607 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -91.9 -16.09 27.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.612 -0.294 . . . . 10.0 111.549 -176.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 84.91 -7.66 0.92 Allowed 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.456 1.098 . . . . 10.0 110.923 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.607 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 9.3 p-10 -126.48 151.75 47.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.235 0.54 . . . . 10.0 110.686 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.86 126.06 28.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.422 -0.808 . . . . 10.0 111.116 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.582 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.2 m -129.66 140.64 48.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.13 0.491 . . . . 10.0 111.334 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.772 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 14.4 m -92.11 117.57 29.98 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.803 HG12 HG21 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -113.04 166.34 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 115.269 -0.878 . . . . 10.0 110.88 -178.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -150.17 157.96 43.65 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.293 -0.867 . . . . 10.0 108.887 176.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.24 141.68 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 120.904 0.383 . . . . 10.0 111.449 -173.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -107.83 119.1 38.48 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.77 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 25.3 m-85 -92.4 164.3 13.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.21 0.529 . . . . 10.0 111.287 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 49.2 m -50.04 -24.03 2.42 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.764 -1.107 . . . . 10.0 111.875 171.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.432 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 71.8 m-70 -117.68 -79.51 0.59 Allowed 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.118 -0.364 . . . . 10.0 110.033 172.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.57 51.53 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.344 -0.932 . . . . 10.0 112.031 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.4 141.96 57.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 75' ' ' PRO . 59.4 t-105 -70.16 116.22 10.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.059 0.457 . . . . 10.0 110.499 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.792 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -175.33 -44.4 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.022 -0.99 . . . . 10.0 112.278 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.792 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 1.6 Cg_endo -40.54 70.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.874 1 C-N-CA 125.437 4.091 . . . . 10.0 116.639 -175.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.459 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER 169.6 106.46 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.383 1.073 . . . . 10.0 110.421 166.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -152.9 125.82 8.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.854 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -81.26 134.23 27.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.312 -0.555 . . . . 10.0 109.887 173.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -95.88 145.08 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-N 115.273 -0.876 . . . . 10.0 109.625 -177.413 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -85.35 142.78 38.19 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 168.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -41.1 93.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.41 2.74 . . . . 10.0 112.984 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 95.99 10.9 55.82 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 119.851 -1.166 . . . . 10.0 112.179 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.64 -176.49 35.49 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.525 -0.369 . . . . 10.0 112.717 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.808 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 19.8 m0 -116.04 166.87 11.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.686 0.755 . . . . 10.0 111.672 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -141.6 111.85 6.89 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.368 -1.345 . . . . 10.0 107.368 172.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.5 m -79.38 129.82 34.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.699 -0.682 . . . . 10.0 110.663 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.57 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.3 m-85 -140.15 142.71 35.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.406 -0.961 . . . . 10.0 108.406 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.22 104.52 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.668 0.605 . . . . 10.0 110.476 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.02 -179.05 10.86 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 110.652 -0.979 . . . . 10.0 110.652 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 12.4 p90 -76.16 87.36 3.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.163 0.982 . . . . 10.0 111.697 -172.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.96 -54.63 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.668 -1.151 . . . . 10.0 111.662 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.4 m -62.65 110.71 1.81 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.366 0.266 . . . . 10.0 110.582 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 59.48 15.43 4.49 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.16 0.505 . . . . 10.0 111.787 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.5 23.97 77.17 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.698 -0.763 . . . . 10.0 112.758 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -87.55 131.13 34.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 117.496 0.648 . . . . 10.0 109.362 175.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 16.5 t80 -125.12 118.35 25.94 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.999 -0.741 . . . . 10.0 108.999 175.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.548 HG11 HG21 ' A' ' 19' ' ' THR . 1.6 m -59.21 129.67 21.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.703 -0.851 . . . . 10.0 108.703 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 63' ' ' TYR . 40.1 p -127.0 -10.88 5.97 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.654 -0.418 . . . . 10.0 111.46 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -151.36 147.07 16.57 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.02 -1.086 . . . . 10.0 112.872 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.467 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.1 mt -116.94 135.62 53.57 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.103 -0.702 . . . . 10.0 109.103 177.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.411 ' N ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -131.56 157.81 42.62 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.727 -0.67 . . . . 10.0 109.709 -176.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.502 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -80.19 130.65 35.37 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.386 -0.526 . . . . 10.0 110.382 177.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 30' ' ' SER . 43.0 t -96.7 158.65 15.33 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.237 -0.653 . . . . 10.0 109.237 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.5 142.67 29.17 Favored Pre-proline 0 CA--C 1.512 -0.505 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 172.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -21.75 77.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 1 C-N-CA 126.776 4.984 . . . . 10.0 115.303 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -168.91 88.86 0.2 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.901 -1.045 . . . . 10.0 110.637 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.2 t -93.82 133.78 27.29 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.284 -0.416 . . . . 10.0 111.247 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 19.7 Cg_endo -60.75 117.52 4.3 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 123.066 2.511 . . . . 10.0 112.535 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.3 t 66.77 154.81 0.09 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.642 0.734 . . . . 10.0 112.148 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.36 97.61 1.7 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.961 -0.638 . . . . 10.0 111.665 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.492 -0.766 . . . . 10.0 109.014 -179.902 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.488 0.185 . . . . 10.0 110.617 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.0 m 63.61 88.63 0.1 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.399 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.505 ' O ' ' HD3' ' A' ' 5' ' ' PRO . . . -103.47 166.48 16.07 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.925 -0.655 . . . . 10.0 111.875 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -102.63 99.32 13.02 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.403 -0.221 . . . . 10.0 110.403 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 3' ' ' GLY . 71.9 Cg_endo -86.05 -27.23 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.361 2.041 . . . . 10.0 112.136 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.788 HG13 ' HB3' ' A' ' 67' ' ' LEU . 7.5 m -140.94 -147.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.479 -0.782 . . . . 10.0 110.305 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.416 ' H ' ' HB ' ' A' ' 6' ' ' VAL . . . -65.05 16.03 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.802 1.038 . . . . 10.0 113.802 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 6' ' ' VAL . 2.3 mt-10 69.59 -52.07 0.61 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.922 0.889 . . . . 10.0 113.387 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.0 m -71.47 -13.4 61.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.688 0.28 . . . . 10.0 111.677 -173.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -95.59 130.65 44.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 -176.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -137.56 124.2 21.01 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.827 -0.349 . . . . 10.0 110.889 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.732 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.28 164.16 13.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.71 0.766 . . . . 10.0 112.572 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -146.81 137.42 23.8 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.35 -1.296 . . . . 10.0 107.692 169.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HG2' ' HE1' ' A' ' 63' ' ' TYR . 23.9 mp0 -91.1 104.4 16.98 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.038 0.447 . . . . 10.0 110.551 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -102.17 82.24 2.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.29 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 69.6 -77.21 0.05 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.163 -0.926 . . . . 10.0 111.264 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -133.39 26.24 4.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.423 0.63 . . . . 10.0 110.015 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -137.88 97.42 3.42 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 -169.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.622 HG21 HG21 ' A' ' 64' ' ' VAL . 7.5 m -86.05 93.99 9.13 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.117 -0.697 . . . . 10.0 109.117 175.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.732 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 0.9 OUTLIER -84.29 108.37 17.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.868 -1.06 . . . . 10.0 111.564 -177.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -97.9 106.59 18.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.845 0.831 . . . . 10.0 108.788 174.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.81 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 3.0 p80 -97.26 113.14 24.71 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.414 -1.266 . . . . 10.0 109.926 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.774 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 15.4 t30 -81.64 149.04 28.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.953 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -131.9 20.89 4.49 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.775 -0.726 . . . . 10.0 111.886 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.06 155.9 20.63 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.431 -0.951 . . . . 10.0 108.431 175.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.92 -13.09 60.49 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -123.42 159.11 29.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.311 0.577 . . . . 10.0 111.715 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -70.14 125.23 26.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.053 -0.976 . . . . 10.0 111.139 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.553 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.5 m -127.24 138.88 53.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.521 . . . . 10.0 111.489 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.1 m -87.04 126.25 34.63 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.035 -0.529 . . . . 10.0 109.707 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.09 146.15 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.275 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.811 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.4 OUTLIER -125.81 157.09 38.4 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.382 -0.826 . . . . 10.0 109.241 178.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.596 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -131.45 137.94 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.38 0.61 . . . . 10.0 111.555 -177.454 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -99.03 115.03 28.04 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.024 -0.989 . . . . 10.0 109.544 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.801 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 37.6 m-85 -92.61 153.44 19.0 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.377 0.608 . . . . 10.0 110.869 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 62.5 m -48.7 -28.97 3.93 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.236 -1.347 . . . . 10.0 113.533 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -121.27 -79.09 0.6 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.839 -0.538 . . . . 10.0 111.734 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.13 126.75 0.88 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 119.905 -1.141 . . . . 10.0 112.593 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -163.48 146.25 10.03 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.538 -0.912 . . . . 10.0 108.538 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.417 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 24.0 p90 -77.26 136.14 38.5 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.646 -0.501 . . . . 10.0 109.646 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.723 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 161.51 -41.99 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 115.083 -0.962 . . . . 10.0 111.306 -171.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.723 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 9.3 Cg_endo -51.91 63.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 124.54 3.493 . . . . 10.0 116.13 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.1 m 170.93 99.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.718 1.207 . . . . 10.0 109.695 163.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.69 129.95 16.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.557 -0.534 . . . . 10.0 109.557 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -79.68 137.79 21.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.438 0.637 . . . . 10.0 110.286 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.553 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -101.12 146.3 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.638 -177.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.18 141.9 35.45 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.159 -1.052 . . . . 10.0 108.159 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -46.28 91.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.353 2.702 . . . . 10.0 112.851 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 106.88 2.17 36.61 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.205 -0.997 . . . . 10.0 112.475 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.2 -172.57 40.24 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.859 -0.686 . . . . 10.0 113.157 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.81 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 13.2 m0 -120.03 168.55 11.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.427 0.632 . . . . 10.0 111.289 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.99 109.97 5.1 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.631 -1.248 . . . . 10.0 107.631 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.1 m -79.15 126.61 30.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.527 -0.761 . . . . 10.0 110.964 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.596 ' CG ' HG21 ' A' ' 33' ' ' VAL . 46.9 m-85 -136.84 136.58 38.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.25 105.84 0.12 Allowed 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 124.01 0.819 . . . . 10.0 110.815 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.54 -170.47 7.52 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 120.38 -0.914 . . . . 10.0 110.955 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.666 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 4.6 p90 -86.35 78.78 9.21 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.913 0.863 . . . . 10.0 110.784 -176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -125.55 157.22 19.58 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.523 -0.762 . . . . 10.0 111.966 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m 64.17 9.34 4.68 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.894 0.378 . . . . 10.0 110.82 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 65.13 23.33 12.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.601 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.71 -102.05 0.15 Allowed Glycine 0 CA--C 1.502 -0.746 0 C-N-CA 120.829 -0.7 . . . . 10.0 112.026 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.801 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -105.05 -167.41 1.34 Allowed 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 121.629 0.728 . . . . 10.0 109.91 177.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.666 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 12.8 t80 -168.87 117.04 0.67 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 113.904 -1.498 . . . . 10.0 108.666 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.622 HG21 HG21 ' A' ' 19' ' ' THR . 1.4 m -66.08 126.93 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.6 p -123.49 -22.41 5.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.583 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.64 124.15 2.32 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.644 -1.265 . . . . 10.0 112.833 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.788 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.8 mt -84.99 151.91 23.84 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 170.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.642 ' C ' HG12 ' A' ' 6' ' ' VAL . 3.6 m-70 -142.57 142.22 32.14 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.439 -0.949 . . . . 10.0 108.439 -177.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.82 125.46 30.11 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.104 -1.038 . . . . 10.0 110.06 177.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.811 ' HB2' HG22 ' A' ' 32' ' ' THR . 51.7 t -95.38 154.48 17.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.532 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.41 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 8.7 p-10 -105.87 142.24 24.4 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.307 -0.627 . . . . 10.0 109.307 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 38.1 Cg_exo -20.77 80.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.72 1 C-N-CA 126.836 5.024 . . . . 10.0 115.154 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -169.91 92.0 0.21 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.845 -1.07 . . . . 10.0 110.772 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -89.87 125.95 59.12 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.381 -0.372 . . . . 10.0 110.439 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -61.15 -46.89 13.79 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.813 2.342 . . . . 10.0 112.294 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.1 m -156.89 -167.25 2.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.2 -0.455 . . . . 10.0 109.906 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.3 5.06 52.96 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.222 -0.989 . . . . 10.0 112.795 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.245 0.843 0 CA-C-O 119.218 -0.42 . . . . 10.0 111.014 179.555 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.338 -0.245 . . . . 10.0 110.338 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.4 m 73.95 -60.21 0.53 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.04 0.536 . . . . 10.0 111.219 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.98 -73.24 0.89 Allowed Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.984 -0.846 . . . . 10.0 110.984 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.44 ' HB2' ' CB ' ' A' ' 8' ' ' GLU . 14.2 m -102.35 154.9 37.1 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.696 -0.483 . . . . 10.0 109.696 174.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 29.9 Cg_endo -63.1 150.33 88.92 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.935 2.423 . . . . 10.0 112.487 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.853 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.4 m 49.3 -144.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 115.207 -0.906 . . . . 10.0 111.795 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.714 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.32 -5.4 0.3 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.402 1.081 . . . . 10.0 113.107 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.44 ' CB ' ' HB2' ' A' ' 4' ' ' SER . 38.6 mt-10 73.9 -25.28 0.2 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.983 0.913 . . . . 10.0 113.131 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 85.4 m -83.47 -7.14 59.6 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.705 0.261 . . . . 10.0 111.705 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.843 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -97.62 138.81 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.012 -0.736 . . . . 10.0 109.012 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.21 113.88 14.99 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.499 -0.186 . . . . 10.0 110.499 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.813 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -92.87 166.15 12.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.735 0.779 . . . . 10.0 112.762 176.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 19' ' ' THR . 81.7 t80 -149.19 140.8 23.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.187 -1.369 . . . . 10.0 107.886 172.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.512 ' HG3' ' OG1' ' A' ' 19' ' ' THR . 27.5 mp0 -98.71 100.09 11.27 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.538 -0.465 . . . . 10.0 110.1 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 t -96.98 -157.32 0.58 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -64.85 94.36 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.843 0.354 . . . . 10.0 110.804 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.615 ' HG2' ' HA3' ' A' ' 58' ' ' GLY . 53.8 mtt180 61.23 29.22 18.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.675 -0.693 . . . . 10.0 111.622 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.99 102.65 3.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.979 -0.378 . . . . 10.0 109.979 -172.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.9 m -90.46 96.33 10.6 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 168.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.813 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.9 p-10 -85.93 109.04 18.47 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.11 -0.95 . . . . 10.0 111.817 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.89 107.15 19.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 122.016 0.912 . . . . 10.0 108.723 174.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.732 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -99.98 110.08 22.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.105 -1.407 . . . . 10.0 110.356 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.843 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 23.4 t30 -80.51 157.55 26.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.184 -0.462 . . . . 10.0 109.999 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.43 24.12 1.22 Allowed Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.855 -0.688 . . . . 10.0 112.687 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.604 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -75.04 -18.15 60.37 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.088 0.155 . . . . 10.0 111.287 -178.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.23 -4.68 0.9 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.359 1.037 . . . . 10.0 111.202 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.604 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 13.1 p-10 -127.22 154.26 45.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.033 0.444 . . . . 10.0 110.953 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 127.54 33.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.393 -0.821 . . . . 10.0 111.295 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.587 ' H ' HG22 ' A' ' 46' ' ' ILE . 31.1 m -134.17 137.71 51.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.277 0.56 . . . . 10.0 111.355 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.8 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 15.0 m -86.35 123.21 31.34 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.048 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.58 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -123.23 151.21 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.77 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.491 ' HB ' ' C ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -130.52 159.59 36.66 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.411 -0.813 . . . . 10.0 109.538 176.001 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.631 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -132.39 133.6 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 121.322 0.582 . . . . 10.0 111.467 -176.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -98.89 118.15 35.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.169 -0.923 . . . . 10.0 108.946 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -92.5 157.09 16.74 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.058 0.456 . . . . 10.0 110.228 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 100.0 m -46.43 -30.09 2.0 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.925 -1.034 . . . . 10.0 112.874 174.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -107.64 -83.72 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.82 -0.55 . . . . 10.0 110.546 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.93 55.21 0.01 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 119.89 -1.147 . . . . 10.0 113.508 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -70.38 154.87 41.42 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.063 0.458 . . . . 10.0 111.166 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.546 ' CZ2' ' HB3' ' A' ' 75' ' ' PRO . 69.4 t-105 -74.53 118.2 17.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.918 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.769 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -176.52 -43.97 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.153 -0.93 . . . . 10.0 111.675 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.769 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 3.3 Cg_endo -44.4 69.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 125.06 3.84 . . . . 10.0 116.661 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.0 t 172.04 110.51 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.304 1.041 . . . . 10.0 109.52 163.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.27 128.54 8.31 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.935 -0.765 . . . . 10.0 108.935 174.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.8 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -81.02 139.06 18.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.333 0.587 . . . . 10.0 109.75 177.173 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.587 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -99.14 147.79 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 115.309 -0.859 . . . . 10.0 109.978 -177.031 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -87.35 144.54 36.03 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 168.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -41.34 96.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.515 2.81 . . . . 10.0 112.966 173.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 93.53 10.11 59.51 Favored Glycine 0 C--O 1.229 -0.173 0 C-N-CA 119.93 -1.128 . . . . 10.0 112.164 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.06 -177.05 40.77 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.455 -0.402 . . . . 10.0 113.02 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.732 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 15.4 m0 -118.08 165.28 13.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.439 0.638 . . . . 10.0 111.394 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -142.14 109.37 5.57 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.454 -1.248 . . . . 10.0 107.699 172.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -79.8 130.37 35.26 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.611 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.631 ' CG ' HG21 ' A' ' 33' ' ' VAL . 52.6 m-85 -139.23 134.17 32.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 -177.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.34 103.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 O-C-N 124.032 0.832 . . . . 10.0 111.531 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.94 176.32 36.94 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 110.386 -1.086 . . . . 10.0 110.386 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -82.67 80.16 8.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.346 1.073 . . . . 10.0 110.306 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.615 ' HA3' ' HG2' ' A' ' 17' ' ' ARG . . . -97.2 -36.08 5.05 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.202 -0.908 . . . . 10.0 112.17 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.7 p -90.47 10.54 24.87 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.97 0.414 . . . . 10.0 110.016 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 58.59 21.58 8.84 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.224 -0.898 . . . . 10.0 110.061 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.28 -90.12 2.14 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.271 -0.877 . . . . 10.0 112.385 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -75.54 123.53 25.63 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.156 -0.683 . . . . 10.0 109.156 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.463 ' CE2' ' HB ' ' A' ' 65' ' ' THR . 41.4 t80 -130.14 110.88 11.94 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.544 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.545 HG21 HG21 ' A' ' 19' ' ' THR . 0.5 OUTLIER -60.55 127.86 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.771 -0.826 . . . . 10.0 108.771 175.122 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.463 ' HB ' ' CE2' ' A' ' 63' ' ' TYR . 9.0 t -141.01 8.8 2.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.96 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.25 128.36 2.07 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 119.629 -1.272 . . . . 10.0 112.622 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.853 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.2 mt -100.88 132.75 46.13 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 173.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.725 ' C ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -126.26 148.59 49.47 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.4 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -80.89 124.58 29.22 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.961 -0.696 . . . . 10.0 110.846 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.473 ' HB2' HG22 ' A' ' 32' ' ' THR . 0.1 OUTLIER -96.93 174.52 6.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.762 -177.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -109.34 146.48 34.02 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 172.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -29.84 80.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 1 C-N-CA 126.597 4.864 . . . . 10.0 115.039 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -171.05 99.25 0.21 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.928 -1.033 . . . . 10.0 111.011 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.447 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 29.3 m -84.77 122.35 74.6 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.546 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 4.4 Cg_exo -40.73 98.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.076 3.184 . . . . 10.0 113.079 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.9 m -90.87 90.7 8.02 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.45 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.44 -35.09 12.43 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.617 -0.801 . . . . 10.0 111.886 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.246 0.884 0 CA-C-O 119.435 -0.317 . . . . 10.0 110.631 -178.636 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 120.544 0.212 . . . . 10.0 110.776 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.2 m -153.96 -78.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.61 0.243 . . . . 10.0 110.573 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -160.74 77.88 0.17 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.33 -0.938 . . . . 10.0 112.312 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.527 ' HA ' ' HG2' ' A' ' 8' ' ' GLU . 51.0 m 61.31 62.31 2.67 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 175.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.468 ' O ' HG22 ' A' ' 6' ' ' VAL . 87.2 Cg_endo -93.81 135.14 0.99 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.3 2.0 . . . . 10.0 110.749 169.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 67' ' ' LEU . 1.7 m 51.35 -147.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.055 0.542 . . . . 10.0 110.402 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.727 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.3 4.08 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 175.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 4' ' ' SER . 41.4 mt-10 74.57 -39.76 0.43 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.313 0.857 . . . . 10.0 113.313 175.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 32.6 m -79.07 -7.0 57.77 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.973 HG12 HD22 ' A' ' 23' ' ' ASN . 2.0 m -99.35 140.55 18.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -142.74 126.35 16.9 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.716 -0.393 . . . . 10.0 111.304 -175.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.745 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.25 164.71 12.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.99 0.9 . . . . 10.0 112.933 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 19' ' ' THR . 64.1 t80 -143.88 156.51 44.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.066 -1.424 . . . . 10.0 107.628 172.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.425 ' OE1' ' HE1' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -105.76 107.41 18.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.064 0.459 . . . . 10.0 110.858 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 33.6 m -103.82 77.6 1.47 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.608 -0.886 . . . . 10.0 108.608 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 65.26 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.514 -173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -127.67 27.56 5.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.414 0.626 . . . . 10.0 109.667 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.55 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 2.1 t80 -135.36 96.29 3.44 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 -172.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.4 m -85.41 96.3 9.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.562 0.696 . . . . 10.0 110.282 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.745 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.6 p-10 -85.21 108.82 17.92 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.404 -1.271 . . . . 10.0 112.353 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.694 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -98.39 109.22 23.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.588 -0.893 . . . . 10.0 108.588 174.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.786 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.7 p80 -97.85 114.2 26.2 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.138 -1.392 . . . . 10.0 110.343 176.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.973 HD22 HG12 ' A' ' 10' ' ' VAL . 10.8 t-20 -83.09 155.92 23.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.124 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.88 32.86 1.29 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.128 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.641 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -82.63 -16.98 46.28 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 122.824 -0.221 . . . . 10.0 111.108 -178.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 83.85 -3.9 1.12 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.512 1.132 . . . . 10.0 111.025 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 8.7 p-10 -129.25 154.4 46.85 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.073 0.463 . . . . 10.0 110.828 174.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.63 125.54 26.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.041 -0.981 . . . . 10.0 111.183 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.605 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.5 m -133.82 140.38 46.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.511 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.771 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 7.7 m -88.12 120.93 29.95 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.065 -0.516 . . . . 10.0 109.686 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.41 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -120.31 149.07 23.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.549 0.69 . . . . 10.0 110.794 -179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.833 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -128.74 161.29 30.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.208 -0.905 . . . . 10.0 108.997 176.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.599 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -131.82 135.19 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 121.296 0.569 . . . . 10.0 111.316 -175.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -98.81 115.3 28.48 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.096 -0.956 . . . . 10.0 108.958 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.554 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 74.5 m-85 -89.08 161.56 16.46 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.113 0.483 . . . . 10.0 110.97 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.3 m -52.36 -27.01 13.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.918 -1.037 . . . . 10.0 111.171 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.417 ' CD2' ' H ' ' A' ' 62' ' ' ASN . 63.9 m-70 -118.28 -74.85 0.59 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 175.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.11 60.97 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.295 -0.955 . . . . 10.0 113.072 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.451 ' HG2' ' CG ' ' A' ' 62' ' ' ASN . 9.3 mm100 -64.82 148.03 52.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.534 0.207 . . . . 10.0 110.449 172.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -71.3 112.11 7.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.843 -0.429 . . . . 10.0 109.843 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.777 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -175.89 -44.51 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 115.824 -0.625 . . . . 10.0 112.548 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.777 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -41.4 76.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 124.88 3.72 . . . . 10.0 115.908 -176.132 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 41' ' ' ALA . 1.2 m 161.91 108.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.081 1.352 . . . . 10.0 110.702 168.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.407 ' NH1' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -154.07 128.26 9.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.841 -0.8 . . . . 10.0 108.841 179.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.79 137.18 21.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 118.576 0.625 . . . . 10.0 109.986 174.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -97.87 148.42 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 115.239 -0.891 . . . . 10.0 109.783 -177.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.07 145.46 38.25 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 107.905 -1.146 . . . . 10.0 107.905 168.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -43.61 95.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.163 2.575 . . . . 10.0 112.521 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.741 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.6 14.57 55.21 Favored Glycine 0 CA--C 1.511 -0.178 0 C-N-CA 119.756 -1.211 . . . . 10.0 111.926 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.66 -176.99 35.47 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.445 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.786 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.2 m0 -117.28 165.31 13.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.411 0.624 . . . . 10.0 111.134 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.41 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -141.93 114.27 8.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.572 -1.195 . . . . 10.0 107.89 173.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.5 m -81.49 128.44 33.89 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.99 -0.55 . . . . 10.0 111.088 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.599 ' CG ' HG21 ' A' ' 33' ' ' VAL . 54.0 m-85 -137.98 144.78 41.3 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.106 -1.072 . . . . 10.0 108.106 -178.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.79 104.7 0.38 Allowed 'General case' 0 C--N 1.32 -0.712 0 O-C-N 123.618 0.574 . . . . 10.0 110.587 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.37 177.18 12.35 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.074 -1.21 . . . . 10.0 110.074 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.56 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 15.9 p90 -78.66 112.62 15.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 118.484 1.142 . . . . 10.0 110.853 -170.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.8 -178.21 45.03 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.399 -0.819 . . . . 10.0 111.86 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.9 m -70.09 -20.3 63.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.116 0.484 . . . . 10.0 110.585 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -86.38 -30.47 22.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.121 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.28 -147.62 19.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.312 -0.946 . . . . 10.0 113.503 171.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' CG ' ' HG2' ' A' ' 39' ' ' GLN . 23.2 m-80 51.53 97.29 0.01 OUTLIER 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.64 0.776 . . . . 10.0 112.737 -173.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.56 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 29.3 t80 -115.9 123.23 47.59 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.406 -0.815 . . . . 10.0 109.069 173.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.588 HG21 HG21 ' A' ' 19' ' ' THR . 1.5 m -61.11 129.3 23.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.2 p -127.31 -18.57 4.46 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.563 -0.455 . . . . 10.0 112.18 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -144.97 122.78 1.8 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.783 -1.198 . . . . 10.0 113.136 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.766 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -86.64 131.81 34.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.233 0.539 . . . . 10.0 109.595 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.756 ' C ' HG12 ' A' ' 6' ' ' VAL . 9.0 m170 -123.59 147.45 47.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.293 -0.867 . . . . 10.0 108.934 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.4 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -80.64 128.39 33.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 119.341 0.973 . . . . 10.0 110.835 178.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.833 ' HB2' HG22 ' A' ' 32' ' ' THR . 41.2 t -95.48 157.71 15.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.287 -177.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -103.57 148.52 35.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 173.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -26.59 85.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 1 C-N-CA 126.223 4.616 . . . . 10.0 114.896 174.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -168.0 103.77 0.47 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.867 -1.06 . . . . 10.0 111.576 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.4 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 60.9 m -84.82 117.17 68.18 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.892 -0.41 . . . . 10.0 109.892 174.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 74' ' ' THR . 13.5 Cg_endo -56.12 111.15 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.221 2.614 . . . . 10.0 112.56 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.3 p -151.31 -4.17 0.29 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.19 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.34 116.89 4.51 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.443 -0.884 . . . . 10.0 111.818 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.9 t . . . . . 0 C--O 1.249 1.042 0 CA-C-O 117.998 -1.001 . . . . 10.0 110.869 -178.617 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 110.269 -0.271 . . . . 10.0 110.269 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 84.5 m -70.83 -44.88 65.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.105 0.478 . . . . 10.0 109.849 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.09 134.65 11.94 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.681 -0.771 . . . . 10.0 112.479 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 5.0 p -101.06 122.61 48.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.717 -0.475 . . . . 10.0 109.717 174.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.73 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 30.5 Cg_endo -91.05 101.7 0.25 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.717 2.278 . . . . 10.0 112.87 -172.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.678 HG23 HG23 ' A' ' 69' ' ' THR . 0.5 OUTLIER 47.58 126.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 125.661 1.584 . . . . 10.0 114.41 -177.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.715 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 29.04 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.389 1.056 . . . . 10.0 112.513 168.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.495 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 2.0 mp0 -58.57 1.21 0.06 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.619 0.97 . . . . 10.0 113.619 -168.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' ALA . 28.7 m -81.21 -22.02 39.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.528 175.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.831 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.6 m -90.73 137.06 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -139.28 124.39 18.9 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.963 -0.295 . . . . 10.0 110.538 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.783 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -93.63 166.79 12.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.57 0.7 . . . . 10.0 112.316 177.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.657 ' O ' ' HA ' ' A' ' 19' ' ' THR . 74.8 t80 -141.39 156.47 45.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.425 -1.324 . . . . 10.0 107.425 172.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.93 109.24 18.92 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.288 0.566 . . . . 10.0 110.684 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.0 t -117.15 -162.84 0.88 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -63.81 92.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 10.0 111.43 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 56.8 ttp180 62.45 31.42 17.14 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.536 0.684 . . . . 10.0 110.22 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.9 107.44 4.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.873 -174.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 3.5 m -97.75 95.32 7.47 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.303 0.573 . . . . 10.0 109.594 167.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.783 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.8 p-10 -84.78 108.9 17.7 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.905 -1.043 . . . . 10.0 111.94 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.59 106.39 18.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.002 0.906 . . . . 10.0 109.387 175.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.722 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 1.2 p80 -97.14 111.94 23.95 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.145 -1.388 . . . . 10.0 110.581 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.831 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 18.0 t-20 -82.3 157.58 23.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.871 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.49 34.58 1.16 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 121.332 -0.461 . . . . 10.0 112.112 171.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.63 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -85.17 -17.82 36.03 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 122.566 -0.373 . . . . 10.0 111.615 -176.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 86.88 -12.72 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.367 1.042 . . . . 10.0 111.233 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -123.06 154.44 38.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.983 0.42 . . . . 10.0 110.19 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -67.89 123.75 21.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.504 -0.771 . . . . 10.0 111.335 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.636 ' H ' HG22 ' A' ' 46' ' ' ILE . 27.3 m -125.86 139.17 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 121.176 0.513 . . . . 10.0 111.881 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.767 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 6.4 m -88.78 118.25 28.34 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.67 HG12 HG21 ' A' ' 6' ' ' VAL . 1.1 m -114.76 165.35 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 115.218 -0.901 . . . . 10.0 110.362 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.567 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.2 OUTLIER -148.49 161.17 42.17 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.669 -0.863 . . . . 10.0 108.669 178.281 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.651 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -136.49 139.94 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 121.41 0.624 . . . . 10.0 111.482 -174.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -107.04 116.37 31.81 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.981 -1.009 . . . . 10.0 109.078 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 27.8 m-85 -91.27 162.34 14.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.449 0.642 . . . . 10.0 111.348 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -54.48 -21.35 9.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.692 -1.14 . . . . 10.0 112.116 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -119.72 -85.03 0.66 Allowed 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.001 -0.437 . . . . 10.0 110.561 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.37 52.67 0.01 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 119.567 -1.301 . . . . 10.0 114.147 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -65.65 141.6 58.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.33 0.565 . . . . 10.0 109.77 169.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -72.33 120.72 18.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.071 0.462 . . . . 10.0 110.328 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.862 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -174.32 -40.61 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.246 -0.888 . . . . 10.0 112.338 -173.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.862 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 3.1 Cg_endo -44.08 70.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 124.938 3.759 . . . . 10.0 116.33 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 4.5 t 172.5 112.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.059 0.944 . . . . 10.0 110.215 163.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.513 ' HB2' ' HZ ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -151.11 119.04 6.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.308 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.767 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -78.56 128.46 38.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 173.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -90.63 144.66 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 115.46 -0.791 . . . . 10.0 109.621 -175.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -85.17 141.64 37.52 Favored Pre-proline 0 C--N 1.293 -1.868 0 N-CA-C 107.726 -1.213 . . . . 10.0 107.726 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -43.21 95.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.301 2.667 . . . . 10.0 112.942 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.721 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 92.76 13.67 56.36 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.554 -1.307 . . . . 10.0 111.87 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 22' ' ' HIS . . . -97.02 -170.41 33.74 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.106 -0.568 . . . . 10.0 112.846 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.722 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 10.6 m0 -121.46 166.44 14.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.546 0.689 . . . . 10.0 111.425 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.408 ' HB3' HG13 ' A' ' 21' ' ' VAL . . . -142.68 109.7 5.55 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.56 -1.2 . . . . 10.0 108.103 171.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.2 m -78.88 129.76 34.89 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.712 -0.677 . . . . 10.0 110.606 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.651 ' CG ' HG21 ' A' ' 33' ' ' VAL . 51.3 m-85 -136.58 149.9 48.3 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.93 97.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.775 0.672 . . . . 10.0 111.16 -173.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.14 -178.53 10.73 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.107 -0.797 . . . . 10.0 111.107 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 9.0 p90 -79.6 88.98 5.1 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.556 1.169 . . . . 10.0 110.771 -173.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.72 -20.39 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.542 -1.208 . . . . 10.0 112.202 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.3 t -118.62 133.05 56.15 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 122.529 -0.394 . . . . 10.0 110.5 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 62.48 10.63 4.13 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.204 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.45 10.23 59.8 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.923 -0.581 . . . . 10.0 112.946 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.551 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -79.57 137.55 37.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 117.608 0.704 . . . . 10.0 110.468 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.491 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 32.1 t80 -130.96 116.16 17.47 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.028 -0.987 . . . . 10.0 108.846 172.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.556 HG21 HG21 ' A' ' 19' ' ' THR . 1.4 m -59.9 130.14 23.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.949 -0.76 . . . . 10.0 108.949 177.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 p -122.11 -29.04 4.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.653 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -138.5 121.7 2.22 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.417 -1.373 . . . . 10.0 113.63 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.73 ' HB2' ' HB2' ' A' ' 5' ' ' PRO . 5.2 mt -84.35 146.87 27.48 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.974 -0.75 . . . . 10.0 108.974 172.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.525 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 4.2 m-70 -137.92 156.34 47.98 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.846 -0.615 . . . . 10.0 109.944 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.678 HG23 HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -82.61 127.93 33.84 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.984 -0.686 . . . . 10.0 109.59 174.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.567 ' HB2' HG22 ' A' ' 32' ' ' THR . 5.1 t -100.27 171.06 8.02 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.82 -0.352 . . . . 10.0 110.582 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -134.37 145.63 56.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -18.43 83.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 1 C-N-CA 126.675 4.917 . . . . 10.0 115.616 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -167.08 82.95 0.23 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.287 -1.324 . . . . 10.0 109.941 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.3 p -82.89 142.12 44.68 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.81 -0.632 . . . . 10.0 112.089 -173.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.13 169.25 22.87 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.817 2.345 . . . . 10.0 111.141 171.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.7 t -86.58 103.75 15.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.042 0.449 . . . . 10.0 111.947 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.81 170.45 46.18 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.928 -0.653 . . . . 10.0 113.811 171.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.087 -0.557 . . . . 10.0 109.693 176.128 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 109.869 -0.419 . . . . 10.0 109.869 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.0 t -165.35 158.35 16.07 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.495 -0.557 . . . . 10.0 109.495 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 116.16 -148.41 18.89 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.188 -0.765 . . . . 10.0 111.188 -177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.6 m 60.83 89.81 0.1 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.133 0.492 . . . . 10.0 111.56 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.645 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 97.9 Cg_endo -85.32 140.46 7.49 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.27 1.98 . . . . 10.0 112.147 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.6 m 47.92 -147.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.33 -0.85 . . . . 10.0 111.818 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.687 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -59.33 0.09 0.13 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.421 1.088 . . . . 10.0 113.933 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 70.49 -31.23 0.22 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.095 0.776 . . . . 10.0 113.095 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.9 m -76.44 -11.89 59.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 10.0 111.207 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.83 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -97.97 137.82 24.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.875 -0.787 . . . . 10.0 108.875 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -133.23 115.07 14.54 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.888 -0.325 . . . . 10.0 110.508 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.803 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.74 161.51 14.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.786 0.803 . . . . 10.0 113.078 177.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 19' ' ' THR . 69.0 t80 -141.2 145.69 35.97 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.118 -1.401 . . . . 10.0 107.272 170.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.474 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 27.1 mp0 -107.25 130.59 54.73 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.416 -0.514 . . . . 10.0 110.987 -176.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.3 t -118.81 -160.08 0.79 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.675 -1.231 . . . . 10.0 107.675 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -60.29 -48.33 82.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.847 0.356 . . . . 10.0 111.322 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -140.81 28.77 1.93 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.751 0.31 . . . . 10.0 110.949 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.462 ' CE1' HG23 ' A' ' 53' ' ' THR . 0.4 OUTLIER -142.87 105.51 4.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.7 -0.227 . . . . 10.0 110.613 -173.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.539 HG21 HG21 ' A' ' 64' ' ' VAL . 15.6 m -95.12 98.51 10.7 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.401 -0.592 . . . . 10.0 109.401 166.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.803 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -86.35 109.27 18.88 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.382 -0.826 . . . . 10.0 112.224 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -99.83 107.4 20.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.862 0.839 . . . . 10.0 109.065 173.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.749 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 1.9 p80 -98.18 112.53 24.47 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.433 -1.258 . . . . 10.0 110.202 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.83 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 10.7 t-20 -80.72 155.24 26.84 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.563 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -145.32 32.08 1.66 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.082 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.78 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -79.43 -19.95 48.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 122.831 -0.217 . . . . 10.0 111.316 -176.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 85.71 -11.73 0.68 Allowed 'General case' 0 N--CA 1.473 0.675 0 O-C-N 124.515 1.134 . . . . 10.0 111.221 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -126.43 155.4 42.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.989 0.423 . . . . 10.0 110.416 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -67.82 121.9 16.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.54 -0.755 . . . . 10.0 111.249 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.662 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.2 m -126.3 141.92 44.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 10.0 111.106 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.742 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 6.2 m -92.19 122.89 35.11 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.955 -177.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.668 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -124.01 148.02 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.8 -0.637 . . . . 10.0 111.072 -178.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.891 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -126.76 161.84 27.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 177.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.606 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.25 141.7 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.403 0.621 . . . . 10.0 111.787 -176.386 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -104.6 110.94 23.45 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.639 -1.164 . . . . 10.0 109.651 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.701 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 34.2 m-85 -93.82 159.13 15.33 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.369 0.604 . . . . 10.0 111.642 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.4 m -48.19 -34.45 10.1 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.673 -1.149 . . . . 10.0 112.786 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.445 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 54.3 m-70 -112.35 -78.3 0.58 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.508 -0.477 . . . . 10.0 110.41 176.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.08 63.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.053 -1.07 . . . . 10.0 112.922 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.605 ' HB2' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -72.69 144.2 47.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.621 -0.511 . . . . 10.0 109.621 178.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -76.33 102.07 5.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.003 0.43 . . . . 10.0 110.789 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 1.075 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -173.95 10.56 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 114.196 1.184 . . . . 10.0 114.196 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.075 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 5.3 Cg_endo -84.96 64.89 6.35 Favored 'Trans proline' 0 C--N 1.358 1.07 0 CA-C-N 122.088 1.781 . . . . 10.0 112.466 -172.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 172.41 109.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.835 0.854 . . . . 10.0 110.63 168.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.78 122.86 6.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.585 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.742 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -77.8 135.34 26.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.544 -0.462 . . . . 10.0 109.796 175.32 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.1 tp -97.94 147.05 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 115.167 -0.924 . . . . 10.0 109.064 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -85.0 143.49 40.04 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 108.248 -1.019 . . . . 10.0 108.248 168.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -44.07 94.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.41 2.74 . . . . 10.0 112.845 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.758 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 94.77 12.78 55.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 119.813 -1.184 . . . . 10.0 112.289 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.44 -173.95 33.98 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.949 -0.643 . . . . 10.0 112.326 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.749 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 15.7 m0 -117.3 166.07 12.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.535 0.683 . . . . 10.0 111.165 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.427 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -140.82 112.03 7.26 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.317 -1.364 . . . . 10.0 107.317 171.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.462 HG23 ' CE1' ' A' ' 18' ' ' TYR . 26.7 m -80.32 126.26 30.93 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.304 -0.862 . . . . 10.0 110.337 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.606 ' CG ' HG21 ' A' ' 33' ' ' VAL . 46.7 m-85 -136.26 140.8 43.72 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.06 104.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.182 0.926 . . . . 10.0 110.698 -173.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.8 -178.21 16.81 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.387 -0.911 . . . . 10.0 110.988 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.651 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 12.2 p90 -82.72 91.05 6.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.891 0.853 . . . . 10.0 110.698 -173.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.18 179.19 42.82 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.099 -0.955 . . . . 10.0 112.58 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.3 p -66.27 -28.6 68.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.243 0.545 . . . . 10.0 110.575 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -142.57 85.79 1.92 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.286 -0.87 . . . . 10.0 108.831 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.75 -139.35 3.5 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.288 -0.958 . . . . 10.0 112.955 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.701 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 23.9 m-20 -118.81 166.0 13.34 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.141 0.496 . . . . 10.0 109.777 -173.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 37.9 t80 -132.56 120.34 21.72 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.097 -0.956 . . . . 10.0 108.965 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.539 HG21 HG21 ' A' ' 19' ' ' THR . 1.7 m -65.13 129.8 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.575 -0.898 . . . . 10.0 108.575 176.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.2 p -117.93 -29.17 5.72 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.721 -0.392 . . . . 10.0 111.34 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.55 136.08 7.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 119.992 -1.099 . . . . 10.0 113.146 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.895 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.0 mt -95.35 129.87 42.34 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.576 -0.528 . . . . 10.0 109.576 173.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.752 ' C ' HG12 ' A' ' 6' ' ' VAL . 10.5 m170 -117.25 143.27 46.07 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.45 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -81.36 125.46 30.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.805 1.184 . . . . 10.0 111.214 -179.162 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.891 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.0 t -96.55 178.07 5.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.256 -0.884 . . . . 10.0 109.346 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.407 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.8 p-10 -145.2 149.21 40.86 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 174.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -16.98 87.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.126 1 C-N-CA 126.457 4.771 . . . . 10.0 114.951 177.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -168.52 104.84 0.44 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.354 -1.294 . . . . 10.0 109.843 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.1 p -79.42 125.73 82.43 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.699 0.285 . . . . 10.0 111.523 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.72 -53.16 0.46 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.65 2.233 . . . . 10.0 111.954 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.0 m -154.9 -54.19 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 10.0 109.925 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -170.24 -54.72 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.24 -0.744 . . . . 10.0 111.24 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 C--O 1.242 0.669 0 CA-C-O 118.081 -0.962 . . . . 10.0 108.925 174.88 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 110.088 -0.338 . . . . 10.0 110.088 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.2 m -152.11 99.51 2.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.345 -0.613 . . . . 10.0 109.345 -175.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 113.03 116.89 3.4 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.788 -0.925 . . . . 10.0 110.788 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.5 t 61.95 75.22 0.44 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 121.061 0.458 . . . . 10.0 111.198 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.519 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 92.0 Cg_endo -84.33 140.0 8.35 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.78 2.32 . . . . 10.0 112.555 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.842 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.2 m 51.53 -151.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.169 -0.923 . . . . 10.0 112.273 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.691 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -59.67 5.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.652 1.353 . . . . 10.0 114.652 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 42.5 mt-10 75.11 -39.91 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.015 0.746 . . . . 10.0 113.015 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.9 m -74.02 -12.98 60.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.868 0.322 . . . . 10.0 111.868 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.839 HG12 HD22 ' A' ' 23' ' ' ASN . 1.6 m -99.88 141.07 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.829 -0.434 . . . . 10.0 109.829 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -142.44 128.27 19.38 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 121.05 -0.26 . . . . 10.0 110.822 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.776 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -93.1 165.17 12.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.767 0.794 . . . . 10.0 113.118 176.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' THR . 77.7 t80 -144.01 149.85 37.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.281 -1.377 . . . . 10.0 107.281 171.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.4 121.65 45.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.218 0.532 . . . . 10.0 110.832 -176.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.3 t -138.28 75.54 1.53 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.845 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.7 t90 51.2 90.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.074 -0.966 . . . . 10.0 112.535 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 56' ' ' GLY . 22.8 ttt180 68.37 1.62 2.98 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.638 -0.71 . . . . 10.0 112.313 174.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -123.18 97.17 5.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.192 -0.669 . . . . 10.0 109.192 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.466 HG21 HG11 ' A' ' 64' ' ' VAL . 23.3 m -90.46 100.08 12.98 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 172.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.776 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.0 p-10 -86.09 107.91 18.04 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.914 -0.584 . . . . 10.0 111.974 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -97.78 107.41 20.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.036 0.922 . . . . 10.0 108.564 173.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.819 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.2 p80 -96.86 114.44 26.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.021 -1.445 . . . . 10.0 110.219 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.839 HD22 HG12 ' A' ' 10' ' ' VAL . 14.1 t-20 -83.14 150.33 26.32 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.551 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.5 23.97 3.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.898 -0.668 . . . . 10.0 112.315 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.635 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -86.76 159.83 19.0 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 175.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.46 -11.55 59.96 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.045 0.387 . . . . 10.0 112.045 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -129.88 159.89 35.23 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.246 0.546 . . . . 10.0 111.462 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.41 130.42 42.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.813 -1.085 . . . . 10.0 111.24 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.523 ' H ' HG22 ' A' ' 46' ' ' ILE . 32.6 m -129.05 141.36 46.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.987 -0.551 . . . . 10.0 111.057 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.813 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 7.3 m -90.38 122.9 33.66 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.183 0.516 . . . . 10.0 109.861 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.87 150.95 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.286 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -131.86 162.67 30.03 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.508 -0.769 . . . . 10.0 108.934 175.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.596 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -134.1 144.86 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-O 121.026 0.441 . . . . 10.0 110.441 -176.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -114.93 118.87 34.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.319 -0.855 . . . . 10.0 108.964 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.578 ' HB3' ' HB2' ' A' ' 62' ' ' ASN . 22.6 m-85 -94.48 159.44 15.1 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.574 0.702 . . . . 10.0 111.953 -175.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.518 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 52.0 m -50.07 -31.04 12.14 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.132 -1.395 . . . . 10.0 113.452 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.496 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 27.5 m-70 -114.47 -67.29 1.01 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.738 -0.601 . . . . 10.0 110.426 174.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 153.95 62.41 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.951 -1.119 . . . . 10.0 113.125 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.573 ' HA ' ' OE1' ' A' ' 39' ' ' GLN . 7.7 mm-40 -72.47 151.52 42.48 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.922 -0.311 . . . . 10.0 110.319 172.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -80.71 100.18 8.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.333 -0.394 . . . . 10.0 111.513 -177.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.833 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -168.42 21.82 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 113.733 1.012 . . . . 10.0 113.733 172.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.833 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 8.8 Cg_endo -88.34 63.01 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 CA-C-N 121.165 1.452 . . . . 10.0 112.863 -171.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 75' ' ' PRO . 1.2 m 169.89 114.93 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.692 0.797 . . . . 10.0 111.646 169.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.56 132.44 7.73 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 175.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.813 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.2 p -83.81 140.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.345 0.593 . . . . 10.0 110.672 178.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.528 HG21 ' CB ' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -99.29 146.77 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-N 115.194 -0.912 . . . . 10.0 109.691 -177.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -88.49 139.11 29.86 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 169.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -43.13 95.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.343 2.695 . . . . 10.0 112.38 177.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.02 13.54 42.55 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.101 -1.047 . . . . 10.0 112.663 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.47 -171.65 30.67 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.886 -0.673 . . . . 10.0 113.046 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.819 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 13.6 m0 -121.79 165.49 15.78 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.505 0.669 . . . . 10.0 111.014 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -142.95 111.97 6.54 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.446 -1.316 . . . . 10.0 107.446 174.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.1 m -79.63 131.14 35.9 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.479 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.596 ' CG ' HG21 ' A' ' 33' ' ' VAL . 51.1 m-85 -140.63 145.19 36.31 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.096 -0.705 . . . . 10.0 109.096 -178.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.859 ' HB1' ' HA2' ' A' ' 61' ' ' GLY . . . -54.47 107.61 0.3 Allowed 'General case' 0 C--N 1.322 -0.589 0 O-C-N 124.024 0.827 . . . . 10.0 110.585 -176.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' O ' ' HA3' ' A' ' 61' ' ' GLY . . . -71.31 -177.03 25.5 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.836 -0.905 . . . . 10.0 110.836 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.876 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 20.1 p90 -77.4 120.98 23.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 118.465 1.132 . . . . 10.0 109.98 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 151.06 -153.58 25.06 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.404 -0.817 . . . . 10.0 111.573 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -48.92 112.71 0.65 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.485 0.314 . . . . 10.0 111.527 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 68.5 13.03 8.91 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.31 0.644 . . . . 10.0 112.373 175.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.859 ' HA2' ' HB1' ' A' ' 55' ' ' ALA . . . -114.6 -13.19 9.75 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.503 -1.332 . . . . 10.0 115.272 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 35' ' ' TYR . 7.4 m120 52.71 -101.52 0.11 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.774 0.787 . . . . 10.0 109.647 -168.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.876 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 11.1 t80 175.41 115.54 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 114.887 -1.051 . . . . 10.0 108.838 171.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 19' ' ' THR . 1.0 OUTLIER -62.33 126.2 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.312 -0.995 . . . . 10.0 108.312 171.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.4 p -118.19 -29.55 5.53 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.448 -0.501 . . . . 10.0 111.051 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -136.99 125.98 3.56 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 119.87 -1.157 . . . . 10.0 112.932 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.842 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -86.17 131.54 34.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.307 -0.627 . . . . 10.0 109.307 171.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.72 ' C ' HG12 ' A' ' 6' ' ' VAL . 12.4 m170 -119.47 147.83 43.96 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.61 -0.885 . . . . 10.0 108.61 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.457 HG23 ' HB ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -82.71 126.12 32.01 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.266 -0.974 . . . . 10.0 110.318 178.165 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.623 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.2 t -96.22 161.05 14.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.85 -177.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.468 ' HA ' ' HD2' ' A' ' 72' ' ' PRO . 12.8 p-10 -104.59 137.45 19.23 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.142 -0.688 . . . . 10.0 109.142 169.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 22.1 Cg_exo -22.44 79.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 1 C-N-CA 127.058 5.172 . . . . 10.0 115.466 179.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -171.03 92.74 0.16 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.912 -1.04 . . . . 10.0 111.516 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 76' ' ' SER . 18.9 m -86.62 127.56 60.05 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 175.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 43' ' ' CYS . 40.1 Cg_endo -67.05 -2.48 8.02 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.146 2.564 . . . . 10.0 113.643 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.437 ' H ' HG22 ' A' ' 74' ' ' THR . 30.3 m -79.74 85.69 5.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.998 0.428 . . . . 10.0 109.912 176.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.9 114.64 4.89 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.72 -0.752 . . . . 10.0 112.362 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.089 -0.958 . . . . 10.0 109.705 179.681 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.626 0.25 . . . . 10.0 111.084 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.3 m -151.81 -59.51 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.134 0.492 . . . . 10.0 110.326 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 143.95 -82.71 0.21 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 121.068 -0.587 . . . . 10.0 111.768 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 8.5 t -119.16 148.77 45.75 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HB2' ' HB2' ' A' ' 67' ' ' LEU . 26.4 Cg_endo -61.56 149.01 91.59 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.086 2.524 . . . . 10.0 112.805 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.911 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.5 m 50.68 -142.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.018 0.927 . . . . 10.0 111.884 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.729 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -55.73 -5.51 0.16 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.307 1.043 . . . . 10.0 113.148 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 4' ' ' SER . 36.5 mt-10 75.7 -25.93 0.2 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.87 0.868 . . . . 10.0 112.806 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.31 14.66 15.75 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 111.748 0.277 . . . . 10.0 111.748 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.852 HG12 HD22 ' A' ' 23' ' ' ASN . 1.7 m -116.72 142.06 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -135.57 118.0 15.78 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.849 -0.34 . . . . 10.0 111.529 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.74 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -91.36 161.75 14.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.832 0.825 . . . . 10.0 112.515 174.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -146.3 168.05 22.03 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 106.63 -1.619 . . . . 10.0 106.63 170.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.495 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -114.58 107.61 15.73 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.09 -0.644 . . . . 10.0 111.645 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 1.7 p -99.28 50.91 0.94 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.82 -0.808 . . . . 10.0 108.82 175.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 38.7 t-105 74.35 -90.44 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.262 -1.336 . . . . 10.0 111.348 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -100.02 30.99 3.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 10.0 110.93 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.486 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -154.4 107.34 2.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.403 -0.817 . . . . 10.0 109.006 -172.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.495 HG21 HG11 ' A' ' 64' ' ' VAL . 5.4 m -91.85 97.71 11.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.51 0.671 . . . . 10.0 109.539 170.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.74 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.8 p-10 -83.41 108.17 16.4 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.473 -1.239 . . . . 10.0 111.77 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.23 106.97 20.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 122.26 1.029 . . . . 10.0 108.927 172.518 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.805 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -97.32 111.02 23.45 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.109 -1.405 . . . . 10.0 109.982 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.852 HD22 HG12 ' A' ' 10' ' ' VAL . 13.1 t-20 -80.05 154.19 28.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.16 -0.473 . . . . 10.0 109.746 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.49 21.24 3.26 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.581 -0.608 . . . . 10.0 111.581 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.828 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -83.08 160.03 22.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.36 -0.608 . . . . 10.0 109.36 174.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.02 -10.71 59.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.479 -0.328 . . . . 10.0 111.465 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -128.77 159.31 36.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.406 0.622 . . . . 10.0 111.675 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.7 125.65 27.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.85 -1.068 . . . . 10.0 111.253 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.517 ' H ' HG22 ' A' ' 46' ' ' ILE . 34.1 m -125.44 143.67 38.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.961 0.41 . . . . 10.0 111.231 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.8 m -90.68 121.36 32.52 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.386 -0.598 . . . . 10.0 109.386 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.625 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -121.54 143.53 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-O 121.516 0.675 . . . . 10.0 110.994 -178.29 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -122.21 160.62 24.81 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.237 -0.892 . . . . 10.0 109.433 176.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.619 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -133.2 141.04 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.118 0.485 . . . . 10.0 111.61 -177.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -108.34 114.51 28.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.35 -0.841 . . . . 10.0 109.614 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.7 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 56.6 m-85 -90.36 156.56 18.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.277 0.561 . . . . 10.0 112.048 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.4 m -43.21 -46.09 5.94 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.134 -1.394 . . . . 10.0 113.365 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -106.99 -77.21 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.299 -0.56 . . . . 10.0 110.573 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.28 124.83 0.77 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 119.705 -1.236 . . . . 10.0 113.245 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -163.27 151.94 14.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.88 -1.156 . . . . 10.0 107.88 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -75.88 146.08 40.05 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.384 -0.526 . . . . 10.0 111.52 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.732 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 159.41 -44.31 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 114.32 -1.309 . . . . 10.0 110.138 -170.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.732 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 1.4 Cg_endo -45.34 65.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 125.283 3.989 . . . . 10.0 116.519 177.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' ALA . 1.1 m 170.72 100.73 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.431 1.093 . . . . 10.0 110.071 164.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.56 130.73 15.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.74 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -82.23 136.77 22.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.131 0.491 . . . . 10.0 110.53 178.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -96.84 145.89 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 115.24 -0.891 . . . . 10.0 109.652 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -85.24 139.44 36.43 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.063 -1.088 . . . . 10.0 108.063 167.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -43.59 98.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.182 2.588 . . . . 10.0 112.309 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.83 2.5 57.24 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.984 -1.103 . . . . 10.0 112.504 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.54 -170.86 37.58 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.975 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.805 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 15.7 m0 -120.26 166.39 13.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.422 0.63 . . . . 10.0 111.22 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -142.57 115.75 8.91 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 171.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 m -82.52 128.93 34.76 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.521 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.619 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.5 m-85 -135.89 144.41 45.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.705 -0.85 . . . . 10.0 108.705 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.09 101.95 0.07 Allowed 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.826 0.704 . . . . 10.0 110.704 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.01 -166.99 4.78 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.915 -1.038 . . . . 10.0 111.613 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.678 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 1.8 p90 -86.75 75.46 9.63 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.993 0.901 . . . . 10.0 110.782 -174.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.87 179.82 50.01 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.386 -0.824 . . . . 10.0 112.197 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.8 t -68.46 131.13 44.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 110.418 -0.216 . . . . 10.0 110.418 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 58.43 31.85 21.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.606 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.61 -140.59 6.4 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.559 -0.829 . . . . 10.0 112.046 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.7 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 7.8 m120 -120.42 -155.28 0.62 Allowed 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.828 -0.804 . . . . 10.0 108.828 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.678 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 20.8 t80 -168.76 119.0 0.73 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.128 -0.942 . . . . 10.0 108.674 173.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 19' ' ' THR . 1.1 m -64.14 131.19 29.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.12 -0.696 . . . . 10.0 109.12 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.9 p -123.33 -24.41 4.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.403 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.94 125.31 2.45 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.162 -1.018 . . . . 10.0 112.549 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.911 ' HB3' HG13 ' A' ' 6' ' ' VAL . 5.0 mt -86.27 137.84 32.3 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 172.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.744 ' C ' HG12 ' A' ' 6' ' ' VAL . 8.4 m-70 -127.61 145.93 50.71 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.505 -0.77 . . . . 10.0 108.924 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.26 127.52 32.16 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 119.219 -0.992 . . . . 10.0 110.26 178.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.777 ' HB2' HG22 ' A' ' 32' ' ' THR . 40.5 t -93.97 155.68 17.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.914 -0.584 . . . . 10.0 109.867 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -109.63 146.61 34.4 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.041 -0.725 . . . . 10.0 109.041 173.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -24.8 84.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 1 C-N-CA 126.212 4.608 . . . . 10.0 114.746 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -171.81 101.83 0.18 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.539 -1.21 . . . . 10.0 110.904 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.6 m -81.98 129.6 63.79 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.733 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.5 118.46 5.55 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.382 2.055 . . . . 10.0 111.442 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.2 t -151.93 7.51 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.793 0.33 . . . . 10.0 110.881 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.93 -8.97 87.52 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.758 -0.734 . . . . 10.0 112.513 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.851 -0.595 . . . . 10.0 110.377 179.454 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.684 0.278 . . . . 10.0 110.254 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.5 m -75.3 125.27 28.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.14 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.19 99.6 2.56 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.202 -0.759 . . . . 10.0 111.202 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.513 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 14.1 m -88.08 162.03 41.92 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.466 0.174 . . . . 10.0 110.603 -174.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 4' ' ' SER . 41.3 Cg_endo -67.52 143.4 62.78 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.244 1.963 . . . . 10.0 111.717 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.726 HG23 ' N ' ' A' ' 7' ' ' ALA . 1.2 m 56.44 -150.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 115.429 -0.805 . . . . 10.0 111.113 177.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.726 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -57.29 -1.7 0.09 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.4 1.08 . . . . 10.0 113.891 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.499 ' HG2' ' HB2' ' A' ' 4' ' ' SER . 27.0 mt-10 74.08 -29.18 0.19 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.184 0.994 . . . . 10.0 112.946 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.0 m -80.48 -12.27 59.57 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.027 0.38 . . . . 10.0 112.027 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.811 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.9 m -96.42 140.18 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 -175.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -138.79 120.17 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.953 -0.299 . . . . 10.0 110.345 -175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.722 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.2 171.19 8.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.733 0.778 . . . . 10.0 112.626 178.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 19' ' ' THR . 34.3 t80 -149.15 179.99 7.47 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.235 -1.394 . . . . 10.0 107.235 172.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -127.34 116.44 20.52 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.501 0.667 . . . . 10.0 111.156 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 t -121.48 84.19 2.2 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 173.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 59.27 -105.28 0.23 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.333 -0.849 . . . . 10.0 111.047 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 65.8 ttt180 -103.18 24.85 10.25 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.595 0.712 . . . . 10.0 110.13 -177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.98 95.56 4.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.78 -0.646 . . . . 10.0 109.405 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.563 HG21 HG21 ' A' ' 64' ' ' VAL . 2.6 m -86.54 98.82 11.28 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 170.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.722 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -86.65 103.99 15.64 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.195 -0.911 . . . . 10.0 112.123 -176.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -96.24 107.16 19.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.74 -0.837 . . . . 10.0 108.74 174.317 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.797 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 2.5 p80 -97.39 113.46 25.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.621 -1.172 . . . . 10.0 110.439 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.811 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 14.3 t30 -79.41 150.18 31.41 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.679 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.97 16.02 5.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.775 -0.726 . . . . 10.0 112.39 175.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.43 154.96 23.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 174.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.43 -8.9 57.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.346 0.499 . . . . 10.0 112.346 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -127.25 160.63 30.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.51 0.671 . . . . 10.0 112.145 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -71.06 124.12 23.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.68 -1.145 . . . . 10.0 111.583 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.59 ' H ' HG22 ' A' ' 46' ' ' ILE . 30.7 m -125.61 141.06 46.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.322 0.582 . . . . 10.0 111.523 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.672 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 10.6 m -89.78 122.53 32.95 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 m -120.44 153.09 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.444 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.768 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -130.73 157.99 41.31 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.38 -0.827 . . . . 10.0 109.482 176.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.643 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.48 139.78 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 121.14 0.495 . . . . 10.0 110.523 -178.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.09 117.48 34.11 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.128 -0.942 . . . . 10.0 109.323 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.62 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 44.1 m-85 -90.57 155.75 18.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.083 0.468 . . . . 10.0 111.504 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 51.8 m -44.61 -41.93 6.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.824 -1.08 . . . . 10.0 112.731 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.864 ' HB2' HD22 ' A' ' 62' ' ' ASN . 78.3 m-70 -102.86 -87.54 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.648 -0.421 . . . . 10.0 110.556 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.26 130.89 1.23 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.823 -0.703 . . . . 10.0 111.93 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -172.68 151.74 2.4 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.9 p90 -76.27 144.34 40.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.127 0.489 . . . . 10.0 110.407 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.762 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 158.51 -37.4 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 124.997 1.319 . . . . 10.0 110.855 -169.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.762 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 9.9 Cg_endo -53.39 61.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 124.079 3.186 . . . . 10.0 115.504 176.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.539 ' HB3' ' HD3' ' A' ' 75' ' ' PRO . 5.1 t 177.69 105.07 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.501 0.72 . . . . 10.0 109.367 163.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -145.15 122.95 11.9 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.315 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.672 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.26 128.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 174.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -92.67 146.11 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 CA-C-N 114.638 -1.164 . . . . 10.0 109.141 -176.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.34 142.55 43.7 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 107.957 -1.127 . . . . 10.0 107.957 168.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.406 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 13.0 Cg_exo -47.59 96.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.89 2.393 . . . . 10.0 112.034 174.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 101.05 5.19 53.56 Favored Glycine 0 C--O 1.229 -0.166 0 C-N-CA 120.064 -1.065 . . . . 10.0 112.232 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.44 -176.39 37.29 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 121.069 -0.586 . . . . 10.0 112.979 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.797 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 20.5 m0 -117.04 164.7 14.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.647 0.737 . . . . 10.0 110.966 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.457 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -138.4 113.76 9.54 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 171.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.7 m -82.25 128.66 34.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.07 -0.514 . . . . 10.0 109.994 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.643 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.4 m-85 -137.02 139.22 41.24 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.042 -1.096 . . . . 10.0 108.042 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.29 101.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.375 1.047 . . . . 10.0 111.015 -176.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.17 -178.8 11.21 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.605 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 2.5 p90 -85.25 50.07 1.88 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.165 0.983 . . . . 10.0 110.799 -172.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.93 141.68 16.5 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.235 -1.146 . . . . 10.0 110.235 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.9 m 66.31 14.51 9.71 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.251 0.548 . . . . 10.0 110.301 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 58.35 35.84 25.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.433 -0.803 . . . . 10.0 111.526 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.22 -99.5 0.69 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.848 -0.691 . . . . 10.0 111.743 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.864 HD22 ' HB2' ' A' ' 37' ' ' HIS . 2.6 m120 -106.06 145.33 31.55 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 109.287 -0.635 . . . . 10.0 109.287 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 21.7 t80 -125.04 120.72 32.3 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.563 HG21 HG21 ' A' ' 19' ' ' THR . 1.8 m -63.55 130.11 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 174.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 73.4 p -122.3 -30.73 3.94 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.317 -0.553 . . . . 10.0 111.328 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.73 124.16 3.37 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 119.603 -1.284 . . . . 10.0 113.279 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.606 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.4 mt -88.26 141.55 28.46 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.93 -0.767 . . . . 10.0 108.93 172.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.711 ' C ' HG12 ' A' ' 6' ' ' VAL . 3.9 m-70 -132.09 149.61 52.36 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.339 -0.846 . . . . 10.0 108.772 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -81.98 128.59 34.24 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.219 -0.992 . . . . 10.0 110.025 176.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.768 ' HB2' HG22 ' A' ' 32' ' ' THR . 5.5 t -98.06 168.94 9.96 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 73' ' ' ALA . 6.0 p-10 -142.79 146.38 37.62 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 34.4 Cg_exo -22.78 74.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 1 C-N-CA 127.341 5.36 . . . . 10.0 115.59 176.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 71' ' ' ASP . . . -172.18 76.42 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.681 -1.145 . . . . 10.0 109.152 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.04 139.16 79.38 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.631 -0.713 . . . . 10.0 112.403 -170.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 43' ' ' CYS . 73.3 Cg_endo -76.84 122.5 6.36 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.211 2.607 . . . . 10.0 113.246 -174.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.7 m -97.8 173.37 7.13 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.448 -0.797 . . . . 10.0 109.599 173.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.34 -55.35 31.2 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.842 -0.694 . . . . 10.0 111.717 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.6 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.267 -0.873 . . . . 10.0 108.988 173.355 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 110.12 -0.326 . . . . 10.0 110.12 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.87 89.03 1.37 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.283 0.563 . . . . 10.0 111.123 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -168.02 113.9 0.55 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.042 -0.823 . . . . 10.0 111.042 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.46 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 1.9 m -94.17 157.19 38.07 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 120.707 0.289 . . . . 10.0 111.115 -174.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.429 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 39.7 Cg_endo -66.37 153.17 79.04 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.008 2.472 . . . . 10.0 111.924 175.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.824 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.8 m 48.31 -146.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.181 -0.918 . . . . 10.0 111.745 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.697 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -58.35 -0.57 0.1 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.39 1.076 . . . . 10.0 113.889 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.46 ' HG2' ' HB2' ' A' ' 4' ' ' SER . 21.4 mt-10 70.36 -24.5 0.16 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.683 0.793 . . . . 10.0 113.043 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.0 m -78.27 -15.01 59.18 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.41 0.148 . . . . 10.0 111.346 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.9 HG12 HD22 ' A' ' 23' ' ' ASN . 2.0 m -100.45 143.55 13.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.092 -0.336 . . . . 10.0 110.092 -174.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -141.23 125.38 17.36 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.513 -0.18 . . . . 10.0 110.513 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -96.05 162.43 13.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.814 0.816 . . . . 10.0 112.885 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -143.84 138.1 28.42 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.379 -1.282 . . . . 10.0 107.703 172.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -103.48 127.25 50.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.997 0.427 . . . . 10.0 111.02 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.1 m -131.23 -155.98 0.73 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.294 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -63.36 93.82 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.936 0.398 . . . . 10.0 110.852 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.456 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 98.1 mtt180 61.33 30.01 18.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.512 -0.767 . . . . 10.0 111.487 173.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.89 106.44 3.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.805 -0.443 . . . . 10.0 109.805 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.52 HG21 HG21 ' A' ' 64' ' ' VAL . 16.2 m -94.73 102.08 13.94 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.98 -0.378 . . . . 10.0 109.98 168.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.739 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.3 p-10 -88.05 111.7 21.83 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.903 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -100.73 107.58 21.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.936 0.874 . . . . 10.0 108.897 172.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.763 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 2.7 p80 -97.23 114.71 26.48 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.399 -1.273 . . . . 10.0 110.025 176.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.9 HD22 HG12 ' A' ' 10' ' ' VAL . 12.3 t-20 -80.79 153.96 27.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.721 177.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.56 25.38 3.27 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.552 -0.832 . . . . 10.0 112.586 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.596 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -88.42 164.56 15.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 176.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.58 -15.99 56.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.032 0.382 . . . . 10.0 112.032 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -128.15 156.42 42.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.259 0.552 . . . . 10.0 111.774 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.29 126.52 28.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.894 -1.048 . . . . 10.0 111.648 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.607 ' H ' HG22 ' A' ' 46' ' ' ILE . 34.3 m -124.62 146.0 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-O 121.125 0.488 . . . . 10.0 111.059 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.672 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.3 m -95.21 122.87 38.35 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.635 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.573 ' HB ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -123.07 151.33 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 115.769 -0.65 . . . . 10.0 110.658 -177.218 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.854 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -130.21 163.08 27.48 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.227 -0.897 . . . . 10.0 109.116 175.371 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.662 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.4 131.07 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 120.865 0.364 . . . . 10.0 110.089 -176.36 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -103.12 115.29 30.31 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.505 -0.77 . . . . 10.0 109.103 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.651 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 41.4 m-85 -86.26 162.35 18.32 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.729 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.1 m -50.17 -23.42 2.18 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.737 -1.12 . . . . 10.0 112.446 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -131.06 -74.01 0.53 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.919 -0.488 . . . . 10.0 110.402 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.87 133.74 2.29 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.32 -1.112 . . . . 10.0 110.32 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.09 24.76 0.37 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.003 0.43 . . . . 10.0 110.412 -174.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 36.0 t90 58.87 103.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.212 -0.904 . . . . 10.0 112.149 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.703 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -173.83 -45.07 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.355 -0.839 . . . . 10.0 111.587 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.703 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 2.6 Cg_endo -38.27 100.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 123.951 3.101 . . . . 10.0 114.308 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.0 m 129.51 100.38 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.241 1.816 . . . . 10.0 111.244 168.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.808 HH21 HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -153.37 130.96 11.47 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.9 -1.045 . . . . 10.0 108.293 -178.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.672 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -84.56 138.42 19.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.485 0.66 . . . . 10.0 110.731 178.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -99.09 148.77 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.457 -1.247 . . . . 10.0 109.692 -177.186 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -87.66 142.62 32.86 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.803 -1.184 . . . . 10.0 107.803 168.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -45.46 93.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.042 2.494 . . . . 10.0 112.843 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 98.02 15.11 37.24 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.047 -1.073 . . . . 10.0 112.523 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.78 -174.64 28.11 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.084 -0.579 . . . . 10.0 112.733 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.763 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 16.5 m0 -117.61 167.13 11.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.637 0.732 . . . . 10.0 111.653 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -144.64 113.72 6.91 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.56 -1.2 . . . . 10.0 107.982 171.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 m -82.63 131.88 35.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.989 -175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.662 ' CG ' HG21 ' A' ' 33' ' ' VAL . 46.6 m-85 -140.0 144.51 36.99 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.35 -0.981 . . . . 10.0 108.35 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.22 101.98 0.06 Allowed 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 124.131 0.894 . . . . 10.0 111.151 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.14 175.54 42.23 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.247 -0.977 . . . . 10.0 110.86 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.456 ' H ' ' HD1' ' A' ' 57' ' ' TYR . 2.6 p90 -84.28 55.66 3.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.38 1.09 . . . . 10.0 110.041 -177.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.456 ' HA3' ' CG ' ' A' ' 17' ' ' ARG . . . -88.6 5.14 84.96 Favored Glycine 0 N--CA 1.454 -0.144 0 CA-C-N 114.914 -1.039 . . . . 10.0 113.371 -171.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 m -152.71 37.7 0.52 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.525 -0.917 . . . . 10.0 108.525 174.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 66.2 -89.09 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 114.875 -1.057 . . . . 10.0 108.605 -170.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 31.83 -111.88 0.05 OUTLIER Glycine 0 N--CA 1.468 0.82 0 O-C-N 124.698 1.249 . . . . 10.0 114.445 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.651 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -99.39 140.63 33.28 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.413 0.625 . . . . 10.0 110.815 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -124.43 114.1 19.04 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.97 -1.013 . . . . 10.0 109.007 172.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.52 HG21 HG21 ' A' ' 19' ' ' THR . 0.9 OUTLIER -60.19 125.75 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 174.346 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.0 t -138.41 6.56 2.54 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.466 -0.494 . . . . 10.0 110.936 -175.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -156.23 107.17 0.31 Allowed Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 119.246 -1.454 . . . . 10.0 113.395 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.824 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.9 mt -82.28 128.35 34.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.696 -0.853 . . . . 10.0 108.696 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.742 ' C ' HG12 ' A' ' 6' ' ' VAL . 8.5 m-70 -122.36 143.32 49.72 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.254 -0.884 . . . . 10.0 108.685 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -77.76 129.74 35.86 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.055 -1.028 . . . . 10.0 110.445 179.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.854 ' HB2' HG22 ' A' ' 32' ' ' THR . 44.6 t -99.91 157.76 16.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.394 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -106.93 145.3 30.83 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 171.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -19.16 81.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.997 1 C-N-CA 126.788 4.992 . . . . 10.0 115.093 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 43' ' ' CYS . . . -172.33 121.06 0.43 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.777 -1.101 . . . . 10.0 108.738 -175.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.808 HG21 HH21 ' A' ' 44' ' ' ARG . 8.0 t -141.86 138.93 17.54 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 109.116 -0.698 . . . . 10.0 109.116 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.474 ' HD2' ' O ' ' A' ' 43' ' ' CYS . 14.3 Cg_endo -57.66 101.97 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.198 2.598 . . . . 10.0 113.356 -175.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.6 m -81.6 82.57 7.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.905 -0.589 . . . . 10.0 109.715 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.81 -93.19 1.52 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.584 -0.735 . . . . 10.0 112.15 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.873 -0.584 . . . . 10.0 109.997 -177.509 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.559 0.218 . . . . 10.0 110.503 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.2 t -173.38 -47.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.538 -0.301 . . . . 10.0 110.315 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.48 166.67 12.25 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.586 -0.606 . . . . 10.0 111.586 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.65 ' HB3' ' HG2' ' A' ' 8' ' ' GLU . 13.1 m -126.85 101.69 26.11 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 121.026 0.441 . . . . 10.0 111.418 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.46 144.5 20.25 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.164 2.576 . . . . 10.0 111.757 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.727 HG23 ' N ' ' A' ' 7' ' ' ALA . 1.4 m 51.35 -151.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.304 -0.862 . . . . 10.0 111.732 174.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.727 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -60.4 9.4 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.342 1.238 . . . . 10.0 114.342 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.65 ' HG2' ' HB3' ' A' ' 4' ' ' SER . 47.8 mt-10 75.79 -49.72 0.61 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.454 0.909 . . . . 10.0 113.454 176.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 60.9 m -73.57 -9.67 58.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.68 0.276 . . . . 10.0 111.442 -170.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.834 HG12 HD22 ' A' ' 23' ' ' ASN . 1.5 m -98.73 132.82 43.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.917 -0.772 . . . . 10.0 108.917 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -139.57 126.82 21.29 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.85 -0.34 . . . . 10.0 110.207 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -90.65 163.24 14.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.767 0.794 . . . . 10.0 111.937 177.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.431 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 55.8 t80 -142.27 155.91 45.25 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.073 -1.455 . . . . 10.0 107.073 171.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.444 ' HB2' ' HE1' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -103.31 94.38 5.47 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.481 0.657 . . . . 10.0 111.208 -177.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.673 ' HB2' ' HB3' ' A' ' 18' ' ' TYR . 38.3 m -86.37 60.75 6.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.148 -0.933 . . . . 10.0 108.54 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.8 t90 66.35 -92.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.985 -1.007 . . . . 10.0 110.87 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -110.92 40.85 1.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.668 0.747 . . . . 10.0 109.534 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.673 ' HB3' ' HB2' ' A' ' 15' ' ' SER . 1.7 t80 -151.08 99.57 2.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.013 -0.994 . . . . 10.0 108.496 -175.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 12' ' ' TYR . 2.5 m -87.12 98.26 11.2 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.345 0.593 . . . . 10.0 109.783 173.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.73 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.1 p-10 -87.54 104.94 16.96 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.723 -1.126 . . . . 10.0 111.445 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -96.12 105.22 16.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.497 -0.927 . . . . 10.0 108.497 174.541 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.8 ' HB3' ' NE1' ' A' ' 51' ' ' TRP . 3.3 p80 -95.51 112.95 24.57 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.362 -1.29 . . . . 10.0 110.063 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.834 HD22 HG12 ' A' ' 10' ' ' VAL . 14.1 t-20 -81.65 150.1 28.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.737 175.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.14 25.39 3.33 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.078 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.713 ' HB2' HD21 ' A' ' 23' ' ' ASN . 0.5 OUTLIER -89.01 162.59 15.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 176.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.59 -12.96 59.82 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.275 0.472 . . . . 10.0 112.275 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -120.68 152.32 38.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.443 0.64 . . . . 10.0 112.449 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -68.7 118.54 11.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.894 -1.048 . . . . 10.0 110.735 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.548 ' H ' HG22 ' A' ' 46' ' ' ILE . 35.4 m -121.74 137.81 54.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.332 0.586 . . . . 10.0 112.049 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.709 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.4 m -87.46 122.76 31.61 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.707 -0.679 . . . . 10.0 109.786 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.09 151.69 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 115.256 -0.883 . . . . 10.0 110.711 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.775 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.6 OUTLIER -130.1 160.0 35.07 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.964 -0.754 . . . . 10.0 108.964 176.198 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.637 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -133.36 132.78 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.42 0.629 . . . . 10.0 110.81 -177.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -102.53 114.16 28.13 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.806 -1.088 . . . . 10.0 108.97 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 53.3 m-85 -89.84 164.73 14.5 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.575 0.702 . . . . 10.0 112.265 -175.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -52.81 -32.91 46.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.191 -1.368 . . . . 10.0 111.597 169.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.411 ' HD2' ' H ' ' A' ' 62' ' ' ASN . 87.8 m-70 -106.98 -86.22 0.5 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.813 0.34 . . . . 10.0 110.698 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.81 53.22 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.747 -0.74 . . . . 10.0 111.717 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.11 138.39 55.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -73.11 107.48 5.47 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.989 ' H ' ' HD2' ' A' ' 42' ' ' PRO . . . -167.13 -42.15 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 118.281 -0.866 . . . . 10.0 112.879 -173.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.989 ' HD2' ' H ' ' A' ' 41' ' ' ALA . 1.6 Cg_endo -41.77 70.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 125.151 3.9 . . . . 10.0 116.877 -173.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.748 ' HB3' ' HD3' ' A' ' 75' ' ' PRO . 5.7 t 173.77 110.2 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.807 0.843 . . . . 10.0 109.735 164.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HA ' ' NE ' ' A' ' 44' ' ' ARG . 0.6 OUTLIER -149.52 121.09 7.99 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.935 177.329 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -77.98 127.18 38.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.998 -0.741 . . . . 10.0 108.998 173.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -91.41 146.78 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 114.589 -1.187 . . . . 10.0 109.478 -175.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.03 133.05 41.91 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 107.443 -1.317 . . . . 10.0 107.443 168.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -43.11 96.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.189 2.593 . . . . 10.0 112.369 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 103.19 7.6 43.13 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.343 -0.932 . . . . 10.0 113.084 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.16 -171.79 28.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.098 -0.572 . . . . 10.0 113.589 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.8 ' NE1' ' HB3' ' A' ' 22' ' ' HIS . 20.3 m0 -118.43 167.31 11.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.333 0.587 . . . . 10.0 110.896 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.58 114.84 8.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.327 -1.36 . . . . 10.0 107.327 171.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.0 m -83.45 130.21 35.02 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.757 -173.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.637 ' CG ' HG21 ' A' ' 33' ' ' VAL . 56.9 m-85 -138.72 146.63 41.73 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.8 102.59 0.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.601 0.563 . . . . 10.0 110.493 -174.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.97 -169.54 15.15 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.54 -0.838 . . . . 10.0 111.077 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.666 ' HB3' ' HD1' ' A' ' 63' ' ' TYR . 6.3 p90 -84.96 88.36 7.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 122.014 0.912 . . . . 10.0 110.86 -174.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -134.07 -82.19 0.18 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.49 -0.777 . . . . 10.0 112.405 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m -84.62 113.0 20.95 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.853 -0.204 . . . . 10.0 110.542 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 63.14 22.52 13.44 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.958 0.409 . . . . 10.0 110.944 -176.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 57' ' ' TYR . . . 78.19 -95.33 1.29 Allowed Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.368 -0.92 . . . . 10.0 111.471 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.522 ' O ' ' HD2' ' A' ' 35' ' ' TYR . 17.5 m120 61.33 23.62 13.83 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 122.973 0.509 . . . . 10.0 110.87 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.666 ' HD1' ' HB3' ' A' ' 57' ' ' TYR . 89.6 t80 -58.54 110.36 0.97 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.559 -177.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.693 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.3 m -60.65 136.89 23.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 172.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.5 t -144.77 12.82 1.48 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.196 -0.602 . . . . 10.0 111.89 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.04 110.62 0.45 Allowed Glycine 0 C--O 1.224 -0.504 0 C-N-CA 119.438 -1.363 . . . . 10.0 113.482 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.611 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.5 mt -84.65 133.78 34.39 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.388 0.613 . . . . 10.0 109.701 173.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.704 ' C ' HG12 ' A' ' 6' ' ' VAL . 27.2 m-70 -127.06 149.58 49.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.033 -0.985 . . . . 10.0 108.706 -176.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.436 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -83.67 129.41 34.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 119.485 1.039 . . . . 10.0 110.381 177.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.775 ' HB2' HG22 ' A' ' 32' ' ' THR . 5.2 t -98.89 172.9 7.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.349 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -130.35 149.03 72.21 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.917 -0.771 . . . . 10.0 108.917 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -20.91 78.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.11 1 C-N-CA 126.777 4.984 . . . . 10.0 115.272 174.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -167.42 68.97 0.09 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.661 -1.154 . . . . 10.0 109.898 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 67.1 m -70.55 131.43 88.08 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.777 -175.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 43' ' ' CYS . 4.1 Cg_endo -47.54 116.28 1.77 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.829 3.02 . . . . 10.0 112.91 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.4 t -158.26 -34.6 0.07 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.27 -0.877 . . . . 10.0 109.082 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.11 28.65 27.63 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.618 -0.801 . . . . 10.0 112.598 175.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.246 0.893 0 CA-C-O 119.192 -0.432 . . . . 10.0 110.957 -179.518 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 110.168 -0.308 . . . . 10.0 110.168 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.4 p -72.75 -24.73 61.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.943 -176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.11 -97.87 0.11 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.494 -0.86 . . . . 10.0 112.138 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.793 ' HB3' ' HG2' ' A' ' 8' ' ' GLU . 37.8 m 58.57 79.94 0.3 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 121.154 0.502 . . . . 10.0 111.103 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.0 -42.79 1.41 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.588 2.192 . . . . 10.0 113.349 -174.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.628 HG23 HG23 ' A' ' 69' ' ' THR . 0.2 OUTLIER -157.07 118.72 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.584 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.61 -19.54 0.16 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.505 0.722 . . . . 10.0 112.58 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.793 ' HG2' ' HB3' ' A' ' 4' ' ' SER . 32.6 mt-10 74.49 -28.32 0.19 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.283 1.033 . . . . 10.0 112.041 175.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.0 m -87.18 -10.26 53.11 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.919 0.34 . . . . 10.0 111.919 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.3 m -95.56 134.85 31.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.871 -0.788 . . . . 10.0 108.871 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -135.82 121.58 19.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.787 -0.188 . . . . 10.0 110.594 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.813 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -98.18 161.33 13.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.146 0.795 . . . . 10.0 113.146 178.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 19' ' ' THR . 82.9 t80 -148.05 155.62 41.69 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 171.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.553 ' NE2' ' H ' ' A' ' 14' ' ' GLN . 0.7 OUTLIER -110.15 124.95 52.47 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.318 -0.553 . . . . 10.0 110.606 178.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.2 t -136.75 77.2 1.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.25 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 55.95 86.79 0.06 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.215 -0.902 . . . . 10.0 112.092 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 67.49 14.14 9.52 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.965 -0.561 . . . . 10.0 112.271 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -139.03 96.52 3.13 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.521 -0.548 . . . . 10.0 109.521 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.5 m -87.46 100.4 12.73 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.656 -0.498 . . . . 10.0 109.656 171.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.813 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 2.4 p-10 -83.63 111.42 19.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 114.948 -1.024 . . . . 10.0 111.829 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.98 106.65 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 122.015 0.912 . . . . 10.0 108.883 171.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.784 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -97.51 112.07 24.07 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.14 -1.391 . . . . 10.0 110.545 179.02 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.762 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.5 t-20 -80.72 160.03 25.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.89 -0.595 . . . . 10.0 110.255 177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -154.5 32.0 0.7 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.638 -0.791 . . . . 10.0 111.764 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -83.05 -18.4 39.85 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 122.132 0.173 . . . . 10.0 111.015 -178.375 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 86.35 -8.34 0.73 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.753 1.283 . . . . 10.0 111.08 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' OD1' ' HB3' ' A' ' 25' ' ' CYS . 10.9 p-10 -125.07 155.05 40.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.121 0.486 . . . . 10.0 110.841 175.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.67 123.22 20.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.292 -0.867 . . . . 10.0 111.183 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.609 ' H ' HG22 ' A' ' 46' ' ' ILE . 26.8 m -126.03 139.79 50.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.067 0.46 . . . . 10.0 111.364 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.774 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 9.5 m -88.93 119.67 29.65 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.509 -0.552 . . . . 10.0 109.509 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' CYS . 1.1 m -116.66 165.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 115.401 -0.818 . . . . 10.0 110.51 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.489 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -148.57 158.16 43.94 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.641 -0.709 . . . . 10.0 109.206 178.221 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.627 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -135.23 138.22 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.338 0.59 . . . . 10.0 111.717 -173.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -101.22 125.99 47.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.947 -1.024 . . . . 10.0 108.908 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . 57.0 m-85 -95.07 165.6 12.34 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.247 -0.581 . . . . 10.0 110.351 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 88.0 m -49.4 -21.07 0.8 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.245 -0.889 . . . . 10.0 112.142 174.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -118.96 -67.05 1.02 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 174.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.04 50.65 0.07 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.735 -0.745 . . . . 10.0 112.352 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -74.43 158.98 32.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.73 0.3 . . . . 10.0 111.362 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -66.92 112.87 4.54 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.388 0.614 . . . . 10.0 112.224 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.693 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . -174.82 -47.72 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 CA-C-N 114.844 -1.071 . . . . 10.0 111.101 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.693 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 3.0 Cg_endo -37.06 96.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 124.273 3.316 . . . . 10.0 114.128 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 1.6 m 135.99 108.19 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.0 1.72 . . . . 10.0 111.202 170.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.76 130.58 7.44 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.8 OUTLIER -83.45 135.74 24.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.392 0.615 . . . . 10.0 110.236 176.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.37 146.79 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.829 -1.078 . . . . 10.0 109.994 -176.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -88.27 141.56 30.95 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 168.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -38.9 98.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.71 2.94 . . . . 10.0 113.02 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.721 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 89.37 12.22 63.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 119.603 -1.284 . . . . 10.0 112.23 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.28 -176.63 36.03 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 121.276 -0.488 . . . . 10.0 112.214 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.784 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 23.6 m0 -116.65 165.16 13.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.552 0.692 . . . . 10.0 111.182 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -139.46 115.87 10.56 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.14 -1.43 . . . . 10.0 107.14 172.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.0 m -85.2 127.88 34.46 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.374 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.627 ' CG ' HG21 ' A' ' 33' ' ' VAL . 48.5 m-85 -137.42 139.43 40.68 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.462 -0.94 . . . . 10.0 108.462 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.54 100.04 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.172 0.92 . . . . 10.0 111.324 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.29 175.07 43.44 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.233 -1.147 . . . . 10.0 110.233 176.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.44 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 7.7 p90 -83.93 91.05 7.5 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.742 1.271 . . . . 10.0 109.96 -174.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.18 -50.45 6.77 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.166 -0.925 . . . . 10.0 112.525 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.1 p -116.17 26.2 10.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.797 0.332 . . . . 10.0 110.578 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 65.45 14.73 9.64 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.734 -0.667 . . . . 10.0 111.375 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.81 -88.33 0.19 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.782 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -92.62 113.72 26.07 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.451 ' HB3' ' OG1' ' A' ' 36' ' ' THR . 26.9 t80 -115.63 116.84 28.81 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 172.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 1.5 m -61.3 129.02 23.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.9 p -128.23 -16.37 4.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.136 -0.484 . . . . 10.0 111.678 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.37 110.65 0.66 Allowed Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 119.226 -1.464 . . . . 10.0 113.709 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 4.3 mt -82.36 150.53 27.12 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.069 -0.715 . . . . 10.0 109.069 171.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.515 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -148.22 159.65 43.75 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.264 -178.044 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.628 HG23 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -81.44 126.61 31.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.033 0.444 . . . . 10.0 110.66 174.402 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 30' ' ' SER . 48.9 t -98.92 166.97 11.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.492 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -124.04 143.6 42.86 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.164 -0.68 . . . . 10.0 109.164 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -17.37 82.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.803 1 C-N-CA 126.754 4.969 . . . . 10.0 115.115 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -168.96 96.77 0.36 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.538 -1.21 . . . . 10.0 110.229 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.5 m -95.7 114.54 64.22 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 111.885 0.328 . . . . 10.0 111.885 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 43' ' ' CYS . 37.1 Cg_endo -66.92 124.1 11.83 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.894 2.396 . . . . 10.0 112.007 175.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.8 m 60.4 74.78 0.43 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.723 -0.672 . . . . 10.0 111.211 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.2 -150.65 25.02 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.837 -0.697 . . . . 10.0 111.827 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t . . . . . 0 C--O 1.245 0.863 0 CA-C-O 117.847 -1.073 . . . . 10.0 110.321 -176.604 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.463 -0.199 . . . . 10.0 110.463 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 t -162.3 -41.92 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.785 -0.189 . . . . 10.0 111.113 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.96 -17.89 28.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.182 -1.009 . . . . 10.0 112.32 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 t -145.17 95.9 5.03 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 110.034 -0.358 . . . . 10.0 110.034 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HB2' ' CB ' ' A' ' 67' ' ' LEU . 36.0 Cg_endo -87.83 -67.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.559 2.173 . . . . 10.0 112.62 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.584 HG12 ' HB3' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -151.93 124.42 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 177.141 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 71.06 -27.54 0.17 Allowed 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.752 0.657 . . . . 10.0 111.88 172.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 6' ' ' VAL . 47.0 mt-10 77.68 -20.17 0.39 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.609 1.163 . . . . 10.0 111.36 175.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.9 m -84.18 -14.46 50.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.414 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.786 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -96.03 134.19 34.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -133.1 119.6 20.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.583 -175.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.787 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -96.71 162.04 13.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.024 0.916 . . . . 10.0 113.296 177.131 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 19' ' ' THR . 33.5 t80 -143.04 178.98 7.32 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.407 -1.701 . . . . 10.0 106.407 169.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -136.96 117.35 13.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.457 0.571 . . . . 10.0 111.349 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 p -120.66 86.65 2.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.664 -0.698 . . . . 10.0 109.85 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 62.72 -84.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.998 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -120.31 16.75 12.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.983 0.42 . . . . 10.0 110.933 -172.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.69 96.45 3.82 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.218 -0.66 . . . . 10.0 109.218 -173.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.504 HG21 HG11 ' A' ' 64' ' ' VAL . 7.0 m -86.17 99.12 11.3 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.624 0.726 . . . . 10.0 109.192 171.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.787 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 3.0 p-10 -85.27 109.67 18.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.434 -1.257 . . . . 10.0 111.926 -175.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.36 106.48 19.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 172.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.738 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -98.37 110.96 23.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.068 -1.424 . . . . 10.0 110.297 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.786 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 18.6 t-20 -80.98 154.91 26.68 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.957 -0.565 . . . . 10.0 109.939 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.25 36.13 1.03 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.579 -0.82 . . . . 10.0 112.177 173.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -76.59 -66.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.457 -0.306 . . . . 10.0 110.449 -178.032 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 25' ' ' CYS . . . 142.42 -32.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.815 1.322 . . . . 10.0 108.699 -171.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -115.33 157.67 23.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.111 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.35 127.22 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.492 -0.776 . . . . 10.0 111.319 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.599 ' H ' HG22 ' A' ' 46' ' ' ILE . 30.8 m -125.47 139.55 50.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.072 0.463 . . . . 10.0 111.268 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.826 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 14.7 m -88.3 119.7 28.96 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.273 -0.64 . . . . 10.0 109.273 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.442 HG12 HG21 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -119.12 148.45 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 121.775 0.798 . . . . 10.0 111.732 -178.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.5 OUTLIER -127.16 160.88 29.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.8 -1.091 . . . . 10.0 109.287 176.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.73 138.95 47.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.33 0.585 . . . . 10.0 111.867 -178.154 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -100.81 120.36 40.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.72 -1.127 . . . . 10.0 109.241 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.85 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 35.1 m-85 -100.13 158.96 15.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.295 0.569 . . . . 10.0 111.55 -178.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.529 ' OG1' ' HB3' ' A' ' 63' ' ' TYR . 22.7 m -48.48 -34.9 11.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.608 -1.178 . . . . 10.0 112.601 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.441 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 53.4 m-70 -103.29 -83.6 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.931 -0.48 . . . . 10.0 109.876 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.4 49.63 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.246 -0.978 . . . . 10.0 112.898 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -66.3 153.24 43.15 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.088 -0.338 . . . . 10.0 110.088 173.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 14.5 p90 -75.7 136.68 40.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.866 -0.79 . . . . 10.0 108.866 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.73 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 165.95 -42.52 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 123.57 0.748 . . . . 10.0 111.329 -170.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.73 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 6.3 Cg_endo -48.69 71.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 124.212 3.275 . . . . 10.0 115.29 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER 164.1 97.89 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.794 1.238 . . . . 10.0 110.2 166.166 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.73 126.48 10.31 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.944 -0.761 . . . . 10.0 108.944 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.826 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -80.53 137.39 21.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.287 0.565 . . . . 10.0 110.749 179.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -96.0 145.64 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.235 -0.893 . . . . 10.0 109.38 -177.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.58 140.45 31.73 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 107.808 -1.182 . . . . 10.0 107.808 169.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -43.53 95.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.267 2.644 . . . . 10.0 113.107 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 99.59 5.44 55.49 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.064 -1.065 . . . . 10.0 112.511 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.24 -171.79 38.33 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 121.29 -0.481 . . . . 10.0 113.117 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.738 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 16.6 m0 -119.74 167.3 12.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.499 0.666 . . . . 10.0 111.005 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -142.59 114.46 8.13 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.154 -1.424 . . . . 10.0 107.154 171.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.8 m -80.95 129.42 34.53 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.549 -0.751 . . . . 10.0 110.361 -175.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.617 ' CG ' HG21 ' A' ' 33' ' ' VAL . 50.3 m-85 -137.52 141.0 41.45 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.595 -0.891 . . . . 10.0 108.595 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.01 106.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.958 0.786 . . . . 10.0 110.854 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.5 -170.96 6.31 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.338 -0.846 . . . . 10.0 111.818 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.729 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 2.3 p90 -83.79 65.87 8.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.207 1.003 . . . . 10.0 111.556 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.25 163.21 39.16 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.311 -0.859 . . . . 10.0 111.61 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 t -59.49 134.95 57.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.685 0.243 . . . . 10.0 110.558 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 64.59 9.35 5.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.095 0.558 . . . . 10.0 111.418 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.581 ' C ' HD22 ' A' ' 62' ' ' ASN . . . -100.42 -145.63 17.89 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.44 -0.886 . . . . 10.0 112.286 -176.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.85 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -120.57 -153.83 0.56 Allowed 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.218 -1.031 . . . . 10.0 108.218 179.139 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.611 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 8.5 t80 -169.01 109.04 0.47 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.471 -1.307 . . . . 10.0 107.471 176.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 19' ' ' THR . 1.6 m -66.53 128.79 30.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.6 p -119.28 -28.84 5.33 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.344 -0.389 . . . . 10.0 111.277 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.51 115.38 1.1 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.569 -1.3 . . . . 10.0 113.209 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.584 ' HB3' HG12 ' A' ' 6' ' ' VAL . 4.4 mt -79.34 146.62 32.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 170.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.458 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 5.3 m-70 -140.29 157.93 44.81 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.453 -176.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.559 HG23 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -79.63 126.44 30.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.011 0.434 . . . . 10.0 110.571 174.249 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.584 ' HB2' HG22 ' A' ' 32' ' ' THR . 35.8 t -94.44 158.77 15.41 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.154 -0.684 . . . . 10.0 109.154 177.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -136.45 145.36 51.3 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -16.96 81.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.717 1 C-N-CA 126.637 4.891 . . . . 10.0 114.751 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -169.61 71.23 0.07 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.519 -1.219 . . . . 10.0 109.387 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 m -79.7 127.6 77.32 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.144 -0.934 . . . . 10.0 111.433 -173.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.52 -71.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.208 1.939 . . . . 10.0 111.592 175.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 p -94.24 104.75 16.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.387 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 149.46 -112.99 0.58 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.914 -0.66 . . . . 10.0 111.75 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.301 -0.857 . . . . 10.0 110.656 178.714 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.704 0.288 . . . . 10.0 110.72 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.0 t -80.99 -22.34 39.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.389 0.614 . . . . 10.0 109.965 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 152.35 137.31 2.55 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.697 -0.961 . . . . 10.0 110.697 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.649 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . 9.3 t -144.11 -53.96 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 117.237 0.518 . . . . 10.0 111.833 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 4' ' ' SER . 14.7 Cg_endo -77.52 124.99 7.33 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.343 1.362 . . . . 10.0 111.941 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.573 ' CG1' ' HB3' ' A' ' 67' ' ' LEU . 0.2 OUTLIER 41.18 106.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.655 1.354 . . . . 10.0 114.655 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 73.6 -19.11 0.35 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.405 -0.816 . . . . 10.0 112.949 164.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 6' ' ' VAL . 40.1 mt-10 77.5 -40.11 0.32 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.864 . . . . 10.0 112.017 174.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.1 m -77.75 -12.73 60.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.818 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.4 m -90.94 132.43 35.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.869 -0.789 . . . . 10.0 108.869 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.71 113.0 11.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.674 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.765 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -89.34 161.33 16.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.719 0.771 . . . . 10.0 111.996 175.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.45 ' HB3' ' OD2' ' A' ' 20' ' ' ASP . 86.4 t80 -142.69 139.87 31.32 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.192 -1.367 . . . . 10.0 107.454 172.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.03 98.26 9.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.537 0.684 . . . . 10.0 110.123 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' A' ' 18' ' ' TYR . 12.9 p -99.15 -156.35 0.54 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.321 -0.854 . . . . 10.0 108.879 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -69.88 93.22 0.74 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.668 0.271 . . . . 10.0 110.713 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 62.35 32.64 16.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.308 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.446 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 0.7 OUTLIER -146.41 103.07 3.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 -173.11 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.471 HG21 HG21 ' A' ' 64' ' ' VAL . 16.8 m -90.15 91.56 8.59 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.755 -0.831 . . . . 10.0 108.755 170.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.765 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 1.0 OUTLIER -83.37 109.07 16.99 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.975 -1.012 . . . . 10.0 111.757 -178.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -98.28 107.21 19.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 122.066 0.936 . . . . 10.0 108.928 174.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.759 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -98.54 111.01 23.51 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.13 -1.395 . . . . 10.0 110.042 177.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.834 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 17.9 t30 -79.39 147.46 32.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.053 -0.521 . . . . 10.0 109.748 178.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -129.43 13.85 5.89 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.718 -0.753 . . . . 10.0 112.502 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.79 154.79 23.35 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.53 -11.22 60.57 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.443 0.535 . . . . 10.0 112.443 -176.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -124.88 156.75 37.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.365 0.602 . . . . 10.0 112.09 -177.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.31 124.72 24.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.721 -1.127 . . . . 10.0 111.33 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.652 ' H ' HG22 ' A' ' 46' ' ' ILE . 27.8 m -124.14 138.33 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.323 0.582 . . . . 10.0 111.533 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.841 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.2 m -87.01 120.15 27.97 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.383 -0.826 . . . . 10.0 109.061 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.564 HG12 HG21 ' A' ' 6' ' ' VAL . 1.2 m -115.42 165.53 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 121.532 0.682 . . . . 10.0 110.653 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.551 ' HB ' ' C ' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -146.96 159.77 43.15 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.968 -1.015 . . . . 10.0 109.037 177.104 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.621 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -135.41 144.5 33.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.328 0.585 . . . . 10.0 110.633 -176.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -117.44 114.21 23.18 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.074 -0.967 . . . . 10.0 109.114 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 20.3 m-85 -93.1 159.73 15.17 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.626 0.727 . . . . 10.0 111.919 -172.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.6 m -50.67 -44.6 57.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.251 -1.34 . . . . 10.0 113.237 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.429 ' HB2' ' CG ' ' A' ' 62' ' ' ASN . 30.6 m-70 -95.22 -72.68 0.61 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.36 -0.536 . . . . 10.0 110.823 -177.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.71 48.55 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.958 -1.115 . . . . 10.0 113.575 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.534 ' HG2' ' OD1' ' A' ' 62' ' ' ASN . 16.0 mm100 -68.1 150.35 48.5 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 117.022 0.411 . . . . 10.0 110.391 173.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.558 ' HZ2' ' H ' ' A' ' 76' ' ' SER . 53.5 t-105 -82.91 108.81 16.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.83 -0.623 . . . . 10.0 111.219 178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.776 ' H ' ' HD3' ' A' ' 42' ' ' PRO . . . -171.95 26.67 0.01 OUTLIER Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 113.063 0.764 . . . . 10.0 113.063 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.776 ' HD3' ' H ' ' A' ' 41' ' ' ALA . 14.3 Cg_endo -91.27 56.91 1.02 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.259 1.306 . . . . 10.0 112.7 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 177.01 116.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.632 0.582 . . . . 10.0 111.356 171.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.79 124.42 3.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.841 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.7 p -83.15 138.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.359 0.6 . . . . 10.0 110.812 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.652 HG22 ' H ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -100.86 148.3 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 114.941 -1.027 . . . . 10.0 109.494 -177.367 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -90.65 143.26 28.76 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 107.832 -1.173 . . . . 10.0 107.832 168.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -46.08 93.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.106 2.537 . . . . 10.0 112.609 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 102.19 11.52 36.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.86 -1.162 . . . . 10.0 111.884 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.03 -176.79 31.96 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 121.332 -0.461 . . . . 10.0 112.63 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.759 ' HE1' ' HB3' ' A' ' 22' ' ' HIS . 12.0 m0 -119.31 166.71 12.67 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.365 0.603 . . . . 10.0 111.126 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 21' ' ' VAL . . . -143.47 110.07 5.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 172.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.9 m -79.41 131.07 35.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.383 -0.371 . . . . 10.0 110.761 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.621 ' CG ' HG21 ' A' ' 33' ' ' VAL . 49.8 m-85 -140.1 142.83 36.05 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.004 -1.11 . . . . 10.0 108.004 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.91 102.72 0.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.544 0.527 . . . . 10.0 110.837 -174.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.53 -176.26 11.37 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.278 -0.873 . . . . 10.0 111.167 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.666 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 13.4 p90 -86.21 94.52 9.32 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 117.986 0.893 . . . . 10.0 110.903 -174.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.59 170.0 34.78 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.209 -0.905 . . . . 10.0 111.154 174.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.6 m -63.82 114.45 4.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.475 -0.195 . . . . 10.0 110.475 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.3 t70 65.81 63.4 0.6 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.569 0.7 . . . . 10.0 110.106 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.94 -147.23 4.49 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.089 -0.804 . . . . 10.0 111.089 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.693 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -106.71 179.41 4.28 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.969 -0.752 . . . . 10.0 108.969 174.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 57' ' ' TYR . 15.8 t80 -147.75 118.5 7.56 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.706 -1.134 . . . . 10.0 108.574 171.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.471 HG21 HG21 ' A' ' 19' ' ' THR . 1.7 m -63.59 133.0 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.432 -0.951 . . . . 10.0 108.432 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 81.6 p -118.51 -39.29 3.02 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.478 -0.489 . . . . 10.0 111.029 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.45 122.57 3.86 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.719 -1.229 . . . . 10.0 113.21 -174.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.573 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 3.7 mt -86.87 144.37 27.02 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.997 -0.742 . . . . 10.0 108.997 173.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.541 ' C ' ' HB ' ' A' ' 6' ' ' VAL . 8.1 m-70 -138.37 159.6 41.64 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.386 -174.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.562 HG23 HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -84.12 124.88 31.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.129 0.49 . . . . 10.0 111.129 175.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.495 ' HB2' HG22 ' A' ' 32' ' ' THR . 43.3 t -95.37 172.83 7.85 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.809 -0.811 . . . . 10.0 108.809 175.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 6.4 p-10 -137.1 147.89 60.47 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 108.318 -0.994 . . . . 10.0 108.318 172.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -15.66 83.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 1 C-N-CA 126.546 4.831 . . . . 10.0 114.916 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -165.62 104.96 0.72 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.629 -1.169 . . . . 10.0 109.619 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.8 p -77.36 134.8 66.22 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.291 -0.413 . . . . 10.0 111.44 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.84 144.83 94.23 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.594 2.196 . . . . 10.0 111.911 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.558 ' H ' ' HZ2' ' A' ' 40' ' ' TRP . 13.6 t -78.15 101.97 7.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.025 0.441 . . . . 10.0 110.335 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.04 147.44 18.43 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.015 -0.834 . . . . 10.0 111.015 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 m . . . . . 0 C--O 1.242 0.71 0 CA-C-O 118.908 -0.568 . . . . 10.0 110.931 -178.141 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 4' ' ' SER . . . . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.599 0.238 . . . . 10.0 111.238 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -45.98 70.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.141 -0.481 . . . . 10.0 112.038 -177.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.27 48.73 0.91 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.451 -0.88 . . . . 10.0 112.737 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.533 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 19.9 t -139.44 62.45 24.25 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.774 0.321 . . . . 10.0 111.157 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 4' ' ' SER . 90.8 Cg_endo -97.88 139.94 0.49 Allowed 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.961 2.441 . . . . 10.0 112.264 176.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.86 HG13 ' HB3' ' A' ' 67' ' ' LEU . 2.2 m 48.55 -147.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.488 0.715 . . . . 10.0 111.458 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.705 ' N ' HG23 ' A' ' 6' ' ' VAL . . . -56.09 -2.5 0.06 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.275 1.03 . . . . 10.0 113.587 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 69.21 -24.26 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.036 0.934 . . . . 10.0 113.377 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.409 ' H ' ' C ' ' A' ' 7' ' ' ALA . 33.5 m -80.73 -17.44 51.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.866 0.365 . . . . 10.0 111.189 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.903 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 1.5 m -92.09 141.75 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.26 115.03 12.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.62 -0.264 . . . . 10.0 111.028 -172.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.822 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -94.81 164.68 12.83 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.687 0.756 . . . . 10.0 112.895 177.493 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' THR . 25.8 t80 -147.5 172.66 13.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.27 -1.381 . . . . 10.0 107.27 172.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.502 ' HG3' ' HE1' ' A' ' 57' ' ' TYR . 5.7 pm0 -122.55 127.91 50.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 10.0 110.901 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 t -150.75 89.96 1.59 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.123 -0.489 . . . . 10.0 110.733 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.4 t90 55.04 80.02 0.14 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.697 -0.683 . . . . 10.0 112.229 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 58.95 24.74 12.92 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.641 -0.709 . . . . 10.0 111.629 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.36 97.3 3.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 13' ' ' PHE . 4.9 m -89.13 99.86 12.76 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.193 0.521 . . . . 10.0 109.796 173.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.822 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 4.0 p-10 -84.6 109.93 18.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.966 -1.016 . . . . 10.0 112.168 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -101.8 108.62 24.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 122.017 0.913 . . . . 10.0 109.31 174.057 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.683 ' HB3' ' HE1' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -100.28 110.55 22.79 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.802 -1.544 . . . . 10.0 110.45 178.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.903 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 20.4 t30 -80.36 155.88 26.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.066 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.03 31.1 1.46 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.181 -0.533 . . . . 10.0 111.874 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -77.2 -18.92 57.38 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.244 0.218 . . . . 10.0 111.084 -179.264 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . 88.66 -18.1 0.25 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.699 1.249 . . . . 10.0 111.322 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -120.39 158.86 26.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.001 0.429 . . . . 10.0 110.263 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 46' ' ' ILE . . . -66.4 123.61 20.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.433 -0.803 . . . . 10.0 111.002 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.667 ' H ' HG22 ' A' ' 46' ' ' ILE . 29.9 m -127.07 138.8 53.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.058 0.456 . . . . 10.0 111.09 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 9.5 m -87.26 119.48 27.55 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.395 -0.594 . . . . 10.0 109.395 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.38 153.32 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.565 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.676 HG22 ' HB2' ' A' ' 70' ' ' CYS . 0.3 OUTLIER -134.31 159.62 40.42 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 175.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.552 HG21 ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -134.33 141.78 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 120.85 0.357 . . . . 10.0 110.172 -177.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.71 119.95 39.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.619 -0.882 . . . . 10.0 108.619 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.484 ' HE1' ' HD3' ' A' ' 42' ' ' PRO . 43.3 m-85 -94.22 164.62 12.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.971 0.891 . . . . 10.0 112.323 -173.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.6 m -52.12 -28.65 18.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.974 -1.466 . . . . 10.0 112.445 172.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -110.41 -85.94 0.54 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.857 -0.337 . . . . 10.0 111.133 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.23 43.29 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.023 -1.084 . . . . 10.0 113.097 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -71.48 146.18 48.74 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.796 -0.237 . . . . 10.0 110.627 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -75.08 140.54 43.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.222 -0.658 . . . . 10.0 109.222 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.76 ' N ' ' HD2' ' A' ' 42' ' ' PRO . . . 160.71 -43.06 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 124.164 0.986 . . . . 10.0 110.804 -168.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.76 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 4.6 Cg_endo -47.65 66.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 124.894 3.729 . . . . 10.0 116.56 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.419 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER 169.33 102.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.315 1.046 . . . . 10.0 110.276 164.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -148.32 126.51 12.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.474 -0.785 . . . . 10.0 109.837 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.727 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -80.85 130.94 35.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.319 0.581 . . . . 10.0 109.796 174.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -93.41 148.63 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 114.998 -1.001 . . . . 10.0 109.283 -177.689 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -84.86 144.76 42.47 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 108.339 -0.986 . . . . 10.0 108.339 169.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -46.06 95.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.944 2.429 . . . . 10.0 112.711 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.709 ' HA2' ' O ' ' A' ' 23' ' ' ASN . . . 93.55 13.84 54.56 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 119.948 -1.12 . . . . 10.0 111.824 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.55 -174.32 32.44 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 121.446 -0.407 . . . . 10.0 112.267 -177.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.713 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 19.1 m0 -118.8 166.28 12.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.394 0.616 . . . . 10.0 111.529 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.427 ' HB2' HD12 ' A' ' 46' ' ' ILE . . . -142.92 118.69 10.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.71 -1.218 . . . . 10.0 107.71 171.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.1 m -86.58 130.6 34.43 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.663 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.552 ' CG ' HG21 ' A' ' 33' ' ' VAL . 52.6 m-85 -138.53 145.82 41.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.56 -0.904 . . . . 10.0 108.56 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.64 97.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.754 0.659 . . . . 10.0 111.157 -174.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.74 171.79 49.66 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 110.002 -1.239 . . . . 10.0 110.002 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.502 ' HE1' ' HG3' ' A' ' 14' ' ' GLN . 7.8 p90 -86.3 89.89 8.0 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.816 1.308 . . . . 10.0 111.037 -172.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.7 -75.17 0.59 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 114.872 -1.058 . . . . 10.0 111.573 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.6 t -105.14 144.47 31.9 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 72.06 -43.02 0.55 Allowed 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.009 0.818 . . . . 10.0 111.773 175.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.27 -112.92 1.21 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.045 -0.822 . . . . 10.0 111.045 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.1 m120 58.32 41.12 23.73 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 123.881 0.401 . . . . 10.0 111.496 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HB2' ' HB3' ' A' ' 57' ' ' TYR . 30.6 t80 -69.11 124.09 22.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.145 -0.479 . . . . 10.0 110.727 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 19' ' ' THR . 1.5 m -64.91 129.39 28.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 170.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.9 p -120.54 -22.9 6.24 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.994 -0.683 . . . . 10.0 111.924 -175.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -145.64 127.39 2.81 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.711 -1.233 . . . . 10.0 113.258 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.86 ' HB3' HG13 ' A' ' 6' ' ' VAL . 4.7 mt -87.71 139.18 30.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.131 0.491 . . . . 10.0 109.704 172.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.759 ' C ' HG12 ' A' ' 6' ' ' VAL . 14.6 m-70 -129.99 147.44 51.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.411 -0.813 . . . . 10.0 108.942 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -80.84 125.49 30.16 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 118.873 -1.131 . . . . 10.0 110.388 178.387 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.676 ' HB2' HG22 ' A' ' 32' ' ' THR . 38.5 t -87.61 158.75 18.79 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.361 -0.836 . . . . 10.0 109.531 -178.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -137.52 141.79 34.81 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.795 -0.817 . . . . 10.0 108.795 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -14.28 73.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 1 C-N-CA 127.343 5.362 . . . . 10.0 115.932 -176.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -171.26 71.74 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.84 -1.073 . . . . 10.0 109.501 -176.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.0 p -80.14 150.15 70.87 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.825 -0.625 . . . . 10.0 111.528 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.39 102.38 0.58 Allowed 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.57 2.18 . . . . 10.0 111.98 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.6 m 64.73 -160.92 0.28 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.376 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.41 -41.91 1.97 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.709 -0.956 . . . . 10.0 110.709 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 C--O 1.249 1.03 0 N-CA-C 108.937 -0.764 . . . . 10.0 108.937 174.404 . . . . . . . . 0 0 . 1 stop_ save_